<SEC-DOCUMENT>0001493152-22-022662.txt : 20220815
<SEC-HEADER>0001493152-22-022662.hdr.sgml : 20220815
<ACCEPTANCE-DATETIME>20220815113218
ACCESSION NUMBER:		0001493152-22-022662
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		70
CONFORMED PERIOD OF REPORT:	20220630
FILED AS OF DATE:		20220815
DATE AS OF CHANGE:		20220815

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Reliance Global Group, Inc.
		CENTRAL INDEX KEY:			0001812727
		STANDARD INDUSTRIAL CLASSIFICATION:	INSURANCE AGENTS BROKERS & SERVICES [6411]
		IRS NUMBER:				463390293
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40020
		FILM NUMBER:		221163697

	BUSINESS ADDRESS:	
		STREET 1:		300 BOULEVARD OF THE AMERICAS,
		STREET 2:		SUITE 105
		CITY:			LAKEWOOD
		STATE:			NJ
		ZIP:			08701
		BUSINESS PHONE:		732-780-4647

	MAIL ADDRESS:	
		STREET 1:		300 BOULEVARD OF THE AMERICAS,
		STREET 2:		SUITE 105
		CITY:			LAKEWOOD
		STATE:			NJ
		ZIP:			08701
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>form10-q.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:RELI="http://relianceglobalgroup.com/20220630">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_RELI_relianceglobalgroup.com_20220630 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20220101_20220630 -->
<!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0001812727 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DDocumentFiscalPeriodFocus_Q2 -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_060_Policy_0_Policy -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Agent_0_Agent -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_061_Integer_0_Integer -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityCentralIndexKey">0001812727</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:DocumentFiscalPeriodFocus">Q2</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonFraction name="RELI:ChargebackReserveCurrent" contextRef="AsOf2021-12-31" id="xdx2ixbrl0100" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:WarrantCommitmentCurrent" contextRef="AsOf2022-06-30" id="xdx2ixbrl0117" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:WarrantLiabilityNonCurrent" contextRef="AsOf2021-12-31" id="xdx2ixbrl0136" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-12-31" id="xdx2ixbrl0145" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquityNoteSubscriptionsReceivable" contextRef="AsOf2022-06-30" id="xdx2ixbrl0185" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:RecognitionAndChangeInFairValueOfWarrantLiability" contextRef="From2021-04-012021-06-30" id="xdx2ixbrl0263" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:RecognitionAndChangeInFairValueOfWarrantLiability" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0265" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0297" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0299" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0305" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0309" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0311" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0312" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-01-012022-03-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0313" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-01-012022-03-31_custom_SubscriptionReceivableMember" id="xdx2ixbrl0315" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0316" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-03-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0321" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0324" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0331" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-01-012022-03-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0333" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-01-012022-03-31_custom_SubscriptionReceivableMember" id="xdx2ixbrl0335" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0336" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0341" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2022-01-012022-03-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0343" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2022-01-012022-03-31_custom_SubscriptionReceivableMember" id="xdx2ixbrl0345" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0346" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0351" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-01-012022-03-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0353" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-01-012022-03-31_custom_SubscriptionReceivableMember" id="xdx2ixbrl0355" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0356" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-01-012022-03-31" id="xdx2ixbrl0357" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross" contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0361" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross" contextRef="From2022-01-012022-03-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0363" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross" contextRef="From2022-01-012022-03-31_custom_SubscriptionReceivableMember" id="xdx2ixbrl0365" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0366" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross" contextRef="From2022-01-012022-03-31" id="xdx2ixbrl0367" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0371" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0372" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0373" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0374" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_custom_SubscriptionReceivableMember" id="xdx2ixbrl0375" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0381" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_custom_SubscriptionReceivableMember" id="xdx2ixbrl0383" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0391" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-04-012022-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0393" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0394" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-04-012022-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0395" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-04-012022-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0397" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0398" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueWarrantsIntoCommonStock" contextRef="From2022-04-012022-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0401" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueWarrantsIntoCommonStock" contextRef="From2022-04-012022-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0403" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueWarrantsIntoCommonStock" contextRef="From2022-04-012022-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0405" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueWarrantsIntoCommonStock" contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0406" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0411" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0412" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0413" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0414" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0415" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0421" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0423" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0431" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_custom_SubscriptionReceivableMember" id="xdx2ixbrl0437" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0447" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0448" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0449" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0452" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0455" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0457" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0460" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0465" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0467" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0470" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueOverAllotmentShares" contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0477" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueOverAllotmentShares" contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0479" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueOverAllotmentShares" contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0482" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0489" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0491" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0494" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0499" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0502" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-01-012021-03-31" id="xdx2ixbrl0503" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:SharesIssuedDuringPeriodValueToConversionOfDebt" contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0509" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:SharesIssuedDuringPeriodValueToConversionOfDebt" contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0511" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:SharesIssuedDuringPeriodValueToConversionOfDebt" contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0514" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueInitialPublicOffering" contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0519" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueInitialPublicOffering" contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0520" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueInitialPublicOffering" contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0521" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueInitialPublicOffering" contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0522" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueInitialPublicOffering" contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0524" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueInitialPublicOffering" contextRef="From2021-01-012021-03-31" id="xdx2ixbrl0525" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets" contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0531" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets" contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0536" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets" contextRef="From2021-01-012021-03-31" id="xdx2ixbrl0537" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0543" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0544" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0545" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0546" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-03-31_custom_SubscriptionReceivableMember" id="xdx2ixbrl0547" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0553" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_custom_SubscriptionReceivableMember" id="xdx2ixbrl0555" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-03-31_custom_CommonStockIssuableMember" id="xdx2ixbrl0563" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2021-04-012021-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0565" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0566" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2021-04-012021-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0567" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0570" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueInitialPublicOffering" contextRef="From2021-04-012021-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0573" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueInitialPublicOffering" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0574" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueInitialPublicOffering" contextRef="From2021-04-012021-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0575" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueInitialPublicOffering" contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0576" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueInitialPublicOffering" contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0578" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:StockIssuedDuringPeriodValueInitialPublicOffering" contextRef="From2021-04-012021-06-30" id="xdx2ixbrl0579" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-04-012021-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0583" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-04-012021-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0585" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0588" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0593" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0594" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0595" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0596" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0597" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0603" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_custom_SubscriptionReceivableMember" id="xdx2ixbrl0605" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_custom_CommonStockIssuableMember" id="xdx2ixbrl0613" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:EarnoutFairValueAndWriteoffAdjustments" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0637" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:RecognitionAndChangeInFairValueOfWarrantLiability" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0640" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0655" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInRestructuringReserve" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0658" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0673" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ProceedsFromLoanForBusinessAcquisition" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0691" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0694" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:PaymentsOnEarnoutLiabilities" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0697" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl0699" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0706" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0712" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl0714" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:IssuanceOfSeriesDWarrants" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0733" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:IssuanceOfPlacementAgentWarrants" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0736" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:PrepaidInsuranceAcquiredThroughShorttermFinancing" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0739" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConversionOfStockAmountConverted1" contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl0741" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl0747" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl0753" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:IssuanceOfCommonStockPursuantToPurchaseOfSoftware" contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl0756" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:WarrantCommitment" contextRef="AsOf2021-12-31_custom_SeriesBWarrantLiabilityMember" id="xdx2ixbrl0829" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:WarrantCommitment" contextRef="AsOf2021-12-31_custom_PlacementAgentWarrantsMember" id="xdx2ixbrl0830" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:InitialRecognitionOfWarrantCommitment" contextRef="From2022-01-012022-03-31_custom_SeriesBWarrantCommitmentMember" id="xdx2ixbrl0833" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:WarrantCommitment" contextRef="AsOf2022-03-31_custom_SeriesBWarrantCommitmentMember" id="xdx2ixbrl0848" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:WarrantCommitmentUnrealizedGainLoss" contextRef="From2022-04-012022-06-30_custom_SeriesBWarrantCommitmentMember" id="xdx2ixbrl0853" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:WarrantCommitment" contextRef="AsOf2022-06-30_custom_SeriesBWarrantCommitmentMember" id="xdx2ixbrl0858" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:WarrantCommitment" contextRef="AsOf2020-12-31_custom_SeriesBWarrantCommitmentMember" id="xdx2ixbrl0863" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:WarrantCommitment" contextRef="AsOf2020-12-31" id="xdx2ixbrl0864" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:AcquisitionsAndSettlements" contextRef="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_JPKushAcquisitionMember" id="xdx2ixbrl0911" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:AcquisitionsAndSettlements" contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_custom_BarraAcquisitionMember" id="xdx2ixbrl0915" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:AcquisitionsAndSettlements" contextRef="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_CCSWriteoffMember" id="xdx2ixbrl0917" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:AcquisitionsAndSettlements" contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_custom_MontanaFinalSettlementMember" id="xdx2ixbrl0924" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember" id="xdx2ixbrl0946" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember" id="xdx2ixbrl0950" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember" id="xdx2ixbrl0953" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember" id="xdx2ixbrl0958" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember" id="xdx2ixbrl0966" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_KushMember" id="xdx2ixbrl0970" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_MedigapMember" id="xdx2ixbrl0974" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember" id="xdx2ixbrl0988" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember" id="xdx2ixbrl0992" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember" id="xdx2ixbrl0995" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember" id="xdx2ixbrl1000" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember" id="xdx2ixbrl1008" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_KushMember" id="xdx2ixbrl1012" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_MedigapMember" id="xdx2ixbrl1016" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember" id="xdx2ixbrl1030" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember" id="xdx2ixbrl1034" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember" id="xdx2ixbrl1037" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember" id="xdx2ixbrl1042" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember" id="xdx2ixbrl1050" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_KushMember" id="xdx2ixbrl1054" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember" id="xdx2ixbrl1064" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember" id="xdx2ixbrl1068" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember" id="xdx2ixbrl1071" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember" id="xdx2ixbrl1076" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember" id="xdx2ixbrl1084" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_KushMember" id="xdx2ixbrl1088" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_LTCGlobalMember" id="xdx2ixbrl1100" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-04-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_BlueCrossBlueShieldMember" id="xdx2ixbrl1105" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_LTCGlobalMember" id="xdx2ixbrl1115" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_PurchasedSoftwareMember" id="xdx2ixbrl1354" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" xs:nil="true"></ix:nonNumeric>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-06-30_custom_PurchasedSoftwareMember" id="xdx2ixbrl1360" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31_custom_VideoProductionAssetsMember" id="xdx2ixbrl1428" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_custom_BarraMember" id="xdx2ixbrl1512" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:DeemedDividend" contextRef="From2022-04-012022-06-30" id="xdx2ixbrl1724" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:DeemedDividend" contextRef="From2021-04-012021-06-30" id="xdx2ixbrl1725" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2021-04-012021-06-30" id="xdx2ixbrl1731" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="From2021-04-012021-06-30" id="xdx2ixbrl1740" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2021-04-012021-06-30" id="xdx2ixbrl1746" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:DeemedDividend" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl1761" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl1767" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl1776" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:EffectOfSeriesBWarrantLiability" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl1779" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl1782" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2021-12-31_custom_CommercialSolutionsOfInsuranceAgencyLLCMember" id="xdx2ixbrl1831" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2021-12-31_custom_BarraMember" id="xdx2ixbrl1836" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ChangesDueToAcquisitions" contextRef="From2022-01-012022-06-30_custom_CommercialSolutionsOfInsuranceAgencyLLCMember" id="xdx2ixbrl1839" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ChangesDueToAcquisitions" contextRef="From2022-01-012022-06-30_custom_FortmanInsuranceAgencyLLCMember" id="xdx2ixbrl1840" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ChangesDueToAcquisitions" contextRef="From2022-01-012022-06-30_custom_SouthwesternMontanaInsuranceCenterIncMember" id="xdx2ixbrl1841" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ChangesDueToAcquisitions" contextRef="From2022-01-012022-06-30_custom_AltruisBenefitsConsultantsIncMember" id="xdx2ixbrl1842" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ChangesDueToAcquisitions" contextRef="From2022-01-012022-06-30_custom_JPKushAndAssociatesIncMember" id="xdx2ixbrl1843" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ChangesDueToFairValueAdjustments" contextRef="From2022-01-012022-06-30_custom_CommercialSolutionsOfInsuranceAgencyLLCMember" id="xdx2ixbrl1855" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ChangesDueToFairValueAdjustments" contextRef="From2022-01-012022-06-30_custom_AltruisBenefitsConsultantsIncMember" id="xdx2ixbrl1858" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2022-06-30_custom_CommercialSolutionsOfInsuranceAgencyLLCMember" id="xdx2ixbrl1863" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2020-12-31_custom_JPKushAndAssociatesIncMember" id="xdx2ixbrl1875" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ChangesDueToBusinessCombinations" contextRef="From2021-01-012021-12-31_custom_CommercialSolutionsOfInsuranceAgencyLLCMember" id="xdx2ixbrl1878" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ChangesDueToBusinessCombinations" contextRef="From2021-01-012021-12-31_custom_FortmanInsuranceAgencyLLCMember" id="xdx2ixbrl1879" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ChangesDueToBusinessCombinations" contextRef="From2021-01-012021-12-31_custom_SouthwesternMontanaInsuranceCenterIncMember" id="xdx2ixbrl1880" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ChangesDueToBusinessCombinations" contextRef="From2021-01-012021-12-31_custom_AltruisBenefitsConsultantsIncMember" id="xdx2ixbrl1881" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ChangesDueToPayments" contextRef="From2021-01-012021-12-31_custom_CommercialSolutionsOfInsuranceAgencyLLCMember" id="xdx2ixbrl1885" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ChangesDueToPayments" contextRef="From2021-01-012021-12-31_custom_FortmanInsuranceAgencyLLCMember" id="xdx2ixbrl1886" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ChangesDueToPayments" contextRef="From2021-01-012021-12-31_custom_SouthwesternMontanaInsuranceCenterIncMember" id="xdx2ixbrl1887" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ChangesDueToPayments" contextRef="From2021-01-012021-12-31_custom_JPKushAndAssociatesIncMember" id="xdx2ixbrl1889" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ChangesDueToFairValueAdjustments" contextRef="From2021-01-012021-12-31_custom_CommercialSolutionsOfInsuranceAgencyLLCMember" id="xdx2ixbrl1892" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ChangesDueToWriteoffs" contextRef="From2021-01-012021-12-31_custom_FortmanInsuranceAgencyLLCMember" id="xdx2ixbrl1900" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ChangesDueToWriteoffs" contextRef="From2021-01-012021-12-31_custom_SouthwesternMontanaInsuranceCenterIncMember" id="xdx2ixbrl1901" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ChangesDueToWriteoffs" contextRef="From2021-01-012021-12-31_custom_AltruisBenefitsConsultantsIncMember" id="xdx2ixbrl1902" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="RELI:ChangesDueToWriteoffs" contextRef="From2021-01-012021-12-31_custom_JPKushAndAssociatesIncMember" id="xdx2ixbrl1903" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2021-12-31_custom_CommercialSolutionsOfInsuranceAgencyLLCMember" id="xdx2ixbrl1906" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="reli-20220630.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-01-01to2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-08-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-08-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CommonStockIssuableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:CommonStockIssuableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_CommonStockIssuableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:CommonStockIssuableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CommonStockIssuableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:CommonStockIssuableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_CommonStockIssuableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:CommonStockIssuableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_CommonStockIssuableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:CommonStockIssuableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_CommonStockIssuableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:CommonStockIssuableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_custom_CommonStockIssuableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:CommonStockIssuableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_CommonStockIssuableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:CommonStockIssuableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_CommonStockIssuableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:CommonStockIssuableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_CommonStockIssuableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:CommonStockIssuableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_SubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-03-31_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-01-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RELI:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_MeasurementInputSharePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_MeasurementInputSharePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_MeasurementInputExpectedTermMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_MeasurementInputExpectedTermMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SeriesBWarrantCommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantCommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SeriesBWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PlacementAgentWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:PlacementAgentWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_SeriesBWarrantCommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantCommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_SeriesBWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PlacementAgentWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:PlacementAgentWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_SeriesBWarrantCommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantCommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_SeriesBWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_PlacementAgentWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:PlacementAgentWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_SeriesBWarrantCommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantCommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_SeriesBWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_PlacementAgentWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:PlacementAgentWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_SeriesBWarrantCommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantCommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_SeriesBWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_PlacementAgentWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:PlacementAgentWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SeriesBWarrantCommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantCommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SeriesBWarrantCommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantCommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_MeasurementInputRiskPremiumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">RELI:MeasurementInputRiskPremiumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_MeasurementInputCreditSpreadMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputCreditSpreadMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_MeasurementInputPaymentDelayMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">RELI:MeasurementInputPaymentDelayMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_JPKushAcquisitionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:JPKushAcquisitionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_custom_JPKushAcquisitionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:JPKushAcquisitionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_BarraAcquisitionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraAcquisitionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_custom_BarraAcquisitionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraAcquisitionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_CCSWriteoffMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:CCSWriteoffMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_custom_CCSWriteoffMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:CCSWriteoffMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_AltruisPartialSettlementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:AltruisPartialSettlementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_custom_AltruisPartialSettlementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:AltruisPartialSettlementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_MontanaFinalSettlementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MontanaFinalSettlementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_custom_MontanaFinalSettlementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MontanaFinalSettlementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_EmployeeBenefitsSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_USBenefitsAllianceLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_CommercialCoverageSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_SouthwesternMontanaFinancialCenterIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_FortmanInsuranceServicesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_AltruisBenefitsConsultingIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_KushMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_KushMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_KushMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_MedigapMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:MedigapMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_MedigapMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:MedigapMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_MedigapMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:MedigapMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_BarraMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:BarraMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_BarraMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:BarraMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_BarraMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:BarraMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_PropertyAndCasualtyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_EmployeeBenefitsSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_USBenefitsAllianceLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_CommercialCoverageSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_SouthwesternMontanaFinancialCenterIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_FortmanInsuranceServicesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_AltruisBenefitsConsultingIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_KushMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_KushMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_KushMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_MedigapMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:MedigapMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_MedigapMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:MedigapMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_MedigapMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:MedigapMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_BarraMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:BarraMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_BarraMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:BarraMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_BarraMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:BarraMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_PropertyAndCasualtyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_EmployeeBenefitsSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_USBenefitsAllianceLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_CommercialCoverageSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_SouthwesternMontanaFinancialCenterIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_FortmanInsuranceServicesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_AltruisBenefitsConsultingIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_KushMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_KushMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_KushMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_PropertyAndCasualtyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_EmployeeBenefitsSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_USBenefitsAllianceLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_CommercialCoverageSolutionsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_SouthwesternMontanaFinancialCenterIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_FortmanInsuranceServicesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_AltruisBenefitsConsultingIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_KushMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_KushMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_KushMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_PropertyAndCasualtyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_LTCGlobalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:LTCGlobalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_LTCGlobalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:LTCGlobalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_PriorityHealthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:PriorityHealthMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_PriorityHealthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:PriorityHealthMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_BlueCrossBlueShieldMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:BlueCrossBlueShieldMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_BlueCrossBlueShieldMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:BlueCrossBlueShieldMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_BlueCrossBlueShieldMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:BlueCrossBlueShieldMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_BlueCrossBlueShieldMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:BlueCrossBlueShieldMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_PriorityHealthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:PriorityHealthMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_PriorityHealthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:PriorityHealthMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_LTCGlobalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:LTCGlobalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_LTCGlobalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:LTCGlobalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_srt_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_srt_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-082022-01-10_custom_MedigapHealthcareInsuranceCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-08</xbrli:startDate>
        <xbrli:endDate>2022-01-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_MeasurementInputRoyaltyRateMember_us-gaap_TradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">RELI:MeasurementInputRoyaltyRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_us-gaap_TradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_MeasurementInputObsolescenceRateMember_us-gaap_TechnologyBasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">RELI:MeasurementInputObsolescenceRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_custom_BackLogMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:BackLogMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-252022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:APAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">RELI:BarraAndAssociatesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-25</xbrli:startDate>
        <xbrli:endDate>2022-04-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-252022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember_custom_PaidAtClosingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:APAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">RELI:BarraAndAssociatesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RELI:PaidAtClosingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-25</xbrli:startDate>
        <xbrli:endDate>2022-04-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-252022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember_custom_PayableInSixMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:APAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">RELI:BarraAndAssociatesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RELI:PayableInSixMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-25</xbrli:startDate>
        <xbrli:endDate>2022-04-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-252022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember_custom_PayableOverTwoYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:APAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">RELI:BarraAndAssociatesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RELI:PayableOverTwoYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-25</xbrli:startDate>
        <xbrli:endDate>2022-04-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:APAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">RELI:BarraAndAssociatesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_us-gaap_TradeNamesMember_custom_BarraMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_us-gaap_CustomerRelationshipsMember_custom_BarraMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_custom_DevelopedTechnologyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:DevelopedTechnologyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_BarraMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_BarraMember168706375">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_PropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_PropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_custom_RightOfUseAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:RightOfUseAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_TradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_TradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_TechnologyBasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_TechnologyBasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_custom_BackLogMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:BackLogMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_custom_BackLogMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:BackLogMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_custom_ChargebackReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:ChargebackReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_custom_LeaseLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:LeaseLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_BarraMember_custom_AcquiredAccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:AcquiredAccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_BarraMember_us-gaap_PropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_BarraMember_us-gaap_PropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_BarraMember_custom_RightOfUseAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:RightOfUseAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_BarraMember_us-gaap_TradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_BarraMember_us-gaap_TradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_BarraMember_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_BarraMember_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_BarraMember_custom_AgencyRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:AgencyRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_BarraMember_custom_AgencyRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:AgencyRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_BarraMember_custom_DevelopedTechnologyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:DevelopedTechnologyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_BarraMember_custom_DevelopedTechnologyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:DevelopedTechnologyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_BarraMember_custom_LeaseLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:LeaseLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_BarraMember_us-gaap_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_BarraMember_us-gaap_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_MedigapHealthcareInsuranceCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_BarraMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_TrademarksAndTradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_TrademarksAndTradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_InternallyDevelopedSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:InternallyDevelopedSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_InternallyDevelopedSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:InternallyDevelopedSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_PurchasedSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:PurchasedSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_PurchasedSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:PurchasedSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_VideoProductionAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:VideoProductionAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_VideoProductionAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:VideoProductionAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_NoncompetitionAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:NoncompetitionAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_NoncompetitionAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:NoncompetitionAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_ContractsBacklogMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:ContractsBacklogMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ContractsBacklogMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:ContractsBacklogMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_TrademarksAndTradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_TrademarksAndTradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_InternallyDevelopedSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:InternallyDevelopedSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_InternallyDevelopedSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:InternallyDevelopedSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_PurchasedSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:PurchasedSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PurchasedSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:PurchasedSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_VideoProductionAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:VideoProductionAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_VideoProductionAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:VideoProductionAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_NoncompetitionAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:NoncompetitionAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_NoncompetitionAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:NoncompetitionAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_EBSandUSBAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:EBSandUSBAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_EBSandUSBAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:EBSandUSBAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_CCSMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">RELI:CCSMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CCSMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">RELI:CCSMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_SWMTMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:SWMTMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SWMTMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:SWMTMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_FISMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:FISMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_FISMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:FISMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ABCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:ABCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ABCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:ABCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_BarraMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_DirectorsAndOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RELI:DirectorsAndOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_DirectorsAndOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RELI:DirectorsAndOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_DirectorsAndOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RELI:DirectorsAndOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_DirectorsAndOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RELI:DirectorsAndOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-22_us-gaap_CommonStockMember_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-22_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-22_us-gaap_CommonStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-222021-12-23_us-gaap_CommonStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-22</xbrli:startDate>
        <xbrli:endDate>2021-12-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-222021-12-23_custom_SeriesBConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-22</xbrli:startDate>
        <xbrli:endDate>2021-12-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-22_custom_SeriesBConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-05_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-042022-01-05_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-04</xbrli:startDate>
        <xbrli:endDate>2022-01-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_SeriesBConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-01-31_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-01-31_custom_MedigapAcquisitionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapAcquisitionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-01-31_custom_SeriesAWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SeriesAWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_SeriesAWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SeriesAWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-01-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012022-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-05-31_custom_SeriesCPrepaidWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesCPrepaidWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_SeriesCPrepaidWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesCPrepaidWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-05-31_custom_SeriesCPrepaidWarrantsMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesCPrepaidWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_SeriesCPrepaidWarrantsMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesCPrepaidWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_SeriesAWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SeriesAWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_SeriesCPrepaidWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesCPrepaidWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_SeriesCPrepaidWarrantsMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesCPrepaidWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-31_custom_SeriesDPrepaidWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesDPrepaidWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-05-01_custom_SeriesCPrepaidWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesCPrepaidWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-05-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_SeriesCPrepaidWarrantsMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesCPrepaidWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_ThreeEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RELI:ThreeEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_ThreeEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RELI:ThreeEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_CommonStockMember168711000">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_SeriesBWarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_SeriesCPrepaidWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesCPrepaidWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_SeriesCPrepaidWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesCPrepaidWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_SeriesDPrepaidWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesDPrepaidWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_custom_SeriesDPrepaidWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesDPrepaidWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CommercialSolutionsOfInsuranceAgencyLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:CommercialSolutionsOfInsuranceAgencyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_FortmanInsuranceAgencyLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:FortmanInsuranceAgencyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SouthwesternMontanaInsuranceCenterIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:SouthwesternMontanaInsuranceCenterIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_AltruisBenefitsConsultantsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:AltruisBenefitsConsultantsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_JPKushAndAssociatesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:JPKushAndAssociatesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_CommercialSolutionsOfInsuranceAgencyLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:CommercialSolutionsOfInsuranceAgencyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_FortmanInsuranceAgencyLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:FortmanInsuranceAgencyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_SouthwesternMontanaInsuranceCenterIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:SouthwesternMontanaInsuranceCenterIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_AltruisBenefitsConsultantsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:AltruisBenefitsConsultantsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_JPKushAndAssociatesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:JPKushAndAssociatesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_CommercialSolutionsOfInsuranceAgencyLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:CommercialSolutionsOfInsuranceAgencyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_FortmanInsuranceAgencyLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:FortmanInsuranceAgencyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_SouthwesternMontanaInsuranceCenterIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:SouthwesternMontanaInsuranceCenterIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_AltruisBenefitsConsultantsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:AltruisBenefitsConsultantsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_JPKushAndAssociatesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:JPKushAndAssociatesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CommercialSolutionsOfInsuranceAgencyLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:CommercialSolutionsOfInsuranceAgencyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_FortmanInsuranceAgencyLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:FortmanInsuranceAgencyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SouthwesternMontanaInsuranceCenterIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:SouthwesternMontanaInsuranceCenterIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AltruisBenefitsConsultantsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:AltruisBenefitsConsultantsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_JPKushAndAssociatesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:JPKushAndAssociatesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_CommercialSolutionsOfInsuranceAgencyLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:CommercialSolutionsOfInsuranceAgencyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_FortmanInsuranceAgencyLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:FortmanInsuranceAgencyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SouthwesternMontanaInsuranceCenterIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:SouthwesternMontanaInsuranceCenterIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_AltruisBenefitsConsultantsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:AltruisBenefitsConsultantsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_JPKushAndAssociatesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001812727</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:JPKushAndAssociatesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Policy">
      <xbrli:measure>RELI:Policy</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Agent">
      <xbrli:measure>RELI:Agent</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Integer">
      <xbrli:measure>RELI:Integer</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000926" toRefs="Footnote000939"></ix:relationship>
  <ix:relationship fromRefs="Fact000927" toRefs="Footnote000939"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_902_edei--DocumentType_c20220101__20220630_zB8bIEflfTR7"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:DocumentType">10-Q</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--DocumentQuarterlyReport_c20220101__20220630_zdWeqfz365wb"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt:booleantrue" name="dei:DocumentQuarterlyReport">&#9746;</ix:nonNumeric></span>
<b>QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the quarterly period ended <span id="xdx_901_edei--DocumentPeriodEndDate_c20220101__20220630_zeJvoNRDzFZk"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">June 30, <span id="xdx_900_edei--DocumentFiscalYearFocus_c20220101__20220630_zrbjOLO11YSe"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric></span></ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: center; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--DocumentTransitionReport_c20220101__20220630_zZLy4Qz9q3v9"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span>
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: center; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the transition period from _____ to _____</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
file number of the issuing entity: <span id="xdx_904_edei--EntityFileNumber_c20220101__20220630_ze2eehcqr3P7"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityFileNumber">001-40020</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_906_edei--EntityRegistrantName_c20220101__20220630_zIigfezbzbk8"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityRegistrantName">RELIANCE
GLOBAL GROUP, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20220101__20220630_zrbzLQxo7RBd"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Florida</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--EntityTaxIdentificationNumber_c20220101__20220630_z0KN91URyln3"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityTaxIdentificationNumber">46-3390293</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation or organization)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    Number)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">524210&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Primary
Standard Industrial Code Classification Number)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityAddressAddressLine1_c20220101__20220630_zLk3jXGxc5Q8"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityAddressAddressLine1">300
Blvd. of the Americas</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressAddressLine2_c20220101__20220630_zRaqcXM2CCMj"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityAddressAddressLine2">Suite 105</ix:nonNumeric></span> <span id="xdx_906_edei--EntityAddressCityOrTown_c20220101__20220630_zLJ3dTUg6DU1"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityAddressCityOrTown">Lakewood</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressStateOrProvince_c20220101__20220630_zhhw2uG5FlA9"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityAddressStateOrProvince">NJ</ix:nonNumeric></span> <span id="xdx_900_edei--EntityAddressPostalZipCode_c20220101__20220630_zWVV96dGVTc"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityAddressPostalZipCode">08701</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--CityAreaCode_c20220101__20220630_zPS2SnmRLoxk"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:CityAreaCode">732</ix:nonNumeric></span>-<span id="xdx_907_edei--LocalPhoneNumber_c20220101__20220630_zjkNqPwPV1w9"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:LocalPhoneNumber">380-4600</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address,
including zip code, and telephone number, including area code of registrant&#8217;s principal executive offices)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--Security12bTitle_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--CommonStockMember_z40bvQ49jvLg"><ix:nonNumeric contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember" name="dei:Security12bTitle">Common
    Stock</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--TradingSymbol_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--CommonStockMember_z5Wn638YlE3f"><ix:nonNumeric contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember" name="dei:TradingSymbol">RELI</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span id="xdx_907_edei--SecurityExchangeName_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--CommonStockMember_zo9jqsSDD0nb"><ix:nonNumeric contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--Security12bTitle_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zLldeWODQdF7"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_SeriesAWarrantsMember" name="dei:Security12bTitle">Series
    A Warrants</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--TradingSymbol_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zWlxaEPp6JZf"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_SeriesAWarrantsMember" name="dei:TradingSymbol">RELIW</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--SecurityExchangeName_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesAWarrantsMember_zdkrzwNB5s9h"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_SeriesAWarrantsMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span>
    Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntityCurrentReportingStatus_c20220101__20220630_zZEdWRSywkr1"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span>:
&#9746; No: &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--EntityInteractiveDataCurrent_c20220101__20220630_zFciwA3kPyC8"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span>:
&#9746; No: &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller reporting company,&#8221; and &#8220;emerging growth company, in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer &#9744;</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer &#9744;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityFilerCategory_c20220101__20220630_zghU5DyxFST9"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated
    filer</ix:nonNumeric></span> &#9746;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company <span id="xdx_90A_edei--EntitySmallBusiness_c20220101__20220630_zH9tjA9BNVk3"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    Growth Company <span id="xdx_907_edei--EntityEmergingGrowthCompany_c20220101__20220630_z5d0iYlkzwei"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the Act).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes:
&#9744; <span id="xdx_90E_edei--EntityShellCompany_c20220101__20220630_zeEScIJABqt8"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt:booleanfalse" name="dei:EntityShellCompany">No:</ix:nonNumeric></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
August 15, 2022 the registrant had <span><span id="xdx_907_edei--EntityCommonStockSharesOutstanding_iI_c20220815_zq4dgfQ8YOKd"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2022-08-15" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,457,075</ix:nonFraction></span></span> shares of common stock, par value $0.086 per share, outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt; border-bottom: Black 4pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
    I</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#F1_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1. Financial Statements</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#F1_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#F1_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 3. Quantitative and Qualitative Disclosures About Market Risk.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#F1_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 4. Controls and Procedures.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#F1_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART II</b></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#F1_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1. Legal Proceedings.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#F1_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1A. Risk Factors.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#F1_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#F1_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 3. Defaults Upon Senior Securities.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#F1_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 4. Mine Safety Disclosures.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#F1_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 5. Other Information.</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#F1_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 6. Exhibits</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reliance
Global Group, Inc. and Subsidiaries</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F1_001"></span>Condensed
Consolidated Balance Sheets</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_111_zYt3b9HRfWTb" summary="xdx: Statement - Condensed Consolidated Balance Sheets (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20220630_zYWRvvOFQIfg" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20211231_z5mz5GHY7Gef" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AssetsAbstract_iB_zaTdBAIM6Llk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AssetsCurrentAbstract_i01B_zIqqJ5Gz0Mtk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--Cash_i02I_maCzd6I_z92UqmCnrkqb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,979,769</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,136,180</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RestrictedCashCurrent_i02I_maCzd6I_zyiWgf5Fkls2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Restricted cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RestrictedCashCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,417,635</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RestrictedCashCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">484,542</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AccountsReceivableNetCurrent_i02I_maCzd6I_zvi4tdZF6WH5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,072,294</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,024,831</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AccountsReceivableRelatedPartiesCurrent_i02I_maCzd6I_z8MGkeNwT2G2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts receivable, related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableRelatedPartiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,414</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableRelatedPartiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,131</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_maCzd6I_z3DJ1g7F6zd1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Prepaid expense and other current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">576,691</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,328,817</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsCurrent_i02TI_mtCzd6I_maCzeIS_zCTN9fYQYj71" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,100,803</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,981,501</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maCzeIS_zDlq96EavcBg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">164,017</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">130,359</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_maCzeIS_zmxhSIkKcX4h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,421,474</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,067,734</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--Investments_i01I_maCzeIS_zR9Ug2GiSzK7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Investment in NSURE, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Investments" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,350,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Investments" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,350,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i01I_maCzeIS_zClpnLjueod7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Intangibles, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,751,751</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,078,900</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Goodwill_i01I_maCzeIS_zXDAGoBNh4Z" style="vertical-align: bottom; background-color: White">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,486,107</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,050,277</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OtherAssetsNoncurrent_i01I_maCzeIS_z6k8cjL5En03" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Other non-current assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,284</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,792</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Assets_i01TI_mtCzeIS_zD0sI5Ndywdb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,297,436</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,675,563</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Liabilities and stockholders&#8217; equity (deficit)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesCurrentAbstract_i01B_zJjDMAFRg178" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_i02I_maCzRbd_zCGQ6Qdinbge" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts payable and other accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,051,333</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,759,160</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--ChargebackReserveCurrent_i02I_maCzRbd_zwpqOACTpst8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Chargeback reserve</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:ChargebackReserveCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,559,541</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0100">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AccountsPayableOtherCurrent_i02I_maCzRbd_zscc3KoVlefe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableOtherCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,333,484</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableOtherCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">81,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--ShortTermFinancingAgreements_i02I_maCzRbd_zWz3s04v8kLd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Short term Financing Agreements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:ShortTermFinancingAgreements" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">376,647</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LongTermDebtCurrent_i02I_maCzRbd_zAZaHYnUDUF5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current portion of long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">936,263</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">913,920</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_maCzRbd_zoXX8F5KxlI2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current portion of leases payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">528,902</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">276,009</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--BusinessCombinationContingentConsiderationLiabilityCurrent_i02I_maCzRbd_ztKfliIDAuQj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Earn-out liability, current portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,683,596</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,297,855</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--WarrantCommitmentCurrent_i02I_maCzRbd_zt7A7NSm0rKk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Warrant commitment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0117">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="RELI:WarrantCommitmentCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,652,808</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesCurrent_i02TI_mtCzRbd_maCzUwf_zCS9rbl4gp6b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,469,766</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,981,252</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DueToRelatedPartiesNoncurrent_i01I_maCzUwf_zZBzngTE5gKl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loans payable, related parties, less current portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">332,225</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DueToRelatedPartiesNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">353,766</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LongTermDebtNoncurrent_i01I_maCzUwf_zbG2dB7blRW" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Long term debt, less current portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,935,649</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,085,325</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_maCzUwf_zYx33misMcu4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Leases payable, less current portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">930,623</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">805,326</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationContingentConsiderationLiabilityNoncurrent_i01I_maCzUwf_zY0cFDo6fUXc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Earn-out liability, less current portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">673,837</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">516,023</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--WarrantLiabilityNonCurrent_i01I_maCzUwf_z2mwmyUdQMGk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="RELI:WarrantLiabilityNonCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,026,893</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0136">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Liabilities_i01TI_mtCzUwf_maLASEzWjO_znsjpWzukJVd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,368,993</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,741,692</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--StockholdersEquityAbstract_i01B_zGF7JP3fIWlh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stockholders&#8217; equity (deficit):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--PreferredStockValue_i02I_maSEzdnY_z6hSN0vmBGae" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Preferred stock, $<span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20220630_zww14zEVKYt1" title="Preferred stock, par value"><span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20211231_zxjm52UX0R2k" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.086</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20220630_z08u7m8AP1Si" title="Preferred stock, shares authorized"><span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20211231_zCMN8dcxUnSa" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">750,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized and <span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_iI_c20220630_zJSSQ3oWLgx1" title="Preferred stock, shares issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_c20220630_zF169S86lXOl" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,076</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_c20211231_zD4cmsnqmWM7" title="Preferred stock, shares issued"><span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_iI_c20211231_zdQcccOa986f" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></ix:nonFraction></span></span> issued and outstanding as of June 30, 2022 and December 31, 2021, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">781</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0145">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CommonStockValue_i02I_maSEzdnY_zRRZrS8MhBx6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock, $<span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220630_zTbpfI7LVoxe" title="Common Stock, Par or Stated Value Per Share"><span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231_z2r9fqy0fqM" title="Common Stock, Par or Stated Value Per Share"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.086</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_c20220630_zWOcgK4YEftf" title="Common Stock, Shares Authorized"><span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_c20211231_zHhUvE0Arv6f" title="Common Stock, Shares Authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized and <span id="xdx_906_eus-gaap--CommonStockSharesIssued_iI_c20220630_zjAUbIvxvBSi" title="Common Stock, Shares, Issued"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_c20220630_zG2c1fBeyfFk" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,614,038</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_c20211231_zIkAjDYiGRgc" title="Common Stock, Shares, Issued"><span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_c20211231_zGUkd4NySEN5" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,956,109</ix:nonFraction></ix:nonFraction></span></span> issued and outstanding as of June 30, 2022 and December 31, 2021, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,255,408</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">940,829</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AdditionalPaidInCapital_i02I_maSEzdnY_ze7it1TA549h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,294,708</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,451,187</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--StockholdersEquityNoteSubscriptionsReceivable_i02NI_di_msSEzdnY_zwei5SayA10g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock subscription receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0185">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityNoteSubscriptionsReceivable" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,000,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzdnY_zREZIeodIcqc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">13,622,454</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">33,458,145</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--StockholdersEquity_i02TI_mtSEzdnY_maLASEzWjO_zHYyLNniPPpa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total stockholders&#8217; equity (deficit)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,928,443</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">26,066,129</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzWjO_z2fb0tmaBau2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders&#8217; equity (deficit)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,297,436</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,675,563</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these condensed consolidated financial statements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reliance
Global Group, Inc. and Subsidiaries</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed
Consolidated Statements of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_306_113_zefXDFzac9ua" summary="xdx: Statement - Condensed Consolidated Statements of Operations (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_490_20220401__20220630_zs5T6U9t241k" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20210401__20210630_zsaxl5ZpSS0b" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20220101__20220630_z99phJBBzGqb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20210101__20210630_zRm53SzmSTV9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three months ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six months ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenuesAbstract_iB_zItf8Rf1T8Gc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Revenue</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_405_ecustom--CommissionIncome_i01_maCz9UL_zkqM8rnFXLma" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 44%; text-align: left; padding-bottom: 1.5pt">Commission income</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><ix:nonFraction name="RELI:CommissionIncome" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,207,126</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><ix:nonFraction name="RELI:CommissionIncome" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,190,847</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><ix:nonFraction name="RELI:CommissionIncome" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,442,907</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: right"><ix:nonFraction name="RELI:CommissionIncome" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,514,577</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--Revenues_i01T_mtCz9UL_maCzP43_zNxsvLHRF5dc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,207,126</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,190,847</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,442,907</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,514,577</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingExpensesAbstract_iB_z46uvf51P7D3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--CommissionExpense_i01_maCzabx_zihtkme1O11" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Commission expense</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="RELI:CommissionExpense" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">850,128</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="RELI:CommissionExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">558,271</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="RELI:CommissionExpense" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,754,283</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="RELI:CommissionExpense" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,087,743</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--SalariesAndWages_i01_maCzabx_z8KN4rpgxMN" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Salaries and wages</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,176,792</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,110,629</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,258,967</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,029,174</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--GeneralAndAdministrativeExpense_i01_maCzabx_zeLqiN7OImMg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">General and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,759,217</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,202,350</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,212,287</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,206,751</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--MarketingAndAdvertisingExpense_i01_maCzabx_zUPyTsUEJfFg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Marketing and advertising</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">609,383</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,021</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,196,405</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">78,100</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DepreciationAndAmortization_i01_maCzabx_zIe3a7Qq65Me" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Depreciation and amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">756,403</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">369,366</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,363,928</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">702,454</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingExpenses_i01T_mtCzabx_msCzP43_zva7sETBkz9h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,151,923</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,295,637</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,785,870</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,104,222</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingIncomeLoss_iT_mtCzP43_maCzyHJ_zpHR7LHH7DFg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,944,797</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,104,790</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,342,963</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,589,645</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OtherNonoperatingIncomeExpenseAbstract_iB_zRuDFADSlnf5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Other income (expense)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--OtherNonoperatingExpense_iN_di_msCzKIm_zdwFOvGALdc3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other expense, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherNonoperatingExpense" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">192,763</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherNonoperatingExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">172,096</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherNonoperatingExpense" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,560</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherNonoperatingExpense" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">301,167</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_ecustom--RecognitionAndChangeInFairValueOfWarrantLiability_maCzKIm_zSUMd6ILRVI" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Recognition and change in fair value of warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="RELI:RecognitionAndChangeInFairValueOfWarrantLiability" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,633,251</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0263">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="RELI:RecognitionAndChangeInFairValueOfWarrantLiability" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,479,215</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0265">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NonoperatingIncomeExpense_iT_mtCzKIm_maCzyHJ_zrr1IMLxTbo9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other income (expense)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,440,488</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">172,096</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,178,655</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">301,167</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_iT_mtCzyHJ_zhdsBccA0xKi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net income (loss)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,495,691</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,276,886</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,835,692</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,890,812</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_zkJwIWUjtKlh" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Basic earnings (loss) per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.56</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.12</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.75</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.20</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--EarningsPerShareDiluted_zON18dfYSxa9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Diluted earnings (loss) per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.10</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.12</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.59</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.20</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zm028xK2fC5h" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Weighted average number of shares outstanding - Basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,738,290</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,934,489</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,238,285</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,259,738</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zfrRFQchS9F2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Weighted average number of shares outstanding - Diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,989,290</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,934,489</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,134,729</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,259,738</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these condensed consolidated financial statements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reliance
Global Group, Inc. and Subsidiaries</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed
Consolidated Statements of Stockholders&#8217; Equity (Deficit)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_114_z5M3aMir7F3f" summary="xdx: Statement - Condensed Consolidated Statements of Stockholders&apos; Equity (Deficit) (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--PreferredStockMember_zcZtC9bFfmmg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zEpBDqFvcIS6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_custom--CommonStockIssuableMember_zTZZ9uNxrPVj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zIfOOTKLKCh9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_custom--SubscriptionReceivableMember_za6WskuL0INi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Receivable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zanSuOCZ19Gk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Deficit</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" id="xdx_4B3_zUFoYX9oYp3a" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="38" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Reliance
    Global Group, Inc.</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Preferred
    stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Common
    stock</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Common
    stock issuable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Additional
    paid-in</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Subscription</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Accumulated</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Receivable</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Deficit</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_43A_c20220101__20220331_eus-gaap--StockholdersEquity_iS_zOz57vrwzmTh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">Balance, December 31, 2021</span></td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zxLkTKvZurq3" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; width: 4%; font-weight: bold; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0305">-</span></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; width: 4%; font-weight: bold; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0297">-</span></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zH4BGNCDDnI6" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; width: 4%; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,956,109</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; width: 4%; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">940,829</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuableMember_zk4BysZ28Ohi" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; width: 4%; font-weight: bold; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0309">-</span></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; width: 4%; font-weight: bold; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0299">-</span></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; width: 4%; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,451,187</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; width: 4%; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_SubscriptionReceivableMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,000,000</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; width: 4%; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">33,458,145</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; width: 4%; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">26,066,129</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_zl8khYFJOeh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 8pt">Share based compensation</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0311">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0312">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0313">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">739,960</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0315">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0316">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">739,960</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zaCwV67j8Jsc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 8pt">Shares issued due to private placement</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zQle5zCB0CT2" title="Shares issued due to private placement, shares" style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,076</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">781</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zIZfbM03wFPf" title="Shares issued due to private placement, shares" style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,670,892</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">229,694</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0321">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">230,424</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-03-31_custom_SubscriptionReceivableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,000,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0324">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,000,051</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_zvGMSufjtLjl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 8pt">Shares issued pursuant to acquisition of Medigap</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0331">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjIqdfBwUm3f" title="Shares issued pursuant to acquisition, shares" style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">606,037</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">52,119</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0333">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,711,332</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0335">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0336">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,763,451</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_zRGGx1q85Qvf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 8pt">Exercise of Series A warrants</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0341">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_985_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztMIW9I7Ypg5" title="Exercise of Series A warrants, shares" style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="RELI:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">375,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="RELI:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,250</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0343">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="RELI:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,442,750</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0345">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0346">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="RELI:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,475,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueConversionOfUnits_z5TTfVYmGMob" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 8pt">Issuance of prefunded Series C Warrants in exchange for common shares</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0351">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWMVsdHmYR7g" title="Issuance of prefunded Series C Warrants in exchange for common shares, shares" style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">3,276,929</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">281,815</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0353">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">281,815</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0355">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0356">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0357">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensationGross_zjTQdYBr9ava" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 8pt">Shares issued for vested stock awards</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0361">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_985_ecustom--StockGrantedDuringPeriodSharesSharebasedCompensationGross_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgakmFxKQInj" title="Shares issued for vested stock awards, shares" style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="RELI:StockGrantedDuringPeriodSharesSharebasedCompensationGross" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">516</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0363">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">516</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0365">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0366">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0367">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLoss_zqE1kJ0oaAx8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-size: 8pt">Net Income</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0371">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0372">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0373">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0374">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0375">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,340,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,340,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_43D_c20220401__20220630_eus-gaap--StockholdersEquity_iS_zejA8E2HVU09" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">Balance, March 31, 2022</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zA1VAGjTs0Fb" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,076</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">781</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhXXvyWmKGDd" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,337,109</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">973,593</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuableMember_z2UN1VE2UQsk" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0391">-</span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0381">-</span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,396,104</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0383">-</span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,118,145</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,252,333</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_zDmZwI2oWiX1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-size: 8pt">Share based compensation</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0393">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0394">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0395">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">179,083</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0397">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0398">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">179,083</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--StockIssuedDuringPeriodValueWarrantsIntoCommonStock_zqMnD4d04Tn1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 8pt">Exercise of Series C warrants into common shares</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0401">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98F_ecustom--StockIssuedDuringPeriodSharesWarrantsIntoCommonStock_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z4GF29AUYijj" title="Exercise of Series C warrants into common shares, shares" style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="RELI:StockIssuedDuringPeriodSharesWarrantsIntoCommonStock" contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,276,929</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="RELI:StockIssuedDuringPeriodValueWarrantsIntoCommonStock" contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">281,815</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0403">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="RELI:StockIssuedDuringPeriodValueWarrantsIntoCommonStock" contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">280,479</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0405">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0406">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="RELI:StockIssuedDuringPeriodValueWarrantsIntoCommonStock" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,336</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLoss_zCNe77FjT1qd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 8pt">Net Income</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0411">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0412">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0413">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0414">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0415">-</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,495,691</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,495,691</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_434_c20220401__20220630_eus-gaap--StockholdersEquity_iE_zoLIJDi4Ilv8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">Balance, June 30, 2022</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_989_eus-gaap--SharesOutstanding_iE_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z05xPCCJEEG3" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,076</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">781</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98E_eus-gaap--SharesOutstanding_iE_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zTmJ0lgBH5di" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,614,038</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,255,408</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98A_eus-gaap--SharesOutstanding_iE_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuableMember_zMJXU8Md7jr6" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0431">-</span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0421">-</span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,294,708</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0423">-</span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">13,622,454</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,928,443</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these condensed consolidated financial statements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reliance
Global Group, Inc. and Subsidiaries</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed
Consolidated Statements of Stockholders&#8217; Equity (Deficit)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--PreferredStockMember_zUTvVuCpbKD1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zVmH23g3mAni" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_custom--CommonStockIssuableMember_zHhtn2JtX0Rc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_z8seCvxdGJA3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">capital</td>
    <td>&#160;</td><td id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_custom--SubscriptionReceivableMember_zBVoHDE4UKf4" style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zHhjcPMuAcR2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B0_zEo2ze7bQCVl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="35" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Reliance Global Group, Inc.</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Preferred stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common stock</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Common stock issuable</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Additional paid-in</td>
    <td>&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">capital</td>
    <td>&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_437_c20210101__20210331_eus-gaap--StockholdersEquity_iS_zHquZxPUyRae" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; padding-bottom: 2.5pt">Balance, December 31, 2020</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_c20210101__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zQiQVWPFubAe" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; width: 4%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">395,640</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 4%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,912</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_c20210101__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z6oVGVDUIkqg" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; width: 4%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,241,028</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 4%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">363,517</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20210101__20210331__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuableMember_zVZp7ovqqnu9" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; width: 4%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_custom_CommonStockIssuableMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,341</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 4%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_custom_CommonStockIssuableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">340,000</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 4%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,559,239</ix:nonFraction></td>
    <td style="width: 1%">&#160;</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0437">-</span></span></td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 4%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">12,359,680</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 4%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">63,012</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_zHk2FhaQvZ37" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Share based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0447">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0448">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0449">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">246,966</ix:nonFraction></td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0452">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">246,966</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zm8ptAQwGf0e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Shares issued for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0455">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210101__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhirVlegS87l" title="Beginning balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,290</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0457">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89,760</ix:nonFraction></td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0460">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">91,050</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockIssuedDuringPeriodValueNewIssues_z4XpKTh9lmNd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Shares issued due to public offering, net of offering costs of $<span id="xdx_90F_eus-gaap--PaymentsOfStockIssuanceCosts_c20210101__20210331_zETzpY4YGZlb" title="Payments of stock issuance costs"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,672,852</ix:nonFraction></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0465">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVFOipsxV8k4" title="Beginning balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,800,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">154,800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0467">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,954,348</ix:nonFraction></td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0470">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,109,148</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--StockIssuedDuringPeriodValueOverAllotmentShares_znJgL76E0LEb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Over-allotment shares from offering, net of offering costs of $<span id="xdx_905_eus-gaap--PaymentsOfStockIssuanceCosts_c20210101__20210331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zOuT0Ai3iWIi" title="Payments of stock issuance costs"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2021-01-012021-03-31_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,928</ix:nonFraction></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0477">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--StockIssuedDuringPeriodSharesOverAllotmentShares_c20210101__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zh7PGcrotAw9" title="Beginning balance, shares" style="text-align: right"><ix:nonFraction name="RELI:StockIssuedDuringPeriodSharesOverAllotmentShares" contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">270,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:StockIssuedDuringPeriodValueOverAllotmentShares" contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,220</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0479">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:StockIssuedDuringPeriodValueOverAllotmentShares" contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,343,153</ix:nonFraction></td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0482">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:StockIssuedDuringPeriodValueOverAllotmentShares" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,366,373</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_zP5xO4dnlf4k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrants sold during public offering at quoted price</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0489">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0491">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,700</ix:nonFraction></td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0494">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,700</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_zx4GvJpwfhf6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Shares issued due to conversion of preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20210101__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z7zcnlhnQ8d1" title="Beginning balance, shares" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">394,493</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">33,812</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20210101__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z89YZYuUkK16" title="Beginning balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,944,930</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">339,264</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0499">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">305,452</ix:nonFraction></td>
    <td>)</td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0502">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0503">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--SharesIssuedDuringPeriodValueToConversionOfDebt_z22gTjo7P9j8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Shares issued due to conversion of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0509">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--SharesIssuedDuringPeriodSharesToConversionOfDebt_c20210101__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsGwSjUipW24" title="Beginning balance, shares" style="text-align: right"><ix:nonFraction name="RELI:SharesIssuedDuringPeriodSharesToConversionOfDebt" contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">633,333</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:SharesIssuedDuringPeriodValueToConversionOfDebt" contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,467</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0511">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:SharesIssuedDuringPeriodValueToConversionOfDebt" contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,745,533</ix:nonFraction></td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0514">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:SharesIssuedDuringPeriodValueToConversionOfDebt" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,800,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueInitialPublicOffering_zFn8uYNdgjIl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Rounding shares related to initial public offering</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0519">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--StockIssuedDuringPeriodSharesInitialPublicOffering_c20210101__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmMUDT0zk021" title="Beginning balance, shares" style="text-align: right"><ix:nonFraction name="RELI:StockIssuedDuringPeriodSharesInitialPublicOffering" contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,885</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0520">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodSharesInitialPublicOffering_c20210101__20210331__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuableMember_za1XHhx14wSh" title="Beginning balance, shares" style="text-align: right">(<ix:nonFraction name="RELI:StockIssuedDuringPeriodSharesInitialPublicOffering" contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">3</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0521">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0522">-</span></td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0524">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0525">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValuePurchaseOfAssets_zo8t5roIOYy" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Shares issued pursuant to software purchase</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0531">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesPurchaseOfAssets_c20210101__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHzoDfaIpKz8" title="Beginning balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets" contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,338</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets" contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,984</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesPurchaseOfAssets_c20210101__20210331__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuableMember_zRXFsSSc1mw6" title="Beginning balance, shares" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets" contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">23,338</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets" contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">340,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets" contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">338,016</ix:nonFraction></td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0536">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0537">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_z2vE6Lw4ZoJ8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td title="Beginning balance, shares" style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0543">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td title="Beginning balance, shares" style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0544">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td title="Beginning balance, shares" style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0545">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0546">-</span></td>
    <td>&#160;</td><td style="padding-bottom: 1.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0547">-</span></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">613,926</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">613,926</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_434_c20210401__20210630_eus-gaap--StockholdersEquity_iS_zsd51AEutASg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance, March 31, 2021</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zTzIMHz97yv6" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,147</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iS_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNQSKhDiLLF1" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,929,514</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">938,542</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuableMember_zi6LlKNeYBNe" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0563">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0553">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,992,263</ix:nonFraction></td>
    <td>&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0555">-</span></span></td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">12,973,606</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,957,299</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_zF8EJ1ZMKjSf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Share based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0565">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0566">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0567">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">183,132</ix:nonFraction></td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0570">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">183,132</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueInitialPublicOffering_zescfRmq5Pz" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Rounding shares related to initial public offering</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesInitialPublicOffering_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zGahImOtXC09" title="Beginning balance, shares" style="text-align: right"><ix:nonFraction name="RELI:StockIssuedDuringPeriodSharesInitialPublicOffering" contextRef="From2021-04-012021-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0573">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0574">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0575">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0576">-</span></td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0578">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0579">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_zcgraCWKDhv9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Shares issued pursuant to acquisition of Kush</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0583">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zODRjhCSEZg7" title="Beginning balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,925</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,284</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0585">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,716</ix:nonFraction></td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0588">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td>
    <td>&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_zFwqt1a29R2g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0593">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0594">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Beginning balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0595">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0596">-</span></td>
    <td>&#160;</td><td style="text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0597">-</span></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,276,886</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,276,886</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td title="Beginning balance, shares" style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td title="Beginning balance, shares" style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td title="Beginning balance, shares" style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td>
    <td>&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_439_c20210401__20210630_eus-gaap--StockholdersEquity_iE_zyv6CNu6NYc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Balance, June 30, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z5NTiyzuJKG7" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,167</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iE_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zALEFBloHdf6" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,944,439</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">939,826</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_c20210401__20210630__us-gaap--StatementEquityComponentsAxis__custom--CommonStockIssuableMember_z4SR0fvE2gWl" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0613">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0603">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,224,111</ix:nonFraction></td>
    <td>&#160;</td><td style="padding-bottom: 2.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0605">-</span></span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,250,492</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,913,545</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these condensed consolidated financial statements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reliance
Global Group, Inc. and Subsidiaries and Predecessor</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed
Consolidated Statements of Cash Flows</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_112_zCzubY5vxmr3" summary="xdx: Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20220101__20220630_zo2YMSJpR8H4" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20210101__20210630_zqGoXNhUAQ2k" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six months ended June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zn0e3FmUHZ5a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLoss_i01_maNCPBUztya_zlWxUTFTCiZ" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Net income (loss)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,835,692</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,890,812</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zM77ptiPZ4la" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustment to reconcile net income (loss) to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DepreciationDepletionAndAmortization_i02_maNCPBUztya_zPVZed52s4Wh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,363,928</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">702,454</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_i02_maNCPBUztya_zQJBvNOQfO9f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Amortization of debt issuance costs and accretion of debt discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,291</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,206</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--NoncashLeaseExpense_i02_maNCPBUztya_zy47VvKMuTw9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Non-cash lease expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:NoncashLeaseExpense" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,450</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:NoncashLeaseExpense" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,534</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ShareBasedCompensation_i02_maNCPBUztya_zd9cqhXWj6k2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">919,043</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">521,148</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--EarnoutFairValueAndWriteoffAdjustments_i02_maNCPBUztya_zEAzscDY0e67" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Earn-out fair value and write-off adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:EarnoutFairValueAndWriteoffAdjustments" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,963</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0637">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--RecognitionAndChangeInFairValueOfWarrantLiability_i02N_di_msNCPBUztya_zHgipizCkP44" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Recognition and change in fair value of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RELI:RecognitionAndChangeInFairValueOfWarrantLiability" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,479,215</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0640">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zlDgN88K8TA3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Change in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_i03_maNCPBUztya_zOS4lcMqxTm1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accounts payables and other accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,711,287</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">805,092</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUztya_z97ZRXRNymH1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">45,122</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">75,212</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInAccountsReceivableRelatedParties_i03N_di_msNCPBUztya_zR0WpwImvF2d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accounts receivable, related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,283</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,131</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInOtherAccountsPayable_i03_maNCPBUztya_zKGgYjBWJyu1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">126,984</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0655">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInRestructuringReserve_i03_maNCPBUztya_z2ndINRTIwG2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Charge back reserve</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInRestructuringReserve" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,068</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0658">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInOtherNoncurrentAssets_i03N_di_msNCPBUztya_zcgDt3G2Fso1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other non-current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,492</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,035</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_i03N_di_msNCPBUztya_zyPLsizOHukf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Prepaid expense and other current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,169,325</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,736</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i02T_mtNCPBUztya_maCCERCzrzh_zLQlEDCn2qU1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,311,411</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,493,252</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zx0hUx5BAnmd" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUzR1f_zAiDEK7SSQE4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Purchase of property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,989</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0673">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_i01N_di_msNCPBUzR1f_zFGQFpJmPE6h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Business acquisitions, net of cash acquired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,138,750</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,608,586</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--PaymentsToAcquireIntangibleAssets_i01N_di_msNCPBUzR1f_zpmwFSJMSNCl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Purchase of intangibles</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">466,190</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">152,990</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUzR1f_maCCERCzrzh_zuI23Bx2CrWb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash used in investing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,625,929</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,761,576</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zIEArPjyXAwe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RepaymentsOfOtherDebt_i01N_di_msNCPBUzWwB_zNSgDfi490F8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Principal repayments of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfOtherDebt" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">447,908</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfOtherDebt" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">432,833</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_ecustom--ProceedsFromLoanForBusinessAcquisition_i01_maNCPBUzWwB_zsQDX01WMZld" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from loan for business acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:ProceedsFromLoanForBusinessAcquisition" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,520,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0691">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--PaymentsOfDebtIssuanceCosts_i01N_di_msNCPBUzWwB_zqJYz1Coo0Sl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Payment of debt issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">214,257</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0694">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--PaymentsOnEarnoutLiabilities_i01N_di_msNCPBUzWwB_zsTgAtOPFuFd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Payments on earn-out liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RELI:PaymentsOnEarnoutLiabilities" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">411,408</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0697">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ProceedsFromRelatedPartyDebt_i01_maNCPBUzWwB_z18VawTvCmp1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from loans payable, related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0699">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,931</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--RepaymentsOfRelatedPartyDebt_i01N_di_msNCPBUzWwB_zypNa55H9rJk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Payments of loans payable, related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,541</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">508,307</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--ProceedsFromWarrantExercises_i01_maNCPBUzWwB_zCwwa58u9jSg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from exercise of warrants into common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,476,336</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0706">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--RepaymentsOnShorttermFinancing_i01N_di_msNCPBUzWwB_zoXvpGdyfcJ9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Repayments on short-term financing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RELI:RepaymentsOnShorttermFinancing" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,552</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants_i01_maNCPBUzWwB_z7Crl04Wllie" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net proceeds from private placement issuance of shares and warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,853,351</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0712">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_maNCPBUzWwB_zk6GXzHxHlJd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Issuance of common stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0714">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,496,221</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzWwB_maCCERCzrzh_zlxJsduWw6r3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,714,021</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,558,012</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzrzh_z0sEuXFJjqQe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net (decrease) increase in cash and restricted cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">223,319</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,303,184</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zy9gLtKS0Ru7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Cash and restricted cash at beginning of period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,620,722</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">529,581</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zrYzkbWiUAX5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash and restricted cash at end of period</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,397,403</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,832,765</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zYCuRpUCGqsk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Supplemental disclosure of cash and non-cash investing and financing transactions:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IssuanceOfSeriesDWarrants_i01_zENg1x27AjUc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Issuance of Series D Warrants</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="RELI:IssuanceOfSeriesDWarrants" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,930,335</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0733">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--IssuanceOfPlacementAgentWarrants_i01_z1KXN6RkjzBf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Issuance of placement agent warrants</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="RELI:IssuanceOfPlacementAgentWarrants" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,525,923</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0736">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--PrepaidInsuranceAcquiredThroughShorttermFinancing_i01I_z6gN1V2FL4w6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Prepaid insurance acquired through short-term financing</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="RELI:PrepaidInsuranceAcquiredThroughShorttermFinancing" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">417,199</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0739">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ConversionOfStockAmountConverted1_i01_z4T2Ncnn1NPb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Conversion of preferred stock into common stock</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0741">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ConversionOfStockAmountConverted1" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">339,264</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--InterestPaidNet_i01_z7gotcdUjpA1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash paid for interest</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">218,528</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">350,175</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DebtConversionConvertedInstrumentAmount1_i01_zHWtXgg58h0f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Conversion of debt into equity</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0747">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,800,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--CommonStockIssuedPursuantToAcquisition_i01_zdqV6T6WTbMb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Common stock issued pursuant to acquisition</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="RELI:CommonStockIssuedPursuantToAcquisition" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,763,451</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="RELI:CommonStockIssuedPursuantToAcquisition" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--StockIssued1_i01_zBNFroY6rYrh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Common stock issued in lieu of services</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0753">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">91,050</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--IssuanceOfCommonStockPursuantToPurchaseOfSoftware_i01_zsYQ5JFaWts2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Issuance of common stock pursuant to the purchase of software</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0756">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="RELI:IssuanceOfCommonStockPursuantToPurchaseOfSoftware" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">340,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--AcquisitionOfBusinessDeferredPurchasePrice_i01_zwC4Jx7sgPQl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Acquisition of business deferred purchase price</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="RELI:AcquisitionOfBusinessDeferredPurchasePrice" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,125,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="RELI:AcquisitionOfBusinessDeferredPurchasePrice" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--LeaseAssetsAcquiredInExchangeForLeaseLiabilities_i01_zWteXTe3qDZb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Lease assets acquired in exchange for lease liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="RELI:LeaseAssetsAcquiredInExchangeForLeaseLiabilities" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">223,922</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="RELI:LeaseAssetsAcquiredInExchangeForLeaseLiabilities" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">861,443</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these condensed consolidated financial statements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reliance
Global Group, Inc. and Subsidiaries</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes
to the Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80F_eus-gaap--SignificantAccountingPoliciesTextBlock_zeWAZFZ5cqC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1. <span id="xdx_822_zaH8Bt217e27">SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</span></b>&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reliance
Global Group, Inc., formerly known as Ethos Media Network, Inc. (&#8220;RELI&#8221;, &#8220;Reliance&#8221;, or the &#8220;Company&#8221;)
incorporated in Florida on August 2, 2013.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zHDrYB63LSp4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zcKS5w2HHGx7">Basis
of Presentation and Principles of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting
principles in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information and with the instructions for
Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP
for complete financial statements. In the opinion of management, all adjustments (consisting of recurring accruals) necessary for a fair
presentation have been included. These unaudited condensed consolidated financial statements should be read in conjunction with the audited
consolidated financial statements and the notes thereto, set forth in the Company&#8217;s annual report on Form 10-K for the year ended
December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed consolidated financial statements include the accounts of Reliance Global Group, Inc. and its wholly
owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="RELI:LiquidityPolicyTextBlock"><p id="xdx_842_ecustom--LiquidityPolicyTextBlock_zjM206NJluZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zUX1T6recycl">Liquidity</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2022, the Company&#8217;s reported cash and restricted cash aggregated balance was approximately $<span id="xdx_901_eus-gaap--RestrictedCashAndCashEquivalents_iI_c20220630_zmlheEmzb7nl" title="Cash and restricted cash"><ix:nonFraction name="us-gaap:RestrictedCashAndCashEquivalents" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,397,000</ix:nonFraction></span>, current assets
were approximately $<span id="xdx_90E_eus-gaap--AssetsCurrent_iI_pn3d_c20220630_zLkG1HiplZ67" title="Current asset"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" unitRef="USD">6,101,000</ix:nonFraction></span>, while current liabilities were approximately $<span id="xdx_90C_eus-gaap--LiabilitiesCurrent_iI_pn3d_c20220630_zfNZINzZNXf5" title="Current liabilities"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" unitRef="USD">9,470,000</ix:nonFraction></span>. As of June 30, 2022, the Company had a working
capital deficit of approximately $<span id="xdx_908_ecustom--WorkingCapitalDeficiency_iNI_di_c20220630_zYkPNQWKNr4a" title="Working capital deficit"><ix:nonFraction name="RELI:WorkingCapitalDeficiency" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,369,000</ix:nonFraction></span> and stockholders&#8217; equity of approximately $<span id="xdx_90F_eus-gaap--StockholdersEquity_iI_pn3d_c20220630_zR1yBKXFUUWk" title="Stockholders&apos; equity"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" unitRef="USD">21,928,000</ix:nonFraction></span>. For the six months ended June
30, 2022, the Company reported loss from operations of approximately $<span id="xdx_903_eus-gaap--OperatingIncomeLoss_iN_pn3d_di_c20220101__20220630_zhoRK99RrhS5" title="Operating loss"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="-3" sign="-" unitRef="USD">4,343,000</ix:nonFraction></span>, a non-cash, non-operating gain on the recognition and
change in fair value of warrant liabilities of approximately $<span id="xdx_904_ecustom--RecognitionAndChangeInFairValueOfWarrantLiability_pn3d_c20220101__20220630_zU8Ct5P03fpf" title="Recognition and change in fair value of warrant liabilities"><ix:nonFraction name="RELI:RecognitionAndChangeInFairValueOfWarrantLiability" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="-3" unitRef="USD">24,479,000</ix:nonFraction></span>, resulting in an overall net income of approximately $<span id="xdx_904_eus-gaap--NetIncomeLoss_pn3d_c20220101__20220630_z5Tp5cVCrdrj" title="Net income"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="-3" unitRef="USD">19,836,000</ix:nonFraction></span>.
For the six months ended June 30, 2022, the Company reported negative cash flows from operations of approximately $<span id="xdx_90C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3d_di_c20220101__20220630_zCpU11eivpsa" title="Cash flows from operations activites"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="-3" sign="-" unitRef="USD">1,311,000</ix:nonFraction></span>. The Company
completed a capital offering in January 2022 that raised net proceeds of approximately $<span id="xdx_909_ecustom--NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants_iN_di_c20220101__20220131_zzypTyDSMcHg" title="Netproceeds from private placement issuance of shares and warrants"><ix:nonFraction name="RELI:NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants" contextRef="From2022-01-012022-01-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">17,853,000</ix:nonFraction></span>. Management believes the Company&#8217;s
financial position and its ability to raise capital to be reasonable and sufficient.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_846_eus-gaap--UseOfEstimates_zEAeP9pyMgGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zq7klqBZY36i">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets, liabilities, revenues and expenses, and related disclosures in the financial statements and accompanying notes. Management
bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could
differ materially from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"><p id="xdx_842_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_z4NfRxD2cRgf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zX5ejGcEIL4c">Cash
and Restricted Cash</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_ztfGtzNzL7ol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and restricted cash reported on our Condensed Consolidated Balance Sheets are reconciled to the total shown on our Condensed Consolidated
Statements of Cash Flows as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zBvL1V2l6tya" style="display: none">SCHEDULE
OF RESTRICTED CASH IN STATEMENT OF CASH FLOW</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220630_zQUfFS0I7Bdk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20210630_zXhmNmSsa4xg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Cash_iI_maRCACEzxqQ_zAyV56KVYhr2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,979,769</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,348,415</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RestrictedCashCurrent_iI_maRCACEzxqQ_zlkkcI8lwKhb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Restricted cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RestrictedCashCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,417,635</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RestrictedCashCurrent" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">484,350</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RestrictedCashAndCashEquivalentsAtCarryingValue_iTI_mtRCACEzxqQ_zaHanh1g1kVj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total cash and restricted cash</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,397,404</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,832,765</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A3_zoHrcRMRXE07" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_84C_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z2iTIIYMxwd7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zVScM1ivfyda">Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &#8212; Observable inputs reflecting quoted prices (unadjusted) in active markets for identical assets and liabilities;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &#8212; Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly
or indirectly for substantially the full term of the asset or liability; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &#8212; Unobservable inputs for the asset or liability, which include management&#8217;s own assumption about the assumptions market
participants would use in pricing the asset or liability, including assumptions about risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrant
Liabilities: </b>The Company re-measures fair value of its Level 3 warrant liabilities at the balance sheet date, using a binomial option
pricing model. The following summarizes the significant unobservable inputs:</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"><p id="xdx_890_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zuvTGvxglgH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zXZ6z5Sxqugl" style="display: none">SCHEDULE
OF FAIR VALUE OF WARRANT COMMITMENT</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20220630_zdELOVKAbk4d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20211231_zX1MYhWhCdG7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zj5ouKYrGde" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Stock price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-06-30_us-gaap_MeasurementInputSharePriceMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">2.11</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2021-12-31_us-gaap_MeasurementInputSharePriceMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">6.44</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zbdq5NQdG7Q1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-06-30_us-gaap_MeasurementInputPriceVolatilityMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">105</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2021-12-31_us-gaap_MeasurementInputPriceVolatilityMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">90</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Time to expiry</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zr1GMZQNhsNj" title="Warrants and rights outstanding term"><ix:nonNumeric contextRef="AsOf2022-06-30_us-gaap_MeasurementInputExpectedTermMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">4.51</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zKISL3Mn5ps2" title="Warrants and rights outstanding term"><ix:nonNumeric contextRef="AsOf2021-12-31_us-gaap_MeasurementInputExpectedTermMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">5</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zkdPrINnuo38" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-06-30_us-gaap_MeasurementInputExpectedDividendRateMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2021-12-31_us-gaap_MeasurementInputExpectedDividendRateMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_407_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zUpuuQxKipA" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2022-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">3.00</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2021-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">1.10</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A6_zIregxJQX2h6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="RELI:ScheduleOfReconcilesWarrantCommitmentTableTextBlock"><p id="xdx_89D_ecustom--ScheduleOfReconcilesWarrantCommitmentTableTextBlock_zt3kCNHuQ5M9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following reconciles fair value of the liability classified warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z5bchZTVaKEh" style="display: none">SCHEDULE
OF RECONCILES WARRANT COMMITMENT</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td id="xdx_4BE_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantCommitmentMember_zaPZPoar18x8" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Series B Warrant Commitment</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td id="xdx_4B0_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantLiabilityMember_zFVUv6u0gfb8" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Series B warrant liabilities</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td id="xdx_4BA_us-gaap--DerivativeInstrumentRiskAxis_custom--PlacementAgentWarrantsMember_zp5xE03Tw8Yd" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Placement agent warrants</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B3_zULc9txmvSa" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Total</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three and Six Months ended June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Series B Warrant Commitment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Series B warrant liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Placement agent warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_43B_c20220101__20220331_ecustom--WarrantCommitment_iS_zd3vhmbYuyld" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Beginning balance</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="RELI:WarrantCommitment" contextRef="AsOf2021-12-31_custom_SeriesBWarrantCommitmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,652,808</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0829">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0830">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="RELI:WarrantCommitment" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,652,808</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--InitialRecognitionOfWarrantCommitment_zyM2U4DD4yj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Initial recognition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0833">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:InitialRecognitionOfWarrantCommitment" contextRef="From2022-01-012022-03-31_custom_SeriesBWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,061,119</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:InitialRecognitionOfWarrantCommitment" contextRef="From2022-01-012022-03-31_custom_PlacementAgentWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,525,923</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:InitialRecognitionOfWarrantCommitment" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,587,042</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--WarrantCommitmentUnrealizedGainLoss_zLfiRyNIbvRl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Unrealized (gain) loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:WarrantCommitmentUnrealizedGainLoss" contextRef="From2022-01-012022-03-31_custom_SeriesBWarrantCommitmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,408,311</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RELI:WarrantCommitmentUnrealizedGainLoss" contextRef="From2022-01-012022-03-31_custom_SeriesBWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">31,980,437</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RELI:WarrantCommitmentUnrealizedGainLoss" contextRef="From2022-01-012022-03-31_custom_PlacementAgentWarrantsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">946,461</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RELI:WarrantCommitmentUnrealizedGainLoss" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">15,518,587</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_ecustom--WarrantsExercisedOrTransferred_zVYByWZcDdGd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Warrants exercised or transferred</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="RELI:WarrantsExercisedOrTransferred" contextRef="From2022-01-012022-03-31_custom_SeriesBWarrantCommitmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">55,061,119</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="RELI:WarrantsExercisedOrTransferred" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">55,061,119</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_43D_c20220401__20220630_ecustom--WarrantCommitment_iS_zrEwvtfbTO" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Ending balance, March 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0848">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="RELI:WarrantCommitment" contextRef="AsOf2022-03-31_custom_SeriesBWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,080,682</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="RELI:WarrantCommitment" contextRef="AsOf2022-03-31_custom_PlacementAgentWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">579,462</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="RELI:WarrantCommitment" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,660,144</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--WarrantCommitmentUnrealizedGainLoss_zmj2QtkAu6Uj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Unrealized gain</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0853">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="RELI:WarrantCommitmentUnrealizedGainLoss" contextRef="From2022-04-012022-06-30_custom_SeriesBWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">12,322,737</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="RELI:WarrantCommitmentUnrealizedGainLoss" contextRef="From2022-04-012022-06-30_custom_PlacementAgentWarrantsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">310,514</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="RELI:WarrantCommitmentUnrealizedGainLoss" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">12,633,251</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_436_c20220401__20220630_ecustom--WarrantCommitment_iE_z9HKugYon43e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Ending balance, June 30, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="RELI:WarrantCommitment" contextRef="AsOf2022-06-30_custom_SeriesBWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,757,945</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="RELI:WarrantCommitment" contextRef="AsOf2022-06-30_custom_PlacementAgentWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">268,948</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="RELI:WarrantCommitment" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,026,893</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td id="xdx_4BC_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantCommitmentMember_zFjs7ly3vam5" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Series B Warrant Commitment</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td id="xdx_4B0_zTXl22uiCGIi" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Total</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Series B Warrant Commitment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_43A_c20210101__20211231_ecustom--WarrantCommitment_iS_z62K3p0Y2rYb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Beginning balance</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0863">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--InitialRecognitionOfWarrantCommitment_z0J37025AFnf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Initial recognition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="RELI:InitialRecognitionOfWarrantCommitment" contextRef="From2021-01-012021-12-31_custom_SeriesBWarrantCommitmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,244,497</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="RELI:InitialRecognitionOfWarrantCommitment" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,244,497</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--WarrantCommitmentUnrealizedGainLoss_zoUjaLsFSw4i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Unrealized gain</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="RELI:WarrantCommitmentUnrealizedGainLoss" contextRef="From2021-01-012021-12-31_custom_SeriesBWarrantCommitmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,408,311</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="RELI:WarrantCommitmentUnrealizedGainLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,408,311</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43E_c20210101__20211231_ecustom--WarrantCommitment_iE_z3Ptc0oweq7f" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="RELI:WarrantCommitment" contextRef="AsOf2021-12-31_custom_SeriesBWarrantCommitmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,652,808</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="RELI:WarrantCommitment" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,652,808</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zTlHOlOLVKH3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Earn-out
liabilities:</b> The Company generally values its Level 3 earn-out liabilities using the income valuation approach. Key valuation inputs
include contingent payment arrangement terms, projected revenues and cash flows, rate of return, and probability assessments. The following
table summarizes the significant unobservable inputs used in the fair value measurements:</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"><p id="xdx_897_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zJKMYpHycEGh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zYMc3HBmfOK4" style="display: none">SCHEDULE
OF FAIR VALUE MEASUREMENTS</span>&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June
    30, 2022</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31, 2021</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    technique</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_ecustom--ValuationTechnique_c20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zJVisLob1nDj" title="Valuation technique" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 31%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member" name="RELI:ValuationTechnique">Discounted
    cash flow</ix:nonNumeric> </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_ecustom--ValuationTechnique_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zp63Ik5UVtV" title="Valuation technique" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member" name="RELI:ValuationTechnique">Discounted
    cash flow</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
    unobservable input</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_ecustom--SignificantUnobservableInput_c20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zKLexS2RNJ84" title="Significant unobservable input" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member" name="RELI:SignificantUnobservableInput">Projected
    revenue and probability of achievement</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_ecustom--SignificantUnobservableInput_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zo8veHrk3uCd" title="Significant unobservable input" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member" name="RELI:SignificantUnobservableInput">Projected
    revenue and probability of achievement</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

</ix:nonNumeric><p id="xdx_8A1_z52fMoZE7ARe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member" escape="true" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"><p id="xdx_89C_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1pON4iBjjBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company values its Level 3 earn-out liability related to the Barra Acquisition using a Monte Carlo simulation in a risk-neutral framework
(a special case of the Income Approach). The following summarizes the significant unobservable inputs:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zv1lEyyBoaX" style="display: none">SCHEDULE
OF EARN OUT LIABILITY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: justify">WACC Risk Premium:</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputRiskPremiumMember_zjVOsHTdDEbj" title="Derivative Liability, Measurement Input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2022-06-30_custom_MeasurementInputRiskPremiumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">14.6</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zqMn0spx6Qje" title="Derivative Liability, Measurement Input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2022-06-30_us-gaap_MeasurementInputPriceVolatilityMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Credit Spread:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputCreditSpreadMember_zpNZCTnxJM2f" title="Derivative Liability, Measurement Input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2022-06-30_us-gaap_MeasurementInputCreditSpreadMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Payment Delay (days)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputPaymentDelayMember_zFAkyxntXyB2" title="Derivative Liability, Measurement Input"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="AsOf2022-06-30_custom_MeasurementInputPaymentDelayMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">90</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--RiskFreeRate_iI_c20220630_zN0olbNccxBj" title="Risk free rate"><ix:nonNumeric contextRef="AsOf2022-06-30" name="RELI:RiskFreeRate">USD Yield Curve</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Discounting Convention:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--DiscountingConvention_iI_c20220630_zw9XkpJ31uE8" title="Discounting Convention:"><ix:nonNumeric contextRef="AsOf2022-06-30" name="RELI:DiscountingConvention">Mid-period</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Number of Iterations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_ecustom--NumberOfLterations_iI_uInteger_c20220630_z5RyS1Z4xK0a" title="Number of Iterations"><ix:nonFraction name="RELI:NumberOfLterations" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">100,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zItbCfirs94l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Undiscounted
remaining earn out payments are approximately $<span id="xdx_90A_ecustom--PaymentsToUndiscountedRemainingEarnOut_c20220101__20220630_zvpAYsUbwrEf" title="Undiscounted remaining earn out payments"><ix:nonFraction name="RELI:PaymentsToUndiscountedRemainingEarnOut" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,697,644</ix:nonFraction></span> as of June 30, 2022. The following table reconciles fair value of earn-out liabilities
for the period ending June 30, 2022:</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"><p id="xdx_89F_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zlb5iloLraJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zFHjImYwLSU6" style="display: none">SCHEDULE
OF GAIN OR LOSSES RECOGNIZED FAIR VALUE</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkOgZJqsn2G4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_493_20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z5ixBvUV2h84" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--BusinessCombinationContingentConsiderationLiability_iS_zq3ugt4XkIok" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Beginning balance &#8211; January 1</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2021-12-31_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,813,878</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,931,418</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--AcquisitionsAndSettlements_zz0ozKTtJd6f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Acquisitions and Settlements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--JPKushAcquisitionMember_zpGCww08QqRj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">JP Kush Acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0911">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:AcquisitionsAndSettlements" contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_custom_JPKushAcquisitionMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,694,166</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--BarraAcquisitionMember_ztAsfmTA8Ds3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Barra Acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:AcquisitionsAndSettlements" contextRef="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_BarraAcquisitionMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0915">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--CCSWriteoffMember_z7s1LuppWNR7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">CCS Write-off</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0917">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RELI:AcquisitionsAndSettlements" contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_custom_CCSWriteoffMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">81,368</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--AltruisPartialSettlementMember_zTJGFdi49Gl8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Altruis partial settlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RELI:AcquisitionsAndSettlements" contextRef="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_AltruisPartialSettlementMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">84,473</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RELI:AcquisitionsAndSettlements" contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_custom_AltruisPartialSettlementMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">452,236</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--MontanaFinalSettlementMember_zmXpkl6xJoP4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Montana final settlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RELI:AcquisitionsAndSettlements" contextRef="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_MontanaFinalSettlementMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">326,935</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0924">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Period adjustments:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_z7vUDb0QHKck" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value changes and accretion included in earnings<sup id="xdx_F4F_zCuz3bYtjLKf">*</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease" contextRef="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member" id="Fact000926" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,963</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease" contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member" id="Fact000927" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">278,102</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--BusinessCombinationContingentConsiderationLiability_iE_zgOy9LZAQxhi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Ending balance</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,357,433</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2021-12-31_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,813,878</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--EarnoutLiabilityCurrent_iI_c20220630_z010j0AI0K63" title="Less: Current portion" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="RELI:EarnoutLiabilityCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,683,596</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--EarnoutLiabilityCurrent_iI_c20211231_z8oBx77KZRcf" title="Less: Current portion" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="RELI:EarnoutLiabilityCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,297,855</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Ending balance, less current portion</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_ecustom--EarnoutLiabilityNoncurrent_iI_c20220630_zDbKw4KHKjik" title="Ending balance, less current portion" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="RELI:EarnoutLiabilityNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">673,837</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_ecustom--EarnoutLiabilityNoncurrent_iI_c20211231_zQzivkeBba6b" title="Ending balance, less current portion" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="RELI:EarnoutLiabilityNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">516,023</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F04_znbwsMrwCLig" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F16_z4Xsy00weVQ4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000939" xml:lang="en-US">Recorded
    as a reduction to general and administrative expenses</ix:footnote></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AA_zB6iCh8OAzef" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_847_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z2ebPnKcWApg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zxNdZQjhrm83">Revenue
Recognition</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><p id="xdx_891_eus-gaap--DisaggregationOfRevenueTableTextBlock_zKQXJmjaBFd8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table disaggregates the Company&#8217;s revenue by line of business, showing commissions earned:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_z41gn9tNSTfh" style="display: none">SCHEDULE
OF DISAGGREGATION REVENUE</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months ended June 30, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z5tiAU5wjKR2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Medical/Life</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20220401__20220630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zdatYq69YXo7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Property and Casualty</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20220401__20220630_zHcVQK4rAnib" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-weight: bold">Regular</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zVdgVoeWie6i" style="vertical-align: bottom; background-color: White">
    <td>EBS</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">184,851</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0946">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_EmployeeBenefitsSolutionsLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">184,851</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zqGZOvVoHxI6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>USBA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,319</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0950">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_USBenefitsAllianceLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,319</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zwjUHp1CEwn2" style="vertical-align: bottom; background-color: White">
    <td>CCS/UIS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0953">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,195</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_CommercialCoverageSolutionsLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,195</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zjegoCGCfgt9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Montana</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">451,705</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0958">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_SouthwesternMontanaFinancialCenterIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">451,705</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_zVsDiEHYJ40d" style="vertical-align: bottom; background-color: White">
    <td>Fortman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">357,334</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">205,804</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_FortmanInsuranceServicesLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">563,138</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zs08bofcigH4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Altruis</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">882,171</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_AltruisBenefitsConsultingIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">882,171</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zQUL1vnGobQ8" style="vertical-align: bottom; background-color: White">
    <td>Kush</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_KushMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">425,449</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0970">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_KushMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">425,449</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--MedigapMember_zWg9mMrfBhGa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Medigap</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_MedigapMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,359,976</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0974">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_MedigapMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,359,976</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--BarraMember_zmAdJPVXBB98" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Barra</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_BarraMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,925</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_BarraMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">200,397</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_BarraMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">270,322</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zTbS3j7Pa6Bj" title="Revenue from contract with customer, excluding assessed tax" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,743,730</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zrRFuj6duqr3" title="Revenue from contract with customer, excluding assessed tax" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_PropertyAndCasualtyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">463,396</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630_zxCGZQwLBjxi" title="Revenue from contract with customer, excluding assessed tax" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,207,126</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months ended June 30, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z9Be7lQu9voi" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Medical/Life
</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20220101__20220630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z3tydUEu24g3" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property
and Casualty </b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20220630_z8zEBupF4cE7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Regular</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zTy49gmU3rp" style="vertical-align: bottom; background-color: White">
    <td style="width: 46%">EBS</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">406,035</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0988">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_EmployeeBenefitsSolutionsLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">406,035</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zvWL8aZbZeFa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>USBA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,906</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0992">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_USBenefitsAllianceLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,906</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zaP2nNq3HIud" style="vertical-align: bottom; background-color: White">
    <td>CCS/UIS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0995">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">101,077</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_CommercialCoverageSolutionsLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">101,077</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zL1mRS9xGWpj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Montana</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">958,426</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1000">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_SouthwesternMontanaFinancialCenterIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">958,426</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_z3OrVbvYIse8" style="vertical-align: bottom; background-color: White">
    <td>Fortman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">689,933</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">403,064</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_FortmanInsuranceServicesLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,092,997</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zybrrU6NCHc7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Altruis</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,187,043</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1008">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_AltruisBenefitsConsultingIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,187,043</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zIHzljz06991" style="vertical-align: bottom; background-color: White">
    <td>Kush</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_KushMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">864,040</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1012">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_KushMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">864,040</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--MedigapMember_ztqkCcg9omDf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Medigap</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_MedigapMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,537,061</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1016">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_MedigapMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,537,061</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--BarraMember_zno0jYB9HFv8" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Barra</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_BarraMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,925</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_BarraMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">200,397</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_BarraMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">270,322</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zU809EwULDkg" title="Revenue from contract with customer, excluding assessed tax" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,738,369</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zRszIP2S1nr5" title="Revenue from contract with customer, excluding assessed tax" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_PropertyAndCasualtyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">704,538</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630_z9IXsbU2PPXf" title="Revenue from contract with customer, excluding assessed tax" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,442,907</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months ended June 30, 2021</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zwLsapb9gO1e" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Medical/Life</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20210401__20210630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z1tNbXreF2Mj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Property and Casualty</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20210401__20210630_zJI9fqyJstwj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Regular</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zx4IPaQSDQEi" style="vertical-align: bottom; background-color: White">
    <td style="width: 46%">EBS</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">207,201</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1030">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_EmployeeBenefitsSolutionsLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">207,201</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zV2eUnQeUmu9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>USBA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,395</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1034">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_USBenefitsAllianceLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,395</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zEeyxDVrvkKe" style="vertical-align: bottom; background-color: White">
    <td>CCS/UIS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1037">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,348</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_CommercialCoverageSolutionsLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,348</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zMeWaWYAtQU7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Montana</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">404,740</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1042">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_SouthwesternMontanaFinancialCenterIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">404,740</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_zNnTB9fpj3jc" style="vertical-align: bottom; background-color: White">
    <td>Fortman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">276,634</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">226,337</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_FortmanInsuranceServicesLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">502,971</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_z57f2KxlOKCc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Altruis</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">729,874</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1050">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_AltruisBenefitsConsultingIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">729,874</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zLDD68scL5Ec" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Kush</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_KushMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">265,318</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1054">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_KushMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">265,318</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zzd5vle96J6f" title="Revenue from contract with customer, excluding assessed tax" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,899,162</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zNPGE7HG8of3" title="Revenue from contract with customer, excluding assessed tax" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_PropertyAndCasualtyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">291,685</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630_z5plR7MKzIxe" title="Revenue from contract with customer, excluding assessed tax" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,190,847</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months ended June 30, 2021</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_493_20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zPt3IBocgf3c" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Medical/Life</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20210101__20210630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zIJuwrb9Ylx2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Property and Casualty</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20210101__20210630_zOgSGQXGACTk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Regular</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zhA6r9o7rk3k" style="vertical-align: bottom; background-color: White">
    <td style="width: 46%">EBS</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">416,195</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1064">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_EmployeeBenefitsSolutionsLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">416,195</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zYSuyOjX0ddg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>USBA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,620</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1068">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_USBenefitsAllianceLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,620</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zastlTuh8MT3" style="vertical-align: bottom; background-color: White">
    <td>CCS/UIS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1071">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">154,166</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_CommercialCoverageSolutionsLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">154,166</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zsyzyBMUvklk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Montana</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">939,856</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1076">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_SouthwesternMontanaFinancialCenterIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">939,856</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_z5QRZ4XJduNi" style="vertical-align: bottom; background-color: White">
    <td>Fortman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">526,435</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">434,109</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_FortmanInsuranceServicesLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">960,544</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zMTs7cRjWMtc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Altruis</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,750,878</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1084">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_AltruisBenefitsConsultingIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,750,878</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zR7DIBwDZLK5" style="vertical-align: bottom; background-color: White">
    <td>Kush</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_KushMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">265,318</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1088">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_KushMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">265,318</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zr7yWuC1MVu8" title="Revenue from contract with customer, excluding assessed tax" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,926,302</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zlDmhcXqDkN1" title="Revenue from contract with customer, excluding assessed tax" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_PropertyAndCasualtyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">588,275</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630_zz5VKg2KWWYa" title="Revenue from contract with customer, excluding assessed tax" style="text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,514,577</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zulkyUcfW2k4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"><p id="xdx_899_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zurCRq47Ear1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following, are customers representing <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zPtejUWKnux7" title="Concentration Risk, Percentage">10</span>% or more of total revenue:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8B1_zxT12eyYIe4i">SCHEDULE OF CONCENTRATIONS OF REVENUES</span></span>&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="display: none; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Insurance Carrier</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20220401__20220630_zJgUo4vQnJpc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20210401__20210630_zrvfG1T5V6bl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the three months ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Insurance Carrier</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--LTCGlobalMember_zMC8oySoP9Fj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">LTC Global</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-04-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_LTCGlobalMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1100">-</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--PriorityHealthMember_znq06QgPhkK6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Priority Health</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-04-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_PriorityHealthMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_PriorityHealthMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">31</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--BlueCrossBlueShieldMember_zpN2uLLxSJu4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">BlueCross BlueShield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1105">-</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_BlueCrossBlueShieldMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">28</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="display: none; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Insurance Carrier</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20220101__20220630_z7F8k1FxEIp6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20210101__20210630_zOG3RiBI7Prg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the six months ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Insurance Carrier</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--BlueCrossBlueShieldMember_z8TBNIihmAI6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">BlueCross BlueShield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_BlueCrossBlueShieldMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_BlueCrossBlueShieldMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--PriorityHealthMember_zVZvg9YCUls8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Priority Health</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_PriorityHealthMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_PriorityHealthMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">33</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_402_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--LTCGlobalMember_z87VBK7t4WCd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">LTC Global</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_LTCGlobalMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">28</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1115">-</span></td><td style="text-align: left">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_zCaoN9yfGgV8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
other single Customer accounted for more than <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zqaquHjgBYCc" title="Concentration Risk, Percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% of the Company&#8217;s commission revenues. The loss of any significant customer, including
Priority Health, BlueCross BlueShield and LTC Global could have a material adverse effect on the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zVHGbjWqayY" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zwCWv1p7BJqj">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company recorded no income tax expense for the three and six months ended June 30, 2022 and 2021 because the estimated annual effective
tax rate was zero. In determining the estimated annual effective income tax rate, the Company analyzes various factors, including projections
of the Company&#8217;s annual earnings and taxing jurisdictions in which the earnings will be generated, the impact of state and local
income taxes, the ability to use tax credits and net operating loss carry forwards, and available tax planning alternatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As
of June 30, 2022 and December 31, 2021, the Company provided a full valuation allowance against its net deferred tax assets since the
Company believes it is more likely than not that its deferred tax assets will not be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="RELI:PriorPeriodAdjustmentPolicyTextBlock"><p id="xdx_845_ecustom--PriorPeriodAdjustmentPolicyTextBlock_zRObHgRFIn4f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zh54TYGgWZo2">Prior
Period Adjustments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company identified certain immaterial adjustments impacting prior reporting periods. Specifically, the Company identified adjustments
to correct certain asset, liability and equity accounts in relation to historical purchase price allocation accounting, historical accrued
revenues and true ups of the common stock issuable account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company assessed the materiality of the adjustments to prior period financial statements in accordance with Securities and Exchange Commission
Staff Accounting Bulletin No. (SAB) 99, <i>Materiality</i>, and SAB 108, <i>Considering the Effects of Prior Year Misstatements when
Quantifying Misstatements in Current Year Financial Statements</i>, and ASC 250, <i>Accounting Changes and Error Corrections</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
the Company&#8217;s comparative condensed consolidated financial statements and impacted notes have been revised from amounts previously
reported to reflect these adjustments. The following table illustrates the impact on previously reported amounts and adjusted balances
presented in the condensed consolidated financial statements for the period ended June 30, 2022.</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zLtKrbTbf3zc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8B1_zy4nmbqtzRT9">SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION</span></span>&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_srt--RestatementAxis_srt--ScenarioPreviouslyReportedMember_zIlFdCuKKgL6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12/31/2020</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As reported</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_srt--RestatementAxis_srt--RestatementAdjustmentMember_ztSl1ChMHY0l" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_zUdl3tyCyjzd" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12/31/2020</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjusted</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_434_c20201231_eus-gaap--AccountsReceivableNetCurrent_iI_zeNA3cy2zFy6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Earn-out liability</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,631,418</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,931,418</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20201231_eus-gaap--Goodwill_iI_zGbtXLuh31V3" style="vertical-align: bottom; background-color: White">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,265,070</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">503,345</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,761,725</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20201231_eus-gaap--CommonStockSharesSubscriptions_iI_ziWIxMXggjtb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Common stock issuable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">822,116</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">482,116</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">340,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20201231_eus-gaap--AdditionalPaidInCapital_iI_zbUb6d0npFJe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additional paid-in-capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,377,123</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">182,116</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,559,239</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20201231_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zpywJ39h04S7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accumulated Deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">12,482,281</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">122,601</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">12,359,680</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B6_srt--RestatementAxis_srt--ScenarioPreviouslyReportedMember_zDUmDz1cXsN5" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3/31/2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As reported</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BB_srt--RestatementAxis_srt--RestatementAdjustmentMember_zuCTt499jlza" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B7_z0hbKKzwP566" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3/31/2021</b>&#160;&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjusted</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_433_c20210331_eus-gaap--CommonStockSharesSubscriptions_iI_zsto9pkjyeNf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Common stock issuable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">482,116</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(<ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2021-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">482,116</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_434_c20210331_eus-gaap--AdditionalPaidInCapital_iI_zKSe5SMWXzF3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additional paid-in-capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,810,147</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">182,116</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-03-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,992,263</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43C_c20210331_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zcCV7oP7Zy8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accumulated Deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">13,123,609</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-03-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,003</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-03-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">12,973,606</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zyw2DnQljJT6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zK3FCib1Q3ea" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zSQan6anBzxj">Recently
Issued Accounting Pronouncements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not expect any recently issued accounting pronouncements to have a material effect on our financial statements.</span></p>

</ix:nonNumeric><p id="xdx_859_zU62b4ovln8k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:BusinessCombinationDisclosureTextBlock"><p id="xdx_803_eus-gaap--BusinessCombinationDisclosureTextBlock_zm807V5hFOp7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2. <span id="xdx_822_zcSPpGDRyCO3">STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Medigap
Healthcare Insurance Company, LLC Transaction</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 10, 2022, pursuant to an asset purchase agreement, dated December 21, 2021, the Company completed the acquisition of all of the
assets of Medigap Healthcare Insurance Company, LLC (&#8220;Medigap&#8221;) for a purchase price of $<span id="xdx_907_eus-gaap--BusinessCombinationBargainPurchaseGainRecognizedAmount_c20220108__20220110__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zdGex3hbZJ0c" title="Business combination bargain purchase gain recognized amount"><ix:nonFraction name="us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount" contextRef="From2022-01-082022-01-10_custom_MedigapHealthcareInsuranceCompanyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,096,250</ix:nonFraction></span>, consisting of: (i) payment
to Medigap of $<span id="xdx_909_eus-gaap--PaymentsToAcquireBusinessesGross_c20220108__20220110__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zbFrqd5lUhg8" title="Payments to acquire businesses gross"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="From2022-01-082022-01-10_custom_MedigapHealthcareInsuranceCompanyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,138,750</ix:nonFraction></span> in cash and (ii) the issuance to Medigap of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220108__20220110__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zdoy4TLYwhDa" title="Issuance of shares acquistions"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2022-01-082022-01-10_custom_MedigapHealthcareInsuranceCompanyMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">606,037</ix:nonFraction></span> shares of the Company&#8217;s restricted common stock in
a transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended. The purchase price is subject
to post-closing adjustment to reconcile certain pre-closing credits and liabilities of the parties. &#160;&#160;The shares issued to
Medigap as part of the purchase price are further subject to lock up arrangements pursuant to which 50% of the shares may be sold after
the one-year anniversary of the date of closing of the transaction and the balance of the shares may be sold after the second-year anniversary
of the date of closing of the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
acquisition of Medigap was accounted for as a business combination in accordance with the acquisition method pursuant to FASB Topic No.
805, Business Combination (ASC 805). Accordingly, the total purchase consideration was allocated to the assets acquired, and liabilities
assumed based on their respective estimated fair values. The acquisition method of accounting requires, among other things, that assets
acquired, and liabilities assumed, if any, in a business purchase combination be recognized at their fair values as of the acquisition
date. The process for estimating the fair values of identifiable intangible assets and certain tangible assets requires the use of significant
estimates and assumptions, including estimating future cash flows, developing appropriate discount rates, estimating the costs, and timing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember" escape="true" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zPLnyz6qDgO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preliminary allocation of the purchase price in connection with the acquisition of Medigap was calculated as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zwEO6gUZ0pCi" style="display: none">SCHEDULE
OF ALLOCATION OF PURCHASE PRICE</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Description</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Useful Life (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Property, plant and equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zMKYASwrfsPb" title="Property, plant and equipment" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_PropertyPlantAndEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,666</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 16%; text-align: center"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zsAYkgl8hwCe" title="Finite lived intangible asset useful life"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_PropertyPlantAndEquipmentMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">5</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Right-of-use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RightOfUseAssetMember_zKMSL1xLpT3" title="Right-of-use asset" style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_custom_RightOfUseAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">317,787</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Trade names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_z71FK8rBXQ36" title="Trade name and trademarks" style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_TradeNamesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">340,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_ze3mfqbe6mHi" title="Finite lived intangible asset useful life"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_TradeNamesMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">15</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zIjP7idvbwTg" title="Customer relationships" style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,550,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zXfA7XDxZpqe" title="Finite lived intangible asset useful life"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">12</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Technology</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_z00qTdaLiKoi" title="Technology" style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_TechnologyBasedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zL9NVu8yuqH2" title="Finite lived intangible asset useful life"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_TechnologyBasedIntangibleAssetsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">3</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Backlog</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BackLogMember_z8wEoRXfV174" title="Backlog" style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_custom_BackLogMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">210,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BackLogMember_z6xedrYk5V07" title="Finite lived intangible asset useful life"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_custom_BackLogMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">1</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Chargeback reserve</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ChargebackReserveMember_ztJ9cNwbFNll" title="Chargeback reserve" style="text-align: right">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_custom_ChargebackReserveMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,484,473</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LeaseLiabilityMember_z1gCVNCEVtp4" title="Lease liability" style="text-align: right">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_custom_LeaseLiabilityMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">317,787</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Goodwill</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zyKDxIFeMm5l" title="Goodwill" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_GoodwillMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,199,008</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--FinitelivedIntangibleAssetUsefulLives_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zUdpwx64y44k" title="Finite lived intangible asset useful life"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_GoodwillMember" name="RELI:FinitelivedIntangibleAssetUsefulLives">Indefinite</ix:nonNumeric></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zsNbik1a7LM7" title="Purchase consideration allocated" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,902,201</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_zPijXjFoIbc1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
name was measured at fair value using the relief-from-royalty method under the income approach. Significant inputs used to measure the
fair value include an estimate of projected revenue from the trade name, a pre-tax royalty rate of <span id="xdx_907_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputRoyaltyRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zIuu0nLmg8zb" title="Business combination, measurement input"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="AsOf2022-06-30_custom_MeasurementInputRoyaltyRateMember_us-gaap_TradeNamesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.5</ix:nonFraction></span>% and a discount rate of <span id="xdx_90F_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zPLeluEmkM15" title="Business combination, measurement input"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_us-gaap_TradeNamesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">11.0</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
relationships were measured at fair value using the multiple-period excess earnings method under the income approach. Significant inputs
used to measure the fair value include an estimate of projected revenue and costs associated with existing customers, and a discount
rate of <span id="xdx_906_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zlCu0KVzIeL" title="Business combination, measurement input"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">11.0</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Technology
was measured at fair value using the cost replacement method of the cost approach. Significant inputs used to measure the fair value
include an estimate of cost to replace, an obsolescence rate of<span id="xdx_90E_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputObsolescenceRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zUWYAJOZp89k" title="Business combination, measurement input"> <ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="AsOf2022-06-30_custom_MeasurementInputObsolescenceRateMember_us-gaap_TechnologyBasedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">40.3</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
value assigned to backlog acquired was estimated based upon the contractual nature of the backlog as of the acquisition date, using the
income approach to discount back to present value the cash flows attributable to the backlog, using a discount rate of <span id="xdx_90E_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BackLogMember_zICBdcNsk5dk" title="Business combination, measurement input"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_custom_BackLogMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">11.0</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
of $<span id="xdx_90F_eus-gaap--Goodwill_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zorapMdFfqOf" title="Goodwill"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,199,008</ix:nonFraction></span> arising from the acquisition of Medigap consisted of the value of the employee workforce and the residual value after
all identifiable intangible assets were valued. Goodwill recognized pursuant to the acquisition of Medigap is currently expected to be
deductible for income tax purposes. Total acquisition costs for the acquisition of Medigap incurred were $<span id="xdx_90A_eus-gaap--AcquisitionCosts_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_z7oca70usVTf" title="Acquisition costs"><ix:nonFraction name="us-gaap:AcquisitionCosts" contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">94,065</ix:nonFraction></span> recorded as a component
of General and administrative expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approximate revenue and net profit or loss for the acquired business as a standalone entity per ASC 805 from January 10, 2022 to June
30, 2022 was $<span id="xdx_906_eus-gaap--BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_z6RJbXGt5gm1" title="Revenue from acquired entity"><ix:nonFraction name="us-gaap:BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,537,061</ix:nonFraction></span> and a loss of $<span id="xdx_901_ecustom--SharesIssuedUponTerminationOfEmployee_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zMJjSNasw3L2" title="Shares issued upon termination of employee"><ix:nonFraction name="RELI:SharesIssuedUponTerminationOfEmployee" contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">412,943</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Pro
Forma Information</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
results of operations of Medigap will be included in the Company&#8217;s consolidated financial statements as of the date of acquisition
through the current period end. The following supplemental pro forma financial information approximate combined financial information
assumes that the acquisition had occurred at the beginning of the six months ended June 30, 2022 and 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember" escape="true" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock"><p id="xdx_89C_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zphAC9xbDvx4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8BD_zqlCpy4FoW84">SCHEDULE OF PRO FORMA INFORMATION
RELATED TO ACQUISITION</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zrAY1u9qdTVe" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20210101__20210630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_z5TmFC5JKJNh" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_zPXpL5s2Eiif" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,809,482</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="From2021-01-012021-06-30_custom_MedigapHealthcareInsuranceCompanyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,071,329</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zvTbC6rbm2w8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,849,175</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="From2021-01-012021-06-30_custom_MedigapHealthcareInsuranceCompanyMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,796,767</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_zrzBLE85Ditc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Earnings (Loss) per common share, basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.75</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" contextRef="From2021-01-012021-06-30_custom_MedigapHealthcareInsuranceCompanyMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.19</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareDiluted_zI9h1oNzNN7k" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Earnings (Loss) per common share, diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.59</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" contextRef="From2021-01-012021-06-30_custom_MedigapHealthcareInsuranceCompanyMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.19</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zQhsMwhZcx0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Barra
<span style="background-color: white">&amp; Associates, LLC</span> Transaction</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
April 26, 2022, the Company entered into an asset purchase agreement (the &#8220;APA&#8221;) with Barra &amp; Associates, LLC (&#8220;Barra&#8221;)
pursuant to which the Company purchased all of the assets of Barra &amp; Associates, LLC on April 26, 2022 for a purchase price in the
amount of $<span id="xdx_901_eus-gaap--AssetAcquisitionConsiderationTransferred_c20220425__20220426__us-gaap--TypeOfArrangementAxis__custom--APAMember__us-gaap--AssetAcquisitionAxis__custom--BarraAndAssociatesLLCMember_zQ2D6qSm7tBa" title="Asset Acquisition, Consideration Transferred"><ix:nonFraction name="us-gaap:AssetAcquisitionConsiderationTransferred" contextRef="From2022-04-252022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,725,000</ix:nonFraction></span> in cash, with $<span id="xdx_906_eus-gaap--AssetAcquisitionConsiderationTransferred_c20220425__20220426__us-gaap--TypeOfArrangementAxis__custom--APAMember__us-gaap--AssetAcquisitionAxis__custom--BarraAndAssociatesLLCMember__srt--StatementScenarioAxis__custom--PaidAtClosingMember_zP5sftOcaWb1" title="Asset Acquisition, Consideration Transferred"><ix:nonFraction name="us-gaap:AssetAcquisitionConsiderationTransferred" contextRef="From2022-04-252022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember_custom_PaidAtClosingMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,000,000</ix:nonFraction></span> paid to Barra at closing, $<span id="xdx_90C_eus-gaap--AssetAcquisitionConsiderationTransferred_c20220425__20220426__us-gaap--TypeOfArrangementAxis__custom--APAMember__us-gaap--AssetAcquisitionAxis__custom--BarraAndAssociatesLLCMember__srt--StatementScenarioAxis__custom--PayableInSixMonthsMember_zZRfVyOrKJdb" title="Asset Acquisition, Consideration Transferred"><ix:nonFraction name="us-gaap:AssetAcquisitionConsiderationTransferred" contextRef="From2022-04-252022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember_custom_PayableInSixMonthsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,125,000</ix:nonFraction></span> payable in six months from closing, and a final estimated
 earnout of $<span id="xdx_907_eus-gaap--AssetAcquisitionConsiderationTransferred_c20220425__20220426__us-gaap--TypeOfArrangementAxis__custom--APAMember__us-gaap--AssetAcquisitionAxis__custom--BarraAndAssociatesLLCMember__srt--StatementScenarioAxis__custom--PayableOverTwoYearsMember_zR6sAL1clsc" title="Asset Acquisition, Consideration Transferred"><ix:nonFraction name="us-gaap:AssetAcquisitionConsiderationTransferred" contextRef="From2022-04-252022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember_custom_PayableOverTwoYearsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600,000</ix:nonFraction></span> payable over two years from closing, based upon meeting stated milestones. The source of the cash payment was $<span id="xdx_90E_ecustom--WorkingCapital_iI_c20220426__us-gaap--TypeOfArrangementAxis__custom--APAMember__us-gaap--AssetAcquisitionAxis__custom--BarraAndAssociatesLLCMember_zfED6Fn2nxR8" title="Working capital"><ix:nonFraction name="RELI:WorkingCapital" contextRef="AsOf2022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,520,000</ix:nonFraction></span>
in funds borrowed from Oak Street Lending (&#8220;Loan&#8221;), the Company&#8217;s existing lender pursuant to a Fifth Amendment to
Credit Agreement and Promissory Note, of even date. The purchase price is subject to post-closing adjustment to reconcile certain pre-closing
credits and liabilities of the parties.</span>&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
acquisition of Barra was accounted for as a business combination in accordance with the acquisition method pursuant to FASB Topic No.
805, Business Combination (ASC 805). Accordingly, the total purchase consideration was allocated to the assets acquired, and liabilities
assumed based on their respective estimated fair values. The acquisition method of accounting requires, among other things, that assets
acquired, and liabilities assumed, if any, in a business purchase combination be recognized at their fair values as of the acquisition
date. The process for estimating the fair values of identifiable intangible assets and certain tangible assets requires the use of significant
estimates and assumptions, including estimating future cash flows, developing appropriate discount rates, estimating the costs, and timing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_BarraMember168706375" escape="true" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--BarraMember_zAvj3Cczm2we" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preliminary allocation of the purchase price in connection with the acquisition of Barra was calculated as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8B4_z0vHAAqSjuyd" style="display: none">SCHEDULE OF ALLOCATION OF PURCHASE PRICE</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Description</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Useful Life (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Acquired accounts receivable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AcquiredAccountsReceivableMember_zTEQ44tbOljh" title="Acquired accounts receivable" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-06-30_custom_BarraMember_custom_AcquiredAccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,585</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 16%; text-align: center">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zEJUiyX6gjEf" title="Property, plant and equipment" style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-06-30_custom_BarraMember_us-gaap_PropertyPlantAndEquipmentMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,593</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zq9A0wTgQIB" title="Weighted average useful life"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_BarraMember_us-gaap_PropertyPlantAndEquipmentMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">7</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Right-of-use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RightOfUseAssetMember_z2RLvyst8of8" title="Right-of-use asset" style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-06-30_custom_BarraMember_custom_RightOfUseAssetMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">122,984</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_z8wSKvLECqj4" title="Trade name and trademarks" style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-06-30_custom_BarraMember_us-gaap_TradeNamesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zv073tK0qK19" title="Weighted average useful life"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_BarraMember_us-gaap_TradeNamesMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">4</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zF9ypjfpQvz1" title="Customer relationships" style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-06-30_custom_BarraMember_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">550,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zxQh4rOqw2A3" title="Weighted average useful life"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_BarraMember_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">10</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Agency relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AgencyRelationshipsMember_zUNevM86Ndub" title="Agency relationships" style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-06-30_custom_BarraMember_custom_AgencyRelationshipsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,585,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AgencyRelationshipsMember_zSqsuI7S1rUh" title="Weighted average useful life"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_BarraMember_custom_AgencyRelationshipsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">10</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Developed technology</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_z3XK0aUG4hOk" title="Developed Technology" style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-06-30_custom_BarraMember_custom_DevelopedTechnologyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">230,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zlmP7oVyy7Ti" title="Weighted average useful life"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_BarraMember_custom_DevelopedTechnologyMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">5</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LeaseLiabilityMember_zrVPj4rifPd9" title="Lease liability" style="text-align: right">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-06-30_custom_BarraMember_custom_LeaseLiabilityMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">122,984</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Goodwill</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zAjUSJnoUlpj" title="Goodwill" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-06-30_custom_BarraMember_us-gaap_GoodwillMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,236,822</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--FinitelivedIntangibleAssetUsefulLives_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zYilHFApmoYd" title="Weighted average useful life description"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_BarraMember_us-gaap_GoodwillMember" name="RELI:FinitelivedIntangibleAssetUsefulLives">Indefinite</ix:nonNumeric></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zjPXfDbPZwXb" title="Purchase consideration allocated" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2022-06-30_custom_BarraMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,725,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zi2iRZp3dMh2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
name was measured at fair value using the relief-from-royalty method under the income approach. Significant inputs used to measure the
fair value include an estimate of projected revenue from the trade name, a pre-tax royalty rate of <span id="xdx_901_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputRoyaltyRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zlmKsvQaEl2e" title="Business combination, measurement input"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="AsOf2022-06-30_custom_MeasurementInputRoyaltyRateMember_us-gaap_TradeNamesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.5</ix:nonFraction></span>% and a discount rate of <span id="xdx_90D_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_z0LJVvahPzmj" title="Business combination, measurement input"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_us-gaap_TradeNamesMember_custom_BarraMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">19.5</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
and Agency relationships were measured at fair value using the multiple-period excess earnings method under the income approach. Significant
inputs used to measure the fair value include an estimate of projected revenue and costs associated with existing customers, and a discount
rate of <span id="xdx_901_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zN4EsGUFxcki" title="Business combination, measurement input"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_us-gaap_CustomerRelationshipsMember_custom_BarraMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">19.5</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Developed
technology was measured at fair value using the cost replacement method of the cost approach. Significant inputs used to measure the
fair value include an estimate of cost to replace, an obsolescence rate of <span id="xdx_904_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zVQOSjjzPYP7" title="Business combination, measurement input"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_custom_DevelopedTechnologyMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">28.6</ix:nonFraction></span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
of $<span id="xdx_90A_eus-gaap--Goodwill_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zKWEGWYZk8Sd" title="Goodwill"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-06-30_custom_BarraMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,236,822</ix:nonFraction> </span>arising from the acquisition of Barra consisted of the value of the employee workforce and the residual value after
all identifiable intangible assets were valued. Goodwill recognized pursuant to the acquisition of Barra is currently expected to be
deductible for income tax purposes. Total acquisition costs incurred through June 30, 2022 for the acquisition of Barra were $<span id="xdx_902_eus-gaap--AcquisitionCosts_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zDYgeJh9pGoe" title="Acquisition Costs"><ix:nonFraction name="us-gaap:AcquisitionCosts" contextRef="From2022-01-012022-06-30_custom_BarraMember168706375" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,793</ix:nonFraction></span> recorded as a component of General and administrative expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approximate revenue and net profit or loss for the acquired business as a standalone entity per ASC 805 from April 26, 2022 to June 30,
2022 was $<span id="xdx_909_eus-gaap--BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zeKKr04Z9sNc" title="Revenue from acquired entity"><ix:nonFraction name="us-gaap:BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" contextRef="From2022-01-012022-06-30_custom_BarraMember168706375" format="ixt:numdotdecimal" decimals="0" unitRef="USD">270,321</ix:nonFraction></span> and a loss of $<span id="xdx_90B_ecustom--SharesIssuedUponTerminationOfEmployee_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zyPGbZ97Jpx4" title="Shares issued upon termination of employee"><ix:nonFraction name="RELI:SharesIssuedUponTerminationOfEmployee" contextRef="From2022-01-012022-06-30_custom_BarraMember168706375" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,698</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Pro
Forma Information</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
results of operations of Barra will be included in the Company&#8217;s consolidated financial statements as of the date of acquisition
through the current period end. The following supplemental pro forma financial information approximate combined financial information
assumes that the acquisition had occurred at the beginning of the six months ended June 30, 2022 and 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_BarraMember168706375" escape="true" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock"><p id="xdx_893_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--BarraMember_zKn67UKrec71" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8B2_zEZwjxQvbmQ9">SCHEDULE OF PRO FORMA INFORMATION
RELATED TO ACQUISITION</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zqb2SASifGMk" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_494_20210101__20210630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_z2PG1csF5s0j" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_z3UL1f40LbL9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="From2022-01-012022-06-30_custom_BarraMember168706375" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,990,529</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="From2021-01-012021-06-30_custom_BarraMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,364,335</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zT3TvaciS2jc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="From2022-01-012022-06-30_custom_BarraMember168706375" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,070,124</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="From2021-01-012021-06-30_custom_BarraMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,527,038</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_zi9w5pX9pgY3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Earnings (Loss) per common share, basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" contextRef="From2022-01-012022-06-30_custom_BarraMember168706375" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.76</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" contextRef="From2021-01-012021-06-30_custom_BarraMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.16</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareDiluted_zsK40jpQsPcc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Earnings (Loss) per common share, diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" contextRef="From2022-01-012022-06-30_custom_BarraMember168706375" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.58</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" contextRef="From2021-01-012021-06-30_custom_BarraMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.16</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_z2dE6FBLOyh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock"><p id="xdx_80C_eus-gaap--GoodwillAndIntangibleAssetsDisclosureTextBlock_zeZ2eAaKlH83" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3. <span id="xdx_825_zUI8xpZQkF95">GOODWILL AND OTHER INTANGIBLE ASSETS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table rolls forward the Company&#8217;s goodwill balance for the periods ending June 30, 2022 and December 31, 2021. <span style="background-color: white">As
discussed in Note 1 - <i>Prior Period Adjustments</i>, a</span> $<span id="xdx_90E_eus-gaap--Goodwill_iI_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zhTgV7Lhmpz7" title="Goodwill">(<ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">503,345</ix:nonFraction></span>) adjustment was identified for goodwill which impacted the
closing December 31, 2020 balance in the same amount. Accordingly, the December 31, 2020 balance is adjusted in the following table from
the originally reported balance of $<span id="xdx_904_eus-gaap--Goodwill_iI_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zBfsKsI5sxTf" title="Goodwill"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,265,070</ix:nonFraction></span> to $<span id="xdx_909_eus-gaap--Goodwill_iI_c20201231_zYCdTdGYiaK3" title="Goodwill"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,761,725</ix:nonFraction></span>.</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfGoodwillTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfGoodwillTextBlock_zBTnTiFIZfjf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none"><span id="xdx_8B5_zmtgNeJ0kQWi">SCHEDULE OF IMPAIRMENT OF GOODWILL</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Goodwill</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">December 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--Goodwill_iS_pp0p0_c20210101__20211231_ze73yHBBxiaa" title="Goodwill" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,761,725</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Goodwill recognized in connection with Kush acquisition on May 1, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_c20210101__20211231_zg8bFG8xE91j" title="Goodwill acquired during period" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,288,552</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--Goodwill_iS_pp0p0_c20220101__20220630_zPuKIpm4JaNd" title="Goodwill" style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,050,277</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Goodwill recognized in connection with Medigap acquisition on January 10, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zMOr3ej7wz8c" title="Goodwill acquired during period" style="text-align: right"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,199,008</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Goodwill recognized in connection with Barra acquisition on April 26, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_z6HRemAlnwAk" title="Goodwill acquired during period" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2022-01-012022-06-30_custom_BarraMember168706375" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,236,822</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">June 30, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--Goodwill_iE_pp0p0_c20220101__20220630_zXjeJdfRTY69" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,486,107</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_za1w8KOWyCo3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"><p id="xdx_89F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zNRZKbnTkhjg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the major categories of the Company&#8217;s intangible assets and the weighted-average remaining amortization
period as of June 30, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_zL9Gn6g1VN7h" style="display: none">SCHEDULE
OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Amortization period (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accumulated Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying Amount</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Trade name and trademarks</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 10%; text-align: center"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_z9PuGmUoa0Ge" title="Weighted average remaining amortization period"><ix:nonNumeric contextRef="From2022-01-012022-06-30_us-gaap_TrademarksAndTradeNamesMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">4.9</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zooFf4RYL5kc" title="Gross carrying amount" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_us-gaap_TrademarksAndTradeNamesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,142,858</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zksUHP2yJWg5" title="Accumulated amortization" style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-06-30_us-gaap_TrademarksAndTradeNamesMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">804,020</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zcZSWEgTxtW6" title="Net carrying amount" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-06-30_us-gaap_TrademarksAndTradeNamesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,338,838</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Internally developed software</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_z0N2l6CHeMof" title="Weighted average remaining amortization period"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_InternallyDevelopedSoftwareMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">4.5</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zD8UljXApcf5" title="Gross carrying amount" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_custom_InternallyDevelopedSoftwareMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,326,158</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zO2RDVfgZZZ3" title="Accumulated amortization" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-06-30_custom_InternallyDevelopedSoftwareMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">131,655</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zKFCvs7GfSck" title="Net carrying amount" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-06-30_custom_InternallyDevelopedSoftwareMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,194,503</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zFJactYejOGc" title="Weighted average remaining amortization period"><ix:nonNumeric contextRef="From2022-01-012022-06-30_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">9.53</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_znrtJB1YI0oe" title="Gross carrying amount" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,922,290</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zee630SN8k63" title="Accumulated amortization" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,517,174</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zHvBPq6NYKpf" title="Net carrying amount" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,405,116</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Purchased software</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zGVjif2lpjFf" title="Weighted average remaining amortization period"><span style="-sec-ix-hidden: xdx2ixbrl1354">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zXa32kc0rH7g" title="Gross carrying amount" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_custom_PurchasedSoftwareMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">562,327</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zV033eRTcepa" title="Accumulated amortization" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-06-30_custom_PurchasedSoftwareMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">562,327</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zJjcPqadUK0e" title="Net carrying amount" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1360">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Video Production Assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zR1jhaIJslti" title="Weighted average remaining amortization period"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_VideoProductionAssetsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">0.6</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zMs6tRIeZ4Y7" title="Gross carrying amount" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_custom_VideoProductionAssetsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_znpwbIvVNxUl" title="Accumulated amortization" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-06-30_custom_VideoProductionAssetsMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">23,242</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zq45DqhXBxaa" title="Net carrying amount" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-06-30_custom_VideoProductionAssetsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">26,758</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Non-competition agreements</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_z1VIqFQUYD48" title="Weighted average remaining amortization period"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_NoncompetitionAgreementsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">2.4</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zrmvaS95v7M3" title="Gross carrying amount" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_custom_NoncompetitionAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,504,810</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zcsbWn1XYTSd" title="Accumulated amortization" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-06-30_custom_NoncompetitionAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,827,590</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_z14muw9eIR3f" title="Net carrying amount" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-06-30_custom_NoncompetitionAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,677,220</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Contracts Backlog</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractsBacklogMember_zaMEVsEllsNa" title="Weighted average remaining amortization period"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_ContractsBacklogMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">0.5</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractsBacklogMember_z2wVhmovIwW5" title="Gross carrying amount" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_custom_ContractsBacklogMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">210,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractsBacklogMember_znKFaBLlrNIl" title="Accumulated amortization" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-06-30_custom_ContractsBacklogMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">100,684</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractsBacklogMember_zLhRSkeEdAI4" title="Net carrying amount" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-06-30_custom_ContractsBacklogMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">109,316</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630_z2evHmQDOdm6" title="Gross carrying amount" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,718,443</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630_zih8kYD05oh8" title="Accumulated amortization" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,966,692</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630_zgaEWCTcKEnk" title="Net carrying amount" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,751,751</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the major categories of the Company&#8217;s intangible assets and the weighted-average remaining amortization
period as of December 31, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Amortization period (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accumulated Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying Amount</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Trade name and trademarks</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 10%; text-align: center"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zNQwKbQ42Una" title="Weighted average remaining amortization period"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_TrademarksAndTradeNamesMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">3.5</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_z33gOXeZjArf" title="Gross carrying amount" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31_us-gaap_TrademarksAndTradeNamesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,777,475</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zPTwnb3oZKlj" title="Accumulated amortization" style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31_us-gaap_TrademarksAndTradeNamesMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">609,822</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zLo6nNRVCfVa" title="Net carrying amount" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31_us-gaap_TrademarksAndTradeNamesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,167,653</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Internally developed software</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_z6VbNr2UP205" title="Weighted average remaining amortization period"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InternallyDevelopedSoftwareMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">4.7</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zGvAcnQ3EZ4f" title="Gross carrying amount" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31_custom_InternallyDevelopedSoftwareMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">595,351</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zbjRQ78J44Ik" title="Accumulated amortization" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31_custom_InternallyDevelopedSoftwareMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">28,443</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zjlS78Ne5EL3" title="Net carrying amount" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31_custom_InternallyDevelopedSoftwareMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">566,908</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zQGXp4Rx8TUk" title="Weighted average remaining amortization period"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">7.7</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zC6XhFSz6Pw5" title="Gross carrying amount" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,237,290</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zc1nwVarlrr8" title="Accumulated amortization" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,048,726</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyswIb2Sg5J3" title="Net carrying amount" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,188,564</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Purchased software</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zCgS3Bzg49Rh" title="Weighted average remaining amortization period"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_PurchasedSoftwareMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">0.6</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zue2JVRz2eAd" title="Gross carrying amount" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31_custom_PurchasedSoftwareMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">562,327</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zgwqYR54qes4" title="Accumulated amortization" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31_custom_PurchasedSoftwareMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">452,985</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zw3rCEDcHQK" title="Net carrying amount" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31_custom_PurchasedSoftwareMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">109,342</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Video Production Assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zkXDivMWVru3" title="Weighted average remaining amortization period"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_VideoProductionAssetsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">1.0</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zrstMszoUN1" title="Gross carrying amount" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31_custom_VideoProductionAssetsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_ziWRbdMXKny8" title="Accumulated amortization" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1428">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zKIA7arWwbv8" title="Net carrying amount" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31_custom_VideoProductionAssetsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Non-competition agreements</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center"><span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zG1evYRwCCxf" title="Weighted average remaining amortization period"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_NoncompetitionAgreementsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">2.9</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zXU0Ap5T7MA" title="Gross carrying amount" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31_custom_NoncompetitionAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,504,809</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zKdObrufoOZe" title="Accumulated amortization" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31_custom_NoncompetitionAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,478,376</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_z8gyxk2h3yxd" title="Net carrying amount" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31_custom_NoncompetitionAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,026,433</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231_z5WW5B5jNdrc" title="Gross carrying amount" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,697,252</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231_zTjZNFw0UDcj" title="Accumulated amortization" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,618,352</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231_zBCBFnIAnJ7e" title="Net carrying amount" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,078,900</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zx8ir1RMyk8k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"><p id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zYbWqPtf52C7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reflects expected amortization expense as of June 30, 2022, for each of the following five years and thereafter:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_z1S0NyhlATId" style="display: none">SCHEDULE
OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Years ending December 31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220630_zdme31u0Zgi4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization Expense</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_maFLIANziEa_zDwHLkgCzdDa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">2022 (remainder of year)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,374,512</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANziEa_zUWP4DkC850f" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,461,552</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANziEa_zqbyUPGSbDMi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,083,450</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANziEa_zpFaEiSGU3gj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,703,824</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_maFLIANziEa_zzeak3V2R4p1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,463,747</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_maFLIANziEa_ziWqp2dai4ee" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,664,666</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANziEa_zNjjHamLhIke" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,751,751</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zuSt2WaQE0Yf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="RELI:LongTermDebtAndShortTermFinancingsTextBlock"><p id="xdx_806_ecustom--LongTermDebtAndShortTermFinancingsTextBlock_zjhyhn874LU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4. <span id="xdx_827_zqSZ0pkrE164">LONG-TERM DEBT AND SHORT-TERM FINANCINGS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Long-Term
Debt</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zjbMmOY0rSWg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
composition of the long-term debt follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none"><span id="xdx_8BF_zJrtyNzdmdql" style="display: none">SCHEDULE OF LONG TERM DEBT</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Oak Street Funding LLC Term Loan for the acquisition of EBS and USBA, net of deferred financing costs of $<span id="xdx_901_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--EBSandUSBAMember_z1Q5RkjG52Kd" title="Net of deferred financing cost" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="AsOf2022-06-30_custom_EBSandUSBAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,497</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--EBSandUSBAMember_zQj1TwfN8J64" title="Net of deferred financing cost" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="AsOf2021-12-31_custom_EBSandUSBAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,606</ix:nonFraction></span> as of June 30, 2022 and December 31, 2021, respectively</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--EBSandUSBAMember_zZbvKLnBIPvi" title="Long term debt current" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-06-30_custom_EBSandUSBAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">455,391</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--EBSandUSBAMember_zpScUd8AZkW9" title="Long term debt current" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_custom_EBSandUSBAMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">485,317</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Oak Street Funding LLC Senior Secured Amortizing Credit Facility for the acquisition of CCS, net of deferred financing costs of $<span id="xdx_90C_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--CreditFacilityAxis__custom--CCSMember_z2WpvhXWozme" title="Net of deferred financing cost" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="AsOf2022-06-30_custom_CCSMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,351</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--CreditFacilityAxis__custom--CCSMember_zFvjR0bSeRxh" title="Net of deferred financing cost" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="AsOf2021-12-31_custom_CCSMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,626</ix:nonFraction></span> as of June 30, 2022 and December 31, 2021, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--CreditFacilityAxis__custom--CCSMember_zV4OjkqpPbh1" title="Long term debt current" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-06-30_custom_CCSMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">738,547</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--CreditFacilityAxis__custom--CCSMember_zRPOQNAI0nh4" title="Long term debt current" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_custom_CCSMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">785,826</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Oak Street Funding LLC Term Loan for the acquisition of SWMT, net of deferred financing costs of $<span id="xdx_90C_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--SWMTMember_zoOBjeJHvlla" title="Net of deferred financing cost" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="AsOf2022-06-30_custom_SWMTMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,085</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--SWMTMember_zMx3Hy7Usomj" title="Net of deferred financing cost" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="AsOf2021-12-31_custom_SWMTMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,027</ix:nonFraction></span> as of June 30, 2022 and December 31, 2021, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--SWMTMember_zHAvmbxOnHjc" title="Long term debt current" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-06-30_custom_SWMTMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">835,376</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--SWMTMember_z8DbtxvanTIl" title="Long term debt current" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_custom_SWMTMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">884,720</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Oak Street Funding LLC Term Loan for the acquisition of FIS, net of deferred financing costs of $<span id="xdx_90A_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--FISMember_zR0yya1Weuc1" title="Net of deferred financing cost" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="AsOf2022-06-30_custom_FISMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,752</ix:nonFraction> </span>and $<span id="xdx_90E_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--FISMember_zIoPPk2htZEg" title="Net of deferred financing cost" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="AsOf2021-12-31_custom_FISMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,660</ix:nonFraction></span> as of June 30, 2022 and December 31, 2021, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--FISMember_zubETJkAJVgh" title="Long term debt current" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-06-30_custom_FISMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,103,885</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--FISMember_ztGfs2gJt4Qe" title="Long term debt current" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_custom_FISMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,226,628</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Oak Street Funding LLC Term Loan for the acquisition of ABC, net of deferred financing costs of $<span id="xdx_903_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--ABCMember_z4d7ImIa1V66" title="Net of deferred financing cost" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="AsOf2022-06-30_custom_ABCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">45,369</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--ABCMember_zHI3JyAVNVE7" title="Net of deferred financing cost" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="AsOf2021-12-31_custom_ABCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,609</ix:nonFraction></span> as of June 30, 2022 and December 31, 2021, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--ABCMember_ziTwG1hXTyp9" title="Long term debt current" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-06-30_custom_ABCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,427,614</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--ABCMember_z0tslES6PHnb" title="Long term debt current" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31_custom_ABCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,616,754</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Oak Street Funding LLC Term Loan for the acquisition of Barra, net of deferred financing costs of $<span id="xdx_904_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zne1OiYQml26" title="Net of deferred financing cost" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="AsOf2022-06-30_custom_BarraMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">208,901</ix:nonFraction></span> and $<span id="xdx_90D_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zaY7qgk31TJa" title="Net of deferred financing cost" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"><ix:nonFraction name="us-gaap:OtherDeferredCostsNet" contextRef="AsOf2021-12-31_custom_BarraMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span> as of June 30, 2022 and December 31, 2021, respectively</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zhDcrjp2Qv0c" title="Long term debt current" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-06-30_custom_BarraMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,311,099</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zpFldjFvkDMi" title="Long term debt current" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1512">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--LongTermDebt_iI_c20220630_z9FgkrR3f43k" title="Long term debt" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,871,912</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--LongTermDebt_iI_c20211231_zUY96lHUFOIe" title="Long term debt" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,999,245</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--LongTermDebtCurrent_iNI_di_c20220630_zPkYc8wDpQy2" title="Current portion of long-term debt" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">936,263</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--LongTermDebtCurrent_iNI_di_c20211231_zmXBnTIhZcei" title="Current portion of long-term debt" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">913,920</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Long-term debt</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--LongTermDebtNoncurrent_iI_c20220630_z9k2CwFDNtIh" title="Long term debt, excluding current maturities" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,935,649</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--LongTermDebtNoncurrent_iI_c20211231_zTa1bVOHOcD9" title="Long term debt, excluding current maturities" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,085,325</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



</ix:nonNumeric><p id="xdx_8AE_zn8JrmCv6C02" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Oak
Street Funding LLC &#8211; Term Loans and Credit Facilities</i></b></span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zXaJBK35MWd6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;<span id="xdx_8B5_z6T44eRoySf4" style="display: none">SCHEDULE
OF CUMULATIVE MATURITIES OF LONG-TERM LOANS AND CREDIT FACILITIES</span></i></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Fiscal year ending December 31,</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20220630_znKSwTAoKRVi" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Maturities of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Long-Term Debt</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_iI_maDICAzUlL_zD8tjSnVjkP3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">2022 (remainder of year)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">438,616</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_maDICAzUlL_zJS5wiMGmCQd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,228,897</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_maDICAzUlL_zi7pxzsAMSs3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,542,156</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_maDICAzUlL_zvYm6PemCYx9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,656,383</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_maDICAzUlL_z6Fzq2O3Fc3c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,776,385</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_maDICAzUlL_z1XHiwscUX32" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,563,428</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DebtInstrumentCarryingAmount_iI_mtDICAzUlL_zmUYwoJsExI2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,205,865</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredFinanceCostsNet_iNI_di_zgmv3VFGZPC1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: debt issuance costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredFinanceCostsNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">333,953</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--LongTermDebt_iI_ztauDfk8nlR" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,871,912</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zsgbDWZmdxe4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Short-Term
Financings</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company financed certain annual insurance premiums through the use of two short-term notes, payable in nine and ten equal monthly
installments of $<span id="xdx_90E_eus-gaap--ShortTermBankLoansAndNotesPayable_iI_c20220630_zqwrpz3jyRdf" title="Notes Payable"><ix:nonFraction name="us-gaap:ShortTermBankLoansAndNotesPayable" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,894</ix:nonFraction></span> and $<span id="xdx_901_eus-gaap--ShortTermBankLoansAndNotesPayable_iI_c20211231_zdYK8rvIgs5c" title="Notes Payable"><ix:nonFraction name="us-gaap:ShortTermBankLoansAndNotesPayable" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,456</ix:nonFraction></span> at interest rates of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20220630__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_z12nEgwc0eB7" title="Debt Instrument, Interest Rate, Stated Percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2022-06-30_custom_DirectorsAndOfficerMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.51</ix:nonFraction></span>% and <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_zLvjy2F2EMoj" title="Debt Instrument, Interest Rate, Stated Percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-12-31_custom_DirectorsAndOfficerMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.95</ix:nonFraction></span>%, per annum respectively. Policies financed include directors
and officers and errors and omissions insurance coverage with premium financing recognized in 2022 and 2021 of $<span id="xdx_90C_eus-gaap--AmortizationOfDebtDiscountPremium_c20220101__20220630__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_zTTyxOD7qIEh" title="Amortization of Debt Discount (Premium)"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2022-01-012022-06-30_custom_DirectorsAndOfficerMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">417,199</ix:nonFraction></span> and $<span id="xdx_905_eus-gaap--AmortizationOfDebtDiscountPremium_c20210101__20211231__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_zsu1OmMkZ02g" title="Amortization of Debt Discount (Premium)"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2021-01-012021-12-31_custom_DirectorsAndOfficerMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span>, respectively.
Outstanding balances as of June 30, 2022 and December 31, 2021, respectively were $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20220630__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_z2KaEhXnyrnf" title="Debt Instrument, Face Amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2022-06-30_custom_DirectorsAndOfficerMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">376,647</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_zZXcbCXFxPdf" title="Debt Instrument, Face Amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-12-31_custom_DirectorsAndOfficerMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span>. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="RELI:WarrantLiabilitiesTextBlock"><p id="xdx_800_ecustom--WarrantLiabilitiesTextBlock_zAGXQacax8tk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5. <span id="xdx_820_zPyD02zfsFi1">WARRANT LIABILITIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
B Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 22, 2021, the Company entered into a securities purchase agreement with several institutional buyers for the purchase and sale
of (i) warrants to purchase an aggregate of up to <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20211222__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zu96vSpMatG5" title="Warrant to purchase shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2021-12-22_us-gaap_CommonStockMember_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,779,952</ix:nonFraction></span> shares of the Company&#8217;s common stock, par value $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211222__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zj6MebMfxudh" title="Common stock par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-22_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.086</ix:nonFraction></span> per share at
an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211222__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zaEqpQefHyNb" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-12-22_us-gaap_CommonStockMember_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.09</ix:nonFraction></span> per share, (ii) an aggregate of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211222__20211223__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zOYpqkYQ30of" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-12-222021-12-23_us-gaap_CommonStockMember_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,670,892</ix:nonFraction></span> shares of Common Stock, and (iii) <span id="xdx_90C_eus-gaap--ConversionOfStockSharesConverted1_c20211222__20211223__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z6YUcT2JAIS6" title="Shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2021-12-222021-12-23_custom_SeriesBConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,076</ix:nonFraction></span> shares of the Company&#8217;s
newly-designated Series B convertible preferred stock, par value $<span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20211222__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zfBbcVD0hzx1" title="Preferred stock par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-12-22_custom_SeriesBConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.086</ix:nonFraction></span> per share, with a stated value of $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_c20211222__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zAqSDRekkM82" title="Share price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-12-22_custom_SeriesBConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1,000</ix:nonFraction></span> per share, initially
convertible into an aggregate of <span id="xdx_90B_eus-gaap--ConversionOfStockSharesIssued1_c20211222__20211223__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zo1NNnKOcZXh" title="Shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2021-12-222021-12-23_us-gaap_CommonStockMember_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,219,084</ix:nonFraction></span> shares of Common Stock at a conversion price of $<span id="xdx_905_eus-gaap--PreferredStockConvertibleConversionPrice_iI_c20211222__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z5E7Xl5vlUEe" title="Preferred stock conversion price"><ix:nonFraction name="us-gaap:PreferredStockConvertibleConversionPrice" contextRef="AsOf2021-12-22_custom_SeriesBConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.09</ix:nonFraction></span> per share, each a freestanding financial
instrument, (the &#8220;Private Placement&#8221;). The aggregate purchase price for the Common Shares, the Preferred Shares and the Warrants
was approximately $<span id="xdx_909_ecustom--AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zkYlgW3OEtxj" title="Aggregate purchase price of common shares, preferred shares and warrants"><ix:nonFraction name="RELI:AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants" contextRef="From2021-01-012021-12-31_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,000,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
entering into the Private Placement on December 22, 2021, the Company entered into a commitment to issue the Common Shares, Preferred
Shares and Series B Warrants on the Initial Closing Date for a fixed price and exercise price, as applicable. The commitment to issue
Series B Warrants (the &#8220;Warrant Commitment&#8221;) represents a derivative financial instrument, other than an outstanding share,
that, at inception, has both of the following characteristics: (i) embodies a conditional obligation indexed to the Company&#8217;s equity.
The Company classified the commitment to issue the warrants as a derivative liability because it represents a written option that does
not qualify for equity accounting The Company initially measured the derivative liability at its fair value and will subsequently remeasure
the derivative liability, at fair value with changes in fair value recognized in earnings. An option pricing model was utilized to calculate
the fair value of the Warrant Commitment. The Company initially recorded $<span id="xdx_908_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_c20210101__20211231_z5ownjqLX3Sd" title="Unrealized losses"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,652,808</ix:nonFraction></span> of non-operating unrealized losses within the recognition
and change in fair value of warrant liabilities account for the year ended December 31, 2021. The Private Placement closed on January
4, 2022, at which time the Company remeasured the derivative liability for the warrants issued in the transaction. The Company recognized
$<span id="xdx_904_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20220101__20220630_zNmfHpoExDjb" title="Unrealized gain"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiUnrealizedGain" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,322,737</ix:nonFraction></span> and $<span id="xdx_905_ecustom--NonOperatingUnrealizedGains_c20220101__20220630_zgi6pGaDvL2i" title="Unrealized gain"><ix:nonFraction name="RELI:NonOperatingUnrealizedGains" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,748,163</ix:nonFraction></span> of non-operating unrealized gains within the recognition and change in fair value of warrant liabilities
account on the condensed consolidated statement of operations for the three and six months ended June 30, 2022, respectively, related
to the subsequent changes in its fair value through June 30, 2022. A corresponding derivative liability of $<span id="xdx_90E_ecustom--WarrantCommitment_iI_c20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantLiabilityMember_zn9tLwxEawz" title="Derivative liability"><ix:nonFraction name="RELI:WarrantCommitment" contextRef="AsOf2022-06-30_custom_SeriesBWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,757,945</ix:nonFraction></span> is included on
Company&#8217;s condensed consolidated balance sheet as of June 30, 2022. The closing of the Private Placement settled the subscription
receivable reported on the Company&#8217;s balance sheet as of December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Placement
Agent Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Private Placement, the Company issued <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20220105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zZrCwpqan901" title="Warrant issued"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2022-01-05_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">244,539</ix:nonFraction></span> warrants to the placement agent for the Private Placement. The warrants
were issued as compensation for the Placement Agent&#8217;s services. The Placement Agent Warrants are: (i) exercisable on any day after
the six (6) month anniversary of the issue date, (ii) expire <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20220105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zHObZVaIH4n3" title="Warrant term"><ix:nonNumeric contextRef="AsOf2022-01-05_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember" format="ixt-sec:durwordsen" name="us-gaap:WarrantsAndRightsOutstandingTerm">five years</ix:nonNumeric></span> after the closing of the Private Placement, and (iii) exercisable
at $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z3Di9BHz1gm" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-05_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.09</ix:nonFraction></span> per share. The Placement Agent Warrants contain terms that may require the Company to transfer assets to settle the warrants.
Therefore, the Placement Agent Warrants are classified as a derivative liability measured at fair value of $<span id="xdx_905_ecustom--IssuanceOfPlacementAgentWarrants_c20220104__20220105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zPIdhyk1V6S7" title="Derivative liability measured at fair value"><ix:nonFraction name="RELI:IssuanceOfPlacementAgentWarrants" contextRef="From2022-01-042022-01-05_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,525,923</ix:nonFraction> </span>on the date of
issuance and will be remeasured each accounting period with the changes in fair value reported in earnings. The Placement Agent Warrants
are considered financing expense fees paid to the Placement Agent. Since the financing expenses relate to a derivative liability measured
at fair value, this financing expense of $<span id="xdx_903_ecustom--IssuanceOfPlacementAgentWarrants_c20220104__20220105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zhhirMposu15" title="Derivative liability measured at fair value"><ix:nonFraction name="RELI:IssuanceOfPlacementAgentWarrants" contextRef="From2022-01-042022-01-05_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,525,923</ix:nonFraction></span>, along with non-operating unrealized gains of $<span id="xdx_902_ecustom--WarrantCommitmentUnrealizedGainLoss_c20220401__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zQK41qxWAPDe" title="Unrealized gain"><ix:nonFraction name="RELI:WarrantCommitmentUnrealizedGainLoss" contextRef="From2022-04-012022-06-30_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">310,514</ix:nonFraction></span> and losses of $<span id="xdx_90E_ecustom--WarrantCommitmentUnrealizedGainLoss_c20220101__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z13S70B6xUA8" title="Unrealized gain"><ix:nonFraction name="RELI:WarrantCommitmentUnrealizedGainLoss" contextRef="From2022-01-012022-06-30_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">268,948</ix:nonFraction></span>, were
included in the recognition and change in fair value of warrant liabilities account on the condensed consolidated statement of operations
for the three and six months ended June 30, 2022, respectively, A corresponding derivative liability of $<span id="xdx_902_ecustom--WarrantCommitment_iI_c20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z1cJZOVgNzF8" title="Derivative liability"><ix:nonFraction name="RELI:WarrantCommitment" contextRef="AsOf2022-06-30_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">268,948</ix:nonFraction></span> is included on Company&#8217;s
condensed consolidated balance sheet as of June 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zf2I6cV63o01" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6. <span id="xdx_82C_zI7PKNtaDED2">EQUITY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has been authorized to issue <span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20220630_zIM0TDwVfqY6" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">750,000,000</ix:nonFraction></span> shares of $<span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20220630_zs0UjNisi2Al" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.086</ix:nonFraction></span> par value Preferred Stock. The Board of Directors is expressly vested
with the authority to divide any or all of the Preferred Stock into series and to fix and determine the relative rights and preferences
of the shares of each series so established, within certain guidelines established in the Articles of Incorporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2022, the Company issued <span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_c20220131_zi2d1aPdD5tg" title="Preferred stock shares issued"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,076</ix:nonFraction></span> shares of its newly designated Series B convertible preferred stock through the Private Placement
for the purpose of raising capital. These shares remain issued and outstanding as of June 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series B convertible preferred stock has no voting rights and initially each share of Series B convertible preferred stock may be converted
into <span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_z7W3YWBA81Ke" title="Preferred stock shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-06-30_custom_SeriesBConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">245</ix:nonFraction></span> shares of the Company&#8217;s common stock. The holders of the Series B convertible preferred stock are not entitled to receive
any dividends other than any dividends paid on account of the common stock. In the event of any voluntary or involuntary liquidation,
dissolution or winding up of the Company, the holders shall be entitled to receive out of the assets, whether capital or surplus, of
the Company the same amount that a holder of common stock would receive if the Preferred Stock were fully converted (disregarding for
such purposes any conversion limitations hereunder) to common stock which amounts shall be paid pari passu with all holders of common
stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has been authorized to issue <span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20220630_zU8en1ohRcFh" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000,000</ix:nonFraction></span>&#160;&#160; shares of common stock, $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220630_z9nXFbN4Is9d" title="Common stock, at par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.086</ix:nonFraction></span> par value. Each share of issued and outstanding
common stock shall entitle the holder thereof to fully participate in all shareholder meetings, to cast one vote on each matter with
respect to which shareholders have the right to vote, and to share ratably in all dividends and other distributions declared and paid
with respect to common stock, as well as in the net assets of the corporation upon liquidation or dissolution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2022, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220101__20220131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zBaJaNeZdYhf" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-01-012022-01-31_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,670,892</ix:nonFraction></span> shares of common stock through the Private Placement for the purpose of raising capital. See
Note 5 - <i>Warrant Liabilities </i>for proceeds received by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2022, the Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20220101__20220131__us-gaap--BusinessAcquisitionAxis__custom--MedigapAcquisitionMember_zo3UYAsVrpOa" title="Stock issued during period, shares, acquisitions"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2022-01-012022-01-31_custom_MedigapAcquisitionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">606,037</ix:nonFraction></span> shares of common stock pursuant to the Medigap Acquisition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2022, upon agreement with Series A warrant holders, <span id="xdx_909_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_c20220101__20220131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAWarrantMember_zM2qGfECdDz2" title="Exercise of Series A warrants, shares"><ix:nonFraction name="RELI:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="From2022-01-012022-01-31_custom_SeriesAWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">375,000</ix:nonFraction></span> warrants were exercised at a price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAWarrantMember_zdJ3HwqjmuD6" title="Warrants exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-01-31_custom_SeriesAWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.60</ix:nonFraction> </span>into <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20220101__20220131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zSGdXGziHjrb" title="Number of shares converted"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" contextRef="From2022-01-012022-01-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">375,000</ix:nonFraction></span> of the Company&#8217;s
common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2022, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220301__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zI8zsxILvXF6" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-03-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000</ix:nonFraction></span> shares of the Company&#8217;s common stock due to the vesting of <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20220301__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQLYbrI32gVg" title="Vesting of stock award"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2022-03-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000</ix:nonFraction></span> stock awards pursuant to
an employee agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May and June 2022, <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220531__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zbZVYt08oH8k" title="Class of common stock warrant"><span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zlGw6gPWHPPd" title="Class of common stock warrant"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-05-31_custom_SeriesCPrepaidWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-06-30_custom_SeriesCPrepaidWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,276,929</ix:nonFraction></ix:nonFraction></span></span> Series C prepaid warrants were exchanged for <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220531__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zcNTWEVQoXD6" title="Class of common stock warrant"><span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z3aBcx6kKgpl"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-05-31_custom_SeriesCPrepaidWarrantsMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-06-30_custom_SeriesCPrepaidWarrantsMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,276,929</ix:nonFraction></ix:nonFraction></span></span> shares of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2022 and December 31, 2021, there were <span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20220630_zlsq1U6jo7Gj" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,614,038</ix:nonFraction></span> and <span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20211231_z0PZemuTQLi" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,956,109</ix:nonFraction></span> shares of Common Stock outstanding, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series
A warrant holders exercised <span id="xdx_90B_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_c20220101__20220131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAWarrantMember_zvz5rZbio7k2" title="Exercise of Series A warrants, shares"><ix:nonFraction name="RELI:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="From2022-01-012022-01-31_custom_SeriesAWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">375,000</ix:nonFraction></span> Series A warrants in January 2022, resulting in <span id="xdx_904_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_c20220101__20220630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAWarrantMember_zRIPYEAjfFwg" title="Exercise of Series A warrants, shares"><ix:nonFraction name="RELI:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="From2022-01-012022-06-30_custom_SeriesAWarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,695,000</ix:nonFraction></span> of Series A warrants remaining issued and
outstanding as of June 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2022, as a result of the issuance of common stock in the January 2022 stock offering and the Medigap Acquisition, the Company
received a deficiency notification from Nasdaq indicating violation of Listing Rule 5365(a). As part of its remediation plan, in March
2022, the Company entered into Exchange Agreements with the holders of common stock issued in January 2022. Pursuant to the Exchange
Agreements, the Company issued <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220131__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zqYcwUxBI7qj" title="Class of common stock warrant"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-01-31_custom_SeriesCPrepaidWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,276,929</ix:nonFraction></span> Series C prepaid warrants in exchange for <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220131__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZT8f04HNg4k" title="Class of common stock warrant"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-01-31_custom_SeriesCPrepaidWarrantsMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,276,929</ix:nonFraction></span> shares of the Company&#8217;s common stock.
Additionally, as compensation for entering into the Exchange Agreements, the Company issued <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220131__us-gaap--StatementClassOfStockAxis__custom--SeriesDPrepaidWarrantsMember_zWuFt60SfqTd" title="Class of common stock warrant"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-01-31_custom_SeriesDPrepaidWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,222,498</ix:nonFraction></span> Series D prepaid warrants to the
January 2022 stock offering investors for no additional consideration. The fair value of the Series D prepaid warrants was treated as
a deemed dividend and accordingly was treated as a reduction from income available to common stockholders in the calculation of earnings
per share. Refer to Note 7, <i>Earnings (Loss) Per Share</i> for additional information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May and June 2022, the <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220531__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zb3O69O4dbX6" title="Class of common stock warrant"><span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220501__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zSmn87ckgUdi" title="Class of common stock warrant"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-05-31_custom_SeriesCPrepaidWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-05-01_custom_SeriesCPrepaidWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,276,929</ix:nonFraction></ix:nonFraction></span></span> Series C prepaid warrants were converted for <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220531__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zY9dYOZBTsH5" title="Class of common stock warrant"><span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxY3yrZ000L1" title="Class of common stock warrant"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-05-31_custom_SeriesCPrepaidWarrantsMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-06-30_custom_SeriesCPrepaidWarrantsMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,276,929</ix:nonFraction></ix:nonFraction></span></span> shares of the Company&#8217;s common stock for
an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_z8YWEXs0acW8" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-06-30_custom_SeriesCPrepaidWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span>.&#160;&#160; Through June 30, 2022, the Company has received payments of $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfDebt_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zErpyQVZXEL7" title="Proceeds from issuance of debt"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2022-01-012022-06-30_custom_SeriesCPrepaidWarrantsMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,336</ix:nonFraction></span> from one investor for these
issuances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity-based
Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
February and May 2022, three existing employees were awarded  bonuses consisting&#8239;of shares of the Company&#8217;s common stock to
be vested immediately. The shares granted in 2022 were valued at $<span id="xdx_903_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensation_c20220101__20220630__srt--TitleOfIndividualAxis__custom--ThreeEmployeesMember_zLor3DTAoOj8" title="Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture"><ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation" contextRef="From2022-01-012022-06-30_custom_ThreeEmployeesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">766,250</ix:nonFraction></span>. For the three and six months ended June 30, 2022, compensation
expense on these grants totaled $<span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_c20220401__20220630__srt--TitleOfIndividualAxis__custom--ThreeEmployeesMember_zdMEqhb3VD1h"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2022-04-012022-06-30_custom_ThreeEmployeesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20220630__srt--TitleOfIndividualAxis__custom--ThreeEmployeesMember_zOoRq5eusDfj"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2022-01-012022-06-30_custom_ThreeEmployeesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">766,250</ix:nonFraction></span>, respectively. As of June 30, 2022, these shares have not been issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2022&#160;, pursuant to an agreement between the Company and an Executive, the Executive will be compensated with <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxAHuZdmg8de" title="Class of common stock warrant"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-04-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">60,000</ix:nonFraction></span> shares
of the Company&#8217;s Common stock. These shares vest quarterly over a three-year period. The shares granted were valued at $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220101__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbCboKSbIbp3" title="Issuance of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember168711000" format="ixt:numdotdecimal" decimals="0" unitRef="USD">178,200</ix:nonFraction></span>
at the date of the grant. For the three and six months ended June 30, 2022, compensation expense on this grant was $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zlXTjO4ApCo5" title="Share based compensation expense"><span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z4mQzasManxf" title="Share based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember168711000" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70,721</ix:nonFraction></ix:nonFraction></span></span>. As of June
30, 2022, no shares were issued under this contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:EarningsPerShareTextBlock"><p id="xdx_80C_eus-gaap--EarningsPerShareTextBlock_zktdUqg5ylQc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7. <span id="xdx_825_zZICfQ5klw4i">EARNINGS (LOSS) PER SHARE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings per common share (&#8220;EPS&#8221;) applicable to common stockholders is computed by dividing earnings applicable to common
stockholders by the weighted-average number of common shares outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
there is a loss from operations, diluted EPS is computed in the same manner as basic EPS is computed. Similarly, if the Company has net
income but its preferred dividend adjustment made in computing income available to common stockholders results in a net loss available
to common stockholders, diluted EPS would be computed in the same manner as basic EPS. Accordingly, for the three and six months ended
June 30, 2021, due to a net loss, the outstanding Series A Convertible Preferred Stock is considered anti-dilutive in which <span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zuWvqITue2X8" title="Anti-dilutive securities"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,076</ix:nonFraction></span> and
<span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210101__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zRCA3HELvUNh" title="Anti-dilutive securities"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-01-012021-06-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,167</ix:nonFraction></span> were issued and outstanding at June 30, 2022 and 2021, respectively. Series A Convertible Preferred Stock is convertible into common
stock on a <span id="xdx_90D_eus-gaap--PreferredStockConversionBasis_c20220101__20220630_zKJa9trDwEl1" title="Stock conversion basis description"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="us-gaap:PreferredStockConversionBasis">10 for 1 basis</ix:nonNumeric></span>. The outstanding stock options are considered anti-dilutive in which <span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zMYaxFYgLTgg" title="Anti-dilutive option securities"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-06-30_us-gaap_EmployeeStockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">163,925</ix:nonFraction></span> and <span id="xdx_905_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_z2Fn11fm1qK7" title="Anti-dilutive option securities"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2021-01-012021-06-30_us-gaap_EmployeeStockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">163,913</ix:nonFraction></span> were issued and outstanding
at June 30, 2022 and 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following represents the impact of options, stock awards, preferred stock and warrants on basic and diluted EPS for the three and six
months ended June 30, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding
    stock options are considered anti-dilutive, due to the exercise price being greater than the average market price, in which <span id="xdx_906_ecustom--AntidilutiveSharesIssuedAndOutstanding_iI_pid_c20220630_z06pGWt4J6ce" title="Antidilutive shares Issued and Outstanding"><ix:nonFraction name="RELI:AntidilutiveSharesIssuedAndOutstanding" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">163,925</ix:nonFraction></span>,
    were issued and outstanding at June 30, 2022. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested
    Stock awards in the amount of <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20220630_zSvA29IIh2Ui" title="Vested stock awards"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,820</ix:nonFraction></span> have been included in the basic and diluted EPS calculation for the three and six months ended
    June 30, 2022, and nonvested stock awards in the amount of <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_pid_c20220401__20220630_zVNWqpitU5Qa" title="Non-vested stock awards"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,916</ix:nonFraction></span> and <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_pid_c20220101__20220630_zvyMH0Tp4iU4" title="Non-vested stock awards"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">46,084</ix:nonFraction></span> have been included in the diluted EPS calculation for
    the three and six months ended June 30, 2022, respectively. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding
    Series A warrants are considered anti-dilutive, due to the exercise price being greater than the average market price, in which <span id="xdx_903_ecustom--WarrantSharesIssued_iI_pid_c20220630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAWarrantsMember_z2rCT7ziEZPg" title="Warrant shares issued"><span id="xdx_901_ecustom--WarrantSharesOutstanding_iI_pid_c20220630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAWarrantsMember_zPXwp3Lgw5yc" title="Warrant shares outstanding"><ix:nonFraction name="RELI:WarrantSharesIssued" contextRef="AsOf2022-06-30_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="RELI:WarrantSharesOutstanding" contextRef="AsOf2022-06-30_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,695,000</ix:nonFraction></ix:nonFraction></span></span>,
    were issued and outstanding at June 30, 2022. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series
    B Convertible Preferred stock are considered dilutive and included in the calculation of diluted EPS. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantLiabilityMember_zXvb3fErbeIg" title="Antidilutive warrant liabilities"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-06-30_custom_SeriesBWarrantLiabilityMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">631,276</ix:nonFraction></span> potential settlement shares of the warrant liability associated with Series B Warrants are considered dilutive and included
    in the calculation of diluted EPS for the six months ended June 30, 2022. The effects of the warrants that have been recorded in
    net income on the condensed consolidated statement of operations have been eliminated in the calculation of diluted EPS for the three
    and six months ended June 30, 2022. </span></td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    potential settlement shares of the warrant liability associated with the Placement Agent Warrants are considered dilutive and anti-dilutive
    for the three and six months ended June 30, 2022, respectively, and is included in Diluted EPS calculation for the three months ended
    June 30, 2022. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_pid_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zpxOmYa9AMG2" title="Issuance of prefunded  Series Warrants in exchange for common shares, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" contextRef="From2022-01-012022-06-30_custom_SeriesCPrepaidWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,276,929</ix:nonFraction></span> Series C prepaid warrants have been exercised in 2022. <span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220401__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zhZ6tpsEXtQj" title="Antidilutive shares"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-04-012022-06-30_custom_SeriesCPrepaidWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,676,737</ix:nonFraction></span> and <span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_z8UsLsexVx4a" title="Antidilutive shares"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-06-30_custom_SeriesCPrepaidWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,743,896</ix:nonFraction></span> weighted shares were included as outstanding
    shares in the calculation of basic and diluted EPS for the period prior to exercise for the three and six months ended June 30, 2022,
    respectively, because they represent shares issuable for only nominal consideration. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_pid_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesDPrepaidWarrantsMember_zgmlpR6uLjp2" title="Stock Issued During Period, Shares, Conversion of Units"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" contextRef="From2022-01-012022-06-30_custom_SeriesDPrepaidWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,222,497</ix:nonFraction></span> Series D prepaid warrants have been included as outstanding shares in the calculation of basic and diluted EPS, as they
    represent shares issuable for only nominal consideration. The Company reduced income available to common stockholders by $<span id="xdx_900_ecustom--IssuanceOfSeriesDWarrants_c20220401__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesDPrepaidWarrantsMember_zPyTO4A1n9W7" title="Issuance of Series D Warrants"><ix:nonFraction name="RELI:IssuanceOfSeriesDWarrants" contextRef="From2022-04-012022-06-30_custom_SeriesDPrepaidWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_907_ecustom--IssuanceOfSeriesDWarrants_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesDPrepaidWarrantsMember_zdAivslJOLse" title="Issuance of Series D Warrants"><ix:nonFraction name="RELI:IssuanceOfSeriesDWarrants" contextRef="From2022-01-012022-06-30_custom_SeriesDPrepaidWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,930,335</ix:nonFraction></span>
    for the associated Series D deemed dividend in the calculation of basic and diluted EPS for the three and six months ended June 30,
    2022, respectively. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zGNto2cMfdSb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
calculations of basic and diluted EPS, are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zMbpD2rSg2W9" style="display: none">SCHEDULE
OF CALCULATIONS OF BASIC AND DILUTED EPS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20220401__20220630_zQy9RwStOng" style="font-weight: bold; text-align: center">Three Months</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20210401__20210630_zaNbmJd7aBi3" style="font-weight: bold; text-align: center">Three Months</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_mtNILzGtK_z3QE9XkS9JHh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Net income (loss)</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,495,691</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,276,886</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_406_ecustom--DeemedDividend_iN_di_z3wG0v2CD7O7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Deemed dividend</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1724">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1725">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_z0Dv02ZGUW7e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net income (loss), numerator, basic computation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,495,691</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,276,886</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_z6b43Eqt5ZVa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Recognition and change in fair value of warrant liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,633,251</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1731">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_ztJzbLqg3i7a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net income (loss), numerator, diluted computation</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,137,560</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,276,886</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zGmscDeG1a3a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Weighted average shares - denominator basic computation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,738,290</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,934,489</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_zjRIAgRGFSnb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Effect of stock awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,916</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1740">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--EffectOfSeriesBWarrantLiability_zIR34DvUQKwe" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Effect of Series B warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_z5khnvLLB4ek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Effect of preferred stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,219,084</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1746">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zUaDKLhgZ1jj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Weighted average shares, as adjusted - denominator diluted computation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,989,290</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,934,489</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareBasic_z8Zf0k6QXEPi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Earnings (loss) per common share &#8211; basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.56</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.12</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--EarningsPerShareDiluted_za5O3Nkr9ovc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Earnings (loss) per common share &#8211; diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.10</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.12</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20220101__20220630_zlsBe1hLCvoe" style="font-weight: bold; text-align: center">Six Months</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20210101__20210630_zROC7RkXvoOa" style="font-weight: bold; text-align: center">Six Months</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_mtNILzGtK_zWTVW5qp2ZKl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Net income (loss)</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,835,692</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,890,812</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_406_ecustom--DeemedDividend_iN_di_zy3EHCOA6MJh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Deemed dividend</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="RELI:DeemedDividend" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,930,335</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1761">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zjSYIyZNDBYe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net income (loss), numerator, basic computation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,905,357</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,890,812</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_zlO26JmH0dEb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Recognition and change in fair value of warrant liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,748,163</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1767">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_zILyoa8V5bph" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net income (loss), numerator, diluted computation</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,842,806</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,890,812</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_z5DdAS8TLt92" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Weighted average shares - denominator basic computation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,238,285</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,259,738</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ziTY8ZDdAGJ9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Effect of stock awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">46,084</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1776">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--EffectOfSeriesBWarrantLiability_zZk2cRma7Gyb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Effect of Series B warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:EffectOfSeriesBWarrantLiability" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,219,084</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1779">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_zNVX6WXu1hHl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Effect of preferred stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">631,276</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1782">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zNd2Utv4N0Lh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Weighted average shares, as adjusted - denominator diluted computation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,134,729</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,259,738</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareBasic_zwCrgzWhgowd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Earnings (loss) per common share - basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.75</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.20</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--EarningsPerShareDiluted_zU09KYCDAofg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Earnings (loss) per common share - diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.59</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.20</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zTeLKq3ljaWd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_80E_eus-gaap--LesseeOperatingLeasesTextBlock_znNe9KsdI9N1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8. <span id="xdx_82B_zyTtZJ2h31F3">LEASES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
lease expense for the three months ended June 30, 2022 and 2021 was $<span id="xdx_906_eus-gaap--OperatingLeaseExpense_c20220401__20220630_zpuqXvMYyyKi" title="Operating Lease, Expense"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">156,750</ix:nonFraction></span> and $<span id="xdx_903_eus-gaap--OperatingLeaseExpense_c20210401__20210630_zqEAiHLniY9k" title="Operating Lease, Expense"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,931</ix:nonFraction></span> respectively. Operating lease expense for the
six months ended June 30, 2022 and 2021 was $<span id="xdx_90B_eus-gaap--OperatingLeaseExpense_c20220101__20220630_zNgmuVL40sh9" title="Operating Lease, Expense"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">275,174</ix:nonFraction> </span>and $<span id="xdx_904_eus-gaap--OperatingLeaseExpense_c20210101__20210630_zj9i9MeHSVsc" title="Operating Lease, Expense"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">112,199</ix:nonFraction></span> respectively. As of June 30, 2022, the weighted average remaining lease
term and weighted average discount rate for the operating leases were <span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_zUVbNOGp7kJ2" title="Weighted average remaining lease term"><ix:nonNumeric contextRef="AsOf2022-06-30" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">4.01</ix:nonNumeric></span> years and <span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20220630_z5pUd0neE8Si" title="Weighted average discount rate"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.76</ix:nonFraction></span>% respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><p id="xdx_893_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zZU6U7jblKgj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
minimum lease payment under these operating leases consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zd78BSLOcZn8" style="display: none">SCHEDULE
OF FUTURE MINIMUM LEASE PAYMENT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Year ending December 31,</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20220630_zSzHj4i5aRB6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating Lease</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Obligations</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzuGy_zrl6b1uLhx22" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: justify">2022</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">303,256</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzuGy_zyUHSSjV4Mva" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">546,275</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzuGy_zMRy43sOwxZ6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">253,908</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maLOLLPzuGy_zNa8czfeKkLk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">144,124</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_maLOLLPzuGy_zo3z7Tf8TrRd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">113,738</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_maLOLLPzuGy_zuD6r0ScbBtk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">268,202</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzuGy_zqurSQ91mXK7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Total undiscounted operating lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,629,503</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_z69dDRK59Wng" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Less: Imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">169,978</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiability_iI_pp0p0_zlvzQi6wVAH" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Present value of operating lease liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,459,525</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zMTFmP2ar4ze" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zzO75Xr7Pdxf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9. <span id="xdx_820_zCNq6TafMDR1">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Legal
Contingencies</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to various legal proceedings and claims, either asserted or unasserted, arising in the ordinary course of business.
While the outcome of these claims cannot be predicted with certainty, management does not believe the outcome of any of these matters
will have a material adverse effect on our business, financial position, results of operations, or cash flows, and accordingly, no legal
contingencies are accrued as of June 30, 2022 and December 31, 2021. Litigation relating to the insurance brokerage industry is not uncommon.
As such the Company, from time to time have been, subject to such litigation. No assurances can be given with respect to the extent or
outcome of any such litigation in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Earn-out
liabilities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="RELI:EarnOutLiabilitiesTableTextBlock"><p id="xdx_897_ecustom--EarnOutLiabilitiesTableTextBlock_zrOvKquhzsGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following outlines changes to the Company&#8217;s earn-out liability balances inclusive of accumulated accretion for the respective period
ended June 30, 2022 and December 31, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8BA_ztiXawqIV94l">SCHEDULE
OF EARN-OUT LIABILITY</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B9_us-gaap--BusinessAcquisitionAxis_custom--CommercialSolutionsOfInsuranceAgencyLLCMember_zh0EZXvRKAX" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">CCS</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--BusinessAcquisitionAxis_custom--FortmanInsuranceAgencyLLCMember_zMEY8WEGwINg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fortman</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BF_us-gaap--BusinessAcquisitionAxis_custom--SouthwesternMontanaInsuranceCenterIncMember_zZmetVieGoTh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Montana</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BD_us-gaap--BusinessAcquisitionAxis_custom--AltruisBenefitsConsultantsIncMember_z49BTelcNEJ8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Altruis</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B0_us-gaap--BusinessAcquisitionAxis_custom--JPKushAndAssociatesIncMember_zlio9T0dcBU8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Kush</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--BusinessAcquisitionAxis_custom--BarraMember_zCq2Ncn36q6c" style="border-bottom: Black 1.5pt solid; font-weight: bold">Barra</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_zTCixRRcCqWe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_436_c20220101__20220630_eus-gaap--BusinessCombinationContingentConsiderationLiability_iS_z4YGdNEh3432" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%">Ending balance December 31, 2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1831">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2021-12-31_custom_FortmanInsuranceAgencyLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">515,308</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2021-12-31_custom_SouthwesternMontanaInsuranceCenterIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">615,969</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2021-12-31_custom_AltruisBenefitsConsultantsIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">992,868</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2021-12-31_custom_JPKushAndAssociatesIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,689,733</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1836">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,813,878</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--ChangesDueToAcquisitions_zvYs5RPeYF01" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Changes due to acquisitions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1839">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1840">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1841">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1842">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1843">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:ChangesDueToAcquisitions" contextRef="From2022-01-012022-06-30_custom_BarraMember168706375" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:ChangesDueToAcquisitions" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ChangesDueToPayments_zrM2j0F5svp7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Changes due to payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RELI:ChangesDueToPayments" contextRef="From2022-01-012022-06-30_custom_SouthwesternMontanaInsuranceCenterIncMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">326,935</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RELI:ChangesDueToPayments" contextRef="From2022-01-012022-06-30_custom_AltruisBenefitsConsultantsIncMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">84,473</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RELI:ChangesDueToPayments" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">411,408</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_400_ecustom--ChangesDueToFairValueAdjustments_z4SvK01G4Msl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Changes due to fair value adjustments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1855">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="RELI:ChangesDueToFairValueAdjustments" contextRef="From2022-01-012022-06-30_custom_FortmanInsuranceAgencyLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,620</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="RELI:ChangesDueToFairValueAdjustments" contextRef="From2022-01-012022-06-30_custom_SouthwesternMontanaInsuranceCenterIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,741</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1858">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="RELI:ChangesDueToFairValueAdjustments" contextRef="From2022-01-012022-06-30_custom_JPKushAndAssociatesIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">334,602</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="RELI:ChangesDueToFairValueAdjustments" contextRef="From2022-01-012022-06-30_custom_BarraMember168706375" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">50,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="RELI:ChangesDueToFairValueAdjustments" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,963</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20220101__20220630_eus-gaap--BusinessCombinationContingentConsiderationLiability_iE_zclHYT4qFVQ8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Ending balance June 30, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1863">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2022-06-30_custom_FortmanInsuranceAgencyLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">547,928</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2022-06-30_custom_SouthwesternMontanaInsuranceCenterIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">326,775</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2022-06-30_custom_AltruisBenefitsConsultantsIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">908,395</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2022-06-30_custom_JPKushAndAssociatesIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,024,335</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2022-06-30_custom_BarraMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">550,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,357,433</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B9_us-gaap--BusinessAcquisitionAxis_custom--CommercialSolutionsOfInsuranceAgencyLLCMember_zLOPpVA4E4P2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">CCS</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--BusinessAcquisitionAxis_custom--FortmanInsuranceAgencyLLCMember_zxubZrMq7Cyl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fortman</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BF_us-gaap--BusinessAcquisitionAxis_custom--SouthwesternMontanaInsuranceCenterIncMember_zrvlD6iWxtM5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Montana</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BD_us-gaap--BusinessAcquisitionAxis_custom--AltruisBenefitsConsultantsIncMember_zGs6z9B0sfqd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Altruis</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B0_us-gaap--BusinessAcquisitionAxis_custom--JPKushAndAssociatesIncMember_z3NRZrpTcyck" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Kush</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_zRR8aMJHhCA8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_433_c20210101__20211231_eus-gaap--BusinessCombinationContingentConsiderationLiability_iS_zpm4CbaBI2ua" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%">Ending balance December 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2020-12-31_custom_CommercialSolutionsOfInsuranceAgencyLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">81,368</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2020-12-31_custom_FortmanInsuranceAgencyLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">432,655</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2020-12-31_custom_SouthwesternMontanaInsuranceCenterIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">522,553</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2020-12-31_custom_AltruisBenefitsConsultantsIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,894,842</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1875">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,931,418</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--ChangesDueToBusinessCombinations_z1hiuKVdAjzi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Changes due to business combinations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1878">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1879">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1880">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1881">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:ChangesDueToBusinessCombinations" contextRef="From2021-01-012021-12-31_custom_JPKushAndAssociatesIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,694,166</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:ChangesDueToBusinessCombinations" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,694,166</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ChangesDueToPayments_zJHiGXgPK9s6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Changes due to payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1885">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1886">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1887">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RELI:ChangesDueToPayments" contextRef="From2021-01-012021-12-31_custom_AltruisBenefitsConsultantsIncMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">452,236</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1889">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RELI:ChangesDueToPayments" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">452,236</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_400_ecustom--ChangesDueToFairValueAdjustments_zp20CqLcuidf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Changes due to fair value adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1892">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:ChangesDueToFairValueAdjustments" contextRef="From2021-01-012021-12-31_custom_FortmanInsuranceAgencyLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">82,653</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="RELI:ChangesDueToFairValueAdjustments" contextRef="From2021-01-012021-12-31_custom_SouthwesternMontanaInsuranceCenterIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,416</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RELI:ChangesDueToFairValueAdjustments" contextRef="From2021-01-012021-12-31_custom_AltruisBenefitsConsultantsIncMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">449,738</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RELI:ChangesDueToFairValueAdjustments" contextRef="From2021-01-012021-12-31_custom_JPKushAndAssociatesIncMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,433</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="RELI:ChangesDueToFairValueAdjustments" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">278,102</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_402_ecustom--ChangesDueToWriteoffs_zs7oQmvTp6Aj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Changes due to write-offs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="RELI:ChangesDueToWriteoffs" contextRef="From2021-01-012021-12-31_custom_CommercialSolutionsOfInsuranceAgencyLLCMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">81,368</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1900">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1901">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1902">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1903">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="RELI:ChangesDueToWriteoffs" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">81,368</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_431_c20210101__20211231_eus-gaap--BusinessCombinationContingentConsiderationLiability_iE_zvDSOuCOQslb" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Ending balance December 31, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1906">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2021-12-31_custom_FortmanInsuranceAgencyLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">515,308</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2021-12-31_custom_SouthwesternMontanaInsuranceCenterIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">615,969</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2021-12-31_custom_AltruisBenefitsConsultantsIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">992,868</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2021-12-31_custom_JPKushAndAssociatesIncMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,689,733</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiability" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,813,878</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zijsEXqovf5b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><p id="xdx_814_zNAnuEawBs46" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F1_002"></span>Item
2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Overview</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reliance
Global Group, Inc. (formerly known as Ethos Media Network, Inc.) was incorporated in Florida on August 2, 2013. In September 2018, Reliance
Global Holdings, LLC, a related party, purchased a controlling interest in the Company. Ethos Media Network, Inc. was renamed Reliance
Global Group, Inc. on October 18, 2018.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
operate as a diversified company engaging in business in the insurance market, as well as other related sectors. Our focus is to grow
the Company by pursuing an aggressive acquisition strategy, initially and primarily focused upon wholesale and retail insurance agencies.
The Company is controlled by the same management team as Reliance Global Holdings, LLC (&#8220;Reliance Holdings&#8221;), a New York
based firm that is the owner and operator of numerous companies with core interests in real estate and insurance. Our relationship with
Reliance Holdings provides us with significant benefits: (1) experience, knowhow, and industry relations; (2) a source of acquisition
targets currently under Reliance Holdings&#8217; control; and (3) financial and logistics assistance. We are led and advised by a management
team that offers over 100 years of combined business expertise in real estate, insurance, and the financial service industry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the insurance sector, our management has extensive experience acquiring and managing insurance portfolios in several states, as well
as developing specialized programs targeting niche markets. Our primary strategy is to identify specific risk to reward arbitrage opportunities
and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale
and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset
value appreciation while generating interim cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of our growth and acquisition strategy, we continue to survey the current insurance market for value-add acquisition
opportunities. As of June 30, 2022, we have acquired ten insurance agencies, including both affiliated and unaffiliated companies
and long term, we seek to conduct all transactions and acquisitions through our direct operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
the next 12 months, we plan to focus on the expansion and growth of our business through continued asset acquisitions in insurance markets
and organic growth of our current insurance operations through geographic expansion and market share growth.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
we launched our 5MinuteInsure.com (&#8220;5MI&#8221;) platform during 2021 which expanded our national footprint. 5MI is an all new and
high-tech proprietary tool developed by us as a business to consumer portal which enables consumers to compare and purchase car and home
insurance in a time efficient and effective manner. 5MI taps into the growing number of online shoppers and utilizes advanced artificial
intelligence and data mining techniques, to provide competitive insurance quotes in around 5 minutes with minimal data input needed from
the consumer. The platform launched during the summer of 2021 and currently operates in 46 states offering coverage with up to 30 highly
rated insurance carriers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">With the acquisition of Barra, we launched RELI Exchange,
our business-to-business (B2B) InsurTech platform and agency partner network that builds on the artificial intelligence and data mining
backbone of 5MinuteInsure.com. Through RELI Exchange we on-board agency partners and provide them an InsurTech platform which combines
the best of digital and human capabilities by providing agents and customers quotes from multiple carriers within minutes. Since inception,
RELI Exchange, has increased it&#8217;s agent roster by more than 30% in just three months.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
Trends and Uncertainties</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
insurance intermediary business is highly competitive, and we actively compete with numerous firms for customers, properties and insurance
companies, many of which have relationships with insurance companies, or have a significant presence in niche insurance markets that
may give them an advantage over us. Other competitive concerns may include the quality of our products and services, our pricing and
the ability of some of our customers to self-insure and the entrance of technology companies into the insurance intermediary business.
A number of insurance companies are engaged in the direct sale of insurance, primarily to individuals, and do not pay commissions to
agents and brokers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
Instruments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments as of June 30, 2022, consist of  derivative warrants. Accounting treatment is to record the derivative financial instruments at their fair values as
of the inception/issuance date of and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded
as non-operating, non-cash gain or loss at each balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Insurance
Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
insurance operations focus on the acquisition and management of insurance agencies throughout the U.S. Our primary focus is to pinpoint
undervalued wholesale and retail insurance agencies with operations in growing or underserved segments (including healthcare and Medicare,
as well as personal and commercial insurance lines). We then focus on expanding their operations on a national platform and improving
operational efficiencies in order to achieve asset value appreciation while generating interim cash flows. In the insurance sector, our
management team has over 100 years of experiences acquiring and managing insurance portfolios in several states, as well as developing
specialized programs targeting niche markets. We plan to accomplish these objectives by acquiring wholesale and retail insurance agencies
it deems to represent a good buying opportunity (as opposed to insurance carriers) as insurance agencies bear no insurance risk. Once
acquired, we plan to develop them on a national platform to increase revenues and profits through a synergetic structure. The Company
is initially focused on segments that are underserved or growing, including healthcare and Medicare, as well as personal and commercial
insurance lines.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Insurance
Acquisitions and Strategic Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the balance sheet date, we have acquired ten insurance brokerages (see table below), including both acquisitions of affiliated companies
(<i>i.e.</i>, owned by Reliance Holdings before the acquisition) and unaffiliated companies. As our acquisition strategy continues, our
reach within the insurance arena can provide us with the ability to offer lower rates, which could boost our competitive position within
the industry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Acquired
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Location
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Line
    of Business</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Status</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    Benefits Alliance, LLC (USBA)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    24, 2018</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michigan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Health
    Insurance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Affiliated</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    Benefit Solutions, LLC (EBS)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    24, 2018</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michigan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Health
    Insurance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Affiliated</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercial
    Solutions of Insurance Agency, LLC (CCS or Commercial Solutions)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    1, 2018</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Jersey</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">P&amp;C
    &#8211; Trucking Industry</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unaffiliated</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Southwestern
    Montana Insurance Center, Inc. (Southwestern Montana or Montana)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    1, 2019</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Montana</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Group
    Health Insurance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unaffiliated</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fortman
    Insurance Agency, LLC (Fortman or Fortman Insurance)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    1, 2019</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ohio</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">P&amp;C
    and</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Health
    Insurance</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unaffiliated</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Altruis
    Benefits Consultants, Inc. (Altruis)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    1, 2019</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michigan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Health
    Insurance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unaffiliated</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">UIS
    Agency, LLC (UIS)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    17, 2020</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Health
    Insurance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unaffiliated</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.P.
    Kush and Associates, Inc. (Kush)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    1, 2021</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michigan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Health
    Insurance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unaffiliated</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Medigap
    Healthcare Insurance Agency, LLC (Medigap) </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    10, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Florida</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Health
    Insurance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unaffiliated</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Barra
    &amp; Associates, LLC</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    26, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Illinois</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Health
    Insurance</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unaffiliated</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>J.P.
Kush and Associates, Inc. Transaction</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 1, 2021, we entered into a Purchase Agreement with J.P. Kush and Associates, Inc. whereby we purchased the business and certain assets
noted within the Purchase Agreement (the &#8220;Kush Acquisition&#8221;) for a total purchase price of $3,644,166. The purchase price
was paid with a cash payment of $1,900,000, $50,000 in restricted shares of our common stock, in a transaction exempt from registration
under Section 4(a)(2) of the Securities Act of 1933, as amended, and an earn-out payment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Kush Acquisition was accounted for as a business combination in accordance with the acquisition method under the guidance in ASC 805-10
and 805-20. Accordingly, the total purchase consideration was allocated to intangible assets acquired based on their respective estimated
fair values. The acquisition method of accounting requires, among other things, that assets acquired, and liabilities assumed, if any,
in a business purchase combination be recognized at their fair values as of the acquisition date. The process for estimating the fair
values of identifiable intangible assets and certain tangible assets requires the use of significant estimates and assumptions, including
estimating future cash flows, developing appropriate discount rates, estimating the costs, and timing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
allocation of the purchase price in connection with the Kush Acquisition was calculated as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Description</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful Life</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Years)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Accounts receivable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">291,414</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 16%; text-align: center">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade name and trademarks</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">685,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">5</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">551,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">10</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Non-competition agreements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">827,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">5</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Goodwill</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,288,552</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indefinite</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,644,166</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
of $1,288,552 arising from the Kush Acquisition consisted of the value of the employee workforce and the residual value after all identifiable
intangible assets were valued. Goodwill recognized pursuant to the Kush Acquisition is currently expected to be deductible for income
tax purposes. Total acquisition costs for the Kush Acquisition incurred were $58,092 recorded as a component of General and administrative
expenses. The approximate revenue and net profit for the acquired business as a standalone entity per ASC 805 from January 1, 2021 to
April 30, 2021 was $380,349 and $166,667, respectively, and from January 1, 2020 to December 31, 2020, $1,141,047 and $500,000, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Medigap
Healthcare Insurance Agency, LLC Transaction</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 10, 2022, pursuant to an asset purchase agreement, dated December 21, 2021, we completed the acquisition of all of the assets
of Medigap Healthcare Insurance Company, LLC (&#8220;Medigap&#8221;) for a purchase price of $20,096,250 consisting of: (i) payment to
Medigap of $18,138,750 in cash and (ii) the issuance to Medigap of 606,037 shares of the Company&#8217;s restricted common stock in a
transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended. The purchase price is subject to
post-closing adjustment to reconcile certain pre-closing credits and liabilities of the parties. &#160;The shares issued to Medigap as
part of the purchase price are subject to lock up arrangements pursuant to which 50% of the shares may be sold after the one-year anniversary
of the date of closing of the transaction and the balance of the shares may be sold after the second-year anniversary of the date of
closing of the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
acquisition of Medigap was accounted for as a business combination in accordance with the acquisition method under the guidance in ASC
805-10 and 805-20. Accordingly, the total purchase consideration was allocated to intangible assets acquired based on their respective
estimated fair values. The acquisition method of accounting requires, among other things, that assets acquired, and liabilities assumed,
if any, in a business purchase combination be recognized at their fair values as of the acquisition date. The process for estimating
the fair values of identifiable intangible assets and certain tangible assets requires the use of significant estimates and assumptions,
including estimating future cash flows, developing appropriate discount rates, estimating the costs, and timing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
allocation of the purchase price in connection with the acquisition of Medigap was calculated as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Description</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Useful Life (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Property, plant and equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">20,666</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 16%; text-align: center">6</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Right-of-use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">317,787</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Trade name and trademarks</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">340,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">15</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,550,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">12</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Technology</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">67,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">3</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Backlog</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">210,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">1</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Chargeback reserve</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,484,473</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(317,787</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Goodwill</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,199,008</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indefinite</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">22,902,201</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
of $19,199,008 arising from the acquisition of Medigap consisted of the value of the employee workforce and the residual value after
all identifiable intangible assets were valued. Goodwill recognized pursuant to the acquisition of Medigap is currently expected to be
deductible for income tax purposes. Total acquisition costs for the acquisition of Medigap incurred were $94,065 recorded as a component
of General and administrative expenses. The approximate revenue and net profit or loss for the acquired business as a standalone entity
per ASC 805 from January 10, 2022 to June 30, 2022 was $2,537,061 and a loss of $412,943, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Barra
&amp; Associates, LLC Transaction</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
April 26, 2022, we entered into an asset purchase agreement (the &#8220;APA&#8221;) with Barra &amp; Associates, LLC (&#8220;Barra&#8221;)
pursuant to which the Company purchased all of the assets of Barra &amp; Associates, LLC on April 26, 2022 for a purchase price in the
amount of $7,725,000 in cash, with $6,000,000 paid to Barra at closing, $1,125,000 payable in six months from closing, and a final earnout
of $600,000 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="background-color: white">payable
over two years from closing based upon meeting stated milestones. The APA contains standard, commercial representations and warranties
and covenants. The source of the cash payment was $6,520,000 in funds borrowed from Oak Street Lending
(&#8220;Loan&#8221;), our existing lender pursuant to a Fifth Amendment to Credit Agreement and Promissory Note, of even date. The purchase
price is subject to post-closing adjustment to reconcile certain pre-closing credits and liabilities of the parties.</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
acquisition of Barra was accounted for as a business combination in accordance with the acquisition method pursuant to FASB Topic No.
805, Business Combination (ASC 805). Accordingly, the total purchase consideration was allocated to the assets acquired, and liabilities
assumed based on their respective estimated fair values. The acquisition method of accounting requires, among other things, that assets
acquired, and liabilities assumed, if any, in a business purchase combination be recognized at their fair values as of the acquisition
date. The process for estimating the fair values of identifiable intangible assets and certain tangible assets requires the use of significant
estimates and assumptions, including estimating future cash flows, developing appropriate discount rates, estimating the costs, and timing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preliminary allocation of the purchase price in connection with the acquisition of Medigap was calculated as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Description</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Average Useful</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Life (Years)</p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Acquired accounts receivable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">92,585</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 16%; text-align: center">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,593</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">7</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Right-of-use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">122,984</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">4</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">550,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">10</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Developed technology</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">230,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">5</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Agency relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,585,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">10</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(122,984</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Goodwill</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,236,822</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indefinite</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,725,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Goodwill of $4,236,822 arising from the acquisition
of Barra consisted of the value of the employee workforce and the residual value after all identifiable intangible assets were valued.
Goodwill recognized pursuant to the acquisition of Barra is currently expected to be deductible for income tax purposes. Total acquisition
costs incurred through June 30, 2022 for the acquisition of Barra were $72,793 recorded as a component of General and administrative expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The approximate revenue and net profit or loss for
the acquired business as a standalone entity per ASC 805 from April 26, 2022 to June 30, 2022 was $270,321 and a loss of $38,698, respectively.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recent
Developments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Private
Placement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 22, 2021, we entered into a securities purchase agreement with several institutional buyers for the purchase and sale of (i)
warrants to purchase an aggregate of up to 9,779,952 shares of the Company&#8217;s common stock, par value $0.086 per share at an exercise
price of $4.09 per share, (ii) an aggregate of 2,670,892 shares of Common Stock, and (iii) 9,076 shares of the Company&#8217;s newly-designated
Series B convertible preferred stock, par value $0.086 per share, with a stated value of $1,000 per share, initially convertible into
an aggregate of 2,219,084 shares of Common Stock at a conversion price of $4.09 per share in a private placement (the &#8220;Private
Placement&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 5, 2022, pursuant to the securities purchase agreement dated December 22, 2021, the Private Placement was closed. The Private
Placement resulted in aggregate gross proceeds to us of approximately $20,000,000, before deducting placement agent fees and other offering
expenses payable by us. The Warrants are exercisable upon issuance and will expire five years from the date of issuance. In connection
with the Private Placement, we issued to the placement agent warrants to purchase 244,539 shares of the Company&#8217;s Common Stock
at an exercise price of $4.09 per share (the &#8220;Placement Agent Warrants&#8221;). The Placement Agent Warrants have substantially
the same terms as the Warrants issued in the Private Placement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nasdaq
Notification and Warrant Exchange</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 31, 2022, we received a deficiency notification from Nasdaq regarding the issuance of shares in the Medigap Acquisition and Private
Placement in violation of Listing Rule 5635(a). This rule requires an issuer to obtain shareholder approval with respect to an acquisition
paid for from the proceeds of a sale of common stock of the issuer which equals or exceeds 20% of the shares of the issuer, issued and
outstanding prior to the acquisition. The Company submitted a remediation plan under which the Nasdaq granted us an extension to implement
the required changes until May 10, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of its remediation plan, on March 22, 2022 we entered into Exchange Agreements with the holders of common stock issued in January
2022 resulting from the Medigap Acquisition and Private Placement. Pursuant to the Exchange Agreements, we issued 3,276,929 Series C
prepaid warrants in exchange for 3,276,929 shares of our common stock that were previously issued. Additionally, to compensate the Private
Placement investors for entering into the Exchange Agreements, we issued 1,222,498 Series D prepaid warrants to such investors for no
additional consideration on the same date. The fair value of the Series D prepaid warrants upon issuance was $6,930,335; such amount
was treated as a deemed dividend and accordingly reduced income available to common stockholders for the period. Shares of common stock
underlying the Series C and D prepaid warrants are treated as outstanding for purposes of calculating basic and diluted earnings per
share. The Series C warrants were exercised during the quarter ended June 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Split</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 21, 2021 we effected a reverse split of the issued and outstanding shares of common stock in a ratio of 1:85.71 which is simultaneously
occurred with the Company&#8217;s uplisting to the Nasdaq Capital Market. The Company has adjusted all of share and per share numbers
to take into account this reverse stock split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i>Comparison
of the three months ended June 30, 2022 to the three months ended June 30, 2021</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth our revenue and operating expenses for each of the years presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left; padding-bottom: 1.5pt">Commission income</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 18%; text-align: right">4,207,126</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 18%; text-align: right">2,190,847</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,207,126</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,190,847</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Commission expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">850,128</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">558,271</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Salaries and wages</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,176,792</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,110,629</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">General and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,759,217</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,202,350</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Marketing and advertising</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">609,383</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,021</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Depreciation and amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">756,403</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">369,366</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,151,923</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,295,637</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,944,797</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,104,790</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total Other income (expense)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,440,488</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(172,096</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net income (loss)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,495,691</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,276,886</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Revenues</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s revenue is primarily comprised of commission paid by health insurance carriers or their representatives related to
insurance plans that have been purchased by a member who used our services. We define a member as an individual currently covered by
an insurance plan, including individual and family, Medicare-related, small business, and ancillary plans, for which the Company is
entitled to receive compensation from an insurance carrier.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
had revenues of $4.2 million for the three months ended June 30, 2022, as compared to $<span style="background-color: white">2.2</span>
million for the three months ended June 30, 2021. The increase of $2.0 million or 92% is primarily driven by expanded operations, both organic and due to the additional insurance agencies acquired throughout 2021 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Commission
expense</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
had total commission expense of $850<span style="background-color: white">,000</span> for the three months ended June 30, 2022 compared
to $<span style="background-color: white">558,000</span> for the three months ended June 30, 2021. The increase of $292,000 or 52% is primarily driven by expanded operations, both organic and due to the additional insurance agencies acquired throughout
2021 and 2022. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Salaries
and wages</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
reported $2.2 million of salaries and wages expense for the three months ended June 30, 2022 compared to $<span style="background-color: white">1.1
million</span> for the three months ended June 30, 2021. The increase of $1.1 million or 96% is a result of the Company&#8217;s growth
driven by expanded operations, both organic and due to the additional insurance agencies acquired throughout 2021
and 2022. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">General
and administrative expenses</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
had total general and administrative expenses of $1.8 million for the three months ended June 30, 2022, as compared to $<span style="background-color: white">1.2
</span>million for the three months ended June 30, 2021. The increase in expense of $600<span style="background-color: white">,000</span>
or 46% is a result of the Company&#8217;s growth driven by expanded operations, both organic and due to the additional insurance agencies
acquired throughout 2021 and 2022. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Marketing
and advertising</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
reported $609,000 of marketing and advertising expense for the three months ended June 30, 2022 compared to $<span style="background-color: white">55,000 </span>for
the three months ended June 30, 2021. The increase of $554<span style="background-color: white">,000</span> or 1008% is primarily a
result of Medigap&#8217;s direct business to consumer marketing model deployed through social media platforms, in addition to
overall increased branding and outreach efforts to achieve greater industry presence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Depreciation
and amortization</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
reported $756<span style="background-color: white">,000</span> of depreciation and amortization expense for the three months ended June
30, 2022 compared to $<span style="background-color: white">369,000</span> for the three months ended June 30, 2021. The increase of
$387<span style="background-color: white">,000</span> or 105% is a result of our acquired assets through business combinations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Other
income and expense</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
reported $12.4 million of other income for the three months ended June 30, 2022 compared to $<span style="background-color: white">172,000
</span>of other expense for the three months ended June 30, 2021. The increase of $12.6 million or 7329% is attributable primarily to
the  change in fair value of warrant liabilities of $12.6 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Comparison
of the six months ended June 30, 2022 to the six months ended June 30, 2021</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth our revenue and operating expenses for each of the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left; padding-bottom: 1.5pt">Commission income</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">8,442,907</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">4,514,577</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,442,907</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,514,577</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Commission expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,754,283</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,087,743</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Salaries and wages</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,258,967</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,029,174</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">General and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,212,287</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,206,751</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Marketing and advertising</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,196,405</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">78,100</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Depreciation and amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,363,928</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">702,454</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,785,870</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,104,222</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,342,963</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,589,645</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total Other income (expense)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">24,178,655</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(301,167</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net income (loss)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">19,835,692</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,890,812</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Revenues</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
had revenues of $8.4 million for the six months ended June 30, 2022, as compared to $4.5 million for the six months ended June 30, 2021.
The increase of $3.9 million or 87% is primarily driven by expanded operations, both organic and due to the additional insurance agencies
acquired throughout 2021 and 2022. </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Commission
expense</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
had total commission expense of $1.8 million for the six months ended June 30, 2022 compared to $1.1 million for the six months
ended June 30, 2021. The increase of $700<span style="background-color: white">,000</span> or 61% is primarily driven by expanded
operations, both organic and due to the additional insurance agencies acquired throughout 2021 and 2022. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Salaries
and wages</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
reported $4.3 million of salaries and wages expense for the six months ended June 30, 2022 compared to $2.0 million for the six
months ended June 30, 2021. The increase of $2.3 million or 110% is primarily driven by expanded operations, both organic and due to
the additional insurance agencies acquired throughout 2021 and 2022. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">General
and administrative expenses</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
had total general and administrative expenses of $4.2 million for the six months ended June 30, 2022, as compared to $2.2 million for
the six months ended June 30, 2021. The increase in expense of $2.0 million or 91% is primarily driven by expanded operations, both organic and due to the additional insurance agencies acquired throughout
2021 and 2022. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Marketing
and advertising</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
reported $1.2 million of marketing and advertising expense for the six months ended June 30, 2022 compared to $78<span style="background-color: white">,000
</span>for the six months ended June 30, 2021. The increase of $1.1 million or 1432% is primarily a result of Medigap&#8217;s direct business to consumer marketing model deployed through social media platforms,
in addition to overall increased branding and outreach efforts to achieve greater industry presence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Depreciation
and amortization</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
reported $1.4 million of depreciation and amortization expense for the six months ended June 30, 2022 compared to $702<span style="background-color: white">,000
</span>for the six months ended June 30, 2021. The increase of $698<span style="background-color: white">,000</span> or 84% is a result
of the assets we acquired through business combinations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Other
income and expense</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
reported $24.2 million of other income for the six months ended June 30, 2022 compared to a loss of $301<span style="background-color: white">,000
</span>for the six months ended June 30, 2021. The increase of $24.5 million or 8128% is attributable primarily to the recognition and
change in fair value of warrant liabilities of $24.5 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidity
and capital resources</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2022, we had a cash balance of $4.4 million and a working capital deficit of $3.4 million compared with a cash balance
of $4.6 million and working capital deficit of $37 million at December 31, 2021. The increase in working capital is primarily
attributable to the issuance of the derivative warrant liability commitments, effectively reclassifying them from current to non-current
liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
spread of the coronavirus (COVID-19) outbreak in the United States has resulted in economic uncertainties which may negatively impact
our business operations. While the disruption is expected to be temporary, there is uncertainty surrounding the duration and extent of
the impact. Currently we have not seen any material financial impact as a result of the coronavirus outbreak. However, management is
actively monitoring the global situation on its financial condition, liquidity, operations, industry and workforce.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adverse
events such as health-related concerns about working in our offices, the inability to travel and other matters affecting the general
work environment could harm our business and our business strategy. While we do not anticipate any material impact to our business operations
as a result of the coronavirus, in the event of a major disruption caused by the outbreak of pandemic diseases such as coronavirus, we
may lose the services of our employees or experience system interruptions, which could lead to diminishment of our business operations.
Any of the foregoing could harm our business and delay the implementation of our business strategy and we cannot anticipate all the ways
in which the current global health crisis and financial market conditions could adversely impact our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Off-balance
sheet arrangements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any off-balance sheet arrangements as such term is defined in Regulation S-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
Flows</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Net cash used in operating activities</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(1,311,411</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(1,493,252</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net cash used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(24,625,929</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,761,576</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">25,714,021</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,558,012</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net (decrease) increase in cash, cash equivalents, and restricted cash</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(223,319</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,303,184</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Operating
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities for the six months ended June 30, 2022 was $1.3 million, which includes net income of $19.8 million
offset by non-cash expenses of $21.8 million principally related to recognition and change in fair value of warrant liabilities of $24.5
million, offset by share based compensation expense of $919<span style="background-color: white">,000</span>, depreciation and amortization
of $1.4 million, and an earn-out fair value adjustment of $355<span style="background-color: white">,000</span>, as well as changes of
net working capital items in the amount of $651<span style="background-color: white">,000</span> principally due to a decreases in accounts
payable and accrued expenses of $1.7 million, offset by a decrease in accounts receivable of $41<span style="background-color: white">,000</span>,
a decrease prepaid expense and other current assets of $2.2 million, an increase in other payables of $127 million and increase of the
chargeback reserve of $<span style="background-color: white">,000.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Investing
Activities</i>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the six months ended June 30, 2022, cash flows used in investing activities were $24.6 million compared to cash flow used in investing
activities of $1.8 for the six months ended June 30, 2021. The 2021 cash used relates to cash paid for the acquisition of Medigap and
Barra of $24.1 million, the purchase of property and equipment of $21<span style="background-color: white">,000</span> and cash paid
of $466<span style="background-color: white">,000</span> for intangible assets&#160;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financing
Activities</i>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the six months ended June 30, 2022, cash provided by financing activities was $25.7 million as compared to $9.6 million for the six
months ended June 30, 2021. The net cash provided by financing activities is primarily related to proceeds from Private Placement
offering of shares of common stock and preferred stock in January 2022. The net proceeds from the issuance of these shares was $17.9
million. Additionally, we received proceeds of $2.5 million from the exercise of Series A warrants and $6.5 million through loan
proceeds received for a business acquisition. These were offset by debt principal repayments  of $448,000</span>, payment
of debt issuance costs of $214<span style="background-color: white">,000 </span>and the repayments of loans payable to related
parties of $22<span style="background-color: white">,000 and short term financing of $41,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Accounting  Estimates</b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and judgments
that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures. Estimates and judgments are based
on historical experience, forecasted events, and various other assumptions that we believe to be reasonable under the circumstances.
Estimates and judgments may vary under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis.
Our management believes the accounting policies below are critical in the portrayal of our financial condition and results of operations
and require management&#8217;s most difficult, subjective, or complex judgments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
acquisitions</i>:</b> Accounting for acquisitions requires us to estimate the fair value of consideration paid and the individual assets
and liabilities acquired, which involves a number of judgments, assumptions, and estimates that could materially affect the amount and
timing of costs recognized in subsequent periods. Accounting for acquisitions can also involve significant judgment to determine when
control of the acquired entity is transferred. We typically obtain independent third-party valuation studies to assist in determining
fair values, including assistance in determining future cash flows, discount rates, and comparable market values. Items involving significant
assumptions, estimates, and judgments include the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Debt, including discount rate and timing of payments;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Deferred tax assets, including projections of future taxable income and tax rates;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Fair value of consideration paid or transferred;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Intangible assets, including valuation methodology, estimations of future revenue and costs, and discount rates;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Contingencies:
</i></b>We are subject to the possibility of losses from various contingencies. Significant judgment is necessary to estimate the probability
and amount of a loss, if any, from such contingencies. An accrual is made when it is probable that a liability has been incurred or an
asset has been impaired, and the amount of loss can be reasonably estimated. In accounting for the resolution of contingencies, significant
judgment may be necessary to estimate amounts pertaining to periods prior to the resolution that are charged to operations in the period
of resolution and amounts related to future periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Goodwill
and intangible assets</i>:</b> We test goodwill for impairment in our fourth quarter each year, or more frequently if indicators of an
impairment exist, to determine whether it is more likely than not that the fair value of the reporting unit with goodwill is less than
its carrying value. For reporting units for which this assessment concludes that it is more likely than not that the fair value is more
than its carrying value, goodwill is considered not impaired and we are not required to perform the goodwill impairment test. Qualitative
factors considered in this assessment include industry and market considerations, overall financial performance, and other relevant events
and factors affecting the fair value of the reporting unit. For reporting units for which this assessment concludes that it is more likely
than not that the fair value is below the carrying value, goodwill is tested for impairment by determining the fair value of each reporting
unit and comparing it to the carrying value of the net assets assigned to the reporting unit. If the fair value of the reporting unit
exceeds its carrying value, goodwill is considered not impaired. If the carrying value of the reporting unit exceeds its fair value,
we would record an impairment loss up to the difference between the carrying value and implied fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determining
when to test for impairment, the reporting units, the assets and liabilities of the reporting unit, and the fair value of the reporting
unit requires significant judgment and involves the use of significant estimates and assumptions. These estimates and assumptions include
revenue growth rates, and expenses and are developed as part of our long-range planning process. The same estimates are used in business
planning, forecasting, and capital budgeting. We test the reasonableness of the output of our long-range planning process by calculating
an implied value per share and comparing that to current stock prices, analysts&#8217; consensus pricing, and management&#8217;s expectations.
These estimates and assumptions are used to calculate projected future cash flows for the reporting unit, which are discounted using
a risk-adjusted rate to estimate a fair value. The discount rate requires determination of appropriate market comparables. We base fair
value estimates on assumptions we believe to be reasonable but that are unpredictable and inherently uncertain. Actual future results
may differ from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
test other identified intangible assets with definite useful lives when events and circumstances indicate the carrying value may not
be recoverable by comparing the carrying amount to the sum of undiscounted cash flows expected to be generated by the asset. We test
intangible assets with indefinite lives annually for impairment using a fair value method such as discounted cash flows. Estimating fair
values involves significant assumptions, including future sales prices, sales volumes, costs, and discount rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
taxes</i>:</b> We are required to estimate our provision for income taxes and amounts ultimately payable or recoverable in numerous tax
jurisdictions around the world. These estimates involve significant judgment and interpretations of regulations and are inherently complex.
Resolution of income tax treatments in individual jurisdictions may not be known for many years after completion of the applicable year.
We are also required to evaluate the realizability of our deferred tax assets on an ongoing basis in accordance with U.S. GAAP, which
requires the assessment of our performance and other relevant factors. Realization of deferred tax assets is dependent on our ability
to generate future taxable income. In recent periods, our results of operations have benefited from increases in the amount of deferred
taxes we expect to realize, primarily from the levels of capital spending and increases in the amount of taxable income we expect to
realize. Our income tax provision or benefit is dependent, in part, on our ability to forecast future taxable income in these and other
jurisdictions. Such forecasts are inherently difficult and involve significant judgments including, among others, projecting future average
selling prices and sales volumes, manufacturing and overhead costs, levels of capital spending, and other factors that significantly
impact our analyses of the amount of net deferred tax assets that are more likely than not to be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue
recognition</i>:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We recognize revenue in accordance with Accounting
Standards Codification (ASC) 606 <i>Revenue from Contracts with Customers</i> which at its core, recognizes revenue upon the transfer
of promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange
for those goods or services.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
earn additional revenue including contingent commissions, profit-sharing, override and bonuses based on meeting certain revenue or profit
targets established periodically by the carriers (collectively the Contingent Commissions). The Contingent Commissions are earned when
we achieve the targets established by the insurance carries. The insurance carriers notify the company when it has achieved the target.
We only recognize revenue to the extent that it is probable that a significant reversal of the revenue will not occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock-based
compensation</i>:</b> Stock-based compensation is estimated at the grant date based on the fair value of the award and is recognized
as expense using the straight-line amortization method over the requisite service period. For performance-based stock awards, the expense
recognized is dependent on our assessment of the likelihood of the performance measure being achieved. We utilize forecasts of future
performance to assess these probabilities and this assessment requires significant judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determining
the appropriate fair-value model and calculating the fair value of stock-based awards at the grant date requires significant judgment,
including estimating stock price volatility and expected option life. We develop these estimates based on historical data and market
information which can change significantly over time. A small change in the estimates used can result in a relatively large change in
the estimated valuation. We use the Black-Scholes option valuation model to value employee stock options and awards granted under our
employee stock purchase plan. We estimate stock price volatility based on our historical volatility implied volatility derived from traded
options on our stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F1_003"></span>Item
3. Quantitative and Qualitative Disclosures About Market Risk.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F1_004"></span>Item
4. Controls and Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Evaluation
of Disclosure Controls and Procedures</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act
of 1934, as amended (the &#8220;Exchange Act&#8221;), refers to controls and procedures that are designed to ensure that information
required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized
and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without
limitation, controls and procedures designed to ensure that such information is accumulated and communicated to a company&#8217;s management,
including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.
Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance
of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible
controls and procedures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of our disclosure controls and procedures as of
June 30, 2022. Based on the evaluation, management has concluded that the Company&#8217;s disclosure controls and procedures were effective
as of June 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changes
in Internal Control over Financial Reporting</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have not been any changes in our internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f)
under the Exchange Act, during our most recently completed fiscal quarter which is the subject of this report that have materially affected,
or are reasonably likely to materially affect, our internal control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F1_005"></span>PART
II</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F1_006"></span>Item
1. Legal Proceedings.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to various legal proceedings and claims, either asserted or unasserted, arising in the ordinary course of business. While
the outcome of these claims cannot be predicted with certainty, management does not believe the outcome of any of these matters will
have a material adverse effect on our business, financial position, results of operations, or cash flows, and accordingly, no legal contingencies
are accrued as of June 30, 2022. Litigation relating to the insurance brokerage industry is not uncommon. As such we, from time to time
have been, subject to such litigation. No assurances can be given with respect to the extent or outcome of any such litigation in the
future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F1_007"></span>Item
1A. Risk Factors.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-weight: normal">Investing
in our common stock involves a high degree of risk. You should consider carefully the information disclosed in Part I, Item1A, &#8220;Risk
Factors,&#8221; contained in our Annual Report on Form 10-K for the year ended December 31, 2021. There have been no material changes
from the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2021.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F1_008"></span>Item
2. Unregistered Sales of Equity Securities and Use of Proceeds.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
that have not been previously disclosed in our filings with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F1_009"></span>Item
3. Defaults Upon Senior Securities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F1_010"></span>Item
4. Mine Safety Disclosures.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F1_011"></span>Item
5. Other Information.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F1_012"></span>Item
6. Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following exhibits are filed with this Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1812727/000149315221006675/ex3-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles of Incorporation of Issuer (incorporated by reference to exhibit 3.1 to the Registrant&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 24, 2021 (File Number 001-40020))</span></a></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1812727/000149315221006675/ex3-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bylaws of Issuer (incorporated by reference to exhibit 3.2 to the Registrant&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 24, 2021 (File Number 001-40020))</span></a></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1812727/000149315221006675/ex3-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles of Formation of Southwestern Montana Insurance Center, LLC(incorporated by reference to exhibit 3.3 to the Registrant&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 24, 2021 (File Number 001-40020))</span></a></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1812727/000149315221006675/ex3-4.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Formation of Commercial Coverage Solutions LLC(incorporated by reference to exhibit 3.4 to the Registrant&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 24, 2021 (File Number 001-40020))</span></a></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1812727/000149315221006675/ex3-5.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles of Organization of Employee Benefits Solutions, LLC(incorporated by reference to exhibit 3.5 to the Registrant&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 24, 2021 (File Number 001-40020))</span></a></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1812727/000149315221006675/ex3-6.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles of Organization of Fortman Insurance Solutions, LLC (incorporated by reference to exhibit 3.6 to the Registrant&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 24, 2021 (File Number 001-40020))</span></a></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1812727/000149315221006675/ex3-7.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles of Organization of US Benefits Alliance, LLC (incorporated by reference to exhibit 3.7 to the Registrant&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 24, 2021 (File Number 001-40020))</span></a></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1812727/000149315221006675/ex3-8.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles of Incorporation of Altruis Benefits Corporation (incorporated by reference to exhibit 3.8 to the Registrant&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 24, 2021 (File Number 001-40020))</span></a></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1812727/000149315222008413/ex3-9.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles of Incorporation of Kush Benefit Solutions, LLC Corporation (incorporated by reference to exhibit 3.9 to the Registrant&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 24, 2021 (File Number 001-40020)) </span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1812727/000149315221002712/ex3-9.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles of Amendment to the Articles of Incorporation (incorporated by reference to exhibit 3.9 to Amendment No.4 to the Registrant&#8217;s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on February 5, 2021)(File Number 333-249381))</span></a></td></tr>
  </table>




<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72px"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1812727/000149315222000509/ex3-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment to Articles of Incorporation(incorporated by reference to exhibit 3.1 to the Registrant&#8217;s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 6, 2022 (File Number 001-40020)) </span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.12</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1812727/000149315222008413/ex3-11.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Medigap Healthcare Insurance Agency LLC Formation and Assignment Documents(incorporated by reference to exhibit 3.11 to the Registrant&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 24, 2021 (File Number 001-40020)) </span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">3.13</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><a href="ex3-13.htm">Articles of Organization of RELI Exchange, LLC</a></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1812727/000149315222011820/ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset Purchase Agreement with Barra and Associates (Incorporated by reference to the Registrant&#8217;s Current Report on Form 8-K, filed with the Securities and Exchange Commission on May 2, 2022(File Number 001-40020)) </span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1812727/000149315222011820/ex10-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan Agreement with Oak Street Lending (Incorporated by reference to the Registrant&#8217;s Current Report on Form 8-K, File No. 001-40020, filed with the Securities and Exchange Commission on May 2, 2022 (File Number 001-40020))</span></a></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1812727/000149315222011820/ex10-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement with Grant Barra (Incorporated by reference to the Registrant&#8217;s Current Report on Form 8-K, File No. 001-40020, filed with the Securities and Exchange Commission on May 2, 2022(File Number 001-40020))</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex31-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Chief Executive Officer pursuant to Section302 of the Sarbanes-Oxley Act 2002*</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex31-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Chief Financial Officer pursuant to Section302 of the Sarbanes-Oxley Act 2002*</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex32-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 1350 Certification of the Chief Executive Officer and Chief Financial Officer*</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex32-1.htm">Section 1350 Certification of the Chief Financial Officer and Chief Financial Officer*</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Inline
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Instance Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Schema Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Labels Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (formatted in IXBRL, and included in exhibit 101).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act, the registrant has duly caused this Form 10-Q statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Lakewood, State of New Jersey on August 15, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reliance
    Global Group, Inc.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Ezra Beyman</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ezra
    Beyman</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Chairman of the Board</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">(Principal Executive Officer)</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
August 15, 2022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reliance
    Global Group, Inc.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Willian Lebovics</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">William
    Lebovics</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(Principal Financial Officer)</p>
</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
August 15, 2022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 37; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>







































</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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
     PtHNVy5Lh32CZTOo+MrJBZExyd2I4H567TQ3fh+J3yYT6ZyJHTjdbTVJ5ct61f/bCgZNDJy8RH8fYSwu0Eb6+heaKwN7YKfoyuqQwMN54gfGA0uFfRQcrmY0gbOjnoGKfm1zbmqA/SJsqTDOdmg8MFryLxp9Tzdjno2KfGvzXGym73K+TfLoK8BmStSo9wAQ/RpcJ3x8gkhcPetEb5JG6Jcf/3G8cygwi+BUp/ibDfiP9YHRPIsaRQMjFucZxIHxPiftNpr0+mmn6bDLMc3ggqWCl1gDWe52LI1vdwOTNlwDvbM1BAj8rfz1l+VuIaQr1VNRIcIvN+6vx+QNoquzkVWvb8HR4yNCw0S+7uAI2WEMABy6+ptmuh8ILSKWnArT3Wn5OBDVBl/0NHK22jcv9lcAnV7FcaRY3h6g/h/1NT+e -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.13
<SEQUENCE>2
<FILENAME>ex3-13.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 3.13</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex3-13_001.jpg" ALT="" STYLE="height: 518px; width: 670px"></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>ex31-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
OF PRINCIPAL EXECUTIVE OFFICER AND</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRINCIPAL
FINANCIAL AND ACCOUNTING OFFICER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO SECTION 302 OF THE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SARBANES-OXLEY
ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Ezra Beyman, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I have reviewed the Report being filed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
to the period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this
report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
    within those entities, particularly for the period in which this report is being prepared;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designed
    such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
    supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
    for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluated
    the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about
    the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclosed
    in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
    most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of a quarterly report) that has materially affected,
    or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
The registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing
the equivalent function):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
    reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
    internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    August 15, 2022</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ezra Beyman</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ezra
    Beyman</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Executive Chairman (Principal Executive Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>ex31-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
OF PRINCIPAL EXECUTIVE OFFICER AND</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRINCIPAL
FINANCIAL AND ACCOUNTING OFFICER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO SECTION 302 OF THE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SARBANES-OXLEY
ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
William Lebovics, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I have reviewed the Report being filed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
to the period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this
report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
    within those entities, particularly for the period in which this report is being prepared;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designed
    such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
    supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
    for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluated
    the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about
    the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclosed
    in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
    most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of quarterly report) that has materially affected,
    or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
The registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing
the equivalent function):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
    reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
    internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    August 15, 2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    William Lebovics</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">William
    Lebovics</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">(Principal Financial Officer)</P>
</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>ex32-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
32.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certification</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pursuant
to Section 906 of the Sarbanes-Oxley Act Of 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Subsections
(A) And (B) Of Section 1350, Chapter 63 of Title 18, United States Code)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code),
each of the undersigned officers of Reliance Global Group, Inc. (the &ldquo;Company&rdquo;), does hereby certify, that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Quarterly Report on Form 10-Q for the period ending June 30, 2022 (the &ldquo;Form 10-Q&rdquo;) of the Company fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly
presents, in all material respects, the financial condition and results of operations of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    August 15, 2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ezra Beyman</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ezra
    Beyman</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Executive Chairman (Principal Executive Officer)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    August 15, 2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    William Lebovics</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">William
    Lebovics</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">(Principal Financial Officer)</P>
</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

































</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex3-13_001.jpg
<TEXT>
begin 644 ex3-13_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" GV#.0# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **8\L:$!G523CDXIP(/0B@!:*
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHR/6DR#CD<T +11D9QGFB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBN<\<>()?"_@^_UF)%>2V"%5<X5LR*O
M;GO0!T=%?/!^//B0:=]ICTW3/O'AA(>.O7=7M?A'5[C7_#-EJMRB1RW,>\QH
M#A>2,<D^E &Y1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% $<D$4I!D17*G*[ATIX&*6B@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KA?C""?A;K&%#?ZG@
M_P#79*[JN$^,,;3?"_5TC0,P\G@_]=DH ^:KE5;1HP\,4>7"GD]\5]8^"X$M
MO".FQ1A-BP#[G3.37RW.LD6G6:_9U=VD 6-5XSD5]4>$C(WA>P,L8C<Q#*#M
M0!MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\#]T_3- '9T4Q&)8Y(([8I] !1110 4444 %%%% !14-U-]G@:8G"1@L_&>
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M]=\/:9XETQM.U:W-Q:L0Q3S&3D=.5(-4?#G@;P[X3>9]$T\VAF #XFD?./\
M>8^M '-?&.\6T\ RR&62+=.L09=O.0QQW]*\X_9^E*^,M0C*N =/8G=_"=\>
M!_GTKWG7O#>D^)K$66L6GVJV#A_+9V4;@" >"/4U3\/>!_#GA62231=,2UDD
M7:SAV8D=<98GT% &VQ 3&><]1CU]Z^0?$&H >.;N] >5+>]W;&(QE7SU ]J^
MP1&H]?SKD9OA7X+N-0-_-HB/<&3S"QFDP6SG)&[!YH U-1TJU\1^%VL;PE8K
MJV56V_PY7K^M?-4,'B3X6>*!>3V[H%?&Y@=DZCW. 1TZ&OJZ.&.) B+M4*%
M'8"H+_2[#5+9K>_LX;F)A@K*@/\ ^J@#SBS^./A>6P26Y6\MIB?]4T88$D=
M0<$5Y?X_\8O\0/$=E!I*.T<(,<,*99GD/MCC'/>O:W^$/@:0@G0P ,X47,P
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5PWQ=19OACJR
M&3RPWD_-C./WR=J[FN!^,"D_##5E7JSP!><=9HZ /GJ2TF'AH[)AY8D&3M&3
MT''-?4G@F$P>#],C,C/B$<LN#U]*^4[NWN+?1ECN 4<R+L .1C(KZR\*?\BQ
MIW3/D+G% &S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU!+/1/@"T+:5JXB4@_:1ENQ^45[*#D9KQ[X!RF71=5/EA/\ 2_\ V45[".E
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MJ&O=QC:0LS(DG!.3VKTOX-Z5GQ5K&H361B2%$6*1R.0=V:"2&7X1^.YC(O\
M:6DJN[(_?R\_^.4V#X3>.(G?]]I 7L!<2$'W^[7K]YXW\,:>CO=:Y91JAPW[
MT-C\LUG+\4_!+.%'B&V)(R/E;!_'%!5SRV'X3>/4O!,9]*P"3CSWY_\ ':FE
M^$WCJX23?=:,I8_\]I,X^NP_RKUNS\=>%M0"FVUZQ<,VP9F"Y;TP<'-;RRJZ
MAD.Y3T8'@T!<\_\ A;X)U3P587\.IS02O<3[U\ARX' '=%KT(=*,TM PHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ36;)V@&@!])N'J*\:^(OQ7UWPAXHDTJPM+%X416W2J6;D _WA7<_#[Q%?\
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MG@#/>@"6BF[UW!=PW'MGFG4 %(2!U.*6L#Q?K]KX:T"ZU&[E2)0ACCR.6<]
M/U_*@#<\Z+<5\U,CJ-PXH2:*0D)*C$==K XKY(L;8ZO?SSC4+M;Z<-+*(9<<
M$]#C/ _I7:?"35X/#_C&325FFN8K_A9 P?:PZYY]J /H:BDS2;Q0 ZBJ]W?6
MNGP&>\N([>$=9)6"J/Q-8Y\=^$@VW_A)M(W?W1>QY_+=0!T%)D>H]:JV6J6.
MHP>?97<-Q%_?BD##\P:6XNK>TC5IY8XE8@#S'"@Y/;- %K(I P;H0?H:^<?%
M?C[QE#XPUJWT;67-I:2C8D<4;@#'T)_(U[)X1UVUET'2H[[5K.;4I85#@,JL
MS8YP.#^E '5T4F[U!'%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %<!\8US\--3^8KF2WY';]]'7?UP?Q@'F?#34XUP&9X%!;
MH,S)0!\\WL/FP6UH+LMYDJ+EO<C_ !KZM\-1"#P[8P@AMD07([U\LZC:7.E:
M?;7$>V0(ZYW+WR*^IO#4GF^'+"0J 6A!( H U:*** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHR!0 4444 %%%% !1110 4444 %%%%
M !1110 4444 >(?'%A%X@T&7:&(P.3_M&N3\F.X0Y5,%Q@;OYUV7QNF\C5-$
M(\H[VV$2#/<\BN/T^/RHU,J 988+'WH(+_PKMS:_$95"0*&B/^I/N.N:^BJ^
M>/ATJ+\5$VI#DPG)"#/4=Z^AZ"D%&:**!B9I:** "F'AN3U/%/IC?>';)[]Z
M /EGQ4F_XG:OS<$"?G<RD=O;I3M<D=+%$9T2$CDCD8JUXC*2_$?6PPA 68Y9
M(]O''YGWJC?BUEMWD1PJ@$8/5OI02STCX QHF@:FT8.&N_O9X/RK7L0Z5X_\
M!)$;0]3163Y;K.%&"/E'7UKV!>@H!"T444%!1110 Q^H^HKP'XU7%Q=>,--L
M5D;;%$9 "NW.<9Y_ <5[Z^,CUZ5X!\<=-G'C#2;U9$*3(R!1U&W'^-!+.<O5
M=[7&_:>,Y>K_ ,*K5;[XH1,^#]EB=E]3E3U/4]:H?O)$:WEE4*.,GDUL_#*X
MM=-^(BQI;^9YR%3,TF"AV^GX4$MV9]%CD<4HI%Y7FE%!HA:*** $(!Z]/2C
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M(Z8H*0ZBBB@H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%  )WN,GWXKJ_@196,VA7]XUK"UR+C:)6B&\#'0'KB@#G+CXX^*8+XH=.TY
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MQ'3/M7AGQC@DD^)=X47I;QG)XKU_X12L?AE8/( FUY,XP.-Y]: ,+QY\9/\
MA']6GT;2+:.>ZA7$DTOW%8C..H]17-:=JWQ?U[2H]1TJ2:1&8[3B!4<9_A#
M$8Z<YZ5J>*?''@.S\17-K!X/L=9NED!EN$BB"M)@< [26/05I6_Q!\:7J*FD
M?#Z1(5&!YDH"KZ #Y>.E '%OX[^)/AS4 NK2QRD*"+>ZMXR'&3T90I!_&O;/
M!_B^P\9:/]NL<@H0LL;#[C>F?SKPKQPOB:XU(7GB6WCAOI(E6*VAPVU<GH-Q
M!Z^M>C_!;R$T*\BM]RK'(H*E/E!YZ-WH)YM;'G/Q@L1<_$JX=R4C,,>&=,*3
MM'?O]*V/"7C754\()X6\'Z/--JEN&:2Y(4(BLQ8L Q7GGH:S?C:_F>+V4*N5
MAC;AMW8=OZUZ=\&(81\.+&86\44TCREV5 &;]ZV,GJ>*"CS?5-6^+.AVTEYJ
M=SJ429RKK'#(@'')VY _*NC^'WQF%XT6F>)92]]++LBN(HOD;..#@  Y]J]D
MGCBF@DBE53&ZD,&&01[U\7WI-K>7J(Y4K>$JRG!7G]* /KSQ1=7UKX8U&XTU
MMEXD),+8!^;MP>*\#\'?$OQCJ_BC2[&ZULS0RS>7-']GB'&">NWVKVG6?,G^
M'=XRR2B1[+ADY?..WO7S9\/"&^(&C?(W%QC+]<[6YQ0!]2>*44>$]44\+]E?
MIV^4U\Q_"V,'XA:,Q/65L#_@)KZ>\48/A75 V#_HLF<_[IKYA^%J"3X@:. Z
MAUE8A6';:: /IKQ=>7&G^#]8O;-MES;V<LL3X!VLJD@X/'!%>%>#OB1XMU7Q
M-HUC>:R9H;B]1)5$2 NI(R#Q_*O<?'!4> O$!(&/[.N!C./^6;5\S> $^U>/
M-!$,85HKR-V"Y(QGJ<4 >V?$2U\?FX:;PU-"VE_9RLMNVP.#QG[PKP?1;:62
M2WMM+N'&I&7,"HI)#@]SG'KVQ7UQJF%TRZ.T$F-N/PKY1^&X7_A/]$,[ ,9F
MZMM'W&[T >W>'=+^([6^H_VWK,<,TD&+39'$Q$@QRQ"^Q&*\OM?B1XWM?$MK
M9ZAKKDI>K%/&T$8&S>%.?ES@\].QKZ9( 7L!^=>!?'+PQ]FU6V\06\ $-PHB
MN2BX^<< G'7C:* />;&X6ZM(YHW$BNN=P/&:\C^,?CW4_#VH:=9:%J)MI]KR
M7"!5).=OEYR#QP^?PJS\%?$(G\,W6FS70>2SN"R%VR3%M4_SW5Y*]KJ?Q'\=
MWS6D1D>XDR%FF(")G^0[?4T >N_"*\\5>(5N-=UG6Y;FR<&.&W*@(QSRP&,C
M&..>]>K*?N@#''3/(JCH6E0:+HEIIEN=T5M$L:D\Y &*T<4 %?)_Q(\0IK_C
M&_N6A1HH'\B(@G+(.JMSZENF.M?6%?(WCC2_L?C;7K8Q+!MD$L:!<*,@'(_O
M<YH ]_\ A9X8T[1?"%G=P6GEW=VGF322 ;_3&>N/;WKN @!SSFN8^'VJV^J>
M#+!XKQ;F2)/+E;H58=B.QY%=._*D G/M0!SGBOP)HGC&!%U.*03Q_P"JN86"
MR1_0X(_,&L'PQ\)=,\)Z['JVGZIJ;2*&5DED0K(""/F 09QGCZ"MWQAXST_P
M7I:7^HI.Z22B-8X &8G!/<CTK"\,_%S2/%>M1Z7IVE:L)64EGEA0(N!GDAS0
M!I^./'5GX,LX_,BDGO;G*VT2C/S=F;T&?Y5XW9^*OB1XWGFBTFZN"K-AQ ZP
MK%CL&Z\]^3VJU\<;F9?&MM#(Q$<EB$C '0[VZFNS^ <42^#+]@$:7^T'5G'.
MX>7'C^M '+WO@WXL1V!DAU&[\UVWR1KJSO@#L 6QBJWAWXM^)M*UM[?6]]_;
MCY)(9%5)H\=67'4?7-?0Q"#G@>^*^8_C,EO;_$*1[>W>-FB7S<< G'4?UH ^
MBH-1MM4T);^QG9H9X3)$P&UAE<CCL:^<4\<^)[34KB2?7]0-I!<N DEQC=AR
M "<=.V*]9^$2R)\*X6E8E]\Y)/S$?.U>"1NH\:J%>1S_ &L25*84?O* /5=4
ML_BQXOA@NK62/3;)U7RH[:_,;,/[S$<G/UKE;ZY\9>%+L0WVM7UI=!%92=2,
M@8DD9*ME2.!VKZ/@4-;1' /RJ.1GL*^??B_EOB2(VF*_Z#'@[>GS/0!KV_B?
MXB?$:S,&@K:V-O&=LUW'(0']E8@_RKG]>\-^,O!=L+[5M6NS;%MOVBRO)"=Q
MZ!NAY^E=]\!\-X,GR 1]H_QK;^+PQ\-]38 !L)AL\#YQVH Y#X/>.=7U76KC
M1M5N9+J,1EH99\&5<<[2>I&,GFM;XW:GK.F>']/?2KF> 23D32P$J54#(.0>
M.:X'X+?\CS'M@9 L#[B\>3T/(/85U_[0#R+X<TI(F=5>X8, "V[@=?:@#A_"
MGBOQ_+<RZ;I.H3ZA=7B@)]MF,AA[;LL< ?X5MWOPH^(NJ7!N=4UFQORQW;9+
MJ3(/L-@4?@:T/@&B6\NKPRVNV<.K"<CEEQT!ZXKVSJH7.&(Z^E 'S/I/B7Q7
MX0UEC<ZM(ZP2E)].DG\Q0.>5RW'2O?=#\4VOB#PRNN6<<A@:)G,17#[@,D#G
MV(KP+XT>2/B%-.B^6!"JL3_&WM^M>D_"FZ70_A+_ &A=0NL432R8_B(WG'6@
M#S[5?$?CKQEXN6.P35+"SD?;!"%:-(L<;FXP>A/7O716WP-O)();B]U.VEO7
MR8V$3E0Q[DDY//U%8FH?%'QCXPUF#3O#CQV"73$111@>8,9Y9VX[=JZ:#X7^
M-;FYB?4?'-VT9 :9%GF/U4?-@?A0!YQ>OXT\#7LEFFHS6ZVTI8^3+F)SQSM/
MT''M7T7X+UJX\1>$-.U.Y8?:)X%:0JN 21Z=J^<O%YN-+UB_T9IUO$LV*B4.
M0W3OGJ?>O?OAG&R^ =-C=F(6/ W'/&!CF@#P#Q5J^M0>*M;9=9OH$M[V6- 9
MF/ <@ #.*[G2/#'Q%\5:18S7/B=;?2Y( OEL[*SICC*IC/;J:\T\6^4WC;6H
MQ&1)_:,P\POD']X:^J_#48B\,Z2I7:5LHACK_"* /GWQ+\.M1\%(M]>W=M>6
M#R!))XHC'(@)'!YSCGKG/O74_";Q=?MXAD\-WER;BR=&>W,\A=T &<9)^[Z
MY/6NH^-V%^'D['A?.B!QZ%US7EOPH(E^)U@4QM$#XR/SH E^*&A7_ACQ9-/9
M2W=OIU_ABZ2,$+9/RD*17IOP?\2+J_AQK":]FNKNR(!>;.2A^[R>O3GZBMCX
MC^%CXL\(3V<+'SX2)X0<X9@#P:\2^%.J#1O&,$\LBQP31M;2QL6^09!R1ZY
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MH **** "BBB@ HHHH ****  ]*R_$&H2:7H=]>P[-]O$9!OZ<5J&N;\<;_\
MA!]:"8W"S?DCV- 'G'A7Q-\3?&VE?;M-GT.*!7*;IE.=PZC@-6X;?XP87%]X
M> SW5SC_ ,ABN'^&=C\0KCPM.?#>K:;;6AEPHNEW,#W/"-75'1/C1U7Q7I ;
M& /)&/S^ST =GX1C\8QO<?\ "576F3C_ )9FRW=<]P5':MS4=:TK1T#ZGJ5I
M9(>C7,RQ@_F17%ZUJ?B/PC\+KW4=;NHKO5X(U3SH=JH&=P@8848QN]*P/AUX
M'T7Q)X5M?$/B"!M5U&],C,]R[,  [)@#..U 'J=AK6EZHC/I^HVMVJG#&WF6
M0 ^AP>M6VFB6/S&D4)C.XGC\Z\I\>_#S1;/PO<ZIH5LNFWVGH;A9H'=3M7D_
MQ8SQQ6KIVJ3ZK\'/[1UIU:22SW.[#[YQ]XX]: .XN-6TZULVO+B^MHK5?O3/
M* @_'I38]9TR73?[1CU"V:QQG[2)1Y>.GWNE>+_!_P #:/X@\.RZCK,7V^-I
M"D$,COLC /.!N[\=NU=9\4M-T_1?A)J-G86J6UNGEJB1< ?O%_.@#N+KQ#HM
MC;)<W>K6-O!(,I++<*JL/4$G!I^G:WI6L1&73=1M;R,<%K>99!^AKS7X=_#G
MP]<^"+"\U73H;VZF4R&1RQ"#)P #TX]!7+>+M'L_#'QB\.Z?H2R:=:7_ -E^
MT):RM%O!G96Y4@\@8ZT >T3^,/#5K<FWGU[38YEX*-<H"/J,UKQRQRHKQNKJ
MPRK*<@CV-<Q/\/O"=Q T,N@V$F_AI'A4R,3W+XW$^^:XCX :I=WFBZI9S2LU
MO:R1^0K.6V!MW ]OE% 'L-%%% 'B'QY(_M#0!M!+2@$XZ#-<RL%M*ENERR,%
MQAL]!GVKJ?CH8SJ&C"4OA/F"HNXMR>/:N(LKFU4(NV7 Y^;U]"*"6C5^&$"Q
M?%#=(D_S1DQL' 7&1U%?1V:^;]*U?4=*N8M1TZVMOM()0O)\WRG^5;5_\3/&
MD )B?2Q\V!F,G/ZT"C+N>ZD@49%>"P_$SQUO?SGTK9T!$1_/K4#?%?QI'=)&
MIT^52=N(X"2??K0/F1]!9I,UX-=?%?Q9! D>VQCN9&XWPG@?3-02_$OQ_ _F
MR3:5Y./^>)H"Y] Y%,/))Y/]*\S^$?C+6_&4&JS:O)"5MVC$7EQ!1\V[W]J]
M,'*C.?RH*/ECQ')=1?$K6/W):%K@@EG' QZYJ75K>WCL!,0%7KG&?Y5#XR\T
M_$[4EC8NHG+%0N ./2IY+K]]%#L21"1D,< ?AB@EG=?L_P#S:3J[@@GS\ 8]
MA7M((Q7SWX;US4O#T4\6D26T$;R>;(LD603@=_PJPOQ.\7*H9KO37;. JVY.
M??- )GOF1_D4;A[_ )5\\?\ "Q?B I4O?Z2JEL?ZC) ^F*D;Q]XY;,CZ[9+&
M&P%2S!+#\J N?0>?K^5&?K^5?/$OCKQI(4\KQ) N6P56TCR/S%9FI?$;QY80
MR[O$43*?E4BWC4KGO]TT%'TT>N:\_P#BQX3'B+PP9K>T:>]M&WQ!2=Q&.0,?
MA6W\/M2N]8\":3J-]-YUS<0[W? &3DCL!Z5TI&1@T"L?)ND:E;HQB*3!@_S)
M+U#<Y'UJ2XC(U 36WF0M#+YZM&<'.<_G^E>E?$/X1S:C?OK'AAHX;EV+3VV[
M8LG?(]#GVKRV*\;3]1;3[^T^QW<)Q*)3MY]L\&@EH^B?!/BVUU_18@\RI>1C
M9(C9!)[=>I/'2NL!Y_#TKY?OKNPEM\ S>;N!#0R%"#QSQ5^P\7>+]/C$5OXA
M=H 08UG17Q[$L":!IV/I(LH(!(!/:D+J.">?3%>)P?$_Q-% \=R=,:0L/+EV
ML /R(S6=<>.O$TTKEM8^5^!%#"%"CV;K0',CTSQYXUM/#&CW,<,R-J;KM@@S
MDDGN1VQ[UX%%9W=RDMWJUY<2S7$F\E+AEQGMUJ;5X;>XG^TI/-]I3YBP9F8'
MN68]15#^T+W7ECT[2X9KF_9@H:.+Y3[^P]Z N4=8:[O-0L]/4N6D=8T5I&8
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M:< \#./RH ^H1U_*GU$IPV..><?S_I4M !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 AZ5Y/\>T:7P79$*62._1F^4X V..?SKU@
MC((K.U;0-+UVW6#5K*&]A4[@DRY /K0!\V> /$VG>&?&YO[V+S(WA,>Z(C]U
M@<<9P>GZUZ:/CMH)>39I.IR#<0&C,9SCC."PKK/^%9^"PV1X=L1G.<(?\::?
MAAX*./\ BG;( =,*0?SS0!R1^/F@^8(QI&J;SV8Q#_V>NR\&>,+/QKI4E]:V
ML]NJ2>64F )Z>U)_PK;P=MVGP[8%?0QY_K6OI'A_2M M3;:390V<#-N:.%<!
MC[T ?)/B/,7B_5%55'^E':3EMN6]?PKZTM)!_P (S [,<?8P2V/]CK6?<_#[
MPE>7#SW'A_3Y))#N=VA&XGUS6]'9P16RVT<86%4"! !C:!C% 'QUYF/%;2)(
M65M4W=."/,K["LF#64)'&8E.,>PK!/PZ\(?:_M:^'=/$^_?O\GG=US73(@10
MJC"@8 '04 ?-_P =I GQ M\QDC^SX_F(_P!N2NS_ &?I4?PMJ"J>5N02/3@U
MZ%J'@[0-7NUN]4TJSO;A4""2:(,< D_UJ]INC:=H\;QZ=96]JCG++#&%!_*@
M#EOBSS\,]9(/ C!XZ_>%>$?">9I/B?HI,*?,TGS D'_5.1P.#7U+?:=::E;F
MWO;:&X@;[T<R!U(^AJA9>$O#VFW:75CHMA;7"9V2Q6ZJR\8X(Z<$B@#COC8P
M'PWNE=@F9HNI_P"FBFO,O@=?)'X\-J7AD>6W.UP,E< DC/\ GK7T5?Z59ZK
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M]NV)?O'# _RKKTB6/I@?0 4_;Z\T ?//PK\'>*]#\=07=[HUW;63!UEED;:
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MPRJH);Y0.I/ _6G*VX9'2@!:*** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$)K2>(N(E>-DWX^[D=?I0!F'QEX="QD:_I($@RGF7B)D>V36W#*LT2R(P=&
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M'W1@5\J22[-(B=8?LA250Q7[S#(Y_*OJWPXX?0+%D)*&!<,WWC]: -6BBB@
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MV6@#)^'VGWFH^-](CLS*'CN4D=XU/R("#DGTQVZ5]<R65M>1&*[MXIT!SB1
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^(S%?!.I?ZQB4QA$#'OV/\Z"SR[1?C5KHU*W?Q!;0QZ=(F6^RVKF13QC.Z3
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M?;I3_@?H$6HZWJ&M7EODVRHEN6Z;CG=]3C;0!C/X[^*,5F7EOM0CC7DSMI'
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MO*?BKK_BG7]7;1[/2-5AL+1V5O(1V^T'H&;:.V#^=?0WECG.3DYQFC8/?\Z
M/CNVT'Q%;2Q36WAO41)$05W:>[*2.Y!7%=<?&OQ=PJQP:C%&HP%31UQ_Z+KZ
M7VCW_.C:/?\ .@#YJM/&GQ::]ACF_M7895WJ=-C0%21G_EGD5]&698VL+R@^
M:4&XL,'/?L*L% ?8^M!0'\\T >-?'<:O>VFE:;8:?=7<!+RRM!&7Y&W&<?4U
M7^ ^AWFF2:M=:AIT]O-M2.-IHF4XS\W;N0/RKVW8.Y)I2H/_ .J@!:*.@HH
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M&,\@>X-)YB\8.<^AH ?132X'9O\ ODTN[_9- "T4FX>_Y4N: "BDW  T9!H
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MF)A.A;<^1C<. .W>@5SZB3;E2,\<=,?Y%34Q1C;@4^@$%%%% PHHHH ****
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M5@'PS8APH]?]9TJFOP/LXXPL7B355(X&2I'Y5$OP$T;,A?5K]]ZG/('S>O\
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MRC  M\X([YW>]/@^+NOS73JVJ69613M6.UY0COG=7L/_  K_ ,'8 _X1C2,
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MA@5!,73WZ4R[^*&NFU6-?$UPKX^\D8!KZ9%E:C&+:+C_ &!3_(BQCRD_[Y%
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MG)S(Z7$"EO3)W?6OI8@'J*,#TH ^9$^''CM"%3PP1R<EKZ%N.W5J>/A;XO\
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M>T4 <&OPA\'Q\QZ=.K'YBPO)<Y_[[J-_@[X/DV^9874@4Y"O>RD9_%J] HH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'TR:W[.[MKVTBN;2XCGMY%W)+&X96'J".M $]%8.O>,= \-W5M;:MJ4=K+<
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M%S*N2>O 85#_ ,*>\!ELG003ZFZF_P#BZ[FB@#AS\'_ 94K_ &"H!]+J8?\
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M1M+Q4^^;>99-OUP:OCI7#?#/PG%X8\'6T+Q*;NX7S;AUZL3T'Y5W"@!0!TH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7?&-I08/OQ[UZV@*K@G-.H \+T/XN:UH^EP:?JGA&^EN($$9D0-&1@8^8&/
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MQ9^'&J:UJ$>OZ/\ O)8H]LEJGRN?]H$=_P# 5[/10!X?I7Q1\;6.GQ6U_P"
M]3NYXQCSS%+%G_@)4DU2@M?BEX[UX73SZAX>T_=DKOD@4+W '!)/N*]]HH I
MZ=:-8VL-N\\DYCC">;(V6?'<^I]ZN444 )M'' XZ5\U?%/P1K5OX[N;_ $O2
M;^_@N_W_ )D$!=48]5^4>PKZ6HH \T^#GAF\T'PHS7UI):W-PX)CE7:^U<A=
MW /0]^E8GQK\(ZQJCZ=JNDV<UV]NOERQV\9=SGOM'6O92P'K^ HWKNVY&?2@
M#POX-^!=3T_5WU_6--EM72-D@6X0K)N)*]#C'!_*O<%)"\YSCOZU+10!\O\
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ME% &9H>E1Z)I=MIT4DLB0)C?*Y8L>YR?Y5IT44 %%%% !1110 4444 %%%%
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MOHD>I+?[I58F6SQ \F!W&%*_AFM/X9_%*_\ $6I'1=;AS? 9CN$4*#CJ&4<
M]/2@#UXD#J:,CUKGO&%SJ=MX4O[G0XFEU-(\VZB(R;CD<8'7BO/_ (;>)?B!
MJWBIH?$EI=0V)@+G?8&% W'&XB@#V&BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@!#]:S/$6NV?AS0KK5;YF6WMU!;:I).2   /4D5
MIGKSTQ7-^._#TOBCP7J&DP.$GG1?++=,JP;'XXQ^- 'F<GQ0\3>-(+VU\*Z
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:L#PQX@U[P=\1D\&ZMJ;ZK9W3*L4\Q^=6)..I8CITS0![=N))"@'\:"X7[Q
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M3:''XBT"[TR2X,*SQE-X&=N>^.]>/V#?$'X6Q-IL&C_VYI D)ADA1I"I_P"
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-/7\*=43A]QPP
MXX)_.@#Y(\4,5^*FI.O!_M9P.>G[RO2?CYX=;98^(K=0K(?*G*+@_P"RV<]L
M ?C577/@UXCO_%]YK4=YIHMY;PW(5Y'#8+YP,*?UQ7L/B/1(_$OAJ[TFX Q<
M)MW#D*P((/..XH ^?O%?Q*37/AWINA()C<(%6Z,@ #!?N\^Q -=SX?\ #ZZ!
M\!M7>XC"SWEI<7#C_MF0/T4?G7/:;\!-:BU^*2]U#37L(G5FV;RTB@C("E0
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M,0$,3G(^M/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M70X5=LEO)D>/)]0%; _*@#J;^]T^RL6EO;JUM[=A]^>0*A!]SZUX/HHL+O\
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M '15SQ!H5KXAT.\TRZ4[+F,KO'6-L<,/<'!_"KUC8P:=9PVEK&(H(4"(@YP
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MN P.17 :):VND?&#3[/P)?SW6FR-&]TXE#ILW'>N['(V_P Z]=;X6>"VR/\
MA'K0*>R[@/YX_2MG2/"VB: "-)TNTL]PPS0Q!6/U/4T ::!5PJ+@#T'%2T@&
M,8P *6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\PW$Y'/O0!F>+7>T_:%T+R0@,RVZN=HY!D?/XUZ/X]\+IXJ\*75@(HFG7]Y
M7!^5P.#Q[$_G7"?$CPWXB7X@:5XKT;39-02T2/,,8RVY&8\C/0YZUZEH-]?:
MEI,5QJ&GOI]T_,EM(0Q3\J .$^#WB9[WPE-I-[YBWVBY@D67 ^1,@8P>P !K
M$^'5C)XI^(NN>+KT1RQP3/#;?+T(^1<'_=XKFOB3H][H/Q#*Z%=RQ-K@.^*
MG.2PWY ]2<_05[AX2\/0>&?#=EIL2(&BC!F*CEI.Y_,F@#?'09H8XP<T* !@
M4V1@F"<_@0/YT >,?")5A\?>*XEP$#1@@=,@O_C7M&]<9# CUS7ANG:3X_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_%['-;07%V\R,R_*4)Y('\0Y'2O3-!\)1:WIULFD?%'4V"1*RP6UT<HA'"E
MX( X'(H YZY^('Q"\!>(4M_$\PU"#&2FR,*Z_P!Y'50?S_*O:/"7BFS\7:'!
MJMDDBQR$J4?&4(ZCWKQWQ3X5\*65TD'B;XEZA<21$'R9"\YC_ ;]O_UZ]$^%
M^C:1I&@RR:%JUWJ%C<3%U:XB9-O08 8#CB@#O:H:OIT&JZ9<V-PNZ*X3801F
MK])B@#Y7\"O<>$?BQ%8EC\DTEK)D<E<\#Z?**[OX\:O,T6DZ% SC[3+YS8[]
M0%(^I'Y50^-^BRZ-K5AXJLU6/?)LD=<#Y^J_F U<YHU_>_$?XFZ.NHEG$1#E
MHP> B[@3]64?G0!8^)'A.#POI'AW4+%9(KUHT+2,>?- W9QZC^E>P:_K5UIW
MPIEU*0F.[^P9W-U#%.O'YU6^+FB?VQ\/KTI$LDMKB9"PR5PP+$?AD5X'JWCG
M5-8\+V^A7$:-:1D%6&[<W. #SSR.E '?_ ;P^EU<W^MW"1RA'$<4A+!E89).
M,8_B%=#\?6(\&V8VDC[8IS[;6KMO OAZ+PUX4M+)$"R.HDF('WG(Z_D!7%_'
MV:,>#;&$XW->JR\]@K?XT <3\,X?%>MVUQIWAG58M'TZ+'GRF'S&+$<8_7N*
MT?&/AGQOX)TF37E\:7E\L+KY@:24'YF"C"EF7J1UK3_9W'_$MUS)SF://Y&N
MN^,KLGPNU7'<Q?\ HY* ,'X.>.=4\2->Z?K%TUU<P8DCE**HVG'!QCG.>U4?
MCKKFJZ0VD1Z9J5Y9;PY<VUP\6[IUVD9K _9]7=XEU//&+=3]>36C^T,R^=HJ
MGC"R$G\J /0/AI-=:GX LI;V\N)IG5@9'DW-C _B/->*?%'PK-X/U6Q_XFUS
M?BXC?:;@EF0#;G!)/K7M/PC8GX>:=E2,@\?@*\V_:%?&MZ*#C;Y<O5L=U[=Z
M -SX;?#F9-)TS6/^$DOD$BK<+:VLV$ (SM;GKSS[YI?BO\2-2TG4ET3P_=-!
M>1HKS21K'*03SMPV<'!'/6K7PV^(7AJS\(Z;I=W?I9WT?[HV\I8EFW8R"<@9
MZX]ZXOXR>&M2T[Q7<^(H(WDL+Q$W2IN*HP4+@\\9QUZ<T ;>D?#_ ,8^*M*C
MU'4O'=_;F?YEMU:23;]1O 'X"L7QAX=\5_#JS@OK?QE<SQ2-M8>8T3?D6-/\
M)I\)]4T>-M;A^RZFH(E$L\V']PRG&*3Q)=_"31;>-=,T1]4F?^&._N(47_@;
M'G\!0!Z+\)_'\_C+29H;_:;^S"B20,,2@Y^; Z=/UKTA>!C&,<5YC\*+'2YK
M6?6;'PE/H3.HC0R7CS"5>O 8\=NU>FKTX.>: '4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%(3BEH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ (!ZTFT<=>/<TI.*8LJ/C!ZC.",4 /QBDV@G) H9@O4X]Z-
MZD9!X]: $$:JN,9&<\\\TN!2&10<$X^M&]>>>E "A0/7\Z"@92".#2;UQG<
M.F32A@<8(.: #:.??WHVCW_$TGF+NVY.?IUH#J>ASZX[4 *% ]?Q)-! /4 T
MTRH!DL,9QFE61'&58$=CZT *% &  !Z4;5P!C..1FHC=6ZRB(S()2-P3=\Q'
MKCK3F8,"%;!SU]* '[1Z<^M&T'/'6LS6[:^NM)GATZ^%A=,!Y=RR!PA^AX]O
MQK.\)V?B"STR9->U:WU.Z9SY<T,84!>P. ,T =(54]0#SGFC SGO7BOPQ\1:
M[K/CW6K;4=7N;BTMGD"P.1L&&;&/05[,98XE+NP53SDT 28%+42W,#XVS1G/
MHPIX=3TS]".: $\I#U!/U)/?-.P/04UI8T^](J_4TBSPN<)*C'T!H DP*:$4
M=![4N15>ZU&RL0#=W<%N#T\V0)G\Z +&T>E&U<YP,^O>H8;VUN%#07$<JD$A
MHV##\Q4^<T -$:KG:H&>N.,TNT?ICFESBF231Q(7DD5$'5F.!0 [:*"H(QSC
MV-5+?5M.O)#';7]M,XZK'*&/Z5,EW;R2/''/&\B??16!*_4"@"7 SFC:.>!S
MUIKS11J6DD55'4L< ?C6=_PDNA&41#6M.,A. @NDSGTQF@#2\M.XS]3FE*AL
M9&<4Q)HY!E&!!Z$=#]#WJ!=4T][M[1;VW:Z09: 2 N!U^[UH L[%/4=:P?%L
M6O\ ]B'_ (1=K2._\P;C<#Y2F#G\<XZX[\UNO*B#))QC/ )JM'JVFRWSV4=_
M:O=H,M LJEU]<KG- 'FWAGP!KLOBX>+?%EY:3WZ@&""V)V*<8R3P.A/ ##GK
MQFO5:**  #%!&:** $Q2T44 )M /2C:#V%+10 T(H7:!P*7:/3\Z6B@! JC&
M!C Q2;%/44ZB@! H  ' '3FC:/\ )I:* &B- <A1GZ4NT>_YTM% "8&<T;1Z
M<TM% "8HP,4M% !28''7\Z6B@!,#&.?SI:** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#QGX_J?LF@-D "Z;G'3Y:\W81/
MXA\..KJX%VFXL<CJOY5Z3^T BOI^@J0"#>-N&>ORBO*[2WCM/$NB-!&T2O>)
MD;MN>5H ^M(^44@C%2TQ.57Z>M/H **** "BBB@ HI-P.?:C<.?;VH 6BD!!
MZ$4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%)D9Q0 M%-WKC/]*7(R* %HHI"0* %HI-PYZ\>U&10 M%-+J!G/Y<T
M;USU_'M^= #J* <C-% !1110 4444 %%%% !1110 4444 %%%% !115#7)I;
M?0=0GA<I+%;R.K  D$*3WXH OT5\I6OQ2^(%[)MBUV8M&I;"6T70<\@)SQ7J
MGP@\>ZAXFM]2L=;N?M-_!)YB.4";HR!\N!Z$-^= 'K-%8'B?74\.>'+K4ICG
MR4.W)"Y;MC-?.2?$'Q__ &>]R=;O3 &P7\I2>?3Y?;UH ^K**\G^">NZOX@T
MK4[C6;^XO7CF01M/C*\$'&!7J^1G% "T5Y/\8/B%/X;A72-(N&BU.91(TJ_\
ML5)Q^?!KRU?B!X_T:>UO[O4+WR)/F"7$?R3 =?O"@#ZJHK$\,>)++Q-HEOJ5
MEGRY  R'EHV]&QT-;= !17"_$+XB6G@BS 6+[3J$P_=0;L #.-S'TKS31;_X
MI_$*9[NPU)=/T_<1YJ_NH^."%(&YN1C..M 'T+17C\GP^^([J?\ BO9=^/E"
MR. I]SCFN0UC4OBCX#U.!+W4;F_1NC1L;B-_KE<C\J /H^BN7\&>)Y_%6AK?
M7&ESZ?,I >*0=3_LYP:Z=3D9H 6BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y?X@2*G@/6
M9" <6S#]1745S'C^/=X#U@*2!]G)R%R>HH ^6!# GAZ(,TB3RY*8.,^XQVKZ
MG^'JR+X&TM9;A)V$7^L0Y'4\5\Q_VC<)X71@=^TXWL@!3FOI+X6222?#C1FE
M?>YA)W8ZC<U '8T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%(2 .:-P]: %HI"P'>A6##(SCW&* %HHHH *
M*** &L,]>17$^-?AIH_C11+.\UK?HH5)X6S@#^\O?BNXHH \0@^".OV4'V>U
M\;3PP9.V...11SZ@/5O3_@!IJNDNK:Q=7<@?<XC4*'Y[DY->R44 5+6S@L[2
M*W@4K#$ JC/W<5QOBKX4>'?%MX;ZX^TVMR>&DMI0 X]P017=$2>9D%=F.AZT
MX#G- 'CX^!TUHABTOQEJ=I"3]P+GCTRKK5W3/@9X>M[U+S4+V^U&=3N;S'"
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M:-:- LY!DW2N^XCI][/Z5=UO0]/\1:3+IFJP&:TEQO0.4S@AAR"#U K2W $
MD9-&X>HH YGPYX"\-^%;F2YT>Q>&61=C,9W?(!]R14OB7P3H'BQH&UJR-R8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% "-TI>U&<44 %%%% !1110
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MX[T >4_%V29_B5J0E)RNT+N[)M&/PZ5]$^ S:?\ "#:/]A93 +9>4Z;OX_\
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MOM2[O:O)? /@#Q1H7B"]U#7=32Y2Z@*.8[J1GSD'/8=J\V\;W/B7P1XT\O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4A0(H[]!5G;R#^E.HH S[?1-,M;MKJWTVTAN#P94B ;\\5>7CMBG44 %%%%
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MFM)A(6?D9YVQCL1U_2OH< 8P!T]:YOP3X4L_"6@P65I&ZNP#2N_WF;WYKIJ
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M88<UYW>?L_Z'-,7MM5O($)_U9CC<?G@']: -;5? GPVN5>26+3;4A" 8;A4
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M)_&N?T[X!^'+:9)+V\OKM4.1%OV(?KCYOR(KTO3]*LM)L8[*PMHX+>/[J(.
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
MC=*6D;I2]J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHS0 4444 %%%&1ZT %%%% !11D>M&
M1ZT %%&1ZT4 %%%% !1110 4444 %%%% !1110 4444 %%&:* "BBB@ HHHH
M **,CUHH **** "BBB@ HHHH **** "BC-&: "BC-% !1110 4444 %%&:*
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MJ_\ A0!Z%17 Q?&+P?.2L=W<L0,G%J_KCTI?^%O^$1*\7VJZ+)C/^C/SG\*
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MD* /I:BOFBZ^+?BM/+">(X6&<%UL5PQ]?N]/:GS?$WQ@(EE;Q5"HP>!91_\
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M.OO0![3_ ,)[X0_Z&?2/_ Q/\::?B#X.#%?^$GTG<.WVM,_SKQ1OA7XR+?\
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M%:#';#?X5Y3_ ,*=\> %4O\ 1E0]0&;_ .(J9/A'X[C?='=:*.,#=*Y_]DH
M]2'Q0\%M@+K]N2>P1_\ XFD;XH^"T^]KT(Q_TSD_^)KRN?X.^.KFY6:6^T7>
MHP#O? _\<II^"WC3S0_VW1M_]\22#_VG0!ZJGQ3\$R'"Z_ 3UQY<G_Q-!^*G
M@@8_XJ&W)(S@(Y(^H"\5Y4OP9\<12;UU'22<8_ULG_QND;X,>.2WFC4M(##H
M/,?]?W?- 'JLWQ5\$6X4R:]$-Z[E AD)(^@7VHD^*?@R*,22:PRJPR";2?\
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MM5+GXTZ5:W"12:#KJEAG!B3/Y;ZHVWP+6&)E;Q5?ER<@QPJH_$9.3[YJ*3X
MV<\A>?Q+?R.3RQC&<>G6@#3'QITQU+)X?UUE]1''_P#%U%_PO'2%;$F@ZX@Q
MGF./_P"+JJOP%LMC))XCU$H3\JJB@ ?UJ3_A0NE&-4;7]5*#JN4Q_*@"Q+\;
M]+BB$I\/ZV8ST<1QX/\ X_48^.FD$@?V!K>3T^2/_P"+J)O@19.D:'Q'J7EJ
M>4")C'MQP?>G'X"Z02I.NZK\ONG_ ,30!*/C?IC%L>']:XZ_+'_\749^.>F
M?+X?U<_[P0?^S&GCX&:8!M'B'6 G]T&+'_H%,;X"Z(3D:YK"GU#1C_V2@"*7
MX]:3$/WF@ZDN?5H_\:L?\+JL38+<KX?U%LG[HV=/SJ&7X :%,5+ZWJY*^K1_
M_$5:'P.TA5"IK^N*H'W1+'C_ - H =#\9],DB3&A:R93DM&L2'"]OXOI4,GQ
MKLU!8>'-2(&2?,>)2/PW4Z/X%:)&V\:WK6\]6$D8)_\ '*:?@/H1W?\ $ZUK
M+'G$L?/_ (Y0!6_X7SIP91_PCNH_,<#:T9/\ZG'QQLQN#^&]65_X =G/ZTY/
M@-H"'_D,ZR?K)'_\13V^!>B-\IUO6=GH9(L_GLH S?\ A>-_M=T\&3M$/NN+
MT<_^0ZET[XUW&H;RWA:6,(.OVX=?^^15U?@7HD:[(=<UV-/[HGCQ_P"@4]?@
M9X=!).I:PV>N9TY_)* ($^,DKM@^%[E0/XC=+C\]M,/QCO&CD,?A.=F7.W_3
MDY_2K,WP+\.RG U36E3'*?:$Q_Z!0WP*\-&#REU'65'<BX0_S2@#*D^.D\:#
M/A.X#]\W@X_\=J.+X\7#W/E'PLH!X7.I+DG_ +XK<M?@9X7MC\UYJTR_W9)T
M'_H*"K*_!;PE&Y>-;]'QPRW;YH YB3XZ:HGWO",:@'!W:DO/_CE$GQQU9!@>
M$HAQG(U$$8_[XKJG^"_@Z9BUQ;7<Q(Y+W3G^M ^"W@L+@65QTQS=2?XT <@O
MQSU=U)7PI&0/^G__ .QJ<_&O5OL9F_X1ZVC8=GNB?Y+74M\%_!13:+"X7Z7<
MG_Q5 ^"_@G9M:PN6'O>2_P#Q5 '%Q_'76&8*_ANUW'[N+KK^E//QL\1)C?X6
MM?F/R[;P'^0KLA\&/!*L"-.FX[?:Y?Z-4@^#W@I5"KILX _Z?9O_ (N@#C)/
MC5XBC'S>%[,$CC-\*@7XV^),9?PY8C_MZ.?RS7<M\'/!+')TR<GU-[-_\72#
MX-^"<'.FS'/<WDV1_P"/T <A-\;-:MK S3>&H P]+OC\L$U63XYZY(R^7X<L
MBK8P?M9&/7.17=M\(/!C+M;3KAE_NF^GQ_Z'2#X.^!AC_B3N".XO9Q_[/0!Q
M-Y\<-829HK70+1R.DAN3@^V,"J\?QG\7+<;+C0=,*'NLI&/_ !ZO0#\(/!.0
M5TJ4'U^VS_\ Q=.D^$G@V2,J=,ER3][[;/\ _%T <!J'QC\4P%#%I.DQJ?\
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M5QNZ)';QQE?<GTKVS_A!/"6<_P#",Z/G_KQB_P#B:4^!_"9Z^&M'/_;C%_\
M$T >(/\ %7Q6NPOXFT],]3':(^/SJC-\5?&*%]OBRTD)?Y MK#C'_?->_+X)
M\++T\-Z1_P" ,7_Q-2+X/\,H25\.Z2"?^G*/_"@#P,?$_P 8(JE_%]N..2+.
M _\ LM1CXG^+V&4\8Q'!R2;*( #Z;.:]\?P1X4D8LWAC12QZDV$1_P#9:/\
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M.()-T7A>&15X5?M<><?BU?1VWZ48/K04E8^:C\,O&,TA+>"[5 1DDW<&<_\
M?5(_PQ\:D;4\(6@4+@9NH>OX.*^EZ*!GS/I_PT\?07*;_"MFH)QYANXODSW^
M^<CVQ5\?"KQN^H+,=/TY5!P=UR"#[D =/:OHFB@#YT?X;?$*>5%72]/MXX^"
M?M*GS/?KP/:I6^%/BZ>;SIM)TXR!=O,ZX(_^OV]*^AJ*!6/GFY^%GC39$UMH
M^C H,*C2*2OKD]S1_P *P\>21,3INBHV/D&Y<CZG^7I7T-10,^=(_A5X\$YD
M^QZ8IXY,^1^6:T[[X9^/);5D1]*)(W$1L02?3GO[U[Q10!\_V_PE\;)'F3^P
MW+@;@Q;/\C20_!OQ8=8CN9FTD1QCY0LC8SC']WWKZ!HH \%N/A3XX$YEMY]%
M#!L*<MGZ_=Z>U2S_  M\;RB)FN-&DE'#G#X^HKW6B@#PRY^$?C!X%6&_T5&!
MYXD /T&*B?X3>.B@Q?Z$3TVCS/\ "O>** /!(/@SXR5'1M5T:-9/O>7YI/ZK
M5^T^$/B2T@:!;_1F1X]CLR2$FO;** /#T^#'B2+S?)UC28Q*,$>0S <8XS4W
M_"HO%0MQ$NNZ<A"D;TA8$GL.G2O:J* /&)?A-XJDL8XUUK3%F"D,_DMS[#CI
M]>:C_P"%/>)UE\Y/$5FK_P!WR3M/Z9KVNB@#Q?4?@_XBO('C&OV1\W;YF8&
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MF(\86*(-CMSCKUKU&B@5CS&/X.1+,DC^)-1;;Q@1QCC\OUH_X4S:J&V^)-9
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M?XE6[D ?Z_-3C\&?!A1D^P7&UN2/MDO)_P"^J]!HH"QYVGP3\$*NUM.N'/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 44@(/0Y^E!8#J0/K0 M%("#TI: "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH ***,T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!"_0?[P_G4
MU0OT'^\/YU-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !11GWIN[!P<#^M #J*0'-+0 4
M4TM@$]J<.10 44TDYP,?C31*,XSG_@)'\Z )**8'SU&/KC_&GT %%,9V#87:
M?8G!H1]Q(SG\* 'T4'IQ3-_&?7D"@!]%1I,LA^4YQ['^=/!S0 M%(Q('%,$F
MX'9@D?7'YT 2444TMC/MV'6@!U%1"92^T,"?0#I3]WIR.G% #J**A-S&)/+W
MKYG9"PR?H* )J*04,<#.0/K0 M%4YM4LK9MMS=V\#>DLBKG]:9%K6FSR!(M0
MM78]EE!H OT4U'#KD9Q]*4T +14)N858JT\08=06&11]KM_^>\?_ 'V* )J*
M@:\ME!)N(0.O+C_&FVM];7A<03Q2[.OENK8_(F@"S1110 444A)#8H 6BJ1U
M6R%V+4WEN)R<>69EW9],9S^E6PV>GK@^U #J**8[A 2Q  &22< "@!]%5;34
MK*^9A:7EO<;>OE2JV.W.#5J@ HHIN2#S^% #J*J7.HVMD UW<P0*?XI) H_6
MLH^./"RR-&_B71E=3@@WL8_K0!T%%9=GX@TK44+6.I6EV.WD2K)G\%)-:8.0
M#0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %(WW3]*6B@"(Y!^4<XX'0$U1T
MN?5I6N!J=C;VJ*^(3%.7WKZD8XK2V^A(HP/P]* !>ISG\Z6@#%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M,:,L" Y7/<4^B@!J*54 L6([FG444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% $+]!_O#^=35#+\NW'=A4U !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%!.*YBX^(GA*SU&
M:PN];MK>YA(5TFRF"?<B@#IMP]10"& (((/0BO!?'7QHENY1IGA&X,3AOWE[
MP<@_W00>/K[5[-X9:[?PSIK7UP+FZ-M&9)A_RT;:,MT'7KTH U:*** "BBB@
M HHHH **** "BBB@ HHHH *B6ZMVF,*SQ&4'!0.-P/TIQ0%B1WZ^]?/]F\R?
MM&7D:2,$^T?=W'!^5>V: /H/(HIHX.,=:=0 A90I8D8'4YZ4R&X@N4+P31RJ
M#@F-@PS^%9?B2WMKKP_?PWERUM;/&?,F4_<']*YWX6Z3HFC>'[F'1-:;5HI+
M@O),W4-@<?EB@#NJ*SCKVE+J@TPZA;_;B,B#>-Q_"L_6_'7AGPY.L.K:M#;R
MO]U"&8G_ +Y!H Z&BL?1O%.B>(8FDTG48+K:,NL;?,OU7K5+7/B!X5\.N8]3
MUFWBF! ,*$R2#/3*)EA^5 '2TA( ))  ZDU@:#XW\-^)Y&CT?58;F5>3'@H_
M_?+ ']*V;GRVM9EEW",H0Y'4#'- $=GJFG:B'-C?VMT(SAS!,K[3Z'!XJR74
M'!8 ^YKR_P"&.F>%+34=7D\/ZW+J$S$&X20$"(Y;L0!69\6O&D!TJ.V\/:]/
M'J=O=>7+#:O+&YR/]G;G&/?K0![+17G_ (%^(/A_4M(TK36UAI=6,"1R1SJW
MFLX7DDG/)YZFNYGO(+:%YIY%BB099W( 6@">BN#OOC%X)L9WA.J23.AP?)MW
M89^N,5J:!\0O#/B38NGZG%YSG:()3Y<A;TP>IZ?G0!U%%-W@ DY&/6L?7?%>
MB^&K47.K7JV\; E,@L7 ZX R>X_.@#:K(O\ Q+HNE7<5G?:K:6US+@)%-*%9
ML], G-<E!\;? \]PL)U">(/C;));L%.?>O/?BQ+%=_$?P_/;.L\<GDNC(=P*
M[EY^E 'T*A#("IR",@YS2D@=3BHK8@VL..FP?RI[4 5M0U.PTNV^T:A?6UG!
MG;YMQ*L:Y],DXS4>FZO8:S:_:=-O8;N'<5WQ.&7(]Q7(?&"**3X=7PD7<58.
MN>S8/-9WP*"_\*^5@.?/D_G0!Z?2$XZD4M,<#!)&0!0!F:GXFT/1Y5AU+5[*
MSE90ZI/.J,5SC(!/3@\^U:*S(T8<2*5(!!SU!Z5Y9\2[WP!'XDTZ#Q3I]Y/>
M21*L<T/"HFXXW'<.AR>]>G0-%Y$?E A-H"9.<@#B@"SD#N*-RYQD9^M<'XD^
M+OA;PW<M:337%U=H</#;1'<GN=V!CZ$UA)^T!X9).[3M65!CY_+0C&>O#4 >
MLGG'/ZUB^(/%&D^&+%;O5[O[/$S[%.TL2?3"_6I-"\2:7XGT[[;I%R+B'H2
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M=2Q!Y/3(]* /0;CXW^"H' CO;NY))&V*U88^N[;4"?'?P>V[C45 ZDP X_\
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M1/#VD:CK=SY0=HH(L+&2.C$@G(SVK-E^-.I:2\;Z[X&U+3[5S@REG! [D!D
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M%TC5-8^-/B:UTC6'T>X%S=N;B--Y(\[IC(]:](;X>>-S_P U*N__  $_^SH
MD'P.\%AMP@O1QCBY/^%=)X2\"Z+X,^TC2(I$-QCS"\A<G&<=?J:Y7_A7?CC
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M11TH **3<*,^U "T449Q0 44FX>_Y49^OY4 +132X!Z_K1O'^2* '44W</\
M)H\Q<') ^I% #J*;O!''/L"*4,#TH 6BD+ >OY4F\>C?]\F@!U%-WCT;_ODT
M;AZ'\C0 ZBF[QZ'\C1O'HW_?)H =12;A[_D:3>,]&_[Y- #J*3</?\J,_7\J
M %HI-P]_RHR* %HI,T9YQS0 M%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 -8 CD"G4QG&._7%/H **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!",C&<5C7'A#P[=7
M+W,^AZ;+<2$%Y9+2-V;ZD@UM44 ?/GQ\TRPTZZT V5G!;>8DX;R8PF0OEX''
MUKV'P$=W@#P_GMI\ Y_ZYK7DW[13C[5X> ZA+G^<=>L^ ACP!X?_ .P?!_Z
M* .BHIK$J,]N]4M0U?3])A$VHW\%I&>C3RJ@/YF@"_15.PU.RU.V^T6%W%=1
M9QOB=7'YBK@Z<T %%%% !1110 4444 %%%% "-]T_2O -.&W]H^[!.?WW?\
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M%(//'/M6G\?9EC\*V4+0[WDN"(W_ +I !S7(?!KQ'I5KXOOY]2N1#>ZB&6+
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MG )XX/.!CCGF@#>NY?B-=Z7J7VJWT"RB-NQ W.[KQR."1G&:Y;]GI\6&KQG
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M-TZQOHRES# JNJ\X.!Z9H P_C,#_ ,*WOL==\?\ Z$*9\%B3\,M-'&0\W/\
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M7)_'H[_"-I\LA/FG&Q=WIUY&*O#XX>!D;*M>@^HM"*/^%Y>"2,;K]@/6U/\
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M*P/I7,>._&^O>=-HGA31K^>Z/R/>"W944^BL1C\>E-3XZ>#$3"IJ2]\"U_\
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MOBKJ-K#_ ,3GP'X@M91@'R+8R*?^!';FJ8_: \)[BPT[6=QZG[-$#_Z,I/\
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MK@X\#:>#_P!?R?\ Q=5QXZ^(J$J_P])=AA&2?@'U;@\?C56/Q=\7#(S2>#[
M1]%55+'/N?-_I0!LZ=K_ ,3)M6MHM0\(64%B\H6:5+I&*)QD@!^>]=MJ.G6N
MKZ?)97T"RP3+AHW4<?\ UZ\L;Q7\8RS8\'::JX]&)_26@>*_C&1_R)VG<^H/
M]9J %M?AIXJ\%WDMSX-UN.:T9BQT^\!"MZ#T)]^*T#XF^*J +)X$M"P_BCO8
M]I_-\BLUO%7QD)&/!VF?B#_\>IZ^)/C,W!\(:4!Z?YFH BU7PS\2O'/EP:S/
M9Z+II.7M8)BS$>AVY##V)KT#P?X*TSP;I!LK#=(\C>9+-* 7=L#O@<<=*X4^
M(_C,,X\):9^8_P#CU+_PD?QG_P"A3TO\Q_\ 'J /70 HXI:\C3Q#\9F;!\*:
M7_WVH_G-3F\0?&41ICPEIF\]<R)C])J /6J*\B_X2'XT'_F4]*_[[7_X]3WU
MSXSJH/\ PC&D_P#?Q/\ X_0!ZU17D;:[\:2/E\,:5_WTA_\ :]']M_&O _XI
MK2?Q9/\ X_0!ZY17DG]M?&L$?\4UHQ_W73_X]2_VS\:O^A:T?_OM/_C] 'K5
M%>2_VS\:2W_(NZ3[X>/_ ./TPZS\:N<>'=+X[%HQ_P"US0!Z[17E$6J_&611
M(=&T6, \JY!S_P!\RT2ZE\9RN%TC1 2<^8C  #Z-)0!ZO17DJW7QJ!^>QT<C
M']].O_?5-$_QL8;OL^CKGMN3_&@#URBO)%E^-6?FBT<#TRAS^M2/+\9V'R0Z
M2F.N=AS^M 'J]%>2%OC4>VD+]1'_ (T@/QJ)^]I7UVQXH ]<HKR4_P#"Z!UD
MTC\-E-D/QH&W:=,_\A_X4 >N45Y+M^-++D2Z2I]PG^%-\OXUL,_:=(5O[NV/
M_"@#URBO(C'\;,@?:-*)[X6/C]*GEM/C,$!CU/0R?3:#_P"T_P"M 'JU%>1^
M3\:691]NTI?4F./'Z U*UG\9L;EU71\CHOE+AO\ QR@#U>BO*EL_C(R#.J:.
M&[X5?Y>7_6HQ:?&EY&4:KHJ =VC S_XX: /6:*\K&G_&7'.N:%GTV#_XW48T
MOXS^9G_A(M&/^QL3'_HG/ZT >L45Y*=*^-)DS_PD6C*/[HC7'_HBD_L7XU;B
MW_"3Z-C^Z\2X'Y0B@#UH^U&3GIQ7D3:'\:R>/$^D$'N(TP/_ "#3E\/_ !FV
MX;Q5I('_ %S3_P",T >M@Y__ %4$G/05Y'_PCWQH;[WBS2O^_:__ !FF_P#"
M,_&7G'BW2Q[;0/Y0T >NY;T'Y_\ UJ,GTKQ]?#7QI[^+M*_+_P"TT_\ X1?X
MR$<^+M,^O^8: /7@3W%!/H*\=/A+XPEA_P 5AIY7N?3_ ,A5:'A#XGA?D\<0
M%^X,/'Y^70!ZOD^E&X_W3^E>0GPC\7M^!XRL<?\ 70C]!#4T/@_XI-E;CQS$
MA_V(2_\ [** /6-_M_*C<?[A_3_&O)IO!7Q/6,F'Q]"S?[<93^AJ*#P9\66D
M_P!(\;6L<?\ >1F8_D4% 'KVXG^$B@OCM^)XKR:?P!\1[E=A^(+%.Y560_FM
M$7P^^(D2^4GQ!E,1')(=F_,G- 'K.[CG] 31NSVKQ_\ X5=XXYS\1;\9.3B6
M7_XNI5^&'C9?^:DZB/H)?_CE 'K>\>V: Q/;\J\@?X4^,7<NWQ)U(D]_WP_]
MJ4H^$WB]OO\ Q(U+V_UO]9* /7LGT-+FO(#\)/%F/^2D:E_Y$_\ CM"?"#Q.
M3E_B/JF?]GS/_CM 'KV3Z'\J-Q]#7D)^#_B;)_XN1JOY2?\ QVD_X4]XC)^?
MXC:JW_ )#_[5H ]?#>QIU>0#X-ZX?O\ Q"U1AZ>6_P#\=I)/@UKSC"_$+40/
M>)__ ([0!Z_FC->0#X,:R1^]\?ZH3_LH^/\ T93#\%]:WX7X@WZCNOE.3_Z.
M_I0!["'!8@%21V!I"^WM7D4GP)@NHU^V^*M4N)%.<N<@'U"L3C\ZM0_!A[:,
MQ0>--=BC(P4CE*@CTP#0!ZFLF3@J0??%.)/85Y++\"-.N9!)=^(]8G8#&793
M_,&F+\ M(1=L>NZHJ#H!LX_2@#UW/^<49_SBO(#^S]HV<G7-4)]]G^%*?@#H
MY7;_ &WJ>/<)_A0!Z\2!UXHSQGI7D$G[/VCR8WZWJ)QT^6/_  IX^ 6A*&']
ML:I\PP?FCY_\<H ]9\Z,?\M%_.CSXO\ GHG_ 'U7DB?L]^&LX?4]4('H\7_Q
M%./[/?AC?QJ.JX_WXL_^BZ /6?/B_P">B?\ ?5'GQ?\ /1/^^J\F_P"&>_#'
M_01U;_ON+_XW2_\ #/GA;_H(:O\ ]]Q?_&Z /56NX%^]*@^K#_&F'4;->MW;
MCZR ?UKR\?L^^%]N/[1UC'_76(?^TZ!^SYX5!S_:&L?A+%_\;H ]/_M.R_Y_
M+;_OZ*#JE@OWKZV'UE7_ !KS(_L_>%,@KJ&LC_MM%_\ &Z4_L_\ A)A@WNL$
M_P#7>+_XW0!Z6-6TXGB_M3])5_QIW]IV ZWMO_W]%>8K^S]X24?\?NL?]_HO
M_C=*W[/WA0G_ )"&L_\ ?Z+_ .-T >F?VI8?\_MM_P!_5_QI%U2Q=MJ7ELS>
M@E%>9K^S_P"%%8'[=K#8[&:+_P"-T\_ +PFTH<W>KG'83QC^24 >D3ZMI]J#
M]IO;:$CJ))E4C\S45EX@T?4I3%8ZM874HZI!<H[#\ 37GS_ 7PBP_=SZI"W<
MI.F?U0U"O[/_ (3SS>:NWNTD)_7RLT >F-JMBDQ@:[MQ..L1E&[\NM*-4LF(
MQ>6YSG;B5?F ZXY[5YS'\!_""X!?5#CD'[2O\@M2#X$^#E.0VI#@C_7CC_QV
M@#T(:KI[$@7UL<=<2KQ^M4I?%OAV"3RIM>TN.3.-CWD8/Y9KA5^ OA%78^=J
M6#V\Y/\ XFG#X"^#N-QU(XZ?Z0/_ (F@#MY/&'AJ(XD\0:4A/3=>1_\ Q5,/
MC7PJ.3XETC_P-C_QKCS\"O!S'+'46/O<#_XFD/P(\&X^[?G_ +>!_P#$T =A
M_P )OX4_Z&72/_ V/_&F_P#"=>$\?\C+H_\ X&Q_XUR'_"B?!9X\N]S_ -?(
M_P *=_PHWP<!C;??^!(_^)H ZO\ X3SPG_T,VC?^!T?^- \>>$O^AFT?\+V/
M_&N3'P*\&YSMO\>GVD?X4?\ "BO!V[(74/I]I'^% '5KX^\(L2!XFTGC_I[3
M_&C_ (3_ ,)?]#'I?_@4G^-<N/@;X-QS'?\ _@3_ /6I!\#O!('-K>GW\\_X
M4 =1_P + \(9Q_PDNE@_]?*_XTW_ (6'X/S@>)-,)_Z^5_QKG(_@CX)09-I=
M2#T>Z91^F*?+\$_!D@4?8;B,#^Y>/S]<YH Z$?$#PBR!QXCTS:3@?Z2G^-*_
MC_PC&0#XCTOGTND_QKGA\%O!.[)TR9EQC_C\E/\ 6E7X*^!0?^05(WL;I_\
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MX'?[.V#^==2W@?PFW7PQHO\ X 1?_$TJ>"?"D7^K\,Z.I]18Q@_^@T <5/\
M'SP?%CRTU"8>JPJ!^K"D/Q]\([&(MM5)7L($Y_\ 'Z]%31=*CC$::99J@Z*(
M%P/TIZZ5IR_=L+4?2%1_2@#S#_AH3POG_D&ZOC_KG%_\73O^&@O"OE[A8ZJ3
MNQCRX_\ XY7J'V&TQC[+#C_<%*+&T P+6''_ %S% 'E3?M!^'/X=*U8_5(__
M (ND_P"&A/#W_0)U7_OF/_XNO6!:VZ_=@B'T04H@A!R(HP?]T4 >2-^T+X?'
M_,(U3\H__BJ9_P -":0WW-$OF_X$M>OF&(]8U_*G!0O0 4 >+S_M"6Z2 0^&
M+N1<=6G"G\MII8_CS>73;;+P3>7!QDA;DDX^@C)KVBDP#U&?K0!X[_PNO7?^
MB=ZC_P!_I/\ XS3O^%S>(3]WX<ZE^,DG_P 9KV#:O]T?E2T >/'XQ>)NH^'5
M_P#]_)?_ (S2GXO^*, CX=:B<_W3*?\ VD*]?Q]?SH*@]0#]: /(1\6_%K?=
M^&FJGWQ+_P#&Z&^+/C''R?#74R?=9O\ XW7K^,4F* /(A\5O&F 6^&>J?@LO
M_P ;IK?%GQEN&WX:ZG^*S?\ QNO8,44 >0CXK^,\9/PSU3\%E_\ C='_  M?
MQE_T3/5?^^9?_C=>NX^OYTN* /)$^*?C)I5!^&NIE3U!$JD?^0Z63XI>,XF;
M=\-K_;_!AI3GZ_NJ]9(!_P#K48'O^= 'D;_$GX@,B-#\.;H9&3N$AQ_XZ*'^
M)/Q 6'</A[=9 R?DD(_E7K7E1[]^Q=WKCFG;1Z"@#Q^/XF?$*1<CX=W('JZ2
MJ/\ T&DD^*'Q 4;1\.;K>/XECG92/8A*]AP*" 1CG\Z /(4^)GC^Y ,'P[ND
M'?S4E&?S44Y_B%\1UZ^ 'QZ@2?X5ZY@>E&!G.!0!Y#_PL/XCCD^ WQ_NO2CX
M@?$<MC_A V_[Y?\ QKUW'-+0!Y!_PL'XD%BH\!MQ_L/_ (TU/B%\27R1X"=O
M;8_^->PXHQ0!Y"?'7Q.(S_P@>/\ @+?_ !5-_P"$Z^)__0A_^0V_^*KU\ #I
M2X'I0!X__P )S\46(QX$  ]5;_XNG-XW^*?WE\#0CV8/_P#%UZ[M7T'Y4  =
M!B@#R(>-_BDZ'/@FW'X./_9J<GC/XJ22_+X&@48ZEFQ^K"O7*:44]1GZ\T >
M5_\ "5_%7R\?\(1:E_[_ )PQ^7F57_X2?XPF0G_A#+!D/0%@,?CYU>O  # X
M%&* /(AXC^,VXD>#]* [ L/_ (_2-X@^,[?\RCI0_P"!C_X_7KN >U&U?[H_
M*@#R3_A(/C3_ -"AHW_?P?\ Q^C_ (2+XSC@^#]'/T<?_'Z]<I-H/4"@#R0^
M(OC.>G@_2!_P(?\ Q^D_X2+XT?\ 0H:1_P!]#_X_7KFU?[H_*C:O]T?E0!Y(
M?$?QH[>#]('_  (?_'Z/^$A^,Y'/A'2?P<?_ !^O6]J_W1^5&U?[H_*@#R%O
M$'QGW#_BDM,QZ;U_^/T__A(/C*!D>$-)'_ P?_:]>M[5]!^5&U?04 >2?\)%
M\9O^A1TG\Q_\?IO]N_&H_P#,K:5_WVG_ ,=KUW:/2EH \>?6/C4^=OAS34;:
M<;3%C(Z<F6O3]#EOYM(M9-5BCBU QC[1&F,!^^,$BM$HK=5!^HHP,Y_K0 M%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 0OT'^\/YU-4+]!
M_O#^=34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 <5XU^&^G>-Y[2:]NKF%[4,$,..=V,_RK
MI]&TR+1=%L],@+&&TA6%"V,D*  ?TJ]10 UUW+C\:Y?QEX$T_P :V5O;7TUQ
M"('+H8& .3]17544 <SX0\'VG@K1Y=-T]YIXI)VN"TS G<54=@/[HKI0, "E
MHH **** "BBB@ HHHH **** &LN3G'3FN5OOAMX3U/5)-1O=(26YE^^QE<9_
M '%=910!QO\ PJOP5G_D7K8<]0S_ /Q5!^%?@HJ0?#]OCV=P?_0J[*B@#/\
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M/^A:TC_P"C_^)KH** .?_P"$%\)_]"SH_P#X!1__ !-'_"#>%/\ H6=(_P#
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MCOM%/,:$8*#!ZC J2B@"*.&.(_)$J_[H J6BB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DQUI:* (5M85NFN?*0
M3LNPR <D>E3444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% $,Y/R<?Q"IJAG_@_WA4U !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444'I
M0!#/_!_O"IJKS_P?[XJQ0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %!HH- %><?<_WQ5BJ\Y^Y_OBK
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%)N&<9
M%+0 4449H ***,T %%)D4F]1_$/SH =12;E]:-ZCJP_.@!:*3(I<\4 %%)GZ
M_E1N'TH 6BD!!Z'-+0 444@=6Z,#]* %HHS10 449HH **** "BBB@ HI-R^
MHHR#TH 6BC-% !1110 44A8#J<4;AZB@!:*0.I. P)'84F]?6@!U%('4G .?
MI1N'K0 M%)N'K2T %%&:3/U_*@!:*3/U_*ES0 449I"0.M "T4FY<9S06 ZT
M +12!@1D'-&<_P#ZJ %HI"P7J<?6C(- "T4F?K^5&]>>>G6@!:*3< <9YHR,
MX[T +12;@.XHWJ.IH 6BD# G@Y^E(LBO]TYXS0 ZBBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH ***#0!!/CY/]X5/5><'Y/]\58H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***3IU- "T52FU;3[>9
MHIM0M8I%ZH\J@CZC-)'J^GR E-0M7"]=LJG'ZT 7J*H-JMC&W[R^MD/96F0?
MCUH_MBP/34++_O\ K0!?HJA_;&FC@ZE9 _\ 79?\:0:WI9;:NIV3'T$ZY_G0
M!H45G-K>F(<-J5DI_P!JX44+KFEL^P:G8E_[HN%H T:*S?[?T?\ Z"UC_P"!
M*?XT?V]I'7^UK'_P(3_&@#2HK-_X2#1_^@M8_P#@2G^-']OZ/_T%K'_P)3_&
M@#2HK,_X2'1O^@Q8?^!,?^-'_"0Z-_T&+#_P)C_QH TZ*RSXCT1?O:SIP^MT
MG^-'_"2:&?\ F-Z;_P"!2?XT :E%9#>*-!'']N:9G_KZ3_&C_A*- _Z#>F_^
M!*?XT :]%9(\3Z"W36]-)_Z^D_QI'\3Z$N/^)UIQ/I]JC_\ BJ ->BL-_&/A
MN-MK^(=)5O1KZ('_ -"I'\8>&XU4R>(=+B#<@M>1<_\ CU &[16''XO\.21^
M8OB'2C'_ 'OMD>#_ ./4W_A-?"__ $,NC?A?Q'^M &]16(?%WAR.,/)XATI5
M/=KV+'\Z9_PFWA3_ *&?1O\ P.B_^*H WJ*YX^._"0./^$GT?_P-C_\ BJ5?
M'7A-FP/$VC_^!L?_ ,50!T%%<])XZ\)Q\'Q-I'_ ;V,_UJ/_ (3[PE_T,^E?
M^!2?XT =+17,_P#"P?"/_0RZ9_X$I_C2'XA^$%Z^)-,_\"%/\J .GHKE1\1O
M!X/_ ",NG'_ML*4_$?P<!_R,>G?]_: .IHKCS\4/!0DV_P#"26F?QQ_*I5^)
M/@UCQXDL/QEQ0!U=%<J_Q(\'IC/B/3N?2;-4F^+7@A;A8&\00!F.,K'(5_[Z
MV8'YT =O17)M\2O!J8W>(['GIAB?Z56G^+'@B!2S:_$0/[D4C'_T&@#M:*XM
M_BOX(2))#X@BVO\ =Q#(3^06D?XL^"(TC=M>BPXR (9#_): .UHK@W^,G@13
M@ZY^5M+_ /$TU_C-X%501K1/_;M+_P#$T =]17 ?\+G\"_\ 07;_ ,!I?_B:
M1OC3X%'_ #%I#]+64_\ LM 'H%%>??\ "ZO W_05E_\  27_ .)I?^%T^!O^
M@M)_X"2__$T >@45Y]_PNKP-_P!!67_P$E_^)I/^%U^!^VIRG_MTE_\ B: /
M0J*\\/QK\$8XU&8_2VD_J*(/C3X*G;:+^=/=[=@* /0Z*\Y_X7=X)_Y_[@^_
MV9J7_A=O@C&?[0N#_P!NS?X4 >BT5YP?CCX*!_X^[H_2U:D_X7CX*Q_Q]7?_
M (#&@#TBBO.!\;_!.0/M]SSU+6K<?E3F^-W@H.5%Y<N!_$MLV#0!Z+17G"?&
M_P %,1F\NE!!Y-LU,N/CEX,AA\R.>\G;_GE';D-_X\0/S- 'I5%>3#]H/PJ6
MQ_9VL@>ODP__ !VGM^T!X2"!A:ZN<]OLZ?\ Q= 'JU%>3_\ #07A7_H'ZR?I
M#%_62FM^T'X6 XTW62?>&+^DAH ]:HKR/_AH7PS_ - O6/\ OU'_ /%U/!\?
M/"LN_=:ZG$57($D2#/T^>@#U6BO)!^T#X:,NW^SM5 ]3''S_ ./4T?M!^&]V
M/[-U7&>NR/\ ^*H ]=HKR2+]H'PT^[?I^JICI\D?/_CU1-^T+X>#X&E:J1Z[
M(_\ XJ@#V"BO(?\ AH+0NVC:J1ZXC_\ BZ0_M":"I^;2-24>_E__ != 'K]%
M>/M^T'HH7/\ 8FICT+>6 ?R8TS_AH71_^@+>_P#?:T >QT5Y O[07A]DR=-U
M,-_=VI_\52?\+_TORC(-"U(J#@9 &?RS0![!17CS_'NR50W_  CNJ+D9 ? R
M/RJ6U^/>D72D?V5>1R#^ D$_IF@#URBO'T^.\;W0C_X1;4!$?^6OF#G\-M3I
M\=+%HV)\.:QO!X"Q@@CUZT >LT5X[=_'?:R_8/".J7"?Q-(3'CZ85L_I1;?'
M.66=DN/"EY"@!*NDK/N..F/+% 'L5%>.S_'21/+,/A'49-PRX9]A4^G*?YS3
M(?CM-(90?"=YO1-Q592V&[)Q'U/'YT >RT5XU!\<[J02>;X.U"/:/E(EW9/O
ME!BB#XYWDD$[3>#+^*9!^[192RO[9\L8H ]EHKQI/CCJ#V[LW@R^250"J>:<
M-ZC=LI8?CA?-"[2>#;U7!^5 S'=^.R@#V2BO&V^-^H")F'@R_P!P8!5+M\W3
M_8IW_"[=1,3.O@R]+#^$R,/_ &G0![%17B@^..M%CL\#W3(!G=YS?E_JZ7_A
M>&N=?^$$N\?]=F_^-T >U45XK_PO#7"/E\!W7XS-_P#&Z6+XW:X90LO@:Z4-
MP"DK'G_OB@#VFBO&6^,7BGS66/P#>N!ROS28/UQ'0/C'XI#N'^'M\,+D8,O_
M ,:H ]FHKQA/C'XJ;C_A +P_3SA_.*I3\8/%3+^[^'.HY'4DR$?A^[H ]BHK
MQ>3XN^,V.8_A_>JO^W!.?U\O%2+\7?%;Q$+X!OO.48/WRI/;C9F@#V2BO&(_
MB[XR5L3?#Z^/^[%*O_LIIS?%GQFTI\KP!?*G7YH)F_4+_2@#V6BO&G^+WC#R
MOD^'5^)/4K,0?P$>1^-0_P#"VO'0P7\ 7@YZ"UGZ?7;0![717B\GQ8\<-\]O
MX!NC$3@>9#,&!]QMZ4U?BMX^.1_P@,^[_KWN,?\ H- 'M5%>*)\5_'QD"MX!
MN<=RMK.?Z4K?%;Q^TA$7P_NBH];6<'^5 'M5%>*_\+6^((Z_#ZY_\!I_\*/^
M%J?$(]/ %S_X"3_X4 >U45XK_P +3^(7_0@7'_@)<?X4?\+3^(9Z> +G_P !
M)_\ "@#VJBO%?^%H?$;MX N/_ .XH_X6A\2/^A G_P# *Y_^)H ]JHKQ1OBA
M\25P?^$ G(]K.X_PIP^)_P 1W(Q\/[D#OFRN/_K4 >TT5XW#\1?B9<3"*+P#
M(&(SF2WEC'_?3,!27'Q"^*-J?WO@-2/^F4,LA_\ '2: /9:*\3;XG?$K+%/
M<Y4=FL+G/\JLP_$+XG7,7FQ>! BXZ2P2HQ/T)!H ]CHKQV/QS\5[B-6C\$V\
M1])8Y,G_ ,?%/7QU\5"A#>!8MZ'+$*P!'M\_6@#U^BO(4\;?%9G5F\#VXC[C
M+9_]"I6\7?%MH4\OP7:*V/F8D-G\/-7% 'KM%>1'Q5\8'4"/P;8H0.2[*<GV
M'G#'ZT]?%GQ:X#>#K,L%P<-QN_[^?UH ]:HKQ]?$_P 93)\WA/3 -I  Z9]_
MWM+_ ,)'\95+!O"NGR9'RE&0 ?G-0!Z_17D \0?&C _XIG3#ZXV?_'J/[?\
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M!Z)_;.E_]!&S_P"_Z_XU#<^(M'M%#3ZI91@_W[A17!CX%>#MY.-0.3D*;DX
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MM%_Z 1FGQ?#3P7$@5?#EB0. 73<?S/- #9/B;X,CN([?_A(+1I9,[54LWYD
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MG^% '%I\</!D@<BXNU"_W[=AN^GK4?\ PO;P5_SVOO\ P&/^-=Q_PCNB<?\
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M_P "'_\ C5>UTF!0!XL/!7Q?YSXOMNF,_:9/_C=-;P5\7>,^,;1>.]W*,_\
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F@< $8^E.HH
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MT4 51I]F!Q:0C_MFM!L+3_GUB_!%JU10! +6!1Q;H/\ @"TU;2W4[Q:H&/\
MLK5FB@"+[/$1S$G_ 'S33:P?\\$/_ 1_6IZ* (!;0 Y%N@/KL%.\B/\ N+_W
MS4M% " 8  Z"@J"<D4M% "# Z"EHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ IDC,N-JDT^B@!!VXZTM%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5KC@19_YZ#^=6
M:K7(W>5[.*LT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1103CK0 4444
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MC- "T4A(! )&3TI20!DF@ HHR/6@D#J: "BBC- !12$@=2!1D9QGF@!:***
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDC)W+"VX@!L9("U9_P"%RWW_ $(>M?DW_P 17(?L^KCQ#K$NY,-;A!EERQW
MYP*^A0../Y4 >13?''[&Z&_\(ZG:1.=N^5\#/T*BN[\(^,]&\96)NM+F)=0#
M+!)@219Z!@"?0_E5O7]6T?2K%Y-9NK6*WP<K<$$-[;3U_"OG[X)V-[/X[FGL
MX66TAB9)I%& H+# /UP>/8T ?3&[K\IQ2ALC.#CZ5S'C[7KOPWX0OM6L1$;B
M#;CS%R,$@=/QK@-'^+?B77M'B32/#!U#5@<2M%E($'KR?IQF@#V+S 6(7G!
M..H_"O.)_BE<1?$(>&4T)I$\](C=*[$ -CYL!> ,UI>"[[QU?7=V/%6EVEC
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MMJ$2E4N(!*J],;ES_6OFWPGH%SXE^(>JZ8NH3V=K+-*+DQ,59U#-E?Q''XT
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MIWC\C5'56QYB0QE6']X?/G'X5U?ASQ_X;\52&'2K\27"C<89$*-CU&>&_P"
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M>ZO%K/Q=6PUB6X_LFUDVF&)&<\+G.T YY'I0!VVH_'SPO!-Y=K;7]VO>145
M/^^JMZ3\<O"NIZA!92V^HV,DI"A[F-%09]2&Z?A3XOBSX&TB);6V^U1I$ N(
MK!D ^N0*Y_QK\0O /B3PU>VT:-+>R1D0NUB=P;''./6@#VF.9)8EDC8.C<JR
MG((J2O(_@5KM]?\ AZ\T^\^T2?8W!CDD4X*L.%'TV_K7K8/.,T +5'4]7L]'
MLY;N^E6&*,9)9@,_3FKU?.VJ:B_Q#^--MH=\A33;6XEB6(<@^6C$Y'N5/YT
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M]W\9+275+BST#P_J>LM#G=+;)E>#U& W'UJ"U^.%F-7M[#5] U'2S*ZJ9)F
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M =+.B>*]$U9Q;R-Y,Z1=(^,+\VW(SGG/?VKK'^,%CJ-O&/#FB:CJM[+TA";
MG^\P)'Y4 >9QZ0/#?QSM;6 QB$7F]%08PIS@5Z9\<M7O=+\"QQV4C(;FZ6"5
M@#RFUCC(/!RH/T!KS+2].\0I\7[*76[:473W7FRLH9D Y[XQWKWKQCX;B\5>
M'+G2G<QO+S'(/X&'0_S'XT <Q\$]'M;'P!:WD81KB[9VFE1MVXAR ,]L  $>
MHKT=T5T974,K#!4\@CTKPGPKXKU+X8PS:#KWAW49K>*0^5<VJ;U(]><#GKUS
MS73#XUZ)<E8M+T76;ZX/_+*. 9#=@?FS^0H \X\9:/:^'OC38"T58X9IX+K:
MHX4[R#Q_P&OI&4XMVQ_</\J^8KI=>U;XJVFIW^AW5F9[N.;R7B<  $<MQUXK
MZ<F91;O[1G/Y4 ?-/P3TZTU;QVS7\"W!@M7FB\SG:^Y!G\B:^G  5&3[]:^>
M/@7IM]9>-;QKJRN85%BZ;I("%SO3C)^AKZ$ZJ<=\XX]Z /F[5;R34OCQ-+_9
MTFJK#+MCLT<%CLBR<;N.H)KUU_&NM6\08^!-9VJ/NPR128'IA2:XWQAX%U_1
MO')\;^&42X*L&>S089<(%;'J&YX'K6E%\;8(HU74O#&LV]P.&1%W G\2* (_
M%VLZIXS\-7.FP>!M:CEE^6.6Z"QF-STX8@[?TXK4^$-GK6E>&IM.UK3Y;5(F
M#6QE9274YR  > ,+^=8&H^/?%?C18K'PKX=U.P/F?O+NXVK\OIDC 'K@DUZ/
MX8T?4](T);;6-5DU.^+$R7#*,D=EZ<@<]?6@#SWQ3\/O%47CD>+?"\]K).'+
MB"X<H<D'/7@CD\9K0B\<_$'3!NU_P'))$GWY-/EWGZA1N_G6+KM[\0/!OC1M
M0_T[6=%DF9UMK=&(2,YPGW3MQD=./EK:3XW:?M42>&=?$I'00J0#]<C^5 &?
M=>./AOKNM6UUX@TV[L=5M&5D^V0R12(V<KG81GMUKTZ[M;37=#EM&9FM;J$J
M2N=VUACCTKPWQ':^(?B[K]HUAX<DTRSA&TWEY'M9AR>6P#CG@#/->S:AHM[-
MX5DTS3[YK2]$&R*Z7(VN%P&_/OUH \NT?P?\2/A[+<IX>73+^RE8'RY'P21G
M .2ISR>AKH+KX@>+M*$,NM> +H6[+F6:TD%P4]R%&%'U:L32O&GC;P1<W%EX
MJT?4-6A+*(+BW . ,[CNQ\V<C[Q'2MIOC(T\;"P\'Z_<2XX!APH^I&30!+X*
M\3^ -=\1//I-D;+6I@Q=)HC&S@\D@ E<GKFO34[\@\^E>)_#[P)K=QXZE\8Z
MO8_V?#+-+=PV[2[GW2ANHSD<.>#@U[8BX'OW]Z %;A3S@5\]?'S4+IO$.G6$
MJ[+&.$2HX!.YRQW CIP OYU]"D9%<1\1?A\GCC384BG2VO;<EHI'&5.<?> ^
ME '0:!HUAH.C6VGZ>"+6-<*2?F8^IQ6DZJW#@$-\G(ZC'(KQG0_%OC7P7;+H
M^N^&[[58X/D2[M@S94=/F52#]2<U->_%3Q!JT#67AKP=J,=VX_UUTGRHQZXP
M,=SRQ% ',16T>B?M#+:Z2H6 SY8#^$M"2P^F2>*]J\<\^!==X_Y<9L_]\&N'
M^'/PPOM(UM_$OB26&YU24,Z1@9,3MU+-TW<D<9'-=YXSMKJ[\%ZS;V<327$E
MG*JI&,ELJ> .YH \Y_9^RV@ZFQ9CFY'WB3_"*]E'2O)O@;I.HZ1H6H+J5A<V
M;/<95;B)HR1@=B*]9H *S?$./^$;U,L2 +64G SQM-:54-;BEGT'4(8(S)+)
M;R(B#N2I % 'S3\*?"EEXKUV^@GO]0LS#$)%>RD$3,"1@<@^M>O+\']/0$+X
MI\5#/)_XF"__ !%<S\$_"6O>'M;U.YUC3IK2*2W$:F3'+!\XX/I7MM 'E\WP
M2\/W5SOO=6U^]('R_:;I7 _\<KM?#?AW2O#.FK8:5;I%%G+[6W,Q_P!ICR:V
MZ0C.* .&^+H'_"M=7]PF?^^A63\#(8U\ JZJ SS/N8=3\QK?^)NF7^K^ K^Q
MTZW:>YD"[8U(!."">I]JS_@_I&H:)X'CMM2M);6<RNWER#!P6)'% '?X'7O7
MS;J-K-<_M&A8(MWEZG!(W3A1M)KZ2R3TKQ*7P;XN'QJ.O6EBR::U[&\EQYL?
M,6%#?+NSV/:@#T'XC\?#G7L'(^QOG/Z5Q7P MH1X=U*?9^\><!FR>1S7?^-=
M-N]2\&:O9Z?"9+FXMBD<08+D^F2<5ROP;\-ZYX9TB_M=:L!:EGC,(\Q&+ !L
M_=)QU% 'I>U2>@XZ<=*^>8/D_:4!/7SF(_[\5]#@$9Q7C47@GQ&GQN.OOIQ&
MEF7<)_.C/'E[?N[MW7VH UOCE,\'@ I$Q57F3</7# UJ_"6&V7X<:3Y* $H6
M8#@%B>I'<\=372^(]"MO$>@W6EW:CRYDPK'^!OX6'(Y!P:\HT7PW\0OAPS6F
MF6EKKFER-N$:S!-A]><$'Z9Z4 >TMM[D ?>.3TKDM&C\$GQ3<S:.;'^V6#^=
MY+L6Z_-\O3K7,ZSJWQ(\2:<;+3/"@TII%V2W,UW&<#_9[UH_#;X8IX+C>]O'
MCN-6F0QO(CDHJD@G&>Y(&: .9_:#9?[*TF///G;AS_LM7I_@Z,1>$=)&>/LR
M'],UQ'QB\(:[XHLM/BT73UN3%+EAYR(5&"/XB*[OPS9W&F^%;"TNHMD\$ 61
M 0<$=LCB@#Y^^%2Q/\8")@CC-RPR.A'2OIH '!_K7R5X5TG6-:\>SQZ#?P6.
MH)/+*CRLR!@IR<[5;/XU[(FM?%?3%D@NO#%CJ;KQ'<6]VB*_N5+ G\E^E &Q
M\77MX_ASJ FCW,^U8CM!*OGK^6[\ZP?@7'=P^!YYII5-F\S&V3."B@D']:SK
MOP5\0/']Q"?%=U;Z=I:OYIL(64X;H/NYR<$\EC7JNE:'9Z-I$6F6$"0VT2!%
M50!GU)]30!YEJ/Q0U?5O%/\ 8/@[2X9;I&=&FOO50<D8((7@\FM2&P^+DSQF
M?5/#]O'G+%8RY7Z I_6N;;X<>-/"7BJXU_PVUEJ EE9_L[$1L5=B67YC@<$\
M@BNE_M;XJ:DJVUKX<TW2F/#75U=K*J_14)/Z4 >6?&+2->T_5+"XU[7(]1DG
MC9(V2 0J@!' 4?7K7TG8*!80;<[0@ YKQ/Q=\+?B#K2IJ%UK=IJUY <Q0*HC
M"_[N<+^=>F^"9O%$FGO%XFTF*QEB"K'Y<R,KCGH%)QVZXZT >.>/]0?3/CO:
MWJ+%*8_LR[)%R#N3&<?C7T=7CWC'X8Z[XA^),.N6[V<=B#$6+$E_EQ_">.U>
MPT %(WOTI::RYQC@T ?-6DZ%I_B+XUZE9ZI \UOYKL%5BH)R.I'->K#X+^!]
MS-_9<I)_Z>Y!C_QZL70?AOKNF_%*Z\13/:&QDE9AB4[\'';%>MT >>K\%_ J
MG+:.[_[UU*?_ &:NMT/P]H_AZS^RZ3I\-I%WV*=S?5CR?Q-:M% '/^.5_P"*
M \18X)TRX&?3]VU>7_L\7RM8ZS8^65$4D<RN23N#AAZ_[!KUOQ/IT^L>%M5T
MRU9$GN[26!&<G +(5!./K7"?"KX>:QX*?4Y-4DM':[$6S[.Y;!0ODD%1_>'>
M@";XB_$]/"5RFE6$(GU210S&3[D(/0GUS_2H[&Q^+5TPDN]>T.U1X]P6.V+E
M3QVQ_6G?$;X72>,[NVU"PN8;.]B^61I 2)5_A!YZCGMWJ'3[?XOV"16)/AVZ
M1$"_:[EI"W [[<<G_=H ;XK\,>)9/".I2:KXRFD$<7F/%:VRPJ^.<$YSBJ/[
M/R;?#&HOD;7O"1AP2?E4'^5:I\#^,M?L[V+Q3XFA>&X0JEG9VZA(SGY26PI8
M @'!]*SO!7@'QSX(U(PVM_I5UI4DF9%D=E8CNP^0D'';..* ,7]H2.43Z--M
MQ#\Z[ST5@0<_K7L'A:6SN/"^FS:>%%H\"F(+TQ[5!XI\*6'BW1)=.U%"59?E
M=3AD;U'K7G^D> OB)X47[/HWB'3KNQ1MR07NX*#[ (<?@PH ]7N7BMD,SND2
M@'<S'''7^E<SX=\>>'_$^M7.FZ1-)+<0(7=_*VJ0"%/S9YY-<CK'A'XG>*K1
M;'5M9TFSLR294LR_[ST4C )'MNQTKM/"/@VR\(:/%96<8,A0?:)MH#3/W8]3
MZX&3@4 >(^)OM47Q_G2SOQ97)FBCCG*"0J7B4#@C_:KUA?"OCW>&/Q$)&.G]
MCP_XU+XY^'%IXO5+F&7[#JL!#0WB+DY'3=SS]>M8EMX?^+FFRQ+;^)])O8%
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M&%CN<EBS.?4DU'XH\*67BW1YM-U+)C<AD=<9C89P1GOS0!2^&I!^'VC8;/\
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MI;+X:>,M"@:WT/QP\=N/]7%-!D)].3C\JCN/A=XQUB'[/KOCNXN+9CEXHH\
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M1D'/7KS61>^$M U+48]0O='M)KN(ADF:,;E(Z<T :L>TE<$D@9S^G]*EIJJ
M1A< #'X4Z@ KP+X]?NO%.@S3!A L;.652Q #IGI7OM4-3TBPUB'R-0L;>[B_
MNS1A@/SH P_!_C?P]XGA6TTB^\Z>"%6DC9&4J!@9Y]Z\2\6L3^T7 ">!J=CC
M_P A5]!Z/X>TO0(&M])T^"RB;DK"H&3]:;-X8T.YU2/4Y](L9+^-@R7+P*9
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H/2B@]* *UU_RR_WQ5FJ
MUU_RR_WQ5F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "FA<$X"C/7CK3J* $ Q2T44 %%%% !1110
M 4444 %%%% !32H(Y /U%.HH 8$ /;CI[4\# HHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB@T
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M7!]O]57,?#GQ-XLT7P5;VVF^")=2M0[,EP+C86!]MI_I727/CKXAL ;?X>2
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MUH [G0](_L71;33?M4UP+="GG2MEG)/>M<=*A@25;>-9G5I@HWLHP&/>I0,
M"@!<U4U/4(-+TNXOKF14A@0NS$@<#MSW/2K#]CC..0/>O"/C7XWAN)?^$4@G
M58A*IO)3R".NW ]#C\J ,VUT[7/BYJVM:U;ZA/9V465M$#L Q"@+'@<#/#$\
M\DBNR^$'C"6YM9_#&JN_]HV+L$9SDLGISR3D-^&*3PEX[^'_ (8\,66DPZZ6
M$*[I&6UG/S$ESTC(ZG'7I7G7C_Q)H"^,K3Q5X1U-I+K<LDX\EXU#*>OS 9)
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M Z(![Y/_ 'S0!AZ?IC?&7QOJ-W=RSQZ/91[(&!YR2 O'N,M[8J]X'UR?X?\
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MSCK6G0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU.* %HIH=2< TZ@ HHS1F@ HI,CUHR/44 +129'J*,B@!:*3(HW#UH 6BD+
M=3B@$$9'2@!:*3(H)]C0 M%-#@D@9R.H]*7=GH#^5 "T4P2H21N&1VR*<6 Z
MG'UH 6BF[T_O#\Z/,3^^/SH =141N8%.#-&#Z%A2&[MQUGB_[[% $U%0?;+;
M_GO%_P!]BC[9;?\ />+_ +[% $]%5FU"T7K<PC_@8_QH&H69Z74)_P"V@H L
MT53;5M/0X:^MAZ_O5X_6C^U=//2^MB/:5?\ &@"Y15$ZQIH('VZVY./]<O\
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M"_Z#3_\ @'-_\10!YIX8D;X1_$&>QUF22'2KI-D4QY5MIX9N/?\ 6O8CX_\
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M K5^-VCZIJ^J:$=/TV\NE191*T4#L!DIC=@#'0U>7XN^*"<GX:ZH5] TF?\
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MP?PT^'FM6_B.]\0>,+4"_(!A\R6.8EB268D9 (P,<]S3O^$J^,2=?"&G9/\
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M#XUL?^1GL!^$?_QFG_\ ".?&C_H:]*_[Y7_XU0!ZY;PI;V\<,2*D<:A551@
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MW1^=&YAU"_\ ?5>)Q_!'Q%MR_CBX5NX6-_\ XY3O^%(Z\3\WCJZ(_P"N3_\
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MC^:T]?V?/#??4M6'_ XO_B* /6O-3^\G_?5'GQ?\]$_.O)_^&>_#/_04U?\
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M/A_X05LCPUIGT^S*1_*@#*'QD\!DX&N-_P" 4_\ \12-\9O 2]=<;_P"G_\
MB*U_^$!\(EP?^$:TL'_KT3'\J=_P@/A+_H6M)_\  ./_  H Q?\ A<_@/_H-
MG_P%F_\ B*/^%S> _P#H-G_P%F_^(K;_ .$$\)?]"UI'_@''_P#$T?\ "!^$
MLY_X1K2/_ ./_P")H Q#\9_ 8_YC1_\  67_ .)I/^%T> O^@TW_ ("S?_$U
MO#P-X2'3PSHW_@#&?_9:7_A!_"?_ $+.C?\ @!%_\30!SQ^-/@4?\Q>3_P
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MW( _E6W10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2'I2T4
M5KD$F/IPXJS56Z^_']:M#I0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4F.OO2T4 <W?^ ?"NJ7\M_?:!97%U*07ED3+-@ #/X 5
M&GPY\')G'AO31_VQ%=110!RY^'7@XG_D6]._[\BC_A7'@W_H6]._[\BNHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"I=D;H
M5[[P:MU2NO\ 6Q'_ &@*NT %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !110>E %*Z_U\([;LU=JC=D"
MXM\_WJO4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% #2Z@XR,^F:4,#]?2N)^*NI7>C> =0O;&XE@N T:K(CD%=S!3C'UK)^
M!^K:EK/@ZZN=3OKB[E2]>)7GD+':$0]_J: /3:*** "FLVT_=./7(P*1I H)
MYX(' S7C_P 2/%FJZIXLM/!?AFYEMKQG47-S Y5D!^; (ZC:03^- 'L*N&.
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M$8CJ P/\JEKP7]G[!U;7L@9V0\].\E>]4 -W]>.!WJ!M0M(Y_)>YA67@>67
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M-6MPY+"')4L>2&'.": /H$'(!]:6@=** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "@T44 5+I1YL+D9^8"K=4[I
MB98E[;@:N=J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#C/BG;QW/P\U9)!E5C$GXJ<_P!*YO\ 9^;/@.['IJ$G!Z_<CKH_
MBI*L7PZU@L6 ,)48&<Y&*\F^%OQ0T'P7X9N[#4K:_>9[IIP8(@05*(,?,PY^
M4_F* /HVBO)_^&@_"@ +:;KB@]"UO'_\<K:\,?%S0/%6HS65I:ZA;R0PF9VN
MHT5=HQW#GGF@"]X_\5P>$O#=Q=OO-Q+F"W503F1@2.V!@ GGCC'>O*/A-?\
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MF5'' 8^W!X]* /1/"4'V?PEI4+CYDM(@RGJ#M'!]\UMD@#)/%,2,*H4 !0
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M^G-!D5<9R,^QH =14?GPCK*G_?0IIN[<'!GB_P"^Q0!-14!O;8=;B+_OX/\
M&C[=:?\ /U#_ -_!0!/15<WUH/\ EYA_[^#_ !I#J%FHR;N ?]M!0!9HJG_:
MVG\_Z;;\>LJC^M,_MO2MV/[2LP?^OA/\: +]%4O[9TO_ *"5G_W_ %_QI)=:
MTNW3?-J-I$G7=),JC]30!>HK'@\6>'+IREOKVFRL.HCND;'Y&II/$6B1(7DU
MC3T0=2UR@'\Z -*BL8^+O#8C$AU_3-A[_:T_QJ(>-O"AZ>)='_\  V/_ !H
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M>##N'\HU%(/ GQ0X)\?(#WQN/]* /7<T5Y#_ ,(%\3_,W#QXB_\ ?9_I3_\
MA _B;_T/J_\ D2@#UNC(]:\C/@+XFY_Y'U?SDI#X!^)C*0?'O_?+2#^E 'KN
M:*\C7X?_ !(&?^*^;!&.6<G^5)_PKSXCMP?B X'LST >NT9!Z5Y$/AW\1_\
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MNH_&F&Y@'6:,?5A7E"_L]^&@<G4M4_X"\8/_ *#0W[/?AH]-5U<?\#B/_LE
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M$.J3:CJ6EF6[FQOE2>12V  . <= *SU^#7@3&&T5CZ$W<V?_ $*@"V?B%X#
MR=:L,#U!/]*1?B/X"3[FOV*]LJ6&?KQS5?\ X4UX"[:*<^UY-_\ %T?\*:\"
M_P#0'E_\#9__ (N@":'XA> H'+PZ_IL98Y;8 N?R7-6/^%H>"1_S,=E^!8_T
MJC_PISP)_P! 5_\ P-F_^+H/P;\!GKHC?^!DW_Q= %[_ (6AX)/3Q%9_^/?X
M5'-\2O DR;)M>L9%/574L/R(JI_PIKP%_P! 1O\ P,F_^+I1\&_ 8_Y@C?\
M@9-_\70!97XG>!E7:OB"T"XQM ;'Y8H3XF^!8\A-?LU!Z@*1_2JX^#?@,?\
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M !1M'O\ G0!Y<GQHC923X1UX'L/('/ZU&WQI ?">#===NX\H"O5=H&..G2C
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MG\)(_P"LU']L_&S_ *%C2O\ OY'_ /'J]>**>J@_6DV)_=7\J /(O[9^-O\
MT+&E#_MI'_\ 'J9_:WQN_P"A>TW_ +^1?_'*]AV+_='Y4M 'CO\ :OQN/_,O
MZ=_WW#_\=H&J?&WOH-@/<- ?_:HKV HI.2H)^E*%5>@ ^@H \H%S\9S"7^QZ
M,& ^X=N3^3D?K4/V[XU_] O2O^^HO_CE>O44 >30W7QGE/SVV@P_[[ G]#3Y
M)_C+&/E@T&5O[H(!Q^=>K4F.,<_G0!Y2+CXS.0?(T%?4;@<?K3TE^,@/SPZ
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MT)'_ +1J1_"_Q?D51_PE>EIM'56;G_R#7KF*3 ]* /(1X2^,'?QCIW_?1_\
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M? U <_\ "7:P?^!?_7KUNB@#R5_@?&V/^*LU?C_:_P#KTW_A1D?_ $-NK_\
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M2/\ H%V7_?A?\*T** ,_^PM(_P"@79?]^%_PH_L+2?\ H&67_?A?\*T** *
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MSD_3-&WW/YTZB@!NW_:/Y"E XI:* #%)CZ4M% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %!HHH I77_'Q"/4U=JE=?\ 'Y".V:NT
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 -(^;=Z4D<:QYVKC/)I]% !1
M110 4444 %%%% !1110 4444 %%%% !110>E %*Z_P"/R$]LU=JE=?\ 'S#]
M:NT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 444F1G&1F@!:*** "BBB@ HHHH **
M** "BBB@ HHHR/6@ HHHSF@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BDR",Y% 8$9!% "T444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!11D4@(/0@T +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_>$<JMCZX- %FBBB@ HI,@G&12T %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 4KH_Z7"/>KM4;C_C[B^M7J "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH "<4F1_D4DAQ&QXX&>:
M\:\9_$'Q!>^-%\(^$"(+I7$4UPT0)#^V<X4 CG% 'LQ;GH:,@=3CZUY5#\//
M'3HC7/Q%NXI<?,D<!D7/^\67'Y5S-UXG\=_#CQ/:6&O:E'JEE=/^Z9B"2FX
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M>0XRLT6T?0$[@?R'TJ/X<?$'Q!?>*KOPMXDBB>\M4*M+'@%74X8-@X/U [4
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MC;\!C% 'J.\>_P"5'F*" 3@GIDCFO"?!GB[QIX[LSIMM?B%X47[1?[%WG/H
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MRY=%MU?'#K(RLH]CFO-_#EQ<^!?BT?#*ZG<7>E71VJCRAP"<LI))Z@*1QZT
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_MYY/C^C);2X75H7)$9^[\G/Z5[EX_MI[[P%K5M9PR3W+VCJD:*2S$]@/PH
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M /% '@_PS93\:/$ZG<299R KXZ2$\^M;7Q]T^XN?"]E>0JK16EP3,".?F
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MR,C\:J_L^+MT'5/E*_Z2.#_N+5/Q#XPM[_19-(^'&A23-+F.XFL].8)&I/(
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *-U_Q^0^F:O52NO^
M/J$=\U=H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@!",US/B/P!X=\4NLVI6*FY3[MQ$2CC\173T4
M><2_"1&E*P^+O$<%HWWH%O"<_C_]:KWA[X3>%_#EZ+V&">\NQG$UZXD()[\
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M?G6E10!SP\!^$@NT^&M)8?[5G&?Z4G_"!>$CR?#>DD_]>:?X5T5% &/8>%=
MTJY^TZ=HNG6EQ@CS8+5$?'IE0#3[SPSH>HW@O+W2+&XN@ !-+ K. /\ :(S6
MK10! ]JDL;QR;7C8$%&4$$'VJEIWA[2M(W-INGVMH[\,T$"H2,YP< 5J44 -
M*Y[UG0^'M(@U-]2CTVU6]<Y:<1#>?QK3HH 3!]:H7NAZ7J3QM>Z?:W+1G*--
M$K%?IGI6A10!&T*M#Y6!M(P1@$8],=*J66BZ;ILDCV-C;6S2?ZPPPJA;ZE0*
MOT4 ,>,.C*V"I&,$9_/UK'C\(>'(;U;V+0=+CNE?>)ELT#@^H8#-;=% # A
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!GW#@WT8X^4^M:%4;D 7L1 ')YXJ]0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(>12TAZ4 9
M]T<WL*GIFM&LZY.;Z(>A%:- !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !129'J* RGHP_.@!
M:*,@T4 %%%% !1110 4444 %%%% !111F@ HI RDX# GZT9&<9&: %HHI,@'
MD]: %HHHH **** "BBB@ HHHH ***AEN[:&:.&6XBCED^XC. S?0=Z )J***
M "BBB@ HIK.J?>8+WY.*=0 4444 %%%% !1110 4444 %%%% !1110 44C=N
MOX&LG7?$>D^'+:.?5K^.TCD.U#)GYCZ "@#7HJII^HVNJ:?#?6,ZSVTHS'*G
M(85:7H,T +112-]T\XH 6BLK6==L- TV34=2ND@M(\;Y&R<9.!P 3SD5F^'?
M'?ASQ3</#HNI-=2(-S@Q2( /;>H_2@#IZ*:G0_6G4 %%%% !1110 4444 %%
M%% !12$@=2.:7I0 444 @]#0 454N-5TZUN%M[B_M89WQMCDF56/T!.:M9XR
M* %HKC9OB;X9@\3#P])=S_VAYRP;1 Q7<V,?-C'>NQ4Y'6@!:**,YH ****
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M:3_AH34F>'EK9MNQLC&5P>GZ4 >SIG'./PIU-4Y/2G4 %%%% !1110 4444
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M4-*$"C:D<,!91^ 2O)/B1JGANVUZQUOP3J.R\.]9EM8PBH5P00"HP>3[<=*
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MUFCZM%K6D6NHPPS11W"[ECE #@9[X)'ZUX5\=?">GZ9=66K6,,=N]VWES"-
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKPS<>'[*[CNKZ:52XA.1&$8,=Q]< U<C\*_!Z]07*3:9&'&\@:JT9/\ P'S
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M(+=5/M[?K0!X!9.$_:2GR"090O'O&M?0&3G'/.>M4XM(L8]0^WBSM_M>"/M
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M^*S:K=6\A<H_FLJ<(Q&!GGCITKZ3HH XCXGZ!J7B+P7+9:4=TXD67RPVTRJ
M<J,\<Y'6O-_A_P#$#3? FEOHGB+3=1M=04Y=UA+L<>OS$U[^>E1201R_ZR-'
M_P!Y0: /-D^+5EKC&V\*:1J&IZDW,:O&(HUQP2S$]*\NLIM0\ ?%6+6/%=G*
MC.TD[+;8DSYBL/EYY +8_"OIQ(TC4!$"CT QBG;03DC- &5IVH0ZQHPO;(2[
M)HSL65-K9YZC\:\:^"5E<6WB_6S+!(A4 $L.!DM7O73M2T 1')P/S^E?.^AZ
M5?Q?M"2SR6=P(_[2N9MQ4 ;6WX/7T-?1M% #!@<<5X-\<[+4I?%NDWME;S.L
M5NNV1$!VN)&Q^N*]\HH HZ89)--M6D#*YA3<&7!!Q7D>N^#?$?A?QV_BOPK9
M-J$<Q8S0F0!ADC*@$=..N:]JHH \P@^,NG1,(M1T'6[*Y)(\K[+O#-WVD?>Q
M^?UK.U7QIXZ\4WZZ?X-TB?3K?J]]?0!3^N0OT(S[5[!10!C>'+/5;+188-:U
M$WU_@F2;8$&3V& !6R.!110!'(<,ISCD#ZUX-J6@>(O GQ'N/$\6DRZGIMQ(
MV?LR%R@)SRHZ'WZ5[[10!YM:_%VPU&WE-AX>\1SW,9YMTL"W/N03@9[UR/CC
M3/'OCCP\U_=:9%86MJXFM],0;KA^-K%CD<@%N-OX5[O10!YQ\._%MW>:=I^B
MW7A_5[::"(I+<2PXB3&=N2<'ICMWKF/CKHNKZM-I+Z=IUQ=(BR;S"A?'3L!Q
M^->W44 4=+\P:=;"161P@#*PP:SO%:7MQX2U*.RMO/NGAQ%#G&\]Q6_10!Y%
M\$=!U30=,U/^U-/N+0S2@IYH X (/UK<^(OP\B\9V\-]:SO!JEJ@^SR;L*PS
MD*>W7O7H-% 'D>G>-_&_AWR=-U[P9J&H>4,&[T]&D!7H.%4CMZU;U#Q)XZ\3
M0/:Z!X4FTV%Q\UWJK>6P^B$ UZC10!X=\'O#/BGPUXAOTU/3OLMA)$0\K!2/
M,!& #NSW->X+G')!/?%+10 C' S6#XRM+G4/"&KV=G$9KF6UD5(QU)*D "M^
MB@#QWX):+X@T&'4K?5;![2Q=D>#S8P"\AR&Z?1:]A'0<8^M+10 US@9R17A6
MH>!O$.G_ !?/B"TTB6YTPW!DW12IDEP<G!?/4YZ5[O10!5FMHM0L)+>YC)BG
MB,<D9/(!'(R/K7C=MX,\=^!=:NI_"207]A,=S07,F?P 8KV_VJ]NHH \TB\;
M^-T0P7'P^N5NMHV-%<*8V/Y8'_?58H\._$?Q5XBAOM9N_P"PK$?*T-I=;6V]
MU^4G/0=3VKV6B@"M]G7R%B<F15&/WAW=L9)[_P#UZ\BU?X;Z[X>\5KXD\#-#
M+([L\EK<.  6!S@\ KR>,Y'KQ7LI&5(R1D=17D>L>"?B#8Z]<ZIX>\4236[R
MF1;*\G=AS_#M)*$?D: -.V\6_$%+/[-=>""VIDG:\=U&(&]#RQQ],G\.@\X^
M*TWCNXL+67Q,FFVMJS$06L$@+EN,^I/;O7H\6M?%![?RSX2T]9=N!))?+LSZ
M[0V<>V:Q+OX8>+O&.KVE]XMUBU2VB8$V=L#A.<_+V'US0!W/PZADM?A_HT4R
MF-A;KUZ_EVK@KWP5XCG^,UOX@73UDTM9O,\U9E& 0W;/O7L5M;1VL*0PILCC
M&U5SQBIZ .,^(7@__A,O#K6<=U]GN8G62"3>0 WHQ]#D_I7*>%#\3/"5G'I-
MUX>AU2QA#!)8KQ!(OS$YR[#=UZ?K7KU% 'F.I:_\2]1(M=+\)6]JK*0\]Y<Q
M_P#H(<E?QSFG?##X>7OA![Z\U2[MY;NZQF. G:HYX.>O6O3** .(^)?A6^\8
M^%3IMB\27*3B:,2\*V 1U_&N5\$:=\3?#?V;1IM+TD:4CL[S/,-PR<G&ULG_
M +YKV&B@#B_'7@33O&VFHESNBO8AF"=/X3[^V:YK0C\3O#,<>FW6G6NKV4(*
MPS0O&KX[ [W3]1],UZS10!Y-J&K?%G56>#3_  _8Z7;,-@EFD0R ]SRY]>RG
MZUM?#_X;6OA*,WUU(]QK$RCSI6<E0?\ 9]?J>:[^B@#D/B3H>H^(O!\^FZ6D
M+W3L&597V@@>_P"-1?##P_J7AGP=;Z7JBQI<QN[%8WW@ L3U_&NTHH *\<UK
MX7:MIWBDZ]X'U."RN'),D-SN*J<Y.,*<YS_%Z]:]CHH \UL]6^*D,!AN_#>E
M7,IZ7$=V$4_5>>?Q%85SX \;^-]0AD\8:I;6VG1'*P61^8'Z#(_$M^'->ST4
M 9^EZ;;:/I<&GVF1!;H$0N^20..3ZUYYXC^&5W%X@D\4^#]4%AJ^XMY4@!BD
M9N&R??)X(->IT4 >7QWGQ@2U,;Z7H,D^,+('P![GYOZ5S_BCX6^,_%&G1:AJ
M&M6ESJZ;L0; D2@XP%([]?TKW"B@#FO FB7/ASPC8Z9>&/SH5VD1MN ]L]ZZ
M6BB@ Q6-XD\-Z9XHTM].U2$R0OTVMM93Z@ULT4 >-Q?#/Q5X.NWF\$^(%$$G
MWK:]7(S[#:1^.*O1S_&>W4JT&@W!'\3#_!E_E7JU% 'D-UX;^*?B*!;35=9T
M^RLG_P!:+?B0#T&U?F_,5U_A'X>:%X14O90O+=L,/<S'+$]R/[OX5U]% $6-
M@R.>>>M>5_\ "N=9/Q?/BE;FS%EYRML.[S" @![8KUFB@ KQ]/AIK\7Q<?Q1
M'>60L3>&8H-_F;&ZCICMZU[!10!%O#+E2>1GMQ7D>A?"[6-.^*S^*9+RR:P:
M[N;E%0OYA67>0#QCC>._:O8:* ,;Q#X;T[Q/I$VFZE$S12#EE;#*W8@_E7G-
MIX'\?^$O,MO"OB&RN--)W)!J",''MG:?3U%>OT4 >/:IX8^)_BF".RU?6].L
MK"1L31VPPY'L0,G]*[CP?X(TGP;8/;Z>IDF?'G3N!N<CZ=.]=310!RWC/P1I
M7C.P\J^5DGC_ -1<1D[HS].]<98>&/BGX=MDLM,\1:3=64!_=K=JQ?;Z8"$]
M^Y->N44 >3OX4^(/B8?8O%&LV46CR']]%8.4D8>F63->@>'?#>E>&+ 66EVB
M0(!\QVC>_NQ'6MBB@ HHHH \M\6?#;5/%?CBWU2_U.W72+8CRH$C(D4=QG'.
M3W/X5Z7:0QVUM';Q*%2)0BJ.P X_2IZ* &N,KV_&LW6M&M-=T>ZTRZ!$$\9C
M;9]Y<]Q6I10!YY\.O -YX'.H1RZDEY#<!"JJI4@C/;\:W?%_@K2O&=BEIJ?F
MCRWWQ21, R'GUSZUTU% 'F>F>#/&_A^W:RTCQ? UBK'REO;,R.B_7O\ RI-4
M^%<_B+393XA\17EWJ3 ^7(BHD*G^']V!R/UKTVB@#A?AWX$G\#V=W;G4A=+.
M^\?N=NTXQ6YXG\)Z5XOTU;+586D17\R-U;#(WJ/\*WJ* /*+7X=>,/#RO#X<
M\;/';<!8;RV$F%'3YF# ?E4M[\*[OQ)#GQ9XKU&]E095((XX8D/TVX;]*]2H
MH XCP+\/HO XN_(U&:Z6X;.UXU7;@ #IUX%+\0O J>.["VM7O6M)+5RZ,$WY
M!P#D?A7;44 9/AC1E\/>&['25F,PM8]GF$8W<YZ5J2+N0KQSQS3J* /--7^#
M^E27[ZEH-]=Z-?L^[? <QY)R?EZX]LXHD\%>/Y87MV^(A,;C!(T]-V/KNKTN
MB@#@O"'PMTSPQ>?VE/=W.I:H26-Q,Q49/'"Y/ZYKM+RSBO;.2TGC\R"5"DBD
MD9!Z\U9HH \OMOA#'H=^][X7\17NE2R#!#QI,C>@QE2?SJZ/ 7B.\BD@U7QW
M?/$_#+90K 6^I)8UZ'10!RGA7P#H7A")AIT3O</S)/.P>1CW.>,9]JL>*/!^
MC^,+..TU:!F2$[HI(GVNAQC@_P"-='10!YI:?"[4=%BDCT'QMJ]BAP$CE19T
M49SPI(_,8J!_A)/K#$^)O%VKZJG:)5$*_D2U>I44 9^CZ'IOA_3DL-+M5MK5
M/NQJ2?U))KG/&WP[TKQQ-:27]S=P/:*P0P$8(/7.X$5V=% &3X<T6U\.:):Z
M19-*UM;)M1I#DGG.20,=ZUJ** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ***0]* ,Z;_ (_A_O 5I5G3G_3 /]H5HT %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 57N[*WOH6ANH8YHF&"DB@BK%% ')CX9^#%9B/#FG_,<G,6
M>?QK6TOPSHFB@?V;I5G:M_>BA"G\ZUJ* &>6.?0]?>GT44 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2$9
M&#TI:* &&,%=IP1Z$9I'A23[ZJ_.1N&<5)10 W;P,]OPIU%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 444&@#-GXOT']YA6E6;/S?I[,,5I4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2'I2T'I0!FW'_
M "$$_P!X5I5FS\Z@A]"!6E0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1);HW*3O*HCF92,8QR#[U['X!^)D?B/.D:LAL=<MQM>%\+YK#@E1V/JO;\*
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MGUVESS]*].\(W&M7'ARTD\0P"#4<$.@/7T)]Z -ZBD7[HILF[:"K8P<GCK0
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M'XFJ1\<^$U.'\4:(C>AU"+_XJO*_BY8VUW\1/#<4L2.LI(<#[S#CKZBO4?\
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MXW:,]W):QZ!XCDG0!C&MBNX#U/[S('X5.OQETASM30/$CN/O*EB&*_7#UO\
M_"P/!Z<'Q'IW [3@TU_B/X,C4D^(].P!DXE% $OA7QE;^+(KB6VTS4[-86VD
M7UOY98^V"<UTHZ5F:/K6F^(+ 7NEW27-JS%?,1NX[5ICI0 C'&/>J6IZM9Z/
MITU_J%S%!;0@;Y)#M4<X_F:N,0,?G7SW\0+N[\<?%*V\)V]T\%K"_EL-Y*L0
M-S$J.^ U '>M\9]%N;AK?1M)UO5I1P!:V1(/YG./?!J_?^/=7LX8[A? NMO
M5#2?ZLR)Z_NU9C^>*Z+0M!L/#NE0V.GVL<21*%RJ %SW8XZUKXX&<4 <%HGQ
M@\*ZWJ*:>)KFRNV.T1WD6S+>F02,_6N\W'D 'CUKC?''P[TOQL]HUR[VTENQ
M)>!!ND!QPQ]!C]372:=I\.DZ=#:6[.88$V@NY9B/<F@!-4UJPT2Q:]U*[CMK
M=3C?)QSZ>YKAC\8;._>2+PWH.K:W(AQF"#;&#[MR1]<5P,TTWQ*^,7]F7&XZ
M583N#$6+#9&2F[!XY;;GZU] 6UE:V-NL%K;0P0H,+'$@55^@'% 'GTOQ"\86
M826\^&UZMN>6:WO1.ZC_ '%3/X'%2Z=\9O#-W?K8WJWNEW+'&V^@V*/JP) _
M&O0P!UP/RKC_ (A^"K#Q;X<NHGAA2^5";>XV ,KXXRW7;GJ* .L6='561U8,
M,KM(.1ZBN&\9_%/3_!.IQ6-[87,[21[]\3*!V]3[URGP'\0WEY;ZGHUVS21V
MS+)"2V2@;(*\]OE&!]:POC:6E\<Z1$\>(S@9]?F6@#UOP7X]TSQO92SV*20O
M$</%+C<!GKQ75CFO"?$<(^&/Q3LM;LT9-'U'"SPQC9&N1MP2./O?/] :]MBE
M2:UCFAD5XY%#QL&)# \\'/Y4 )J>H6^DZ9<ZA=/LM[:-I9&]%49/\J\NT?XY
MV>M^([32[?1952XD\L3/..,G .,=*K_$G6KKQ1XDL? 6C2MF=T-],C9V)GD8
M]ADGV-<IKFCV6A?&W0+2Q18HUD@8A.<$,<OCWX_*@#Z%N[A[6UEF">844MM
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MK@Y'- ''04M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %(>E+0>E &7.Q^W#_ 'A6I6;,!]N''\0K2H *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8I?Q;+@?ZNYA 61/8'T]?J>E<0/ OQ-T5O(T'QE#-9*/E^V;O, ],.D@Q^5
M'KX(/K^5<;\3?$,&A>";US<11W$Z^7"DG5V/H*X\:9\8[J 1+K&C0>6QW21A
M-S_E&P'X 5H:+\)6N[N+4O&NKW&N7J?<C=SY:CCCD GH/04 4O@1HT^G^';B
M_N8W7[<R>66&-P ).!^5<_\ &$;/B?H#-P"T6/\ OH5[VD"Q1+&@VQH,!0,
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MV_D:^>_@CH6BZW>:D=4T^VNG1%\H3+GKU[5]$26XEC>-V8JZ[3C@_G7/>%?
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !0>E%(>10!FS$&^&#_$*TZS
M)5"WOU85IT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %-V+G..?6G44 -V+QQTZ4
MH4#H!2T4 %)@>E+10 THI[8^G%&Q<YQS3J* &[%]*4*HZ 4M% ";12%%.,@<
M'-.HH ;L7=G'-.HHH ,4FT>_YTM% ";1G..>E!56&",CTI:* $VCTI-B\]>?
M>G44 ( !TI:** $VC&*-H%+10 F!2X%%% "8&:6BB@ QBD(S2T4 )M%&U?04
MM% ";5'0#F@*H.0 *6B@!"H)R1S05!ZBEHH ,4FT YP*6B@!,#.<4M%% #=B
MCU_.E  &!2Y'K10 =:3:#Z_G2YQ1F@!-H_R:-HQC%+10   =**3(]?SI"Z@X
M+#\Z '449XHH ,#.<4FT>E&0*"P'4X^M  5!ZC/UI<4A8 9)P/>DWK_>'YT
M+M&<X&:  /7\31N7^\/SHW ]Q0 M%)FEH 3:,YHVCT_.EI,C.,^]  % .0.:
M6C-)F@ Q_G-  %&1C-&1ZT +@48HS1F@ HHIH=22 P)'7GI0 N,FEIN]?[P_
M.G4 %)M7.<#-+29&0,]: # ]!2X Z"DS2T %)@4N:3(/>@!0 !@4A /6EH)Q
M0 @51T HVKZ"D+H&P6 /IFER/44 *!@8HI P/0@_2EH " >HS2;1Z4$@#)(
M]Z P(R""/:@ VCL,?2EI-P]:7(-  0#UI-H]*-Z[BNX;AU&>:6@!,#T%+@44
M4 )@4N.<T44 %%%% !BDQSFEHH *3 ]*6B@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MH/2B@]* ,V;_ (_A_O"M*LV;_C^'^\*TJ "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *.@
MHH/2@!-W&>U<UXF\?^'/"3"/5KX).PRD"*6=OIV_,UT,F=A56VDY (]:^<O"
M)L?#?Q+O4\=Q;;N7F*YO%(1CG[V3P1TYH ]$M?COX1GN#%+%J=J ,EY;=6'T
MPC,<_A7=Z/K^FZ]8I>Z9=1W-NX!WQL#MXSA@.5/L<5B:GXF\'#29&N]4TF2T
M*E0GG(X;C@!.:\W^#=KJ+>,-4U*RM9K?P_-O\O<A2,C=P$!Z_7VH ]S,J*NY
MB N,DG@ >]>?ZW\:?"&B736WVB>]F7AEM$# ?\"8@?K6/\===N]+\+P65G.R
M&]FV3$$@E,9P,?3%=7\/O"=CX;\,60@2&2XEC$LDXC4,2PSC- &3HWQM\'ZQ
M<K;F2[L968*HNXU4'/?*LPQ^->AI*LBAD964\@@Y!%<OXY\)V/BGPW=6LUO&
M;@H6BD9<LKXXYZX]JX3X">(;S4-'U#29V,BV/EM%(Q))#;O7M\M 'LA=5ZD#
MZG%9VL:]8Z%I,^I7LH6WA0L?F&6]AD\FL[Q?#XDN-&\KPQ+;07CRX>6X)&V/
M!SM]\XKSK4OA+)-X?O=6\3>)+_4=0AMY)@/.S%$P4G W9R.W:@#T/P;XVL/&
M^GSWFG6]S%'#+Y1$Z@$G .>"?6NE!##(KR#]GXY\):BN>!?< _[B5Z\I)ZT
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0]* ,IO^/T?]=*
MUJRI#B^V]RXK5H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#)<@WX/^V!6M62Q_P!-'_72M:@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BB@C(Q0 FX9_2O-/$OQ<L](UUM'TS2;O6+X<
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M@"CK6KVFAZ/=ZE>,5@MHR[XZX]J\NTK7O'OQ%D>[T>X@\/:0K';-+ )7D],
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!DM_P ?H_ZZ5K5DM_Q^C_KI6M0 4444 %%%% !1110 4444 %%%% !1110
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M'_OFM>7P=X:G.9?#NDN?>RC_ )XHM_"/ARUGCN+7P]IEO-&<QR0V<:LOX[:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R6_X_1_UT
MK6K)8C[</^NE:U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 9+8^VC_KI6M62W_'Z/^NE:U !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 444AZ4 93?\ 'Z/^NE:U8I9C>CY?^6E;5 !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 444ASCK^5 "T5''*DA8*Z,5Z[6!Q]:DH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBFR.L<;.[!549+,< "@!U%4K
M#5;#4U=K&^MKH(<-Y,@;:??%7: "BBB@ HHHH **** "BBB@ HJEJ&JV&DVQ
MN=0O;:TA!QYDTH4?F:DL;^TU*U6YLKF&Y@;[LD+AE/XB@"S1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %!Z
M44AZ4 8ZY-WU_P"6E;-8WW;T ?\ /2MF@ HHHH **** "BBB@ HHHH ****
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M>,5M=OB.+2X;5(4%N\!;<1M&,\D5@W7Q/U/6=>ET'P=I*WD\)VR7=RY6,'Z
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MH]<TB5O+D;[*L1C/49VCT!H ]FR*6LS1]8M];TBSU"UR8KJ))5[XW+NQ6G0
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M;Q5XI^''BZRM-8UT:SI]R@R)850HN<;L@=:]FM[@7%O'/&#Y,R!U;/0$9!H
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MG*'RYK:$1NA['(Z_0UY[\.==U+POX_N_!%Y=O=V4;E82Q^X< YYR><CCV]Z
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M;R;#7K*>3.!&),,3]#UKHB1TKYC^)&K>![W[!J?@TPQ:A',#*T$#Q84 \A2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH'.1Z=37L7B7CPOJI(! LYL@]_D-?//PIO/%&DW%WJNCZ6^H:6'Q=VT4@#C
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MQ*6&"1G'/]: '$9K$\9*/^$'\0?]@VX_]%M6Y535;%-3TB]T^1BJ74#PL1U
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M>"? &F^!HKJ/3KB[D%P5+^>ZG[N<8PH]3ZUTM]:I>V%Q:R,P2>-HV*]0",4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !129&<9YI: "BBB@ HHHH *
M*** "BD) ZD#ZTN1C- !129'J*"0" 2,GI0 M%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !0>E%!Z4 8QXO0/62MFL;_E[_[:5LT
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MW%/HH 0 CJ<TM%% "$9I%7:33J* "BBB@ HHHH **** "BBB@ HHHH ****
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MX7YOI@F@#K**09QR,4M !117+^-?'%AX'TV"_P!0@GEAFF$0$(7.2I/<CTH
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M/PKJ=U);)=0QVLKR0/RL@"$X/#<'Z4 0^$_&FF>,K"6[TV.YC6-RA2X158\
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MK+$1D&J:> K.+P*WA5)YOLQC,?F@*'YSS^M &?IMSXTU?P)%>6>LZ4VL3L)
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M^%-1U>?6;*0#'GN25W#<I!8GD#KS0![O161X@UF#P[HEWJUWCRK=0=N<;R2
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MTLU)N+J./V=@"*DM[J&Z3?!,DB^JG-<7%\+/"[2R3ZC92:I=S-F6>[E9B?H
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M+#@$Y'4;N:U[CXC:':^+QX8D-XVI&1(]J6S%06 ();TYZUT&E0PP:9:K#$B
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MDO2&55]\;3_.O.].TNWU?]H'4H;M"T<=]++L[,0V/ZU](QJJ1A54*HX ':@
M1BW7@XY'I45[-+;V-Q-!#YTT<3.D6[&]@,A<]LGBIZ#TH X#P/\ $^#QC>7E
MD^G/8W-KDNK2[P0,]/E'I71^*/$ \->'[K57A,P@7.S=LS^.#7C\UM/\/OC?
M;K;+Y.E:S(F4C4B,*QVX/J0=S?\  A6M\7II-?\ $GASP;;W/E_:I&DG;&=N
M=H1O4?Q]* .D^'OQ/A\<SW-L]BEC<0HLB)]H$OF*>IX48QQ^==5XEUV#P[X<
MO=7G_P!7;Q[@#GYF) 4< ]20*\<U73K7X7_%/1[K3A)::3?(8I%QN5>F1GKU
MQ6S\:-5N;K^RO"MF[[]2E#2%%S\@;&./0X/X4 =AX#\57OC+PW+J=WIHL8&<
MK -^[S% PQR1QAMP_"O'_ 'BZS\/^+M>O-4%U<.[^5#';IO,A+L  O3T%>Z:
M1HD'A[PK#IENJ"."V*L57@MC+-Z\DG\Z\5^#%A#=>/\ 6;B6$226Q;RG_N99
MJ /0X?%?C^='DMO ($'5#/?I$^/=<'G\:7PE\4[/Q'JSZ+?V4VFZJG6)R'4X
MX/S#H?8UZ#R3SQTZ=Z^?-1CCC_:*LQ$ @-T"VTXR<-UH ]J\5:W;^'O"]]J]
MQ 9X;:,,8L?>R0 .?<BL+X<>,W\:Z7=WAT]+)()A&B(^0?E]A4WQ3('PTUDD
MG'E)T./^6BUA?!60+\.8B8]VR24_+U/SL<4 ;7BWXC:7X4E6P"RWVK2X\JQM
MA\Q)Z!C@[?Q%9Z^+/B-)'YL7P^C\ME!0/JD08?4<>U<)\+8H]<^*6NZGJ+--
M<VS.T;.<MRQ3''HH'Y5[X<*#G&#SS0!YWX<^+$&H:^OA_7M,FTG578*D9;S$
M<^FX#BLSX^,R>#[ (\B WR ,K$#[CUV.L>!/#FMZS#JM_;$W\0XD2=HS^0-<
M5\?F(\*Z>N,H+]#[C]W)WZT 2^&/&&I2^#=,T_PKH=QJMY#!'')/.1% C!0&
MRQ;+<@],9IVI>-OB)X7B34/$>AZ6=,# 2R6;X=!GT+G)]/>NM^'-M%;> -&\
MF!8?-M4D?;W9E!+'ZDD_C3OB$0/ &LY&?]'.2.] %_POXELO%6DIJ6GR[X68
MJ58 -&?[K8/7O]"*VZ\A_9[.?!NHXS_R$&Z_]<XZ]>H 3_&OG[Q!&K?M&6B'
M.W>G&3_SS)KZ [#ZU\_:SS^T;:XQ_K%[_P#3-J /H!  20 #Z@4^FJ1ZTH8&
M@"*1]B.P;)Y8<\<5YS\+_'VI^-KG5X]0M;>&.T,7E&'<=V[?G.<_W17HMQ_J
M9/\ =/\ *O$/V?,F?Q-P<9@&!WYE]: .D\;?$G4/!GC"SM)8+?\ LB8;GD*,
MSGCG!S@')'&*FD\4>/O$,2WWA71K*#3)%S$^I';+(/[VT,, ^]<1\2[--5^,
M^F6$TRK&_EY#R9 &,]#TS@=*]]A18HT1% 10%4#T' H \?B^+VM^&=2DTSQS
MHWDS;=T4MBF[=QD84M@CWW"MV;7OB7JR)<Z)H6E65I(H:,7TV^4@]"0K +G\
M:X_XMJ)?BOX5CD7<#Y*,/8S_ /UZ]WC4)&JCHH % 'D.F?%'Q%I/BZ'P]XQT
MNWCFN-OEO:<  DC<<DY7CK[&O5[J22.UEDCVED5B >G [XKPOXGSO#\<O#[K
MG*16[ *N[_EH^>/RKW*ZW?8)@?\ GDW;'8T >=_"SX@:GXU?4%OK>WB6WQL,
M ;D=.]<C\;_^$E$%K_:"V/\ 8WVK_1I(=XE#%"!OJS^SSQ_;(/7;'_*M+]H/
M+>%M,]!?#/M^[:@#9\%2^/PNE)>QZ*-#$"Y:%V,NW;QU[]*T?&7Q'L?"U]!I
M,<,]WJ]RFZ*") P&20I;)'!(/?M6]X<*Q^&-* /(M8NG.00*\-BDUJZ^/-Y]
MA$#7L;,$6[?" !0<\9/?M0!W$=S\8KY#*8M TXCI$^78YZ9"[L?G4!\?^+?"
M.K6]IXULK0V=PVU;^UX13[^GXXK8EE^*I90D?A14_O*T_P"7S5@^-?"_C[QE
MI%KI]W;Z! B,)W*3R'+XQCE>.IH ]7CO8)K-;N*9)('C\U)$.59<9R"/:O,K
MGXA^(?%.L3:7X'L4"V\A6:^NT&P =2,GUXJYXAMM:T7X+7%J0(]1MK1( UN[
M2?)N52 6&?NYJE\!K*VMO!,]RL\<CW%R6:-1S%M^3!]<[=WXT 6X_P#A;5HP
MFN7T/48D;,EM"61G3O@E!SU[UYMJ^O0^*?C'HUW%:26CQM##)%=84[P[<9';
MFOI1F^7CKVKYW\46D"_'S3ET^.,9EA:01]0X8Y;^7% 'T51110!YQ\;]W_"N
M+K&,>9'G(_VQ5OX/ GX9Z22!QYF/;]XU<]^T&Q7PAIV-W-YSM('\#5T7P> '
MPOT<^HD[?]-6H [NF$_,#GCFGTQN3P1P#0!Y3\3/'6M^&?%.DV&FS0QPW!Q*
M)(E<MDKTR1BN_P#$6MVOACP_=ZS= ^7;IN.T9R6( &/J17CGQA,;_$70E?#@
M $@DC!RM>K^-?%EIX/\ #\FH74)GR0D<", 9&/;\LG\* .+\,:S\1/&]JVK6
MVIZ9I&FNY$"FT\UV ..<FI_$3?$W0-&EU*UU[2]16V5IIXVLA&=B\G;@\\ ^
MAJ'2->^(GC*P6[T6RTG0M.<'RY+@-)(>>JC&!^(JMXD\.>/D\)ZM/J/C<30Q
MV4SRVT=E& ZA#D;PJD4 =7\-?&MQXU\.&\NX4ANHIO*D\L$*W .0#TZ_I7 ?
MM NL-UX:FVG(\XYSZ&.MGX +CP?>_P#7\W<?W5]*Q_C^JR7_ (9#;2A\X$.<
M C,?6@#IX+KQ[XIM-,O-$N++0M*FMUE\V15FE<,H*X!!'2J6N7'Q.\'0G5Y-
M9M-=TZ( SPM:)$P'3(V@5Z5I:6\&DV<5JJ?9UA18S&?E"[>,>HZ5!XHE1/"F
MKEV"C['*,MP,E"!^IH I>"_%]IXRT)-0MP8Y 2DL6>485Q'BSQIK^F_&#1=!
ML[]8],N&MQ/"84)?=(RMR02. .A%4?V?$(T35FV./])(SD@$[5K/\= R?M >
M&L/D(UL<=?\ ELU 'H?Q56%?AWJH;:I:+ _#.,51^#$,]O\ #:T%RNQFFD=5
M']TD8J_\5A_Q;G51M!'EG@MCM5+X.W]W?_#JS^TS&8Q.\"/_ +*$!1^5 &+J
MWC/7K?XW6_AR.\1=*(&^$PH-Q,6[[V,_K6I\4=/\22^'[VYTK68H+!+<B>S:
M!?WBC[QW8R.,]^U<9JP)_:5AQWV?^B:]1^(I)^'VM%4WD6S_ (#N?RS0!YO\
M*]%\87OA""XT_P 3_P!GV/G,$A%LDH9<C)^8''.>/:M;XL>(O%WA%]/OM+U)
MDM)5*2HT$3*''U&[G/KVK9^#,CR?#BSBE.5C=T'^[U_K71^+?#4/BGPW=:5+
MY:O(I:.4KPDG\+?A0!I:1JEOK.EP7]I()()UW*ZCM7%?%;QO<^&-)MK/29@N
MKWSXA^0-A!U/.1UP/QKG/@WKCZ?-J?A#4I MU9.9(\L6P <-U]/E_.JFBFZ\
M=?&NZU'<W]G:.TBQ,C;D8@[ 0?<9- 'I?@.'7$\,V\OB"\-S?SKYA^1%" ]
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M"37[]?%7B6WB@BN'$T%C -JLN/D) Z#@'W_&K'@[PKH5U>+XE\6^)M.U6_G
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M):F0!^.X![5W+HLB%'4,K#!4C((]Z\_U;X->$-3F\];2>SEW;@;64J WK@T
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M[,:3IPOS?BQMA>%0OVCRAOP.@W=>YJE?>$_#VIS^??Z)I]U+W>:V1V/XD9H
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M=.XK,\;?#?49/$4?BSPM.L6IQ;2UJ,()B#G.[/&>A^E>JA0HXS^=)L7CC&*
M/+#XW^(-FB?:_AX\[D8=[:Z&W/T^;'XFL/5O#_CWXE:A:V^KZ:-"T%&\TQI(
MC'/O@[B>3Z#VKW#:/I]*"H/6@#-MM'AAT*WTHR220Q6PMP\G+D!-N3TYQ[5Y
M/%X&\7?#K6Y[_P 'PKJVGS$E[*5PA7/U8!OK^E>U8XQ2&-6()&2* /,[;QA\
M0;H^1'X!CMV+ >;/>@(A]2IQG\":XR'X8^+X/B59ZM<VEE-&TXN9;F&0!%.1
M\NTG=V[ U[^5!QR>/0D4>6N<\_@QH =1110!YW\7_"NJ>+/#ME:Z3:BXFAN?
M-9"ZKQM(ZLP]:YWPVWQ4\.:'::/!X/TYH+<D+))=QYP6+9.)/>O9J.] 'F$G
MB'XLB38O@O2V']_[6N/_ $96GX=O_B#<ZNW_  D&CZ5::=LZP/N?/UWG-=WM
M&<\_F:-HSGG\Z /&O''@+Q#K?Q)M=8L+>.2RPBN[.HV =\=37:_$3P=_PFGA
MEK&(PK=QRB6!I<[0PX.<<]":[ * <\_G2;!F@#QW1+SXH^&K&/1V\,6FHQVW
MR0SB[1/E].7!_2M>ZTKQUXST2YL=7;3M MY49'2 &YDD!&,,=V *]+**1CD?
M0XI/+4XR,XZ9YQ0!Y'\-=&\9>#;^;2;S3;671I9C*UZ;A 02 ,@ D]NF*N?%
MGP%JWC&32/[,$ BMB\<Q>3:P#;><' (^7USTKU(* <Y.?K0% .1U]: /*K>P
M^)7@S38;+3HM+U^R1=JJ<PR(!]2!C\:K:EHWQ&\>VB:;JD&G:'I,F/.$$N^0
M@<XX)';UKUW8HZ#!]1Q04!Z\_C0!B>&?#EKX6\/6ND618PP=9'&&<ELDGUZX
MKA];\ ZSJ'Q9L/$D?V1K*W>-_FDPZA6S@#OFO5 H P !CTHQ0!RWC_0=0\2^
M$KG3-.GBCFE.<S=",?=SV^M5OAKX:O\ PIX1ATK4#";A97E/E,2/F[=*[(#%
M&T$#)/YT >5WO@36)_C+%XHC-N=-4 DF3# A-F,?6O0->TD:WH-]I;.J"Y@>
M/?C.TD'FM3:, =A1@4 >3^!_"GC_ ,)WD>EF[TTZ&LQD:0IN=AQQC(QG'7/%
M>JC('!!'6G%01ST^M<QXMM_%EQ';?\(O?V5HZL?-%TI(8<8QQ]: /(?C-I\-
MMXQT^?3'9]0OHV6>V@/(.1@\<Y;)_P"^37L7@7PTGACPI96!ACCN1$IN-G(W
MX^;GN,YKE?#'PYU1O$Q\2^,-2AU#4TVF%;<81",X[#ID_G7IRC"@<\>IS0
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M@ ?2IZ* ..\7_#;1?&MW;W.I37L4L">6K6TH3*]<'(/?FNFLK%+"P@M(V+I
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M]Y<&NHHH XC3_A)X+TV<S0Z-$[$[L3%I57Z!B0!79Q0I#&L: *BC"JH "CL
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MWHY_Y:5LUB(Q-X/][-;8Z4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 &!Z4444 %)@>@I:* "BBB@ Q1BBB@
M HHHH **** "DP/04M% !BCK110 4444 &**** "BBB@ HHHH " >HHQQBBB
M@ HHHH *,444 %&!C%%% "8'I2T44 %%%% !BBBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH ****  ]*RM5\/:1K\21ZOIEO>
MJGW1-&#BM6B@#*TKP]H^B*RZ7IEM9[Q@F&,*2*U!UI:* "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** # SG'-%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %)@#M2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !37^XWTIU-?[C?2@#$C_ ./F/_?K=K#AXN4'HU;E !1110 4444
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MJ* %HHK,O=>TG3KR.UO=3M+>>3[D<LRHQ^@[T :=%-4G)S^!)%.R* "BBB@
MHI,@]"*7(H **** "BF-_>ST]ZXC2/BAH^M>+F\/6D-^;A21YAB C)'7G.:
M.ZHIF22/7/;FGT %%%% !1110 449'K0"#T- !102!U-(3\IQUH 6BO.=#^+
MFG:[XK70K?3;V-R6S+*R@#:<'CKVKT5<[1GKWYS0 M%%% !11D&N>UGQGH/A
M_4K>PU/4EM[JXQY<94G@G .<4 =#1348.@8'(/(/K3LB@ HHR** "BC-% !1
M1D>M% !1110 4444 %%&110 449HR,XS0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !2/]QOI2TU_]6WT- &+'_P ?8_WJW!T%8<'-
MS'_O5N4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 C8QR>O%<EXY\<67@[17N797O)!BW@.<N?IV_&
MNL<X7ZG%?./Q(U6"#XRV5S?*TEK:&/S(^#E0Q)&#QS0!UFAZ+\0?%^GF\UKQ
M'=Z##( 8(K9%C8_4+M/YFJ/B*V\??#JR75+3Q3)K%LI\N;[9%DQJ><G+$GD
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MX:40>&].C! /V<;0>E>;#QI\,_#_ (GNKC2M.N+S6),AY+5&D#DGH"S8_(4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *:_^K;Z&G4U_N-]* ,6'BYCS_?K<K#B!-S'Q_'6Y
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% "-G:2.2.<>M?//Q<TN/1_B)IVM7UIY^FSJ&D54R&*'+
M_4,*^AZS=9T33]?T][#4[9;BV?JK'% $FG7UCJ5HESI]Q%<0MT>)PPKA/C%K
MFF6/@F^L+BXA%U=!4BA!#/G<&W%1R!@$9]Q4!^!_AS[.\%O=ZO:([;V"7"\G
M\C5S2_@SX2TV_BO##>WDT9RK75QN /K@ 4 )\&+6YL_AU9M<I+'YKN\:2,22
MI=B#@] 1@CVKKI_$VAV]^+";6]/CO"P46[W48D)/0;2<YY]*TTC$:JB* BC
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MOP3X=\1SI/J^E0W4J A69F&,]>A'I5%_AGX/=U=_#]JY10BARQ&![9H O_\
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MBC7HB* !^524 %9'BEQ'X3U<G_GSF_\ 0#6O4,T*3Q-%+$)(F&&5@&##W!H
M\<_9[/\ Q)]4QT\_/_CJU[,3SSTS5/3]*L-+A:*PLH+.-B24AB"CGKP.*O8_
M"@#YU\0S+>?M 600D".XBB)*D8Y:O0_C+;:K<>!I%TWS6Q<*TZ1+N)CPW&!S
MUQ7H/V6#[3Y_E)YO3?MYJ>@#P_X6^*/ VGZ!%:7HM-/U.(MYKW,8#.<GN1\O
MTKI]8^*>E+NT_P -PW&LZ@P*HEK&61"1P6;'3FNOOO"GA_4KEKF^T/3[F8G/
MF2VR.V?7)%:-M:064*P6L$<,2CY4B0*!^7% 'SW\(M;M=#\<:K;ZV_V2]O9
MBQR*<F0GIGTY&!7T3G.,'/T[5GSZ#I-U?QWUQI=J]W']R=X5+K]&ZUHA??\
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M(?AWJ,5R5P':&=U4YX.WRUR/QI_@KX<ZA>:L/%GC&6;^U_M F@MU<%4(Y&[
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-D_P!4
MWTIU-?\ U;?0T 8MN,W$?^]6Y6'!_P ?$?\ OUN4 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %(1D8-+10 W;^?K1C].G-.HH 100.3G\*6BB@ HHHH ****
M "BBB@!"#G.:0J<\''XFG44 (!BEHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ IK_ZMOH:=37^XWT- &+!_Q\1_[];E
M8<7%S'_OUN4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTM#=O I81 X)_&@#8S17&?#SQL?'6CR7[Z?]D,3A<"7S 3^(!KL@P/(!Q]*
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MI6I7-Q;V-]!<S6Y F2)PQ0GU[5S^J?%+P;HVIMI][K"I<H<.JQ.RK]6 Q^M
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M?M&J>"M:M+/KYLB8ZGL"JC]:[?PGXLTOQ?I9U'2VE,0?8PECVLK8!QZ'KVH
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MX3U?5/- Q<3(T$7_ 'U@@T >DT9S7E&K_%#Q#X9"3^(?!<MI:D[3-%>HX_\
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M[?0U[CIFGVFEZ=;V5C$L5M"@2-5.1@#U[_4\T /LK2*QMH;6#"PPQK&B
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M^P18\Z6SD'RCW^=L?7I7H7A?Q7IGBW35U#2Y?,C.-Z'[T9/9AVJSXDL;6_\
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M:1)X UF0:=:))#:221LD" JP4X(...E,^#BX^&.E>N9?_1C5I_$3Y?A]K@!
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M1J&MKF.-""5SM^;K^9JAXA\2?#CPY973VUEH-W>A3LMK2UB=F?' ;:. 3U-
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M1HN!_P N<7_H(H T[^W22PN8W =&B8%6'!&.GTKP_P"!+M'XHU^) !$<$KP
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M.$*)NQCW//XU[\L:A0J@ +T &,5Y#X^\$:U9>+X_&7A>$W%RF)+F#(R2!M)
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MUS7*^-?!?B76/BIIFKVM@)-.MI;=S*)(Q@*X)X+@_D#0![#!$L4**@ 54"@
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M>'UB\42Q2ZB)#\T3#E<#K@8]: .FHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:_^K;Z&G4R4XB;Z4 8
MT!'VB/\ WZW*Q+?FZ4'LU;= !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 (W3BO/OBSKLNC^#Y;6UBN
MGN;[,,?V9"2HQR?;K7H)&12!<9^8\T >8_!3P\^C^$7NKFU:"YO9?,^<8)1?
MNDCJ/O'K7IXZ#-&WG.>: ,#% %35;S^S]+N;SR6F,$32"->K$#.!Q7$>!/B)
M>^+]4NK6X\/7.GQ0J&6260MNR<?W17H1&1@TU(@F>2?J2?YT /HHHH ****
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M/'=OX^\<>'A='0#9V$+Y&G"0M<2G_GIT' ].O6O1_A_IT^G?#_3+*X@>"X2
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M@$8&>M=-#KGQ&UM4CL?#%CHJ'AI]1NC-@?[*IM.?K7HA7)ZD?2EQ0!\\>*?
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MC=F5XUP%4XP #[Y_.NJHH \B;X2ZLWQ,'B<ZC9_8_M?V@PX;S"/3IBO6U&W
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M#&"VVG'T0)G\37JU% '&>"_AQI/@J!WMLW-_(H$EW(OS'UP">,_6NP4-D$C
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MX6_\)SJUI?'539B"'RBGDA]W);.<C')]*]%HH J6-HUG:P0;W?RHUCR2!D
M9Q5/Q!HHU[0+O2GE:$741C:15!QFM>B@#A_ 'P[A\"6=[#'?274MVREI"@0+
MMSC !]ZSO%GPDM==UK^V])OY='U4OO::%<ASZD9&">Y'6O2:* /,X? GCN>#
MR+[XB7*1$@$6]L ^T'L^0P/OS4^O_"/3-;T$6(NK@7:D$7UU(]Q(Q[Y!8<'^
MM>BT4 <?X+\)ZUX;MIK?5?$<FKQ, L4;0[!$N.@RQKE?&&N^ M8\4?V#XIL+
MNVNK<LL5[/'Y2\XY5U.[;QU.!7K5<]XF\%Z-XM@2+58"_EL2DB-M=<]L^GL1
M0!PMA\/=<M+/R-&^(\\6G !DC$(DVKZ ^9^N>U<-\3]!TG2-.MY+?79=6\07
M$X%S.\^]C'@\; 3MYV_E7=']GSPN7^74M71,DA5DC&/;.RNJT#X8>%?#EW%>
M66G![R,8%Q<.TC],$\G X] * (OA9I<VC_#G2K:Z0I-M>1E/8-(S#]"#5SQ3
MX"T/Q<N_4+3_ $I%*Q74;;9$].0>>>QKI]B[MV.0,#VIU 'EL'PR\66D8@M/
MB+J,5NHQ&AAW%1_WT*DTSX,:>-274?$>J7FNW2]!<$B//N"6)_[ZQ[5Z=10!
M7@MH[:!888E2)!M2- %"@=@!7'W'PSTRY\<#Q7)<WIN]RMY6]/+&U-HX*Y[#
MO7<44 ,"G;R#G&#S7->*O 6A>+XA_:=H#<JNV.Y0[9$^A'7\:ZBB@#S*+X9>
M(K1(H;'X@ZI!;(,"-XM[ >QW@?H:LP?"/3;B^2]\0:IJ>NSQ_=6]E'E_]\@?
MUKT2B@".W@BM;:*W@C6*&) B1H,!5 P /8"I*** *VH6%MJ=C+9WD*36\JE7
M1QP0:\[/P=M;&[EN?#^NZIHS.,!+:8E5_ GG\:]-HH \_M?A5ISH!KVIZOKS
MJ=RB_O&:)3[*#_/-9]_\&K/^VO[1T'5;K0V(^9;/CN.G(Z]\YKU"B@#(FT7[
M7H#:3>7$LZ/!Y,LS-^\?C&[(P,_A6?X/\$Z?X+LYK337N'CEE\PFX<,<X'3
M'I73T4 %<=/\-/#\_BO_ (2-X[@WOF&4CSCL+'OC\*[&B@")XQ*C1RJ'1@0R
MGD$5P>I_"'PW=W8N]/2YTFZWEC-83%#DYS@'@=>U>@T4 >>1_"#1)R/[:O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1SG$#D
M>E24R;_4M]* ,BV'^E)]:VJQ+;_C[7/]ZMN@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *CG_U#_2I*
MCG_U#X]* ,JWRURA /6MFL:U#>>O/>MF@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@!&("DDX '6L&3QGX:AF>";Q#I4<T9PR27T:
ML#[C-;DW^HD_W3_*OGWP5J?@FPUOQ(OBL6#3OJ$IC:]MO.7 8]"5(H ]E7QK
MX9>547Q/HNYC@+]MC))]/O5KV]W;WD?FVUQ%/&/XHI P_2O+YO$/P<2)\6VA
M,7&%2#21YC9XP,)G)]:B^$WAZ[T_7];U2/2KO2])N2BVL,HV;\9R=I)/<<X
M_*@#TC4?$.CZ/(B:GK%C:.W*K/<)&3^!JI_PG7A3_H9=(_\  V/_ !KRSXGP
M6-O\6/#M]J4!GMI JRPM$90R*>1L .?O#C%=9)?_  Y2($>%XV3''_%.2_\
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M$%SSXJN3_:"SB3 4E]VT#.!\O&/6NW^&'B[_ (27P\D-ZX_M:T)CN(U/W@.
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MPGPO\4-;\,6<SR:64,D<>X-Y;'!YX'J1P:QKO4'TG]HG4+R+3[G495(46UJ
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MA_$72]?\67?AZV@O%NK5&D9W0!"%(![Y[UV)(W8[UXQ\++2W;XE>+;KRRUQ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %17/
M_'N_TJ6HKG_CW?Z4 9=D/WR_6MFL:SXG4'UK9H **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ'N*P6\7_!S<RO8:7DDG*Z/US]$K4\)^-?AZ_B&/2O#5I%;W=R"H:#3O*W@
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MSBU<XST_G0!GV?RS@"M>L>U?=<K]T5L4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 !Y%<YJ7@3PSJ]W]KO=%M)+GO+L 8_4UT=%
M&)HWA/0O#Y9M*TJULW<Y9XD^8_C6C>6%O?P-;W<$4\+##1R(&4_@:M44 <O;
M_#KPA:7!G@\.Z<DA/)\K/Y \"NECC6) B*%4#"J. !3Z* ,75?"FB:X_F:II
M5I=R#I++$-ZCV;&:-(\*:'H1+:;I5I;.3GS$C&X_4XS6U10 @SQ05#=12T4
M<W_P@'A'_H6]*_\  1/\*=%X$\*02B6+PYI:..A%I'_A7144 0);HD0B6-1&
M!M"C  'I@#I6++X%\*32-))X=TMW8EB6M4))]3Q70T4 <W_PK_PCD8\-Z4,'
M/%HG^%=!;V\-K;I!;Q)%#&-J1HH"J/0 5)10!2U'2;'5$C6]L[:Y\MMR^=&&
MVGV]*L"$*@154(!@ #H/2I:* *=YIMK?VSVUW;Q3P.06CE0,IQC''X"LL^!/
M").3X7T8GU^PQ_\ Q-=!10!DV'AC0M+F\W3]&T^T?^]!;(A_,"M0*=VXXIU%
M !3&7<"I *GJ#SFGT4 8-YX+\-:A.\]WX?TJ:5^6>2T1F/U.*N:?H&DZ3_R#
M]+L;3_KWMUC_ )"M*B@!A3((XQZ>M5[+3;33XS'9VL%O&QRRQ(%!/KQ5NB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *@O!FV?\
MSWJ>H+PXM)/P_G0!GV!_?XK7K(LABX'O6O0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 & .@HQ110 8I-H]!Q2T4 &****
M# HZ444 %&.<T44 &*,#.<<T44 %&!Z444 &**** # ]*.M%% !BBBB@ HP*
M** "C%%% !2%0P((!![$4M% !@#M1110 4444 &!Z4F!Z4M% !0 !T%%% !1
MBBB@ Q1@8QBBB@ Z4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4-W_QZOGV
M_G4U5[QL6LGX?SH S[/_ (^@1TK8K)L"3+T%:U !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56OO^/9
MAZU9JI?\VI(- %73U'FUJUDZ<3YM:U !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 54OSBUP.AJT>OX5
M4OAFUZT 5=._UM:U96GK^]ZUJT %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !5*^_P!0/K5P]?PJI?'_
M $;\: (-/_UM:=9FGC]YFM.@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0U3U$XMA]<5=-4M0YMA]<T
M 0:<VY\8K4K)TWB6M:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *I7_P#Q[CZU</6JE^?]%_'% $&G
MX\YNGM6G63IW^MK6H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH ;DYZ?C3NM126\<P <$@=,,
M1_*I    .@H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M ]JHZB<6N?\ :J\:HZG_ ,>P'8F@"OIP^?-:U9NF@9K2H **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $
M/:JFH?\ 'N#_ +6:MGK^%5+_ /X]?QH KZ>1YM:E9.G?ZVM:@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *I7__ ![?C5P]JI:G_P >ZC_:H KZ=_K:UJS=. S6E0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M(>OZ50U)<0JV> <5?/;ZU2U(9M@/]J@"+3V!:M.LS3%!R:TZ "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ JCJ3?N4&.IJ\:HZD?W*_6@"/3^#Q6E6;I_)R*TJ "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ -9^
MIG]TGUJ^>M4-1Y1/K0 W2^AK2K-TW@'%:5 !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 51U%L(GIFKI
MZ5GZG_JH_K0 W3?O-6G6;IG.X^M:5 !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 AK/U,_ZM>U:!Z5GZ
MG]R/UH 73!A36A6=IAX-:- !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 5G:D.%-:/>J&I+^[7ZT ,TO
MH:TJS=-X!K2H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** #O5+4?]4OUJX?K5#4>@R>* &Z=T-:54--4
M!":OT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !6=J9QM'K6C6;J?5: )-._P!4:O51T[_5&KU !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5G:C]Y<UHDXK-U(@E10!)IY'EG%7JHZ=CRCBKU !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 'FLW4E&]/>M*L_4/OK0!+8*%AR*MU4L#^Z-6Z "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K-U/J
MM:59VHC+)0!)IP(BR:NU4L/]3BK= !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 &LR_8^>!G@5IUF:H0
M2H'6@"S8_P"IS5JJ>GC]Q5R@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH #65J/,P'I6J:RM1_UP/K0!
M;L/]15JJMA_J*M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%%  :RM0_X^!G\*U:R]1YG7VH M6/^HJU5
M6R_U%6J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ -95_\ \?'X5JFLK4/]?^% %NR_U%6JJV/^HJU0
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 (:R=1(,Y%:Q'(K)OT_TD\]: +]I_Q[BK%5K,YMQ5F@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH #65?\ _'Q^%:IK*O\ _CX_"@"W9?ZBK55;'_45:H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M***  UE:A_Q\?A6K65J7RSJ1WH MV'%L!Z5:JK8\P5:H **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $;
MI67J7^N%:AK*U$YG(]J +MIQ;C%6:K6AS; U9H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $(S63J Q
M<$^U:YK*U#_7T 7+,8M5%6:@M0/(6IZ "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ -8UX<WK$=!6R:Q
MK[Y;PX[T :=OS *FJ&U_U"U-0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 (W K(OQ_I>:US6/??\?AH
M T[7_4+4U0VO^H6IJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT %%%'2@ HI,TM !1110 444FX?Y% "T4=:* "B@G R:3(]_RH 6BD) /?\
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M_ UZL6 H 6BDR/6C<N<9YH 6BD+ '!ZTN: "BC(HR* "BDW#_(I"ZCJ?_K4
M.HI-PHW#&?;- "T49S10 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 F*QKU=MV<=*
MVJQ;[F\:@#5M^85^E2U#;<PK]*FH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD- '/\ C?Q!)X7\(W^K
M0VYN)88SLCVDC)Z$^WK7D/P\\'V7Q$^W>(O$MU)J#B9H%M?,,87 !#DH0?XB
M!].]>O\ B[7-*T7P[<3ZRI>UE!A,*KDR%N H[<YQSQ7B7A+P]XLGU&\U[P.(
M='TF\D!B2YF!&T= R\\\GIQ0!W&N_!GPG+I4IL8I],>-2ZO%<.Z CU#%JH_
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M$&%D ('(' /()P<5M_$K6=0\.^"+S5-,D6.Z@:,JS(&!S(HQSVYKR7]GZ/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M ;ICQ]-O'ZT^/X':[JUPEUKWB1#.>'*(\KJOHKL0>Y[<9H U/@!&R^%K]RN
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M6@!U%-5U= P.5(R#U&*%=7SM(./0T .HHHH **** "BBB@ HHIN]<D=QUXH
M=1445Q%,,QNK#.,A@?Y5(3@=#0 M%-\Q>_'XBG4 %%%% !1110 44TN V,$G
M&>*4-DXP>F>: %HHHH **** "BBB@ HHHH **1F"C)JEJ.LZ;I,2RZA>P6J,
M<!II H/YT 7J*K6NH6M[;1W-M,DT$@W1R(P*N.Y!%6: "BBB@ HHHH ****
M"BBB@ HK%UGQ;H'AV>*'5]4M[.649C65L%A6M#,D\8DC.48 JW8@^E $E%%%
M !1110 4444 %%%% !1110 444A8 X[T +15+^UM/%\+(WEN+H_\L3*N_P#+
M.:N9YQ0 M%%% !1110 4444 %%-+[3R#CU]*ISZSIMM>)9W%[;PW,@W)#)(
MS#H"!GU!_*@"]13=P YKG=.\=^']6UZ;1;.[DDOH2P=# X VD _,1CO0!TE%
M(#D ^M+0 4444 %%%% !145S<PVD#SW$BQPQJ6=V. H'<U1TKQ#I.N1-+I5_
M!>1J<%H7!P?2@#3HHHH **S]8UW2_#]F+O5KV*TMRVT22G SZ?H:EL=2M=2M
M(KNSE$UM,H:.5?NL",@B@"W17%^,OB=H?@?4+>RU2"^DEGC\Q3;QHP R1SN8
M>E==:W*7EI#<QA@DR+(H;K@C(S0!-1110 4444 %%%% !1110 4444 %%%%
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MO)]9^,L$FL/I/A72I=<NAT9"?+)Q_#M#$_B!_6F_\))\8I4$D'A'3$4_PS2
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M H =130X(Z$?6E!S0 M%%(3CZ>OI0 M%)D>_Y4@8'I0 ZBDW#.,\^E-\P>A
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MN7VEVEG<02V6[S&E*D'!QQ@^M;OB&34_[ OCH@/]HB%C "!][!Q][CK7SO\
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MM=4IZD_3KQ0 -&K1E&7>IZAN<U\W?$C0AX(\?:?J.BDV2W3"11'\JH00&QV
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M+;KPMXAD2\EA5BTR 94J0,9&,CGTJZOPO\774@EO_B1J@!^\D'F 'Z?O /\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O'/VA5
MW>%]+&5_X_B1G/\ SS;TKV,]#7D_QRTK4M7\.:<NFZ==7CQW99UMHFD;'EL,
MX4=,F@#M_ Q+>!]')VY^SC[O2NAK#\&VDMCX.TJVGB:*5+=0R,""IZX((!S6
MY0 V0A8V+$  <DUX[=^-]%_X2";_ (0?PG'K.L;R\MU%'M7KR=P&2,GKTKU^
MYA%Q:RPL2 ZE<@X->#>%;+Q)\+/$5XE[X>O=3LKB,HDVG0>82<@YZ\# /RX_
M'B@#I+?7_C!?RB,>%]*MXG8XEGR!&,\$_OMQ_P"^1]!7->#[+4'^.MVWB6XM
M_P"V;9=^VWX1B8AC:.OW"*[AO'6OZC$;7P_X*U>&Y/ EU:$6L2'N>3\Q]A7G
M4>C>-_#/Q&A\4ZMH5SJUPS$R_8!Y@&Y=@^Z#C"D<'T]Z /H@;0I 'TKYZ^"P
MM;CXAZG<2RA;B-)/)C]=Q^<_AA:]]L[DW5HEP()8FD4-Y<RE&!QT(->)?#+P
M5XCT7XAR:EJ&DR6UJT4H\UF4@Y(QT- 'LVM_+HUZ3T\D_P J\;_9Y4B36,]@
MH_6O9M:BEGTB[BA0O(\3!5'<UYE\%/"^L^'DU*;5;)K9)PNP.1N//H* .A^,
M@/\ PJW63[P?^CHZA^"__)-K#_?D_P#0S5[XJZ7?:S\/-1LM.@>>Y?RV$:8R
M=LBL>OL*;\*],OM'\"6-I?VS6\RLY9'ZC+$B@#R7Q3.-3_:!L[:2/$:7EO W
MN-V3_P"A5](* J@ 8 [5X+J7@WQ%+\<X]632IVL/[0AG\\%=OEC;D]<]CQ7O
M= 'D'[09 \):<2"<7RG@_P"P]=G\/+=;?P!HR($&ZTC8[1C)*C_&N=^-'AK6
M/$FA6,.D6;73QW&YT5@#C!YY-==X.M+C3?"&E6EY$T4\-NB.AZ@@ 4 >>_'Z
MYEA\+Z;%$56.>Z97##)X4D?R%>@>#$5/!.EA% 'V?. ,#O7(_&3PSK'B;0]-
M@TBR>ZDAN2\@5E!"D$=R*[?PO93Z?X9TZSNDV311;67T- 'GGQ[;'@ZVSCFX
M]/85U_PU('P]T4Y_Y=E_D*P/C%H.L>(] L['2=.>ZE,C.^QU&W&/4CK73>"-
M/N](\&:98WL1AG@A"NI()' ]#0!TN?K^5&1TSS7C7Q-UWQKX<\16]S:7GDZ'
M/,D*8AB<ESR0=RDC@-S7K=C,T]C;SL<LZ LVW':@"W3)!N7;SAN#BG 8%(XX
M]_4=J /GOX'Q+?\ CW5=4EF)N%B.59AE]YZ@=_N?A7T-FO!+CX?^+/!GC676
M/".GQWMG("L:>8HVH3DHP8CKQS[5V+^+?'.KV/DZ9X-N+.](VO-=NJQQGU4D
MY/X T </XEV_\-)6K%(Y<F,!')X_<=1BO0?C.1_PJS5!T.Z#''?S4K@M&^&W
MC2R^)-AK6J*E[\[2W%VLP(#%2,8.",$^G:O2/BAHNI^(/ MWINE0"XNI6CVH
M75<X=2>2<=J ,?X&6T</@%76/:\ERY9O[W KOM5XT>[)_P">)KF?A=HFI>'_
M  3!8ZI;K#<AV<H)%?'/3()':NHU2&6;2[F&% \K1$*I.,F@#Q']GEB+O6P>
MZQ?IN_QK-^)S%/C3:F[\X6P$!3 XSA<]>O-=C\'_  5K_A2ZU*36+(6ZS*H3
M]ZCDX)_NDUT7Q'\!KXUL+=[5XK?4K63?'*X.2N#\F0>.2IS@_=H [<,K(&!R
MN/3K7#_%PV@^'6I_:QV7R\@_?R-OZXKFM&O?BUH<2V%YH%OJZ0IY:3B=%) Z
M$L6&1^&:H>(O#7Q.\:6I757L-/LE!*VD,I)<]1N*@CKCJ<?2@#7^  SX"N^N
M3J;G\/+CK@];N=:NOCM*MDMLEW'<^5;_ &H80H#UYSZ]J]5^$OAK5?"GA6?3
M]6CC$[W33($D5A@JHZC/]VJ7Q#^&=QXEU.UUO1;E;/5H5(9F8C>!RN&P=I'/
M;G/M0!%]D^, 0!=2T D'&4!Q^7E5E^(O#7Q0U_19M.U?4_#WV.0J9"Q*X ((
MY\KCD"KD&H?&*PLOLTN@Z;J,PPOV@7,:_B1O7=GZ"LBX\&?$CQOJ,4/BB[AT
MS2@P)M[>1", < ("<^G+4 >@_#O0[_PWX.M=,OY8)I(F?:UN^]=K2,1@X'&#
M7E&BH+C]H>XW<XG+\@$<(O\ A7O6EZ;#I6EVUC;_ .K@C$:DCG KRG1/AYXB
ML/BS+XBN!;&R+LV^-P&((QC;0![#&=RYS_\ 6IU-0@C(]:=0 5\^7ODR?M*1
MB\""/>/OGJP@^7^E?0=?,_BW2;GQ'\=[G3;&Y6SNY)%,4S]$9(-W;UVX_&@#
MZ65N.<_EBO-OCE+"/A\\3,OFM<1LB$\L ><50C'QATVV6T6+1M11!M6Y+?,W
MN06 XZ=.U9?_  KOQMXOUBUN/'&HPBP@D#_9XV'*Y^95"],@8SDT ;GPV@O[
M7X090-+/*LDL.X= 0N!QSZUYW\'[;Q1<Q:JGAO5[+3PNQI5N(1+N//3OCWKZ
M*L[*UTZQBL[:,16\2;$C[!17DVL_"W7]&\02:OX"U*.Q$B@-:.Q1<CKV(8>Q
MQB@#8BT#XJR@O-XPTZ!N1L6Q5UZ\'E:XO4/A[J,WQ MM2\2^,= CU!YHI=H<
M12R[  NU#C^Z!71R2?&=K,6PM](CFVA1<>8F[W/+8Y^E'A+X5ZJWB(>(?&&H
MK>7R.'2*,D@,!PV[ _( CWH [#Q]A/AOKFW+L;"7#]B?+(S7%?L_X/AS4\HG
MF"YPS <GY17H_B_2+C7/"FI:9:,BS7%N\:%S@9*D5S'PH\'ZKX-T:\MM66W$
MT\^]1%)O&, <G% '?2G$3?[IKP#X0M_Q=_Q S=?(N!_Y'2O?IO,:&1$QYC*=
MN>E>3?#[X>>(?#_CK4]<U;[*L%PLB*L<NXG<X8'I[4 ;/Q.^(<WA"*ULM,BB
MGU"[/RHY)*J>,@ C/.!U%9VCZ?\ %;6K=;F^\1V>CQ2+N2**S29P#TR&4X_[
M[-:?Q-^'+^,X+6[T^:*WU2U.5D88WKV7/;G!S[5AV5M\8[#3AIN-(FVH42YD
M<NRCMR>./<'Z&@#!^*'A;Q%8>&9=1U7QG<:E#',JM:_9A#&2<>C ?I7H/P?8
M'X;Z:,!0!Q@]>!7+:A\+O&?BG3U'B/Q>DD\>66T2W!A+=L[2F/K@UM_#/1?%
MWAU)]/\ $-U:O8Q@""..17(_'J.W6@#COCD2WB_P\,#@GO\ [25[A.2FF2-@
MDB G@9[5YS\1?AYJ_BWQ+IFH:?/9I%;_ .L$SLK8R#Q@'/3VKTH@/:A'X!38
MV,_3TH \/^"D<A\<^);@K@LK @\,/WN>1U'%>G_$,C_A7VO_ /7E-_Z :\U_
MX5CXW\.>*KG4O"NJ6@AN)BT@:0Q_*6W8=2&R!GU[5Z=KND:CK?@F\TMIH3?W
M-LT7F<A-S+C/3IF@#C/@$Q'@2YSPIOY.?3Y$KSC4H-3E^.EU#'JCZ9.]XPBN
MBOW5)../?'>O9OAAX/O_  ?X9GT_4I;:2=[II?W!+* 54<D@9Z>E,\>_#.P\
M9&.[206VI1#$<VW*G_> (].M %63PGX[97"_$5MP^7G1HE_'(;)K$\5>"M8G
MT(Q^)?B2@TW(#&:QCA7(/0$-FJZ^'_C)H]NMO:^(K*XC3"H79&.![O&/YFFI
M\+O%GBC58;CQIKXEM5Q(;6!RW/HO 5/UH [SP3;Z3H'@BW2RUF.\TV)'=;UV
M 3:&.[\ 0:YJ[^'O@CQ?J\NI:-K30:@JAY)-,ND;;DG#$#.,D'TZ5Z)9Z186
MNCII<-M$+!8S'Y&T%2#USVYR<_4UY9J7PCU?0M5EU/P+K0T_SCF2VD&T9]F
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M&FVVFV$%G9Q+#!",*@],8Y]3[T >#?M# G7]'//_ ![$>WWZ]R\/?\BWI?\
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M</%+""ZY!SRI;K[@@UVGA_1&T/1X+&2_N;Z2/EKBY=F=S^).![4 >/>-M/\
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M.>%K3PQI0TZTN+J>'_IZD\P_ATP* /%=<O+?2OVAHKV_D%O:QR;GE<$*H*$
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M .D<*!5_*F7VCV&IIY=_:P74.[=Y<T08=,=_I0!E^'H8[[P/90*WR26NS(Y
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MQZ\#KP>16A\2?A[=Z]+!K6AS"/6+4!@C,0LH7D <\'@<UZ7CGV]*0J&//\J
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M@3X-C<LUO=N VX(TY(/L?7]*[S0]#T[P]8"QTNSCM+;.[RT_O=">_H.]:5%
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M69XAYDLH +-@9Z4 4M=^'EEXC\2PZKJ6H7\L,&#%8APL088YXY[5V@50H4
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M9W4-Q$WW7B<,#^(J8.A3<&!7KG/% "[1Z4%0>HJG9:OIVI1F2ROK>X1>28Y
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MQ]#BL;6/%_A[0)1%JFL6EI(?X)).?R[5F)\3?!4C ?\ "1629. SMM4_B>*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M# /:D  I:* #%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1BBB@!-H]/SH  &!2T4 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "&L5_
M^/M_][-;1[5BR?\ 'W)_OF@#8C_U:_2GTR/_ %:_2GT %%%% !1110 4444
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M<:9X?B)4PVN%+KV4GUQUSD<=*ZI/@9X1^P)$%OC,02+E[C+J3STP%Z^U<O\
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M,C@C'MB@#Q?XF^ (_#'A>2Z\/7%Q;::9 MUIRS.86!!^?#%N:Z7X%(J_#X,
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MT!E"[L(8W8CTVC)S[5QF@^.K_P 4>-8;+P_X7TI=)692]W-:,K(@.6.X$8;
M.T$=<4 >TJ^Y V,9&<4ZLS6]571=&N]0EA>9+>)I&2(#+8!.!D^U<[X(^)&F
M^.I+M+"WGA:V"EO.'!!STQ]* .UI" 1S0"3G(QS0WW30!XE\;==U'^U-,\+V
M5P]O%>8,K9P) S$8)]*]*\*^$-&\.:1:166GVJ2J@9Y@F79B.3N/->?_ !K\
M)7]_':>)-,CDDN;%0DD<8W$*&SN _&M3P=\8=!U'28X=7N%TR]@ C9;CY0V
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M@>M3>-- F\3^%[O2H9_(><#YVSC /3BNBHH YOP5X67PAX:M]*6=YS'EG<@
M;CR<>V2:Z,=Z6B@!K9Q\H!.>YK@/B)\.)O'DM@PU,6(M@W6'S>3C_:'I7H-%
M $-O"8($B+%BJXR>]<G\0?!#>.='M]/^WFR$,XFW^1YV?E9<8W#^]ZUV5% &
M7H6E?V)H=EIH991:P+%O5-FXJ,9VY/7&>O>J'C7PRWB[PQ<:.EV;0S,C>;LW
M8PP/3\/:NCHH X_P%X,/@3P_-I:WAO?,N6N/,\OR^JJ,8R?[OZUTEQ)';0O+
M<,JPH,LSG@#O5LC((Z5YOK/PKO-;UNZGN/&.KKI-TQ>33HWPN3Z'. /^ GZT
M >4>#/"EEXO^)M[)90L- MIGD5PFP% WR+TQD\''L?2OIM$VR#:N%Q[]>WZ5
MD^'/">D>%;(VNE6:1*0-\AY>3'0L<<UMB@ HHHH Y/Q]X-/C;1%TT7YLL2!_
M,\GS1^61_.K_ (4T#_A&_#UKI?VA[GR4"^8R;,\=<9/\ZW:* .:\7^#-.\9Z
M4EEJ'FH$;<DL. R_F/>H/!O@W_A#+.:SAU*ZN[=SN19P"8QZ*1@#Z 5UE% '
M#^%?AO9>%_$-_K,%W/++=NS!) OR;B21G'/)-=H.X&>F,X(YJ2B@#BO%_P .
M-,\9ZE:7FI7-VJ6P*B&,KM8''MD=*ZR&W%O;Q01YVQ  %^3C_&K-% 'G_B;X
M2^'O$]Y+J+"YLM0<[EG@E/#?WBI[UC1?"+7D;RY?B)K;VG3R8V=./3F4K_X[
M7K-% '#>&OA9X;\-:C'J$,=S=WZDOY]W)YAW>O  S[XS7<8'H*6B@#A?&'PN
MT3QCJ<>HW<MU;WJ)L\V!EY4= 00:ZC1-'M="TBUTVS5A#!&$0OR3@=3[FM*B
M@#D/&?P^TGQL+?\ M'[0CP]'MV5&(]"2IX[UI^&_#EGX5T>+3+'S3"K$EI6#
M,Q/<D 9K<HH S=6TJ/6-'O=,GDD6*[A:!V7J P()].]8'@KX?:=X(6__ +/N
M;J4W@C#F<C(V;L8P!_?-=C10!E:UX?TSQ#IS6.J6B75N7\P))V;D9!Z@X)Y'
MK7"?\*/T*UN?.TG4]8TW@@"WN!P#U )&<5ZA10!Y8OP,\/W%TEQJFHZQJ10Y
M*7-R"&^IQN_(UZ79V5M86<5K:P)#!$H5$08"BK%% &1K_A_3?$=B]EJEHL\!
M7C*@E<]=O'%<(OP-T& 2K:ZQKMK'* &2"X4*WURI)_&O4J* /-(/@CX.AM7@
M6VNGD8<SR3DOGVXVC\!73>$_!NF>#[2>WTQ)ECG;?)YDN\EO7H*Z6B@#S3Q_
MXL\*VNH)X<\5:5=-;7&&2XP"N3W7:=XZ8Z=JQ8/A+\.M2C6YLM5NC;_>VI>(
M5^AW+Q^//->GZWX:TCQ'!Y&KZ=!>1=A(#D?0CD5R_P#PIGP-G(T;9@Y 2ZF&
M/I\_% 'EWCFP^'WAS1'T[1#;ZAJ]PVT.LYE>%/JN1G/;BO4_A5H5UHW@*TBO
M4,5S,6G,9&W8'P0".Q'3%7M+^&?A/1KA9[32(S*#D//(\Q'TWDUU>PGC/![Y
MH Q]?\+Z3XGL39ZM9K-$#E,?*R_0CI7$-\!_"09!')J<:#(V"=6'ZJ:]2HH
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M2\/:3K8B_M33+:\\HDH9X5;;G&<9Z9P,_05>M+2WL;6.VM((X((U"I'&H55
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M4U8HT)*HJDG)(&,GUIU% !28&,8&/2EHH 3:.>!SUXI$BCC^XBK_ +HQ3J*
M&E$8$%5(/4$4&-"I4HI4]1CBG44 )M&,8&,8Q1@>@I:* $VC.<#/K1M!.<#-
M+10 A /4"EHHH 0 #H /I00#U I:* "C ]*** $VC.<#-& 3G S2T4 -9%8$
M,H(88.1U%&Q<D[1DC!..M.HH 0*HZ*!QC@4!0!@ 8^E+10 8'''2DVKG.T9]
M<4M% "8&<X&:-J^@_*EHH 3:O]T<#'2EP/2BB@")P-P.UOESC&?3GI7C&M>!
M/%NH?%^#719QR:7#=1O'(9D&(E()!'7KNKVRB@"*/)/S(0V!GT_.I BJ %4
M#H .E+10 8I-JXQ@8^E+10 4F 3G'2EHH 3 '04M%% "8'H*" >H!I:* $V+
M@C:,'MBEP,YQ110 8![48HHH ,#TI,#'04M% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 AK%N#F[//>MHUBRC%VP]30!L1?ZI?I3Z9%Q$OTI] !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 AK%;]Y>'/&#6T?NFL4Y2Y;U)H V5&$7Z4ZF(<QK]*?0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 (>U8LG_'W)_OFMH]JQ9/^/N3_ 'S0!L1_ZM?I
M3Z9'_JU^E/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:/<ZE>2B*"W0NS'/'Y=:M'"  _P\^E>$_%SQ1'XB\26?@ZVO8+:U67-U<O,
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M -6OTI],C_U:_2GT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MUW?@M)&;(2LPR2"P+!><YZ="*[0>$/'8Z_$J3_P30_\ Q5=W%$D,:QQJ%50
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M'\#0!Y!^SV<>%M4(#$/> @@<<1J#^HKV*JMIIUI81M':6\5NC')6) HSC&<
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MK8%CYBPKB.%B.8^.@;D].*]4O-?@\0?"R^UFV0 7&G3?*XQM;:RLN3Z,"*[
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% "'M6+)_P ?<G^^:VCTK%^]>/G^
M]F@#8C_U:_2GTU1A /04Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU% $<=O!""(H8T![*H%28 [444 %%%% !1110 4444 %&*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MZT44 -"(!@* /I3J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBDR,XH 6C(]:RM;\2:/X<MEN=8U""SA8X4R-RQ] !R?PKG(
M/BMX9O5F>REO[I(?O-!83,!]?DXH [C.:*YC1?'_ (8U^Y-I8ZJANQP;>96B
MD_[Y8 G\*Z;</?IGI0 M%<UX@\=>&?#4PBU;4XHKAA\L*HTCG_@*@FLU_B?X
M<CA$\BZC';XRTSZ?,J#\=E ';T5BZ#XHT3Q+;F71M1BNT498+D,OU4@$?B*V
M-Z[2VX8'4^E #J.E<9J/Q/\ "UE>O8Q7DU_?+TMK"!Y7)] 0,9_&LX_%W1+*
M8+J^F:[HZMC:^H63*&^FTL?Y4 >B9S15#2=9T[7+-;S3+V*[MF.!)$V1GTJ_
M0 445Q/C+XF:)X*U*VL=2M;^>:>+S4^S1(PQDC'S,#G(H [:BO-D^,.ER &+
MPSXG;(R"M@AX_P"^Z;+\9=&MR&O-#U^UA/6>XLE"C_Q[- 'I=%87A_QEX?\
M%*2-HNIQW?E\NH5E8?\  6 /Z5IW]TEC9W%VT;.(8RY50,D#ZT 6L\XHKC/!
M'Q$T_P ;3W,-G97=N;==Q,P&TC.."/K79T %%%<%KOQ/TKPUXD32M6TZ^MO,
M?"W31J8W'J-I)(_#- '>T5'#(LT8E1E9'&593D$=J>V<<4 +D49KGO%OBVQ\
M(:%+J=V#( =D<2D R,3C ]>M1>"O%,OB[0EU.339K$.Y5$D(^8#N/U_*@#IJ
M*\LN_C/#!XDN-%MO#]]>3Q2;%\@@EOPJY<_$S5865'^'_B)F/.U8"QQZX H
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M4RZ3X,T^VU$6L;&=V1GP01GD'%=7\./'2>,] 6:X,,>IQY%Q;QYRHS@''H:
M.UR**8QR,IUKS;XM>--6\&V.G7&E"!9;B9D?SH0X( R.^10!Z917D/P[^*.I
M>(?$!TCQ'#:VLLB![4HCIYGY^_YUZZ.0.<T +1574+V#3K*:[NI5B@A0N[L<
M 5\\W/QK\477B)X;*6U2QDNA%"'@W$H6X/..HH ^D*3(SC(S5:Q9S8P.^"[1
MJS$*%!)'H*\AD\6>/]7^(.IZ!X?GL!!:LI+W,?RJ",\G!- 'M%%>7-:?&*,A
M([WP^5 Z@$C]4% L/C"_#ZCH&.X((S_XX: /4:,CUKEO"5OXRABN!XIN]/F<
MG]P;53\H]#P,US/Q:\7ZWX2L;";2)X(FFF\MQ-").N>>>E 'I]%>=V6F?$:^
MTZUNAXKTV/SHUDV_V<IP",^M,OM'^*<:+]C\4:+,S'!\^T\L#\E;/Z4 >CT9
MKQ#6O&7Q(\"7D%QXBBLK[2V<*9+:, $_W0>"#]17KFAZQ!K^CVNIVNX0W$8<
M*W;(H TZ 0>AKQ[XK^,?$/ASQ-HUII5ZMO!<KF13$DF_YQQ\R\5ZK8N\MA;2
MR_?:-7(7U(&>GO0!<R/6DR,XR,UYWX[^)T'AFZ32-,@^WZW+C9;C.$+' !Q_
M$?3W'K67I>G?%;Q!;FXU+6;;0HV^[ EK'*V/<<C\S0!ZSG/2BO.9O"/Q#BC)
MM_B"LS==DVF1#]>:YJR^)GBKPYXIAT3QK90>3*VQ;J)""2>AXX.?8<4 >UT5
M''(KHKC.TC*D@C(J#4=1M-+TVYOKR816T$32R.<\*!D_C[4 6@P.,$<TM?/Y
M\8_$;7['5/$FBWL$6C6<S8A>--P5%#$<INY!!Z]Z]1^'_C&#QCX;CNQ(GVV)
M0+J-"1L8^Q['!P>^#0!U^:3(]14>]#R,D=..QKS3XG^/M0\,W-CI6B1(^I7I
M&))AE57.!P>,YQ^M 'J&1C.:*\PL/!7BS6+:.?Q+XTU"*X?YA#I3+#Y8/3YP
M ?THNOA]XFT]9)="\>ZJ\P7<(-3;[2KD=OF.!_WS0!Z?D45Y+\.OB'X@U/Q!
M-X>\2VJ_:X\[9XXM@(_#C\>.M>LC% "T45DW7BGP_9736MWKFFV]PGWH9;I$
M<?52<T :I900"1D]LTN1ZUX;K^LVOB[XSZ996VLJFFZ?L=W2Y"QLP^?@@\[O
MNUW?Q%\3V&C^"]10:E#%=SVSQVX64;R2" 1CDX- ';;AZBEKS#X-WEE!X1M[
M2;7;>YU2X=IW@-RKRJ"!QM)SQ_6NN\3>--"\(VPGU>]6$OQ'&%+.Y]  ./QH
M Z'- .>E>!>./'WBW7/#UU<Z/H]W8: 4'F7LB@2'+  @YX!..@KT+X./)+\+
M=(EEE>61C/N=F+9(FD'4\]J .[Z4F03C(ID[!('D8X" L3]*\2L_%/B7XE>+
M9]+T6]N=)T*V 6>2)4\T@D_Q'E3P<8SB@#W'-&:\[_X52D09[?QAXI6<_,&:
M^#*#_N[<5SWA7QOK^C^/'\(>*[Q)D8L+>>1%5SW4DKQROK0![+FDR/455OKI
M;+3KB[D+!((GD; ).%!)/Z5X7X T[5?'^IZSJ-YXGUVVL5G,<)L[UD[Y"X((
MZ$<>] 'O]&17G/\ PJB!F(/C'Q7GT_M 9_\ 0:Z'PSX3C\,1W*1:IJNH&8+D
MZA<^;C&>G QUH Z6BF("-V?7TQ3Z "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@!&^Z?I6&I_TH<\[N:VW^X>*Q4/^F].] &V/N_A2TU>@'M3
MJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "FE,Y^8@'TZBG4QB<_*P]P30!PWB/X8:;X
MF\41:OJE_=RVZ+C["2#&3QZ]!UX YXYK6O?$GA?PHBZ?<ZA:6"01C9;*>44
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M_P!IZDYV D[8T)W'9R>#Q@^@XZFN7^.,F?&_AW)5=B]>^/,% 'NUE_R#[?\
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M-,U"6*6_T^TNI(FS$T\"R%#Z@D''Z5SE_P#%+P=IML9Y-?MI@/X+?,K$_P#
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!&^Z?I
M6)'_ ,?8/JU;;?=/TK#3BY7_ 'J -M>Q]13J0?='TI: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #7^Z1[5B+S>
M?\"K;;^AK#C_ ./K_@5 &Z/NCZ4M(/NCZ4M !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6OAS1=)OGM64/-+'&P20DX(+],  4 <-8^+-%\2?$%]>\73O]CAP((?*:1
M20#C_/->GZC\6OAWK>G3Z;>WDLMO.I5T:U<J1^ KL_"OAFT\/^&;/3$2-C$@
M\R0( 7;N36O]AME'R01*/[JH #0!\W?#3QY;>$O$L^E/)//HMR_E1R2 @QD'
M"N5[;O3WZ\5]+A@RK@@Y&1]/6O/OB?X!B\2Z T]C;*=5MOGBD1<.X[CC!/\
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M]OTKS#XP>"_$OC"_L)-$M(;B"&-E8F<(RL3W![=.E>N6B-'9PH^-RH <=,T
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@!&Z'Z5AP?\?)_WC6VYPI/M6+;K_I&?5C0!M#U]13J:. M.H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *0HK8R.AR*6B@!OEH<94$CH3S2[1]/H:6B@!-HQCG
M\^:3:.>3R<]33J* $  &!TI:** $*@]:01H.0H!]:=10 FT8(Y(/J<T!0.@
MI:*  C(Q2; 221GZTM% "% >O\Z-H_R:6B@ Q1110 A4&DV)C&T8^E.HH 3:
M/2C I:* &[%].^:7:/2EHH  ,4444 -V+W&?KS2X%+10 U8T7[J*._ I0 !@
M9_$YI:* "@@$8(HHH ;Y:<?(O'M1L3^ZOY4ZB@ P*0@$8(S2T4 %%%% "%0>
MW-&T4M% %6_L+?4;.2UND9X95*.%<J2#[@@U3T'PSI'AFQ:STFS%O"SEV&YF
M)).>I)-:U% !1110 THIZC/.>><4ZBB@ (S2;1Z4M% ";1[_ )T8%+10 @4
M]_SH  I:* "BBB@!" >M!4'J!Q2T4 ( !T&*6BB@!-H[C/?GF@JIZJ#]12T4
M )M7<&VC(Z'%+110 F!Q[>]+110 4444 -V+SG)SV)R*/+3^XOY4ZB@ HHHH
M :44\E03ZXIW:BB@  Q1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 U_N'
MZ5CV_P#KQ_O&MAOND>U8L'_'T!_M4 ;784ZF_P!13J "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!KG"
M$^U8=J?]*Y[L:VY?]6W/:L2T&;C.>=QH W.PIU-["G4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $<P
M!B;Z5D6'_'T!M[GM6M<KNMW&<#':LJQ(%RA.<#@>] &R.E+110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 ,FYB;Z5C67_'P/9C6S+_ *IOI6)99^TCCC<: -T=!2T@Z"EH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBB@ HHHH **** "BJU_J%GI=JUU?7,5O I ,DKA5&3@<FI(KB*>))8762*0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@!DW^J;G'%8]BI^T]>Y-:UR-T#C...M9-B?])0@=!C
MZT ;0Z4M(.E+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5[#\7;_[05W-&UT%VD]O*+<?3%=AXYN?$>E6%C'H>APZM8#,=Y;M'O<Q@ #
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH 9( 8VSZ5B6)_P!*QZ,16U-_JF^E
M8UC_ ,? H W1T%% Z"B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\LU'X>:Q??%6W
M\4->V:V,$@; 8A\ _=(QC//K7J=)CWH 1,\YQUSP:\]^(/P_OO%NN:1J%G=P
MPBQ;++(#\WS@\8^E>AXY-&/RH CB!1$C/)50#CZ5Y]XE\ W^O?$C1?$L%Y;I
M:61B+HZG<=DA<@?7.*]%*@C';T%(%QGD_P"% '%^+_!EUXD\0^']2BO(XXM-
MF,C1LA._E3QR,=*M^,?#.H^(;*#^RM;FTN_M9-T4\;.5((Y5E#8/0<GICWKJ
MMH]*0J"/2@#@(8/BA;Q11&^\,72XVF>>&=''Y'!-0:#\/-0B\:_\)=X@U&"Y
MU-2?+BM8_+1<H8^>,GY3^=>C;1^-+CWH %&!BL[7=$L?$6DSZ;J,*RV\RD$$
M=#V(]Q6D  ,"B@#S'1_!?CCPM:FRT?Q)97=FN/*2_MR3'UR 0<XZ=^U4O$/P
MR\7>++8)JOB^W54E,D=G#9 1+Z<@@Y )'(/6O6MJCH*,>] &+;^'8?\ A$+7
MP_>[;F*.SCM92_\ 'L0#=^8!KB[;X?\ BKPO*8_"?B*)=-)W?8KZ+>JD_> /
MH3DXXZUZ?THH \RNOA_XH\32I#XJ\26[Z6""UA8V_EH^#G!)Y_6NTD\,:7)X
M<;0#;!=-:,Q&)6(^4]>>N:V,<\4M 'F.C^ O&'A8M::'XIMI-+SE+:]M=WE_
M0@T^#X;:OJWB*'5O&&O)J26[[[>TAB*1(?I7I=% '(>./ D/C+3K:%;MK&YM
M9!)!.B;BI'0<]JQ8_"WQ-CMX[9?'5FB(=OF?V>K/L_$<G\:])HH \OT/X47^
MF>.(O$M_XD_M.< ^9OM!&6X[88XK<\6> SXH\2Z)JQOA NFL[&/9NWYV]/3[
MM=I10 S8=H&1QWK@?#/PT;P_XZU7Q&VHK.+UI&6(Q8*;GW=<_A7H-% '/>-/
M#!\6^%;K1!=?9A<%"9-F[&UPW3\*=X7\,Q^'/"EIH33?:HH$9&9UP) Q)Y'X
MUOT4 >9W/PPU72]3FN_!WB1](@F.Z2R>/?%N]1DD?ABH[CX=^,==5(/$?CEI
M[,'+PVMJ(O-]F*D?RKU"B@#&MO#5CI_AUM%T]?LUN83$,?-U&,G/6L3X=^ ?
M^$"TR[LQJ/VW[1-YI?R?+QQCH":[2B@# \7^&1XK\-W6C/=M;K/M_>!-Q&"#
MT[]*3P?X9_X1/PY;Z0+QKI82<2E F<^PKH** /,Q\*;VR\2W&KZ+XJN=.%RX
M>:)+=6W?B3[UZ0L96,*3N( Y(QD^M244 -*G'7GUKS[Q7\)-)\5^)8=8GN&M
M\!?M$4<8_P!(V]"3U!P ./2O0Z* *0TR :<UAL5K8P^2(W&1MQC!]17(>#OA
M7I'@[5KC4H)6N;F0D1LZA?*4]5 '%=Y10!B>*?"]AXMT9],U%"82P=64X*,,
M@$?@37'Q_#/Q'9".WTSX@ZA;6$2A(H'MA(40< !MP/ KTNB@#RS5?@M'JICO
M)_%.K2ZM'@I<W&V1%(/4+P1_WU76ZAX*L=<\.1Z1KC&^*Q!#<XVR _WE.21]
M"2/8UTU% 'F<'PQU_3P+?3/'^I6VGJ?EMV@$C*/0,6 '_?-:NF?#/3;36UUG
M4;V]U?48]OE37LFXQ@9Z8X[UV]% #4!"@,03CDBH;]S'83NL?FE4)\OCY^/N
M\\<]*L4=: /!=,O_  3<ZS>2V>IZEX+U4,WVJ!)E$9/KW4Y&#^-9GC-O#]U8
MQ:?#XEU+Q3KETZI9!I\0Q$G .!A<D^N>1SBOH"XT?3+N7S;C3[663^])"K']
M121:/IUO-YT%G!#+C&^.-5/Z"@#)\%:-/I'@G3],OXT,T<.V4;@P8^Y'6L-O
MA186EW-<>']8U/0C*#NCLIODS_NG(KOU4*,#/XTM 'GY^%EOJ#1?\)%X@UC6
MHH^1;W$^R$GU*+_C75W&@6<^A2:.$$-HT!MU$0QY:8P,9STK5HH Q?"_ANT\
M*Z!;Z/9N\D$)8AY,;F)8MS@ =Z9XK\+6?B_1)=*OI)4@<A@T1 8,.AY!K=HH
M R=)T"ST?0X-(MU+VT,?EKYN"=OX 5SC?"W2(+EI](U'6=&,C;IET^]*I*?5
ME8,/RQ7<T4 <%'\*-(FU5;_6;_4M;9#E(]1G\Q5/;@ "NON=)M+G2IM,:+9:
M2Q&%HXSM 0C! QTXJ]10!@^%_"6F>$-,DT_2HW6"24RL'<L2Q '4^P%'B/P?
MHOBJVCAU:T$WE$F)U8HT>?0CZ5O44 <(GPPA#*)?%WBV> =8)=3RC?7"@G\Z
MEO/A9X;N+^TO[6WDL+NVD5Q+;2%2^ 1AOKW-=M10!EZWX?T[Q%I;Z;JD'VBT
M<@O&7*YP<CD<CD#I5+PUX/L/"EM);:=/>- [EECGG+K'[*.@%=#10!RNL?#O
MPUKM^M_>:?MO5^[/!*\3C\5(JK/\+] O'B_M"74[^*/D17E_+*A/J037:44
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #)?]4WT
MK%L?^/C_ ($:VI?]4WTK&L!FY _VC0!N#H**0=*6@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****  Y[4G-+1
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1
M7/\ Q[O@XXK+TU1]I'.>,UJ7(S;N/:LK3#FY'TH VJ*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"
M*X($#D^E96F BZ'ICBM.[P;23/I6=I9#2C)SA>* -BBBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MKWI'V60>U9NDC$P_W:U+L VLGTK+TL$W /;;0!M4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $-W
M_P >LGTK-TH_O!_NUHWF/LSY!Z5GZ9GS1@C&V@#7HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (;
MO_CUD^E9NE#]X#_LUH7QQ:2?2L_23^]Q_LT ;%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!7O2!
M:R9&>*H:4O[S/^S6E<1>='LRP![KBH[:S2V8E7=L_P!XT 6:*** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
$@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>reli-20220630.xsd
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaGJ6bP9z5Z8eekhvWBybYlKjyAm9n4MWyhithcGMYwA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:RELI="http://relianceglobalgroup.com/20220630" elementFormDefault="qualified" targetNamespace="http://relianceglobalgroup.com/20220630">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/StatementsOfOperations" id="StatementsOfOperations">
	  <link:definition>00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit" id="StatementsOfStockholdersEquityDeficit">
	  <link:definition>00000005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficitParenthetical" id="StatementsOfStockholdersEquityDeficitParenthetical">
	  <link:definition>00000006 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPolicies" id="SummaryOfBusinessAndSignificantAccountingPolicies">
	  <link:definition>00000008 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinations" id="StrategicInvestmentsAndBusinessCombinations">
	  <link:definition>00000009 - Disclosure - STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssets" id="GoodwillAndOtherIntangibleAssets">
	  <link:definition>00000010 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancings" id="Long-termDebtAndShort-termFinancings">
	  <link:definition>00000011 - Disclosure - LONG-TERM DEBT AND SHORT-TERM FINANCINGS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/WarrantLiabilities" id="WarrantLiabilities">
	  <link:definition>00000012 - Disclosure - WARRANT LIABILITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/Equity" id="Equity">
	  <link:definition>00000013 - Disclosure - EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/EarningsLossPerShare" id="EarningsLossPerShare">
	  <link:definition>00000014 - Disclosure - EARNINGS (LOSS) PER SHARE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/Leases" id="Leases">
	  <link:definition>00000015 - Disclosure - LEASES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesPolicies" id="SummaryOfBusinessAndSignificantAccountingPoliciesPolicies">
	  <link:definition>00000017 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables" id="SummaryOfBusinessAndSignificantAccountingPoliciesTables">
	  <link:definition>00000018 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsTables" id="StrategicInvestmentsAndBusinessCombinationsTables">
	  <link:definition>00000019 - Disclosure - STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsTables" id="GoodwillAndOtherIntangibleAssetsTables">
	  <link:definition>00000020 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsTables" id="Long-termDebtAndShort-termFinancingsTables">
	  <link:definition>00000021 - Disclosure - LONG-TERM DEBT AND SHORT-TERM FINANCINGS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/EarningsLossPerShareTables" id="EarningsLossPerShareTables">
	  <link:definition>00000022 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/LeasesTables" id="LeasesTables">
	  <link:definition>00000023 - Disclosure - LEASES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
	  <link:definition>00000024 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/ScheduleOfRestrictedCashInStatementOfCashFlowDetails" id="ScheduleOfRestrictedCashInStatementOfCashFlowDetails">
	  <link:definition>00000025 - Disclosure - SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/ScheduleOfFairValueOfWarrantCommitmentDetails" id="ScheduleOfFairValueOfWarrantCommitmentDetails">
	  <link:definition>00000026 - Disclosure - SCHEDULE OF FAIR VALUE OF WARRANT COMMITMENT (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/ScheduleOfReconcilesWarrantCommitmentDetails" id="ScheduleOfReconcilesWarrantCommitmentDetails">
	  <link:definition>00000027 - Disclosure - SCHEDULE OF RECONCILES WARRANT COMMITMENT (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/ScheduleOfFairValueMeasurementsDetails" id="ScheduleOfFairValueMeasurementsDetails">
	  <link:definition>00000028 - Disclosure - SCHEDULE OF FAIR VALUE MEASUREMENTS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails" id="ScheduleOfEarnOutLiabilityDetails">
	  <link:definition>00000029 - Disclosure - SCHEDULE OF EARN OUT LIABILITY (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails" id="ScheduleOfGainOrLossesRecognizedFairValueDetails">
	  <link:definition>00000030 - Disclosure - SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails" id="ScheduleOfDisaggregationRevenueDetails">
	  <link:definition>00000031 - Disclosure - SCHEDULE OF DISAGGREGATION REVENUE (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails" id="ScheduleOfConcentrationsOfRevenuesDetails">
	  <link:definition>00000032 - Disclosure - SCHEDULE OF CONCENTRATIONS OF REVENUES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/SummarizesChangesToPreviouslyIssuedFinancialInformationDetails" id="SummarizesChangesToPreviouslyIssuedFinancialInformationDetails">
	  <link:definition>00000033 - Disclosure - SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000034 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails" id="ScheduleOfAllocationOfPurchasePriceDetails">
	  <link:definition>00000035 - Disclosure - SCHEDULE OF ALLOCATION OF PURCHASE PRICE (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/ScheduleOfProFormaInformationRelatedToAcquisitionDetails" id="ScheduleOfProFormaInformationRelatedToAcquisitionDetails">
	  <link:definition>00000036 - Disclosure - SCHEDULE OF PRO FORMA INFORMATION RELATED TO ACQUISITION (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative" id="StrategicInvestmentsAndBusinessCombinationsDetailsNarrative">
	  <link:definition>00000037 - Disclosure - STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/ScheduleOfImpairmentOfGoodwillDetails" id="ScheduleOfImpairmentOfGoodwillDetails">
	  <link:definition>00000038 - Disclosure - SCHEDULE OF IMPAIRMENT OF GOODWILL (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails" id="ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails">
	  <link:definition>00000039 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails" id="ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails">
	  <link:definition>00000040 - Disclosure - SCHEDULE OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsDetailsNarrative" id="GoodwillAndOtherIntangibleAssetsDetailsNarrative">
	  <link:definition>00000041 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical" id="ScheduleOfLongTermDebtDetailsParenthetical">
	  <link:definition>00000042 - Disclosure - SCHEDULE OF LONG TERM DEBT (Details) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails" id="ScheduleOfLongTermDebtDetails">
	  <link:definition>00000043 - Disclosure - SCHEDULE OF LONG TERM DEBT (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails" id="ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails">
	  <link:definition>00000044 - Disclosure - SCHEDULE OF CUMULATIVE MATURITIES OF LONG-TERM LOANS AND CREDIT FACILITIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsDetailsNarrative" id="Long-termDebtAndShort-termFinancingsDetailsNarrative">
	  <link:definition>00000045 - Disclosure - LONG-TERM DEBT AND SHORT-TERM FINANCINGS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative" id="WarrantLiabilitiesDetailsNarrative">
	  <link:definition>00000046 - Disclosure - WARRANT LIABILITIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/EquityDetailsNarrative" id="EquityDetailsNarrative">
	  <link:definition>00000047 - Disclosure - EQUITY (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails" id="ScheduleOfCalculationsOfBasicAndDilutedEpsDetails">
	  <link:definition>00000048 - Disclosure - SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative" id="EarningsLossPerShareDetailsNarrative">
	  <link:definition>00000049 - Disclosure - EARNINGS (LOSS) PER SHARE (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails" id="ScheduleOfFutureMinimumLeasePaymentDetails">
	  <link:definition>00000050 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENT (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/LeasesDetailsNarrative" id="LeasesDetailsNarrative">
	  <link:definition>00000051 - Disclosure - LEASES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails" id="ScheduleOfEarn-outLiabilityDetails">
	  <link:definition>00000052 - Disclosure - SCHEDULE OF EARN-OUT LIABILITY (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="reli-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="reli-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="reli-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="reli-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
    <element id="RELI_SeriesAWarrantsMember" name="SeriesAWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_CommonStockIssuableMember" name="CommonStockIssuableMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_SubscriptionReceivableMember" name="SubscriptionReceivableMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_CustomerMember" name="CustomerMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_SeriesBWarrantCommitmentMember" name="SeriesBWarrantCommitmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_SeriesBWarrantLiabilityMember" name="SeriesBWarrantLiabilityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_PlacementAgentWarrantsMember" name="PlacementAgentWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_MeasurementInputRiskPremiumMember" name="MeasurementInputRiskPremiumMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_MeasurementInputPaymentDelayMember" name="MeasurementInputPaymentDelayMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_JPKushAcquisitionMember" name="JPKushAcquisitionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_BarraAcquisitionMember" name="BarraAcquisitionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_CCSWriteoffMember" name="CCSWriteoffMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_AltruisPartialSettlementMember" name="AltruisPartialSettlementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_MontanaFinalSettlementMember" name="MontanaFinalSettlementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_MedicalLifeMember" name="MedicalLifeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_RegularMember" name="RegularMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_EmployeeBenefitsSolutionsLLCMember" name="EmployeeBenefitsSolutionsLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_PropertyAndCasualtyMember" name="PropertyAndCasualtyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_USBenefitsAllianceLLCMember" name="USBenefitsAllianceLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_CommercialCoverageSolutionsLLCMember" name="CommercialCoverageSolutionsLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_SouthwesternMontanaFinancialCenterIncMember" name="SouthwesternMontanaFinancialCenterIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_FortmanInsuranceServicesLLCMember" name="FortmanInsuranceServicesLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_AltruisBenefitsConsultingIncMember" name="AltruisBenefitsConsultingIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_KushMember" name="KushMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_MedigapMember" name="MedigapMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_BarraMember" name="BarraMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_LTCGlobalMember" name="LTCGlobalMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_PriorityHealthMember" name="PriorityHealthMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_BlueCrossBlueShieldMember" name="BlueCrossBlueShieldMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_MedigapHealthcareInsuranceCompanyMember" name="MedigapHealthcareInsuranceCompanyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_MeasurementInputRoyaltyRateMember" name="MeasurementInputRoyaltyRateMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_MeasurementInputObsolescenceRateMember" name="MeasurementInputObsolescenceRateMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_BackLogMember" name="BackLogMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_APAMember" name="APAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_BarraAndAssociatesLLCMember" name="BarraAndAssociatesLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_PaidAtClosingMember" name="PaidAtClosingMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_PayableInSixMonthsMember" name="PayableInSixMonthsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_PayableOverTwoYearsMember" name="PayableOverTwoYearsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_DevelopedTechnologyMember" name="DevelopedTechnologyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_RightOfUseAssetMember" name="RightOfUseAssetMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_ChargebackReserveMember" name="ChargebackReserveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_LeaseLiabilityMember" name="LeaseLiabilityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_AcquiredAccountsReceivableMember" name="AcquiredAccountsReceivableMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_AgencyRelationshipsMember" name="AgencyRelationshipsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_InternallyDevelopedSoftwareMember" name="InternallyDevelopedSoftwareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_PurchasedSoftwareMember" name="PurchasedSoftwareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_VideoProductionAssetsMember" name="VideoProductionAssetsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_NoncompetitionAgreementsMember" name="NoncompetitionAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_ContractsBacklogMember" name="ContractsBacklogMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_EBSandUSBAMember" name="EBSandUSBAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_CCSMember" name="CCSMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_SWMTMember" name="SWMTMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_FISMember" name="FISMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_ABCMember" name="ABCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_DirectorsAndOfficerMember" name="DirectorsAndOfficerMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_SeriesBConvertiblePreferredStockMember" name="SeriesBConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_MedigapAcquisitionMember" name="MedigapAcquisitionMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_SeriesAWarrantMember" name="SeriesAWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_SeriesCPrepaidWarrantsMember" name="SeriesCPrepaidWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_SeriesDPrepaidWarrantsMember" name="SeriesDPrepaidWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_ThreeEmployeesMember" name="ThreeEmployeesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_CommercialSolutionsOfInsuranceAgencyLLCMember" name="CommercialSolutionsOfInsuranceAgencyLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_FortmanInsuranceAgencyLLCMember" name="FortmanInsuranceAgencyLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_SouthwesternMontanaInsuranceCenterIncMember" name="SouthwesternMontanaInsuranceCenterIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_AltruisBenefitsConsultantsIncMember" name="AltruisBenefitsConsultantsIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_JPKushAndAssociatesIncMember" name="JPKushAndAssociatesIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_ChargebackReserveCurrent" name="ChargebackReserveCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_ShortTermFinancingAgreements" name="ShortTermFinancingAgreements" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_WarrantCommitmentCurrent" name="WarrantCommitmentCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_WarrantLiabilityNonCurrent" name="WarrantLiabilityNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_CommissionIncome" name="CommissionIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_CommissionExpense" name="CommissionExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_RecognitionAndChangeInFairValueOfWarrantLiability" name="RecognitionAndChangeInFairValueOfWarrantLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_StockIssuedDuringPeriodValueWarrantsExercised" name="StockIssuedDuringPeriodValueWarrantsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_StockIssuedDuringPeriodSharesWarrantsExercised" name="StockIssuedDuringPeriodSharesWarrantsExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_StockGrantedDuringPeriodSharesSharebasedCompensationGross" name="StockGrantedDuringPeriodSharesSharebasedCompensationGross" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_StockIssuedDuringPeriodValueWarrantsIntoCommonStock" name="StockIssuedDuringPeriodValueWarrantsIntoCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_StockIssuedDuringPeriodSharesWarrantsIntoCommonStock" name="StockIssuedDuringPeriodSharesWarrantsIntoCommonStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_StockIssuedDuringPeriodValueOverAllotmentShares" name="StockIssuedDuringPeriodValueOverAllotmentShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_StockIssuedDuringPeriodSharesOverAllotmentShares" name="StockIssuedDuringPeriodSharesOverAllotmentShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_SharesIssuedDuringPeriodValueToConversionOfDebt" name="SharesIssuedDuringPeriodValueToConversionOfDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_SharesIssuedDuringPeriodSharesToConversionOfDebt" name="SharesIssuedDuringPeriodSharesToConversionOfDebt" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_StockIssuedDuringPeriodValueInitialPublicOffering" name="StockIssuedDuringPeriodValueInitialPublicOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_StockIssuedDuringPeriodSharesInitialPublicOffering" name="StockIssuedDuringPeriodSharesInitialPublicOffering" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_NoncashLeaseExpense" name="NoncashLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_EarnoutFairValueAndWriteoffAdjustments" name="EarnoutFairValueAndWriteoffAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_ProceedsFromLoanForBusinessAcquisition" name="ProceedsFromLoanForBusinessAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_PaymentsOnEarnoutLiabilities" name="PaymentsOnEarnoutLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_RepaymentsOnShorttermFinancing" name="RepaymentsOnShorttermFinancing" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants" name="NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_IssuanceOfSeriesDWarrants" name="IssuanceOfSeriesDWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_IssuanceOfPlacementAgentWarrants" name="IssuanceOfPlacementAgentWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_PrepaidInsuranceAcquiredThroughShorttermFinancing" name="PrepaidInsuranceAcquiredThroughShorttermFinancing" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_CommonStockIssuedPursuantToAcquisition" name="CommonStockIssuedPursuantToAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_IssuanceOfCommonStockPursuantToPurchaseOfSoftware" name="IssuanceOfCommonStockPursuantToPurchaseOfSoftware" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_AcquisitionOfBusinessDeferredPurchasePrice" name="AcquisitionOfBusinessDeferredPurchasePrice" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_LeaseAssetsAcquiredInExchangeForLeaseLiabilities" name="LeaseAssetsAcquiredInExchangeForLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract" name="DisclosureLongtermDebtAndShorttermFinancingsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_LongTermDebtAndShortTermFinancingsTextBlock" name="LongTermDebtAndShortTermFinancingsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_DisclosureWarrantLiabilitiesAbstract" name="DisclosureWarrantLiabilitiesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_WarrantLiabilitiesTextBlock" name="WarrantLiabilitiesTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_DisclosureLeasesAbstract" name="DisclosureLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_LiquidityPolicyTextBlock" name="LiquidityPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_PriorPeriodAdjustmentPolicyTextBlock" name="PriorPeriodAdjustmentPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_ScheduleOfReconcilesWarrantCommitmentTableTextBlock" name="ScheduleOfReconcilesWarrantCommitmentTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_EarnOutLiabilitiesTableTextBlock" name="EarnOutLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_WarrantCommitment" name="WarrantCommitment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_InitialRecognitionOfWarrantCommitment" name="InitialRecognitionOfWarrantCommitment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_WarrantCommitmentUnrealizedGainLoss" name="WarrantCommitmentUnrealizedGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_WarrantsExercisedOrTransferred" name="WarrantsExercisedOrTransferred" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_ValuationTechnique" name="ValuationTechnique" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_SignificantUnobservableInput" name="SignificantUnobservableInput" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_RiskFreeRate" name="RiskFreeRate" nillable="true" xbrli:periodType="instant" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_DiscountingConvention" name="DiscountingConvention" nillable="true" xbrli:periodType="instant" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_NumberOfLterations" name="NumberOfLterations" nillable="true" xbrli:periodType="instant" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_AcquisitionsAndSettlements" name="AcquisitionsAndSettlements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_EarnoutLiabilityCurrent" name="EarnoutLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_EarnoutLiabilityNoncurrent" name="EarnoutLiabilityNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_WorkingCapitalDeficiency" name="WorkingCapitalDeficiency" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_PaymentsToUndiscountedRemainingEarnOut" name="PaymentsToUndiscountedRemainingEarnOut" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_FinitelivedIntangibleAssetUsefulLives" name="FinitelivedIntangibleAssetUsefulLives" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_SharesIssuedUponTerminationOfEmployee" name="SharesIssuedUponTerminationOfEmployee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_WorkingCapital" name="WorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants" name="AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_NonOperatingUnrealizedGains" name="NonOperatingUnrealizedGains" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_DeemedDividend" name="DeemedDividend" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_EffectOfSeriesBWarrantLiability" name="EffectOfSeriesBWarrantLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_AntidilutiveSharesIssuedAndOutstanding" name="AntidilutiveSharesIssuedAndOutstanding" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_WarrantSharesIssued" name="WarrantSharesIssued" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_WarrantSharesOutstanding" name="WarrantSharesOutstanding" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_ChangesDueToAcquisitions" name="ChangesDueToAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_ChangesDueToPayments" name="ChangesDueToPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_ChangesDueToFairValueAdjustments" name="ChangesDueToFairValueAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_ChangesDueToBusinessCombinations" name="ChangesDueToBusinessCombinations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_ChangesDueToWriteoffs" name="ChangesDueToWriteoffs" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="RELI_TechnologyMember" name="TechnologyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>reli-20220630_cal.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/Cover" xlink:href="reli-20220630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/BalanceSheets" xlink:href="reli-20220630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/BalanceSheetsParenthetical" xlink:href="reli-20220630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StatementsOfOperations" xlink:href="reli-20220630.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit" xlink:href="reli-20220630.xsd#StatementsOfStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficitParenthetical" xlink:href="reli-20220630.xsd#StatementsOfStockholdersEquityDeficitParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StatementsOfCashFlows" xlink:href="reli-20220630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPolicies" xlink:href="reli-20220630.xsd#SummaryOfBusinessAndSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinations" xlink:href="reli-20220630.xsd#StrategicInvestmentsAndBusinessCombinations" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssets" xlink:href="reli-20220630.xsd#GoodwillAndOtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancings" xlink:href="reli-20220630.xsd#Long-termDebtAndShort-termFinancings" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/WarrantLiabilities" xlink:href="reli-20220630.xsd#WarrantLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/Equity" xlink:href="reli-20220630.xsd#Equity" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/EarningsLossPerShare" xlink:href="reli-20220630.xsd#EarningsLossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/Leases" xlink:href="reli-20220630.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/CommitmentsAndContingencies" xlink:href="reli-20220630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesPolicies" xlink:href="reli-20220630.xsd#SummaryOfBusinessAndSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables" xlink:href="reli-20220630.xsd#SummaryOfBusinessAndSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsTables" xlink:href="reli-20220630.xsd#StrategicInvestmentsAndBusinessCombinationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:href="reli-20220630.xsd#GoodwillAndOtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsTables" xlink:href="reli-20220630.xsd#Long-termDebtAndShort-termFinancingsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/EarningsLossPerShareTables" xlink:href="reli-20220630.xsd#EarningsLossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/LeasesTables" xlink:href="reli-20220630.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/CommitmentsAndContingenciesTables" xlink:href="reli-20220630.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfRestrictedCashInStatementOfCashFlowDetails" xlink:href="reli-20220630.xsd#ScheduleOfRestrictedCashInStatementOfCashFlowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfFairValueOfWarrantCommitmentDetails" xlink:href="reli-20220630.xsd#ScheduleOfFairValueOfWarrantCommitmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfReconcilesWarrantCommitmentDetails" xlink:href="reli-20220630.xsd#ScheduleOfReconcilesWarrantCommitmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfFairValueMeasurementsDetails" xlink:href="reli-20220630.xsd#ScheduleOfFairValueMeasurementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails" xlink:href="reli-20220630.xsd#ScheduleOfEarnOutLiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails" xlink:href="reli-20220630.xsd#ScheduleOfGainOrLossesRecognizedFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails" xlink:href="reli-20220630.xsd#ScheduleOfDisaggregationRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails" xlink:href="reli-20220630.xsd#ScheduleOfConcentrationsOfRevenuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/SummarizesChangesToPreviouslyIssuedFinancialInformationDetails" xlink:href="reli-20220630.xsd#SummarizesChangesToPreviouslyIssuedFinancialInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative" xlink:href="reli-20220630.xsd#SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails" xlink:href="reli-20220630.xsd#ScheduleOfAllocationOfPurchasePriceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfProFormaInformationRelatedToAcquisitionDetails" xlink:href="reli-20220630.xsd#ScheduleOfProFormaInformationRelatedToAcquisitionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative" xlink:href="reli-20220630.xsd#StrategicInvestmentsAndBusinessCombinationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfImpairmentOfGoodwillDetails" xlink:href="reli-20220630.xsd#ScheduleOfImpairmentOfGoodwillDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails" xlink:href="reli-20220630.xsd#ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails" xlink:href="reli-20220630.xsd#ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsDetailsNarrative" xlink:href="reli-20220630.xsd#GoodwillAndOtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical" xlink:href="reli-20220630.xsd#ScheduleOfLongTermDebtDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails" xlink:href="reli-20220630.xsd#ScheduleOfLongTermDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails" xlink:href="reli-20220630.xsd#ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsDetailsNarrative" xlink:href="reli-20220630.xsd#Long-termDebtAndShort-termFinancingsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative" xlink:href="reli-20220630.xsd#WarrantLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/EquityDetailsNarrative" xlink:href="reli-20220630.xsd#EquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails" xlink:href="reli-20220630.xsd#ScheduleOfCalculationsOfBasicAndDilutedEpsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative" xlink:href="reli-20220630.xsd#EarningsLossPerShareDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails" xlink:href="reli-20220630.xsd#ScheduleOfFutureMinimumLeasePaymentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/LeasesDetailsNarrative" xlink:href="reli-20220630.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails" xlink:href="reli-20220630.xsd#ScheduleOfEarn-outLiabilityDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaapRestrictedCashCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapRestrictedCashCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChargebackReserveCurrent" xlink:label="loc_RELIChargebackReserveCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_RELIChargebackReserveCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:label="loc_us-gaapAccountsPayableOtherCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableOtherCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ShortTermFinancingAgreements" xlink:label="loc_RELIShortTermFinancingAgreements" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_RELIShortTermFinancingAgreements" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantCommitmentCurrent" xlink:label="loc_RELIWarrantCommitmentCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_RELIWarrantCommitmentCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDueToRelatedPartiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantLiabilityNonCurrent" xlink:label="loc_RELIWarrantLiabilityNonCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_RELIWarrantLiabilityNonCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteSubscriptionsReceivable" xlink:label="loc_us-gaapStockholdersEquityNoteSubscriptionsReceivable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityNoteSubscriptionsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CommissionIncome" xlink:label="loc_RELICommissionIncome" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_RELICommissionIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CommissionExpense" xlink:label="loc_RELICommissionExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_RELICommissionExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaapSalariesAndWages" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSalariesAndWages" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="loc_us-gaapOtherNonoperatingExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_RecognitionAndChangeInFairValueOfWarrantLiability" xlink:label="loc_RELIRecognitionAndChangeInFairValueOfWarrantLiability" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_RELIRecognitionAndChangeInFairValueOfWarrantLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Stockholders&apos; Equity (Deficit) (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficitParenthetical" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Stockholders&apos; Equity (Deficit) (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_NoncashLeaseExpense" xlink:label="loc_RELINoncashLeaseExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_RELINoncashLeaseExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EarnoutFairValueAndWriteoffAdjustments" xlink:label="loc_RELIEarnoutFairValueAndWriteoffAdjustments" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_RELIEarnoutFairValueAndWriteoffAdjustments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_RecognitionAndChangeInFairValueOfWarrantLiability" xlink:label="loc_RELIRecognitionAndChangeInFairValueOfWarrantLiability" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_RELIRecognitionAndChangeInFairValueOfWarrantLiability" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivableRelatedParties" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivableRelatedParties" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayable" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInRestructuringReserve" xlink:label="loc_us-gaapIncreaseDecreaseInRestructuringReserve" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInRestructuringReserve" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherDebt" xlink:label="loc_us-gaapRepaymentsOfOtherDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfOtherDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ProceedsFromLoanForBusinessAcquisition" xlink:label="loc_RELIProceedsFromLoanForBusinessAcquisition" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_RELIProceedsFromLoanForBusinessAcquisition" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PaymentsOnEarnoutLiabilities" xlink:label="loc_RELIPaymentsOnEarnoutLiabilities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_RELIPaymentsOnEarnoutLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_RepaymentsOnShorttermFinancing" xlink:label="loc_RELIRepaymentsOnShorttermFinancing" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_RELIRepaymentsOnShorttermFinancing" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants" xlink:label="loc_RELINetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_RELINetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinations" xlink:title="00000009 - Disclosure - STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssets" xlink:title="00000010 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancings" xlink:title="00000011 - Disclosure - LONG-TERM DEBT AND SHORT-TERM FINANCINGS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/WarrantLiabilities" xlink:title="00000012 - Disclosure - WARRANT LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/Equity" xlink:title="00000013 - Disclosure - EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/EarningsLossPerShare" xlink:title="00000014 - Disclosure - EARNINGS (LOSS) PER SHARE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/Leases" xlink:title="00000015 - Disclosure - LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/CommitmentsAndContingencies" xlink:title="00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesPolicies" xlink:title="00000017 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables" xlink:title="00000018 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsTables" xlink:title="00000019 - Disclosure - STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:title="00000020 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsTables" xlink:title="00000021 - Disclosure - LONG-TERM DEBT AND SHORT-TERM FINANCINGS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/EarningsLossPerShareTables" xlink:title="00000022 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/LeasesTables" xlink:title="00000023 - Disclosure - LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/CommitmentsAndContingenciesTables" xlink:title="00000024 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfRestrictedCashInStatementOfCashFlowDetails" xlink:title="00000025 - Disclosure - SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaapRestrictedCashCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="loc_us-gaapRestrictedCashCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfFairValueOfWarrantCommitmentDetails" xlink:title="00000026 - Disclosure - SCHEDULE OF FAIR VALUE OF WARRANT COMMITMENT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfReconcilesWarrantCommitmentDetails" xlink:title="00000027 - Disclosure - SCHEDULE OF RECONCILES WARRANT COMMITMENT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfFairValueMeasurementsDetails" xlink:title="00000028 - Disclosure - SCHEDULE OF FAIR VALUE MEASUREMENTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails" xlink:title="00000029 - Disclosure - SCHEDULE OF EARN OUT LIABILITY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails" xlink:title="00000030 - Disclosure - SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails" xlink:title="00000031 - Disclosure - SCHEDULE OF DISAGGREGATION REVENUE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails" xlink:title="00000032 - Disclosure - SCHEDULE OF CONCENTRATIONS OF REVENUES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/SummarizesChangesToPreviouslyIssuedFinancialInformationDetails" xlink:title="00000033 - Disclosure - SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000034 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails" xlink:title="00000035 - Disclosure - SCHEDULE OF ALLOCATION OF PURCHASE PRICE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfProFormaInformationRelatedToAcquisitionDetails" xlink:title="00000036 - Disclosure - SCHEDULE OF PRO FORMA INFORMATION RELATED TO ACQUISITION (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative" xlink:title="00000037 - Disclosure - STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfImpairmentOfGoodwillDetails" xlink:title="00000038 - Disclosure - SCHEDULE OF IMPAIRMENT OF GOODWILL (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails" xlink:title="00000039 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails" xlink:title="00000040 - Disclosure - SCHEDULE OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsDetailsNarrative" xlink:title="00000041 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical" xlink:title="00000042 - Disclosure - SCHEDULE OF LONG TERM DEBT (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails" xlink:title="00000043 - Disclosure - SCHEDULE OF LONG TERM DEBT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails" xlink:title="00000044 - Disclosure - SCHEDULE OF CUMULATIVE MATURITIES OF LONG-TERM LOANS AND CREDIT FACILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDebtInstrumentCarryingAmount" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDebtInstrumentCarryingAmount" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDebtInstrumentCarryingAmount" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDebtInstrumentCarryingAmount" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDebtInstrumentCarryingAmount" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDebtInstrumentCarryingAmount" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsDetailsNarrative" xlink:title="00000045 - Disclosure - LONG-TERM DEBT AND SHORT-TERM FINANCINGS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative" xlink:title="00000046 - Disclosure - WARRANT LIABILITIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/EquityDetailsNarrative" xlink:title="00000047 - Disclosure - EQUITY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails" xlink:title="00000048 - Disclosure - SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative" xlink:title="00000049 - Disclosure - EARNINGS (LOSS) PER SHARE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails" xlink:title="00000050 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/LeasesDetailsNarrative" xlink:title="00000051 - Disclosure - LEASES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails" xlink:title="00000052 - Disclosure - SCHEDULE OF EARN-OUT LIABILITY (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>reli-20220630_def.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/Cover" xlink:href="reli-20220630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/BalanceSheets" xlink:href="reli-20220630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/BalanceSheetsParenthetical" xlink:href="reli-20220630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StatementsOfOperations" xlink:href="reli-20220630.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit" xlink:href="reli-20220630.xsd#StatementsOfStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficitParenthetical" xlink:href="reli-20220630.xsd#StatementsOfStockholdersEquityDeficitParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StatementsOfCashFlows" xlink:href="reli-20220630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPolicies" xlink:href="reli-20220630.xsd#SummaryOfBusinessAndSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinations" xlink:href="reli-20220630.xsd#StrategicInvestmentsAndBusinessCombinations" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssets" xlink:href="reli-20220630.xsd#GoodwillAndOtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancings" xlink:href="reli-20220630.xsd#Long-termDebtAndShort-termFinancings" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/WarrantLiabilities" xlink:href="reli-20220630.xsd#WarrantLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/Equity" xlink:href="reli-20220630.xsd#Equity" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/EarningsLossPerShare" xlink:href="reli-20220630.xsd#EarningsLossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/Leases" xlink:href="reli-20220630.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/CommitmentsAndContingencies" xlink:href="reli-20220630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesPolicies" xlink:href="reli-20220630.xsd#SummaryOfBusinessAndSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables" xlink:href="reli-20220630.xsd#SummaryOfBusinessAndSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsTables" xlink:href="reli-20220630.xsd#StrategicInvestmentsAndBusinessCombinationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:href="reli-20220630.xsd#GoodwillAndOtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsTables" xlink:href="reli-20220630.xsd#Long-termDebtAndShort-termFinancingsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/EarningsLossPerShareTables" xlink:href="reli-20220630.xsd#EarningsLossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/LeasesTables" xlink:href="reli-20220630.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/CommitmentsAndContingenciesTables" xlink:href="reli-20220630.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfRestrictedCashInStatementOfCashFlowDetails" xlink:href="reli-20220630.xsd#ScheduleOfRestrictedCashInStatementOfCashFlowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfFairValueOfWarrantCommitmentDetails" xlink:href="reli-20220630.xsd#ScheduleOfFairValueOfWarrantCommitmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfReconcilesWarrantCommitmentDetails" xlink:href="reli-20220630.xsd#ScheduleOfReconcilesWarrantCommitmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfFairValueMeasurementsDetails" xlink:href="reli-20220630.xsd#ScheduleOfFairValueMeasurementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails" xlink:href="reli-20220630.xsd#ScheduleOfEarnOutLiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails" xlink:href="reli-20220630.xsd#ScheduleOfGainOrLossesRecognizedFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails" xlink:href="reli-20220630.xsd#ScheduleOfDisaggregationRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails" xlink:href="reli-20220630.xsd#ScheduleOfConcentrationsOfRevenuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/SummarizesChangesToPreviouslyIssuedFinancialInformationDetails" xlink:href="reli-20220630.xsd#SummarizesChangesToPreviouslyIssuedFinancialInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative" xlink:href="reli-20220630.xsd#SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails" xlink:href="reli-20220630.xsd#ScheduleOfAllocationOfPurchasePriceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfProFormaInformationRelatedToAcquisitionDetails" xlink:href="reli-20220630.xsd#ScheduleOfProFormaInformationRelatedToAcquisitionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative" xlink:href="reli-20220630.xsd#StrategicInvestmentsAndBusinessCombinationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfImpairmentOfGoodwillDetails" xlink:href="reli-20220630.xsd#ScheduleOfImpairmentOfGoodwillDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails" xlink:href="reli-20220630.xsd#ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails" xlink:href="reli-20220630.xsd#ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsDetailsNarrative" xlink:href="reli-20220630.xsd#GoodwillAndOtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical" xlink:href="reli-20220630.xsd#ScheduleOfLongTermDebtDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails" xlink:href="reli-20220630.xsd#ScheduleOfLongTermDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails" xlink:href="reli-20220630.xsd#ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsDetailsNarrative" xlink:href="reli-20220630.xsd#Long-termDebtAndShort-termFinancingsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative" xlink:href="reli-20220630.xsd#WarrantLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/EquityDetailsNarrative" xlink:href="reli-20220630.xsd#EquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails" xlink:href="reli-20220630.xsd#ScheduleOfCalculationsOfBasicAndDilutedEpsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative" xlink:href="reli-20220630.xsd#EarningsLossPerShareDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails" xlink:href="reli-20220630.xsd#ScheduleOfFutureMinimumLeasePaymentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/LeasesDetailsNarrative" xlink:href="reli-20220630.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails" xlink:href="reli-20220630.xsd#ScheduleOfEarn-outLiabilityDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesAWarrantsMember" xlink:label="loc_RELISeriesAWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_RELISeriesAWarrantsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_50" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_50" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_50" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_50" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_50" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_50" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_50" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_50" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_50" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_50" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_50" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_50" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_50" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_50" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_50" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_50" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_50" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_50" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_50" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_50" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_50" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_50" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_50" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_50" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_50" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_50" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_50" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_50" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_50" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_50" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_50" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_50" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_50" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_50" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_50" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_50" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_50" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" xlink:type="arc" order="57" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Stockholders&apos; Equity (Deficit) (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CommonStockIssuableMember" xlink:label="loc_RELICommonStockIssuableMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_RELICommonStockIssuableMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SubscriptionReceivableMember" xlink:label="loc_RELISubscriptionReceivableMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_RELISubscriptionReceivableMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="loc_RELIStockIssuedDuringPeriodValueWarrantsExercised_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIStockIssuedDuringPeriodValueWarrantsExercised_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_RELIStockIssuedDuringPeriodSharesWarrantsExercised_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIStockIssuedDuringPeriodSharesWarrantsExercised_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits_80" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationGross_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationGross_80" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockGrantedDuringPeriodSharesSharebasedCompensationGross" xlink:label="loc_RELIStockGrantedDuringPeriodSharesSharebasedCompensationGross_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIStockGrantedDuringPeriodSharesSharebasedCompensationGross_80" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_80" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodValueWarrantsIntoCommonStock" xlink:label="loc_RELIStockIssuedDuringPeriodValueWarrantsIntoCommonStock_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIStockIssuedDuringPeriodValueWarrantsIntoCommonStock_80" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodSharesWarrantsIntoCommonStock" xlink:label="loc_RELIStockIssuedDuringPeriodSharesWarrantsIntoCommonStock_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIStockIssuedDuringPeriodSharesWarrantsIntoCommonStock_80" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_80" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_80" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodValueOverAllotmentShares" xlink:label="loc_RELIStockIssuedDuringPeriodValueOverAllotmentShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIStockIssuedDuringPeriodValueOverAllotmentShares_80" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodSharesOverAllotmentShares" xlink:label="loc_RELIStockIssuedDuringPeriodSharesOverAllotmentShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIStockIssuedDuringPeriodSharesOverAllotmentShares_80" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_80" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_80" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_80" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SharesIssuedDuringPeriodValueToConversionOfDebt" xlink:label="loc_RELISharesIssuedDuringPeriodValueToConversionOfDebt_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELISharesIssuedDuringPeriodValueToConversionOfDebt_80" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SharesIssuedDuringPeriodSharesToConversionOfDebt" xlink:label="loc_RELISharesIssuedDuringPeriodSharesToConversionOfDebt_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELISharesIssuedDuringPeriodSharesToConversionOfDebt_80" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodValueInitialPublicOffering" xlink:label="loc_RELIStockIssuedDuringPeriodValueInitialPublicOffering_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIStockIssuedDuringPeriodValueInitialPublicOffering_80" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:label="loc_RELIStockIssuedDuringPeriodSharesInitialPublicOffering_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIStockIssuedDuringPeriodSharesInitialPublicOffering_80" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets_80" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets_80" xlink:type="arc" order="29" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficitParenthetical" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Stockholders&apos; Equity (Deficit) (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinations" xlink:title="00000009 - Disclosure - STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssets" xlink:title="00000010 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancings" xlink:title="00000011 - Disclosure - LONG-TERM DEBT AND SHORT-TERM FINANCINGS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/WarrantLiabilities" xlink:title="00000012 - Disclosure - WARRANT LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/Equity" xlink:title="00000013 - Disclosure - EQUITY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/EarningsLossPerShare" xlink:title="00000014 - Disclosure - EARNINGS (LOSS) PER SHARE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/Leases" xlink:title="00000015 - Disclosure - LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/CommitmentsAndContingencies" xlink:title="00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesPolicies" xlink:title="00000017 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables" xlink:title="00000018 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:label="loc_us-gaapScheduleOfRestrictedCashAndCashEquivalentsTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfRestrictedCashAndCashEquivalentsTextBlock_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ScheduleOfReconcilesWarrantCommitmentTableTextBlock" xlink:label="loc_RELIScheduleOfReconcilesWarrantCommitmentTableTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_RELIScheduleOfReconcilesWarrantCommitmentTableTextBlock_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:label="loc_us-gaapFairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapFairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="loc_us-gaapSchedulesOfConcentrationOfRiskByRiskFactorTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapSchedulesOfConcentrationOfRiskByRiskFactorTextBlock_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:label="loc_us-gaapScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_30" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsTables" xlink:title="00000019 - Disclosure - STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MedigapHealthcareInsuranceCompanyMember" xlink:label="loc_RELIMedigapHealthcareInsuranceCompanyMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIMedigapHealthcareInsuranceCompanyMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraMember" xlink:label="loc_RELIBarraMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIBarraMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:title="00000020 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsTables" xlink:title="00000021 - Disclosure - LONG-TERM DEBT AND SHORT-TERM FINANCINGS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/EarningsLossPerShareTables" xlink:title="00000022 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/LeasesTables" xlink:title="00000023 - Disclosure - LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/CommitmentsAndContingenciesTables" xlink:title="00000024 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfRestrictedCashInStatementOfCashFlowDetails" xlink:title="00000025 - Disclosure - SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfFairValueOfWarrantCommitmentDetails" xlink:title="00000026 - Disclosure - SCHEDULE OF FAIR VALUE OF WARRANT COMMITMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaapMeasurementInputSharePriceMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputSharePriceMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_110" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfReconcilesWarrantCommitmentDetails" xlink:title="00000027 - Disclosure - SCHEDULE OF RECONCILES WARRANT COMMITMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="loc_us-gaapOffsettingAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsTable" xlink:label="loc_us-gaapOffsettingAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapOffsettingAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesBWarrantCommitmentMember" xlink:label="loc_RELISeriesBWarrantCommitmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_RELISeriesBWarrantCommitmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesBWarrantLiabilityMember" xlink:label="loc_RELISeriesBWarrantLiabilityMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_RELISeriesBWarrantLiabilityMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PlacementAgentWarrantsMember" xlink:label="loc_RELIPlacementAgentWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_RELIPlacementAgentWarrantsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantCommitment" xlink:label="loc_RELIWarrantCommitment_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_RELIWarrantCommitment_250" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_InitialRecognitionOfWarrantCommitment" xlink:label="loc_RELIInitialRecognitionOfWarrantCommitment_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_RELIInitialRecognitionOfWarrantCommitment_250" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantCommitmentUnrealizedGainLoss" xlink:label="loc_RELIWarrantCommitmentUnrealizedGainLoss_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_RELIWarrantCommitmentUnrealizedGainLoss_250" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantsExercisedOrTransferred" xlink:label="loc_RELIWarrantsExercisedOrTransferred_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_RELIWarrantsExercisedOrTransferred_250" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfFairValueMeasurementsDetails" xlink:title="00000028 - Disclosure - SCHEDULE OF FAIR VALUE MEASUREMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ValuationTechnique" xlink:label="loc_RELIValuationTechnique_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_RELIValuationTechnique_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SignificantUnobservableInput" xlink:label="loc_RELISignificantUnobservableInput_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_RELISignificantUnobservableInput_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails" xlink:title="00000029 - Disclosure - SCHEDULE OF EARN OUT LIABILITY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MeasurementInputRiskPremiumMember" xlink:label="loc_RELIMeasurementInputRiskPremiumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_RELIMeasurementInputRiskPremiumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputCreditSpreadMember" xlink:label="loc_us-gaapMeasurementInputCreditSpreadMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputCreditSpreadMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MeasurementInputPaymentDelayMember" xlink:label="loc_RELIMeasurementInputPaymentDelayMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_RELIMeasurementInputPaymentDelayMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="loc_us-gaapDerivativeLiabilityMeasurementInput_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapDerivativeLiabilityMeasurementInput_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_RiskFreeRate" xlink:label="loc_RELIRiskFreeRate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_RELIRiskFreeRate_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DiscountingConvention" xlink:label="loc_RELIDiscountingConvention_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_RELIDiscountingConvention_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_NumberOfLterations" xlink:label="loc_RELINumberOfLterations_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_RELINumberOfLterations_60" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails" xlink:title="00000030 - Disclosure - SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_JPKushAcquisitionMember" xlink:label="loc_RELIJPKushAcquisitionMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIJPKushAcquisitionMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraAcquisitionMember" xlink:label="loc_RELIBarraAcquisitionMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIBarraAcquisitionMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CCSWriteoffMember" xlink:label="loc_RELICCSWriteoffMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELICCSWriteoffMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AltruisPartialSettlementMember" xlink:label="loc_RELIAltruisPartialSettlementMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIAltruisPartialSettlementMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MontanaFinalSettlementMember" xlink:label="loc_RELIMontanaFinalSettlementMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIMontanaFinalSettlementMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiability_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiability_180" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AcquisitionsAndSettlements" xlink:label="loc_RELIAcquisitionsAndSettlements_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_RELIAcquisitionsAndSettlements_180" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease" xlink:label="loc_us-gaapFairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapFairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_180" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EarnoutLiabilityCurrent" xlink:label="loc_RELIEarnoutLiabilityCurrent_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_RELIEarnoutLiabilityCurrent_180" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EarnoutLiabilityNoncurrent" xlink:label="loc_RELIEarnoutLiabilityNoncurrent_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_RELIEarnoutLiabilityNoncurrent_180" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails" xlink:title="00000031 - Disclosure - SCHEDULE OF DISAGGREGATION REVENUE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MedicalLifeMember" xlink:label="loc_RELIMedicalLifeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_RELIMedicalLifeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PropertyAndCasualtyMember" xlink:label="loc_RELIPropertyAndCasualtyMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_RELIPropertyAndCasualtyMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" xlink:to="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" xlink:to="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_RegularMember" xlink:label="loc_RELIRegularMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" xlink:to="loc_RELIRegularMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PropertyAndCasualtyMember" xlink:label="loc_RELIPropertyAndCasualtyMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" xlink:to="loc_RELIPropertyAndCasualtyMember_280" xlink:type="arc" order="282" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtConsolidatedEntitiesAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EmployeeBenefitsSolutionsLLCMember" xlink:label="loc_RELIEmployeeBenefitsSolutionsLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_RELIEmployeeBenefitsSolutionsLLCMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_USBenefitsAllianceLLCMember" xlink:label="loc_RELIUSBenefitsAllianceLLCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_RELIUSBenefitsAllianceLLCMember_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CommercialCoverageSolutionsLLCMember" xlink:label="loc_RELICommercialCoverageSolutionsLLCMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_RELICommercialCoverageSolutionsLLCMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SouthwesternMontanaFinancialCenterIncMember" xlink:label="loc_RELISouthwesternMontanaFinancialCenterIncMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_RELISouthwesternMontanaFinancialCenterIncMember_90" xlink:type="arc" order="93" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_FortmanInsuranceServicesLLCMember" xlink:label="loc_RELIFortmanInsuranceServicesLLCMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_RELIFortmanInsuranceServicesLLCMember_120" xlink:type="arc" order="123" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AltruisBenefitsConsultingIncMember" xlink:label="loc_RELIAltruisBenefitsConsultingIncMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_RELIAltruisBenefitsConsultingIncMember_150" xlink:type="arc" order="153" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_KushMember" xlink:label="loc_RELIKushMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_RELIKushMember_180" xlink:type="arc" order="183" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MedigapMember" xlink:label="loc_RELIMedigapMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_RELIMedigapMember_210" xlink:type="arc" order="213" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraMember" xlink:label="loc_RELIBarraMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_RELIBarraMember_240" xlink:type="arc" order="243" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_1090" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails" xlink:title="00000032 - Disclosure - SCHEDULE OF CONCENTRATIONS OF REVENUES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_LTCGlobalMember" xlink:label="loc_RELILTCGlobalMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RELILTCGlobalMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PriorityHealthMember" xlink:label="loc_RELIPriorityHealthMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RELIPriorityHealthMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BlueCrossBlueShieldMember" xlink:label="loc_RELIBlueCrossBlueShieldMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_RELIBlueCrossBlueShieldMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_130" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/SummarizesChangesToPreviouslyIssuedFinancialInformationDetails" xlink:title="00000033 - Disclosure - SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember" xlink:label="loc_srtRestatementAdjustmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRestatementAdjustmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="loc_us-gaapCommonStockSharesSubscriptions_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesSubscriptions_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000034 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CustomerMember" xlink:label="loc_RELICustomerMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_RELICustomerMember_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalents_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalents_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAssetsCurrent_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapLiabilitiesCurrent_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WorkingCapitalDeficiency" xlink:label="loc_RELIWorkingCapitalDeficiency_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_RELIWorkingCapitalDeficiency_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapStockholdersEquity_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_RecognitionAndChangeInFairValueOfWarrantLiability" xlink:label="loc_RELIRecognitionAndChangeInFairValueOfWarrantLiability_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_RELIRecognitionAndChangeInFairValueOfWarrantLiability_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapNetIncomeLoss_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants" xlink:label="loc_RELINetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_RELINetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PaymentsToUndiscountedRemainingEarnOut" xlink:label="loc_RELIPaymentsToUndiscountedRemainingEarnOut_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_RELIPaymentsToUndiscountedRemainingEarnOut_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_50" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails" xlink:title="00000035 - Disclosure - SCHEDULE OF ALLOCATION OF PURCHASE PRICE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MedigapHealthcareInsuranceCompanyMember" xlink:label="loc_RELIMedigapHealthcareInsuranceCompanyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIMedigapHealthcareInsuranceCompanyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraMember" xlink:label="loc_RELIBarraMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIBarraMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_RightOfUseAssetMember" xlink:label="loc_RELIRightOfUseAssetMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIRightOfUseAssetMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaapTradeNamesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTradeNamesMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:label="loc_us-gaapTechnologyBasedIntangibleAssetsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTechnologyBasedIntangibleAssetsMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BackLogMember" xlink:label="loc_RELIBackLogMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIBackLogMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChargebackReserveMember" xlink:label="loc_RELIChargebackReserveMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIChargebackReserveMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_LeaseLiabilityMember" xlink:label="loc_RELILeaseLiabilityMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELILeaseLiabilityMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillMember" xlink:label="loc_us-gaapGoodwillMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapGoodwillMember_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AcquiredAccountsReceivableMember" xlink:label="loc_RELIAcquiredAccountsReceivableMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIAcquiredAccountsReceivableMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AgencyRelationshipsMember" xlink:label="loc_RELIAgencyRelationshipsMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIAgencyRelationshipsMember_240" xlink:type="arc" order="242" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DevelopedTechnologyMember" xlink:label="loc_RELIDevelopedTechnologyMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIDevelopedTechnologyMember_260" xlink:type="arc" order="262" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_330" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_330" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_FinitelivedIntangibleAssetUsefulLives" xlink:label="loc_RELIFinitelivedIntangibleAssetUsefulLives_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_RELIFinitelivedIntangibleAssetUsefulLives_330" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfProFormaInformationRelatedToAcquisitionDetails" xlink:title="00000036 - Disclosure - SCHEDULE OF PRO FORMA INFORMATION RELATED TO ACQUISITION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MedigapHealthcareInsuranceCompanyMember" xlink:label="loc_RELIMedigapHealthcareInsuranceCompanyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIMedigapHealthcareInsuranceCompanyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraMember" xlink:label="loc_RELIBarraMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIBarraMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:label="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareBasic_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareBasic_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:label="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareDiluted_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareDiluted_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative" xlink:title="00000037 - Disclosure - STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MedigapHealthcareInsuranceCompanyMember" xlink:label="loc_RELIMedigapHealthcareInsuranceCompanyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIMedigapHealthcareInsuranceCompanyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraMember" xlink:label="loc_RELIBarraMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIBarraMember_130" xlink:type="arc" order="133" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MeasurementInputRoyaltyRateMember" xlink:label="loc_RELIMeasurementInputRoyaltyRateMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_RELIMeasurementInputRoyaltyRateMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaapMeasurementInputDiscountRateMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputDiscountRateMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MeasurementInputObsolescenceRateMember" xlink:label="loc_RELIMeasurementInputObsolescenceRateMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_RELIMeasurementInputObsolescenceRateMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaapTradeNamesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTradeNamesMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:label="loc_us-gaapTechnologyBasedIntangibleAssetsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTechnologyBasedIntangibleAssetsMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BackLogMember" xlink:label="loc_RELIBackLogMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIBackLogMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DevelopedTechnologyMember" xlink:label="loc_RELIDevelopedTechnologyMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIDevelopedTechnologyMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_APAMember" xlink:label="loc_RELIAPAMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RELIAPAMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaapAssetAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapAssetAcquisitionAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraAndAssociatesLLCMember" xlink:label="loc_RELIBarraAndAssociatesLLCMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_RELIBarraAndAssociatesLLCMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PaidAtClosingMember" xlink:label="loc_RELIPaidAtClosingMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_RELIPaidAtClosingMember_90" xlink:type="arc" order="93" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PayableInSixMonthsMember" xlink:label="loc_RELIPayableInSixMonthsMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_RELIPayableInSixMonthsMember_100" xlink:type="arc" order="103" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PayableOverTwoYearsMember" xlink:label="loc_RELIPayableOverTwoYearsMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_RELIPayableOverTwoYearsMember_110" xlink:type="arc" order="113" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:label="loc_us-gaapBusinessCombinationBargainPurchaseGainRecognizedAmount_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationBargainPurchaseGainRecognizedAmount_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesGross_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesGross_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_190" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityMeasurementInput_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityMeasurementInput_190" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapGoodwill_190" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionCosts" xlink:label="loc_us-gaapAcquisitionCosts_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapAcquisitionCosts_190" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" xlink:label="loc_us-gaapBusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_190" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SharesIssuedUponTerminationOfEmployee" xlink:label="loc_RELISharesIssuedUponTerminationOfEmployee_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_RELISharesIssuedUponTerminationOfEmployee_190" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferred" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferred_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferred_190" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WorkingCapital" xlink:label="loc_RELIWorkingCapital_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_RELIWorkingCapital_190" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfImpairmentOfGoodwillDetails" xlink:title="00000038 - Disclosure - SCHEDULE OF IMPAIRMENT OF GOODWILL (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MedigapHealthcareInsuranceCompanyMember" xlink:label="loc_RELIMedigapHealthcareInsuranceCompanyMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIMedigapHealthcareInsuranceCompanyMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraMember" xlink:label="loc_RELIBarraMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIBarraMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapGoodwill_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaapGoodwillAcquiredDuringPeriod_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapGoodwillAcquiredDuringPeriod_70" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails" xlink:title="00000039 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="loc_us-gaapTrademarksAndTradeNamesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksAndTradeNamesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_InternallyDevelopedSoftwareMember" xlink:label="loc_RELIInternallyDevelopedSoftwareMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIInternallyDevelopedSoftwareMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PurchasedSoftwareMember" xlink:label="loc_RELIPurchasedSoftwareMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIPurchasedSoftwareMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_VideoProductionAssetsMember" xlink:label="loc_RELIVideoProductionAssetsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIVideoProductionAssetsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_NoncompetitionAgreementsMember" xlink:label="loc_RELINoncompetitionAgreementsMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELINoncompetitionAgreementsMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ContractsBacklogMember" xlink:label="loc_RELIContractsBacklogMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIContractsBacklogMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_290" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_290" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_290" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_290" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails" xlink:title="00000040 - Disclosure - SCHEDULE OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsDetailsNarrative" xlink:title="00000041 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember" xlink:label="loc_srtRestatementAdjustmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRestatementAdjustmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical" xlink:title="00000042 - Disclosure - SCHEDULE OF LONG TERM DEBT (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EBSandUSBAMember" xlink:label="loc_RELIEBSandUSBAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIEBSandUSBAMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SWMTMember" xlink:label="loc_RELISWMTMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELISWMTMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_FISMember" xlink:label="loc_RELIFISMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIFISMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ABCMember" xlink:label="loc_RELIABCMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIABCMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraMember" xlink:label="loc_RELIBarraMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIBarraMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaapCreditFacilityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapCreditFacilityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CCSMember" xlink:label="loc_RELICCSMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_RELICCSMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDeferredCostsNet" xlink:label="loc_us-gaapOtherDeferredCostsNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOtherDeferredCostsNet_130" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails" xlink:title="00000043 - Disclosure - SCHEDULE OF LONG TERM DEBT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EBSandUSBAMember" xlink:label="loc_RELIEBSandUSBAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIEBSandUSBAMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SWMTMember" xlink:label="loc_RELISWMTMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELISWMTMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_FISMember" xlink:label="loc_RELIFISMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIFISMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ABCMember" xlink:label="loc_RELIABCMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIABCMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraMember" xlink:label="loc_RELIBarraMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIBarraMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaapCreditFacilityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapCreditFacilityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CCSMember" xlink:label="loc_RELICCSMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_RELICCSMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapLongTermDebt_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapLongTermDebtNoncurrent_150" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails" xlink:title="00000044 - Disclosure - SCHEDULE OF CUMULATIVE MATURITIES OF LONG-TERM LOANS AND CREDIT FACILITIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsDetailsNarrative" xlink:title="00000045 - Disclosure - LONG-TERM DEBT AND SHORT-TERM FINANCINGS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DirectorsAndOfficerMember" xlink:label="loc_RELIDirectorsAndOfficerMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RELIDirectorsAndOfficerMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBankLoansAndNotesPayable" xlink:label="loc_us-gaapShortTermBankLoansAndNotesPayable_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapShortTermBankLoansAndNotesPayable_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_70" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative" xlink:title="00000046 - Disclosure - WARRANT LIABILITIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SecuritiesPurchaseAgreementMember" xlink:label="loc_RELISecuritiesPurchaseAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RELISecuritiesPurchaseAgreementMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesBConvertiblePreferredStockMember" xlink:label="loc_RELISeriesBConvertiblePreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_RELISeriesBConvertiblePreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesBWarrantLiabilityMember" xlink:label="loc_RELISeriesBWarrantLiabilityMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_RELISeriesBWarrantLiabilityMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_160" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1_160" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_160" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_160" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaapConversionOfStockSharesIssued1_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesIssued1_160" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleConversionPrice" xlink:label="loc_us-gaapPreferredStockConvertibleConversionPrice_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockConvertibleConversionPrice_160" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants" xlink:label="loc_RELIAggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIAggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants_160" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:label="loc_us-gaapEquitySecuritiesFvNiUnrealizedLoss_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquitySecuritiesFvNiUnrealizedLoss_160" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:label="loc_us-gaapEquitySecuritiesFvNiUnrealizedGain_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquitySecuritiesFvNiUnrealizedGain_160" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_NonOperatingUnrealizedGains" xlink:label="loc_RELINonOperatingUnrealizedGains_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELINonOperatingUnrealizedGains_160" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantCommitment" xlink:label="loc_RELIWarrantCommitment_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIWarrantCommitment_160" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_160" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_IssuanceOfPlacementAgentWarrants" xlink:label="loc_RELIIssuanceOfPlacementAgentWarrants_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIIssuanceOfPlacementAgentWarrants_160" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantCommitmentUnrealizedGainLoss" xlink:label="loc_RELIWarrantCommitmentUnrealizedGainLoss_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIWarrantCommitmentUnrealizedGainLoss_160" xlink:type="arc" order="16" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/EquityDetailsNarrative" xlink:title="00000047 - Disclosure - EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesBConvertiblePreferredStockMember" xlink:label="loc_RELISeriesBConvertiblePreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_RELISeriesBConvertiblePreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesCPrepaidWarrantsMember" xlink:label="loc_RELISeriesCPrepaidWarrantsMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_RELISeriesCPrepaidWarrantsMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesDPrepaidWarrantsMember" xlink:label="loc_RELISeriesDPrepaidWarrantsMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_RELISeriesDPrepaidWarrantsMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesAWarrantMember" xlink:label="loc_RELISeriesAWarrantMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_RELISeriesAWarrantMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MedigapAcquisitionMember" xlink:label="loc_RELIMedigapAcquisitionMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIMedigapAcquisitionMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ThreeEmployeesMember" xlink:label="loc_RELIThreeEmployeesMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RELIThreeEmployeesMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_260" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_260" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_260" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_260" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_260" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_260" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_260" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_RELIStockIssuedDuringPeriodSharesWarrantsExercised_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_RELIStockIssuedDuringPeriodSharesWarrantsExercised_260" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_260" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits_260" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_260" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_260" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_260" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt_260" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation_260" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_260" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_260" xlink:type="arc" order="16" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails" xlink:title="00000048 - Disclosure - SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative" xlink:title="00000049 - Disclosure - EARNINGS (LOSS) PER SHARE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:label="loc_us-gaapEarningsPerShareBasicLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesCPrepaidWarrantsMember" xlink:label="loc_RELISeriesCPrepaidWarrantsMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_RELISeriesCPrepaidWarrantsMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesDPrepaidWarrantsMember" xlink:label="loc_RELISeriesDPrepaidWarrantsMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_RELISeriesDPrepaidWarrantsMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesAWarrantsMember" xlink:label="loc_RELISeriesAWarrantsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_RELISeriesAWarrantsMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesBWarrantLiabilityMember" xlink:label="loc_RELISeriesBWarrantLiabilityMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_RELISeriesBWarrantLiabilityMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConversionBasis" xlink:label="loc_us-gaapPreferredStockConversionBasis_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapPreferredStockConversionBasis_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AntidilutiveSharesIssuedAndOutstanding" xlink:label="loc_RELIAntidilutiveSharesIssuedAndOutstanding_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_RELIAntidilutiveSharesIssuedAndOutstanding_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantSharesIssued" xlink:label="loc_RELIWarrantSharesIssued_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_RELIWarrantSharesIssued_140" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantSharesOutstanding" xlink:label="loc_RELIWarrantSharesOutstanding_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_RELIWarrantSharesOutstanding_140" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits_140" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_IssuanceOfSeriesDWarrants" xlink:label="loc_RELIIssuanceOfSeriesDWarrants_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_RELIIssuanceOfSeriesDWarrants_140" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails" xlink:title="00000050 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENT (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/LeasesDetailsNarrative" xlink:title="00000051 - Disclosure - LEASES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails" xlink:title="00000052 - Disclosure - SCHEDULE OF EARN-OUT LIABILITY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CommercialSolutionsOfInsuranceAgencyLLCMember" xlink:label="loc_RELICommercialSolutionsOfInsuranceAgencyLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELICommercialSolutionsOfInsuranceAgencyLLCMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_FortmanInsuranceAgencyLLCMember" xlink:label="loc_RELIFortmanInsuranceAgencyLLCMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIFortmanInsuranceAgencyLLCMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SouthwesternMontanaInsuranceCenterIncMember" xlink:label="loc_RELISouthwesternMontanaInsuranceCenterIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELISouthwesternMontanaInsuranceCenterIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AltruisBenefitsConsultantsIncMember" xlink:label="loc_RELIAltruisBenefitsConsultantsIncMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIAltruisBenefitsConsultantsIncMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_JPKushAndAssociatesIncMember" xlink:label="loc_RELIJPKushAndAssociatesIncMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIJPKushAndAssociatesIncMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraMember" xlink:label="loc_RELIBarraMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIBarraMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiability_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiability_340" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChangesDueToAcquisitions" xlink:label="loc_RELIChangesDueToAcquisitions_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RELIChangesDueToAcquisitions_340" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChangesDueToPayments" xlink:label="loc_RELIChangesDueToPayments_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RELIChangesDueToPayments_340" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChangesDueToFairValueAdjustments" xlink:label="loc_RELIChangesDueToFairValueAdjustments_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RELIChangesDueToFairValueAdjustments_340" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChangesDueToBusinessCombinations" xlink:label="loc_RELIChangesDueToBusinessCombinations_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RELIChangesDueToBusinessCombinations_340" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChangesDueToWriteoffs" xlink:label="loc_RELIChangesDueToWriteoffs_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RELIChangesDueToWriteoffs_340" xlink:type="arc" order="6" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>reli-20220630_lab.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesAWarrantsMember" xlink:label="RELI_SeriesAWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SeriesAWarrantsMember" xlink:to="RELI_SeriesAWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_SeriesAWarrantsMember_lbl" xml:lang="en-US">Series A Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CommonStockIssuableMember" xlink:label="RELI_CommonStockIssuableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_CommonStockIssuableMember" xlink:to="RELI_CommonStockIssuableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_CommonStockIssuableMember_lbl" xml:lang="en-US">Common stock issuable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SubscriptionReceivableMember" xlink:label="RELI_SubscriptionReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SubscriptionReceivableMember" xlink:to="RELI_SubscriptionReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_SubscriptionReceivableMember_lbl" xml:lang="en-US">Subscription receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CustomerMember" xlink:label="RELI_CustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_CustomerMember" xlink:to="RELI_CustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_CustomerMember_lbl" xml:lang="en-US">Customer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputSharePriceMember" xlink:to="us-gaap_MeasurementInputSharePriceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputSharePriceMember_lbl" xml:lang="en-US">Measurement Input, Share Price [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesBWarrantCommitmentMember" xlink:label="RELI_SeriesBWarrantCommitmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SeriesBWarrantCommitmentMember" xlink:to="RELI_SeriesBWarrantCommitmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_SeriesBWarrantCommitmentMember_lbl" xml:lang="en-US">Series B Warrant Commitment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesBWarrantLiabilityMember" xlink:label="RELI_SeriesBWarrantLiabilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SeriesBWarrantLiabilityMember" xlink:to="RELI_SeriesBWarrantLiabilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_SeriesBWarrantLiabilityMember_lbl" xml:lang="en-US">Series B Warrant Liability [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PlacementAgentWarrantsMember" xlink:label="RELI_PlacementAgentWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PlacementAgentWarrantsMember" xlink:to="RELI_PlacementAgentWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_PlacementAgentWarrantsMember_lbl" xml:lang="en-US">Placement Agent Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MeasurementInputRiskPremiumMember" xlink:label="RELI_MeasurementInputRiskPremiumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_MeasurementInputRiskPremiumMember" xlink:to="RELI_MeasurementInputRiskPremiumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_MeasurementInputRiskPremiumMember_lbl" xml:lang="en-US">Measurement Input Risk Premium [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputCreditSpreadMember" xlink:label="us-gaap_MeasurementInputCreditSpreadMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputCreditSpreadMember" xlink:to="us-gaap_MeasurementInputCreditSpreadMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputCreditSpreadMember_lbl" xml:lang="en-US">Measurement Input, Credit Spread [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MeasurementInputPaymentDelayMember" xlink:label="RELI_MeasurementInputPaymentDelayMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_MeasurementInputPaymentDelayMember" xlink:to="RELI_MeasurementInputPaymentDelayMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_MeasurementInputPaymentDelayMember_lbl" xml:lang="en-US">Measurement Input Payment Delay [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_JPKushAcquisitionMember" xlink:label="RELI_JPKushAcquisitionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_JPKushAcquisitionMember" xlink:to="RELI_JPKushAcquisitionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_JPKushAcquisitionMember_lbl" xml:lang="en-US">J P Kush Acquisition [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraAcquisitionMember" xlink:label="RELI_BarraAcquisitionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_BarraAcquisitionMember" xlink:to="RELI_BarraAcquisitionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_BarraAcquisitionMember_lbl" xml:lang="en-US">Barra Acquisition [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CCSWriteoffMember" xlink:label="RELI_CCSWriteoffMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_CCSWriteoffMember" xlink:to="RELI_CCSWriteoffMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_CCSWriteoffMember_lbl" xml:lang="en-US">C C S Writeoff [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AltruisPartialSettlementMember" xlink:label="RELI_AltruisPartialSettlementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_AltruisPartialSettlementMember" xlink:to="RELI_AltruisPartialSettlementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_AltruisPartialSettlementMember_lbl" xml:lang="en-US">Altruis Partial Settlement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MontanaFinalSettlementMember" xlink:label="RELI_MontanaFinalSettlementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_MontanaFinalSettlementMember" xlink:to="RELI_MontanaFinalSettlementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_MontanaFinalSettlementMember_lbl" xml:lang="en-US">Montana Final Settlement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MedicalLifeMember" xlink:label="RELI_MedicalLifeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_MedicalLifeMember" xlink:to="RELI_MedicalLifeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_MedicalLifeMember_lbl" xml:lang="en-US">Medical/Life [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis_lbl" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_RegularMember" xlink:label="RELI_RegularMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_RegularMember" xlink:to="RELI_RegularMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_RegularMember_lbl" xml:lang="en-US">Regular [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EmployeeBenefitsSolutionsLLCMember" xlink:label="RELI_EmployeeBenefitsSolutionsLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_EmployeeBenefitsSolutionsLLCMember" xlink:to="RELI_EmployeeBenefitsSolutionsLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_EmployeeBenefitsSolutionsLLCMember_lbl" xml:lang="en-US">Employee Benefits, Solutions, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PropertyAndCasualtyMember" xlink:label="RELI_PropertyAndCasualtyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PropertyAndCasualtyMember" xlink:to="RELI_PropertyAndCasualtyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_PropertyAndCasualtyMember_lbl" xml:lang="en-US">Property and Casualty [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_USBenefitsAllianceLLCMember" xlink:label="RELI_USBenefitsAllianceLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_USBenefitsAllianceLLCMember" xlink:to="RELI_USBenefitsAllianceLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_USBenefitsAllianceLLCMember_lbl" xml:lang="en-US">US Benefits Alliance, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CommercialCoverageSolutionsLLCMember" xlink:label="RELI_CommercialCoverageSolutionsLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_CommercialCoverageSolutionsLLCMember" xlink:to="RELI_CommercialCoverageSolutionsLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_CommercialCoverageSolutionsLLCMember_lbl" xml:lang="en-US">Commercial Coverage Solutions LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SouthwesternMontanaFinancialCenterIncMember" xlink:label="RELI_SouthwesternMontanaFinancialCenterIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SouthwesternMontanaFinancialCenterIncMember" xlink:to="RELI_SouthwesternMontanaFinancialCenterIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_SouthwesternMontanaFinancialCenterIncMember_lbl" xml:lang="en-US">Southwestern Montana Financial Center, Inc. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_FortmanInsuranceServicesLLCMember" xlink:label="RELI_FortmanInsuranceServicesLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_FortmanInsuranceServicesLLCMember" xlink:to="RELI_FortmanInsuranceServicesLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_FortmanInsuranceServicesLLCMember_lbl" xml:lang="en-US">Fortman Insurance Services, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AltruisBenefitsConsultingIncMember" xlink:label="RELI_AltruisBenefitsConsultingIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_AltruisBenefitsConsultingIncMember" xlink:to="RELI_AltruisBenefitsConsultingIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_AltruisBenefitsConsultingIncMember_lbl" xml:lang="en-US">Altruis Benefits Consulting, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_KushMember" xlink:label="RELI_KushMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_KushMember" xlink:to="RELI_KushMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_KushMember_lbl" xml:lang="en-US">Kush [Member].</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MedigapMember" xlink:label="RELI_MedigapMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_MedigapMember" xlink:to="RELI_MedigapMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_MedigapMember_lbl" xml:lang="en-US">Medigap [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraMember" xlink:label="RELI_BarraMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_BarraMember" xlink:to="RELI_BarraMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_BarraMember_lbl" xml:lang="en-US">Barra [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_LTCGlobalMember" xlink:label="RELI_LTCGlobalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_LTCGlobalMember" xlink:to="RELI_LTCGlobalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_LTCGlobalMember_lbl" xml:lang="en-US">LTC Global [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PriorityHealthMember" xlink:label="RELI_PriorityHealthMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PriorityHealthMember" xlink:to="RELI_PriorityHealthMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_PriorityHealthMember_lbl" xml:lang="en-US">Priority Health [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BlueCrossBlueShieldMember" xlink:label="RELI_BlueCrossBlueShieldMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_BlueCrossBlueShieldMember" xlink:to="RELI_BlueCrossBlueShieldMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_BlueCrossBlueShieldMember_lbl" xml:lang="en-US">BlueCross BlueShield [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="srt_RestatementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAxis_lbl" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="srt_ScenarioPreviouslyReportedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl" xml:lang="en-US">Previously Reported [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember" xlink:label="srt_RestatementAdjustmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAdjustmentMember" xlink:to="srt_RestatementAdjustmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAdjustmentMember_lbl" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MedigapHealthcareInsuranceCompanyMember" xlink:label="RELI_MedigapHealthcareInsuranceCompanyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_MedigapHealthcareInsuranceCompanyMember" xlink:to="RELI_MedigapHealthcareInsuranceCompanyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_MedigapHealthcareInsuranceCompanyMember_lbl" xml:lang="en-US">Medigap Healthcare Insurance Company [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MeasurementInputRoyaltyRateMember" xlink:label="RELI_MeasurementInputRoyaltyRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_MeasurementInputRoyaltyRateMember" xlink:to="RELI_MeasurementInputRoyaltyRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_MeasurementInputRoyaltyRateMember_lbl" xml:lang="en-US">Measurement Input Royalty Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember" xlink:label="us-gaap_TradeNamesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeNamesMember" xlink:to="us-gaap_TradeNamesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeNamesMember_lbl" xml:lang="en-US">Trade Names [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="us-gaap_MeasurementInputDiscountRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputDiscountRateMember" xlink:to="us-gaap_MeasurementInputDiscountRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputDiscountRateMember_lbl" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MeasurementInputObsolescenceRateMember" xlink:label="RELI_MeasurementInputObsolescenceRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_MeasurementInputObsolescenceRateMember" xlink:to="RELI_MeasurementInputObsolescenceRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_MeasurementInputObsolescenceRateMember_lbl" xml:lang="en-US">Measurement Input Obsolescence Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:label="us-gaap_TechnologyBasedIntangibleAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="us-gaap_TechnologyBasedIntangibleAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TechnologyBasedIntangibleAssetsMember_lbl" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BackLogMember" xlink:label="RELI_BackLogMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_BackLogMember" xlink:to="RELI_BackLogMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_BackLogMember_lbl" xml:lang="en-US">Back log [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_APAMember" xlink:label="RELI_APAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_APAMember" xlink:to="RELI_APAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_APAMember_lbl" xml:lang="en-US">APA [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="us-gaap_AssetAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionAxis_lbl" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraAndAssociatesLLCMember" xlink:label="RELI_BarraAndAssociatesLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_BarraAndAssociatesLLCMember" xlink:to="RELI_BarraAndAssociatesLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_BarraAndAssociatesLLCMember_lbl" xml:lang="en-US">Barra and Associates LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PaidAtClosingMember" xlink:label="RELI_PaidAtClosingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PaidAtClosingMember" xlink:to="RELI_PaidAtClosingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_PaidAtClosingMember_lbl" xml:lang="en-US">Paid at closing [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PayableInSixMonthsMember" xlink:label="RELI_PayableInSixMonthsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PayableInSixMonthsMember" xlink:to="RELI_PayableInSixMonthsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_PayableInSixMonthsMember_lbl" xml:lang="en-US">Payable in six months [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PayableOverTwoYearsMember" xlink:label="RELI_PayableOverTwoYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PayableOverTwoYearsMember" xlink:to="RELI_PayableOverTwoYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_PayableOverTwoYearsMember_lbl" xml:lang="en-US">Payable over two years [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DevelopedTechnologyMember" xlink:label="RELI_DevelopedTechnologyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_DevelopedTechnologyMember" xlink:to="RELI_DevelopedTechnologyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_DevelopedTechnologyMember_lbl" xml:lang="en-US">Developed Technology [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="us-gaap_PropertyPlantAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentMember" xlink:to="us-gaap_PropertyPlantAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentMember_lbl" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_RightOfUseAssetMember" xlink:label="RELI_RightOfUseAssetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_RightOfUseAssetMember" xlink:to="RELI_RightOfUseAssetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_RightOfUseAssetMember_lbl" xml:lang="en-US">Right of use asset [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChargebackReserveMember" xlink:label="RELI_ChargebackReserveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ChargebackReserveMember" xlink:to="RELI_ChargebackReserveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_ChargebackReserveMember_lbl" xml:lang="en-US">Chargeback reserve [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_LeaseLiabilityMember" xlink:label="RELI_LeaseLiabilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_LeaseLiabilityMember" xlink:to="RELI_LeaseLiabilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_LeaseLiabilityMember_lbl" xml:lang="en-US">Lease liability [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillMember" xlink:label="us-gaap_GoodwillMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillMember" xlink:to="us-gaap_GoodwillMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillMember_lbl" xml:lang="en-US">Goodwill [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AcquiredAccountsReceivableMember" xlink:label="RELI_AcquiredAccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_AcquiredAccountsReceivableMember" xlink:to="RELI_AcquiredAccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_AcquiredAccountsReceivableMember_lbl" xml:lang="en-US">Acquired Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AgencyRelationshipsMember" xlink:label="RELI_AgencyRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_AgencyRelationshipsMember" xlink:to="RELI_AgencyRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_AgencyRelationshipsMember_lbl" xml:lang="en-US">Agency Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="us-gaap_TrademarksAndTradeNamesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TrademarksAndTradeNamesMember" xlink:to="us-gaap_TrademarksAndTradeNamesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TrademarksAndTradeNamesMember_lbl" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_InternallyDevelopedSoftwareMember" xlink:label="RELI_InternallyDevelopedSoftwareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_InternallyDevelopedSoftwareMember" xlink:to="RELI_InternallyDevelopedSoftwareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_InternallyDevelopedSoftwareMember_lbl" xml:lang="en-US">Internally Developed Software [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PurchasedSoftwareMember" xlink:label="RELI_PurchasedSoftwareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PurchasedSoftwareMember" xlink:to="RELI_PurchasedSoftwareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_PurchasedSoftwareMember_lbl" xml:lang="en-US">Purchased Software [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_VideoProductionAssetsMember" xlink:label="RELI_VideoProductionAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_VideoProductionAssetsMember" xlink:to="RELI_VideoProductionAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_VideoProductionAssetsMember_lbl" xml:lang="en-US">Video Production Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_NoncompetitionAgreementsMember" xlink:label="RELI_NoncompetitionAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_NoncompetitionAgreementsMember" xlink:to="RELI_NoncompetitionAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_NoncompetitionAgreementsMember_lbl" xml:lang="en-US">Non-competition Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ContractsBacklogMember" xlink:label="RELI_ContractsBacklogMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ContractsBacklogMember" xlink:to="RELI_ContractsBacklogMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_ContractsBacklogMember_lbl" xml:lang="en-US">Contracts backlog [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EBSandUSBAMember" xlink:label="RELI_EBSandUSBAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_EBSandUSBAMember" xlink:to="RELI_EBSandUSBAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_EBSandUSBAMember_lbl" xml:lang="en-US">EBS and USBA [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CreditFacilityAxis_lbl" xml:lang="en-US">Credit Facility [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CCSMember" xlink:label="RELI_CCSMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_CCSMember" xlink:to="RELI_CCSMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_CCSMember_lbl" xml:lang="en-US">CCS [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SWMTMember" xlink:label="RELI_SWMTMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SWMTMember" xlink:to="RELI_SWMTMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_SWMTMember_lbl" xml:lang="en-US">SWMT [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_FISMember" xlink:label="RELI_FISMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_FISMember" xlink:to="RELI_FISMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_FISMember_lbl" xml:lang="en-US">FIS [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ABCMember" xlink:label="RELI_ABCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ABCMember" xlink:to="RELI_ABCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_ABCMember_lbl" xml:lang="en-US">ABC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DirectorsAndOfficerMember" xlink:label="RELI_DirectorsAndOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_DirectorsAndOfficerMember" xlink:to="RELI_DirectorsAndOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_DirectorsAndOfficerMember_lbl" xml:lang="en-US">Directors and Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SecuritiesPurchaseAgreementMember" xlink:label="RELI_SecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SecuritiesPurchaseAgreementMember" xlink:to="RELI_SecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_SecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesBConvertiblePreferredStockMember" xlink:label="RELI_SeriesBConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SeriesBConvertiblePreferredStockMember" xlink:to="RELI_SeriesBConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_SeriesBConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series B Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MedigapAcquisitionMember" xlink:label="RELI_MedigapAcquisitionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_MedigapAcquisitionMember" xlink:to="RELI_MedigapAcquisitionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_MedigapAcquisitionMember_lbl" xml:lang="en-US">Medigap Acquisition [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesAWarrantMember" xlink:label="RELI_SeriesAWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SeriesAWarrantMember" xlink:to="RELI_SeriesAWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_SeriesAWarrantMember_lbl" xml:lang="en-US">Series A Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesCPrepaidWarrantsMember" xlink:label="RELI_SeriesCPrepaidWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SeriesCPrepaidWarrantsMember" xlink:to="RELI_SeriesCPrepaidWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_SeriesCPrepaidWarrantsMember_lbl" xml:lang="en-US">Series C Prepaid Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesDPrepaidWarrantsMember" xlink:label="RELI_SeriesDPrepaidWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SeriesDPrepaidWarrantsMember" xlink:to="RELI_SeriesDPrepaidWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_SeriesDPrepaidWarrantsMember_lbl" xml:lang="en-US">Series D Prepaid Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ThreeEmployeesMember" xlink:label="RELI_ThreeEmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ThreeEmployeesMember" xlink:to="RELI_ThreeEmployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_ThreeEmployeesMember_lbl" xml:lang="en-US">Three Employees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CommercialSolutionsOfInsuranceAgencyLLCMember" xlink:label="RELI_CommercialSolutionsOfInsuranceAgencyLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_CommercialSolutionsOfInsuranceAgencyLLCMember" xlink:to="RELI_CommercialSolutionsOfInsuranceAgencyLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_CommercialSolutionsOfInsuranceAgencyLLCMember_lbl" xml:lang="en-US">Commercial Solutions Of Insurance Agency LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_FortmanInsuranceAgencyLLCMember" xlink:label="RELI_FortmanInsuranceAgencyLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_FortmanInsuranceAgencyLLCMember" xlink:to="RELI_FortmanInsuranceAgencyLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_FortmanInsuranceAgencyLLCMember_lbl" xml:lang="en-US">Fortman Insurance Agency LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SouthwesternMontanaInsuranceCenterIncMember" xlink:label="RELI_SouthwesternMontanaInsuranceCenterIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SouthwesternMontanaInsuranceCenterIncMember" xlink:to="RELI_SouthwesternMontanaInsuranceCenterIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_SouthwesternMontanaInsuranceCenterIncMember_lbl" xml:lang="en-US">Southwestern Montana Insurance Center Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AltruisBenefitsConsultantsIncMember" xlink:label="RELI_AltruisBenefitsConsultantsIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_AltruisBenefitsConsultantsIncMember" xlink:to="RELI_AltruisBenefitsConsultantsIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_AltruisBenefitsConsultantsIncMember_lbl" xml:lang="en-US">Altruis Benefits Consultants Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_JPKushAndAssociatesIncMember" xlink:label="RELI_JPKushAndAssociatesIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_JPKushAndAssociatesIncMember" xlink:to="RELI_JPKushAndAssociatesIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_JPKushAndAssociatesIncMember_lbl" xml:lang="en-US">JP Kush and Associates Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xml:lang="en-US">Restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsReceivableRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:to="us-gaap_AccountsReceivableRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableRelatedPartiesCurrent_lbl" xml:lang="en-US">Accounts receivable, related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expense and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments" xlink:label="us-gaap_Investments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Investments_lbl" xml:lang="en-US">Investment in NSURE, Inc.</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangibles, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and stockholders&#8217; equity (deficit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and other accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChargebackReserveCurrent" xlink:label="RELI_ChargebackReserveCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ChargebackReserveCurrent" xlink:to="RELI_ChargebackReserveCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_ChargebackReserveCurrent_lbl" xml:lang="en-US">Chargeback reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:label="us-gaap_AccountsPayableOtherCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrent" xlink:to="us-gaap_AccountsPayableOtherCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableOtherCurrent_lbl" xml:lang="en-US">Other payables</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ShortTermFinancingAgreements" xlink:label="RELI_ShortTermFinancingAgreements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ShortTermFinancingAgreements" xlink:to="RELI_ShortTermFinancingAgreements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_ShortTermFinancingAgreements_lbl" xml:lang="en-US">Short term Financing Agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">Current portion of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Current portion of leases payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_lbl" xml:lang="en-US">Earn-out liability, current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantCommitmentCurrent" xlink:label="RELI_WarrantCommitmentCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WarrantCommitmentCurrent" xlink:to="RELI_WarrantCommitmentCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_WarrantCommitmentCurrent_lbl" xml:lang="en-US">Warrant commitment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesNoncurrent_lbl" xml:lang="en-US">Loans payable, related parties, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US">Long term debt, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Leases payable, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_lbl" xml:lang="en-US">Earn-out liability, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantLiabilityNonCurrent" xlink:label="RELI_WarrantLiabilityNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WarrantLiabilityNonCurrent" xlink:to="RELI_WarrantLiabilityNonCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_WarrantLiabilityNonCurrent_lbl" xml:lang="en-US">Warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; equity (deficit):</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $0.086 par value; 750,000,000 shares authorized and 9,076 and 0 issued and outstanding as of June 30, 2022 and December 31, 2021, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.086 par value; 2,000,000,000 shares authorized and 14,614,038 and 10,956,109 issued and outstanding as of June 30, 2022 and December 31, 2021, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteSubscriptionsReceivable" xlink:label="us-gaap_StockholdersEquityNoteSubscriptionsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteSubscriptionsReceivable" xlink:to="us-gaap_StockholdersEquityNoteSubscriptionsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockholdersEquityNoteSubscriptionsReceivable_lbl" xml:lang="en-US">Stock subscription receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders&#8217; equity (deficit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders&#8217; equity (deficit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CommissionIncome" xlink:label="RELI_CommissionIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_CommissionIncome" xlink:to="RELI_CommissionIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_CommissionIncome_lbl" xml:lang="en-US">Commission income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Total revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CommissionExpense" xlink:label="RELI_CommissionExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_CommissionExpense" xlink:to="RELI_CommissionExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_CommissionExpense_lbl" xml:lang="en-US">Commission expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalariesAndWages" xlink:label="us-gaap_SalariesAndWages" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalariesAndWages" xlink:to="us-gaap_SalariesAndWages_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalariesAndWages_lbl" xml:lang="en-US">Salaries and wages</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="us-gaap_MarketingAndAdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketingAndAdvertisingExpense" xlink:to="us-gaap_MarketingAndAdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketingAndAdvertisingExpense_lbl" xml:lang="en-US">Marketing and advertising</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_OtherNonoperatingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherNonoperatingExpense_lbl" xml:lang="en-US">Other expense, net</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_RecognitionAndChangeInFairValueOfWarrantLiability" xlink:label="RELI_RecognitionAndChangeInFairValueOfWarrantLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_RecognitionAndChangeInFairValueOfWarrantLiability" xlink:to="RELI_RecognitionAndChangeInFairValueOfWarrantLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_RecognitionAndChangeInFairValueOfWarrantLiability_lbl" xml:lang="en-US">Recognition and change in fair value of warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic earnings (loss) per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted earnings (loss) per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average number of shares outstanding - Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted average number of shares outstanding - Diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Share based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Shares issued due to public offering, net of offering costs of $1,672,852</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Shares issued pursuant to acquisition of Kush</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="RELI_StockIssuedDuringPeriodValueWarrantsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_StockIssuedDuringPeriodValueWarrantsExercised" xlink:to="RELI_StockIssuedDuringPeriodValueWarrantsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_StockIssuedDuringPeriodValueWarrantsExercised_lbl" xml:lang="en-US">Exercise of Series A warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="RELI_StockIssuedDuringPeriodSharesWarrantsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:to="RELI_StockIssuedDuringPeriodSharesWarrantsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_StockIssuedDuringPeriodSharesWarrantsExercised_lbl" xml:lang="en-US">Exercise of Series A warrants, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xml:lang="en-US">Issuance of prefunded Series C Warrants in exchange for common shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xml:lang="en-US">Issuance of prefunded Series C Warrants in exchange for common shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:to="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross_lbl" xml:lang="en-US">Shares issued for vested stock awards</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockGrantedDuringPeriodSharesSharebasedCompensationGross" xlink:label="RELI_StockGrantedDuringPeriodSharesSharebasedCompensationGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_StockGrantedDuringPeriodSharesSharebasedCompensationGross" xlink:to="RELI_StockGrantedDuringPeriodSharesSharebasedCompensationGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_StockGrantedDuringPeriodSharesSharebasedCompensationGross_lbl" xml:lang="en-US">Shares issued for vested stock awards, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodValueWarrantsIntoCommonStock" xlink:label="RELI_StockIssuedDuringPeriodValueWarrantsIntoCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_StockIssuedDuringPeriodValueWarrantsIntoCommonStock" xlink:to="RELI_StockIssuedDuringPeriodValueWarrantsIntoCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_StockIssuedDuringPeriodValueWarrantsIntoCommonStock_lbl" xml:lang="en-US">Exercise of Series C warrants into common shares</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodSharesWarrantsIntoCommonStock" xlink:label="RELI_StockIssuedDuringPeriodSharesWarrantsIntoCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_StockIssuedDuringPeriodSharesWarrantsIntoCommonStock" xlink:to="RELI_StockIssuedDuringPeriodSharesWarrantsIntoCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_StockIssuedDuringPeriodSharesWarrantsIntoCommonStock_lbl" xml:lang="en-US">Exercise of Series C warrants into common shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Shares issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodValueOverAllotmentShares" xlink:label="RELI_StockIssuedDuringPeriodValueOverAllotmentShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_StockIssuedDuringPeriodValueOverAllotmentShares" xlink:to="RELI_StockIssuedDuringPeriodValueOverAllotmentShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_StockIssuedDuringPeriodValueOverAllotmentShares_lbl" xml:lang="en-US">Over-allotment shares from offering, net of offering costs of $250,928</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodSharesOverAllotmentShares" xlink:label="RELI_StockIssuedDuringPeriodSharesOverAllotmentShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_StockIssuedDuringPeriodSharesOverAllotmentShares" xlink:to="RELI_StockIssuedDuringPeriodSharesOverAllotmentShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RELI_StockIssuedDuringPeriodSharesOverAllotmentShares_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US">Warrants sold during public offering at quoted price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Shares issued due to conversion of preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SharesIssuedDuringPeriodValueToConversionOfDebt" xlink:label="RELI_SharesIssuedDuringPeriodValueToConversionOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SharesIssuedDuringPeriodValueToConversionOfDebt" xlink:to="RELI_SharesIssuedDuringPeriodValueToConversionOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_SharesIssuedDuringPeriodValueToConversionOfDebt_lbl" xml:lang="en-US">Shares issued due to conversion of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SharesIssuedDuringPeriodSharesToConversionOfDebt" xlink:label="RELI_SharesIssuedDuringPeriodSharesToConversionOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SharesIssuedDuringPeriodSharesToConversionOfDebt" xlink:to="RELI_SharesIssuedDuringPeriodSharesToConversionOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RELI_SharesIssuedDuringPeriodSharesToConversionOfDebt_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodValueInitialPublicOffering" xlink:label="RELI_StockIssuedDuringPeriodValueInitialPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_StockIssuedDuringPeriodValueInitialPublicOffering" xlink:to="RELI_StockIssuedDuringPeriodValueInitialPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_StockIssuedDuringPeriodValueInitialPublicOffering_lbl" xml:lang="en-US">Rounding shares related to initial public offering</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:label="RELI_StockIssuedDuringPeriodSharesInitialPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:to="RELI_StockIssuedDuringPeriodSharesInitialPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RELI_StockIssuedDuringPeriodSharesInitialPublicOffering_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_lbl" xml:lang="en-US">Shares issued pursuant to software purchase</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Payments of stock issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustment to reconcile net income (loss) to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xml:lang="en-US">Amortization of debt issuance costs and accretion of debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_NoncashLeaseExpense" xlink:label="RELI_NoncashLeaseExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_NoncashLeaseExpense" xlink:to="RELI_NoncashLeaseExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_NoncashLeaseExpense_lbl" xml:lang="en-US">Non-cash lease expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EarnoutFairValueAndWriteoffAdjustments" xlink:label="RELI_EarnoutFairValueAndWriteoffAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_EarnoutFairValueAndWriteoffAdjustments" xlink:to="RELI_EarnoutFairValueAndWriteoffAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_EarnoutFairValueAndWriteoffAdjustments_lbl" xml:lang="en-US">Earn-out fair value and write-off adjustments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_RecognitionAndChangeInFairValueOfWarrantLiability" xlink:to="RELI_RecognitionAndChangeInFairValueOfWarrantLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RELI_RecognitionAndChangeInFairValueOfWarrantLiability_2_lbl" xml:lang="en-US">Recognition and change in fair value of warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Change in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payables and other accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties_lbl" xml:lang="en-US">Accounts receivable, related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable_lbl" xml:lang="en-US">Other payables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInRestructuringReserve" xlink:label="us-gaap_IncreaseDecreaseInRestructuringReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInRestructuringReserve" xlink:to="us-gaap_IncreaseDecreaseInRestructuringReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInRestructuringReserve_lbl" xml:lang="en-US">Charge back reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xml:lang="en-US">Other non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expense and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Purchase of intangibles</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherDebt" xlink:label="us-gaap_RepaymentsOfOtherDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfOtherDebt" xlink:to="us-gaap_RepaymentsOfOtherDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfOtherDebt_lbl" xml:lang="en-US">Principal repayments of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ProceedsFromLoanForBusinessAcquisition" xlink:label="RELI_ProceedsFromLoanForBusinessAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ProceedsFromLoanForBusinessAcquisition" xlink:to="RELI_ProceedsFromLoanForBusinessAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_ProceedsFromLoanForBusinessAcquisition_lbl" xml:lang="en-US">Proceeds from loan for business acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xml:lang="en-US">Payment of debt issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PaymentsOnEarnoutLiabilities" xlink:label="RELI_PaymentsOnEarnoutLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PaymentsOnEarnoutLiabilities" xlink:to="RELI_PaymentsOnEarnoutLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RELI_PaymentsOnEarnoutLiabilities_lbl" xml:lang="en-US">Payments on earn-out liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Proceeds from loans payable, related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Payments of loans payable, related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xml:lang="en-US">Proceeds from exercise of warrants into common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_RepaymentsOnShorttermFinancing" xlink:label="RELI_RepaymentsOnShorttermFinancing" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_RepaymentsOnShorttermFinancing" xlink:to="RELI_RepaymentsOnShorttermFinancing_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RELI_RepaymentsOnShorttermFinancing_lbl" xml:lang="en-US">Repayments on short-term financing</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants" xlink:label="RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants" xlink:to="RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants_lbl" xml:lang="en-US">Net proceeds from private placement issuance of shares and warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Issuance of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net (decrease) increase in cash and restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash and restricted cash at beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash and restricted cash at end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosure of cash and non-cash investing and financing transactions:</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_IssuanceOfSeriesDWarrants" xlink:label="RELI_IssuanceOfSeriesDWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_IssuanceOfSeriesDWarrants" xlink:to="RELI_IssuanceOfSeriesDWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_IssuanceOfSeriesDWarrants_lbl" xml:lang="en-US">Issuance of Series D Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_IssuanceOfPlacementAgentWarrants" xlink:label="RELI_IssuanceOfPlacementAgentWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_IssuanceOfPlacementAgentWarrants" xlink:to="RELI_IssuanceOfPlacementAgentWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_IssuanceOfPlacementAgentWarrants_lbl" xml:lang="en-US">Issuance of placement agent warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PrepaidInsuranceAcquiredThroughShorttermFinancing" xlink:label="RELI_PrepaidInsuranceAcquiredThroughShorttermFinancing" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PrepaidInsuranceAcquiredThroughShorttermFinancing" xlink:to="RELI_PrepaidInsuranceAcquiredThroughShorttermFinancing_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_PrepaidInsuranceAcquiredThroughShorttermFinancing_lbl" xml:lang="en-US">Prepaid insurance acquired through short-term financing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="us-gaap_ConversionOfStockAmountConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl" xml:lang="en-US">Conversion of preferred stock into common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Cash paid for interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US">Conversion of debt into equity</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CommonStockIssuedPursuantToAcquisition" xlink:label="RELI_CommonStockIssuedPursuantToAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_CommonStockIssuedPursuantToAcquisition" xlink:to="RELI_CommonStockIssuedPursuantToAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_CommonStockIssuedPursuantToAcquisition_lbl" xml:lang="en-US">Common stock issued pursuant to acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssued1_lbl" xml:lang="en-US">Common stock issued in lieu of services</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_IssuanceOfCommonStockPursuantToPurchaseOfSoftware" xlink:label="RELI_IssuanceOfCommonStockPursuantToPurchaseOfSoftware" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_IssuanceOfCommonStockPursuantToPurchaseOfSoftware" xlink:to="RELI_IssuanceOfCommonStockPursuantToPurchaseOfSoftware_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_IssuanceOfCommonStockPursuantToPurchaseOfSoftware_lbl" xml:lang="en-US">Issuance of common stock pursuant to the purchase of software</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AcquisitionOfBusinessDeferredPurchasePrice" xlink:label="RELI_AcquisitionOfBusinessDeferredPurchasePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_AcquisitionOfBusinessDeferredPurchasePrice" xlink:to="RELI_AcquisitionOfBusinessDeferredPurchasePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_AcquisitionOfBusinessDeferredPurchasePrice_lbl" xml:lang="en-US">Acquisition of business deferred purchase price</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_LeaseAssetsAcquiredInExchangeForLeaseLiabilities" xlink:label="RELI_LeaseAssetsAcquiredInExchangeForLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_LeaseAssetsAcquiredInExchangeForLeaseLiabilities" xlink:to="RELI_LeaseAssetsAcquiredInExchangeForLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_LeaseAssetsAcquiredInExchangeForLeaseLiabilities_lbl" xml:lang="en-US">Lease assets acquired in exchange for lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:label="RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:to="RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract_lbl" xml:lang="en-US">Long-term Debt And Short-term Financings</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_LongTermDebtAndShortTermFinancingsTextBlock" xlink:label="RELI_LongTermDebtAndShortTermFinancingsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_LongTermDebtAndShortTermFinancingsTextBlock" xlink:to="RELI_LongTermDebtAndShortTermFinancingsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_LongTermDebtAndShortTermFinancingsTextBlock_lbl" xml:lang="en-US">LONG-TERM DEBT AND SHORT-TERM FINANCINGS</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DisclosureWarrantLiabilitiesAbstract" xlink:label="RELI_DisclosureWarrantLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_DisclosureWarrantLiabilitiesAbstract" xlink:to="RELI_DisclosureWarrantLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_DisclosureWarrantLiabilitiesAbstract_lbl" xml:lang="en-US">Warrant Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantLiabilitiesTextBlock" xlink:label="RELI_WarrantLiabilitiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WarrantLiabilitiesTextBlock" xlink:to="RELI_WarrantLiabilitiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_WarrantLiabilitiesTextBlock_lbl" xml:lang="en-US">WARRANT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">EARNINGS (LOSS) PER SHARE</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DisclosureLeasesAbstract" xlink:label="RELI_DisclosureLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_DisclosureLeasesAbstract" xlink:to="RELI_DisclosureLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_DisclosureLeasesAbstract_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation and Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_LiquidityPolicyTextBlock" xlink:label="RELI_LiquidityPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_LiquidityPolicyTextBlock" xlink:to="RELI_LiquidityPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_LiquidityPolicyTextBlock_lbl" xml:lang="en-US">Liquidity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xml:lang="en-US">Cash and Restricted Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PriorPeriodAdjustmentPolicyTextBlock" xlink:label="RELI_PriorPeriodAdjustmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PriorPeriodAdjustmentPolicyTextBlock" xlink:to="RELI_PriorPeriodAdjustmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_PriorPeriodAdjustmentPolicyTextBlock_lbl" xml:lang="en-US">Prior Period Adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently Issued Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:label="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_lbl" xml:lang="en-US">SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF EARN OUT LIABILITY</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ScheduleOfReconcilesWarrantCommitmentTableTextBlock" xlink:label="RELI_ScheduleOfReconcilesWarrantCommitmentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ScheduleOfReconcilesWarrantCommitmentTableTextBlock" xlink:to="RELI_ScheduleOfReconcilesWarrantCommitmentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_ScheduleOfReconcilesWarrantCommitmentTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF RECONCILES WARRANT COMMITMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US">SCHEDULE OF FAIR VALUE MEASUREMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:to="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF DISAGGREGATION REVENUE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xml:lang="en-US">SCHEDULE OF CONCENTRATIONS OF REVENUES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl" xml:lang="en-US">SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF ALLOCATION OF PURCHASE PRICE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xml:lang="en-US">SCHEDULE OF PRO FORMA INFORMATION RELATED TO ACQUISITION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xml:lang="en-US">SCHEDULE OF IMPAIRMENT OF GOODWILL</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xml:lang="en-US">SCHEDULE OF LONG TERM DEBT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF CUMULATIVE MATURITIES OF LONG-TERM LOANS AND CREDIT FACILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF FUTURE MINIMUM LEASE PAYMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EarnOutLiabilitiesTableTextBlock" xlink:label="RELI_EarnOutLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_EarnOutLiabilitiesTableTextBlock" xlink:to="RELI_EarnOutLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_EarnOutLiabilitiesTableTextBlock_lbl" xml:lang="en-US">SCHEDULE OF EARN-OUT LIABILITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Total cash and restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xml:lang="en-US">Risk free rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Warrants and rights outstanding term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsTable" xlink:label="us-gaap_OffsettingAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OffsettingAssetsTable" xlink:to="us-gaap_OffsettingAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OffsettingAssetsTable_lbl" xml:lang="en-US">Offsetting Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="us-gaap_OffsettingAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OffsettingAssetsLineItems" xlink:to="us-gaap_OffsettingAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OffsettingAssetsLineItems_lbl" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantCommitment" xlink:label="RELI_WarrantCommitment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WarrantCommitment" xlink:to="RELI_WarrantCommitment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="RELI_WarrantCommitment_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_InitialRecognitionOfWarrantCommitment" xlink:label="RELI_InitialRecognitionOfWarrantCommitment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_InitialRecognitionOfWarrantCommitment" xlink:to="RELI_InitialRecognitionOfWarrantCommitment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_InitialRecognitionOfWarrantCommitment_lbl" xml:lang="en-US">Initial recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantCommitmentUnrealizedGainLoss" xlink:label="RELI_WarrantCommitmentUnrealizedGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WarrantCommitmentUnrealizedGainLoss" xlink:to="RELI_WarrantCommitmentUnrealizedGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_WarrantCommitmentUnrealizedGainLoss_lbl" xml:lang="en-US">Unrealized gain</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantsExercisedOrTransferred" xlink:label="RELI_WarrantsExercisedOrTransferred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WarrantsExercisedOrTransferred" xlink:to="RELI_WarrantsExercisedOrTransferred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_WarrantsExercisedOrTransferred_lbl" xml:lang="en-US">Warrants exercised or transferred</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WarrantCommitment" xlink:to="RELI_WarrantCommitment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="RELI_WarrantCommitment_2_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ValuationTechnique" xlink:label="RELI_ValuationTechnique" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ValuationTechnique" xlink:to="RELI_ValuationTechnique_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_ValuationTechnique_lbl" xml:lang="en-US">Valuation technique</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SignificantUnobservableInput" xlink:label="RELI_SignificantUnobservableInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SignificantUnobservableInput" xlink:to="RELI_SignificantUnobservableInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_SignificantUnobservableInput_lbl" xml:lang="en-US">Significant unobservable input</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilityMeasurementInput" xlink:to="us-gaap_DerivativeLiabilityMeasurementInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilityMeasurementInput_lbl" xml:lang="en-US">Derivative Liability, Measurement Input</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_RiskFreeRate" xlink:label="RELI_RiskFreeRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_RiskFreeRate" xlink:to="RELI_RiskFreeRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RELI_RiskFreeRate_lbl" xml:lang="en-US">Risk free rate</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DiscountingConvention" xlink:label="RELI_DiscountingConvention" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_DiscountingConvention" xlink:to="RELI_DiscountingConvention_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_DiscountingConvention_lbl" xml:lang="en-US">Discounting Convention:</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_NumberOfLterations" xlink:label="RELI_NumberOfLterations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_NumberOfLterations" xlink:to="RELI_NumberOfLterations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_NumberOfLterations_lbl" xml:lang="en-US">Number of Iterations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xml:lang="en-US">Beginning balance &#8211; January 1</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AcquisitionsAndSettlements" xlink:label="RELI_AcquisitionsAndSettlements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_AcquisitionsAndSettlements" xlink:to="RELI_AcquisitionsAndSettlements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_AcquisitionsAndSettlements_lbl" xml:lang="en-US">Montana final settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease" xlink:to="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_lbl" xml:lang="en-US">Fair value changes and accretion included in earnings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_2_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EarnoutLiabilityCurrent" xlink:label="RELI_EarnoutLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_EarnoutLiabilityCurrent" xlink:to="RELI_EarnoutLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_EarnoutLiabilityCurrent_lbl" xml:lang="en-US">Less: Current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EarnoutLiabilityNoncurrent" xlink:label="RELI_EarnoutLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_EarnoutLiabilityNoncurrent" xlink:to="RELI_EarnoutLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_EarnoutLiabilityNoncurrent_lbl" xml:lang="en-US">Ending balance, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Revenue from contract with customer, excluding assessed tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">LTC Global</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsReceivableNetCurrent_2_lbl" xml:lang="en-US">Earn-out liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="us-gaap_CommonStockSharesSubscriptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesSubscriptions" xlink:to="us-gaap_CommonStockSharesSubscriptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesSubscriptions_lbl" xml:lang="en-US">Common stock issuable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_2_lbl" xml:lang="en-US">Additional paid-in-capital</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="us-gaap_RestrictedCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalents" xlink:to="us-gaap_RestrictedCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalents_lbl" xml:lang="en-US">Cash and restricted cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Current asset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WorkingCapitalDeficiency" xlink:label="RELI_WorkingCapitalDeficiency" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WorkingCapitalDeficiency" xlink:to="RELI_WorkingCapitalDeficiency_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RELI_WorkingCapitalDeficiency_lbl" xml:lang="en-US">Working capital deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_4_lbl" xml:lang="en-US">Net income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Cash flows from operations activites</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants" xlink:to="RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants_2_lbl" xml:lang="en-US">Netproceeds from private placement issuance of shares and warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PaymentsToUndiscountedRemainingEarnOut" xlink:label="RELI_PaymentsToUndiscountedRemainingEarnOut" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PaymentsToUndiscountedRemainingEarnOut" xlink:to="RELI_PaymentsToUndiscountedRemainingEarnOut_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_PaymentsToUndiscountedRemainingEarnOut_lbl" xml:lang="en-US">Undiscounted remaining earn out payments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConcentrationRiskPercentage1_2_lbl" xml:lang="en-US">Concentration Risk, Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xml:lang="en-US">Purchase consideration allocated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Weighted average useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_FinitelivedIntangibleAssetUsefulLives" xlink:label="RELI_FinitelivedIntangibleAssetUsefulLives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_FinitelivedIntangibleAssetUsefulLives" xlink:to="RELI_FinitelivedIntangibleAssetUsefulLives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_FinitelivedIntangibleAssetUsefulLives_lbl" xml:lang="en-US">Weighted average useful life description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xml:lang="en-US">Net Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:to="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_lbl" xml:lang="en-US">Earnings (Loss) per common share, basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:to="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_lbl" xml:lang="en-US">Earnings (Loss) per common share, diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:to="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_lbl" xml:lang="en-US">Business combination bargain purchase gain recognized amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xml:lang="en-US">Payments to acquire businesses gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2_lbl" xml:lang="en-US">Issuance of shares acquistions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_lbl" xml:lang="en-US">Business combination, measurement input</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionCosts" xlink:label="us-gaap_AcquisitionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquisitionCosts" xlink:to="us-gaap_AcquisitionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquisitionCosts_lbl" xml:lang="en-US">Acquisition Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" xlink:label="us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" xlink:to="us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_lbl" xml:lang="en-US">Revenue from acquired entity</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SharesIssuedUponTerminationOfEmployee" xlink:label="RELI_SharesIssuedUponTerminationOfEmployee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SharesIssuedUponTerminationOfEmployee" xlink:to="RELI_SharesIssuedUponTerminationOfEmployee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_SharesIssuedUponTerminationOfEmployee_lbl" xml:lang="en-US">Shares issued upon termination of employee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferred" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred_lbl" xml:lang="en-US">Asset Acquisition, Consideration Transferred</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WorkingCapital" xlink:label="RELI_WorkingCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WorkingCapital" xlink:to="RELI_WorkingCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_WorkingCapital_lbl" xml:lang="en-US">Working capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringCostAndReserveLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCostAndReserveLineItems_lbl" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_Goodwill_2_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xml:lang="en-US">Goodwill acquired during period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_Goodwill_3_lbl" xml:lang="en-US">Goodwill, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_2_lbl" xml:lang="en-US">Weighted average remaining amortization period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Gross carrying amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Net carrying amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" xml:lang="en-US">2022 (remainder of year)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDeferredCostsNet" xlink:label="us-gaap_OtherDeferredCostsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDeferredCostsNet" xlink:to="us-gaap_OtherDeferredCostsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherDeferredCostsNet_lbl" xml:lang="en-US">Net of deferred financing cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Long term debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LongTermDebtCurrent_2_lbl" xml:lang="en-US">Current portion of long-term debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtNoncurrent_2_lbl" xml:lang="en-US">Long term debt, excluding current maturities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:to="RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract_2_lbl" xml:lang="en-US">Schedule Of Cumulative Maturities Of Long-term Loans And Credit Facilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl" xml:lang="en-US">2022 (remainder of year)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNet" xlink:to="us-gaap_DeferredFinanceCostsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xml:lang="en-US">Less: debt issuance costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebt_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBankLoansAndNotesPayable" xlink:label="us-gaap_ShortTermBankLoansAndNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBankLoansAndNotesPayable" xlink:to="us-gaap_ShortTermBankLoansAndNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermBankLoansAndNotesPayable_lbl" xml:lang="en-US">Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Warrant issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Common stock par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrant exercise price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Number of shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US">Shares converted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Preferred stock par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Share price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xml:lang="en-US">Shares converted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleConversionPrice" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockConvertibleConversionPrice" xlink:to="us-gaap_PreferredStockConvertibleConversionPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockConvertibleConversionPrice_lbl" xml:lang="en-US">Preferred stock conversion price</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants" xlink:label="RELI_AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants" xlink:to="RELI_AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants_lbl" xml:lang="en-US">Aggregate purchase price of common shares, preferred shares and warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedLoss_lbl" xml:lang="en-US">Unrealized losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGain" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGain_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGain_lbl" xml:lang="en-US">Unrealized gain</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_NonOperatingUnrealizedGains" xlink:label="RELI_NonOperatingUnrealizedGains" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_NonOperatingUnrealizedGains" xlink:to="RELI_NonOperatingUnrealizedGains_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RELI_NonOperatingUnrealizedGains_lbl" xml:lang="en-US">Unrealized gain</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WarrantCommitment" xlink:to="RELI_WarrantCommitment_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_WarrantCommitment_3_lbl" xml:lang="en-US">Derivative liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_2_lbl" xml:lang="en-US">Warrant term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_IssuanceOfPlacementAgentWarrants" xlink:to="RELI_IssuanceOfPlacementAgentWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RELI_IssuanceOfPlacementAgentWarrants_2_lbl" xml:lang="en-US">Derivative liability measured at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Class of Stock [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_2_lbl" xml:lang="en-US">Preferred stock shares authorized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_2_lbl" xml:lang="en-US">Preferred stock shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_2_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_3_lbl" xml:lang="en-US">Common stock, at par value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_3_lbl" xml:lang="en-US">Stock issued during period, shares, acquisitions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_2_lbl" xml:lang="en-US">Number of shares converted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xml:lang="en-US">Vesting of stock award</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Class of common stock warrant</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_2_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US">Proceeds from issuance of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:to="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_lbl" xml:lang="en-US">Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Share based compensation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">Issuance of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DeemedDividend" xlink:label="RELI_DeemedDividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_DeemedDividend" xlink:to="RELI_DeemedDividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="RELI_DeemedDividend_lbl" xml:lang="en-US">Deemed dividend</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net income (loss), numerator, basic computation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xml:lang="en-US">Recognition and change in fair value of warrant liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xml:lang="en-US">Net income (loss), numerator, diluted computation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Weighted average shares - denominator basic computation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xml:lang="en-US">Effect of stock awards</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EffectOfSeriesBWarrantLiability" xlink:label="RELI_EffectOfSeriesBWarrantLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_EffectOfSeriesBWarrantLiability" xlink:to="RELI_EffectOfSeriesBWarrantLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_EffectOfSeriesBWarrantLiability_lbl" xml:lang="en-US">Effect of Series B warrant liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xml:lang="en-US">Effect of preferred stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Weighted average shares, as adjusted - denominator diluted computation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_2_lbl" xml:lang="en-US">Earnings (loss) per common share - basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Earnings (loss) per common share - diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_lbl" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:label="us-gaap_EarningsPerShareBasicLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="us-gaap_EarningsPerShareBasicLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicLineItems_lbl" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConversionBasis" xlink:label="us-gaap_PreferredStockConversionBasis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockConversionBasis" xlink:to="us-gaap_PreferredStockConversionBasis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockConversionBasis_lbl" xml:lang="en-US">Stock conversion basis description</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AntidilutiveSharesIssuedAndOutstanding" xlink:label="RELI_AntidilutiveSharesIssuedAndOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_AntidilutiveSharesIssuedAndOutstanding" xlink:to="RELI_AntidilutiveSharesIssuedAndOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_AntidilutiveSharesIssuedAndOutstanding_lbl" xml:lang="en-US">Antidilutive shares Issued and Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_lbl" xml:lang="en-US">Vested stock awards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xml:lang="en-US">Non-vested stock awards</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantSharesIssued" xlink:label="RELI_WarrantSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WarrantSharesIssued" xlink:to="RELI_WarrantSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_WarrantSharesIssued_lbl" xml:lang="en-US">Warrant shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantSharesOutstanding" xlink:label="RELI_WarrantSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WarrantSharesOutstanding" xlink:to="RELI_WarrantSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_WarrantSharesOutstanding_lbl" xml:lang="en-US">Warrant shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_3_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Units</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_DisclosureLeasesAbstract" xlink:to="RELI_DisclosureLeasesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="RELI_DisclosureLeasesAbstract_2_lbl" xml:lang="en-US">Schedule Of Future Minimum Lease Payment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total undiscounted operating lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less: Imputed interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Present value of operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Operating Lease, Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Weighted average remaining lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted average discount rate</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChangesDueToAcquisitions" xlink:label="RELI_ChangesDueToAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ChangesDueToAcquisitions" xlink:to="RELI_ChangesDueToAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_ChangesDueToAcquisitions_lbl" xml:lang="en-US">Changes due to acquisitions</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChangesDueToPayments" xlink:label="RELI_ChangesDueToPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ChangesDueToPayments" xlink:to="RELI_ChangesDueToPayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_ChangesDueToPayments_lbl" xml:lang="en-US">Changes due to payments</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChangesDueToFairValueAdjustments" xlink:label="RELI_ChangesDueToFairValueAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ChangesDueToFairValueAdjustments" xlink:to="RELI_ChangesDueToFairValueAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_ChangesDueToFairValueAdjustments_lbl" xml:lang="en-US">Changes due to fair value adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChangesDueToBusinessCombinations" xlink:label="RELI_ChangesDueToBusinessCombinations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ChangesDueToBusinessCombinations" xlink:to="RELI_ChangesDueToBusinessCombinations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_ChangesDueToBusinessCombinations_lbl" xml:lang="en-US">Changes due to business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChangesDueToWriteoffs" xlink:label="RELI_ChangesDueToWriteoffs" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ChangesDueToWriteoffs" xlink:to="RELI_ChangesDueToWriteoffs_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_ChangesDueToWriteoffs_lbl" xml:lang="en-US">Changes due to write-offs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SeriesAWarrantsMember" xlink:to="RELI_SeriesAWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_SeriesAWarrantsMember_doc" xml:lang="en-US">Series A Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ChargebackReserveCurrent" xlink:to="RELI_ChargebackReserveCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_ChargebackReserveCurrent_doc" xml:lang="en-US">Chargeback reserve current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WarrantCommitmentCurrent" xlink:to="RELI_WarrantCommitmentCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_WarrantCommitmentCurrent_doc" xml:lang="en-US">Warrant commitment current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WarrantLiabilityNonCurrent" xlink:to="RELI_WarrantLiabilityNonCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_WarrantLiabilityNonCurrent_doc" xml:lang="en-US">Warrant liability non current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ShortTermFinancingAgreements" xlink:to="RELI_ShortTermFinancingAgreements_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_ShortTermFinancingAgreements_doc" xml:lang="en-US">Short term financing agreements.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_CommissionIncome" xlink:to="RELI_CommissionIncome_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_CommissionIncome_doc" xml:lang="en-US">Commission income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_CommissionExpense" xlink:to="RELI_CommissionExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_CommissionExpense_doc" xml:lang="en-US">Commission expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_RecognitionAndChangeInFairValueOfWarrantLiability" xlink:to="RELI_RecognitionAndChangeInFairValueOfWarrantLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_RecognitionAndChangeInFairValueOfWarrantLiability_doc" xml:lang="en-US">Recognition and change in fair value of warrant liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_CommonStockIssuableMember" xlink:to="RELI_CommonStockIssuableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_CommonStockIssuableMember_doc" xml:lang="en-US">Common stock issuable [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SubscriptionReceivableMember" xlink:to="RELI_SubscriptionReceivableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_SubscriptionReceivableMember_doc" xml:lang="en-US">Subscription receivable [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_StockIssuedDuringPeriodValueWarrantsExercised" xlink:to="RELI_StockIssuedDuringPeriodValueWarrantsExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_StockIssuedDuringPeriodValueWarrantsExercised_doc" xml:lang="en-US">Value of stock issued as a result of the exercise of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_StockIssuedDuringPeriodValueWarrantsIntoCommonStock" xlink:to="RELI_StockIssuedDuringPeriodValueWarrantsIntoCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_StockIssuedDuringPeriodValueWarrantsIntoCommonStock_doc" xml:lang="en-US">Stock issued during period value warrants into common stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:to="RELI_StockIssuedDuringPeriodSharesWarrantsExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_StockIssuedDuringPeriodSharesWarrantsExercised_doc" xml:lang="en-US">Number of warrants (or share units) exercised during the current period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_StockGrantedDuringPeriodSharesSharebasedCompensationGross" xlink:to="RELI_StockGrantedDuringPeriodSharesSharebasedCompensationGross_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_StockGrantedDuringPeriodSharesSharebasedCompensationGross_doc" xml:lang="en-US">Stock granted during period shares share based compensation gross.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_StockIssuedDuringPeriodSharesWarrantsIntoCommonStock" xlink:to="RELI_StockIssuedDuringPeriodSharesWarrantsIntoCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_StockIssuedDuringPeriodSharesWarrantsIntoCommonStock_doc" xml:lang="en-US">Stock issued during period shares warrants into common stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_StockIssuedDuringPeriodValueOverAllotmentShares" xlink:to="RELI_StockIssuedDuringPeriodValueOverAllotmentShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_StockIssuedDuringPeriodValueOverAllotmentShares_doc" xml:lang="en-US">Stock issued during period value over allotment shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SharesIssuedDuringPeriodValueToConversionOfDebt" xlink:to="RELI_SharesIssuedDuringPeriodValueToConversionOfDebt_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_SharesIssuedDuringPeriodValueToConversionOfDebt_doc" xml:lang="en-US">shares issued during period value to conversion of debt.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_StockIssuedDuringPeriodValueInitialPublicOffering" xlink:to="RELI_StockIssuedDuringPeriodValueInitialPublicOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_StockIssuedDuringPeriodValueInitialPublicOffering_doc" xml:lang="en-US">Stock issued during period value initial public offering</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:to="RELI_StockIssuedDuringPeriodSharesInitialPublicOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_StockIssuedDuringPeriodSharesInitialPublicOffering_doc" xml:lang="en-US">Stock issued during period shares initial public offering</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_StockIssuedDuringPeriodSharesOverAllotmentShares" xlink:to="RELI_StockIssuedDuringPeriodSharesOverAllotmentShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_StockIssuedDuringPeriodSharesOverAllotmentShares_doc" xml:lang="en-US">Stock issued during period shares over allotment shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SharesIssuedDuringPeriodSharesToConversionOfDebt" xlink:to="RELI_SharesIssuedDuringPeriodSharesToConversionOfDebt_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_SharesIssuedDuringPeriodSharesToConversionOfDebt_doc" xml:lang="en-US">Shares issued during period shares to conversion of debt.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_NoncashLeaseExpense" xlink:to="RELI_NoncashLeaseExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_NoncashLeaseExpense_doc" xml:lang="en-US">Non cash lease expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_EarnoutFairValueAndWriteoffAdjustments" xlink:to="RELI_EarnoutFairValueAndWriteoffAdjustments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_EarnoutFairValueAndWriteoffAdjustments_doc" xml:lang="en-US">Earnout fair value and writeoff adjustments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants" xlink:to="RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants_doc" xml:lang="en-US">Net proceeds from private placement issuance of shares and warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_IssuanceOfSeriesDWarrants" xlink:to="RELI_IssuanceOfSeriesDWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_IssuanceOfSeriesDWarrants_doc" xml:lang="en-US">Issuance of Series D Warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_IssuanceOfPlacementAgentWarrants" xlink:to="RELI_IssuanceOfPlacementAgentWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_IssuanceOfPlacementAgentWarrants_doc" xml:lang="en-US">Issuance of placement agent warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_CommonStockIssuedPursuantToAcquisition" xlink:to="RELI_CommonStockIssuedPursuantToAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_CommonStockIssuedPursuantToAcquisition_doc" xml:lang="en-US">Common stock issued pursuant to acquisition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_IssuanceOfCommonStockPursuantToPurchaseOfSoftware" xlink:to="RELI_IssuanceOfCommonStockPursuantToPurchaseOfSoftware_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_IssuanceOfCommonStockPursuantToPurchaseOfSoftware_doc" xml:lang="en-US">Issuance of common stock pursuant to purchase of software</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_AcquisitionOfBusinessDeferredPurchasePrice" xlink:to="RELI_AcquisitionOfBusinessDeferredPurchasePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_AcquisitionOfBusinessDeferredPurchasePrice_doc" xml:lang="en-US">Acquisition of business deferred purchase price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_LeaseAssetsAcquiredInExchangeForLeaseLiabilities" xlink:to="RELI_LeaseAssetsAcquiredInExchangeForLeaseLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_LeaseAssetsAcquiredInExchangeForLeaseLiabilities_doc" xml:lang="en-US">Lease assets acquired in exchange for lease liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PrepaidInsuranceAcquiredThroughShorttermFinancing" xlink:to="RELI_PrepaidInsuranceAcquiredThroughShorttermFinancing_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_PrepaidInsuranceAcquiredThroughShorttermFinancing_doc" xml:lang="en-US">Prepaid insurance acquired through short term financing.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ProceedsFromLoanForBusinessAcquisition" xlink:to="RELI_ProceedsFromLoanForBusinessAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_ProceedsFromLoanForBusinessAcquisition_doc" xml:lang="en-US">Proceeds from loan for business acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PaymentsOnEarnoutLiabilities" xlink:to="RELI_PaymentsOnEarnoutLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_PaymentsOnEarnoutLiabilities_doc" xml:lang="en-US">Payments on earnout liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_RepaymentsOnShorttermFinancing" xlink:to="RELI_RepaymentsOnShorttermFinancing_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_RepaymentsOnShorttermFinancing_doc" xml:lang="en-US">Repayments on short term financing.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_LiquidityPolicyTextBlock" xlink:to="RELI_LiquidityPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_LiquidityPolicyTextBlock_doc" xml:lang="en-US">Liquidity [PolicyTextBlock]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WorkingCapitalDeficiency" xlink:to="RELI_WorkingCapitalDeficiency_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_WorkingCapitalDeficiency_doc" xml:lang="en-US">Working capital deficiency.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ScheduleOfReconcilesWarrantCommitmentTableTextBlock" xlink:to="RELI_ScheduleOfReconcilesWarrantCommitmentTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_ScheduleOfReconcilesWarrantCommitmentTableTextBlock_doc" xml:lang="en-US">Schedule of reconciles warrant commitment [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WarrantCommitment" xlink:to="RELI_WarrantCommitment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_WarrantCommitment_doc" xml:lang="en-US">Warrant commitment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_InitialRecognitionOfWarrantCommitment" xlink:to="RELI_InitialRecognitionOfWarrantCommitment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_InitialRecognitionOfWarrantCommitment_doc" xml:lang="en-US">Initial recognition of warrant commitment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WarrantCommitmentUnrealizedGainLoss" xlink:to="RELI_WarrantCommitmentUnrealizedGainLoss_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_WarrantCommitmentUnrealizedGainLoss_doc" xml:lang="en-US">Unrealized (gain) loss.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WarrantsExercisedOrTransferred" xlink:to="RELI_WarrantsExercisedOrTransferred_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_WarrantsExercisedOrTransferred_doc" xml:lang="en-US">Warrants exercised or transferred.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SeriesBWarrantCommitmentMember" xlink:to="RELI_SeriesBWarrantCommitmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_SeriesBWarrantCommitmentMember_doc" xml:lang="en-US">Series B Warrant Commitment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ValuationTechnique" xlink:to="RELI_ValuationTechnique_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_ValuationTechnique_doc" xml:lang="en-US">Valuation technique.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SignificantUnobservableInput" xlink:to="RELI_SignificantUnobservableInput_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_SignificantUnobservableInput_doc" xml:lang="en-US">Significant unobservable input.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PaymentsToUndiscountedRemainingEarnOut" xlink:to="RELI_PaymentsToUndiscountedRemainingEarnOut_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_PaymentsToUndiscountedRemainingEarnOut_doc" xml:lang="en-US">Payments to undiscounted remaining earn out.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_AcquisitionsAndSettlements" xlink:to="RELI_AcquisitionsAndSettlements_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_AcquisitionsAndSettlements_doc" xml:lang="en-US">Acquisitions and settlements.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_BarraAcquisitionMember" xlink:to="RELI_BarraAcquisitionMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_BarraAcquisitionMember_doc" xml:lang="en-US">Barra Acquisition [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_MontanaFinalSettlementMember" xlink:to="RELI_MontanaFinalSettlementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_MontanaFinalSettlementMember_doc" xml:lang="en-US">Montana Final Settlement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_MedicalLifeMember" xlink:to="RELI_MedicalLifeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_MedicalLifeMember_doc" xml:lang="en-US">Medical/Life [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_RegularMember" xlink:to="RELI_RegularMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_RegularMember_doc" xml:lang="en-US">Regular [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_USBenefitsAllianceLLCMember" xlink:to="RELI_USBenefitsAllianceLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_USBenefitsAllianceLLCMember_doc" xml:lang="en-US">US Benefits Alliance, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PropertyAndCasualtyMember" xlink:to="RELI_PropertyAndCasualtyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_PropertyAndCasualtyMember_doc" xml:lang="en-US">Property and Casualty [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_CommercialCoverageSolutionsLLCMember" xlink:to="RELI_CommercialCoverageSolutionsLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_CommercialCoverageSolutionsLLCMember_doc" xml:lang="en-US">Commercial Coverage Solutions LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_EmployeeBenefitsSolutionsLLCMember" xlink:to="RELI_EmployeeBenefitsSolutionsLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_EmployeeBenefitsSolutionsLLCMember_doc" xml:lang="en-US">Employee Benefits, Solutions, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SouthwesternMontanaFinancialCenterIncMember" xlink:to="RELI_SouthwesternMontanaFinancialCenterIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_SouthwesternMontanaFinancialCenterIncMember_doc" xml:lang="en-US">Southwestern Montana Financial Center, Inc. [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_FortmanInsuranceServicesLLCMember" xlink:to="RELI_FortmanInsuranceServicesLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_FortmanInsuranceServicesLLCMember_doc" xml:lang="en-US">Fortman Insurance Services, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_AltruisBenefitsConsultingIncMember" xlink:to="RELI_AltruisBenefitsConsultingIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_AltruisBenefitsConsultingIncMember_doc" xml:lang="en-US">Altruis Benefits Consulting, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_KushMember" xlink:to="RELI_KushMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_KushMember_doc" xml:lang="en-US">Kush [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_MedigapMember" xlink:to="RELI_MedigapMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_MedigapMember_doc" xml:lang="en-US">Medigap [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_BarraMember" xlink:to="RELI_BarraMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_BarraMember_doc" xml:lang="en-US">Barra [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PriorPeriodAdjustmentPolicyTextBlock" xlink:to="RELI_PriorPeriodAdjustmentPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_PriorPeriodAdjustmentPolicyTextBlock_doc" xml:lang="en-US">Prior period adjustment [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_MedigapHealthcareInsuranceCompanyMember" xlink:to="RELI_MedigapHealthcareInsuranceCompanyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_MedigapHealthcareInsuranceCompanyMember_doc" xml:lang="en-US">Medigap healthcare insurance company [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_RightOfUseAssetMember" xlink:to="RELI_RightOfUseAssetMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_RightOfUseAssetMember_doc" xml:lang="en-US">Right of use asset [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_BackLogMember" xlink:to="RELI_BackLogMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_BackLogMember_doc" xml:lang="en-US">Back log [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ChargebackReserveMember" xlink:to="RELI_ChargebackReserveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_ChargebackReserveMember_doc" xml:lang="en-US">Chargeback reserve [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_LeaseLiabilityMember" xlink:to="RELI_LeaseLiabilityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_LeaseLiabilityMember_doc" xml:lang="en-US">Lease liability [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_FinitelivedIntangibleAssetUsefulLives" xlink:to="RELI_FinitelivedIntangibleAssetUsefulLives_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_FinitelivedIntangibleAssetUsefulLives_doc" xml:lang="en-US">Finite-lived intangible asset, useful lives.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_MeasurementInputRoyaltyRateMember" xlink:to="RELI_MeasurementInputRoyaltyRateMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_MeasurementInputRoyaltyRateMember_doc" xml:lang="en-US">Measurement Input Royalty Rate [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_MeasurementInputObsolescenceRateMember" xlink:to="RELI_MeasurementInputObsolescenceRateMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_MeasurementInputObsolescenceRateMember_doc" xml:lang="en-US">Measurement Input Obsolescence Rate [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SharesIssuedUponTerminationOfEmployee" xlink:to="RELI_SharesIssuedUponTerminationOfEmployee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_SharesIssuedUponTerminationOfEmployee_doc" xml:lang="en-US">Shares issued upon termination of employee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_InternallyDevelopedSoftwareMember" xlink:to="RELI_InternallyDevelopedSoftwareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_InternallyDevelopedSoftwareMember_doc" xml:lang="en-US">Internally Developed Software [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PurchasedSoftwareMember" xlink:to="RELI_PurchasedSoftwareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_PurchasedSoftwareMember_doc" xml:lang="en-US">Purchased Software [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_VideoProductionAssetsMember" xlink:to="RELI_VideoProductionAssetsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_VideoProductionAssetsMember_doc" xml:lang="en-US">Video Production Assets [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_NoncompetitionAgreementsMember" xlink:to="RELI_NoncompetitionAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_NoncompetitionAgreementsMember_doc" xml:lang="en-US">Non-competition Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_LongTermDebtAndShortTermFinancingsTextBlock" xlink:to="RELI_LongTermDebtAndShortTermFinancingsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_LongTermDebtAndShortTermFinancingsTextBlock_doc" xml:lang="en-US">Long Term Debt And Short Term Financings [TextBlock]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_EBSandUSBAMember" xlink:to="RELI_EBSandUSBAMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_EBSandUSBAMember_doc" xml:lang="en-US">EBS and USBA [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_CCSMember" xlink:to="RELI_CCSMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_CCSMember_doc" xml:lang="en-US">CCS [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SWMTMember" xlink:to="RELI_SWMTMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_SWMTMember_doc" xml:lang="en-US">SWMT [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_FISMember" xlink:to="RELI_FISMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_FISMember_doc" xml:lang="en-US">FIS [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ABCMember" xlink:to="RELI_ABCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_ABCMember_doc" xml:lang="en-US">ABC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WarrantLiabilitiesTextBlock" xlink:to="RELI_WarrantLiabilitiesTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_WarrantLiabilitiesTextBlock_doc" xml:lang="en-US">Warrant Liabilities [TextBlock]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SecuritiesPurchaseAgreementMember" xlink:to="RELI_SecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_SecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SeriesBConvertiblePreferredStockMember" xlink:to="RELI_SeriesBConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_SeriesBConvertiblePreferredStockMember_doc" xml:lang="en-US">Series B Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants" xlink:to="RELI_AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants_doc" xml:lang="en-US">Aggregate purchase price of common shares, preferred shares and warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SeriesBWarrantLiabilityMember" xlink:to="RELI_SeriesBWarrantLiabilityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_SeriesBWarrantLiabilityMember_doc" xml:lang="en-US">Series B Warrant Liability [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_MedigapAcquisitionMember" xlink:to="RELI_MedigapAcquisitionMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_MedigapAcquisitionMember_doc" xml:lang="en-US">Medigap Acquisition [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SeriesAWarrantMember" xlink:to="RELI_SeriesAWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_SeriesAWarrantMember_doc" xml:lang="en-US">Series A Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_AntidilutiveSharesIssuedAndOutstanding" xlink:to="RELI_AntidilutiveSharesIssuedAndOutstanding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_AntidilutiveSharesIssuedAndOutstanding_doc" xml:lang="en-US">Antidilutive shares issued and outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WarrantSharesOutstanding" xlink:to="RELI_WarrantSharesOutstanding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_WarrantSharesOutstanding_doc" xml:lang="en-US">Warrant shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SeriesCPrepaidWarrantsMember" xlink:to="RELI_SeriesCPrepaidWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_SeriesCPrepaidWarrantsMember_doc" xml:lang="en-US">Series C Prepaid Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SeriesDPrepaidWarrantsMember" xlink:to="RELI_SeriesDPrepaidWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_SeriesDPrepaidWarrantsMember_doc" xml:lang="en-US">Series D Prepaid Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_DeemedDividend" xlink:to="RELI_DeemedDividend_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_DeemedDividend_doc" xml:lang="en-US">Deemed Dividend.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_EffectOfSeriesBWarrantLiability" xlink:to="RELI_EffectOfSeriesBWarrantLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_EffectOfSeriesBWarrantLiability_doc" xml:lang="en-US">Effect of series B warrant liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_EarnOutLiabilitiesTableTextBlock" xlink:to="RELI_EarnOutLiabilitiesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_EarnOutLiabilitiesTableTextBlock_doc" xml:lang="en-US">Earn Out Liabilities [TableTextBlock]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_CommercialSolutionsOfInsuranceAgencyLLCMember" xlink:to="RELI_CommercialSolutionsOfInsuranceAgencyLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_CommercialSolutionsOfInsuranceAgencyLLCMember_doc" xml:lang="en-US">Commercial Solutions Of Insurance Agency LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_FortmanInsuranceAgencyLLCMember" xlink:to="RELI_FortmanInsuranceAgencyLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_FortmanInsuranceAgencyLLCMember_doc" xml:lang="en-US">Fortman Insurance Agency LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SouthwesternMontanaInsuranceCenterIncMember" xlink:to="RELI_SouthwesternMontanaInsuranceCenterIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_SouthwesternMontanaInsuranceCenterIncMember_doc" xml:lang="en-US">Southwestern Montana Insurance Center Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_AltruisBenefitsConsultantsIncMember" xlink:to="RELI_AltruisBenefitsConsultantsIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_AltruisBenefitsConsultantsIncMember_doc" xml:lang="en-US">Altruis Benefits Consultants Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_JPKushAndAssociatesIncMember" xlink:to="RELI_JPKushAndAssociatesIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_JPKushAndAssociatesIncMember_doc" xml:lang="en-US">JP Kush and Associates Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ChangesDueToPayments" xlink:to="RELI_ChangesDueToPayments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_ChangesDueToPayments_doc" xml:lang="en-US">Changes due to payments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ChangesDueToBusinessCombinations" xlink:to="RELI_ChangesDueToBusinessCombinations_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_ChangesDueToBusinessCombinations_doc" xml:lang="en-US">Changes due to business combinations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ChangesDueToFairValueAdjustments" xlink:to="RELI_ChangesDueToFairValueAdjustments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_ChangesDueToFairValueAdjustments_doc" xml:lang="en-US">Changes due to fair value adjustments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ChangesDueToWriteoffs" xlink:to="RELI_ChangesDueToWriteoffs_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_ChangesDueToWriteoffs_doc" xml:lang="en-US">Changes due to writeoffs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WarrantSharesIssued" xlink:to="RELI_WarrantSharesIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_WarrantSharesIssued_doc" xml:lang="en-US">Warrant shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ThreeEmployeesMember" xlink:to="RELI_ThreeEmployeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_ThreeEmployeesMember_doc" xml:lang="en-US">Three Employees [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_NonOperatingUnrealizedGains" xlink:to="RELI_NonOperatingUnrealizedGains_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_NonOperatingUnrealizedGains_doc" xml:lang="en-US">Non operating unrealized gains.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ContractsBacklogMember" xlink:to="RELI_ContractsBacklogMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_ContractsBacklogMember_doc" xml:lang="en-US">Contracts backlog [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_APAMember" xlink:to="RELI_APAMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_APAMember_doc" xml:lang="en-US">APA [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_BarraAndAssociatesLLCMember" xlink:to="RELI_BarraAndAssociatesLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_BarraAndAssociatesLLCMember_doc" xml:lang="en-US">Barra and Associates LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PaidAtClosingMember" xlink:to="RELI_PaidAtClosingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_PaidAtClosingMember_doc" xml:lang="en-US">Paid at closing [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PayableInSixMonthsMember" xlink:to="RELI_PayableInSixMonthsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_PayableInSixMonthsMember_doc" xml:lang="en-US">Payable in six months [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PayableOverTwoYearsMember" xlink:to="RELI_PayableOverTwoYearsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_PayableOverTwoYearsMember_doc" xml:lang="en-US">Payable over two years [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WorkingCapital" xlink:to="RELI_WorkingCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_WorkingCapital_doc" xml:lang="en-US">Working capital.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_AcquiredAccountsReceivableMember" xlink:to="RELI_AcquiredAccountsReceivableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_AcquiredAccountsReceivableMember_doc" xml:lang="en-US">Acquired Accounts Receivable [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_AgencyRelationshipsMember" xlink:to="RELI_AgencyRelationshipsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_AgencyRelationshipsMember_doc" xml:lang="en-US">Agency Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_TechnologyMember" xlink:label="RELI_TechnologyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_TechnologyMember" xlink:to="RELI_TechnologyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_TechnologyMember_doc" xml:lang="en-US">Technology [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_DevelopedTechnologyMember" xlink:to="RELI_DevelopedTechnologyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_DevelopedTechnologyMember_doc" xml:lang="en-US">Developed Technology [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_CustomerMember" xlink:to="RELI_CustomerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_CustomerMember_doc" xml:lang="en-US">Customer [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_LTCGlobalMember" xlink:to="RELI_LTCGlobalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_LTCGlobalMember_doc" xml:lang="en-US">LTC Global [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PriorityHealthMember" xlink:to="RELI_PriorityHealthMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_PriorityHealthMember_doc" xml:lang="en-US">Priority Health [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_BlueCrossBlueShieldMember" xlink:to="RELI_BlueCrossBlueShieldMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_BlueCrossBlueShieldMember_doc" xml:lang="en-US">BlueCross BlueShield [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_ChangesDueToAcquisitions" xlink:to="RELI_ChangesDueToAcquisitions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_ChangesDueToAcquisitions_doc" xml:lang="en-US">Changes due to acquisitions.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_DirectorsAndOfficerMember" xlink:to="RELI_DirectorsAndOfficerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_DirectorsAndOfficerMember_doc" xml:lang="en-US">Directors and Officer [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_NumberOfLterations" xlink:to="RELI_NumberOfLterations_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_NumberOfLterations_doc" xml:lang="en-US">Number of lterations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_RiskFreeRate" xlink:to="RELI_RiskFreeRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_RiskFreeRate_doc" xml:lang="en-US">Risk free rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_DiscountingConvention" xlink:to="RELI_DiscountingConvention_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="RELI_DiscountingConvention_doc" xml:lang="en-US">Discounting convention.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteSubscriptionsReceivable" xlink:to="us-gaap_StockholdersEquityNoteSubscriptionsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteSubscriptionsReceivable_2_lbl" xml:lang="en-US">Stockholders' Equity Note, Subscriptions Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Revenues</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_3_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_OtherNonoperatingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingExpense_2_lbl" xml:lang="en-US">Other Nonoperating Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_StockIssuedDuringPeriodSharesOverAllotmentShares" xlink:to="RELI_StockIssuedDuringPeriodSharesOverAllotmentShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_StockIssuedDuringPeriodSharesOverAllotmentShares_3_lbl" xml:lang="en-US">StockIssuedDuringPeriodSharesOverAllotmentShares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_SharesIssuedDuringPeriodSharesToConversionOfDebt" xlink:to="RELI_SharesIssuedDuringPeriodSharesToConversionOfDebt_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_SharesIssuedDuringPeriodSharesToConversionOfDebt_3_lbl" xml:lang="en-US">SharesIssuedDuringPeriodSharesToConversionOfDebt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:to="RELI_StockIssuedDuringPeriodSharesInitialPublicOffering_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_StockIssuedDuringPeriodSharesInitialPublicOffering_3_lbl" xml:lang="en-US">StockIssuedDuringPeriodSharesInitialPublicOffering</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_2_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Purchase of Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable, Related Parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_3_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2_lbl" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfOtherDebt" xlink:to="us-gaap_RepaymentsOfOtherDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfOtherDebt_2_lbl" xml:lang="en-US">Repayments of Other Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_2_lbl" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_PaymentsOnEarnoutLiabilities" xlink:to="RELI_PaymentsOnEarnoutLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_PaymentsOnEarnoutLiabilities_3_lbl" xml:lang="en-US">PaymentsOnEarnoutLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xml:lang="en-US">Repayments of Related Party Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_RepaymentsOnShorttermFinancing" xlink:to="RELI_RepaymentsOnShorttermFinancing_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_RepaymentsOnShorttermFinancing_3_lbl" xml:lang="en-US">RepaymentsOnShorttermFinancing</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_RiskFreeRate" xlink:to="RELI_RiskFreeRate_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_RiskFreeRate_3_lbl" xml:lang="en-US">RiskFreeRate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_3_lbl" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_WorkingCapitalDeficiency" xlink:to="RELI_WorkingCapitalDeficiency_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_WorkingCapitalDeficiency_3_lbl" xml:lang="en-US">Working capital deficiency</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_2_lbl" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_2_lbl" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2_lbl" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_2_lbl" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2_lbl" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_2_lbl" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_2_lbl" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNet" xlink:to="us-gaap_DeferredFinanceCostsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFinanceCostsNet_2_lbl" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesIssued1_2_lbl" xml:lang="en-US">Conversion of Stock, Shares Issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGain_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGain_2_lbl" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_NonOperatingUnrealizedGains" xlink:to="RELI_NonOperatingUnrealizedGains_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_NonOperatingUnrealizedGains_3_lbl" xml:lang="en-US">NonOperatingUnrealizedGains</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RELI_DeemedDividend" xlink:to="RELI_DeemedDividend_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="RELI_DeemedDividend_3_lbl" xml:lang="en-US">DeemedDividend</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_2_lbl" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>reli-20220630_pre.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/Cover" xlink:href="reli-20220630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/BalanceSheets" xlink:href="reli-20220630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/BalanceSheetsParenthetical" xlink:href="reli-20220630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StatementsOfOperations" xlink:href="reli-20220630.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit" xlink:href="reli-20220630.xsd#StatementsOfStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficitParenthetical" xlink:href="reli-20220630.xsd#StatementsOfStockholdersEquityDeficitParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StatementsOfCashFlows" xlink:href="reli-20220630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPolicies" xlink:href="reli-20220630.xsd#SummaryOfBusinessAndSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinations" xlink:href="reli-20220630.xsd#StrategicInvestmentsAndBusinessCombinations" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssets" xlink:href="reli-20220630.xsd#GoodwillAndOtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancings" xlink:href="reli-20220630.xsd#Long-termDebtAndShort-termFinancings" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/WarrantLiabilities" xlink:href="reli-20220630.xsd#WarrantLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/Equity" xlink:href="reli-20220630.xsd#Equity" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/EarningsLossPerShare" xlink:href="reli-20220630.xsd#EarningsLossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/Leases" xlink:href="reli-20220630.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/CommitmentsAndContingencies" xlink:href="reli-20220630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesPolicies" xlink:href="reli-20220630.xsd#SummaryOfBusinessAndSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables" xlink:href="reli-20220630.xsd#SummaryOfBusinessAndSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsTables" xlink:href="reli-20220630.xsd#StrategicInvestmentsAndBusinessCombinationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:href="reli-20220630.xsd#GoodwillAndOtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsTables" xlink:href="reli-20220630.xsd#Long-termDebtAndShort-termFinancingsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/EarningsLossPerShareTables" xlink:href="reli-20220630.xsd#EarningsLossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/LeasesTables" xlink:href="reli-20220630.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/CommitmentsAndContingenciesTables" xlink:href="reli-20220630.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfRestrictedCashInStatementOfCashFlowDetails" xlink:href="reli-20220630.xsd#ScheduleOfRestrictedCashInStatementOfCashFlowDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfFairValueOfWarrantCommitmentDetails" xlink:href="reli-20220630.xsd#ScheduleOfFairValueOfWarrantCommitmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfReconcilesWarrantCommitmentDetails" xlink:href="reli-20220630.xsd#ScheduleOfReconcilesWarrantCommitmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfFairValueMeasurementsDetails" xlink:href="reli-20220630.xsd#ScheduleOfFairValueMeasurementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails" xlink:href="reli-20220630.xsd#ScheduleOfEarnOutLiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails" xlink:href="reli-20220630.xsd#ScheduleOfGainOrLossesRecognizedFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails" xlink:href="reli-20220630.xsd#ScheduleOfDisaggregationRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails" xlink:href="reli-20220630.xsd#ScheduleOfConcentrationsOfRevenuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/SummarizesChangesToPreviouslyIssuedFinancialInformationDetails" xlink:href="reli-20220630.xsd#SummarizesChangesToPreviouslyIssuedFinancialInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative" xlink:href="reli-20220630.xsd#SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails" xlink:href="reli-20220630.xsd#ScheduleOfAllocationOfPurchasePriceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfProFormaInformationRelatedToAcquisitionDetails" xlink:href="reli-20220630.xsd#ScheduleOfProFormaInformationRelatedToAcquisitionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative" xlink:href="reli-20220630.xsd#StrategicInvestmentsAndBusinessCombinationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfImpairmentOfGoodwillDetails" xlink:href="reli-20220630.xsd#ScheduleOfImpairmentOfGoodwillDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails" xlink:href="reli-20220630.xsd#ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails" xlink:href="reli-20220630.xsd#ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsDetailsNarrative" xlink:href="reli-20220630.xsd#GoodwillAndOtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical" xlink:href="reli-20220630.xsd#ScheduleOfLongTermDebtDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails" xlink:href="reli-20220630.xsd#ScheduleOfLongTermDebtDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails" xlink:href="reli-20220630.xsd#ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsDetailsNarrative" xlink:href="reli-20220630.xsd#Long-termDebtAndShort-termFinancingsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative" xlink:href="reli-20220630.xsd#WarrantLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/EquityDetailsNarrative" xlink:href="reli-20220630.xsd#EquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails" xlink:href="reli-20220630.xsd#ScheduleOfCalculationsOfBasicAndDilutedEpsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative" xlink:href="reli-20220630.xsd#EarningsLossPerShareDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails" xlink:href="reli-20220630.xsd#ScheduleOfFutureMinimumLeasePaymentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/LeasesDetailsNarrative" xlink:href="reli-20220630.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails" xlink:href="reli-20220630.xsd#ScheduleOfEarn-outLiabilityDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesAWarrantsMember" xlink:label="loc_RELISeriesAWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_RELISeriesAWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaapRestrictedCashCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapRestrictedCashCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChargebackReserveCurrent" xlink:label="loc_RELIChargebackReserveCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_RELIChargebackReserveCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:label="loc_us-gaapAccountsPayableOtherCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableOtherCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ShortTermFinancingAgreements" xlink:label="loc_RELIShortTermFinancingAgreements" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_RELIShortTermFinancingAgreements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantCommitmentCurrent" xlink:label="loc_RELIWarrantCommitmentCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_RELIWarrantCommitmentCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesNoncurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapDueToRelatedPartiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityNoncurrent" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantLiabilityNonCurrent" xlink:label="loc_RELIWarrantLiabilityNonCurrent" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_RELIWarrantLiabilityNonCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteSubscriptionsReceivable" xlink:label="loc_us-gaapStockholdersEquityNoteSubscriptionsReceivable" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteSubscriptionsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CommissionIncome" xlink:label="loc_RELICommissionIncome" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_RELICommissionIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CommissionExpense" xlink:label="loc_RELICommissionExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_RELICommissionExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaapSalariesAndWages" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSalariesAndWages" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="loc_us-gaapOtherNonoperatingExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherNonoperatingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_RecognitionAndChangeInFairValueOfWarrantLiability" xlink:label="loc_RELIRecognitionAndChangeInFairValueOfWarrantLiability" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_RELIRecognitionAndChangeInFairValueOfWarrantLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Stockholders&apos; Equity (Deficit) (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CommonStockIssuableMember" xlink:label="loc_RELICommonStockIssuableMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_RELICommonStockIssuableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SubscriptionReceivableMember" xlink:label="loc_RELISubscriptionReceivableMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_RELISubscriptionReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="loc_RELIStockIssuedDuringPeriodValueWarrantsExercised" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIStockIssuedDuringPeriodValueWarrantsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_RELIStockIssuedDuringPeriodSharesWarrantsExercised" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIStockIssuedDuringPeriodSharesWarrantsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationGross" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockGrantedDuringPeriodSharesSharebasedCompensationGross" xlink:label="loc_RELIStockGrantedDuringPeriodSharesSharebasedCompensationGross" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIStockGrantedDuringPeriodSharesSharebasedCompensationGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodValueWarrantsIntoCommonStock" xlink:label="loc_RELIStockIssuedDuringPeriodValueWarrantsIntoCommonStock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIStockIssuedDuringPeriodValueWarrantsIntoCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodSharesWarrantsIntoCommonStock" xlink:label="loc_RELIStockIssuedDuringPeriodSharesWarrantsIntoCommonStock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIStockIssuedDuringPeriodSharesWarrantsIntoCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodValueOverAllotmentShares" xlink:label="loc_RELIStockIssuedDuringPeriodValueOverAllotmentShares" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIStockIssuedDuringPeriodValueOverAllotmentShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodSharesOverAllotmentShares" xlink:label="loc_RELIStockIssuedDuringPeriodSharesOverAllotmentShares" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIStockIssuedDuringPeriodSharesOverAllotmentShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SharesIssuedDuringPeriodValueToConversionOfDebt" xlink:label="loc_RELISharesIssuedDuringPeriodValueToConversionOfDebt" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELISharesIssuedDuringPeriodValueToConversionOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SharesIssuedDuringPeriodSharesToConversionOfDebt" xlink:label="loc_RELISharesIssuedDuringPeriodSharesToConversionOfDebt" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELISharesIssuedDuringPeriodSharesToConversionOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodValueInitialPublicOffering" xlink:label="loc_RELIStockIssuedDuringPeriodValueInitialPublicOffering" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIStockIssuedDuringPeriodValueInitialPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:label="loc_RELIStockIssuedDuringPeriodSharesInitialPublicOffering" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIStockIssuedDuringPeriodSharesInitialPublicOffering" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficitParenthetical" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Stockholders&apos; Equity (Deficit) (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_NoncashLeaseExpense" xlink:label="loc_RELINoncashLeaseExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_RELINoncashLeaseExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EarnoutFairValueAndWriteoffAdjustments" xlink:label="loc_RELIEarnoutFairValueAndWriteoffAdjustments" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_RELIEarnoutFairValueAndWriteoffAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_RecognitionAndChangeInFairValueOfWarrantLiability" xlink:label="loc_RELIRecognitionAndChangeInFairValueOfWarrantLiability" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_RELIRecognitionAndChangeInFairValueOfWarrantLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivableRelatedParties" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivableRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayable" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInRestructuringReserve" xlink:label="loc_us-gaapIncreaseDecreaseInRestructuringReserve" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInRestructuringReserve" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherDebt" xlink:label="loc_us-gaapRepaymentsOfOtherDebt" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfOtherDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ProceedsFromLoanForBusinessAcquisition" xlink:label="loc_RELIProceedsFromLoanForBusinessAcquisition" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_RELIProceedsFromLoanForBusinessAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PaymentsOnEarnoutLiabilities" xlink:label="loc_RELIPaymentsOnEarnoutLiabilities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_RELIPaymentsOnEarnoutLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_RepaymentsOnShorttermFinancing" xlink:label="loc_RELIRepaymentsOnShorttermFinancing" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_RELIRepaymentsOnShorttermFinancing" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants" xlink:label="loc_RELINetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_RELINetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_IssuanceOfSeriesDWarrants" xlink:label="loc_RELIIssuanceOfSeriesDWarrants" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_RELIIssuanceOfSeriesDWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_IssuanceOfPlacementAgentWarrants" xlink:label="loc_RELIIssuanceOfPlacementAgentWarrants" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_RELIIssuanceOfPlacementAgentWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PrepaidInsuranceAcquiredThroughShorttermFinancing" xlink:label="loc_RELIPrepaidInsuranceAcquiredThroughShorttermFinancing" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_RELIPrepaidInsuranceAcquiredThroughShorttermFinancing" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaapConversionOfStockAmountConverted1" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapConversionOfStockAmountConverted1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CommonStockIssuedPursuantToAcquisition" xlink:label="loc_RELICommonStockIssuedPursuantToAcquisition" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_RELICommonStockIssuedPursuantToAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssued1" xlink:label="loc_us-gaapStockIssued1" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapStockIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_IssuanceOfCommonStockPursuantToPurchaseOfSoftware" xlink:label="loc_RELIIssuanceOfCommonStockPursuantToPurchaseOfSoftware" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_RELIIssuanceOfCommonStockPursuantToPurchaseOfSoftware" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AcquisitionOfBusinessDeferredPurchasePrice" xlink:label="loc_RELIAcquisitionOfBusinessDeferredPurchasePrice" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_RELIAcquisitionOfBusinessDeferredPurchasePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_LeaseAssetsAcquiredInExchangeForLeaseLiabilities" xlink:label="loc_RELILeaseAssetsAcquiredInExchangeForLeaseLiabilities" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_RELILeaseAssetsAcquiredInExchangeForLeaseLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinations" xlink:title="00000009 - Disclosure - STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssets" xlink:title="00000010 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancings" xlink:title="00000011 - Disclosure - LONG-TERM DEBT AND SHORT-TERM FINANCINGS">
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:label="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_LongTermDebtAndShortTermFinancingsTextBlock" xlink:label="loc_RELILongTermDebtAndShortTermFinancingsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:to="loc_RELILongTermDebtAndShortTermFinancingsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/WarrantLiabilities" xlink:title="00000012 - Disclosure - WARRANT LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DisclosureWarrantLiabilitiesAbstract" xlink:label="loc_RELIDisclosureWarrantLiabilitiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantLiabilitiesTextBlock" xlink:label="loc_RELIWarrantLiabilitiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureWarrantLiabilitiesAbstract" xlink:to="loc_RELIWarrantLiabilitiesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/Equity" xlink:title="00000013 - Disclosure - EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/EarningsLossPerShare" xlink:title="00000014 - Disclosure - EARNINGS (LOSS) PER SHARE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/Leases" xlink:title="00000015 - Disclosure - LEASES">
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DisclosureLeasesAbstract" xlink:label="loc_RELIDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/CommitmentsAndContingencies" xlink:title="00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesPolicies" xlink:title="00000017 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_LiquidityPolicyTextBlock" xlink:label="loc_RELILiquidityPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RELILiquidityPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PriorPeriodAdjustmentPolicyTextBlock" xlink:label="loc_RELIPriorPeriodAdjustmentPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_RELIPriorPeriodAdjustmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables" xlink:title="00000018 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:label="loc_us-gaapScheduleOfRestrictedCashAndCashEquivalentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ScheduleOfReconcilesWarrantCommitmentTableTextBlock" xlink:label="loc_RELIScheduleOfReconcilesWarrantCommitmentTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_RELIScheduleOfReconcilesWarrantCommitmentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:label="loc_us-gaapFairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapFairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="loc_us-gaapSchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapSchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:label="loc_us-gaapScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsTables" xlink:title="00000019 - Disclosure - STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MedigapHealthcareInsuranceCompanyMember" xlink:label="loc_RELIMedigapHealthcareInsuranceCompanyMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIMedigapHealthcareInsuranceCompanyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraMember" xlink:label="loc_RELIBarraMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIBarraMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:title="00000020 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaapScheduleOfGoodwillTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfGoodwillTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsTables" xlink:title="00000021 - Disclosure - LONG-TERM DEBT AND SHORT-TERM FINANCINGS (Tables)">
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:label="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="loc_us-gaapScheduleOfDebtInstrumentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:to="loc_us-gaapScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:to="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/EarningsLossPerShareTables" xlink:title="00000022 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/LeasesTables" xlink:title="00000023 - Disclosure - LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DisclosureLeasesAbstract" xlink:label="loc_RELIDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/CommitmentsAndContingenciesTables" xlink:title="00000024 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EarnOutLiabilitiesTableTextBlock" xlink:label="loc_RELIEarnOutLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_RELIEarnOutLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfRestrictedCashInStatementOfCashFlowDetails" xlink:title="00000025 - Disclosure - SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaapRestrictedCashCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRestrictedCashCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfFairValueOfWarrantCommitmentDetails" xlink:title="00000026 - Disclosure - SCHEDULE OF FAIR VALUE OF WARRANT COMMITMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaapMeasurementInputSharePriceMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputSharePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfReconcilesWarrantCommitmentDetails" xlink:title="00000027 - Disclosure - SCHEDULE OF RECONCILES WARRANT COMMITMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsTable" xlink:label="loc_us-gaapOffsettingAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOffsettingAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="loc_us-gaapOffsettingAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapOffsettingAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesBWarrantCommitmentMember" xlink:label="loc_RELISeriesBWarrantCommitmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_RELISeriesBWarrantCommitmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesBWarrantLiabilityMember" xlink:label="loc_RELISeriesBWarrantLiabilityMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_RELISeriesBWarrantLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PlacementAgentWarrantsMember" xlink:label="loc_RELIPlacementAgentWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_RELIPlacementAgentWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantCommitment" xlink:label="loc_RELIWarrantCommitment" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_RELIWarrantCommitment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_InitialRecognitionOfWarrantCommitment" xlink:label="loc_RELIInitialRecognitionOfWarrantCommitment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_RELIInitialRecognitionOfWarrantCommitment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantCommitmentUnrealizedGainLoss" xlink:label="loc_RELIWarrantCommitmentUnrealizedGainLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_RELIWarrantCommitmentUnrealizedGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantsExercisedOrTransferred" xlink:label="loc_RELIWarrantsExercisedOrTransferred" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_RELIWarrantsExercisedOrTransferred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantCommitment" xlink:label="loc_RELIWarrantCommitment_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_RELIWarrantCommitment_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfFairValueMeasurementsDetails" xlink:title="00000028 - Disclosure - SCHEDULE OF FAIR VALUE MEASUREMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ValuationTechnique" xlink:label="loc_RELIValuationTechnique" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_RELIValuationTechnique" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SignificantUnobservableInput" xlink:label="loc_RELISignificantUnobservableInput" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_RELISignificantUnobservableInput" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails" xlink:title="00000029 - Disclosure - SCHEDULE OF EARN OUT LIABILITY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MeasurementInputRiskPremiumMember" xlink:label="loc_RELIMeasurementInputRiskPremiumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_RELIMeasurementInputRiskPremiumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputCreditSpreadMember" xlink:label="loc_us-gaapMeasurementInputCreditSpreadMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputCreditSpreadMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MeasurementInputPaymentDelayMember" xlink:label="loc_RELIMeasurementInputPaymentDelayMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_RELIMeasurementInputPaymentDelayMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="loc_us-gaapDerivativeLiabilityMeasurementInput" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapDerivativeLiabilityMeasurementInput" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_RiskFreeRate" xlink:label="loc_RELIRiskFreeRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_RELIRiskFreeRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DiscountingConvention" xlink:label="loc_RELIDiscountingConvention" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_RELIDiscountingConvention" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_NumberOfLterations" xlink:label="loc_RELINumberOfLterations" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_RELINumberOfLterations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails" xlink:title="00000030 - Disclosure - SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_JPKushAcquisitionMember" xlink:label="loc_RELIJPKushAcquisitionMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIJPKushAcquisitionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraAcquisitionMember" xlink:label="loc_RELIBarraAcquisitionMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIBarraAcquisitionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CCSWriteoffMember" xlink:label="loc_RELICCSWriteoffMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELICCSWriteoffMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AltruisPartialSettlementMember" xlink:label="loc_RELIAltruisPartialSettlementMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIAltruisPartialSettlementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MontanaFinalSettlementMember" xlink:label="loc_RELIMontanaFinalSettlementMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIMontanaFinalSettlementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiability" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AcquisitionsAndSettlements" xlink:label="loc_RELIAcquisitionsAndSettlements" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_RELIAcquisitionsAndSettlements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease" xlink:label="loc_us-gaapFairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapFairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiability_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiability_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EarnoutLiabilityCurrent" xlink:label="loc_RELIEarnoutLiabilityCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_RELIEarnoutLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EarnoutLiabilityNoncurrent" xlink:label="loc_RELIEarnoutLiabilityNoncurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_RELIEarnoutLiabilityNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails" xlink:title="00000031 - Disclosure - SCHEDULE OF DISAGGREGATION REVENUE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MedicalLifeMember" xlink:label="loc_RELIMedicalLifeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_RELIMedicalLifeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PropertyAndCasualtyMember" xlink:label="loc_RELIPropertyAndCasualtyMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_RELIPropertyAndCasualtyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" xlink:to="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_RegularMember" xlink:label="loc_RELIRegularMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" xlink:to="loc_RELIRegularMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PropertyAndCasualtyMember" xlink:label="loc_RELIPropertyAndCasualtyMember_2" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" xlink:to="loc_RELIPropertyAndCasualtyMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtConsolidatedEntitiesAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EmployeeBenefitsSolutionsLLCMember" xlink:label="loc_RELIEmployeeBenefitsSolutionsLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_RELIEmployeeBenefitsSolutionsLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_USBenefitsAllianceLLCMember" xlink:label="loc_RELIUSBenefitsAllianceLLCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_RELIUSBenefitsAllianceLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CommercialCoverageSolutionsLLCMember" xlink:label="loc_RELICommercialCoverageSolutionsLLCMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_RELICommercialCoverageSolutionsLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SouthwesternMontanaFinancialCenterIncMember" xlink:label="loc_RELISouthwesternMontanaFinancialCenterIncMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_RELISouthwesternMontanaFinancialCenterIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_FortmanInsuranceServicesLLCMember" xlink:label="loc_RELIFortmanInsuranceServicesLLCMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_RELIFortmanInsuranceServicesLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AltruisBenefitsConsultingIncMember" xlink:label="loc_RELIAltruisBenefitsConsultingIncMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_RELIAltruisBenefitsConsultingIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_KushMember" xlink:label="loc_RELIKushMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_RELIKushMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MedigapMember" xlink:label="loc_RELIMedigapMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_RELIMedigapMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraMember" xlink:label="loc_RELIBarraMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_RELIBarraMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails" xlink:title="00000032 - Disclosure - SCHEDULE OF CONCENTRATIONS OF REVENUES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_LTCGlobalMember" xlink:label="loc_RELILTCGlobalMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RELILTCGlobalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PriorityHealthMember" xlink:label="loc_RELIPriorityHealthMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RELIPriorityHealthMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BlueCrossBlueShieldMember" xlink:label="loc_RELIBlueCrossBlueShieldMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_RELIBlueCrossBlueShieldMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/SummarizesChangesToPreviouslyIssuedFinancialInformationDetails" xlink:title="00000033 - Disclosure - SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember" xlink:label="loc_srtRestatementAdjustmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRestatementAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="loc_us-gaapCommonStockSharesSubscriptions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesSubscriptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000034 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CustomerMember" xlink:label="loc_RELICustomerMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_RELICustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalents" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WorkingCapitalDeficiency" xlink:label="loc_RELIWorkingCapitalDeficiency" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_RELIWorkingCapitalDeficiency" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_RecognitionAndChangeInFairValueOfWarrantLiability" xlink:label="loc_RELIRecognitionAndChangeInFairValueOfWarrantLiability" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_RELIRecognitionAndChangeInFairValueOfWarrantLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants" xlink:label="loc_RELINetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_RELINetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PaymentsToUndiscountedRemainingEarnOut" xlink:label="loc_RELIPaymentsToUndiscountedRemainingEarnOut" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_RELIPaymentsToUndiscountedRemainingEarnOut" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails" xlink:title="00000035 - Disclosure - SCHEDULE OF ALLOCATION OF PURCHASE PRICE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MedigapHealthcareInsuranceCompanyMember" xlink:label="loc_RELIMedigapHealthcareInsuranceCompanyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIMedigapHealthcareInsuranceCompanyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraMember" xlink:label="loc_RELIBarraMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIBarraMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_RightOfUseAssetMember" xlink:label="loc_RELIRightOfUseAssetMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIRightOfUseAssetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaapTradeNamesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTradeNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:label="loc_us-gaapTechnologyBasedIntangibleAssetsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTechnologyBasedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BackLogMember" xlink:label="loc_RELIBackLogMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIBackLogMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChargebackReserveMember" xlink:label="loc_RELIChargebackReserveMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIChargebackReserveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_LeaseLiabilityMember" xlink:label="loc_RELILeaseLiabilityMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELILeaseLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillMember" xlink:label="loc_us-gaapGoodwillMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapGoodwillMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AcquiredAccountsReceivableMember" xlink:label="loc_RELIAcquiredAccountsReceivableMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIAcquiredAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AgencyRelationshipsMember" xlink:label="loc_RELIAgencyRelationshipsMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIAgencyRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DevelopedTechnologyMember" xlink:label="loc_RELIDevelopedTechnologyMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIDevelopedTechnologyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_FinitelivedIntangibleAssetUsefulLives" xlink:label="loc_RELIFinitelivedIntangibleAssetUsefulLives" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_RELIFinitelivedIntangibleAssetUsefulLives" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfProFormaInformationRelatedToAcquisitionDetails" xlink:title="00000036 - Disclosure - SCHEDULE OF PRO FORMA INFORMATION RELATED TO ACQUISITION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MedigapHealthcareInsuranceCompanyMember" xlink:label="loc_RELIMedigapHealthcareInsuranceCompanyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIMedigapHealthcareInsuranceCompanyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraMember" xlink:label="loc_RELIBarraMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIBarraMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:label="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareBasic" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:label="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareDiluted" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative" xlink:title="00000037 - Disclosure - STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MedigapHealthcareInsuranceCompanyMember" xlink:label="loc_RELIMedigapHealthcareInsuranceCompanyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIMedigapHealthcareInsuranceCompanyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraMember" xlink:label="loc_RELIBarraMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIBarraMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MeasurementInputRoyaltyRateMember" xlink:label="loc_RELIMeasurementInputRoyaltyRateMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_RELIMeasurementInputRoyaltyRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaapMeasurementInputDiscountRateMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputDiscountRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MeasurementInputObsolescenceRateMember" xlink:label="loc_RELIMeasurementInputObsolescenceRateMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_RELIMeasurementInputObsolescenceRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaapTradeNamesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTradeNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:label="loc_us-gaapTechnologyBasedIntangibleAssetsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTechnologyBasedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BackLogMember" xlink:label="loc_RELIBackLogMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIBackLogMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DevelopedTechnologyMember" xlink:label="loc_RELIDevelopedTechnologyMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIDevelopedTechnologyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_APAMember" xlink:label="loc_RELIAPAMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RELIAPAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaapAssetAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapAssetAcquisitionAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraAndAssociatesLLCMember" xlink:label="loc_RELIBarraAndAssociatesLLCMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_RELIBarraAndAssociatesLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_srtStatementScenarioAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PaidAtClosingMember" xlink:label="loc_RELIPaidAtClosingMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_RELIPaidAtClosingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PayableInSixMonthsMember" xlink:label="loc_RELIPayableInSixMonthsMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_RELIPayableInSixMonthsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PayableOverTwoYearsMember" xlink:label="loc_RELIPayableOverTwoYearsMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_RELIPayableOverTwoYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:label="loc_us-gaapBusinessCombinationBargainPurchaseGainRecognizedAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityMeasurementInput" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquisitionCosts" xlink:label="loc_us-gaapAcquisitionCosts" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapAcquisitionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" xlink:label="loc_us-gaapBusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SharesIssuedUponTerminationOfEmployee" xlink:label="loc_RELISharesIssuedUponTerminationOfEmployee" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_RELISharesIssuedUponTerminationOfEmployee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferred" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferred" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WorkingCapital" xlink:label="loc_RELIWorkingCapital" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_RELIWorkingCapital" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfImpairmentOfGoodwillDetails" xlink:title="00000038 - Disclosure - SCHEDULE OF IMPAIRMENT OF GOODWILL (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MedigapHealthcareInsuranceCompanyMember" xlink:label="loc_RELIMedigapHealthcareInsuranceCompanyMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIMedigapHealthcareInsuranceCompanyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraMember" xlink:label="loc_RELIBarraMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIBarraMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaapGoodwillAcquiredDuringPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapGoodwillAcquiredDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapGoodwill_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails" xlink:title="00000039 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="loc_us-gaapTrademarksAndTradeNamesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksAndTradeNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_InternallyDevelopedSoftwareMember" xlink:label="loc_RELIInternallyDevelopedSoftwareMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIInternallyDevelopedSoftwareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_PurchasedSoftwareMember" xlink:label="loc_RELIPurchasedSoftwareMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIPurchasedSoftwareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_VideoProductionAssetsMember" xlink:label="loc_RELIVideoProductionAssetsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIVideoProductionAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_NoncompetitionAgreementsMember" xlink:label="loc_RELINoncompetitionAgreementsMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELINoncompetitionAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ContractsBacklogMember" xlink:label="loc_RELIContractsBacklogMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_RELIContractsBacklogMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails" xlink:title="00000040 - Disclosure - SCHEDULE OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsDetailsNarrative" xlink:title="00000041 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember" xlink:label="loc_srtRestatementAdjustmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRestatementAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical" xlink:title="00000042 - Disclosure - SCHEDULE OF LONG TERM DEBT (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:label="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EBSandUSBAMember" xlink:label="loc_RELIEBSandUSBAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIEBSandUSBAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SWMTMember" xlink:label="loc_RELISWMTMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELISWMTMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_FISMember" xlink:label="loc_RELIFISMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIFISMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ABCMember" xlink:label="loc_RELIABCMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIABCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraMember" xlink:label="loc_RELIBarraMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIBarraMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaapCreditFacilityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapCreditFacilityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CCSMember" xlink:label="loc_RELICCSMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_RELICCSMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDeferredCostsNet" xlink:label="loc_us-gaapOtherDeferredCostsNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapOtherDeferredCostsNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails" xlink:title="00000043 - Disclosure - SCHEDULE OF LONG TERM DEBT (Details)">
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:label="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EBSandUSBAMember" xlink:label="loc_RELIEBSandUSBAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIEBSandUSBAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SWMTMember" xlink:label="loc_RELISWMTMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELISWMTMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_FISMember" xlink:label="loc_RELIFISMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIFISMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ABCMember" xlink:label="loc_RELIABCMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIABCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraMember" xlink:label="loc_RELIBarraMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIBarraMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaapCreditFacilityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapCreditFacilityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaapCreditFacilityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditFacilityAxis" xlink:to="loc_us-gaapCreditFacilityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CCSMember" xlink:label="loc_RELICCSMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreditFacilityDomain" xlink:to="loc_RELICCSMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails" xlink:title="00000044 - Disclosure - SCHEDULE OF CUMULATIVE MATURITIES OF LONG-TERM LOANS AND CREDIT FACILITIES (Details)">
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:label="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaapDeferredFinanceCostsNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:to="loc_us-gaapDeferredFinanceCostsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsDetailsNarrative" xlink:title="00000045 - Disclosure - LONG-TERM DEBT AND SHORT-TERM FINANCINGS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:label="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLongtermDebtAndShorttermFinancingsAbstract" xlink:to="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DirectorsAndOfficerMember" xlink:label="loc_RELIDirectorsAndOfficerMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RELIDirectorsAndOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBankLoansAndNotesPayable" xlink:label="loc_us-gaapShortTermBankLoansAndNotesPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapShortTermBankLoansAndNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative" xlink:title="00000046 - Disclosure - WARRANT LIABILITIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DisclosureWarrantLiabilitiesAbstract" xlink:label="loc_RELIDisclosureWarrantLiabilitiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureWarrantLiabilitiesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SecuritiesPurchaseAgreementMember" xlink:label="loc_RELISecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_RELISecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesBConvertiblePreferredStockMember" xlink:label="loc_RELISeriesBConvertiblePreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_RELISeriesBConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesBWarrantLiabilityMember" xlink:label="loc_RELISeriesBWarrantLiabilityMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_RELISeriesBWarrantLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaapConversionOfStockSharesIssued1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesIssued1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConvertibleConversionPrice" xlink:label="loc_us-gaapPreferredStockConvertibleConversionPrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockConvertibleConversionPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants" xlink:label="loc_RELIAggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIAggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:label="loc_us-gaapEquitySecuritiesFvNiUnrealizedLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquitySecuritiesFvNiUnrealizedLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGain" xlink:label="loc_us-gaapEquitySecuritiesFvNiUnrealizedGain" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquitySecuritiesFvNiUnrealizedGain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_NonOperatingUnrealizedGains" xlink:label="loc_RELINonOperatingUnrealizedGains" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELINonOperatingUnrealizedGains" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantCommitment" xlink:label="loc_RELIWarrantCommitment" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIWarrantCommitment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_IssuanceOfPlacementAgentWarrants" xlink:label="loc_RELIIssuanceOfPlacementAgentWarrants" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIIssuanceOfPlacementAgentWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantCommitmentUnrealizedGainLoss" xlink:label="loc_RELIWarrantCommitmentUnrealizedGainLoss" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_RELIWarrantCommitmentUnrealizedGainLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/EquityDetailsNarrative" xlink:title="00000047 - Disclosure - EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesBConvertiblePreferredStockMember" xlink:label="loc_RELISeriesBConvertiblePreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_RELISeriesBConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesCPrepaidWarrantsMember" xlink:label="loc_RELISeriesCPrepaidWarrantsMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_RELISeriesCPrepaidWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesDPrepaidWarrantsMember" xlink:label="loc_RELISeriesDPrepaidWarrantsMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_RELISeriesDPrepaidWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesAWarrantMember" xlink:label="loc_RELISeriesAWarrantMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_RELISeriesAWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_MedigapAcquisitionMember" xlink:label="loc_RELIMedigapAcquisitionMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIMedigapAcquisitionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtTitleOfIndividualAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ThreeEmployeesMember" xlink:label="loc_RELIThreeEmployeesMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_RELIThreeEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_RELIStockIssuedDuringPeriodSharesWarrantsExercised" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_RELIStockIssuedDuringPeriodSharesWarrantsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails" xlink:title="00000048 - Disclosure - SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DeemedDividend" xlink:label="loc_RELIDeemedDividend" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_RELIDeemedDividend" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToShareBasedPaymentArrangements" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_EffectOfSeriesBWarrantLiability" xlink:label="loc_RELIEffectOfSeriesBWarrantLiability" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_RELIEffectOfSeriesBWarrantLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative" xlink:title="00000049 - Disclosure - EARNINGS (LOSS) PER SHARE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:label="loc_us-gaapEarningsPerShareBasicLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapEarningsPerShareBasicLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesCPrepaidWarrantsMember" xlink:label="loc_RELISeriesCPrepaidWarrantsMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_RELISeriesCPrepaidWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesDPrepaidWarrantsMember" xlink:label="loc_RELISeriesDPrepaidWarrantsMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_RELISeriesDPrepaidWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesAWarrantsMember" xlink:label="loc_RELISeriesAWarrantsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_RELISeriesAWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SeriesBWarrantLiabilityMember" xlink:label="loc_RELISeriesBWarrantLiabilityMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_RELISeriesBWarrantLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockConversionBasis" xlink:label="loc_us-gaapPreferredStockConversionBasis" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapPreferredStockConversionBasis" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AntidilutiveSharesIssuedAndOutstanding" xlink:label="loc_RELIAntidilutiveSharesIssuedAndOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_RELIAntidilutiveSharesIssuedAndOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantSharesIssued" xlink:label="loc_RELIWarrantSharesIssued" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_RELIWarrantSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_WarrantSharesOutstanding" xlink:label="loc_RELIWarrantSharesOutstanding" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_RELIWarrantSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_IssuanceOfSeriesDWarrants" xlink:label="loc_RELIIssuanceOfSeriesDWarrants" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_RELIIssuanceOfSeriesDWarrants" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails" xlink:title="00000050 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DisclosureLeasesAbstract" xlink:label="loc_RELIDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/LeasesDetailsNarrative" xlink:title="00000051 - Disclosure - LEASES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_DisclosureLeasesAbstract" xlink:label="loc_RELIDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_RELIDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails" xlink:title="00000052 - Disclosure - SCHEDULE OF EARN-OUT LIABILITY (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_CommercialSolutionsOfInsuranceAgencyLLCMember" xlink:label="loc_RELICommercialSolutionsOfInsuranceAgencyLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELICommercialSolutionsOfInsuranceAgencyLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_FortmanInsuranceAgencyLLCMember" xlink:label="loc_RELIFortmanInsuranceAgencyLLCMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIFortmanInsuranceAgencyLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_SouthwesternMontanaInsuranceCenterIncMember" xlink:label="loc_RELISouthwesternMontanaInsuranceCenterIncMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELISouthwesternMontanaInsuranceCenterIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_AltruisBenefitsConsultantsIncMember" xlink:label="loc_RELIAltruisBenefitsConsultantsIncMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIAltruisBenefitsConsultantsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_JPKushAndAssociatesIncMember" xlink:label="loc_RELIJPKushAndAssociatesIncMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIJPKushAndAssociatesIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_BarraMember" xlink:label="loc_RELIBarraMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_RELIBarraMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiability" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChangesDueToAcquisitions" xlink:label="loc_RELIChangesDueToAcquisitions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RELIChangesDueToAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChangesDueToPayments" xlink:label="loc_RELIChangesDueToPayments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RELIChangesDueToPayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChangesDueToFairValueAdjustments" xlink:label="loc_RELIChangesDueToFairValueAdjustments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RELIChangesDueToFairValueAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiability_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiability_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChangesDueToBusinessCombinations" xlink:label="loc_RELIChangesDueToBusinessCombinations" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RELIChangesDueToBusinessCombinations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="reli-20220630.xsd#RELI_ChangesDueToWriteoffs" xlink:label="loc_RELIChangesDueToWriteoffs" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_RELIChangesDueToWriteoffs" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472844898368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Aug. 15, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RELIANCE
GLOBAL GROUP, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001812727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-3390293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">FL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">300
Blvd. of the Americas<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lakewood<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">380-4600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,457,075<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RELI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=RELI_SeriesAWarrantsMember', window );">Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Series
    A Warrants<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RELIW<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=RELI_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=RELI_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472844960208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 2,979,769<span></span>
</td>
<td class="nump">$ 4,136,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">1,417,635<span></span>
</td>
<td class="nump">484,542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">1,072,294<span></span>
</td>
<td class="nump">1,024,831<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedPartiesCurrent', window );">Accounts receivable, related parties</a></td>
<td class="nump">54,414<span></span>
</td>
<td class="nump">7,131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expense and other current assets</a></td>
<td class="nump">576,691<span></span>
</td>
<td class="nump">2,328,817<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">6,100,803<span></span>
</td>
<td class="nump">7,981,501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">164,017<span></span>
</td>
<td class="nump">130,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">1,421,474<span></span>
</td>
<td class="nump">1,067,734<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investment in NSURE, Inc.</a></td>
<td class="nump">1,350,000<span></span>
</td>
<td class="nump">1,350,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangibles, net</a></td>
<td class="nump">14,751,751<span></span>
</td>
<td class="nump">7,078,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">33,486,107<span></span>
</td>
<td class="nump">10,050,277<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">23,284<span></span>
</td>
<td class="nump">16,792<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">57,297,436<span></span>
</td>
<td class="nump">27,675,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and other accrued liabilities</a></td>
<td class="nump">1,051,333<span></span>
</td>
<td class="nump">2,759,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChargebackReserveCurrent', window );">Chargeback reserve</a></td>
<td class="nump">1,559,541<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Other payables</a></td>
<td class="nump">1,333,484<span></span>
</td>
<td class="nump">81,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ShortTermFinancingAgreements', window );">Short term Financing Agreements</a></td>
<td class="nump">376,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">936,263<span></span>
</td>
<td class="nump">913,920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of leases payable</a></td>
<td class="nump">528,902<span></span>
</td>
<td class="nump">276,009<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Earn-out liability, current portion</a></td>
<td class="nump">3,683,596<span></span>
</td>
<td class="nump">3,297,855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantCommitmentCurrent', window );">Warrant commitment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">37,652,808<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">9,469,766<span></span>
</td>
<td class="nump">44,981,252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesNoncurrent', window );">Loans payable, related parties, less current portion</a></td>
<td class="nump">332,225<span></span>
</td>
<td class="nump">353,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long term debt, less current portion</a></td>
<td class="nump">12,935,649<span></span>
</td>
<td class="nump">7,085,325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Leases payable, less current portion</a></td>
<td class="nump">930,623<span></span>
</td>
<td class="nump">805,326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Earn-out liability, less current portion</a></td>
<td class="nump">673,837<span></span>
</td>
<td class="nump">516,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantLiabilityNonCurrent', window );">Warrant liabilities</a></td>
<td class="nump">11,026,893<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">35,368,993<span></span>
</td>
<td class="nump">53,741,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.086 par value; 750,000,000 shares authorized and 9,076 and 0 issued and outstanding as of June 30, 2022 and December 31, 2021, respectively</a></td>
<td class="nump">781<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.086 par value; 2,000,000,000 shares authorized and 14,614,038 and 10,956,109 issued and outstanding as of June 30, 2022 and December 31, 2021, respectively</a></td>
<td class="nump">1,255,408<span></span>
</td>
<td class="nump">940,829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">34,294,708<span></span>
</td>
<td class="nump">26,451,187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteSubscriptionsReceivable', window );">Stock subscription receivable</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(20,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(13,622,454)<span></span>
</td>
<td class="num">(33,458,145)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity (deficit)</a></td>
<td class="nump">21,928,443<span></span>
</td>
<td class="num">(26,066,129)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity (deficit)</a></td>
<td class="nump">$ 57,297,436<span></span>
</td>
<td class="nump">$ 27,675,563<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_ChargebackReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Chargeback reserve current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_ChargebackReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_ShortTermFinancingAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short term financing agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_ShortTermFinancingAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_WarrantCommitmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant commitment current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_WarrantCommitmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_WarrantLiabilityNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant liability non current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_WarrantLiabilityNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableOtherCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteSubscriptionsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Note received instead of cash as contribution to equity. The transaction may be a sale of capital stock or a contribution to paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=65888546&amp;loc=d3e21300-112643<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteSubscriptionsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472844910896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.086<span></span>
</td>
<td class="nump">$ 0.086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">9,076<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">9,076<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.086<span></span>
</td>
<td class="nump">$ 0.086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">14,614,038<span></span>
</td>
<td class="nump">10,956,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">14,614,038<span></span>
</td>
<td class="nump">10,956,109<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472843737136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_CommissionIncome', window );">Commission income</a></td>
<td class="nump">$ 4,207,126<span></span>
</td>
<td class="nump">$ 2,190,847<span></span>
</td>
<td class="nump">$ 8,442,907<span></span>
</td>
<td class="nump">$ 4,514,577<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">4,207,126<span></span>
</td>
<td class="nump">2,190,847<span></span>
</td>
<td class="nump">8,442,907<span></span>
</td>
<td class="nump">4,514,577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_CommissionExpense', window );">Commission expense</a></td>
<td class="nump">850,128<span></span>
</td>
<td class="nump">558,271<span></span>
</td>
<td class="nump">1,754,283<span></span>
</td>
<td class="nump">1,087,743<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Salaries and wages</a></td>
<td class="nump">2,176,792<span></span>
</td>
<td class="nump">1,110,629<span></span>
</td>
<td class="nump">4,258,967<span></span>
</td>
<td class="nump">2,029,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">1,759,217<span></span>
</td>
<td class="nump">1,202,350<span></span>
</td>
<td class="nump">4,212,287<span></span>
</td>
<td class="nump">2,206,751<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Marketing and advertising</a></td>
<td class="nump">609,383<span></span>
</td>
<td class="nump">55,021<span></span>
</td>
<td class="nump">1,196,405<span></span>
</td>
<td class="nump">78,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">756,403<span></span>
</td>
<td class="nump">369,366<span></span>
</td>
<td class="nump">1,363,928<span></span>
</td>
<td class="nump">702,454<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">6,151,923<span></span>
</td>
<td class="nump">3,295,637<span></span>
</td>
<td class="nump">12,785,870<span></span>
</td>
<td class="nump">6,104,222<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(1,944,797)<span></span>
</td>
<td class="num">(1,104,790)<span></span>
</td>
<td class="num">(4,342,963)<span></span>
</td>
<td class="num">(1,589,645)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Other expense, net</a></td>
<td class="num">(192,763)<span></span>
</td>
<td class="num">(172,096)<span></span>
</td>
<td class="num">(300,560)<span></span>
</td>
<td class="num">(301,167)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_RecognitionAndChangeInFairValueOfWarrantLiability', window );">Recognition and change in fair value of warrant liabilities</a></td>
<td class="nump">12,633,251<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">24,479,215<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="nump">12,440,488<span></span>
</td>
<td class="num">(172,096)<span></span>
</td>
<td class="nump">24,178,655<span></span>
</td>
<td class="num">(301,167)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 10,495,691<span></span>
</td>
<td class="num">$ (1,276,886)<span></span>
</td>
<td class="nump">$ 19,835,692<span></span>
</td>
<td class="num">$ (1,890,812)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings (loss) per share</a></td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="num">$ (0.20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings (loss) per share</a></td>
<td class="num">$ (0.10)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.59)<span></span>
</td>
<td class="num">$ (0.20)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of shares outstanding - Basic</a></td>
<td class="nump">18,738,290<span></span>
</td>
<td class="nump">10,934,489<span></span>
</td>
<td class="nump">17,238,285<span></span>
</td>
<td class="nump">9,259,738<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of shares outstanding - Diluted</a></td>
<td class="nump">20,989,290<span></span>
</td>
<td class="nump">10,934,489<span></span>
</td>
<td class="nump">20,134,729<span></span>
</td>
<td class="nump">9,259,738<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_CommissionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_CommissionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_CommissionIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_CommissionIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_RecognitionAndChangeInFairValueOfWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recognition and change in fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_RecognitionAndChangeInFairValueOfWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalariesAndWages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalariesAndWages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472838299968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Preferred Stock [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Common stock issuable [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Subscription receivable [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2020</a></td>
<td class="nump">$ 33,912<span></span>
</td>
<td class="nump">$ 363,517<span></span>
</td>
<td class="nump">$ 340,000<span></span>
</td>
<td class="nump">$ 11,559,239<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (12,359,680)<span></span>
</td>
<td class="num">$ (63,012)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2020</a></td>
<td class="nump">395,640<span></span>
</td>
<td class="nump">4,241,028<span></span>
</td>
<td class="nump">23,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Share based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">246,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">246,966<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued due to public offering, net of offering costs of $1,672,852</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 154,800<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,954,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,109,148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Beginning balance, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(613,926)<span></span>
</td>
<td class="num">(613,926)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Shares issued for services</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,290<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">89,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">91,050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Beginning balance, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_StockIssuedDuringPeriodValueOverAllotmentShares', window );">Over-allotment shares from offering, net of offering costs of $250,928</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 23,220<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,343,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,366,373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_StockIssuedDuringPeriodSharesOverAllotmentShares', window );">Beginning balance, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Warrants sold during public offering at quoted price</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">20,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">20,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Shares issued due to conversion of preferred stock</a></td>
<td class="num">$ (33,812)<span></span>
</td>
<td class="nump">$ 339,264<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(305,452)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Beginning balance, shares</a></td>
<td class="num">(394,493)<span></span>
</td>
<td class="nump">3,944,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_SharesIssuedDuringPeriodValueToConversionOfDebt', window );">Shares issued due to conversion of debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 54,467<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,745,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_SharesIssuedDuringPeriodSharesToConversionOfDebt', window );">Beginning balance, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">633,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_StockIssuedDuringPeriodValueInitialPublicOffering', window );">Rounding shares related to initial public offering</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_StockIssuedDuringPeriodSharesInitialPublicOffering', window );">Beginning balance, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,885<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets', window );">Shares issued pursuant to software purchase</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,984<span></span>
</td>
<td class="num">$ (340,000)<span></span>
</td>
<td class="nump">338,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Beginning balance, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,338<span></span>
</td>
<td class="num">(23,338)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Mar. 31, 2021</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 938,542<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">25,992,263<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(12,973,606)<span></span>
</td>
<td class="nump">13,957,299<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Mar. 31, 2021</a></td>
<td class="nump">1,147<span></span>
</td>
<td class="nump">10,929,514<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2020</a></td>
<td class="nump">$ 33,912<span></span>
</td>
<td class="nump">$ 363,517<span></span>
</td>
<td class="nump">$ 340,000<span></span>
</td>
<td class="nump">11,559,239<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(12,359,680)<span></span>
</td>
<td class="num">(63,012)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2020</a></td>
<td class="nump">395,640<span></span>
</td>
<td class="nump">4,241,028<span></span>
</td>
<td class="nump">23,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,890,812)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Jun. 30, 2021</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 939,826<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">26,224,111<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(14,250,492)<span></span>
</td>
<td class="nump">12,913,545<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Jun. 30, 2021</a></td>
<td class="nump">1,167<span></span>
</td>
<td class="nump">10,944,439<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Mar. 31, 2021</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 938,542<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">25,992,263<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(12,973,606)<span></span>
</td>
<td class="nump">13,957,299<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Mar. 31, 2021</a></td>
<td class="nump">1,147<span></span>
</td>
<td class="nump">10,929,514<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Share based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">183,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">183,132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Shares issued pursuant to acquisition of Kush</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,284<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">48,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Beginning balance, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,276,886)<span></span>
</td>
<td class="num">(1,276,886)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_StockIssuedDuringPeriodValueInitialPublicOffering', window );">Rounding shares related to initial public offering</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_StockIssuedDuringPeriodSharesInitialPublicOffering', window );">Beginning balance, shares</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Jun. 30, 2021</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 939,826<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">26,224,111<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(14,250,492)<span></span>
</td>
<td class="nump">12,913,545<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Jun. 30, 2021</a></td>
<td class="nump">1,167<span></span>
</td>
<td class="nump">10,944,439<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 940,829<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">26,451,187<span></span>
</td>
<td class="num">(20,000,000)<span></span>
</td>
<td class="num">(33,458,145)<span></span>
</td>
<td class="num">(26,066,129)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">10,956,109<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Share based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">739,960<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">739,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued due to public offering, net of offering costs of $1,672,852</a></td>
<td class="nump">$ 781<span></span>
</td>
<td class="nump">$ 229,694<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(230,424)<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">20,000,051<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Beginning balance, shares</a></td>
<td class="nump">9,076<span></span>
</td>
<td class="nump">2,670,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Shares issued pursuant to acquisition of Kush</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 52,119<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,711,332<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,763,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Beginning balance, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">606,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of Series A warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 32,250<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,442,750<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,475,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of Series A warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Issuance of prefunded Series C Warrants in exchange for common shares</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (281,815)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">281,815<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Issuance of prefunded Series C Warrants in exchange for common shares, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,276,929)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross', window );">Shares issued for vested stock awards</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 516<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(516)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_StockGrantedDuringPeriodSharesSharebasedCompensationGross', window );">Shares issued for vested stock awards, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,340,000<span></span>
</td>
<td class="nump">9,340,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Mar. 31, 2022</a></td>
<td class="nump">$ 781<span></span>
</td>
<td class="nump">$ 973,593<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">34,396,104<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(24,118,145)<span></span>
</td>
<td class="nump">11,252,333<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Mar. 31, 2022</a></td>
<td class="nump">9,076<span></span>
</td>
<td class="nump">11,337,109<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 940,829<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">26,451,187<span></span>
</td>
<td class="num">(20,000,000)<span></span>
</td>
<td class="num">(33,458,145)<span></span>
</td>
<td class="num">(26,066,129)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">10,956,109<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued due to public offering, net of offering costs of $1,672,852</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 178,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,835,692<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Jun. 30, 2022</a></td>
<td class="nump">$ 781<span></span>
</td>
<td class="nump">$ 1,255,408<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">34,294,708<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(13,622,454)<span></span>
</td>
<td class="nump">21,928,443<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Jun. 30, 2022</a></td>
<td class="nump">9,076<span></span>
</td>
<td class="nump">14,614,038<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Mar. 31, 2022</a></td>
<td class="nump">$ 781<span></span>
</td>
<td class="nump">$ 973,593<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">34,396,104<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(24,118,145)<span></span>
</td>
<td class="nump">11,252,333<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Mar. 31, 2022</a></td>
<td class="nump">9,076<span></span>
</td>
<td class="nump">11,337,109<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Share based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">179,083<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">179,083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,495,691<span></span>
</td>
<td class="nump">10,495,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_StockIssuedDuringPeriodValueWarrantsIntoCommonStock', window );">Exercise of Series C warrants into common shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 281,815<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(280,479)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_StockIssuedDuringPeriodSharesWarrantsIntoCommonStock', window );">Exercise of Series C warrants into common shares, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,276,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Jun. 30, 2022</a></td>
<td class="nump">$ 781<span></span>
</td>
<td class="nump">$ 1,255,408<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 34,294,708<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (13,622,454)<span></span>
</td>
<td class="nump">$ 21,928,443<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Jun. 30, 2022</a></td>
<td class="nump">9,076<span></span>
</td>
<td class="nump">14,614,038<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_SharesIssuedDuringPeriodSharesToConversionOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued during period shares to conversion of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_SharesIssuedDuringPeriodSharesToConversionOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_SharesIssuedDuringPeriodValueToConversionOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>shares issued during period value to conversion of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_SharesIssuedDuringPeriodValueToConversionOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_StockGrantedDuringPeriodSharesSharebasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock granted during period shares share based compensation gross.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_StockGrantedDuringPeriodSharesSharebasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_StockIssuedDuringPeriodSharesInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares initial public offering</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_StockIssuedDuringPeriodSharesInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_StockIssuedDuringPeriodSharesOverAllotmentShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares over allotment shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_StockIssuedDuringPeriodSharesOverAllotmentShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_StockIssuedDuringPeriodSharesWarrantsIntoCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares warrants into common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_StockIssuedDuringPeriodSharesWarrantsIntoCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_StockIssuedDuringPeriodValueInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value initial public offering</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_StockIssuedDuringPeriodValueInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_StockIssuedDuringPeriodValueOverAllotmentShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value over allotment shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_StockIssuedDuringPeriodValueOverAllotmentShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_StockIssuedDuringPeriodValueWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_StockIssuedDuringPeriodValueWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_StockIssuedDuringPeriodValueWarrantsIntoCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value warrants into common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_StockIssuedDuringPeriodValueWarrantsIntoCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472842932336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) (Parenthetical)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of stock issuance costs</a></td>
<td class="nump">$ 1,672,852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of stock issuance costs</a></td>
<td class="nump">$ 250,928<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472840722640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 19,835,692<span></span>
</td>
<td class="num">$ (1,890,812)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustment to reconcile net income (loss) to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,363,928<span></span>
</td>
<td class="nump">702,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt issuance costs and accretion of debt discount</a></td>
<td class="nump">18,291<span></span>
</td>
<td class="nump">20,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_NoncashLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">24,450<span></span>
</td>
<td class="nump">1,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation expense</a></td>
<td class="nump">919,043<span></span>
</td>
<td class="nump">521,148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_EarnoutFairValueAndWriteoffAdjustments', window );">Earn-out fair value and write-off adjustments</a></td>
<td class="nump">354,963<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_RecognitionAndChangeInFairValueOfWarrantLiability', window );">Recognition and change in fair value of warrant liabilities</a></td>
<td class="num">(24,479,215)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Accounts payables and other accrued liabilities</a></td>
<td class="num">(1,711,287)<span></span>
</td>
<td class="num">(805,092)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">45,122<span></span>
</td>
<td class="nump">75,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties', window );">Accounts receivable, related parties</a></td>
<td class="num">(47,283)<span></span>
</td>
<td class="num">(7,131)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayable', window );">Other payables</a></td>
<td class="nump">126,984<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInRestructuringReserve', window );">Charge back reserve</a></td>
<td class="nump">75,068<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="num">(6,492)<span></span>
</td>
<td class="num">(18,035)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expense and other current assets</a></td>
<td class="nump">2,169,325<span></span>
</td>
<td class="num">(92,736)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(1,311,411)<span></span>
</td>
<td class="num">(1,493,252)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(20,989)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="num">(24,138,750)<span></span>
</td>
<td class="num">(1,608,586)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangibles</a></td>
<td class="num">(466,190)<span></span>
</td>
<td class="num">(152,990)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(24,625,929)<span></span>
</td>
<td class="num">(1,761,576)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherDebt', window );">Principal repayments of debt</a></td>
<td class="num">(447,908)<span></span>
</td>
<td class="num">(432,833)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ProceedsFromLoanForBusinessAcquisition', window );">Proceeds from loan for business acquisition</a></td>
<td class="nump">6,520,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance costs</a></td>
<td class="num">(214,257)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_PaymentsOnEarnoutLiabilities', window );">Payments on earn-out liabilities</a></td>
<td class="num">(411,408)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from loans payable, related parties</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,931<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payments of loans payable, related parties</a></td>
<td class="num">(21,541)<span></span>
</td>
<td class="num">(508,307)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of warrants into common stock</a></td>
<td class="nump">2,476,336<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_RepaymentsOnShorttermFinancing', window );">Repayments on short-term financing</a></td>
<td class="num">(40,552)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants', window );">Net proceeds from private placement issuance of shares and warrants</a></td>
<td class="nump">17,853,351<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Issuance of common stock</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">10,496,221<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">25,714,021<span></span>
</td>
<td class="nump">9,558,012<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash and restricted cash</a></td>
<td class="num">(223,319)<span></span>
</td>
<td class="nump">6,303,184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and restricted cash at beginning of period</a></td>
<td class="nump">4,620,722<span></span>
</td>
<td class="nump">529,581<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and restricted cash at end of period</a></td>
<td class="nump">4,397,403<span></span>
</td>
<td class="nump">6,832,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash and non-cash investing and financing transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_IssuanceOfSeriesDWarrants', window );">Issuance of Series D Warrants</a></td>
<td class="nump">6,930,335<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_IssuanceOfPlacementAgentWarrants', window );">Issuance of placement agent warrants</a></td>
<td class="nump">1,525,923<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_PrepaidInsuranceAcquiredThroughShorttermFinancing', window );">Prepaid insurance acquired through short-term financing</a></td>
<td class="nump">417,199<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of preferred stock into common stock</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">339,264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">218,528<span></span>
</td>
<td class="nump">350,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Conversion of debt into equity</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_CommonStockIssuedPursuantToAcquisition', window );">Common stock issued pursuant to acquisition</a></td>
<td class="nump">4,763,451<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Common stock issued in lieu of services</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">91,050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_IssuanceOfCommonStockPursuantToPurchaseOfSoftware', window );">Issuance of common stock pursuant to the purchase of software</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">340,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_AcquisitionOfBusinessDeferredPurchasePrice', window );">Acquisition of business deferred purchase price</a></td>
<td class="nump">1,125,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_LeaseAssetsAcquiredInExchangeForLeaseLiabilities', window );">Lease assets acquired in exchange for lease liabilities</a></td>
<td class="nump">$ 223,922<span></span>
</td>
<td class="nump">$ 861,443<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_AcquisitionOfBusinessDeferredPurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition of business deferred purchase price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_AcquisitionOfBusinessDeferredPurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_CommonStockIssuedPursuantToAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock issued pursuant to acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_CommonStockIssuedPursuantToAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_EarnoutFairValueAndWriteoffAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earnout fair value and writeoff adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_EarnoutFairValueAndWriteoffAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_IssuanceOfCommonStockPursuantToPurchaseOfSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock pursuant to purchase of software</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_IssuanceOfCommonStockPursuantToPurchaseOfSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_IssuanceOfPlacementAgentWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of placement agent warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_IssuanceOfPlacementAgentWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_IssuanceOfSeriesDWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Series D Warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_IssuanceOfSeriesDWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_LeaseAssetsAcquiredInExchangeForLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease assets acquired in exchange for lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_LeaseAssetsAcquiredInExchangeForLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net proceeds from private placement issuance of shares and warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_NoncashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non cash lease expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_NoncashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_PaymentsOnEarnoutLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments on earnout liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_PaymentsOnEarnoutLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_PrepaidInsuranceAcquiredThroughShorttermFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid insurance acquired through short term financing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_PrepaidInsuranceAcquiredThroughShorttermFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_ProceedsFromLoanForBusinessAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from loan for business acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_ProceedsFromLoanForBusinessAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_RecognitionAndChangeInFairValueOfWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recognition and change in fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_RecognitionAndChangeInFairValueOfWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_RepaymentsOnShorttermFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayments on short term financing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_RepaymentsOnShorttermFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due to the reporting entity for good and services provided to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInRestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the carrying amount (including both current and noncurrent portions of the accrual) of the liability pertaining to the exit from or disposal of business activities or restructuring pursuant to a duly authorized plan, excluding costs or losses pertaining to an entity newly acquired in a business combination and to asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInRestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472841662256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--SignificantAccountingPoliciesTextBlock_zeWAZFZ5cqC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1. <span id="xdx_822_zaH8Bt217e27">SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</span></b>&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reliance
Global Group, Inc., formerly known as Ethos Media Network, Inc. (&#8220;RELI&#8221;, &#8220;Reliance&#8221;, or the &#8220;Company&#8221;)
incorporated in Florida on August 2, 2013.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zHDrYB63LSp4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zcKS5w2HHGx7">Basis
of Presentation and Principles of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting
principles in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information and with the instructions for
Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP
for complete financial statements. In the opinion of management, all adjustments (consisting of recurring accruals) necessary for a fair
presentation have been included. These unaudited condensed consolidated financial statements should be read in conjunction with the audited
consolidated financial statements and the notes thereto, set forth in the Company&#8217;s annual report on Form 10-K for the year ended
December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed consolidated financial statements include the accounts of Reliance Global Group, Inc. and its wholly
owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_ecustom--LiquidityPolicyTextBlock_zjM206NJluZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zUX1T6recycl">Liquidity</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2022, the Company&#8217;s reported cash and restricted cash aggregated balance was approximately $<span id="xdx_901_eus-gaap--RestrictedCashAndCashEquivalents_iI_c20220630_zmlheEmzb7nl" title="Cash and restricted cash">4,397,000</span>, current assets
were approximately $<span id="xdx_90E_eus-gaap--AssetsCurrent_iI_pn3d_c20220630_zLkG1HiplZ67" title="Current asset">6,101,000</span>, while current liabilities were approximately $<span id="xdx_90C_eus-gaap--LiabilitiesCurrent_iI_pn3d_c20220630_zfNZINzZNXf5" title="Current liabilities">9,470,000</span>. As of June 30, 2022, the Company had a working
capital deficit of approximately $<span id="xdx_908_ecustom--WorkingCapitalDeficiency_iNI_di_c20220630_zYkPNQWKNr4a" title="Working capital deficit">3,369,000</span> and stockholders&#8217; equity of approximately $<span id="xdx_90F_eus-gaap--StockholdersEquity_iI_pn3d_c20220630_zR1yBKXFUUWk" title="Stockholders' equity">21,928,000</span>. For the six months ended June
30, 2022, the Company reported loss from operations of approximately $<span id="xdx_903_eus-gaap--OperatingIncomeLoss_iN_pn3d_di_c20220101__20220630_zhoRK99RrhS5" title="Operating loss">4,343,000</span>, a non-cash, non-operating gain on the recognition and
change in fair value of warrant liabilities of approximately $<span id="xdx_904_ecustom--RecognitionAndChangeInFairValueOfWarrantLiability_pn3d_c20220101__20220630_zU8Ct5P03fpf" title="Recognition and change in fair value of warrant liabilities">24,479,000</span>, resulting in an overall net income of approximately $<span id="xdx_904_eus-gaap--NetIncomeLoss_pn3d_c20220101__20220630_z5Tp5cVCrdrj" title="Net income">19,836,000</span>.
For the six months ended June 30, 2022, the Company reported negative cash flows from operations of approximately $<span id="xdx_90C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3d_di_c20220101__20220630_zCpU11eivpsa" title="Cash flows from operations activites">1,311,000</span>. The Company
completed a capital offering in January 2022 that raised net proceeds of approximately $<span id="xdx_909_ecustom--NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants_iN_di_c20220101__20220131_zzypTyDSMcHg" title="Netproceeds from private placement issuance of shares and warrants">17,853,000</span>. Management believes the Company&#8217;s
financial position and its ability to raise capital to be reasonable and sufficient.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_846_eus-gaap--UseOfEstimates_zEAeP9pyMgGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zq7klqBZY36i">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets, liabilities, revenues and expenses, and related disclosures in the financial statements and accompanying notes. Management
bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could
differ materially from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_z4NfRxD2cRgf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zX5ejGcEIL4c">Cash
and Restricted Cash</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89D_eus-gaap--ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_ztfGtzNzL7ol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and restricted cash reported on our Condensed Consolidated Balance Sheets are reconciled to the total shown on our Condensed Consolidated
Statements of Cash Flows as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zBvL1V2l6tya" style="display: none">SCHEDULE
OF RESTRICTED CASH IN STATEMENT OF CASH FLOW</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220630_zQUfFS0I7Bdk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20210630_zXhmNmSsa4xg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Cash_iI_maRCACEzxqQ_zAyV56KVYhr2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,979,769</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6,348,415</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RestrictedCashCurrent_iI_maRCACEzxqQ_zlkkcI8lwKhb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Restricted cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,417,635</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">484,350</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RestrictedCashAndCashEquivalentsAtCarryingValue_iTI_mtRCACEzxqQ_zaHanh1g1kVj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total cash and restricted cash</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,397,404</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,832,765</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A3_zoHrcRMRXE07" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_84C_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z2iTIIYMxwd7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zVScM1ivfyda">Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &#8212; Observable inputs reflecting quoted prices (unadjusted) in active markets for identical assets and liabilities;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &#8212; Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly
or indirectly for substantially the full term of the asset or liability; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &#8212; Unobservable inputs for the asset or liability, which include management&#8217;s own assumption about the assumptions market
participants would use in pricing the asset or liability, including assumptions about risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrant
Liabilities: </b>The Company re-measures fair value of its Level 3 warrant liabilities at the balance sheet date, using a binomial option
pricing model. The following summarizes the significant unobservable inputs:</span></p>

<p id="xdx_890_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zuvTGvxglgH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zXZ6z5Sxqugl" style="display: none">SCHEDULE
OF FAIR VALUE OF WARRANT COMMITMENT</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20220630_zdELOVKAbk4d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20211231_zX1MYhWhCdG7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zj5ouKYrGde" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Stock price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2.11</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6.44</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zbdq5NQdG7Q1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">105</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Time to expiry</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zr1GMZQNhsNj" title="Warrants and rights outstanding term">4.51</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zKISL3Mn5ps2" title="Warrants and rights outstanding term">5</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zkdPrINnuo38" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_407_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zUpuuQxKipA" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.00</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.10</td><td style="text-align: left">%</td></tr>
  </table>

<p id="xdx_8A6_zIregxJQX2h6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89D_ecustom--ScheduleOfReconcilesWarrantCommitmentTableTextBlock_zt3kCNHuQ5M9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following reconciles fair value of the liability classified warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z5bchZTVaKEh" style="display: none">SCHEDULE
OF RECONCILES WARRANT COMMITMENT</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td id="xdx_4BE_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantCommitmentMember_zaPZPoar18x8" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Series B Warrant Commitment</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td id="xdx_4B0_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantLiabilityMember_zFVUv6u0gfb8" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Series B warrant liabilities</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td id="xdx_4BA_us-gaap--DerivativeInstrumentRiskAxis_custom--PlacementAgentWarrantsMember_zp5xE03Tw8Yd" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Placement agent warrants</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B3_zULc9txmvSa" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Total</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three and Six Months ended June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Series B Warrant Commitment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Series B warrant liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Placement agent warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_43B_c20220101__20220331_ecustom--WarrantCommitment_iS_zd3vhmbYuyld" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Beginning balance</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">37,652,808</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0829">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0830">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">37,652,808</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--InitialRecognitionOfWarrantCommitment_zyM2U4DD4yj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Initial recognition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0833">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,061,119</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,525,923</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">56,587,042</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--WarrantCommitmentUnrealizedGainLoss_zLfiRyNIbvRl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Unrealized (gain) loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,408,311</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(31,980,437</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(946,461</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,518,587</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_ecustom--WarrantsExercisedOrTransferred_zVYByWZcDdGd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Warrants exercised or transferred</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(55,061,119</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(55,061,119</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_43D_c20220401__20220630_ecustom--WarrantCommitment_iS_zrEwvtfbTO" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Ending balance, March 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0848">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">23,080,682</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">579,462</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">23,660,144</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--WarrantCommitmentUnrealizedGainLoss_zmj2QtkAu6Uj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Unrealized gain</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0853">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,322,737</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(310,514</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,633,251</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_436_c20220401__20220630_ecustom--WarrantCommitment_iE_z9HKugYon43e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Ending balance, June 30, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,757,945</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">268,948</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,026,893</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td id="xdx_4BC_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantCommitmentMember_zFjs7ly3vam5" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Series B Warrant Commitment</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td id="xdx_4B0_zTXl22uiCGIi" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Total</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Series B Warrant Commitment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_43A_c20210101__20211231_ecustom--WarrantCommitment_iS_z62K3p0Y2rYb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Beginning balance</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0863">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--InitialRecognitionOfWarrantCommitment_z0J37025AFnf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Initial recognition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">20,244,497</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">20,244,497</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--WarrantCommitmentUnrealizedGainLoss_zoUjaLsFSw4i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Unrealized gain</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,408,311</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,408,311</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43E_c20210101__20211231_ecustom--WarrantCommitment_iE_z3Ptc0oweq7f" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">37,652,808</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">37,652,808</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A4_zTlHOlOLVKH3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Earn-out
liabilities:</b> The Company generally values its Level 3 earn-out liabilities using the income valuation approach. Key valuation inputs
include contingent payment arrangement terms, projected revenues and cash flows, rate of return, and probability assessments. The following
table summarizes the significant unobservable inputs used in the fair value measurements:</span></p>

<p id="xdx_897_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zJKMYpHycEGh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zYMc3HBmfOK4" style="display: none">SCHEDULE
OF FAIR VALUE MEASUREMENTS</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June
    30, 2022</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31, 2021</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    technique</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_ecustom--ValuationTechnique_c20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zJVisLob1nDj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 31%" title="Valuation technique"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discounted
    cash flow </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_ecustom--ValuationTechnique_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zp63Ik5UVtV" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 30%" title="Valuation technique"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discounted
    cash flow</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
    unobservable input</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_ecustom--SignificantUnobservableInput_c20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zKLexS2RNJ84" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center" title="Significant unobservable input"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Projected
    revenue and probability of achievement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_ecustom--SignificantUnobservableInput_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zo8veHrk3uCd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center" title="Significant unobservable input"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Projected
    revenue and probability of achievement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p id="xdx_8A1_z52fMoZE7ARe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89C_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1pON4iBjjBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company values its Level 3 earn-out liability related to the Barra Acquisition using a Monte Carlo simulation in a risk-neutral framework
(a special case of the Income Approach). The following summarizes the significant unobservable inputs:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zv1lEyyBoaX" style="display: none">SCHEDULE
OF EARN OUT LIABILITY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: justify">WACC Risk Premium:</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputRiskPremiumMember_zjVOsHTdDEbj" title="Derivative Liability, Measurement Input">14.6</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zqMn0spx6Qje" title="Derivative Liability, Measurement Input">50</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Credit Spread:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputCreditSpreadMember_zpNZCTnxJM2f" title="Derivative Liability, Measurement Input">11</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Payment Delay (days)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputPaymentDelayMember_zFAkyxntXyB2" title="Derivative Liability, Measurement Input">90</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--RiskFreeRate_iI_c20220630_zN0olbNccxBj" title="Risk free rate">USD Yield Curve</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Discounting Convention:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--DiscountingConvention_iI_c20220630_zw9XkpJ31uE8" title="Discounting Convention:">Mid-period</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Number of Iterations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_ecustom--NumberOfLterations_iI_uInteger_c20220630_z5RyS1Z4xK0a" title="Number of Iterations">100,000</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A2_zItbCfirs94l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Undiscounted
remaining earn out payments are approximately $<span id="xdx_90A_ecustom--PaymentsToUndiscountedRemainingEarnOut_c20220101__20220630_zvpAYsUbwrEf" title="Undiscounted remaining earn out payments">4,697,644</span> as of June 30, 2022. The following table reconciles fair value of earn-out liabilities
for the period ending June 30, 2022:</span></p>

<p id="xdx_89F_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zlb5iloLraJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zFHjImYwLSU6" style="display: none">SCHEDULE
OF GAIN OR LOSSES RECOGNIZED FAIR VALUE</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkOgZJqsn2G4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_493_20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z5ixBvUV2h84" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--BusinessCombinationContingentConsiderationLiability_iS_zq3ugt4XkIok" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Beginning balance &#8211; January 1</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,813,878</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,931,418</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--AcquisitionsAndSettlements_zz0ozKTtJd6f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Acquisitions and Settlements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--JPKushAcquisitionMember_zpGCww08QqRj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">JP Kush Acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0911">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,694,166</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--BarraAcquisitionMember_ztAsfmTA8Ds3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Barra Acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">600,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0915">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--CCSWriteoffMember_z7s1LuppWNR7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">CCS Write-off</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0917">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(81,368</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--AltruisPartialSettlementMember_zTJGFdi49Gl8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Altruis partial settlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(84,473</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(452,236</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--MontanaFinalSettlementMember_zmXpkl6xJoP4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Montana final settlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(326,935</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0924">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Period adjustments:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_z7vUDb0QHKck" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value changes and accretion included in earnings<sup id="xdx_F4F_zCuz3bYtjLKf">*</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">354,963</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(278,102</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--BusinessCombinationContingentConsiderationLiability_iE_zgOy9LZAQxhi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Ending balance</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,357,433</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,813,878</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--EarnoutLiabilityCurrent_iI_c20220630_z010j0AI0K63" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Current portion">(3,683,596</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--EarnoutLiabilityCurrent_iI_c20211231_z8oBx77KZRcf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Current portion">(3,297,855</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Ending balance, less current portion</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_ecustom--EarnoutLiabilityNoncurrent_iI_c20220630_zDbKw4KHKjik" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, less current portion">673,837</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_ecustom--EarnoutLiabilityNoncurrent_iI_c20211231_zQzivkeBba6b" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, less current portion">516,023</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F04_znbwsMrwCLig" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F16_z4Xsy00weVQ4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recorded
    as a reduction to general and administrative expenses</span></td></tr>
  </table>
<p id="xdx_8AA_zB6iCh8OAzef" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z2ebPnKcWApg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zxNdZQjhrm83">Revenue
Recognition</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_eus-gaap--DisaggregationOfRevenueTableTextBlock_zKQXJmjaBFd8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table disaggregates the Company&#8217;s revenue by line of business, showing commissions earned:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_z41gn9tNSTfh" style="display: none">SCHEDULE
OF DISAGGREGATION REVENUE</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months ended June 30, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z5tiAU5wjKR2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Medical/Life</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20220401__20220630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zdatYq69YXo7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Property and Casualty</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20220401__20220630_zHcVQK4rAnib" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-weight: bold">Regular</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"/><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"/><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"/><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zVdgVoeWie6i" style="vertical-align: bottom; background-color: White">
    <td>EBS</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">184,851</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0946">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">184,851</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zqGZOvVoHxI6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>USBA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,319</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0950">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,319</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zwjUHp1CEwn2" style="vertical-align: bottom; background-color: White">
    <td>CCS/UIS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0953">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57,195</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57,195</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zjegoCGCfgt9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Montana</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">451,705</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0958">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">451,705</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_zVsDiEHYJ40d" style="vertical-align: bottom; background-color: White">
    <td>Fortman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">357,334</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">205,804</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">563,138</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zs08bofcigH4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Altruis</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">882,171</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">882,171</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zQUL1vnGobQ8" style="vertical-align: bottom; background-color: White">
    <td>Kush</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">425,449</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0970">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">425,449</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--MedigapMember_zWg9mMrfBhGa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Medigap</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,359,976</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0974">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,359,976</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--BarraMember_zmAdJPVXBB98" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Barra</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">69,925</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">200,397</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">270,322</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zTbS3j7Pa6Bj" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">3,743,730</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zrRFuj6duqr3" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">463,396</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630_zxCGZQwLBjxi" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">4,207,126</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months ended June 30, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z9Be7lQu9voi" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Medical/Life
</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20220101__20220630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z3tydUEu24g3" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property
and Casualty </b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20220630_z8zEBupF4cE7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Regular</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zTy49gmU3rp" style="vertical-align: bottom; background-color: White">
    <td style="width: 46%">EBS</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">406,035</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0988">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">406,035</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zvWL8aZbZeFa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>USBA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,906</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0992">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,906</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zaP2nNq3HIud" style="vertical-align: bottom; background-color: White">
    <td>CCS/UIS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0995">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101,077</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101,077</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zL1mRS9xGWpj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Montana</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">958,426</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1000">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">958,426</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_z3OrVbvYIse8" style="vertical-align: bottom; background-color: White">
    <td>Fortman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">689,933</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">403,064</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,092,997</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zybrrU6NCHc7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Altruis</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,187,043</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1008">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,187,043</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zIHzljz06991" style="vertical-align: bottom; background-color: White">
    <td>Kush</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">864,040</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1012">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">864,040</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--MedigapMember_ztqkCcg9omDf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Medigap</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,537,061</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1016">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,537,061</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--BarraMember_zno0jYB9HFv8" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Barra</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">69,925</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">200,397</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">270,322</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zU809EwULDkg" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue from contract with customer, excluding assessed tax">7,738,369</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zRszIP2S1nr5" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue from contract with customer, excluding assessed tax">704,538</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630_z9IXsbU2PPXf" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue from contract with customer, excluding assessed tax">8,442,907</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months ended June 30, 2021</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zwLsapb9gO1e" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Medical/Life</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20210401__20210630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z1tNbXreF2Mj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Property and Casualty</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20210401__20210630_zJI9fqyJstwj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Regular</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zx4IPaQSDQEi" style="vertical-align: bottom; background-color: White">
    <td style="width: 46%">EBS</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">207,201</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1030">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">207,201</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zV2eUnQeUmu9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>USBA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,395</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1034">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,395</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zEeyxDVrvkKe" style="vertical-align: bottom; background-color: White">
    <td>CCS/UIS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1037">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65,348</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65,348</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zMeWaWYAtQU7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Montana</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">404,740</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1042">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">404,740</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_zNnTB9fpj3jc" style="vertical-align: bottom; background-color: White">
    <td>Fortman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">276,634</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">226,337</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">502,971</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_z57f2KxlOKCc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Altruis</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">729,874</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1050">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">729,874</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zLDD68scL5Ec" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Kush</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">265,318</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1054">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">265,318</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zzd5vle96J6f" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">1,899,162</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zNPGE7HG8of3" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">291,685</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630_z5plR7MKzIxe" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">2,190,847</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months ended June 30, 2021</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_493_20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zPt3IBocgf3c" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Medical/Life</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20210101__20210630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zIJuwrb9Ylx2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Property and Casualty</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20210101__20210630_zOgSGQXGACTk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Regular</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zhA6r9o7rk3k" style="vertical-align: bottom; background-color: White">
    <td style="width: 46%">EBS</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">416,195</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1064">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">416,195</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zYSuyOjX0ddg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>USBA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,620</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1068">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,620</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zastlTuh8MT3" style="vertical-align: bottom; background-color: White">
    <td>CCS/UIS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1071">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">154,166</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">154,166</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zsyzyBMUvklk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Montana</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">939,856</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1076">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">939,856</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_z5QRZ4XJduNi" style="vertical-align: bottom; background-color: White">
    <td>Fortman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">526,435</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">434,109</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">960,544</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zMTs7cRjWMtc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Altruis</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,750,878</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1084">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,750,878</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zR7DIBwDZLK5" style="vertical-align: bottom; background-color: White">
    <td>Kush</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">265,318</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1088">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">265,318</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zr7yWuC1MVu8" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">3,926,302</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zlDmhcXqDkN1" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">588,275</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630_zz5VKg2KWWYa" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">4,514,577</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A1_zulkyUcfW2k4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_899_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zurCRq47Ear1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following, are customers representing <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zPtejUWKnux7" title="Concentration Risk, Percentage">10</span>% or more of total revenue:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8B1_zxT12eyYIe4i">SCHEDULE OF CONCENTRATIONS OF REVENUES</span></span>&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="display: none; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Insurance Carrier</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20220401__20220630_zJgUo4vQnJpc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20210401__20210630_zrvfG1T5V6bl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the three months ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Insurance Carrier</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--LTCGlobalMember_zMC8oySoP9Fj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">LTC Global</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">30</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1100">-</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--PriorityHealthMember_znq06QgPhkK6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Priority Health</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--BlueCrossBlueShieldMember_zpN2uLLxSJu4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">BlueCross BlueShield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1105">-</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="display: none; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Insurance Carrier</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20220101__20220630_z7F8k1FxEIp6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20210101__20210630_zOG3RiBI7Prg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the six months ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Insurance Carrier</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--BlueCrossBlueShieldMember_z8TBNIihmAI6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">BlueCross BlueShield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">10</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">25</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--PriorityHealthMember_zVZvg9YCUls8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Priority Health</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_402_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--LTCGlobalMember_z87VBK7t4WCd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">LTC Global</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1115">-</span></td><td style="text-align: left">%</td></tr>
  </table>

<p id="xdx_8AC_zCaoN9yfGgV8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
other single Customer accounted for more than <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zqaquHjgBYCc" title="Concentration Risk, Percentage">10</span>% of the Company&#8217;s commission revenues. The loss of any significant customer, including
Priority Health, BlueCross BlueShield and LTC Global could have a material adverse effect on the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zVHGbjWqayY" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zwCWv1p7BJqj">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company recorded no income tax expense for the three and six months ended June 30, 2022 and 2021 because the estimated annual effective
tax rate was zero. In determining the estimated annual effective income tax rate, the Company analyzes various factors, including projections
of the Company&#8217;s annual earnings and taxing jurisdictions in which the earnings will be generated, the impact of state and local
income taxes, the ability to use tax credits and net operating loss carry forwards, and available tax planning alternatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As
of June 30, 2022 and December 31, 2021, the Company provided a full valuation allowance against its net deferred tax assets since the
Company believes it is more likely than not that its deferred tax assets will not be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_845_ecustom--PriorPeriodAdjustmentPolicyTextBlock_zRObHgRFIn4f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zh54TYGgWZo2">Prior
Period Adjustments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company identified certain immaterial adjustments impacting prior reporting periods. Specifically, the Company identified adjustments
to correct certain asset, liability and equity accounts in relation to historical purchase price allocation accounting, historical accrued
revenues and true ups of the common stock issuable account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company assessed the materiality of the adjustments to prior period financial statements in accordance with Securities and Exchange Commission
Staff Accounting Bulletin No. (SAB) 99, <i>Materiality</i>, and SAB 108, <i>Considering the Effects of Prior Year Misstatements when
Quantifying Misstatements in Current Year Financial Statements</i>, and ASC 250, <i>Accounting Changes and Error Corrections</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
the Company&#8217;s comparative condensed consolidated financial statements and impacted notes have been revised from amounts previously
reported to reflect these adjustments. The following table illustrates the impact on previously reported amounts and adjusted balances
presented in the condensed consolidated financial statements for the period ended June 30, 2022.</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zLtKrbTbf3zc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8B1_zy4nmbqtzRT9">SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION</span></span>&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_srt--RestatementAxis_srt--ScenarioPreviouslyReportedMember_zIlFdCuKKgL6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12/31/2020</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As reported</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_srt--RestatementAxis_srt--RestatementAdjustmentMember_ztSl1ChMHY0l" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_zUdl3tyCyjzd" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12/31/2020</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjusted</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_434_c20201231_eus-gaap--AccountsReceivableNetCurrent_iI_zeNA3cy2zFy6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Earn-out liability</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">2,631,418</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">300,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">2,931,418</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20201231_eus-gaap--Goodwill_iI_zGbtXLuh31V3" style="vertical-align: bottom; background-color: White">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,265,070</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(503,345</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,761,725</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20201231_eus-gaap--CommonStockSharesSubscriptions_iI_ziWIxMXggjtb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Common stock issuable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">822,116</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(482,116</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">340,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20201231_eus-gaap--AdditionalPaidInCapital_iI_zbUb6d0npFJe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additional paid-in-capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,377,123</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">182,116</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,559,239</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20201231_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zpywJ39h04S7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accumulated Deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,482,281</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">122,601</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,359,680</td><td style="text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B6_srt--RestatementAxis_srt--ScenarioPreviouslyReportedMember_zDUmDz1cXsN5" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3/31/2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As reported</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BB_srt--RestatementAxis_srt--RestatementAdjustmentMember_zuCTt499jlza" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B7_z0hbKKzwP566" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3/31/2021</b>&#160;&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjusted</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_433_c20210331_eus-gaap--CommonStockSharesSubscriptions_iI_zsto9pkjyeNf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Common stock issuable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">482,116</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(482,116</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_434_c20210331_eus-gaap--AdditionalPaidInCapital_iI_zKSe5SMWXzF3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additional paid-in-capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,810,147</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">182,116</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,992,263</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43C_c20210331_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zcCV7oP7Zy8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accumulated Deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13,123,609</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150,003</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,973,606</td><td style="text-align: left">)</td></tr>
  </table>

<p id="xdx_8A0_zyw2DnQljJT6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zK3FCib1Q3ea" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zSQan6anBzxj">Recently
Issued Accounting Pronouncements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not expect any recently issued accounting pronouncements to have a material effect on our financial statements.</span></p>

<p id="xdx_859_zU62b4ovln8k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472846888448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS</a></td>
<td class="text"><p id="xdx_803_eus-gaap--BusinessCombinationDisclosureTextBlock_zm807V5hFOp7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2. <span id="xdx_822_zcSPpGDRyCO3">STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Medigap
Healthcare Insurance Company, LLC Transaction</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 10, 2022, pursuant to an asset purchase agreement, dated December 21, 2021, the Company completed the acquisition of all of the
assets of Medigap Healthcare Insurance Company, LLC (&#8220;Medigap&#8221;) for a purchase price of $<span id="xdx_907_eus-gaap--BusinessCombinationBargainPurchaseGainRecognizedAmount_c20220108__20220110__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zdGex3hbZJ0c" title="Business combination bargain purchase gain recognized amount">20,096,250</span>, consisting of: (i) payment
to Medigap of $<span id="xdx_909_eus-gaap--PaymentsToAcquireBusinessesGross_c20220108__20220110__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zbFrqd5lUhg8" title="Payments to acquire businesses gross">18,138,750</span> in cash and (ii) the issuance to Medigap of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220108__20220110__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zdoy4TLYwhDa" title="Issuance of shares acquistions">606,037</span> shares of the Company&#8217;s restricted common stock in
a transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended. The purchase price is subject
to post-closing adjustment to reconcile certain pre-closing credits and liabilities of the parties. &#160;&#160;The shares issued to
Medigap as part of the purchase price are further subject to lock up arrangements pursuant to which 50% of the shares may be sold after
the one-year anniversary of the date of closing of the transaction and the balance of the shares may be sold after the second-year anniversary
of the date of closing of the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
acquisition of Medigap was accounted for as a business combination in accordance with the acquisition method pursuant to FASB Topic No.
805, Business Combination (ASC 805). Accordingly, the total purchase consideration was allocated to the assets acquired, and liabilities
assumed based on their respective estimated fair values. The acquisition method of accounting requires, among other things, that assets
acquired, and liabilities assumed, if any, in a business purchase combination be recognized at their fair values as of the acquisition
date. The process for estimating the fair values of identifiable intangible assets and certain tangible assets requires the use of significant
estimates and assumptions, including estimating future cash flows, developing appropriate discount rates, estimating the costs, and timing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zPLnyz6qDgO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preliminary allocation of the purchase price in connection with the acquisition of Medigap was calculated as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zwEO6gUZ0pCi" style="display: none">SCHEDULE
OF ALLOCATION OF PURCHASE PRICE</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Description</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Useful Life (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Property, plant and equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zMKYASwrfsPb" style="width: 16%; text-align: right" title="Property, plant and equipment">20,666</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 16%; text-align: center"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zsAYkgl8hwCe" title="Finite lived intangible asset useful life">5</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Right-of-use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RightOfUseAssetMember_zKMSL1xLpT3" style="text-align: right" title="Right-of-use asset">317,787</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Trade names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_z71FK8rBXQ36" style="text-align: right" title="Trade name and trademarks">340,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_ze3mfqbe6mHi" title="Finite lived intangible asset useful life">15</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zIjP7idvbwTg" style="text-align: right" title="Customer relationships">4,550,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zXfA7XDxZpqe" title="Finite lived intangible asset useful life">12</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Technology</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_z00qTdaLiKoi" style="text-align: right" title="Technology">67,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zL9NVu8yuqH2" title="Finite lived intangible asset useful life">3</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Backlog</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BackLogMember_z8wEoRXfV174" style="text-align: right" title="Backlog">210,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BackLogMember_z6xedrYk5V07" title="Finite lived intangible asset useful life">1</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Chargeback reserve</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ChargebackReserveMember_ztJ9cNwbFNll" style="text-align: right" title="Chargeback reserve">(1,484,473</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LeaseLiabilityMember_z1gCVNCEVtp4" style="text-align: right" title="Lease liability">(317,787</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Goodwill</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zyKDxIFeMm5l" style="border-bottom: Black 1.5pt solid; text-align: right" title="Goodwill">19,199,008</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--FinitelivedIntangibleAssetUsefulLives_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zUdpwx64y44k" title="Finite lived intangible asset useful life">Indefinite</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zsNbik1a7LM7" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase consideration allocated">22,902,201</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AE_zPijXjFoIbc1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
name was measured at fair value using the relief-from-royalty method under the income approach. Significant inputs used to measure the
fair value include an estimate of projected revenue from the trade name, a pre-tax royalty rate of <span id="xdx_907_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputRoyaltyRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zIuu0nLmg8zb" title="Business combination, measurement input">0.5</span>% and a discount rate of <span id="xdx_90F_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zPLeluEmkM15" title="Business combination, measurement input">11.0</span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
relationships were measured at fair value using the multiple-period excess earnings method under the income approach. Significant inputs
used to measure the fair value include an estimate of projected revenue and costs associated with existing customers, and a discount
rate of <span id="xdx_906_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zlCu0KVzIeL" title="Business combination, measurement input">11.0</span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Technology
was measured at fair value using the cost replacement method of the cost approach. Significant inputs used to measure the fair value
include an estimate of cost to replace, an obsolescence rate of<span id="xdx_90E_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputObsolescenceRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zUWYAJOZp89k" title="Business combination, measurement input"> 40.3</span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
value assigned to backlog acquired was estimated based upon the contractual nature of the backlog as of the acquisition date, using the
income approach to discount back to present value the cash flows attributable to the backlog, using a discount rate of <span id="xdx_90E_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BackLogMember_zICBdcNsk5dk" title="Business combination, measurement input">11.0</span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
of $<span id="xdx_90F_eus-gaap--Goodwill_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zorapMdFfqOf" title="Goodwill">19,199,008</span> arising from the acquisition of Medigap consisted of the value of the employee workforce and the residual value after
all identifiable intangible assets were valued. Goodwill recognized pursuant to the acquisition of Medigap is currently expected to be
deductible for income tax purposes. Total acquisition costs for the acquisition of Medigap incurred were $<span id="xdx_90A_eus-gaap--AcquisitionCosts_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_z7oca70usVTf" title="Acquisition costs">94,065</span> recorded as a component
of General and administrative expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approximate revenue and net profit or loss for the acquired business as a standalone entity per ASC 805 from January 10, 2022 to June
30, 2022 was $<span id="xdx_906_eus-gaap--BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_z6RJbXGt5gm1" title="Revenue from acquired entity">2,537,061</span> and a loss of $<span id="xdx_901_ecustom--SharesIssuedUponTerminationOfEmployee_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zMJjSNasw3L2" title="Shares issued upon termination of employee">412,943</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Pro
Forma Information</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
results of operations of Medigap will be included in the Company&#8217;s consolidated financial statements as of the date of acquisition
through the current period end. The following supplemental pro forma financial information approximate combined financial information
assumes that the acquisition had occurred at the beginning of the six months ended June 30, 2022 and 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89C_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zphAC9xbDvx4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8BD_zqlCpy4FoW84">SCHEDULE OF PRO FORMA INFORMATION
RELATED TO ACQUISITION</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zrAY1u9qdTVe" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20210101__20210630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_z5TmFC5JKJNh" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_zPXpL5s2Eiif" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">8,809,482</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">7,071,329</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zvTbC6rbm2w8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">19,849,175</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1,796,767</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_zrzBLE85Ditc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Earnings (Loss) per common share, basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.19</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareDiluted_zI9h1oNzNN7k" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Earnings (Loss) per common share, diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.59</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.19</td><td style="text-align: left">)</td></tr>
  </table>

<p id="xdx_8A8_zQhsMwhZcx0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Barra
<span style="background-color: white">&amp; Associates, LLC</span> Transaction</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
April 26, 2022, the Company entered into an asset purchase agreement (the &#8220;APA&#8221;) with Barra &amp; Associates, LLC (&#8220;Barra&#8221;)
pursuant to which the Company purchased all of the assets of Barra &amp; Associates, LLC on April 26, 2022 for a purchase price in the
amount of $<span id="xdx_901_eus-gaap--AssetAcquisitionConsiderationTransferred_c20220425__20220426__us-gaap--TypeOfArrangementAxis__custom--APAMember__us-gaap--AssetAcquisitionAxis__custom--BarraAndAssociatesLLCMember_zQ2D6qSm7tBa" title="Asset Acquisition, Consideration Transferred">7,725,000</span> in cash, with $<span id="xdx_906_eus-gaap--AssetAcquisitionConsiderationTransferred_c20220425__20220426__us-gaap--TypeOfArrangementAxis__custom--APAMember__us-gaap--AssetAcquisitionAxis__custom--BarraAndAssociatesLLCMember__srt--StatementScenarioAxis__custom--PaidAtClosingMember_zP5sftOcaWb1" title="Asset Acquisition, Consideration Transferred">6,000,000</span> paid to Barra at closing, $<span id="xdx_90C_eus-gaap--AssetAcquisitionConsiderationTransferred_c20220425__20220426__us-gaap--TypeOfArrangementAxis__custom--APAMember__us-gaap--AssetAcquisitionAxis__custom--BarraAndAssociatesLLCMember__srt--StatementScenarioAxis__custom--PayableInSixMonthsMember_zZRfVyOrKJdb" title="Asset Acquisition, Consideration Transferred">1,125,000</span> payable in six months from closing, and a final estimated
 earnout of $<span id="xdx_907_eus-gaap--AssetAcquisitionConsiderationTransferred_c20220425__20220426__us-gaap--TypeOfArrangementAxis__custom--APAMember__us-gaap--AssetAcquisitionAxis__custom--BarraAndAssociatesLLCMember__srt--StatementScenarioAxis__custom--PayableOverTwoYearsMember_zR6sAL1clsc" title="Asset Acquisition, Consideration Transferred">600,000</span> payable over two years from closing, based upon meeting stated milestones. The source of the cash payment was $<span id="xdx_90E_ecustom--WorkingCapital_iI_c20220426__us-gaap--TypeOfArrangementAxis__custom--APAMember__us-gaap--AssetAcquisitionAxis__custom--BarraAndAssociatesLLCMember_zfED6Fn2nxR8" title="Working capital">6,520,000</span>
in funds borrowed from Oak Street Lending (&#8220;Loan&#8221;), the Company&#8217;s existing lender pursuant to a Fifth Amendment to
Credit Agreement and Promissory Note, of even date. The purchase price is subject to post-closing adjustment to reconcile certain pre-closing
credits and liabilities of the parties.</span>&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
acquisition of Barra was accounted for as a business combination in accordance with the acquisition method pursuant to FASB Topic No.
805, Business Combination (ASC 805). Accordingly, the total purchase consideration was allocated to the assets acquired, and liabilities
assumed based on their respective estimated fair values. The acquisition method of accounting requires, among other things, that assets
acquired, and liabilities assumed, if any, in a business purchase combination be recognized at their fair values as of the acquisition
date. The process for estimating the fair values of identifiable intangible assets and certain tangible assets requires the use of significant
estimates and assumptions, including estimating future cash flows, developing appropriate discount rates, estimating the costs, and timing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--BarraMember_zAvj3Cczm2we" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preliminary allocation of the purchase price in connection with the acquisition of Barra was calculated as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8B4_z0vHAAqSjuyd" style="display: none">SCHEDULE OF ALLOCATION OF PURCHASE PRICE</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Description</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Useful Life (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Acquired accounts receivable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AcquiredAccountsReceivableMember_zTEQ44tbOljh" style="width: 16%; text-align: right" title="Acquired accounts receivable">92,585</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 16%; text-align: center">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zEJUiyX6gjEf" style="text-align: right" title="Property, plant and equipment">8,593</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zq9A0wTgQIB" title="Weighted average useful life">7</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Right-of-use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RightOfUseAssetMember_z2RLvyst8of8" style="text-align: right" title="Right-of-use asset">122,984</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_z8wSKvLECqj4" style="text-align: right" title="Trade name and trademarks">22,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zv073tK0qK19" title="Weighted average useful life">4</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zF9ypjfpQvz1" style="text-align: right" title="Customer relationships">550,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zxQh4rOqw2A3" title="Weighted average useful life">10</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Agency relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AgencyRelationshipsMember_zUNevM86Ndub" style="text-align: right" title="Agency relationships">2,585,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AgencyRelationshipsMember_zSqsuI7S1rUh" title="Weighted average useful life">10</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Developed technology</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_z3XK0aUG4hOk" style="text-align: right" title="Developed Technology">230,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zlmP7oVyy7Ti" title="Weighted average useful life">5</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LeaseLiabilityMember_zrVPj4rifPd9" style="text-align: right" title="Lease liability">(122,984</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Goodwill</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zAjUSJnoUlpj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Goodwill">4,236,822</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--FinitelivedIntangibleAssetUsefulLives_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zYilHFApmoYd" title="Weighted average useful life description">Indefinite</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zjPXfDbPZwXb" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase consideration allocated">7,725,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A4_zi2iRZp3dMh2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
name was measured at fair value using the relief-from-royalty method under the income approach. Significant inputs used to measure the
fair value include an estimate of projected revenue from the trade name, a pre-tax royalty rate of <span id="xdx_901_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputRoyaltyRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zlmKsvQaEl2e" title="Business combination, measurement input">0.5</span>% and a discount rate of <span id="xdx_90D_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_z0LJVvahPzmj" title="Business combination, measurement input">19.5</span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
and Agency relationships were measured at fair value using the multiple-period excess earnings method under the income approach. Significant
inputs used to measure the fair value include an estimate of projected revenue and costs associated with existing customers, and a discount
rate of <span id="xdx_901_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zN4EsGUFxcki" title="Business combination, measurement input">19.5</span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Developed
technology was measured at fair value using the cost replacement method of the cost approach. Significant inputs used to measure the
fair value include an estimate of cost to replace, an obsolescence rate of <span id="xdx_904_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zVQOSjjzPYP7" title="Business combination, measurement input">28.6</span>%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
of $<span id="xdx_90A_eus-gaap--Goodwill_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zKWEGWYZk8Sd" title="Goodwill">4,236,822 </span>arising from the acquisition of Barra consisted of the value of the employee workforce and the residual value after
all identifiable intangible assets were valued. Goodwill recognized pursuant to the acquisition of Barra is currently expected to be
deductible for income tax purposes. Total acquisition costs incurred through June 30, 2022 for the acquisition of Barra were $<span id="xdx_902_eus-gaap--AcquisitionCosts_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zDYgeJh9pGoe" title="Acquisition Costs">72,793</span> recorded as a component of General and administrative expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approximate revenue and net profit or loss for the acquired business as a standalone entity per ASC 805 from April 26, 2022 to June 30,
2022 was $<span id="xdx_909_eus-gaap--BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zeKKr04Z9sNc" title="Revenue from acquired entity">270,321</span> and a loss of $<span id="xdx_90B_ecustom--SharesIssuedUponTerminationOfEmployee_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zyPGbZ97Jpx4" title="Shares issued upon termination of employee">38,698</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Pro
Forma Information</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
results of operations of Barra will be included in the Company&#8217;s consolidated financial statements as of the date of acquisition
through the current period end. The following supplemental pro forma financial information approximate combined financial information
assumes that the acquisition had occurred at the beginning of the six months ended June 30, 2022 and 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_893_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--BarraMember_zKn67UKrec71" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8B2_zEZwjxQvbmQ9">SCHEDULE OF PRO FORMA INFORMATION
RELATED TO ACQUISITION</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zqb2SASifGMk" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_494_20210101__20210630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_z2PG1csF5s0j" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_z3UL1f40LbL9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">8,990,529</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">5,364,335</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zT3TvaciS2jc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,070,124</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1,527,038</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_zi9w5pX9pgY3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Earnings (Loss) per common share, basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.76</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.16</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareDiluted_zsK40jpQsPcc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Earnings (Loss) per common share, diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.58</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.16</td><td style="text-align: left">)</td></tr>
  </table>

<p id="xdx_8A4_z2dE6FBLOyh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472841774272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--GoodwillAndIntangibleAssetsDisclosureTextBlock_zeZ2eAaKlH83" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3. <span id="xdx_825_zUI8xpZQkF95">GOODWILL AND OTHER INTANGIBLE ASSETS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table rolls forward the Company&#8217;s goodwill balance for the periods ending June 30, 2022 and December 31, 2021. <span style="background-color: white">As
discussed in Note 1 - <i>Prior Period Adjustments</i>, a</span> $<span id="xdx_90E_eus-gaap--Goodwill_iI_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zhTgV7Lhmpz7" title="Goodwill">(503,345</span>) adjustment was identified for goodwill which impacted the
closing December 31, 2020 balance in the same amount. Accordingly, the December 31, 2020 balance is adjusted in the following table from
the originally reported balance of $<span id="xdx_904_eus-gaap--Goodwill_iI_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zBfsKsI5sxTf" title="Goodwill">9,265,070</span> to $<span id="xdx_909_eus-gaap--Goodwill_iI_c20201231_zYCdTdGYiaK3" title="Goodwill">8,761,725</span>.</span></p>

<p id="xdx_893_eus-gaap--ScheduleOfGoodwillTextBlock_zBTnTiFIZfjf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none"><span id="xdx_8B5_zmtgNeJ0kQWi">SCHEDULE OF IMPAIRMENT OF GOODWILL</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Goodwill</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">December 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--Goodwill_iS_pp0p0_c20210101__20211231_ze73yHBBxiaa" style="width: 16%; text-align: right" title="Goodwill">8,761,725</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Goodwill recognized in connection with Kush acquisition on May 1, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_c20210101__20211231_zg8bFG8xE91j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Goodwill acquired during period">1,288,552</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--Goodwill_iS_pp0p0_c20220101__20220630_zPuKIpm4JaNd" style="text-align: right" title="Goodwill">10,050,277</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Goodwill recognized in connection with Medigap acquisition on January 10, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zMOr3ej7wz8c" style="text-align: right" title="Goodwill acquired during period">19,199,008</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Goodwill recognized in connection with Barra acquisition on April 26, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_z6HRemAlnwAk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Goodwill acquired during period">4,236,822</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">June 30, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--Goodwill_iE_pp0p0_c20220101__20220630_zXjeJdfRTY69" style="border-bottom: Black 2.5pt double; text-align: right">33,486,107</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_za1w8KOWyCo3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zNRZKbnTkhjg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the major categories of the Company&#8217;s intangible assets and the weighted-average remaining amortization
period as of June 30, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_zL9Gn6g1VN7h" style="display: none">SCHEDULE
OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Amortization period (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accumulated Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying Amount</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Trade name and trademarks</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 10%; text-align: center"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_z9PuGmUoa0Ge" title="Weighted average remaining amortization period">4.9</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zooFf4RYL5kc" style="width: 10%; text-align: right" title="Gross carrying amount">2,142,858</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zksUHP2yJWg5" style="width: 10%; text-align: right" title="Accumulated amortization">(804,020</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zcZSWEgTxtW6" style="width: 10%; text-align: right" title="Net carrying amount">1,338,838</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Internally developed software</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_z0N2l6CHeMof" title="Weighted average remaining amortization period">4.5</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zD8UljXApcf5" style="text-align: right" title="Gross carrying amount">1,326,158</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zO2RDVfgZZZ3" style="text-align: right" title="Accumulated amortization">(131,655</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zKFCvs7GfSck" style="text-align: right" title="Net carrying amount">1,194,503</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zFJactYejOGc" title="Weighted average remaining amortization period">9.53</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_znrtJB1YI0oe" style="text-align: right" title="Gross carrying amount">11,922,290</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zee630SN8k63" style="text-align: right" title="Accumulated amortization">(1,517,174</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zHvBPq6NYKpf" style="text-align: right" title="Net carrying amount">10,405,116</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Purchased software</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zGVjif2lpjFf" title="Weighted average remaining amortization period"><span style="-sec-ix-hidden: xdx2ixbrl1354">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zXa32kc0rH7g" style="text-align: right" title="Gross carrying amount">562,327</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zV033eRTcepa" style="text-align: right" title="Accumulated amortization">(562,327</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zJjcPqadUK0e" style="text-align: right" title="Net carrying amount"><span style="-sec-ix-hidden: xdx2ixbrl1360">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Video Production Assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zR1jhaIJslti" title="Weighted average remaining amortization period">0.6</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zMs6tRIeZ4Y7" style="text-align: right" title="Gross carrying amount">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_znpwbIvVNxUl" style="text-align: right" title="Accumulated amortization">(23,242</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zq45DqhXBxaa" style="text-align: right" title="Net carrying amount">26,758</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Non-competition agreements</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_z1VIqFQUYD48" title="Weighted average remaining amortization period">2.4</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zrmvaS95v7M3" style="text-align: right" title="Gross carrying amount">3,504,810</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zcsbWn1XYTSd" style="text-align: right" title="Accumulated amortization">(1,827,590</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_z14muw9eIR3f" style="text-align: right" title="Net carrying amount">1,677,220</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Contracts Backlog</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractsBacklogMember_zaMEVsEllsNa" title="Weighted average remaining amortization period">0.5</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractsBacklogMember_z2wVhmovIwW5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gross carrying amount">210,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractsBacklogMember_znKFaBLlrNIl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization">(100,684</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractsBacklogMember_zLhRSkeEdAI4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net carrying amount">109,316</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630_z2evHmQDOdm6" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross carrying amount">19,718,443</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630_zih8kYD05oh8" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization">(4,966,692</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630_zgaEWCTcKEnk" style="border-bottom: Black 2.5pt double; text-align: right" title="Net carrying amount">14,751,751</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the major categories of the Company&#8217;s intangible assets and the weighted-average remaining amortization
period as of December 31, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Amortization period (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accumulated Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying Amount</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Trade name and trademarks</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 10%; text-align: center"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zNQwKbQ42Una" title="Weighted average remaining amortization period">3.5</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_z33gOXeZjArf" style="width: 10%; text-align: right" title="Gross carrying amount">1,777,475</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zPTwnb3oZKlj" style="width: 10%; text-align: right" title="Accumulated amortization">(609,822</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zLo6nNRVCfVa" style="width: 10%; text-align: right" title="Net carrying amount">1,167,653</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Internally developed software</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_z6VbNr2UP205" title="Weighted average remaining amortization period">4.7</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zGvAcnQ3EZ4f" style="text-align: right" title="Gross carrying amount">595,351</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zbjRQ78J44Ik" style="text-align: right" title="Accumulated amortization">(28,443</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zjlS78Ne5EL3" style="text-align: right" title="Net carrying amount">566,908</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zQGXp4Rx8TUk" title="Weighted average remaining amortization period">7.7</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zC6XhFSz6Pw5" style="text-align: right" title="Gross carrying amount">4,237,290</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zc1nwVarlrr8" style="text-align: right" title="Accumulated amortization">(1,048,726</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyswIb2Sg5J3" style="text-align: right" title="Net carrying amount">3,188,564</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Purchased software</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zCgS3Bzg49Rh" title="Weighted average remaining amortization period">0.6</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zue2JVRz2eAd" style="text-align: right" title="Gross carrying amount">562,327</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zgwqYR54qes4" style="text-align: right" title="Accumulated amortization">(452,985</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zw3rCEDcHQK" style="text-align: right" title="Net carrying amount">109,342</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Video Production Assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zkXDivMWVru3" title="Weighted average remaining amortization period">1.0</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zrstMszoUN1" style="text-align: right" title="Gross carrying amount">20,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_ziWRbdMXKny8" style="text-align: right" title="Accumulated amortization"><span style="-sec-ix-hidden: xdx2ixbrl1428">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zKIA7arWwbv8" style="text-align: right" title="Net carrying amount">20,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Non-competition agreements</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center"><span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zG1evYRwCCxf" title="Weighted average remaining amortization period">2.9</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zXU0Ap5T7MA" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gross carrying amount">3,504,809</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zKdObrufoOZe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization">(1,478,376</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_z8gyxk2h3yxd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net carrying amount">2,026,433</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231_z5WW5B5jNdrc" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross carrying amount">10,697,252</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231_zTjZNFw0UDcj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization">(3,618,352</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231_zBCBFnIAnJ7e" style="border-bottom: Black 2.5pt double; text-align: right" title="Net carrying amount">7,078,900</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A4_zx8ir1RMyk8k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zYbWqPtf52C7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reflects expected amortization expense as of June 30, 2022, for each of the following five years and thereafter:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_z1S0NyhlATId" style="display: none">SCHEDULE
OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Years ending December 31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220630_zdme31u0Zgi4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization Expense</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_maFLIANziEa_zDwHLkgCzdDa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">2022 (remainder of year)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,374,512</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANziEa_zUWP4DkC850f" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,461,552</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANziEa_zqbyUPGSbDMi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,083,450</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANziEa_zpFaEiSGU3gj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,703,824</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_maFLIANziEa_zzeak3V2R4p1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,463,747</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_maFLIANziEa_ziWqp2dai4ee" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,664,666</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANziEa_zNjjHamLhIke" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,751,751</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AB_zuSt2WaQE0Yf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472841584448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT AND SHORT-TERM FINANCINGS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract', window );"><strong>Long-term Debt And Short-term Financings</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_LongTermDebtAndShortTermFinancingsTextBlock', window );">LONG-TERM DEBT AND SHORT-TERM FINANCINGS</a></td>
<td class="text"><p id="xdx_806_ecustom--LongTermDebtAndShortTermFinancingsTextBlock_zjhyhn874LU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4. <span id="xdx_827_zqSZ0pkrE164">LONG-TERM DEBT AND SHORT-TERM FINANCINGS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Long-Term
Debt</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_890_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zjbMmOY0rSWg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
composition of the long-term debt follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none"><span id="xdx_8BF_zJrtyNzdmdql" style="display: none">SCHEDULE OF LONG TERM DEBT</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Oak Street Funding LLC Term Loan for the acquisition of EBS and USBA, net of deferred financing costs of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--EBSandUSBAMember_z1Q5RkjG52Kd" title="Net of deferred financing cost">13,497</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--EBSandUSBAMember_zQj1TwfN8J64" title="Net of deferred financing cost">14,606</span> as of June 30, 2022 and December 31, 2021, respectively</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--EBSandUSBAMember_zZbvKLnBIPvi" style="width: 16%; text-align: right" title="Long term debt current">455,391</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--EBSandUSBAMember_zpScUd8AZkW9" style="width: 16%; text-align: right" title="Long term debt current">485,317</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Oak Street Funding LLC Senior Secured Amortizing Credit Facility for the acquisition of CCS, net of deferred financing costs of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--CreditFacilityAxis__custom--CCSMember_z2WpvhXWozme" title="Net of deferred financing cost">16,351</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--CreditFacilityAxis__custom--CCSMember_zFvjR0bSeRxh" title="Net of deferred financing cost">17,626</span> as of June 30, 2022 and December 31, 2021, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--CreditFacilityAxis__custom--CCSMember_zV4OjkqpPbh1" style="text-align: right" title="Long term debt current">738,547</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--CreditFacilityAxis__custom--CCSMember_zRPOQNAI0nh4" style="text-align: right" title="Long term debt current">785,826</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Oak Street Funding LLC Term Loan for the acquisition of SWMT, net of deferred financing costs of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--SWMTMember_zoOBjeJHvlla" title="Net of deferred financing cost">10,085</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--SWMTMember_zMx3Hy7Usomj" title="Net of deferred financing cost">11,027</span> as of June 30, 2022 and December 31, 2021, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--SWMTMember_zHAvmbxOnHjc" style="text-align: right" title="Long term debt current">835,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--SWMTMember_z8DbtxvanTIl" style="text-align: right" title="Long term debt current">884,720</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Oak Street Funding LLC Term Loan for the acquisition of FIS, net of deferred financing costs of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--FISMember_zR0yya1Weuc1" title="Net of deferred financing cost">39,752 </span>and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--FISMember_zIoPPk2htZEg" title="Net of deferred financing cost">42,660</span> as of June 30, 2022 and December 31, 2021, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--FISMember_zubETJkAJVgh" style="text-align: right" title="Long term debt current">2,103,885</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--FISMember_ztGfs2gJt4Qe" style="text-align: right" title="Long term debt current">2,226,628</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Oak Street Funding LLC Term Loan for the acquisition of ABC, net of deferred financing costs of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--ABCMember_z4d7ImIa1V66" title="Net of deferred financing cost">45,369</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_908_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--ABCMember_zHI3JyAVNVE7" title="Net of deferred financing cost">48,609</span> as of June 30, 2022 and December 31, 2021, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--ABCMember_ziTwG1hXTyp9" style="text-align: right" title="Long term debt current">3,427,614</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--ABCMember_z0tslES6PHnb" style="text-align: right" title="Long term debt current">3,616,754</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Oak Street Funding LLC Term Loan for the acquisition of Barra, net of deferred financing costs of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zne1OiYQml26" title="Net of deferred financing cost">208,901</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90D_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zaY7qgk31TJa" title="Net of deferred financing cost">0</span> as of June 30, 2022 and December 31, 2021, respectively</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zhDcrjp2Qv0c" style="border-bottom: Black 1.5pt solid; text-align: right" title="Long term debt current">6,311,099</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zpFldjFvkDMi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Long term debt current"><span style="-sec-ix-hidden: xdx2ixbrl1512">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--LongTermDebt_iI_c20220630_z9FgkrR3f43k" style="text-align: right" title="Long term debt">13,871,912</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--LongTermDebt_iI_c20211231_zUY96lHUFOIe" style="text-align: right" title="Long term debt">7,999,245</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--LongTermDebtCurrent_iNI_di_c20220630_zPkYc8wDpQy2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Current portion of long-term debt">(936,263</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--LongTermDebtCurrent_iNI_di_c20211231_zmXBnTIhZcei" style="border-bottom: Black 1.5pt solid; text-align: right" title="Current portion of long-term debt">(913,920</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Long-term debt</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--LongTermDebtNoncurrent_iI_c20220630_z9k2CwFDNtIh" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term debt, excluding current maturities">12,935,649</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--LongTermDebtNoncurrent_iI_c20211231_zTa1bVOHOcD9" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term debt, excluding current maturities">7,085,325</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p id="xdx_8AE_zn8JrmCv6C02" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Oak
Street Funding LLC &#8211; Term Loans and Credit Facilities</i></b></span></p>

<p id="xdx_893_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zXaJBK35MWd6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;<span id="xdx_8B5_z6T44eRoySf4" style="display: none">SCHEDULE
OF CUMULATIVE MATURITIES OF LONG-TERM LOANS AND CREDIT FACILITIES</span></i></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Fiscal year ending December 31,</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20220630_znKSwTAoKRVi" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Maturities of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Long-Term Debt</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_iI_maDICAzUlL_zD8tjSnVjkP3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">2022 (remainder of year)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">438,616</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_maDICAzUlL_zJS5wiMGmCQd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,228,897</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_maDICAzUlL_zi7pxzsAMSs3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,542,156</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_maDICAzUlL_zvYm6PemCYx9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,656,383</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_maDICAzUlL_z6Fzq2O3Fc3c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,776,385</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_maDICAzUlL_z1XHiwscUX32" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,563,428</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DebtInstrumentCarryingAmount_iI_mtDICAzUlL_zmUYwoJsExI2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,205,865</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredFinanceCostsNet_iNI_di_zgmv3VFGZPC1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: debt issuance costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(333,953</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--LongTermDebt_iI_ztauDfk8nlR" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,871,912</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zsgbDWZmdxe4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Short-Term
Financings</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company financed certain annual insurance premiums through the use of two short-term notes, payable in nine and ten equal monthly
installments of $<span id="xdx_90E_eus-gaap--ShortTermBankLoansAndNotesPayable_iI_c20220630_zqwrpz3jyRdf" title="Notes Payable">42,894</span> and $<span id="xdx_901_eus-gaap--ShortTermBankLoansAndNotesPayable_iI_c20211231_zdYK8rvIgs5c" title="Notes Payable">4,456</span> at interest rates of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20220630__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_z12nEgwc0eB7" title="Debt Instrument, Interest Rate, Stated Percentage">7.51</span>% and <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_zLvjy2F2EMoj" title="Debt Instrument, Interest Rate, Stated Percentage">7.95</span>%, per annum respectively. Policies financed include directors
and officers and errors and omissions insurance coverage with premium financing recognized in 2022 and 2021 of $<span id="xdx_90C_eus-gaap--AmortizationOfDebtDiscountPremium_c20220101__20220630__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_zTTyxOD7qIEh" title="Amortization of Debt Discount (Premium)">417,199</span> and $<span id="xdx_905_eus-gaap--AmortizationOfDebtDiscountPremium_c20210101__20211231__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_zsu1OmMkZ02g" title="Amortization of Debt Discount (Premium)">0</span>, respectively.
Outstanding balances as of June 30, 2022 and December 31, 2021, respectively were $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20220630__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_z2KaEhXnyrnf" title="Debt Instrument, Face Amount">376,647</span> and $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_zZXcbCXFxPdf" title="Debt Instrument, Face Amount">0</span>. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_LongTermDebtAndShortTermFinancingsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long Term Debt And Short Term Financings [TextBlock]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_LongTermDebtAndShortTermFinancingsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472841644336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_DisclosureWarrantLiabilitiesAbstract', window );"><strong>Warrant Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantLiabilitiesTextBlock', window );">WARRANT LIABILITIES</a></td>
<td class="text"><p id="xdx_800_ecustom--WarrantLiabilitiesTextBlock_zAGXQacax8tk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5. <span id="xdx_820_zPyD02zfsFi1">WARRANT LIABILITIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
B Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 22, 2021, the Company entered into a securities purchase agreement with several institutional buyers for the purchase and sale
of (i) warrants to purchase an aggregate of up to <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20211222__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zu96vSpMatG5" title="Warrant to purchase shares">9,779,952</span> shares of the Company&#8217;s common stock, par value $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211222__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zj6MebMfxudh" title="Common stock par value">0.086</span> per share at
an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211222__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zaEqpQefHyNb" title="Exercise price">4.09</span> per share, (ii) an aggregate of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211222__20211223__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zOYpqkYQ30of" title="Number of shares issued">2,670,892</span> shares of Common Stock, and (iii) <span id="xdx_90C_eus-gaap--ConversionOfStockSharesConverted1_c20211222__20211223__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z6YUcT2JAIS6" title="Shares converted">9,076</span> shares of the Company&#8217;s
newly-designated Series B convertible preferred stock, par value $<span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20211222__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zfBbcVD0hzx1" title="Preferred stock par value">0.086</span> per share, with a stated value of $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_c20211222__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zAqSDRekkM82" title="Share price per share">1,000</span> per share, initially
convertible into an aggregate of <span id="xdx_90B_eus-gaap--ConversionOfStockSharesIssued1_c20211222__20211223__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zo1NNnKOcZXh" title="Shares converted">2,219,084</span> shares of Common Stock at a conversion price of $<span id="xdx_905_eus-gaap--PreferredStockConvertibleConversionPrice_iI_c20211222__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z5E7Xl5vlUEe" title="Preferred stock conversion price">4.09</span> per share, each a freestanding financial
instrument, (the &#8220;Private Placement&#8221;). The aggregate purchase price for the Common Shares, the Preferred Shares and the Warrants
was approximately $<span id="xdx_909_ecustom--AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zkYlgW3OEtxj" title="Aggregate purchase price of common shares, preferred shares and warrants">20,000,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
entering into the Private Placement on December 22, 2021, the Company entered into a commitment to issue the Common Shares, Preferred
Shares and Series B Warrants on the Initial Closing Date for a fixed price and exercise price, as applicable. The commitment to issue
Series B Warrants (the &#8220;Warrant Commitment&#8221;) represents a derivative financial instrument, other than an outstanding share,
that, at inception, has both of the following characteristics: (i) embodies a conditional obligation indexed to the Company&#8217;s equity.
The Company classified the commitment to issue the warrants as a derivative liability because it represents a written option that does
not qualify for equity accounting The Company initially measured the derivative liability at its fair value and will subsequently remeasure
the derivative liability, at fair value with changes in fair value recognized in earnings. An option pricing model was utilized to calculate
the fair value of the Warrant Commitment. The Company initially recorded $<span id="xdx_908_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_c20210101__20211231_z5ownjqLX3Sd" title="Unrealized losses">17,652,808</span> of non-operating unrealized losses within the recognition
and change in fair value of warrant liabilities account for the year ended December 31, 2021. The Private Placement closed on January
4, 2022, at which time the Company remeasured the derivative liability for the warrants issued in the transaction. The Company recognized
$<span id="xdx_904_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20220101__20220630_zNmfHpoExDjb" title="Unrealized gain">12,322,737</span> and $<span id="xdx_905_ecustom--NonOperatingUnrealizedGains_c20220101__20220630_zgi6pGaDvL2i" title="Unrealized gain">24,748,163</span> of non-operating unrealized gains within the recognition and change in fair value of warrant liabilities
account on the condensed consolidated statement of operations for the three and six months ended June 30, 2022, respectively, related
to the subsequent changes in its fair value through June 30, 2022. A corresponding derivative liability of $<span id="xdx_90E_ecustom--WarrantCommitment_iI_c20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantLiabilityMember_zn9tLwxEawz" title="Derivative liability">10,757,945</span> is included on
Company&#8217;s condensed consolidated balance sheet as of June 30, 2022. The closing of the Private Placement settled the subscription
receivable reported on the Company&#8217;s balance sheet as of December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Placement
Agent Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Private Placement, the Company issued <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20220105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zZrCwpqan901" title="Warrant issued">244,539</span> warrants to the placement agent for the Private Placement. The warrants
were issued as compensation for the Placement Agent&#8217;s services. The Placement Agent Warrants are: (i) exercisable on any day after
the six (6) month anniversary of the issue date, (ii) expire <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20220105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zHObZVaIH4n3" title="Warrant term">five years</span> after the closing of the Private Placement, and (iii) exercisable
at $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z3Di9BHz1gm" title="Warrant exercise price">4.09</span> per share. The Placement Agent Warrants contain terms that may require the Company to transfer assets to settle the warrants.
Therefore, the Placement Agent Warrants are classified as a derivative liability measured at fair value of $<span id="xdx_905_ecustom--IssuanceOfPlacementAgentWarrants_c20220104__20220105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zPIdhyk1V6S7" title="Derivative liability measured at fair value">1,525,923 </span>on the date of
issuance and will be remeasured each accounting period with the changes in fair value reported in earnings. The Placement Agent Warrants
are considered financing expense fees paid to the Placement Agent. Since the financing expenses relate to a derivative liability measured
at fair value, this financing expense of $<span id="xdx_903_ecustom--IssuanceOfPlacementAgentWarrants_c20220104__20220105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zhhirMposu15" title="Derivative liability measured at fair value">1,525,923</span>, along with non-operating unrealized gains of $<span id="xdx_902_ecustom--WarrantCommitmentUnrealizedGainLoss_c20220401__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zQK41qxWAPDe" title="Unrealized gain">310,514</span> and losses of $<span id="xdx_90E_ecustom--WarrantCommitmentUnrealizedGainLoss_c20220101__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z13S70B6xUA8" title="Unrealized gain">268,948</span>, were
included in the recognition and change in fair value of warrant liabilities account on the condensed consolidated statement of operations
for the three and six months ended June 30, 2022, respectively, A corresponding derivative liability of $<span id="xdx_902_ecustom--WarrantCommitment_iI_c20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z1cJZOVgNzF8" title="Derivative liability">268,948</span> is included on Company&#8217;s
condensed consolidated balance sheet as of June 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_DisclosureWarrantLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_DisclosureWarrantLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_WarrantLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant Liabilities [TextBlock]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_WarrantLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472841779056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">EQUITY</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zf2I6cV63o01" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6. <span id="xdx_82C_zI7PKNtaDED2">EQUITY</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has been authorized to issue <span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20220630_zIM0TDwVfqY6" title="Preferred stock, shares authorized">750,000,000</span> shares of $<span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20220630_zs0UjNisi2Al" title="Preferred stock, par value">0.086</span> par value Preferred Stock. The Board of Directors is expressly vested
with the authority to divide any or all of the Preferred Stock into series and to fix and determine the relative rights and preferences
of the shares of each series so established, within certain guidelines established in the Articles of Incorporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2022, the Company issued <span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_c20220131_zi2d1aPdD5tg" title="Preferred stock shares issued">9,076</span> shares of its newly designated Series B convertible preferred stock through the Private Placement
for the purpose of raising capital. These shares remain issued and outstanding as of June 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series B convertible preferred stock has no voting rights and initially each share of Series B convertible preferred stock may be converted
into <span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_z7W3YWBA81Ke" title="Preferred stock shares authorized">245</span> shares of the Company&#8217;s common stock. The holders of the Series B convertible preferred stock are not entitled to receive
any dividends other than any dividends paid on account of the common stock. In the event of any voluntary or involuntary liquidation,
dissolution or winding up of the Company, the holders shall be entitled to receive out of the assets, whether capital or surplus, of
the Company the same amount that a holder of common stock would receive if the Preferred Stock were fully converted (disregarding for
such purposes any conversion limitations hereunder) to common stock which amounts shall be paid pari passu with all holders of common
stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has been authorized to issue <span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20220630_zU8en1ohRcFh" title="Common stock, shares authorized">2,000,000,000</span>&#160;&#160; shares of common stock, $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220630_z9nXFbN4Is9d" title="Common stock, at par value">0.086</span> par value. Each share of issued and outstanding
common stock shall entitle the holder thereof to fully participate in all shareholder meetings, to cast one vote on each matter with
respect to which shareholders have the right to vote, and to share ratably in all dividends and other distributions declared and paid
with respect to common stock, as well as in the net assets of the corporation upon liquidation or dissolution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2022, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220101__20220131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zBaJaNeZdYhf" title="Number of shares issued">2,670,892</span> shares of common stock through the Private Placement for the purpose of raising capital. See
Note 5 - <i>Warrant Liabilities </i>for proceeds received by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2022, the Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20220101__20220131__us-gaap--BusinessAcquisitionAxis__custom--MedigapAcquisitionMember_zo3UYAsVrpOa" title="Stock issued during period, shares, acquisitions">606,037</span> shares of common stock pursuant to the Medigap Acquisition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2022, upon agreement with Series A warrant holders, <span id="xdx_909_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_c20220101__20220131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAWarrantMember_zM2qGfECdDz2" title="Exercise of Series A warrants, shares">375,000</span> warrants were exercised at a price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAWarrantMember_zdJ3HwqjmuD6" title="Warrants exercise price">6.60 </span>into <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20220101__20220131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zSGdXGziHjrb" title="Number of shares converted">375,000</span> of the Company&#8217;s
common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2022, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220301__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zI8zsxILvXF6" title="Number of shares issued">6,000</span> shares of the Company&#8217;s common stock due to the vesting of <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20220301__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQLYbrI32gVg" title="Vesting of stock award">6,000</span> stock awards pursuant to
an employee agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May and June 2022, <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220531__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zbZVYt08oH8k" title="Class of common stock warrant"><span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zlGw6gPWHPPd" title="Class of common stock warrant">3,276,929</span></span> Series C prepaid warrants were exchanged for <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220531__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zcNTWEVQoXD6" title="Class of common stock warrant"><span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z3aBcx6kKgpl">3,276,929</span></span> shares of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2022 and December 31, 2021, there were <span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20220630_zlsq1U6jo7Gj" title="Common stock, shares outstanding">14,614,038</span> and <span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20211231_z0PZemuTQLi" title="Common stock, shares outstanding">10,956,109</span> shares of Common Stock outstanding, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series
A warrant holders exercised <span id="xdx_90B_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_c20220101__20220131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAWarrantMember_zvz5rZbio7k2" title="Exercise of Series A warrants, shares">375,000</span> Series A warrants in January 2022, resulting in <span id="xdx_904_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_c20220101__20220630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAWarrantMember_zRIPYEAjfFwg" title="Exercise of Series A warrants, shares">1,695,000</span> of Series A warrants remaining issued and
outstanding as of June 30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2022, as a result of the issuance of common stock in the January 2022 stock offering and the Medigap Acquisition, the Company
received a deficiency notification from Nasdaq indicating violation of Listing Rule 5365(a). As part of its remediation plan, in March
2022, the Company entered into Exchange Agreements with the holders of common stock issued in January 2022. Pursuant to the Exchange
Agreements, the Company issued <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220131__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zqYcwUxBI7qj" title="Class of common stock warrant">3,276,929</span> Series C prepaid warrants in exchange for <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220131__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZT8f04HNg4k" title="Class of common stock warrant">3,276,929</span> shares of the Company&#8217;s common stock.
Additionally, as compensation for entering into the Exchange Agreements, the Company issued <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220131__us-gaap--StatementClassOfStockAxis__custom--SeriesDPrepaidWarrantsMember_zWuFt60SfqTd" title="Class of common stock warrant">1,222,498</span> Series D prepaid warrants to the
January 2022 stock offering investors for no additional consideration. The fair value of the Series D prepaid warrants was treated as
a deemed dividend and accordingly was treated as a reduction from income available to common stockholders in the calculation of earnings
per share. Refer to Note 7, <i>Earnings (Loss) Per Share</i> for additional information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May and June 2022, the <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220531__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zb3O69O4dbX6" title="Class of common stock warrant"><span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220501__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zSmn87ckgUdi" title="Class of common stock warrant">3,276,929</span></span> Series C prepaid warrants were converted for <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220531__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zY9dYOZBTsH5" title="Class of common stock warrant"><span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxY3yrZ000L1" title="Class of common stock warrant">3,276,929</span></span> shares of the Company&#8217;s common stock for
an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_z8YWEXs0acW8" title="Warrant exercise price">0.001</span>.&#160;&#160; Through June 30, 2022, the Company has received payments of $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfDebt_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zErpyQVZXEL7" title="Proceeds from issuance of debt">1,336</span> from one investor for these
issuances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity-based
Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
February and May 2022, three existing employees were awarded  bonuses consisting&#8239;of shares of the Company&#8217;s common stock to
be vested immediately. The shares granted in 2022 were valued at $<span id="xdx_903_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensation_c20220101__20220630__srt--TitleOfIndividualAxis__custom--ThreeEmployeesMember_zLor3DTAoOj8" title="Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture">766,250</span>. For the three and six months ended June 30, 2022, compensation
expense on these grants totaled $<span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_c20220401__20220630__srt--TitleOfIndividualAxis__custom--ThreeEmployeesMember_zdMEqhb3VD1h">100,000</span> and $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20220630__srt--TitleOfIndividualAxis__custom--ThreeEmployeesMember_zOoRq5eusDfj">766,250</span>, respectively. As of June 30, 2022, these shares have not been issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2022&#160;, pursuant to an agreement between the Company and an Executive, the Executive will be compensated with <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxAHuZdmg8de" title="Class of common stock warrant">60,000</span> shares
of the Company&#8217;s Common stock. These shares vest quarterly over a three-year period. The shares granted were valued at $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220101__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbCboKSbIbp3" title="Issuance of shares">178,200</span>
at the date of the grant. For the three and six months ended June 30, 2022, compensation expense on this grant was $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zlXTjO4ApCo5" title="Share based compensation expense"><span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z4mQzasManxf" title="Share based compensation expense">70,721</span></span>. As of June
30, 2022, no shares were issued under this contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472841524992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS (LOSS) PER SHARE<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS (LOSS) PER SHARE</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--EarningsPerShareTextBlock_zktdUqg5ylQc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7. <span id="xdx_825_zZICfQ5klw4i">EARNINGS (LOSS) PER SHARE</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings per common share (&#8220;EPS&#8221;) applicable to common stockholders is computed by dividing earnings applicable to common
stockholders by the weighted-average number of common shares outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
there is a loss from operations, diluted EPS is computed in the same manner as basic EPS is computed. Similarly, if the Company has net
income but its preferred dividend adjustment made in computing income available to common stockholders results in a net loss available
to common stockholders, diluted EPS would be computed in the same manner as basic EPS. Accordingly, for the three and six months ended
June 30, 2021, due to a net loss, the outstanding Series A Convertible Preferred Stock is considered anti-dilutive in which <span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zuWvqITue2X8" title="Anti-dilutive securities">9,076</span> and
<span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210101__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zRCA3HELvUNh" title="Anti-dilutive securities">1,167</span> were issued and outstanding at June 30, 2022 and 2021, respectively. Series A Convertible Preferred Stock is convertible into common
stock on a <span id="xdx_90D_eus-gaap--PreferredStockConversionBasis_c20220101__20220630_zKJa9trDwEl1" title="Stock conversion basis description">10 for 1 basis</span>. The outstanding stock options are considered anti-dilutive in which <span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zMYaxFYgLTgg" title="Anti-dilutive option securities">163,925</span> and <span id="xdx_905_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_z2Fn11fm1qK7" title="Anti-dilutive option securities">163,913</span> were issued and outstanding
at June 30, 2022 and 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following represents the impact of options, stock awards, preferred stock and warrants on basic and diluted EPS for the three and six
months ended June 30, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding
    stock options are considered anti-dilutive, due to the exercise price being greater than the average market price, in which <span id="xdx_906_ecustom--AntidilutiveSharesIssuedAndOutstanding_iI_pid_c20220630_z06pGWt4J6ce" title="Antidilutive shares Issued and Outstanding">163,925</span>,
    were issued and outstanding at June 30, 2022. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested
    Stock awards in the amount of <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20220630_zSvA29IIh2Ui" title="Vested stock awards">200,820</span> have been included in the basic and diluted EPS calculation for the three and six months ended
    June 30, 2022, and nonvested stock awards in the amount of <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_pid_c20220401__20220630_zVNWqpitU5Qa" title="Non-vested stock awards">31,916</span> and <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_pid_c20220101__20220630_zvyMH0Tp4iU4" title="Non-vested stock awards">46,084</span> have been included in the diluted EPS calculation for
    the three and six months ended June 30, 2022, respectively. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding
    Series A warrants are considered anti-dilutive, due to the exercise price being greater than the average market price, in which <span id="xdx_903_ecustom--WarrantSharesIssued_iI_pid_c20220630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAWarrantsMember_z2rCT7ziEZPg" title="Warrant shares issued"><span id="xdx_901_ecustom--WarrantSharesOutstanding_iI_pid_c20220630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAWarrantsMember_zPXwp3Lgw5yc" title="Warrant shares outstanding">1,695,000</span></span>,
    were issued and outstanding at June 30, 2022. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series
    B Convertible Preferred stock are considered dilutive and included in the calculation of diluted EPS. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantLiabilityMember_zXvb3fErbeIg" title="Antidilutive warrant liabilities">631,276</span> potential settlement shares of the warrant liability associated with Series B Warrants are considered dilutive and included
    in the calculation of diluted EPS for the six months ended June 30, 2022. The effects of the warrants that have been recorded in
    net income on the condensed consolidated statement of operations have been eliminated in the calculation of diluted EPS for the three
    and six months ended June 30, 2022. </span></td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    potential settlement shares of the warrant liability associated with the Placement Agent Warrants are considered dilutive and anti-dilutive
    for the three and six months ended June 30, 2022, respectively, and is included in Diluted EPS calculation for the three months ended
    June 30, 2022. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_pid_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zpxOmYa9AMG2" title="Issuance of prefunded  Series Warrants in exchange for common shares, shares">3,276,929</span> Series C prepaid warrants have been exercised in 2022. <span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220401__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zhZ6tpsEXtQj" title="Antidilutive shares">1,676,737</span> and <span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_z8UsLsexVx4a" title="Antidilutive shares">2,743,896</span> weighted shares were included as outstanding
    shares in the calculation of basic and diluted EPS for the period prior to exercise for the three and six months ended June 30, 2022,
    respectively, because they represent shares issuable for only nominal consideration. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_pid_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesDPrepaidWarrantsMember_zgmlpR6uLjp2" title="Stock Issued During Period, Shares, Conversion of Units">1,222,497</span> Series D prepaid warrants have been included as outstanding shares in the calculation of basic and diluted EPS, as they
    represent shares issuable for only nominal consideration. The Company reduced income available to common stockholders by $<span id="xdx_900_ecustom--IssuanceOfSeriesDWarrants_c20220401__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesDPrepaidWarrantsMember_zPyTO4A1n9W7" title="Issuance of Series D Warrants">0</span> and $<span id="xdx_907_ecustom--IssuanceOfSeriesDWarrants_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesDPrepaidWarrantsMember_zdAivslJOLse" title="Issuance of Series D Warrants">6,930,335</span>
    for the associated Series D deemed dividend in the calculation of basic and diluted EPS for the three and six months ended June 30,
    2022, respectively. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zGNto2cMfdSb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
calculations of basic and diluted EPS, are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zMbpD2rSg2W9" style="display: none">SCHEDULE
OF CALCULATIONS OF BASIC AND DILUTED EPS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20220401__20220630_zQy9RwStOng" style="font-weight: bold; text-align: center">Three Months</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20210401__20210630_zaNbmJd7aBi3" style="font-weight: bold; text-align: center">Three Months</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_mtNILzGtK_z3QE9XkS9JHh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Net income (loss)</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">10,495,691</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">(1,276,886</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_406_ecustom--DeemedDividend_iN_di_z3wG0v2CD7O7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Deemed dividend</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1724">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1725">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_z0Dv02ZGUW7e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net income (loss), numerator, basic computation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,495,691</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,276,886</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_z6b43Eqt5ZVa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Recognition and change in fair value of warrant liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,633,251</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1731">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_ztJzbLqg3i7a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net income (loss), numerator, diluted computation</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,137,560</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,276,886</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zGmscDeG1a3a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Weighted average shares - denominator basic computation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,738,290</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,934,489</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_zjRIAgRGFSnb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Effect of stock awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,916</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1740">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--EffectOfSeriesBWarrantLiability_zIR34DvUQKwe" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Effect of Series B warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_z5khnvLLB4ek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Effect of preferred stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,219,084</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1746">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zUaDKLhgZ1jj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Weighted average shares, as adjusted - denominator diluted computation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">20,989,290</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,934,489</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareBasic_z8Zf0k6QXEPi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Earnings (loss) per common share &#8211; basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.56</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.12</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--EarningsPerShareDiluted_za5O3Nkr9ovc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Earnings (loss) per common share &#8211; diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.10</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.12</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20220101__20220630_zlsBe1hLCvoe" style="font-weight: bold; text-align: center">Six Months</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20210101__20210630_zROC7RkXvoOa" style="font-weight: bold; text-align: center">Six Months</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_mtNILzGtK_zWTVW5qp2ZKl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Net income (loss)</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">19,835,692</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">(1,890,812</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_406_ecustom--DeemedDividend_iN_di_zy3EHCOA6MJh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Deemed dividend</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,930,335</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1761">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zjSYIyZNDBYe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net income (loss), numerator, basic computation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,905,357</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,890,812</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_zlO26JmH0dEb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Recognition and change in fair value of warrant liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(24,748,163</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1767">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_zILyoa8V5bph" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net income (loss), numerator, diluted computation</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(11,842,806</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,890,812</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_z5DdAS8TLt92" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Weighted average shares - denominator basic computation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,238,285</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,259,738</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ziTY8ZDdAGJ9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Effect of stock awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46,084</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1776">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--EffectOfSeriesBWarrantLiability_zZk2cRma7Gyb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Effect of Series B warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,219,084</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1779">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_zNVX6WXu1hHl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Effect of preferred stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">631,276</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1782">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zNd2Utv4N0Lh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Weighted average shares, as adjusted - denominator diluted computation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">20,134,729</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,259,738</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareBasic_zwCrgzWhgowd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Earnings (loss) per common share - basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.75</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.20</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--EarningsPerShareDiluted_zU09KYCDAofg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Earnings (loss) per common share - diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.59</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.20</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A8_zTeLKq3ljaWd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472841748528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--LesseeOperatingLeasesTextBlock_znNe9KsdI9N1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8. <span id="xdx_82B_zyTtZJ2h31F3">LEASES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
lease expense for the three months ended June 30, 2022 and 2021 was $<span id="xdx_906_eus-gaap--OperatingLeaseExpense_c20220401__20220630_zpuqXvMYyyKi" title="Operating Lease, Expense">156,750</span> and $<span id="xdx_903_eus-gaap--OperatingLeaseExpense_c20210401__20210630_zqEAiHLniY9k" title="Operating Lease, Expense">43,931</span> respectively. Operating lease expense for the
six months ended June 30, 2022 and 2021 was $<span id="xdx_90B_eus-gaap--OperatingLeaseExpense_c20220101__20220630_zNgmuVL40sh9" title="Operating Lease, Expense">275,174 </span>and $<span id="xdx_904_eus-gaap--OperatingLeaseExpense_c20210101__20210630_zj9i9MeHSVsc" title="Operating Lease, Expense">112,199</span> respectively. As of June 30, 2022, the weighted average remaining lease
term and weighted average discount rate for the operating leases were <span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_zUVbNOGp7kJ2" title="Weighted average remaining lease term">4.01</span> years and <span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20220630_z5pUd0neE8Si" title="Weighted average discount rate">5.76</span>% respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_893_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zZU6U7jblKgj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
minimum lease payment under these operating leases consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zd78BSLOcZn8" style="display: none">SCHEDULE
OF FUTURE MINIMUM LEASE PAYMENT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Year ending December 31,</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20220630_zSzHj4i5aRB6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating Lease</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Obligations</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzuGy_zrl6b1uLhx22" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: justify">2022</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">303,256</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzuGy_zyUHSSjV4Mva" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">546,275</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzuGy_zMRy43sOwxZ6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">253,908</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maLOLLPzuGy_zNa8czfeKkLk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">144,124</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_maLOLLPzuGy_zo3z7Tf8TrRd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">113,738</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_maLOLLPzuGy_zuD6r0ScbBtk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">268,202</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzuGy_zqurSQ91mXK7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Total undiscounted operating lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,629,503</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_z69dDRK59Wng" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Less: Imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(169,978</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiability_iI_pp0p0_zlvzQi6wVAH" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Present value of operating lease liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,459,525</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AB_zMTFmP2ar4ze" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472841564000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zzO75Xr7Pdxf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9. <span id="xdx_820_zCNq6TafMDR1">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Legal
Contingencies</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to various legal proceedings and claims, either asserted or unasserted, arising in the ordinary course of business.
While the outcome of these claims cannot be predicted with certainty, management does not believe the outcome of any of these matters
will have a material adverse effect on our business, financial position, results of operations, or cash flows, and accordingly, no legal
contingencies are accrued as of June 30, 2022 and December 31, 2021. Litigation relating to the insurance brokerage industry is not uncommon.
As such the Company, from time to time have been, subject to such litigation. No assurances can be given with respect to the extent or
outcome of any such litigation in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Earn-out
liabilities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_ecustom--EarnOutLiabilitiesTableTextBlock_zrOvKquhzsGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following outlines changes to the Company&#8217;s earn-out liability balances inclusive of accumulated accretion for the respective period
ended June 30, 2022 and December 31, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8BA_ztiXawqIV94l">SCHEDULE
OF EARN-OUT LIABILITY</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B9_us-gaap--BusinessAcquisitionAxis_custom--CommercialSolutionsOfInsuranceAgencyLLCMember_zh0EZXvRKAX" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">CCS</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--BusinessAcquisitionAxis_custom--FortmanInsuranceAgencyLLCMember_zMEY8WEGwINg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fortman</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BF_us-gaap--BusinessAcquisitionAxis_custom--SouthwesternMontanaInsuranceCenterIncMember_zZmetVieGoTh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Montana</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BD_us-gaap--BusinessAcquisitionAxis_custom--AltruisBenefitsConsultantsIncMember_z49BTelcNEJ8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Altruis</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B0_us-gaap--BusinessAcquisitionAxis_custom--JPKushAndAssociatesIncMember_zlio9T0dcBU8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Kush</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--BusinessAcquisitionAxis_custom--BarraMember_zCq2Ncn36q6c" style="border-bottom: Black 1.5pt solid; font-weight: bold">Barra</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_zTCixRRcCqWe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_436_c20220101__20220630_eus-gaap--BusinessCombinationContingentConsiderationLiability_iS_z4YGdNEh3432" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%">Ending balance December 31, 2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1831">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">515,308</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">615,969</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">992,868</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">1,689,733</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1836">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">3,813,878</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--ChangesDueToAcquisitions_zvYs5RPeYF01" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Changes due to acquisitions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1839">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1840">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1841">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1842">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1843">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">600,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">600,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ChangesDueToPayments_zrM2j0F5svp7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Changes due to payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(326,935</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(84,473</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(411,408</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_400_ecustom--ChangesDueToFairValueAdjustments_z4SvK01G4Msl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Changes due to fair value adjustments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1855">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">32,620</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">37,741</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1858">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">334,602</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(50,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">354,963</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20220101__20220630_eus-gaap--BusinessCombinationContingentConsiderationLiability_iE_zclHYT4qFVQ8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Ending balance June 30, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1863">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">547,928</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">326,775</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">908,395</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,024,335</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">550,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,357,433</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B9_us-gaap--BusinessAcquisitionAxis_custom--CommercialSolutionsOfInsuranceAgencyLLCMember_zLOPpVA4E4P2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">CCS</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--BusinessAcquisitionAxis_custom--FortmanInsuranceAgencyLLCMember_zxubZrMq7Cyl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fortman</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BF_us-gaap--BusinessAcquisitionAxis_custom--SouthwesternMontanaInsuranceCenterIncMember_zrvlD6iWxtM5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Montana</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BD_us-gaap--BusinessAcquisitionAxis_custom--AltruisBenefitsConsultantsIncMember_zGs6z9B0sfqd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Altruis</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B0_us-gaap--BusinessAcquisitionAxis_custom--JPKushAndAssociatesIncMember_z3NRZrpTcyck" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Kush</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_zRR8aMJHhCA8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_433_c20210101__20211231_eus-gaap--BusinessCombinationContingentConsiderationLiability_iS_zpm4CbaBI2ua" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%">Ending balance December 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">81,368</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">432,655</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">522,553</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">1,894,842</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1875">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">2,931,418</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--ChangesDueToBusinessCombinations_z1hiuKVdAjzi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Changes due to business combinations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1878">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1879">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1880">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1881">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,694,166</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,694,166</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ChangesDueToPayments_zJHiGXgPK9s6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Changes due to payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1885">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1886">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1887">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(452,236</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1889">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(452,236</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_400_ecustom--ChangesDueToFairValueAdjustments_zp20CqLcuidf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Changes due to fair value adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1892">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">82,653</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">93,416</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(449,738</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,433</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(278,102</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_402_ecustom--ChangesDueToWriteoffs_zs7oQmvTp6Aj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Changes due to write-offs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(81,368</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1900">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1901">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1902">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1903">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(81,368</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_431_c20210101__20211231_eus-gaap--BusinessCombinationContingentConsiderationLiability_iE_zvDSOuCOQslb" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Ending balance December 31, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1906">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">515,308</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">615,969</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">992,868</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,689,733</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,813,878</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_zijsEXqovf5b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472845307296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Principles of Consolidation</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zHDrYB63LSp4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zcKS5w2HHGx7">Basis
of Presentation and Principles of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting
principles in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information and with the instructions for
Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP
for complete financial statements. In the opinion of management, all adjustments (consisting of recurring accruals) necessary for a fair
presentation have been included. These unaudited condensed consolidated financial statements should be read in conjunction with the audited
consolidated financial statements and the notes thereto, set forth in the Company&#8217;s annual report on Form 10-K for the year ended
December 31, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed consolidated financial statements include the accounts of Reliance Global Group, Inc. and its wholly
owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_LiquidityPolicyTextBlock', window );">Liquidity</a></td>
<td class="text"><p id="xdx_842_ecustom--LiquidityPolicyTextBlock_zjM206NJluZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zUX1T6recycl">Liquidity</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2022, the Company&#8217;s reported cash and restricted cash aggregated balance was approximately $<span id="xdx_901_eus-gaap--RestrictedCashAndCashEquivalents_iI_c20220630_zmlheEmzb7nl" title="Cash and restricted cash">4,397,000</span>, current assets
were approximately $<span id="xdx_90E_eus-gaap--AssetsCurrent_iI_pn3d_c20220630_zLkG1HiplZ67" title="Current asset">6,101,000</span>, while current liabilities were approximately $<span id="xdx_90C_eus-gaap--LiabilitiesCurrent_iI_pn3d_c20220630_zfNZINzZNXf5" title="Current liabilities">9,470,000</span>. As of June 30, 2022, the Company had a working
capital deficit of approximately $<span id="xdx_908_ecustom--WorkingCapitalDeficiency_iNI_di_c20220630_zYkPNQWKNr4a" title="Working capital deficit">3,369,000</span> and stockholders&#8217; equity of approximately $<span id="xdx_90F_eus-gaap--StockholdersEquity_iI_pn3d_c20220630_zR1yBKXFUUWk" title="Stockholders' equity">21,928,000</span>. For the six months ended June
30, 2022, the Company reported loss from operations of approximately $<span id="xdx_903_eus-gaap--OperatingIncomeLoss_iN_pn3d_di_c20220101__20220630_zhoRK99RrhS5" title="Operating loss">4,343,000</span>, a non-cash, non-operating gain on the recognition and
change in fair value of warrant liabilities of approximately $<span id="xdx_904_ecustom--RecognitionAndChangeInFairValueOfWarrantLiability_pn3d_c20220101__20220630_zU8Ct5P03fpf" title="Recognition and change in fair value of warrant liabilities">24,479,000</span>, resulting in an overall net income of approximately $<span id="xdx_904_eus-gaap--NetIncomeLoss_pn3d_c20220101__20220630_z5Tp5cVCrdrj" title="Net income">19,836,000</span>.
For the six months ended June 30, 2022, the Company reported negative cash flows from operations of approximately $<span id="xdx_90C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3d_di_c20220101__20220630_zCpU11eivpsa" title="Cash flows from operations activites">1,311,000</span>. The Company
completed a capital offering in January 2022 that raised net proceeds of approximately $<span id="xdx_909_ecustom--NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants_iN_di_c20220101__20220131_zzypTyDSMcHg" title="Netproceeds from private placement issuance of shares and warrants">17,853,000</span>. Management believes the Company&#8217;s
financial position and its ability to raise capital to be reasonable and sufficient.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_846_eus-gaap--UseOfEstimates_zEAeP9pyMgGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zq7klqBZY36i">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets, liabilities, revenues and expenses, and related disclosures in the financial statements and accompanying notes. Management
bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could
differ materially from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and Restricted Cash</a></td>
<td class="text"><p id="xdx_842_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_z4NfRxD2cRgf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zX5ejGcEIL4c">Cash
and Restricted Cash</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89D_eus-gaap--ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_ztfGtzNzL7ol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and restricted cash reported on our Condensed Consolidated Balance Sheets are reconciled to the total shown on our Condensed Consolidated
Statements of Cash Flows as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zBvL1V2l6tya" style="display: none">SCHEDULE
OF RESTRICTED CASH IN STATEMENT OF CASH FLOW</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220630_zQUfFS0I7Bdk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20210630_zXhmNmSsa4xg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Cash_iI_maRCACEzxqQ_zAyV56KVYhr2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,979,769</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6,348,415</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RestrictedCashCurrent_iI_maRCACEzxqQ_zlkkcI8lwKhb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Restricted cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,417,635</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">484,350</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RestrictedCashAndCashEquivalentsAtCarryingValue_iTI_mtRCACEzxqQ_zaHanh1g1kVj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total cash and restricted cash</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,397,404</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,832,765</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A3_zoHrcRMRXE07" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z2iTIIYMxwd7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zVScM1ivfyda">Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &#8212; Observable inputs reflecting quoted prices (unadjusted) in active markets for identical assets and liabilities;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &#8212; Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly
or indirectly for substantially the full term of the asset or liability; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &#8212; Unobservable inputs for the asset or liability, which include management&#8217;s own assumption about the assumptions market
participants would use in pricing the asset or liability, including assumptions about risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrant
Liabilities: </b>The Company re-measures fair value of its Level 3 warrant liabilities at the balance sheet date, using a binomial option
pricing model. The following summarizes the significant unobservable inputs:</span></p>

<p id="xdx_890_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zuvTGvxglgH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zXZ6z5Sxqugl" style="display: none">SCHEDULE
OF FAIR VALUE OF WARRANT COMMITMENT</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20220630_zdELOVKAbk4d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20211231_zX1MYhWhCdG7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zj5ouKYrGde" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Stock price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2.11</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6.44</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zbdq5NQdG7Q1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">105</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Time to expiry</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zr1GMZQNhsNj" title="Warrants and rights outstanding term">4.51</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zKISL3Mn5ps2" title="Warrants and rights outstanding term">5</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zkdPrINnuo38" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_407_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zUpuuQxKipA" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.00</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.10</td><td style="text-align: left">%</td></tr>
  </table>

<p id="xdx_8A6_zIregxJQX2h6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89D_ecustom--ScheduleOfReconcilesWarrantCommitmentTableTextBlock_zt3kCNHuQ5M9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following reconciles fair value of the liability classified warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z5bchZTVaKEh" style="display: none">SCHEDULE
OF RECONCILES WARRANT COMMITMENT</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td id="xdx_4BE_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantCommitmentMember_zaPZPoar18x8" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Series B Warrant Commitment</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td id="xdx_4B0_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantLiabilityMember_zFVUv6u0gfb8" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Series B warrant liabilities</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td id="xdx_4BA_us-gaap--DerivativeInstrumentRiskAxis_custom--PlacementAgentWarrantsMember_zp5xE03Tw8Yd" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Placement agent warrants</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B3_zULc9txmvSa" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Total</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three and Six Months ended June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Series B Warrant Commitment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Series B warrant liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Placement agent warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_43B_c20220101__20220331_ecustom--WarrantCommitment_iS_zd3vhmbYuyld" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Beginning balance</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">37,652,808</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0829">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0830">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">37,652,808</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--InitialRecognitionOfWarrantCommitment_zyM2U4DD4yj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Initial recognition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0833">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,061,119</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,525,923</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">56,587,042</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--WarrantCommitmentUnrealizedGainLoss_zLfiRyNIbvRl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Unrealized (gain) loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,408,311</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(31,980,437</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(946,461</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,518,587</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_ecustom--WarrantsExercisedOrTransferred_zVYByWZcDdGd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Warrants exercised or transferred</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(55,061,119</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(55,061,119</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_43D_c20220401__20220630_ecustom--WarrantCommitment_iS_zrEwvtfbTO" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Ending balance, March 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0848">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">23,080,682</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">579,462</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">23,660,144</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--WarrantCommitmentUnrealizedGainLoss_zmj2QtkAu6Uj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Unrealized gain</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0853">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,322,737</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(310,514</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,633,251</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_436_c20220401__20220630_ecustom--WarrantCommitment_iE_z9HKugYon43e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Ending balance, June 30, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,757,945</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">268,948</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,026,893</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td id="xdx_4BC_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantCommitmentMember_zFjs7ly3vam5" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Series B Warrant Commitment</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td id="xdx_4B0_zTXl22uiCGIi" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Total</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Series B Warrant Commitment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_43A_c20210101__20211231_ecustom--WarrantCommitment_iS_z62K3p0Y2rYb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Beginning balance</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0863">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--InitialRecognitionOfWarrantCommitment_z0J37025AFnf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Initial recognition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">20,244,497</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">20,244,497</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--WarrantCommitmentUnrealizedGainLoss_zoUjaLsFSw4i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Unrealized gain</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,408,311</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,408,311</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43E_c20210101__20211231_ecustom--WarrantCommitment_iE_z3Ptc0oweq7f" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">37,652,808</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">37,652,808</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A4_zTlHOlOLVKH3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Earn-out
liabilities:</b> The Company generally values its Level 3 earn-out liabilities using the income valuation approach. Key valuation inputs
include contingent payment arrangement terms, projected revenues and cash flows, rate of return, and probability assessments. The following
table summarizes the significant unobservable inputs used in the fair value measurements:</span></p>

<p id="xdx_897_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zJKMYpHycEGh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zYMc3HBmfOK4" style="display: none">SCHEDULE
OF FAIR VALUE MEASUREMENTS</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June
    30, 2022</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31, 2021</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    technique</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_ecustom--ValuationTechnique_c20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zJVisLob1nDj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 31%" title="Valuation technique"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discounted
    cash flow </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_ecustom--ValuationTechnique_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zp63Ik5UVtV" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 30%" title="Valuation technique"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discounted
    cash flow</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
    unobservable input</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_ecustom--SignificantUnobservableInput_c20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zKLexS2RNJ84" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center" title="Significant unobservable input"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Projected
    revenue and probability of achievement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_ecustom--SignificantUnobservableInput_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zo8veHrk3uCd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center" title="Significant unobservable input"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Projected
    revenue and probability of achievement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p id="xdx_8A1_z52fMoZE7ARe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89C_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1pON4iBjjBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company values its Level 3 earn-out liability related to the Barra Acquisition using a Monte Carlo simulation in a risk-neutral framework
(a special case of the Income Approach). The following summarizes the significant unobservable inputs:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zv1lEyyBoaX" style="display: none">SCHEDULE
OF EARN OUT LIABILITY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: justify">WACC Risk Premium:</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputRiskPremiumMember_zjVOsHTdDEbj" title="Derivative Liability, Measurement Input">14.6</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zqMn0spx6Qje" title="Derivative Liability, Measurement Input">50</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Credit Spread:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputCreditSpreadMember_zpNZCTnxJM2f" title="Derivative Liability, Measurement Input">11</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Payment Delay (days)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputPaymentDelayMember_zFAkyxntXyB2" title="Derivative Liability, Measurement Input">90</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--RiskFreeRate_iI_c20220630_zN0olbNccxBj" title="Risk free rate">USD Yield Curve</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Discounting Convention:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--DiscountingConvention_iI_c20220630_zw9XkpJ31uE8" title="Discounting Convention:">Mid-period</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Number of Iterations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_ecustom--NumberOfLterations_iI_uInteger_c20220630_z5RyS1Z4xK0a" title="Number of Iterations">100,000</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A2_zItbCfirs94l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Undiscounted
remaining earn out payments are approximately $<span id="xdx_90A_ecustom--PaymentsToUndiscountedRemainingEarnOut_c20220101__20220630_zvpAYsUbwrEf" title="Undiscounted remaining earn out payments">4,697,644</span> as of June 30, 2022. The following table reconciles fair value of earn-out liabilities
for the period ending June 30, 2022:</span></p>

<p id="xdx_89F_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zlb5iloLraJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zFHjImYwLSU6" style="display: none">SCHEDULE
OF GAIN OR LOSSES RECOGNIZED FAIR VALUE</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkOgZJqsn2G4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_493_20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z5ixBvUV2h84" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--BusinessCombinationContingentConsiderationLiability_iS_zq3ugt4XkIok" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Beginning balance &#8211; January 1</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,813,878</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,931,418</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--AcquisitionsAndSettlements_zz0ozKTtJd6f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Acquisitions and Settlements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--JPKushAcquisitionMember_zpGCww08QqRj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">JP Kush Acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0911">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,694,166</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--BarraAcquisitionMember_ztAsfmTA8Ds3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Barra Acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">600,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0915">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--CCSWriteoffMember_z7s1LuppWNR7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">CCS Write-off</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0917">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(81,368</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--AltruisPartialSettlementMember_zTJGFdi49Gl8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Altruis partial settlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(84,473</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(452,236</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--MontanaFinalSettlementMember_zmXpkl6xJoP4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Montana final settlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(326,935</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0924">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Period adjustments:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_z7vUDb0QHKck" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value changes and accretion included in earnings<sup id="xdx_F4F_zCuz3bYtjLKf">*</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">354,963</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(278,102</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--BusinessCombinationContingentConsiderationLiability_iE_zgOy9LZAQxhi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Ending balance</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,357,433</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,813,878</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--EarnoutLiabilityCurrent_iI_c20220630_z010j0AI0K63" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Current portion">(3,683,596</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--EarnoutLiabilityCurrent_iI_c20211231_z8oBx77KZRcf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Current portion">(3,297,855</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Ending balance, less current portion</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_ecustom--EarnoutLiabilityNoncurrent_iI_c20220630_zDbKw4KHKjik" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, less current portion">673,837</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_ecustom--EarnoutLiabilityNoncurrent_iI_c20211231_zQzivkeBba6b" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, less current portion">516,023</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F04_znbwsMrwCLig" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F16_z4Xsy00weVQ4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recorded
    as a reduction to general and administrative expenses</span></td></tr>
  </table>
<p id="xdx_8AA_zB6iCh8OAzef" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_847_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z2ebPnKcWApg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zxNdZQjhrm83">Revenue
Recognition</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_eus-gaap--DisaggregationOfRevenueTableTextBlock_zKQXJmjaBFd8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table disaggregates the Company&#8217;s revenue by line of business, showing commissions earned:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_z41gn9tNSTfh" style="display: none">SCHEDULE
OF DISAGGREGATION REVENUE</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months ended June 30, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z5tiAU5wjKR2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Medical/Life</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20220401__20220630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zdatYq69YXo7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Property and Casualty</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20220401__20220630_zHcVQK4rAnib" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-weight: bold">Regular</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"/><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"/><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"/><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zVdgVoeWie6i" style="vertical-align: bottom; background-color: White">
    <td>EBS</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">184,851</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0946">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">184,851</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zqGZOvVoHxI6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>USBA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,319</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0950">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,319</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zwjUHp1CEwn2" style="vertical-align: bottom; background-color: White">
    <td>CCS/UIS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0953">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57,195</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57,195</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zjegoCGCfgt9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Montana</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">451,705</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0958">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">451,705</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_zVsDiEHYJ40d" style="vertical-align: bottom; background-color: White">
    <td>Fortman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">357,334</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">205,804</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">563,138</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zs08bofcigH4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Altruis</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">882,171</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">882,171</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zQUL1vnGobQ8" style="vertical-align: bottom; background-color: White">
    <td>Kush</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">425,449</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0970">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">425,449</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--MedigapMember_zWg9mMrfBhGa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Medigap</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,359,976</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0974">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,359,976</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--BarraMember_zmAdJPVXBB98" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Barra</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">69,925</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">200,397</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">270,322</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zTbS3j7Pa6Bj" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">3,743,730</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zrRFuj6duqr3" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">463,396</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630_zxCGZQwLBjxi" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">4,207,126</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months ended June 30, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z9Be7lQu9voi" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Medical/Life
</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20220101__20220630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z3tydUEu24g3" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property
and Casualty </b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20220630_z8zEBupF4cE7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Regular</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zTy49gmU3rp" style="vertical-align: bottom; background-color: White">
    <td style="width: 46%">EBS</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">406,035</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0988">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">406,035</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zvWL8aZbZeFa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>USBA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,906</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0992">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,906</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zaP2nNq3HIud" style="vertical-align: bottom; background-color: White">
    <td>CCS/UIS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0995">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101,077</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101,077</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zL1mRS9xGWpj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Montana</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">958,426</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1000">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">958,426</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_z3OrVbvYIse8" style="vertical-align: bottom; background-color: White">
    <td>Fortman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">689,933</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">403,064</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,092,997</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zybrrU6NCHc7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Altruis</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,187,043</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1008">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,187,043</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zIHzljz06991" style="vertical-align: bottom; background-color: White">
    <td>Kush</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">864,040</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1012">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">864,040</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--MedigapMember_ztqkCcg9omDf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Medigap</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,537,061</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1016">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,537,061</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--BarraMember_zno0jYB9HFv8" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Barra</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">69,925</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">200,397</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">270,322</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zU809EwULDkg" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue from contract with customer, excluding assessed tax">7,738,369</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zRszIP2S1nr5" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue from contract with customer, excluding assessed tax">704,538</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630_z9IXsbU2PPXf" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue from contract with customer, excluding assessed tax">8,442,907</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months ended June 30, 2021</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zwLsapb9gO1e" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Medical/Life</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20210401__20210630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z1tNbXreF2Mj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Property and Casualty</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20210401__20210630_zJI9fqyJstwj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Regular</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zx4IPaQSDQEi" style="vertical-align: bottom; background-color: White">
    <td style="width: 46%">EBS</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">207,201</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1030">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">207,201</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zV2eUnQeUmu9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>USBA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,395</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1034">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,395</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zEeyxDVrvkKe" style="vertical-align: bottom; background-color: White">
    <td>CCS/UIS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1037">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65,348</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65,348</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zMeWaWYAtQU7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Montana</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">404,740</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1042">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">404,740</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_zNnTB9fpj3jc" style="vertical-align: bottom; background-color: White">
    <td>Fortman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">276,634</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">226,337</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">502,971</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_z57f2KxlOKCc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Altruis</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">729,874</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1050">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">729,874</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zLDD68scL5Ec" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Kush</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">265,318</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1054">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">265,318</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zzd5vle96J6f" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">1,899,162</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zNPGE7HG8of3" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">291,685</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630_z5plR7MKzIxe" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">2,190,847</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months ended June 30, 2021</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_493_20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zPt3IBocgf3c" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Medical/Life</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20210101__20210630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zIJuwrb9Ylx2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Property and Casualty</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20210101__20210630_zOgSGQXGACTk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Regular</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zhA6r9o7rk3k" style="vertical-align: bottom; background-color: White">
    <td style="width: 46%">EBS</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">416,195</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1064">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">416,195</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zYSuyOjX0ddg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>USBA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,620</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1068">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,620</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zastlTuh8MT3" style="vertical-align: bottom; background-color: White">
    <td>CCS/UIS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1071">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">154,166</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">154,166</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zsyzyBMUvklk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Montana</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">939,856</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1076">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">939,856</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_z5QRZ4XJduNi" style="vertical-align: bottom; background-color: White">
    <td>Fortman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">526,435</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">434,109</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">960,544</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zMTs7cRjWMtc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Altruis</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,750,878</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1084">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,750,878</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zR7DIBwDZLK5" style="vertical-align: bottom; background-color: White">
    <td>Kush</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">265,318</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1088">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">265,318</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zr7yWuC1MVu8" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">3,926,302</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zlDmhcXqDkN1" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">588,275</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630_zz5VKg2KWWYa" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">4,514,577</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A1_zulkyUcfW2k4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_899_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zurCRq47Ear1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following, are customers representing <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zPtejUWKnux7" title="Concentration Risk, Percentage">10</span>% or more of total revenue:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8B1_zxT12eyYIe4i">SCHEDULE OF CONCENTRATIONS OF REVENUES</span></span>&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="display: none; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Insurance Carrier</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20220401__20220630_zJgUo4vQnJpc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20210401__20210630_zrvfG1T5V6bl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the three months ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Insurance Carrier</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--LTCGlobalMember_zMC8oySoP9Fj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">LTC Global</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">30</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1100">-</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--PriorityHealthMember_znq06QgPhkK6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Priority Health</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--BlueCrossBlueShieldMember_zpN2uLLxSJu4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">BlueCross BlueShield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1105">-</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="display: none; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Insurance Carrier</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20220101__20220630_z7F8k1FxEIp6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20210101__20210630_zOG3RiBI7Prg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the six months ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Insurance Carrier</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--BlueCrossBlueShieldMember_z8TBNIihmAI6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">BlueCross BlueShield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">10</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">25</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--PriorityHealthMember_zVZvg9YCUls8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Priority Health</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_402_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--LTCGlobalMember_z87VBK7t4WCd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">LTC Global</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1115">-</span></td><td style="text-align: left">%</td></tr>
  </table>

<p id="xdx_8AC_zCaoN9yfGgV8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
other single Customer accounted for more than <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zqaquHjgBYCc" title="Concentration Risk, Percentage">10</span>% of the Company&#8217;s commission revenues. The loss of any significant customer, including
Priority Health, BlueCross BlueShield and LTC Global could have a material adverse effect on the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zVHGbjWqayY" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zwCWv1p7BJqj">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company recorded no income tax expense for the three and six months ended June 30, 2022 and 2021 because the estimated annual effective
tax rate was zero. In determining the estimated annual effective income tax rate, the Company analyzes various factors, including projections
of the Company&#8217;s annual earnings and taxing jurisdictions in which the earnings will be generated, the impact of state and local
income taxes, the ability to use tax credits and net operating loss carry forwards, and available tax planning alternatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As
of June 30, 2022 and December 31, 2021, the Company provided a full valuation allowance against its net deferred tax assets since the
Company believes it is more likely than not that its deferred tax assets will not be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_PriorPeriodAdjustmentPolicyTextBlock', window );">Prior Period Adjustments</a></td>
<td class="text"><p id="xdx_845_ecustom--PriorPeriodAdjustmentPolicyTextBlock_zRObHgRFIn4f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zh54TYGgWZo2">Prior
Period Adjustments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company identified certain immaterial adjustments impacting prior reporting periods. Specifically, the Company identified adjustments
to correct certain asset, liability and equity accounts in relation to historical purchase price allocation accounting, historical accrued
revenues and true ups of the common stock issuable account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company assessed the materiality of the adjustments to prior period financial statements in accordance with Securities and Exchange Commission
Staff Accounting Bulletin No. (SAB) 99, <i>Materiality</i>, and SAB 108, <i>Considering the Effects of Prior Year Misstatements when
Quantifying Misstatements in Current Year Financial Statements</i>, and ASC 250, <i>Accounting Changes and Error Corrections</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
the Company&#8217;s comparative condensed consolidated financial statements and impacted notes have been revised from amounts previously
reported to reflect these adjustments. The following table illustrates the impact on previously reported amounts and adjusted balances
presented in the condensed consolidated financial statements for the period ended June 30, 2022.</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zLtKrbTbf3zc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8B1_zy4nmbqtzRT9">SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION</span></span>&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_srt--RestatementAxis_srt--ScenarioPreviouslyReportedMember_zIlFdCuKKgL6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12/31/2020</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As reported</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_srt--RestatementAxis_srt--RestatementAdjustmentMember_ztSl1ChMHY0l" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_zUdl3tyCyjzd" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12/31/2020</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjusted</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_434_c20201231_eus-gaap--AccountsReceivableNetCurrent_iI_zeNA3cy2zFy6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Earn-out liability</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">2,631,418</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">300,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">2,931,418</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20201231_eus-gaap--Goodwill_iI_zGbtXLuh31V3" style="vertical-align: bottom; background-color: White">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,265,070</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(503,345</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,761,725</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20201231_eus-gaap--CommonStockSharesSubscriptions_iI_ziWIxMXggjtb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Common stock issuable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">822,116</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(482,116</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">340,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20201231_eus-gaap--AdditionalPaidInCapital_iI_zbUb6d0npFJe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additional paid-in-capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,377,123</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">182,116</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,559,239</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20201231_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zpywJ39h04S7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accumulated Deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,482,281</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">122,601</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,359,680</td><td style="text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B6_srt--RestatementAxis_srt--ScenarioPreviouslyReportedMember_zDUmDz1cXsN5" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3/31/2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As reported</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BB_srt--RestatementAxis_srt--RestatementAdjustmentMember_zuCTt499jlza" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B7_z0hbKKzwP566" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3/31/2021</b>&#160;&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjusted</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_433_c20210331_eus-gaap--CommonStockSharesSubscriptions_iI_zsto9pkjyeNf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Common stock issuable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">482,116</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(482,116</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_434_c20210331_eus-gaap--AdditionalPaidInCapital_iI_zKSe5SMWXzF3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additional paid-in-capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,810,147</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">182,116</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,992,263</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43C_c20210331_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zcCV7oP7Zy8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accumulated Deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13,123,609</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150,003</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,973,606</td><td style="text-align: left">)</td></tr>
  </table>

<p id="xdx_8A0_zyw2DnQljJT6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zK3FCib1Q3ea" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zSQan6anBzxj">Recently
Issued Accounting Pronouncements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not expect any recently issued accounting pronouncements to have a material effect on our financial statements.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_LiquidityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidity [PolicyTextBlock]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_LiquidityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_PriorPeriodAdjustmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prior period adjustment [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_PriorPeriodAdjustmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472845313728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_ztfGtzNzL7ol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and restricted cash reported on our Condensed Consolidated Balance Sheets are reconciled to the total shown on our Condensed Consolidated
Statements of Cash Flows as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zBvL1V2l6tya" style="display: none">SCHEDULE
OF RESTRICTED CASH IN STATEMENT OF CASH FLOW</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20220630_zQUfFS0I7Bdk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20210630_zXhmNmSsa4xg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Cash_iI_maRCACEzxqQ_zAyV56KVYhr2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,979,769</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6,348,415</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RestrictedCashCurrent_iI_maRCACEzxqQ_zlkkcI8lwKhb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Restricted cash</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,417,635</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">484,350</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RestrictedCashAndCashEquivalentsAtCarryingValue_iTI_mtRCACEzxqQ_zaHanh1g1kVj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total cash and restricted cash</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,397,404</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,832,765</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">SCHEDULE OF EARN OUT LIABILITY</a></td>
<td class="text"><p id="xdx_890_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zuvTGvxglgH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B1_zXZ6z5Sxqugl" style="display: none">SCHEDULE
OF FAIR VALUE OF WARRANT COMMITMENT</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20220630_zdELOVKAbk4d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20211231_zX1MYhWhCdG7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zj5ouKYrGde" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Stock price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2.11</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6.44</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zbdq5NQdG7Q1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">105</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Time to expiry</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zr1GMZQNhsNj" title="Warrants and rights outstanding term">4.51</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zKISL3Mn5ps2" title="Warrants and rights outstanding term">5</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zkdPrINnuo38" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_407_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zUpuuQxKipA" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.00</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.10</td><td style="text-align: left">%</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ScheduleOfReconcilesWarrantCommitmentTableTextBlock', window );">SCHEDULE OF RECONCILES WARRANT COMMITMENT</a></td>
<td class="text"><p id="xdx_89D_ecustom--ScheduleOfReconcilesWarrantCommitmentTableTextBlock_zt3kCNHuQ5M9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following reconciles fair value of the liability classified warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z5bchZTVaKEh" style="display: none">SCHEDULE
OF RECONCILES WARRANT COMMITMENT</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td id="xdx_4BE_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantCommitmentMember_zaPZPoar18x8" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Series B Warrant Commitment</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td id="xdx_4B0_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantLiabilityMember_zFVUv6u0gfb8" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Series B warrant liabilities</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td id="xdx_4BA_us-gaap--DerivativeInstrumentRiskAxis_custom--PlacementAgentWarrantsMember_zp5xE03Tw8Yd" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Placement agent warrants</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B3_zULc9txmvSa" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Total</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three and Six Months ended June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Series B Warrant Commitment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Series B warrant liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Placement agent warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_43B_c20220101__20220331_ecustom--WarrantCommitment_iS_zd3vhmbYuyld" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Beginning balance</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">37,652,808</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0829">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0830">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">37,652,808</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--InitialRecognitionOfWarrantCommitment_zyM2U4DD4yj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Initial recognition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0833">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,061,119</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,525,923</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">56,587,042</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--WarrantCommitmentUnrealizedGainLoss_zLfiRyNIbvRl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Unrealized (gain) loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,408,311</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(31,980,437</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(946,461</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,518,587</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_ecustom--WarrantsExercisedOrTransferred_zVYByWZcDdGd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Warrants exercised or transferred</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(55,061,119</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(55,061,119</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_43D_c20220401__20220630_ecustom--WarrantCommitment_iS_zrEwvtfbTO" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Ending balance, March 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0848">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">23,080,682</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">579,462</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">23,660,144</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--WarrantCommitmentUnrealizedGainLoss_zmj2QtkAu6Uj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Unrealized gain</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0853">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,322,737</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(310,514</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,633,251</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_436_c20220401__20220630_ecustom--WarrantCommitment_iE_z9HKugYon43e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Ending balance, June 30, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,757,945</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">268,948</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,026,893</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td id="xdx_4BC_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantCommitmentMember_zFjs7ly3vam5" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Series B Warrant Commitment</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">&#160;</td>
    <td id="xdx_4B0_zTXl22uiCGIi" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Total</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Series B Warrant Commitment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_43A_c20210101__20211231_ecustom--WarrantCommitment_iS_z62K3p0Y2rYb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Beginning balance</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0863">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--InitialRecognitionOfWarrantCommitment_z0J37025AFnf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Initial recognition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">20,244,497</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">20,244,497</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--WarrantCommitmentUnrealizedGainLoss_zoUjaLsFSw4i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Unrealized gain</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,408,311</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,408,311</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43E_c20210101__20211231_ecustom--WarrantCommitment_iE_z3Ptc0oweq7f" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">37,652,808</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">37,652,808</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">SCHEDULE OF FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><p id="xdx_897_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zJKMYpHycEGh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zYMc3HBmfOK4" style="display: none">SCHEDULE
OF FAIR VALUE MEASUREMENTS</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June
    30, 2022</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
    31, 2021</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation
    technique</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_ecustom--ValuationTechnique_c20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zJVisLob1nDj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 31%" title="Valuation technique"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discounted
    cash flow </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_ecustom--ValuationTechnique_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zp63Ik5UVtV" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 30%" title="Valuation technique"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discounted
    cash flow</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
    unobservable input</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_ecustom--SignificantUnobservableInput_c20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zKLexS2RNJ84" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center" title="Significant unobservable input"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Projected
    revenue and probability of achievement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_ecustom--SignificantUnobservableInput_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zo8veHrk3uCd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center" title="Significant unobservable input"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Projected
    revenue and probability of achievement</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock', window );">SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zlb5iloLraJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zFHjImYwLSU6" style="display: none">SCHEDULE
OF GAIN OR LOSSES RECOGNIZED FAIR VALUE</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkOgZJqsn2G4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_493_20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z5ixBvUV2h84" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--BusinessCombinationContingentConsiderationLiability_iS_zq3ugt4XkIok" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Beginning balance &#8211; January 1</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,813,878</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,931,418</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--AcquisitionsAndSettlements_zz0ozKTtJd6f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Acquisitions and Settlements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--JPKushAcquisitionMember_zpGCww08QqRj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">JP Kush Acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0911">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,694,166</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--BarraAcquisitionMember_ztAsfmTA8Ds3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Barra Acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">600,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0915">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--CCSWriteoffMember_z7s1LuppWNR7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">CCS Write-off</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0917">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(81,368</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--AltruisPartialSettlementMember_zTJGFdi49Gl8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Altruis partial settlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(84,473</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(452,236</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--MontanaFinalSettlementMember_zmXpkl6xJoP4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Montana final settlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(326,935</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0924">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Period adjustments:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_z7vUDb0QHKck" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value changes and accretion included in earnings<sup id="xdx_F4F_zCuz3bYtjLKf">*</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">354,963</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(278,102</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--BusinessCombinationContingentConsiderationLiability_iE_zgOy9LZAQxhi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Ending balance</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,357,433</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,813,878</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: Current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--EarnoutLiabilityCurrent_iI_c20220630_z010j0AI0K63" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Current portion">(3,683,596</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--EarnoutLiabilityCurrent_iI_c20211231_z8oBx77KZRcf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Current portion">(3,297,855</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Ending balance, less current portion</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_ecustom--EarnoutLiabilityNoncurrent_iI_c20220630_zDbKw4KHKjik" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, less current portion">673,837</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_ecustom--EarnoutLiabilityNoncurrent_iI_c20211231_zQzivkeBba6b" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, less current portion">516,023</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F04_znbwsMrwCLig" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F16_z4Xsy00weVQ4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recorded
    as a reduction to general and administrative expenses</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">SCHEDULE OF DISAGGREGATION REVENUE</a></td>
<td class="text"><p id="xdx_891_eus-gaap--DisaggregationOfRevenueTableTextBlock_zKQXJmjaBFd8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table disaggregates the Company&#8217;s revenue by line of business, showing commissions earned:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_z41gn9tNSTfh" style="display: none">SCHEDULE
OF DISAGGREGATION REVENUE</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months ended June 30, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z5tiAU5wjKR2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Medical/Life</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20220401__20220630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zdatYq69YXo7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Property and Casualty</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20220401__20220630_zHcVQK4rAnib" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-weight: bold">Regular</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"/><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"/><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"/><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zVdgVoeWie6i" style="vertical-align: bottom; background-color: White">
    <td>EBS</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">184,851</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0946">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">184,851</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zqGZOvVoHxI6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>USBA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,319</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0950">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,319</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zwjUHp1CEwn2" style="vertical-align: bottom; background-color: White">
    <td>CCS/UIS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0953">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57,195</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57,195</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zjegoCGCfgt9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Montana</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">451,705</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0958">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">451,705</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_zVsDiEHYJ40d" style="vertical-align: bottom; background-color: White">
    <td>Fortman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">357,334</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">205,804</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">563,138</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zs08bofcigH4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Altruis</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">882,171</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">882,171</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zQUL1vnGobQ8" style="vertical-align: bottom; background-color: White">
    <td>Kush</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">425,449</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0970">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">425,449</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--MedigapMember_zWg9mMrfBhGa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Medigap</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,359,976</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0974">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,359,976</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--BarraMember_zmAdJPVXBB98" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Barra</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">69,925</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">200,397</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">270,322</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zTbS3j7Pa6Bj" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">3,743,730</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zrRFuj6duqr3" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">463,396</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630_zxCGZQwLBjxi" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">4,207,126</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months ended June 30, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z9Be7lQu9voi" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Medical/Life
</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20220101__20220630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z3tydUEu24g3" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property
and Casualty </b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20220630_z8zEBupF4cE7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Regular</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zTy49gmU3rp" style="vertical-align: bottom; background-color: White">
    <td style="width: 46%">EBS</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">406,035</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0988">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">406,035</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zvWL8aZbZeFa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>USBA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,906</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0992">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,906</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zaP2nNq3HIud" style="vertical-align: bottom; background-color: White">
    <td>CCS/UIS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0995">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101,077</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101,077</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zL1mRS9xGWpj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Montana</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">958,426</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1000">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">958,426</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_z3OrVbvYIse8" style="vertical-align: bottom; background-color: White">
    <td>Fortman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">689,933</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">403,064</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,092,997</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zybrrU6NCHc7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Altruis</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,187,043</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1008">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,187,043</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zIHzljz06991" style="vertical-align: bottom; background-color: White">
    <td>Kush</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">864,040</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1012">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">864,040</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--MedigapMember_ztqkCcg9omDf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Medigap</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,537,061</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1016">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,537,061</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--BarraMember_zno0jYB9HFv8" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Barra</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">69,925</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">200,397</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">270,322</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zU809EwULDkg" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue from contract with customer, excluding assessed tax">7,738,369</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zRszIP2S1nr5" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue from contract with customer, excluding assessed tax">704,538</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630_z9IXsbU2PPXf" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue from contract with customer, excluding assessed tax">8,442,907</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months ended June 30, 2021</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zwLsapb9gO1e" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Medical/Life</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_496_20210401__20210630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z1tNbXreF2Mj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Property and Casualty</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20210401__20210630_zJI9fqyJstwj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Regular</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zx4IPaQSDQEi" style="vertical-align: bottom; background-color: White">
    <td style="width: 46%">EBS</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">207,201</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1030">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">207,201</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zV2eUnQeUmu9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>USBA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,395</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1034">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,395</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zEeyxDVrvkKe" style="vertical-align: bottom; background-color: White">
    <td>CCS/UIS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1037">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65,348</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65,348</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zMeWaWYAtQU7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Montana</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">404,740</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1042">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">404,740</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_zNnTB9fpj3jc" style="vertical-align: bottom; background-color: White">
    <td>Fortman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">276,634</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">226,337</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">502,971</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_z57f2KxlOKCc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Altruis</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">729,874</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1050">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">729,874</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zLDD68scL5Ec" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Kush</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">265,318</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1054">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">265,318</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zzd5vle96J6f" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">1,899,162</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zNPGE7HG8of3" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">291,685</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630_z5plR7MKzIxe" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">2,190,847</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months ended June 30, 2021</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_493_20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zPt3IBocgf3c" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Medical/Life</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20210101__20210630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zIJuwrb9Ylx2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Property and Casualty</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20210101__20210630_zOgSGQXGACTk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Regular</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zhA6r9o7rk3k" style="vertical-align: bottom; background-color: White">
    <td style="width: 46%">EBS</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">416,195</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1064">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">416,195</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zYSuyOjX0ddg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>USBA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,620</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1068">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,620</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zastlTuh8MT3" style="vertical-align: bottom; background-color: White">
    <td>CCS/UIS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1071">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">154,166</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">154,166</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zsyzyBMUvklk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Montana</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">939,856</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1076">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">939,856</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_z5QRZ4XJduNi" style="vertical-align: bottom; background-color: White">
    <td>Fortman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">526,435</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">434,109</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">960,544</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zMTs7cRjWMtc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Altruis</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,750,878</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1084">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,750,878</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zR7DIBwDZLK5" style="vertical-align: bottom; background-color: White">
    <td>Kush</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">265,318</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1088">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">265,318</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zr7yWuC1MVu8" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">3,926,302</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zlDmhcXqDkN1" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">588,275</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630_zz5VKg2KWWYa" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax">4,514,577</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">SCHEDULE OF CONCENTRATIONS OF REVENUES</a></td>
<td class="text"><p id="xdx_899_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zurCRq47Ear1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following, are customers representing <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zPtejUWKnux7" title="Concentration Risk, Percentage">10</span>% or more of total revenue:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8B1_zxT12eyYIe4i">SCHEDULE OF CONCENTRATIONS OF REVENUES</span></span>&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="display: none; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Insurance Carrier</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20220401__20220630_zJgUo4vQnJpc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20210401__20210630_zrvfG1T5V6bl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the three months ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Insurance Carrier</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--LTCGlobalMember_zMC8oySoP9Fj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">LTC Global</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">30</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1100">-</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--PriorityHealthMember_znq06QgPhkK6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Priority Health</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--BlueCrossBlueShieldMember_zpN2uLLxSJu4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">BlueCross BlueShield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1105">-</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="display: none; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Insurance Carrier</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20220101__20220630_z7F8k1FxEIp6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_492_20210101__20210630_zOG3RiBI7Prg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the six months ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Insurance Carrier</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--BlueCrossBlueShieldMember_z8TBNIihmAI6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">BlueCross BlueShield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">10</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">25</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--PriorityHealthMember_zVZvg9YCUls8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Priority Health</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_402_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--LTCGlobalMember_z87VBK7t4WCd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">LTC Global</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1115">-</span></td><td style="text-align: left">%</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock', window );">SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zLtKrbTbf3zc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8B1_zy4nmbqtzRT9">SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION</span></span>&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_srt--RestatementAxis_srt--ScenarioPreviouslyReportedMember_zIlFdCuKKgL6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12/31/2020</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As reported</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_srt--RestatementAxis_srt--RestatementAdjustmentMember_ztSl1ChMHY0l" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_zUdl3tyCyjzd" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12/31/2020</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjusted</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_434_c20201231_eus-gaap--AccountsReceivableNetCurrent_iI_zeNA3cy2zFy6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Earn-out liability</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">2,631,418</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">300,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">2,931,418</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20201231_eus-gaap--Goodwill_iI_zGbtXLuh31V3" style="vertical-align: bottom; background-color: White">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,265,070</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(503,345</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,761,725</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20201231_eus-gaap--CommonStockSharesSubscriptions_iI_ziWIxMXggjtb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Common stock issuable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">822,116</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(482,116</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">340,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20201231_eus-gaap--AdditionalPaidInCapital_iI_zbUb6d0npFJe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additional paid-in-capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,377,123</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">182,116</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,559,239</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20201231_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zpywJ39h04S7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accumulated Deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,482,281</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">122,601</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,359,680</td><td style="text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Account</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B6_srt--RestatementAxis_srt--ScenarioPreviouslyReportedMember_zDUmDz1cXsN5" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3/31/2021</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As reported</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BB_srt--RestatementAxis_srt--RestatementAdjustmentMember_zuCTt499jlza" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B7_z0hbKKzwP566" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3/31/2021</b>&#160;&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjusted</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_433_c20210331_eus-gaap--CommonStockSharesSubscriptions_iI_zsto9pkjyeNf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Common stock issuable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">482,116</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">(482,116</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_434_c20210331_eus-gaap--AdditionalPaidInCapital_iI_zKSe5SMWXzF3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additional paid-in-capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,810,147</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">182,116</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,992,263</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43C_c20210331_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zcCV7oP7Zy8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accumulated Deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13,123,609</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150,003</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,973,606</td><td style="text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">SCHEDULE OF EARN OUT LIABILITY</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1pON4iBjjBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company values its Level 3 earn-out liability related to the Barra Acquisition using a Monte Carlo simulation in a risk-neutral framework
(a special case of the Income Approach). The following summarizes the significant unobservable inputs:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zv1lEyyBoaX" style="display: none">SCHEDULE
OF EARN OUT LIABILITY</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: justify">WACC Risk Premium:</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputRiskPremiumMember_zjVOsHTdDEbj" title="Derivative Liability, Measurement Input">14.6</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zqMn0spx6Qje" title="Derivative Liability, Measurement Input">50</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Credit Spread:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputCreditSpreadMember_zpNZCTnxJM2f" title="Derivative Liability, Measurement Input">11</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Payment Delay (days)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputPaymentDelayMember_zFAkyxntXyB2" title="Derivative Liability, Measurement Input">90</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--RiskFreeRate_iI_c20220630_zN0olbNccxBj" title="Risk free rate">USD Yield Curve</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Discounting Convention:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--DiscountingConvention_iI_c20220630_zw9XkpJ31uE8" title="Discounting Convention:">Mid-period</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Number of Iterations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_ecustom--NumberOfLterations_iI_uInteger_c20220630_z5RyS1Z4xK0a" title="Number of Iterations">100,000</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_ScheduleOfReconcilesWarrantCommitmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of reconciles warrant commitment [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_ScheduleOfReconcilesWarrantCommitmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472845301984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember', window );">Medigap Healthcare Insurance Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">SCHEDULE OF ALLOCATION OF PURCHASE PRICE</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zPLnyz6qDgO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preliminary allocation of the purchase price in connection with the acquisition of Medigap was calculated as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zwEO6gUZ0pCi" style="display: none">SCHEDULE
OF ALLOCATION OF PURCHASE PRICE</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Description</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Useful Life (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Property, plant and equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zMKYASwrfsPb" style="width: 16%; text-align: right" title="Property, plant and equipment">20,666</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 16%; text-align: center"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zsAYkgl8hwCe" title="Finite lived intangible asset useful life">5</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Right-of-use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RightOfUseAssetMember_zKMSL1xLpT3" style="text-align: right" title="Right-of-use asset">317,787</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Trade names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_z71FK8rBXQ36" style="text-align: right" title="Trade name and trademarks">340,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_ze3mfqbe6mHi" title="Finite lived intangible asset useful life">15</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zIjP7idvbwTg" style="text-align: right" title="Customer relationships">4,550,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zXfA7XDxZpqe" title="Finite lived intangible asset useful life">12</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Technology</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_z00qTdaLiKoi" style="text-align: right" title="Technology">67,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zL9NVu8yuqH2" title="Finite lived intangible asset useful life">3</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Backlog</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BackLogMember_z8wEoRXfV174" style="text-align: right" title="Backlog">210,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BackLogMember_z6xedrYk5V07" title="Finite lived intangible asset useful life">1</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Chargeback reserve</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ChargebackReserveMember_ztJ9cNwbFNll" style="text-align: right" title="Chargeback reserve">(1,484,473</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LeaseLiabilityMember_z1gCVNCEVtp4" style="text-align: right" title="Lease liability">(317,787</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Goodwill</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zyKDxIFeMm5l" style="border-bottom: Black 1.5pt solid; text-align: right" title="Goodwill">19,199,008</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--FinitelivedIntangibleAssetUsefulLives_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zUdpwx64y44k" title="Finite lived intangible asset useful life">Indefinite</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zsNbik1a7LM7" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase consideration allocated">22,902,201</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">SCHEDULE OF PRO FORMA INFORMATION RELATED TO ACQUISITION</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zphAC9xbDvx4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8BD_zqlCpy4FoW84">SCHEDULE OF PRO FORMA INFORMATION
RELATED TO ACQUISITION</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zrAY1u9qdTVe" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20210101__20210630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_z5TmFC5JKJNh" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_zPXpL5s2Eiif" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">8,809,482</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">7,071,329</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zvTbC6rbm2w8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">19,849,175</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1,796,767</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_zrzBLE85Ditc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Earnings (Loss) per common share, basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.19</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareDiluted_zI9h1oNzNN7k" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Earnings (Loss) per common share, diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.59</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.19</td><td style="text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember', window );">Barra [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">SCHEDULE OF ALLOCATION OF PURCHASE PRICE</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--BarraMember_zAvj3Cczm2we" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preliminary allocation of the purchase price in connection with the acquisition of Barra was calculated as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8B4_z0vHAAqSjuyd" style="display: none">SCHEDULE OF ALLOCATION OF PURCHASE PRICE</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Description</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Useful Life (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Acquired accounts receivable</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AcquiredAccountsReceivableMember_zTEQ44tbOljh" style="width: 16%; text-align: right" title="Acquired accounts receivable">92,585</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 16%; text-align: center">&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zEJUiyX6gjEf" style="text-align: right" title="Property, plant and equipment">8,593</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zq9A0wTgQIB" title="Weighted average useful life">7</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Right-of-use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RightOfUseAssetMember_z2RLvyst8of8" style="text-align: right" title="Right-of-use asset">122,984</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade names</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_z8wSKvLECqj4" style="text-align: right" title="Trade name and trademarks">22,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zv073tK0qK19" title="Weighted average useful life">4</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zF9ypjfpQvz1" style="text-align: right" title="Customer relationships">550,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zxQh4rOqw2A3" title="Weighted average useful life">10</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Agency relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AgencyRelationshipsMember_zUNevM86Ndub" style="text-align: right" title="Agency relationships">2,585,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AgencyRelationshipsMember_zSqsuI7S1rUh" title="Weighted average useful life">10</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Developed technology</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_z3XK0aUG4hOk" style="text-align: right" title="Developed Technology">230,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zlmP7oVyy7Ti" title="Weighted average useful life">5</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LeaseLiabilityMember_zrVPj4rifPd9" style="text-align: right" title="Lease liability">(122,984</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Goodwill</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zAjUSJnoUlpj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Goodwill">4,236,822</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--FinitelivedIntangibleAssetUsefulLives_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zYilHFApmoYd" title="Weighted average useful life description">Indefinite</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zjPXfDbPZwXb" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase consideration allocated">7,725,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">SCHEDULE OF PRO FORMA INFORMATION RELATED TO ACQUISITION</a></td>
<td class="text"><p id="xdx_893_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--BarraMember_zKn67UKrec71" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8B2_zEZwjxQvbmQ9">SCHEDULE OF PRO FORMA INFORMATION
RELATED TO ACQUISITION</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zqb2SASifGMk" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_494_20210101__20210630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_z2PG1csF5s0j" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_z3UL1f40LbL9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">8,990,529</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">5,364,335</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zT3TvaciS2jc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,070,124</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1,527,038</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_zi9w5pX9pgY3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Earnings (Loss) per common share, basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.76</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.16</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareDiluted_zsK40jpQsPcc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Earnings (Loss) per common share, diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.58</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.16</td><td style="text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_BarraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472845319296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">SCHEDULE OF IMPAIRMENT OF GOODWILL</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfGoodwillTextBlock_zBTnTiFIZfjf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none"><span id="xdx_8B5_zmtgNeJ0kQWi">SCHEDULE OF IMPAIRMENT OF GOODWILL</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Goodwill</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">December 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--Goodwill_iS_pp0p0_c20210101__20211231_ze73yHBBxiaa" style="width: 16%; text-align: right" title="Goodwill">8,761,725</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Goodwill recognized in connection with Kush acquisition on May 1, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_c20210101__20211231_zg8bFG8xE91j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Goodwill acquired during period">1,288,552</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--Goodwill_iS_pp0p0_c20220101__20220630_zPuKIpm4JaNd" style="text-align: right" title="Goodwill">10,050,277</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Goodwill recognized in connection with Medigap acquisition on January 10, 2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zMOr3ej7wz8c" style="text-align: right" title="Goodwill acquired during period">19,199,008</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Goodwill recognized in connection with Barra acquisition on April 26, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_z6HRemAlnwAk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Goodwill acquired during period">4,236,822</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">June 30, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--Goodwill_iE_pp0p0_c20220101__20220630_zXjeJdfRTY69" style="border-bottom: Black 2.5pt double; text-align: right">33,486,107</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">SCHEDULE OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zNRZKbnTkhjg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the major categories of the Company&#8217;s intangible assets and the weighted-average remaining amortization
period as of June 30, 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B5_zL9Gn6g1VN7h" style="display: none">SCHEDULE
OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Amortization period (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accumulated Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying Amount</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Trade name and trademarks</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 10%; text-align: center"><span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_z9PuGmUoa0Ge" title="Weighted average remaining amortization period">4.9</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zooFf4RYL5kc" style="width: 10%; text-align: right" title="Gross carrying amount">2,142,858</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zksUHP2yJWg5" style="width: 10%; text-align: right" title="Accumulated amortization">(804,020</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zcZSWEgTxtW6" style="width: 10%; text-align: right" title="Net carrying amount">1,338,838</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Internally developed software</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_z0N2l6CHeMof" title="Weighted average remaining amortization period">4.5</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zD8UljXApcf5" style="text-align: right" title="Gross carrying amount">1,326,158</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zO2RDVfgZZZ3" style="text-align: right" title="Accumulated amortization">(131,655</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zKFCvs7GfSck" style="text-align: right" title="Net carrying amount">1,194,503</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zFJactYejOGc" title="Weighted average remaining amortization period">9.53</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_znrtJB1YI0oe" style="text-align: right" title="Gross carrying amount">11,922,290</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zee630SN8k63" style="text-align: right" title="Accumulated amortization">(1,517,174</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zHvBPq6NYKpf" style="text-align: right" title="Net carrying amount">10,405,116</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Purchased software</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zGVjif2lpjFf" title="Weighted average remaining amortization period"><span style="-sec-ix-hidden: xdx2ixbrl1354">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zXa32kc0rH7g" style="text-align: right" title="Gross carrying amount">562,327</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zV033eRTcepa" style="text-align: right" title="Accumulated amortization">(562,327</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zJjcPqadUK0e" style="text-align: right" title="Net carrying amount"><span style="-sec-ix-hidden: xdx2ixbrl1360">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Video Production Assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zR1jhaIJslti" title="Weighted average remaining amortization period">0.6</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zMs6tRIeZ4Y7" style="text-align: right" title="Gross carrying amount">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_znpwbIvVNxUl" style="text-align: right" title="Accumulated amortization">(23,242</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zq45DqhXBxaa" style="text-align: right" title="Net carrying amount">26,758</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Non-competition agreements</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_z1VIqFQUYD48" title="Weighted average remaining amortization period">2.4</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zrmvaS95v7M3" style="text-align: right" title="Gross carrying amount">3,504,810</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zcsbWn1XYTSd" style="text-align: right" title="Accumulated amortization">(1,827,590</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_z14muw9eIR3f" style="text-align: right" title="Net carrying amount">1,677,220</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Contracts Backlog</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractsBacklogMember_zaMEVsEllsNa" title="Weighted average remaining amortization period">0.5</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractsBacklogMember_z2wVhmovIwW5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gross carrying amount">210,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractsBacklogMember_znKFaBLlrNIl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization">(100,684</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractsBacklogMember_zLhRSkeEdAI4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net carrying amount">109,316</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630_z2evHmQDOdm6" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross carrying amount">19,718,443</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630_zih8kYD05oh8" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization">(4,966,692</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630_zgaEWCTcKEnk" style="border-bottom: Black 2.5pt double; text-align: right" title="Net carrying amount">14,751,751</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the major categories of the Company&#8217;s intangible assets and the weighted-average remaining amortization
period as of December 31, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Remaining Amortization period (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accumulated Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying Amount</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Trade name and trademarks</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 10%; text-align: center"><span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zNQwKbQ42Una" title="Weighted average remaining amortization period">3.5</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_z33gOXeZjArf" style="width: 10%; text-align: right" title="Gross carrying amount">1,777,475</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zPTwnb3oZKlj" style="width: 10%; text-align: right" title="Accumulated amortization">(609,822</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zLo6nNRVCfVa" style="width: 10%; text-align: right" title="Net carrying amount">1,167,653</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Internally developed software</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_z6VbNr2UP205" title="Weighted average remaining amortization period">4.7</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zGvAcnQ3EZ4f" style="text-align: right" title="Gross carrying amount">595,351</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zbjRQ78J44Ik" style="text-align: right" title="Accumulated amortization">(28,443</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zjlS78Ne5EL3" style="text-align: right" title="Net carrying amount">566,908</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zQGXp4Rx8TUk" title="Weighted average remaining amortization period">7.7</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zC6XhFSz6Pw5" style="text-align: right" title="Gross carrying amount">4,237,290</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zc1nwVarlrr8" style="text-align: right" title="Accumulated amortization">(1,048,726</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyswIb2Sg5J3" style="text-align: right" title="Net carrying amount">3,188,564</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Purchased software</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zCgS3Bzg49Rh" title="Weighted average remaining amortization period">0.6</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zue2JVRz2eAd" style="text-align: right" title="Gross carrying amount">562,327</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zgwqYR54qes4" style="text-align: right" title="Accumulated amortization">(452,985</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zw3rCEDcHQK" style="text-align: right" title="Net carrying amount">109,342</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Video Production Assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zkXDivMWVru3" title="Weighted average remaining amortization period">1.0</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zrstMszoUN1" style="text-align: right" title="Gross carrying amount">20,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_ziWRbdMXKny8" style="text-align: right" title="Accumulated amortization"><span style="-sec-ix-hidden: xdx2ixbrl1428">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zKIA7arWwbv8" style="text-align: right" title="Net carrying amount">20,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Non-competition agreements</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center"><span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zG1evYRwCCxf" title="Weighted average remaining amortization period">2.9</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zXU0Ap5T7MA" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gross carrying amount">3,504,809</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zKdObrufoOZe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization">(1,478,376</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_z8gyxk2h3yxd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net carrying amount">2,026,433</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231_z5WW5B5jNdrc" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross carrying amount">10,697,252</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231_zTjZNFw0UDcj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization">(3,618,352</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231_zBCBFnIAnJ7e" style="border-bottom: Black 2.5pt double; text-align: right" title="Net carrying amount">7,078,900</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">SCHEDULE OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS</a></td>
<td class="text"><p id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zYbWqPtf52C7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reflects expected amortization expense as of June 30, 2022, for each of the following five years and thereafter:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_z1S0NyhlATId" style="display: none">SCHEDULE
OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Years ending December 31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220630_zdme31u0Zgi4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization Expense</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_maFLIANziEa_zDwHLkgCzdDa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">2022 (remainder of year)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,374,512</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANziEa_zUWP4DkC850f" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,461,552</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANziEa_zqbyUPGSbDMi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,083,450</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANziEa_zpFaEiSGU3gj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,703,824</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_maFLIANziEa_zzeak3V2R4p1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,463,747</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_maFLIANziEa_ziWqp2dai4ee" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,664,666</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANziEa_zNjjHamLhIke" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,751,751</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472841538448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT AND SHORT-TERM FINANCINGS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract', window );"><strong>Long-term Debt And Short-term Financings</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">SCHEDULE OF LONG TERM DEBT</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zjbMmOY0rSWg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
composition of the long-term debt follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none"><span id="xdx_8BF_zJrtyNzdmdql" style="display: none">SCHEDULE OF LONG TERM DEBT</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Oak Street Funding LLC Term Loan for the acquisition of EBS and USBA, net of deferred financing costs of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--EBSandUSBAMember_z1Q5RkjG52Kd" title="Net of deferred financing cost">13,497</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--EBSandUSBAMember_zQj1TwfN8J64" title="Net of deferred financing cost">14,606</span> as of June 30, 2022 and December 31, 2021, respectively</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--EBSandUSBAMember_zZbvKLnBIPvi" style="width: 16%; text-align: right" title="Long term debt current">455,391</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--EBSandUSBAMember_zpScUd8AZkW9" style="width: 16%; text-align: right" title="Long term debt current">485,317</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Oak Street Funding LLC Senior Secured Amortizing Credit Facility for the acquisition of CCS, net of deferred financing costs of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--CreditFacilityAxis__custom--CCSMember_z2WpvhXWozme" title="Net of deferred financing cost">16,351</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--CreditFacilityAxis__custom--CCSMember_zFvjR0bSeRxh" title="Net of deferred financing cost">17,626</span> as of June 30, 2022 and December 31, 2021, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--CreditFacilityAxis__custom--CCSMember_zV4OjkqpPbh1" style="text-align: right" title="Long term debt current">738,547</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--CreditFacilityAxis__custom--CCSMember_zRPOQNAI0nh4" style="text-align: right" title="Long term debt current">785,826</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Oak Street Funding LLC Term Loan for the acquisition of SWMT, net of deferred financing costs of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--SWMTMember_zoOBjeJHvlla" title="Net of deferred financing cost">10,085</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--SWMTMember_zMx3Hy7Usomj" title="Net of deferred financing cost">11,027</span> as of June 30, 2022 and December 31, 2021, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--SWMTMember_zHAvmbxOnHjc" style="text-align: right" title="Long term debt current">835,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--SWMTMember_z8DbtxvanTIl" style="text-align: right" title="Long term debt current">884,720</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Oak Street Funding LLC Term Loan for the acquisition of FIS, net of deferred financing costs of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--FISMember_zR0yya1Weuc1" title="Net of deferred financing cost">39,752 </span>and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--FISMember_zIoPPk2htZEg" title="Net of deferred financing cost">42,660</span> as of June 30, 2022 and December 31, 2021, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--FISMember_zubETJkAJVgh" style="text-align: right" title="Long term debt current">2,103,885</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--FISMember_ztGfs2gJt4Qe" style="text-align: right" title="Long term debt current">2,226,628</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Oak Street Funding LLC Term Loan for the acquisition of ABC, net of deferred financing costs of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--ABCMember_z4d7ImIa1V66" title="Net of deferred financing cost">45,369</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_908_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--ABCMember_zHI3JyAVNVE7" title="Net of deferred financing cost">48,609</span> as of June 30, 2022 and December 31, 2021, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--ABCMember_ziTwG1hXTyp9" style="text-align: right" title="Long term debt current">3,427,614</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--ABCMember_z0tslES6PHnb" style="text-align: right" title="Long term debt current">3,616,754</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Oak Street Funding LLC Term Loan for the acquisition of Barra, net of deferred financing costs of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zne1OiYQml26" title="Net of deferred financing cost">208,901</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90D_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zaY7qgk31TJa" title="Net of deferred financing cost">0</span> as of June 30, 2022 and December 31, 2021, respectively</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zhDcrjp2Qv0c" style="border-bottom: Black 1.5pt solid; text-align: right" title="Long term debt current">6,311,099</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zpFldjFvkDMi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Long term debt current"><span style="-sec-ix-hidden: xdx2ixbrl1512">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--LongTermDebt_iI_c20220630_z9FgkrR3f43k" style="text-align: right" title="Long term debt">13,871,912</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--LongTermDebt_iI_c20211231_zUY96lHUFOIe" style="text-align: right" title="Long term debt">7,999,245</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: current portion</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--LongTermDebtCurrent_iNI_di_c20220630_zPkYc8wDpQy2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Current portion of long-term debt">(936,263</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--LongTermDebtCurrent_iNI_di_c20211231_zmXBnTIhZcei" style="border-bottom: Black 1.5pt solid; text-align: right" title="Current portion of long-term debt">(913,920</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Long-term debt</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--LongTermDebtNoncurrent_iI_c20220630_z9k2CwFDNtIh" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term debt, excluding current maturities">12,935,649</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--LongTermDebtNoncurrent_iI_c20211231_zTa1bVOHOcD9" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term debt, excluding current maturities">7,085,325</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">SCHEDULE OF CUMULATIVE MATURITIES OF LONG-TERM LOANS AND CREDIT FACILITIES</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zXaJBK35MWd6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;<span id="xdx_8B5_z6T44eRoySf4" style="display: none">SCHEDULE
OF CUMULATIVE MATURITIES OF LONG-TERM LOANS AND CREDIT FACILITIES</span></i></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Fiscal year ending December 31,</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_495_20220630_znKSwTAoKRVi" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Maturities of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Long-Term Debt</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_iI_maDICAzUlL_zD8tjSnVjkP3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">2022 (remainder of year)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">438,616</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_maDICAzUlL_zJS5wiMGmCQd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,228,897</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_maDICAzUlL_zi7pxzsAMSs3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,542,156</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_maDICAzUlL_zvYm6PemCYx9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,656,383</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_maDICAzUlL_z6Fzq2O3Fc3c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,776,385</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_maDICAzUlL_z1XHiwscUX32" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,563,428</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DebtInstrumentCarryingAmount_iI_mtDICAzUlL_zmUYwoJsExI2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,205,865</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredFinanceCostsNet_iNI_di_zgmv3VFGZPC1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: debt issuance costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(333,953</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--LongTermDebt_iI_ztauDfk8nlR" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">13,871,912</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472841469728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS (LOSS) PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS</a></td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zGNto2cMfdSb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
calculations of basic and diluted EPS, are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zMbpD2rSg2W9" style="display: none">SCHEDULE
OF CALCULATIONS OF BASIC AND DILUTED EPS</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20220401__20220630_zQy9RwStOng" style="font-weight: bold; text-align: center">Three Months</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20210401__20210630_zaNbmJd7aBi3" style="font-weight: bold; text-align: center">Three Months</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_mtNILzGtK_z3QE9XkS9JHh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Net income (loss)</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">10,495,691</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">(1,276,886</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_406_ecustom--DeemedDividend_iN_di_z3wG0v2CD7O7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Deemed dividend</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1724">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1725">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_z0Dv02ZGUW7e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net income (loss), numerator, basic computation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,495,691</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,276,886</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_z6b43Eqt5ZVa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Recognition and change in fair value of warrant liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,633,251</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1731">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_ztJzbLqg3i7a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net income (loss), numerator, diluted computation</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,137,560</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,276,886</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zGmscDeG1a3a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Weighted average shares - denominator basic computation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,738,290</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,934,489</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_zjRIAgRGFSnb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Effect of stock awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,916</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1740">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--EffectOfSeriesBWarrantLiability_zIR34DvUQKwe" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Effect of Series B warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_z5khnvLLB4ek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Effect of preferred stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,219,084</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1746">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zUaDKLhgZ1jj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Weighted average shares, as adjusted - denominator diluted computation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">20,989,290</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,934,489</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareBasic_z8Zf0k6QXEPi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Earnings (loss) per common share &#8211; basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.56</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.12</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--EarningsPerShareDiluted_za5O3Nkr9ovc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Earnings (loss) per common share &#8211; diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.10</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.12</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20220101__20220630_zlsBe1hLCvoe" style="font-weight: bold; text-align: center">Six Months</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_493_20210101__20210630_zROC7RkXvoOa" style="font-weight: bold; text-align: center">Six Months</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_mtNILzGtK_zWTVW5qp2ZKl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Net income (loss)</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">19,835,692</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">(1,890,812</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_406_ecustom--DeemedDividend_iN_di_zy3EHCOA6MJh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Deemed dividend</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,930,335</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1761">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zjSYIyZNDBYe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net income (loss), numerator, basic computation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,905,357</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,890,812</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_zlO26JmH0dEb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Recognition and change in fair value of warrant liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(24,748,163</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1767">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_zILyoa8V5bph" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net income (loss), numerator, diluted computation</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(11,842,806</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,890,812</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_z5DdAS8TLt92" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Weighted average shares - denominator basic computation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,238,285</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,259,738</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ziTY8ZDdAGJ9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Effect of stock awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46,084</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1776">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--EffectOfSeriesBWarrantLiability_zZk2cRma7Gyb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Effect of Series B warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,219,084</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1779">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_zNVX6WXu1hHl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Effect of preferred stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">631,276</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1782">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zNd2Utv4N0Lh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt">Weighted average shares, as adjusted - denominator diluted computation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">20,134,729</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,259,738</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareBasic_zwCrgzWhgowd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Earnings (loss) per common share - basic</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">0.75</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.20</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--EarningsPerShareDiluted_zU09KYCDAofg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Earnings (loss) per common share - diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.59</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.20</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472841555712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">SCHEDULE OF FUTURE MINIMUM LEASE PAYMENT</a></td>
<td class="text"><p id="xdx_893_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zZU6U7jblKgj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
minimum lease payment under these operating leases consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zd78BSLOcZn8" style="display: none">SCHEDULE
OF FUTURE MINIMUM LEASE PAYMENT</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Year ending December 31,</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20220630_zSzHj4i5aRB6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating Lease</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Obligations</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzuGy_zrl6b1uLhx22" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: justify">2022</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">303,256</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzuGy_zyUHSSjV4Mva" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">546,275</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzuGy_zMRy43sOwxZ6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">253,908</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maLOLLPzuGy_zNa8czfeKkLk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">2025</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">144,124</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_maLOLLPzuGy_zo3z7Tf8TrRd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">113,738</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_maLOLLPzuGy_zuD6r0ScbBtk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">268,202</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzuGy_zqurSQ91mXK7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Total undiscounted operating lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,629,503</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_z69dDRK59Wng" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Less: Imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(169,978</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiability_iI_pp0p0_zlvzQi6wVAH" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Present value of operating lease liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,459,525</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472841561568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_EarnOutLiabilitiesTableTextBlock', window );">SCHEDULE OF EARN-OUT LIABILITY</a></td>
<td class="text"><p id="xdx_897_ecustom--EarnOutLiabilitiesTableTextBlock_zrOvKquhzsGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following outlines changes to the Company&#8217;s earn-out liability balances inclusive of accumulated accretion for the respective period
ended June 30, 2022 and December 31, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8BA_ztiXawqIV94l">SCHEDULE
OF EARN-OUT LIABILITY</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B9_us-gaap--BusinessAcquisitionAxis_custom--CommercialSolutionsOfInsuranceAgencyLLCMember_zh0EZXvRKAX" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">CCS</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--BusinessAcquisitionAxis_custom--FortmanInsuranceAgencyLLCMember_zMEY8WEGwINg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fortman</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BF_us-gaap--BusinessAcquisitionAxis_custom--SouthwesternMontanaInsuranceCenterIncMember_zZmetVieGoTh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Montana</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BD_us-gaap--BusinessAcquisitionAxis_custom--AltruisBenefitsConsultantsIncMember_z49BTelcNEJ8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Altruis</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B0_us-gaap--BusinessAcquisitionAxis_custom--JPKushAndAssociatesIncMember_zlio9T0dcBU8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Kush</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--BusinessAcquisitionAxis_custom--BarraMember_zCq2Ncn36q6c" style="border-bottom: Black 1.5pt solid; font-weight: bold">Barra</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_zTCixRRcCqWe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_436_c20220101__20220630_eus-gaap--BusinessCombinationContingentConsiderationLiability_iS_z4YGdNEh3432" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%">Ending balance December 31, 2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1831">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">515,308</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">615,969</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">992,868</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">1,689,733</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1836">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">3,813,878</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--ChangesDueToAcquisitions_zvYs5RPeYF01" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Changes due to acquisitions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1839">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1840">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1841">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1842">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1843">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">600,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">600,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ChangesDueToPayments_zrM2j0F5svp7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Changes due to payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(326,935</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(84,473</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(411,408</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_400_ecustom--ChangesDueToFairValueAdjustments_z4SvK01G4Msl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Changes due to fair value adjustments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1855">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">32,620</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">37,741</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1858">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">334,602</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(50,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">354,963</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20220101__20220630_eus-gaap--BusinessCombinationContingentConsiderationLiability_iE_zclHYT4qFVQ8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Ending balance June 30, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1863">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">547,928</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">326,775</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">908,395</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,024,335</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">550,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,357,433</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B9_us-gaap--BusinessAcquisitionAxis_custom--CommercialSolutionsOfInsuranceAgencyLLCMember_zLOPpVA4E4P2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">CCS</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--BusinessAcquisitionAxis_custom--FortmanInsuranceAgencyLLCMember_zxubZrMq7Cyl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fortman</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BF_us-gaap--BusinessAcquisitionAxis_custom--SouthwesternMontanaInsuranceCenterIncMember_zrvlD6iWxtM5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Montana</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BD_us-gaap--BusinessAcquisitionAxis_custom--AltruisBenefitsConsultantsIncMember_zGs6z9B0sfqd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Altruis</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B0_us-gaap--BusinessAcquisitionAxis_custom--JPKushAndAssociatesIncMember_z3NRZrpTcyck" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Kush</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_zRR8aMJHhCA8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_433_c20210101__20211231_eus-gaap--BusinessCombinationContingentConsiderationLiability_iS_zpm4CbaBI2ua" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%">Ending balance December 31, 2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">81,368</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">432,655</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">522,553</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">1,894,842</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1875">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">2,931,418</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--ChangesDueToBusinessCombinations_z1hiuKVdAjzi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Changes due to business combinations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1878">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1879">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1880">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1881">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,694,166</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,694,166</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ChangesDueToPayments_zJHiGXgPK9s6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Changes due to payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1885">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1886">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1887">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(452,236</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1889">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(452,236</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_400_ecustom--ChangesDueToFairValueAdjustments_zp20CqLcuidf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Changes due to fair value adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1892">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">82,653</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">93,416</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(449,738</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,433</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(278,102</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_402_ecustom--ChangesDueToWriteoffs_zs7oQmvTp6Aj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Changes due to write-offs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(81,368</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1900">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1901">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1902">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1903">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(81,368</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_431_c20210101__20211231_eus-gaap--BusinessCombinationContingentConsiderationLiability_iE_zvDSOuCOQslb" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Ending balance December 31, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1906">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">515,308</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">615,969</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">992,868</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,689,733</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,813,878</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_EarnOutLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earn Out Liabilities [TableTextBlock]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_EarnOutLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472840740176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 2,979,769<span></span>
</td>
<td class="nump">$ 4,136,180<span></span>
</td>
<td class="nump">$ 6,348,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">1,417,635<span></span>
</td>
<td class="nump">$ 484,542<span></span>
</td>
<td class="nump">484,350<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Total cash and restricted cash</a></td>
<td class="nump">$ 4,397,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,832,765<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472843714256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF FAIR VALUE OF WARRANT COMMITMENT (Details)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Measurement Input, Share Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Risk free rate</a></td>
<td class="nump">2.11<span></span>
</td>
<td class="nump">6.44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Risk free rate</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and rights outstanding term</a></td>
<td class="text">4 years 6 months 3 days<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Risk free rate</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Risk free rate</a></td>
<td class="nump">3.00<span></span>
</td>
<td class="nump">1.10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472844099440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF RECONCILES WARRANT COMMITMENT (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantCommitment', window );">Beginning balance</a></td>
<td class="nump">$ 23,660,144<span></span>
</td>
<td class="nump">$ 37,652,808<span></span>
</td>
<td class="nump">$ 37,652,808<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_InitialRecognitionOfWarrantCommitment', window );">Initial recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,587,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,244,497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantCommitmentUnrealizedGainLoss', window );">Unrealized gain</a></td>
<td class="num">(12,633,251)<span></span>
</td>
<td class="num">(15,518,587)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,408,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantsExercisedOrTransferred', window );">Warrants exercised or transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,061,119)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantCommitment', window );">Ending balance</a></td>
<td class="nump">11,026,893<span></span>
</td>
<td class="nump">23,660,144<span></span>
</td>
<td class="nump">11,026,893<span></span>
</td>
<td class="nump">37,652,808<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=RELI_SeriesBWarrantCommitmentMember', window );">Series B Warrant Commitment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantCommitment', window );">Beginning balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">37,652,808<span></span>
</td>
<td class="nump">37,652,808<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_InitialRecognitionOfWarrantCommitment', window );">Initial recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,244,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantCommitmentUnrealizedGainLoss', window );">Unrealized gain</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">17,408,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,408,311<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantsExercisedOrTransferred', window );">Warrants exercised or transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,061,119)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantCommitment', window );">Ending balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">37,652,808<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=RELI_SeriesBWarrantLiabilityMember', window );">Series B Warrant Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantCommitment', window );">Beginning balance</a></td>
<td class="nump">23,080,682<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_InitialRecognitionOfWarrantCommitment', window );">Initial recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,061,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantCommitmentUnrealizedGainLoss', window );">Unrealized gain</a></td>
<td class="num">(12,322,737)<span></span>
</td>
<td class="num">(31,980,437)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantCommitment', window );">Ending balance</a></td>
<td class="nump">10,757,945<span></span>
</td>
<td class="nump">23,080,682<span></span>
</td>
<td class="nump">10,757,945<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=RELI_PlacementAgentWarrantsMember', window );">Placement Agent Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantCommitment', window );">Beginning balance</a></td>
<td class="nump">579,462<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_InitialRecognitionOfWarrantCommitment', window );">Initial recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,525,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantCommitmentUnrealizedGainLoss', window );">Unrealized gain</a></td>
<td class="num">(310,514)<span></span>
</td>
<td class="num">(946,461)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantCommitment', window );">Ending balance</a></td>
<td class="nump">$ 268,948<span></span>
</td>
<td class="nump">$ 579,462<span></span>
</td>
<td class="nump">$ 268,948<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_InitialRecognitionOfWarrantCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial recognition of warrant commitment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_InitialRecognitionOfWarrantCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_WarrantCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant commitment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_WarrantCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_WarrantCommitmentUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrealized (gain) loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_WarrantCommitmentUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_WarrantsExercisedOrTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants exercised or transferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_WarrantsExercisedOrTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=RELI_SeriesBWarrantCommitmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=RELI_SeriesBWarrantCommitmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=RELI_SeriesBWarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=RELI_SeriesBWarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=RELI_PlacementAgentWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=RELI_PlacementAgentWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472843734672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF FAIR VALUE MEASUREMENTS (Details) - Fair Value, Inputs, Level 3 [Member]<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ValuationTechnique', window );">Valuation technique</a></td>
<td class="text">Discounted
    cash flow<span></span>
</td>
<td class="text">Discounted
    cash flow<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_SignificantUnobservableInput', window );">Significant unobservable input</a></td>
<td class="text">Projected
    revenue and probability of achievement<span></span>
</td>
<td class="text">Projected
    revenue and probability of achievement<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_SignificantUnobservableInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Significant unobservable input.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_SignificantUnobservableInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_ValuationTechnique">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Valuation technique.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_ValuationTechnique</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472838227520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF EARN OUT LIABILITY (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>Integer</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_RiskFreeRate', window );">Risk free rate</a></td>
<td class="text">USD Yield Curve<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_DiscountingConvention', window );">Discounting Convention:</a></td>
<td class="text">Mid-period<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_NumberOfLterations', window );">Number of Iterations</a></td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=RELI_MeasurementInputRiskPremiumMember', window );">Measurement Input Risk Premium [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative Liability, Measurement Input</a></td>
<td class="nump">0.146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative Liability, Measurement Input</a></td>
<td class="nump">0.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCreditSpreadMember', window );">Measurement Input, Credit Spread [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative Liability, Measurement Input</a></td>
<td class="nump">0.11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=RELI_MeasurementInputPaymentDelayMember', window );">Measurement Input Payment Delay [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative Liability, Measurement Input</a></td>
<td class="nump">0.90<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_DiscountingConvention">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discounting convention.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_DiscountingConvention</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_NumberOfLterations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of lterations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_NumberOfLterations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_RiskFreeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Risk free rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_RiskFreeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=RELI_MeasurementInputRiskPremiumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=RELI_MeasurementInputRiskPremiumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCreditSpreadMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCreditSpreadMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=RELI_MeasurementInputPaymentDelayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=RELI_MeasurementInputPaymentDelayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472844996704">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beginning balance &#8211; January 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3,813,878<span></span>
</td>
<td class="nump">$ 2,931,418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,357,433<span></span>
</td>
<td class="nump">3,813,878<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_EarnoutLiabilityCurrent', window );">Less: Current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,683,596)<span></span>
</td>
<td class="num">(3,297,855)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_EarnoutLiabilityNoncurrent', window );">Ending balance, less current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">673,837<span></span>
</td>
<td class="nump">516,023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beginning balance &#8211; January 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,813,878<span></span>
</td>
<td class="nump">2,931,418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease', window );">Fair value changes and accretion included in earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">354,963<span></span>
</td>
<td class="num">(278,102)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,357,433<span></span>
</td>
<td class="nump">3,813,878<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | J P Kush Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_AcquisitionsAndSettlements', window );">Montana final settlement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,694,166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Barra Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_AcquisitionsAndSettlements', window );">Montana final settlement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">600,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | C C S Writeoff [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_AcquisitionsAndSettlements', window );">Montana final settlement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="num">(81,368)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Altruis Partial Settlement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_AcquisitionsAndSettlements', window );">Montana final settlement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(84,473)<span></span>
</td>
<td class="num">(452,236)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Montana Final Settlement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_AcquisitionsAndSettlements', window );">Montana final settlement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (326,935)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Recorded
    as a reduction to general and administrative expenses</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_AcquisitionsAndSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisitions and settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_AcquisitionsAndSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_EarnoutLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_EarnoutLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_EarnoutLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_EarnoutLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_JPKushAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_JPKushAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_BarraAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_CCSWriteoffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_CCSWriteoffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_AltruisPartialSettlementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_AltruisPartialSettlementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_MontanaFinalSettlementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_MontanaFinalSettlementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472838953696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF DISAGGREGATION REVENUE (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">$ 4,207,126<span></span>
</td>
<td class="nump">$ 2,190,847<span></span>
</td>
<td class="nump">$ 8,442,907<span></span>
</td>
<td class="nump">$ 4,514,577<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=RELI_EmployeeBenefitsSolutionsLLCMember', window );">Employee Benefits, Solutions, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">184,851<span></span>
</td>
<td class="nump">207,201<span></span>
</td>
<td class="nump">406,035<span></span>
</td>
<td class="nump">416,195<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=RELI_USBenefitsAllianceLLCMember', window );">US Benefits Alliance, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">12,319<span></span>
</td>
<td class="nump">15,395<span></span>
</td>
<td class="nump">25,906<span></span>
</td>
<td class="nump">27,620<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=RELI_CommercialCoverageSolutionsLLCMember', window );">Commercial Coverage Solutions LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">57,195<span></span>
</td>
<td class="nump">65,348<span></span>
</td>
<td class="nump">101,077<span></span>
</td>
<td class="nump">154,166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=RELI_SouthwesternMontanaFinancialCenterIncMember', window );">Southwestern Montana Financial Center, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">451,705<span></span>
</td>
<td class="nump">404,740<span></span>
</td>
<td class="nump">958,426<span></span>
</td>
<td class="nump">939,856<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=RELI_FortmanInsuranceServicesLLCMember', window );">Fortman Insurance Services, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">563,138<span></span>
</td>
<td class="nump">502,971<span></span>
</td>
<td class="nump">1,092,997<span></span>
</td>
<td class="nump">960,544<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=RELI_AltruisBenefitsConsultingIncMember', window );">Altruis Benefits Consulting, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">882,171<span></span>
</td>
<td class="nump">729,874<span></span>
</td>
<td class="nump">2,187,043<span></span>
</td>
<td class="nump">1,750,878<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=RELI_KushMember', window );">Kush [Member].</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">425,449<span></span>
</td>
<td class="nump">265,318<span></span>
</td>
<td class="nump">864,040<span></span>
</td>
<td class="nump">265,318<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=RELI_MedigapMember', window );">Medigap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">1,359,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,537,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=RELI_BarraMember', window );">Barra [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">270,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RELI_MedicalLifeMember', window );">Medical/Life [Member] | Regular [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">3,743,730<span></span>
</td>
<td class="nump">1,899,162<span></span>
</td>
<td class="nump">7,738,369<span></span>
</td>
<td class="nump">3,926,302<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RELI_MedicalLifeMember', window );">Medical/Life [Member] | Regular [Member] | Employee Benefits, Solutions, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">184,851<span></span>
</td>
<td class="nump">207,201<span></span>
</td>
<td class="nump">406,035<span></span>
</td>
<td class="nump">416,195<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RELI_MedicalLifeMember', window );">Medical/Life [Member] | Regular [Member] | US Benefits Alliance, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">12,319<span></span>
</td>
<td class="nump">15,395<span></span>
</td>
<td class="nump">25,906<span></span>
</td>
<td class="nump">27,620<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RELI_MedicalLifeMember', window );">Medical/Life [Member] | Regular [Member] | Commercial Coverage Solutions LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RELI_MedicalLifeMember', window );">Medical/Life [Member] | Regular [Member] | Southwestern Montana Financial Center, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">451,705<span></span>
</td>
<td class="nump">404,740<span></span>
</td>
<td class="nump">958,426<span></span>
</td>
<td class="nump">939,856<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RELI_MedicalLifeMember', window );">Medical/Life [Member] | Regular [Member] | Fortman Insurance Services, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">357,334<span></span>
</td>
<td class="nump">276,634<span></span>
</td>
<td class="nump">689,933<span></span>
</td>
<td class="nump">526,435<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RELI_MedicalLifeMember', window );">Medical/Life [Member] | Regular [Member] | Altruis Benefits Consulting, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">882,171<span></span>
</td>
<td class="nump">729,874<span></span>
</td>
<td class="nump">2,187,043<span></span>
</td>
<td class="nump">1,750,878<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RELI_MedicalLifeMember', window );">Medical/Life [Member] | Regular [Member] | Kush [Member].</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">425,449<span></span>
</td>
<td class="nump">265,318<span></span>
</td>
<td class="nump">864,040<span></span>
</td>
<td class="nump">265,318<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RELI_MedicalLifeMember', window );">Medical/Life [Member] | Regular [Member] | Medigap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">1,359,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,537,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RELI_MedicalLifeMember', window );">Medical/Life [Member] | Regular [Member] | Barra [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">69,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RELI_MedicalLifeMember', window );">Medical/Life [Member] | Property and Casualty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">463,396<span></span>
</td>
<td class="nump">291,685<span></span>
</td>
<td class="nump">704,538<span></span>
</td>
<td class="nump">588,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RELI_PropertyAndCasualtyMember', window );">Property and Casualty [Member] | Regular [Member] | Employee Benefits, Solutions, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RELI_PropertyAndCasualtyMember', window );">Property and Casualty [Member] | Regular [Member] | US Benefits Alliance, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RELI_PropertyAndCasualtyMember', window );">Property and Casualty [Member] | Regular [Member] | Commercial Coverage Solutions LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">57,195<span></span>
</td>
<td class="nump">65,348<span></span>
</td>
<td class="nump">101,077<span></span>
</td>
<td class="nump">154,166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RELI_PropertyAndCasualtyMember', window );">Property and Casualty [Member] | Regular [Member] | Southwestern Montana Financial Center, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RELI_PropertyAndCasualtyMember', window );">Property and Casualty [Member] | Regular [Member] | Fortman Insurance Services, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">205,804<span></span>
</td>
<td class="nump">226,337<span></span>
</td>
<td class="nump">403,064<span></span>
</td>
<td class="nump">434,109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RELI_PropertyAndCasualtyMember', window );">Property and Casualty [Member] | Regular [Member] | Altruis Benefits Consulting, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RELI_PropertyAndCasualtyMember', window );">Property and Casualty [Member] | Regular [Member] | Kush [Member].</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RELI_PropertyAndCasualtyMember', window );">Property and Casualty [Member] | Regular [Member] | Medigap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=RELI_PropertyAndCasualtyMember', window );">Property and Casualty [Member] | Regular [Member] | Barra [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="nump">$ 200,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=RELI_EmployeeBenefitsSolutionsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=RELI_EmployeeBenefitsSolutionsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=RELI_USBenefitsAllianceLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=RELI_USBenefitsAllianceLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=RELI_CommercialCoverageSolutionsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=RELI_CommercialCoverageSolutionsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=RELI_SouthwesternMontanaFinancialCenterIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=RELI_SouthwesternMontanaFinancialCenterIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=RELI_FortmanInsuranceServicesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=RELI_FortmanInsuranceServicesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=RELI_AltruisBenefitsConsultingIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=RELI_AltruisBenefitsConsultingIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=RELI_KushMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=RELI_KushMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=RELI_MedigapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=RELI_MedigapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=RELI_BarraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=RELI_BarraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=RELI_MedicalLifeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=RELI_MedicalLifeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=RELI_RegularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=RELI_RegularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=RELI_PropertyAndCasualtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=RELI_PropertyAndCasualtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=RELI_PropertyAndCasualtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=RELI_PropertyAndCasualtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472844876688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF CONCENTRATIONS OF REVENUES (Details) - Customer Concentration Risk [Member] - Revenue Benchmark [Member]<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">LTC Global [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">LTC Global</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Priority Health [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">LTC Global</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">BlueCross BlueShield [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">LTC Global</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RELI_LTCGlobalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RELI_LTCGlobalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RELI_PriorityHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RELI_PriorityHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=RELI_BlueCrossBlueShieldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=RELI_BlueCrossBlueShieldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472845282928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Earn-out liability</a></td>
<td class="nump">$ 1,072,294<span></span>
</td>
<td class="nump">$ 1,024,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,931,418<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">33,486,107<span></span>
</td>
<td class="nump">10,050,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,761,725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesSubscriptions', window );">Common stock issuable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">340,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">34,294,708<span></span>
</td>
<td class="nump">26,451,187<span></span>
</td>
<td class="nump">25,992,263<span></span>
</td>
<td class="nump">11,559,239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated Deficit</a></td>
<td class="num">$ (13,622,454)<span></span>
</td>
<td class="num">$ (33,458,145)<span></span>
</td>
<td class="num">(12,973,606)<span></span>
</td>
<td class="num">(12,359,680)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Earn-out liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,631,418<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,265,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesSubscriptions', window );">Common stock issuable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">482,116<span></span>
</td>
<td class="nump">822,116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,810,147<span></span>
</td>
<td class="nump">11,377,123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,123,609)<span></span>
</td>
<td class="num">(12,482,281)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Revision of Prior Period, Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Earn-out liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(503,345)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesSubscriptions', window );">Common stock issuable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(482,116)<span></span>
</td>
<td class="num">(482,116)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,116<span></span>
</td>
<td class="nump">182,116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,003<span></span>
</td>
<td class="nump">$ 122,601<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesSubscriptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=65888546&amp;loc=d3e21300-112643<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesSubscriptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472840553200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Cash and restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,397,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,397,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,100,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,100,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,981,501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,469,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,469,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,981,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WorkingCapitalDeficiency', window );">Working capital deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,369,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,369,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,928,443<span></span>
</td>
<td class="nump">$ 11,252,333<span></span>
</td>
<td class="nump">$ 12,913,545<span></span>
</td>
<td class="nump">$ 13,957,299<span></span>
</td>
<td class="nump">21,928,443<span></span>
</td>
<td class="nump">$ 12,913,545<span></span>
</td>
<td class="num">$ (26,066,129)<span></span>
</td>
<td class="num">$ (63,012)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,944,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,104,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,342,963<span></span>
</td>
<td class="nump">1,589,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_RecognitionAndChangeInFairValueOfWarrantLiability', window );">Recognition and change in fair value of warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,633,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,479,215<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,495,691<span></span>
</td>
<td class="nump">$ 9,340,000<span></span>
</td>
<td class="num">$ (1,276,886)<span></span>
</td>
<td class="num">$ (613,926)<span></span>
</td>
<td class="nump">19,835,692<span></span>
</td>
<td class="num">(1,890,812)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash flows from operations activites</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,311,411<span></span>
</td>
<td class="nump">1,493,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants', window );">Netproceeds from private placement issuance of shares and warrants</a></td>
<td class="nump">$ 17,853,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,853,351)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_PaymentsToUndiscountedRemainingEarnOut', window );">Undiscounted remaining earn out payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,697,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net proceeds from private placement issuance of shares and warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_PaymentsToUndiscountedRemainingEarnOut">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to undiscounted remaining earn out.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_PaymentsToUndiscountedRemainingEarnOut</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_RecognitionAndChangeInFairValueOfWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recognition and change in fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_RecognitionAndChangeInFairValueOfWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_WorkingCapitalDeficiency">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Working capital deficiency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_WorkingCapitalDeficiency</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=RELI_CustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=RELI_CustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472838937184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF ALLOCATION OF PURCHASE PRICE (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">9 years 6 months 10 days<span></span>
</td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember', window );">Medigap Healthcare Insurance Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Purchase consideration allocated</a></td>
<td class="nump">$ 22,902,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember', window );">Medigap Healthcare Insurance Company [Member] | Property, Plant and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Purchase consideration allocated</a></td>
<td class="nump">$ 20,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember', window );">Medigap Healthcare Insurance Company [Member] | Right of use asset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Purchase consideration allocated</a></td>
<td class="nump">$ 317,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember', window );">Medigap Healthcare Insurance Company [Member] | Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Purchase consideration allocated</a></td>
<td class="nump">$ 340,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember', window );">Medigap Healthcare Insurance Company [Member] | Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Purchase consideration allocated</a></td>
<td class="nump">$ 4,550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember', window );">Medigap Healthcare Insurance Company [Member] | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Purchase consideration allocated</a></td>
<td class="nump">$ 67,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember', window );">Medigap Healthcare Insurance Company [Member] | Back log [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Purchase consideration allocated</a></td>
<td class="nump">$ 210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember', window );">Medigap Healthcare Insurance Company [Member] | Chargeback reserve [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Purchase consideration allocated</a></td>
<td class="num">$ (1,484,473)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember', window );">Medigap Healthcare Insurance Company [Member] | Lease liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Purchase consideration allocated</a></td>
<td class="num">(317,787)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember', window );">Medigap Healthcare Insurance Company [Member] | Goodwill [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Purchase consideration allocated</a></td>
<td class="nump">$ 19,199,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_FinitelivedIntangibleAssetUsefulLives', window );">Weighted average useful life description</a></td>
<td class="text">Indefinite<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember', window );">Barra [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Purchase consideration allocated</a></td>
<td class="nump">$ 7,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember', window );">Barra [Member] | Property, Plant and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Purchase consideration allocated</a></td>
<td class="nump">$ 8,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember', window );">Barra [Member] | Right of use asset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Purchase consideration allocated</a></td>
<td class="nump">$ 122,984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember', window );">Barra [Member] | Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Purchase consideration allocated</a></td>
<td class="nump">$ 22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember', window );">Barra [Member] | Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Purchase consideration allocated</a></td>
<td class="nump">$ 550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember', window );">Barra [Member] | Lease liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Purchase consideration allocated</a></td>
<td class="num">$ (122,984)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember', window );">Barra [Member] | Goodwill [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Purchase consideration allocated</a></td>
<td class="nump">$ 4,236,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_FinitelivedIntangibleAssetUsefulLives', window );">Weighted average useful life description</a></td>
<td class="text">Indefinite<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember', window );">Barra [Member] | Acquired Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Purchase consideration allocated</a></td>
<td class="nump">$ 92,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember', window );">Barra [Member] | Agency Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Purchase consideration allocated</a></td>
<td class="nump">$ 2,585,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember', window );">Barra [Member] | Developed Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Purchase consideration allocated</a></td>
<td class="nump">$ 230,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_FinitelivedIntangibleAssetUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-lived intangible asset, useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_FinitelivedIntangibleAssetUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_RightOfUseAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_RightOfUseAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_BackLogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_BackLogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_ChargebackReserveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_ChargebackReserveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_LeaseLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_LeaseLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_BarraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_AcquiredAccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_AcquiredAccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_AgencyRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_AgencyRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472838230992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF PRO FORMA INFORMATION RELATED TO ACQUISITION (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember', window );">Medigap Healthcare Insurance Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 8,809,482<span></span>
</td>
<td class="nump">$ 7,071,329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 19,849,175<span></span>
</td>
<td class="num">$ (1,796,767)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Earnings (Loss) per common share, basic</a></td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="num">$ (0.19)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Earnings (Loss) per common share, diluted</a></td>
<td class="num">$ (0.59)<span></span>
</td>
<td class="num">$ (0.19)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember', window );">Barra [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 8,990,529<span></span>
</td>
<td class="nump">$ 5,364,335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 20,070,124<span></span>
</td>
<td class="num">$ (1,527,038)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Earnings (Loss) per common share, basic</a></td>
<td class="nump">$ 0.76<span></span>
</td>
<td class="num">$ (0.16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Earnings (Loss) per common share, diluted</a></td>
<td class="num">$ (0.58)<span></span>
</td>
<td class="num">$ (0.16)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_BarraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472839402400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 26, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 10, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,486,107<span></span>
</td>
<td class="nump">$ 10,050,277<span></span>
</td>
<td class="nump">$ 8,761,725<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RELI_APAMember', window );">APA [Member] | Barra and Associates LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Asset Acquisition, Consideration Transferred</a></td>
<td class="nump">$ 7,725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WorkingCapital', window );">Working capital</a></td>
<td class="nump">6,520,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RELI_APAMember', window );">APA [Member] | Barra and Associates LLC [Member] | Paid at closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Asset Acquisition, Consideration Transferred</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RELI_APAMember', window );">APA [Member] | Barra and Associates LLC [Member] | Payable in six months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Asset Acquisition, Consideration Transferred</a></td>
<td class="nump">1,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RELI_APAMember', window );">APA [Member] | Barra and Associates LLC [Member] | Payable over two years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Asset Acquisition, Consideration Transferred</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=RELI_MeasurementInputRoyaltyRateMember', window );">Measurement Input Royalty Rate [Member] | Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business combination, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member] | Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business combination, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member] | Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business combination, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member] | Back log [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business combination, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member] | Developed Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business combination, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=RELI_MeasurementInputObsolescenceRateMember', window );">Measurement Input Obsolescence Rate [Member] | Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business combination, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember', window );">Medigap Healthcare Insurance Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Business combination bargain purchase gain recognized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,096,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire businesses gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,138,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of shares acquistions | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">606,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,199,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquisitionCosts', window );">Acquisition Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod', window );">Revenue from acquired entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,537,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_SharesIssuedUponTerminationOfEmployee', window );">Shares issued upon termination of employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">412,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember', window );">Barra [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,236,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquisitionCosts', window );">Acquisition Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod', window );">Revenue from acquired entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270,321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_SharesIssuedUponTerminationOfEmployee', window );">Shares issued upon termination of employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember', window );">Barra [Member] | Measurement Input, Discount Rate [Member] | Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business combination, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember', window );">Barra [Member] | Measurement Input, Discount Rate [Member] | Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business combination, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_SharesIssuedUponTerminationOfEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued upon termination of employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_SharesIssuedUponTerminationOfEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Working capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(7)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126954596&amp;loc=d3e511914-122862<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(3)(ii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126954596&amp;loc=d3e511914-122862<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 55<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6829253&amp;loc=SL6831962-166255<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total revenue reported by the acquired entity for its previous full fiscal year before the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6571-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6387-128476<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6396-128476<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6527-128477<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6393-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RELI_APAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RELI_APAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=RELI_BarraAndAssociatesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=RELI_BarraAndAssociatesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=RELI_PaidAtClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=RELI_PaidAtClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=RELI_PayableInSixMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=RELI_PayableInSixMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=RELI_PayableOverTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=RELI_PayableOverTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=RELI_MeasurementInputRoyaltyRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=RELI_MeasurementInputRoyaltyRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_BackLogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_BackLogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=RELI_MeasurementInputObsolescenceRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=RELI_MeasurementInputObsolescenceRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_BarraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472844067376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF IMPAIRMENT OF GOODWILL (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 10,050,277<span></span>
</td>
<td class="nump">$ 8,761,725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,288,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">33,486,107<span></span>
</td>
<td class="nump">$ 10,050,277<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember', window );">Medigap Healthcare Insurance Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired during period</a></td>
<td class="nump">19,199,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">19,199,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember', window );">Barra [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired during period</a></td>
<td class="nump">4,236,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">$ 4,236,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_MedigapHealthcareInsuranceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_BarraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472839311872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">$ 19,718,443<span></span>
</td>
<td class="nump">$ 10,697,252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(4,966,692)<span></span>
</td>
<td class="num">(3,618,352)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount</a></td>
<td class="nump">$ 14,751,751<span></span>
</td>
<td class="nump">$ 7,078,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks and Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average remaining amortization period</a></td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">3 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">$ 2,142,858<span></span>
</td>
<td class="nump">$ 1,777,475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(804,020)<span></span>
</td>
<td class="num">(609,822)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount</a></td>
<td class="nump">$ 1,338,838<span></span>
</td>
<td class="nump">$ 1,167,653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_InternallyDevelopedSoftwareMember', window );">Internally Developed Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average remaining amortization period</a></td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">$ 1,326,158<span></span>
</td>
<td class="nump">$ 595,351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(131,655)<span></span>
</td>
<td class="num">(28,443)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount</a></td>
<td class="nump">$ 1,194,503<span></span>
</td>
<td class="nump">$ 566,908<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average remaining amortization period</a></td>
<td class="text">9 years 6 months 10 days<span></span>
</td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">$ 11,922,290<span></span>
</td>
<td class="nump">$ 4,237,290<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(1,517,174)<span></span>
</td>
<td class="num">(1,048,726)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount</a></td>
<td class="nump">$ 10,405,116<span></span>
</td>
<td class="nump">$ 3,188,564<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_PurchasedSoftwareMember', window );">Purchased Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average remaining amortization period</a></td>
<td class="text"> <span></span>
</td>
<td class="text">7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">$ 562,327<span></span>
</td>
<td class="nump">$ 562,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(562,327)<span></span>
</td>
<td class="num">(452,985)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 109,342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_VideoProductionAssetsMember', window );">Video Production Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average remaining amortization period</a></td>
<td class="text">7 months 6 days<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(23,242)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount</a></td>
<td class="nump">$ 26,758<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_NoncompetitionAgreementsMember', window );">Non-competition Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average remaining amortization period</a></td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">$ 3,504,810<span></span>
</td>
<td class="nump">$ 3,504,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(1,827,590)<span></span>
</td>
<td class="num">(1,478,376)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount</a></td>
<td class="nump">$ 1,677,220<span></span>
</td>
<td class="nump">$ 2,026,433<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_ContractsBacklogMember', window );">Contracts backlog [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average remaining amortization period</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">$ 210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(100,684)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount</a></td>
<td class="nump">$ 109,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_InternallyDevelopedSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_InternallyDevelopedSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_PurchasedSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_PurchasedSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_VideoProductionAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_VideoProductionAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_NoncompetitionAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_NoncompetitionAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_ContractsBacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=RELI_ContractsBacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472840681152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2022 (remainder of year)</a></td>
<td class="nump">$ 1,374,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">2,461,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">2,083,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">1,703,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">1,463,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">5,664,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 14,751,751<span></span>
</td>
<td class="nump">$ 7,078,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472843731408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 33,486,107<span></span>
</td>
<td class="nump">$ 10,050,277<span></span>
</td>
<td class="nump">$ 8,761,725<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Revision of Prior Period, Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(503,345)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,265,070<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472842721136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF LONG TERM DEBT (Details) (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=RELI_CCSMember', window );">CCS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCostsNet', window );">Net of deferred financing cost</a></td>
<td class="nump">$ 16,351<span></span>
</td>
<td class="nump">$ 17,626<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_EBSandUSBAMember', window );">EBS and USBA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCostsNet', window );">Net of deferred financing cost</a></td>
<td class="nump">13,497<span></span>
</td>
<td class="nump">14,606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_SWMTMember', window );">SWMT [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCostsNet', window );">Net of deferred financing cost</a></td>
<td class="nump">10,085<span></span>
</td>
<td class="nump">11,027<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_FISMember', window );">FIS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCostsNet', window );">Net of deferred financing cost</a></td>
<td class="nump">39,752<span></span>
</td>
<td class="nump">42,660<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_ABCMember', window );">ABC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCostsNet', window );">Net of deferred financing cost</a></td>
<td class="nump">45,369<span></span>
</td>
<td class="nump">48,609<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember', window );">Barra [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCostsNet', window );">Net of deferred financing cost</a></td>
<td class="nump">$ 208,901<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDeferredCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net amount of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs or deferred acquisition costs of insurance companies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDeferredCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=RELI_CCSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=RELI_CCSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_EBSandUSBAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_EBSandUSBAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_SWMTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_SWMTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_FISMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_FISMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_ABCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_ABCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_BarraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472844028912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF LONG TERM DEBT (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="nump">$ 13,871,912<span></span>
</td>
<td class="nump">$ 7,999,245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="num">(936,263)<span></span>
</td>
<td class="num">(913,920)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long term debt, excluding current maturities</a></td>
<td class="nump">12,935,649<span></span>
</td>
<td class="nump">7,085,325<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=RELI_CCSMember', window );">CCS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="nump">738,547<span></span>
</td>
<td class="nump">785,826<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_EBSandUSBAMember', window );">EBS and USBA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="nump">455,391<span></span>
</td>
<td class="nump">485,317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_SWMTMember', window );">SWMT [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="nump">835,376<span></span>
</td>
<td class="nump">884,720<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_FISMember', window );">FIS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="nump">2,103,885<span></span>
</td>
<td class="nump">2,226,628<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_ABCMember', window );">ABC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="nump">3,427,614<span></span>
</td>
<td class="nump">3,616,754<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember', window );">Barra [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="nump">$ 6,311,099<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=RELI_CCSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=RELI_CCSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_EBSandUSBAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_EBSandUSBAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_SWMTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_SWMTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_FISMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_FISMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_ABCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_ABCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_BarraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472843742800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF CUMULATIVE MATURITIES OF LONG-TERM LOANS AND CREDIT FACILITIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract', window );"><strong>Long-term Debt And Short-term Financings</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2022 (remainder of year)</a></td>
<td class="nump">$ 438,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">1,228,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">1,542,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">1,656,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">1,776,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">7,563,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">14,205,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Less: debt issuance costs</a></td>
<td class="num">(333,953)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 13,871,912<span></span>
</td>
<td class="nump">$ 7,999,245<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472842490176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT AND SHORT-TERM FINANCINGS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBankLoansAndNotesPayable', window );">Notes Payable</a></td>
<td class="nump">$ 42,894<span></span>
</td>
<td class="nump">$ 4,456<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RELI_DirectorsAndOfficerMember', window );">Directors and Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">7.51%<span></span>
</td>
<td class="nump">7.95%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of Debt Discount (Premium)</a></td>
<td class="nump">$ 417,199<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 376,647<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBankLoansAndNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBankLoansAndNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RELI_DirectorsAndOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RELI_DirectorsAndOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472838692624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WARRANT LIABILITIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 05, 2022</div></th>
<th class="th"><div>Dec. 23, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 22, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss', window );">Unrealized losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,652,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain', window );">Unrealized gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,322,737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_NonOperatingUnrealizedGains', window );">Unrealized gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,748,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantCommitment', window );">Derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,660,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,026,893<span></span>
</td>
<td class="nump">$ 23,660,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,026,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,652,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_IssuanceOfPlacementAgentWarrants', window );">Derivative liability measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,525,923<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantCommitmentUnrealizedGainLoss', window );">Unrealized gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,633,251)<span></span>
</td>
<td class="num">(15,518,587)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,408,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=RELI_SeriesBWarrantLiabilityMember', window );">Series B Warrant Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantCommitment', window );">Derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,080,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,757,945<span></span>
</td>
<td class="nump">23,080,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,757,945<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantCommitmentUnrealizedGainLoss', window );">Unrealized gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,322,737)<span></span>
</td>
<td class="num">$ (31,980,437)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RELI_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants', window );">Aggregate purchase price of common shares, preferred shares and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RELI_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrant issued</a></td>
<td class="nump">244,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="nump">$ 4.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantCommitment', window );">Derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">268,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">268,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrant term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_IssuanceOfPlacementAgentWarrants', window );">Derivative liability measured at fair value</a></td>
<td class="nump">$ 1,525,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantCommitmentUnrealizedGainLoss', window );">Unrealized gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 310,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 268,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=RELI_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Series B Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Preferred stock conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,670,892<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,670,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,670,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,219,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Securities Purchase Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrant issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,779,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate purchase price of common shares, preferred shares and warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_IssuanceOfPlacementAgentWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of placement agent warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_IssuanceOfPlacementAgentWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_NonOperatingUnrealizedGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non operating unrealized gains.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_NonOperatingUnrealizedGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_WarrantCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant commitment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_WarrantCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_WarrantCommitmentUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrealized (gain) loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_WarrantCommitmentUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share conversion price of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=RELI_SeriesBWarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=RELI_SeriesBWarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=RELI_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=RELI_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=RELI_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=RELI_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472835857904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>May 01, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.086<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,076<span></span>
</td>
<td class="nump">9,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, at par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,614,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,614,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,956,109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,109,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=RELI_ThreeEmployeesMember', window );">Three Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 766,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">766,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapAcquisitionMember', window );">Medigap Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock issued during period, shares, acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">606,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,670,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock issued during period, shares, acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">606,037<span></span>
</td>
<td class="nump">14,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of Series A warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,276,929)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Vesting of stock award</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of common stock warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 229,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 154,800<span></span>
</td>
<td class="nump">$ 178,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,670,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=RELI_SeriesAWarrantMember', window );">Series A Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of Series A warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,695,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=RELI_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=RELI_SeriesCPrepaidWarrantsMember', window );">Series C Prepaid Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,276,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of common stock warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,276,929<span></span>
</td>
<td class="nump">3,276,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,276,929<span></span>
</td>
<td class="nump">3,276,929<span></span>
</td>
<td class="nump">3,276,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=RELI_SeriesCPrepaidWarrantsMember', window );">Series C Prepaid Warrants [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of common stock warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,276,929<span></span>
</td>
<td class="nump">3,276,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,276,929<span></span>
</td>
<td class="nump">3,276,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=RELI_SeriesDPrepaidWarrantsMember', window );">Series D Prepaid Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,222,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of common stock warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,222,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 30<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=128088960&amp;loc=d3e3913-113898<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126965701&amp;loc=d3e15009-113911<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=RELI_ThreeEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=RELI_ThreeEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_MedigapAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_MedigapAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=RELI_SeriesAWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=RELI_SeriesAWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=RELI_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=RELI_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=RELI_SeriesCPrepaidWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=RELI_SeriesCPrepaidWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=RELI_SeriesDPrepaidWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=RELI_SeriesDPrepaidWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472845283472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 10,495,691<span></span>
</td>
<td class="nump">$ 9,340,000<span></span>
</td>
<td class="num">$ (1,276,886)<span></span>
</td>
<td class="num">$ (613,926)<span></span>
</td>
<td class="nump">$ 19,835,692<span></span>
</td>
<td class="num">$ (1,890,812)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_DeemedDividend', window );">Deemed dividend</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,930,335)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss), numerator, basic computation</a></td>
<td class="nump">10,495,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,276,886)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,905,357<span></span>
</td>
<td class="num">(1,890,812)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Recognition and change in fair value of warrant liability</a></td>
<td class="num">(12,633,251)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,748,163)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income (loss), numerator, diluted computation</a></td>
<td class="num">$ (2,137,560)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,276,886)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11,842,806)<span></span>
</td>
<td class="num">$ (1,890,812)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares - denominator basic computation</a></td>
<td class="nump">18,738,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,934,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,238,285<span></span>
</td>
<td class="nump">9,259,738<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of stock awards</a></td>
<td class="nump">31,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,084<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_EffectOfSeriesBWarrantLiability', window );">Effect of Series B warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,219,084<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Effect of preferred stock</a></td>
<td class="nump">2,219,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">631,276<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares, as adjusted - denominator diluted computation</a></td>
<td class="nump">20,989,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,934,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,134,729<span></span>
</td>
<td class="nump">9,259,738<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings (loss) per common share - basic</a></td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="num">$ (0.20)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings (loss) per common share - diluted</a></td>
<td class="num">$ (0.10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.59)<span></span>
</td>
<td class="num">$ (0.20)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_DeemedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deemed Dividend.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_DeemedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_EffectOfSeriesBWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effect of series B warrant liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_EffectOfSeriesBWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472844000304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS (LOSS) PER SHARE (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConversionBasis', window );">Stock conversion basis description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 for 1 basis<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_AntidilutiveSharesIssuedAndOutstanding', window );">Antidilutive shares Issued and Outstanding</a></td>
<td class="nump">163,925<span></span>
</td>
<td class="nump">163,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber', window );">Vested stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Non-vested stock awards</a></td>
<td class="nump">31,916<span></span>
</td>
<td class="nump">46,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_IssuanceOfSeriesDWarrants', window );">Issuance of Series D Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,930,335<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=RELI_SeriesBWarrantLiabilityMember', window );">Series B Warrant Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">631,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=RELI_SeriesAWarrantsMember', window );">Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantSharesIssued', window );">Warrant shares issued</a></td>
<td class="nump">1,695,000<span></span>
</td>
<td class="nump">1,695,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_WarrantSharesOutstanding', window );">Warrant shares outstanding</a></td>
<td class="nump">1,695,000<span></span>
</td>
<td class="nump">1,695,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163,925<span></span>
</td>
<td class="nump">163,913<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,076<span></span>
</td>
<td class="nump">1,167<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=RELI_SeriesCPrepaidWarrantsMember', window );">Series C Prepaid Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">1,676,737<span></span>
</td>
<td class="nump">2,743,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Stock Issued During Period, Shares, Conversion of Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,276,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=RELI_SeriesDPrepaidWarrantsMember', window );">Series D Prepaid Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Stock Issued During Period, Shares, Conversion of Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,222,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_IssuanceOfSeriesDWarrants', window );">Issuance of Series D Warrants</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 6,930,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_AntidilutiveSharesIssuedAndOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Antidilutive shares issued and outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_AntidilutiveSharesIssuedAndOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_IssuanceOfSeriesDWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Series D Warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_IssuanceOfSeriesDWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_WarrantSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant shares issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_WarrantSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_WarrantSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant shares outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_WarrantSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConversionBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConversionBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=RELI_SeriesBWarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=RELI_SeriesBWarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=RELI_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=RELI_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=RELI_SeriesCPrepaidWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=RELI_SeriesCPrepaidWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=RELI_SeriesDPrepaidWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=RELI_SeriesDPrepaidWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472842489600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE OF FUTURE MINIMUM LEASE PAYMENT (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 303,256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">546,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">253,908<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">144,124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">113,738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">268,202<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted operating lease payments</a></td>
<td class="nump">1,629,503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="num">(169,978)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of operating lease liabilities</a></td>
<td class="nump">$ 1,459,525<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472844031488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating Lease, Expense</a></td>
<td class="nump">$ 156,750<span></span>
</td>
<td class="nump">$ 43,931<span></span>
</td>
<td class="nump">$ 275,174<span></span>
</td>
<td class="nump">$ 112,199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">4 years 3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">5.76%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.76%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140472833845296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE OF EARN-OUT LIABILITY (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beginning balance &#8211; January 1</a></td>
<td class="nump">$ 3,813,878<span></span>
</td>
<td class="nump">$ 2,931,418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToAcquisitions', window );">Changes due to acquisitions</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToPayments', window );">Changes due to payments</a></td>
<td class="num">(411,408)<span></span>
</td>
<td class="num">(452,236)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToFairValueAdjustments', window );">Changes due to fair value adjustments</a></td>
<td class="nump">354,963<span></span>
</td>
<td class="num">(278,102)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td>
<td class="nump">4,357,433<span></span>
</td>
<td class="nump">3,813,878<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToBusinessCombinations', window );">Changes due to business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,694,166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToWriteoffs', window );">Changes due to write-offs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81,368)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_CommercialSolutionsOfInsuranceAgencyLLCMember', window );">Commercial Solutions Of Insurance Agency LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beginning balance &#8211; January 1</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">81,368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToAcquisitions', window );">Changes due to acquisitions</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToPayments', window );">Changes due to payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToFairValueAdjustments', window );">Changes due to fair value adjustments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToBusinessCombinations', window );">Changes due to business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToWriteoffs', window );">Changes due to write-offs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81,368)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_FortmanInsuranceAgencyLLCMember', window );">Fortman Insurance Agency LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beginning balance &#8211; January 1</a></td>
<td class="nump">515,308<span></span>
</td>
<td class="nump">432,655<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToAcquisitions', window );">Changes due to acquisitions</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToPayments', window );">Changes due to payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToFairValueAdjustments', window );">Changes due to fair value adjustments</a></td>
<td class="nump">32,620<span></span>
</td>
<td class="nump">82,653<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td>
<td class="nump">547,928<span></span>
</td>
<td class="nump">515,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToBusinessCombinations', window );">Changes due to business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToWriteoffs', window );">Changes due to write-offs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_SouthwesternMontanaInsuranceCenterIncMember', window );">Southwestern Montana Insurance Center Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beginning balance &#8211; January 1</a></td>
<td class="nump">615,969<span></span>
</td>
<td class="nump">522,553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToAcquisitions', window );">Changes due to acquisitions</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToPayments', window );">Changes due to payments</a></td>
<td class="num">(326,935)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToFairValueAdjustments', window );">Changes due to fair value adjustments</a></td>
<td class="nump">37,741<span></span>
</td>
<td class="nump">93,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td>
<td class="nump">326,775<span></span>
</td>
<td class="nump">615,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToBusinessCombinations', window );">Changes due to business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToWriteoffs', window );">Changes due to write-offs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_AltruisBenefitsConsultantsIncMember', window );">Altruis Benefits Consultants Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beginning balance &#8211; January 1</a></td>
<td class="nump">992,868<span></span>
</td>
<td class="nump">1,894,842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToAcquisitions', window );">Changes due to acquisitions</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToPayments', window );">Changes due to payments</a></td>
<td class="num">(84,473)<span></span>
</td>
<td class="num">(452,236)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToFairValueAdjustments', window );">Changes due to fair value adjustments</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(449,738)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td>
<td class="nump">908,395<span></span>
</td>
<td class="nump">992,868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToBusinessCombinations', window );">Changes due to business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToWriteoffs', window );">Changes due to write-offs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_JPKushAndAssociatesIncMember', window );">JP Kush and Associates Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beginning balance &#8211; January 1</a></td>
<td class="nump">1,689,733<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToAcquisitions', window );">Changes due to acquisitions</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToPayments', window );">Changes due to payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToFairValueAdjustments', window );">Changes due to fair value adjustments</a></td>
<td class="nump">334,602<span></span>
</td>
<td class="num">(4,433)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td>
<td class="nump">2,024,335<span></span>
</td>
<td class="nump">1,689,733<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToBusinessCombinations', window );">Changes due to business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,694,166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToWriteoffs', window );">Changes due to write-offs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember', window );">Barra [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beginning balance &#8211; January 1</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToAcquisitions', window );">Changes due to acquisitions</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_RELI_ChangesDueToFairValueAdjustments', window );">Changes due to fair value adjustments</a></td>
<td class="num">(50,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td>
<td class="nump">$ 550,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_ChangesDueToAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes due to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_ChangesDueToAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_ChangesDueToBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes due to business combinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_ChangesDueToBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_ChangesDueToFairValueAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes due to fair value adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_ChangesDueToFairValueAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_ChangesDueToPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes due to payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_ChangesDueToPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_RELI_ChangesDueToWriteoffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes due to writeoffs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">RELI_ChangesDueToWriteoffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>RELI_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_CommercialSolutionsOfInsuranceAgencyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_CommercialSolutionsOfInsuranceAgencyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_FortmanInsuranceAgencyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_FortmanInsuranceAgencyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_SouthwesternMontanaInsuranceCenterIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_SouthwesternMontanaInsuranceCenterIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_AltruisBenefitsConsultantsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_AltruisBenefitsConsultantsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_JPKushAndAssociatesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_JPKushAndAssociatesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=RELI_BarraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=RELI_BarraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>form10-q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:RELI="http://relianceglobalgroup.com/20220630"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="reli-20220630.xsd" xlink:type="simple"/>
    <context id="From2022-01-01to2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-08-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
        </entity>
        <period>
            <instant>2022-08-15</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-04-012022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CommonStockIssuableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:CommonStockIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_CommonStockIssuableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:CommonStockIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CommonStockIssuableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:CommonStockIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_custom_CommonStockIssuableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:CommonStockIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_CommonStockIssuableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:CommonStockIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_CommonStockIssuableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:CommonStockIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_custom_CommonStockIssuableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:CommonStockIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_CommonStockIssuableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:CommonStockIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_CommonStockIssuableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:CommonStockIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_CommonStockIssuableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:CommonStockIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_SubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-03-31_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-01-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">RELI:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_MeasurementInputSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_MeasurementInputSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SeriesBWarrantCommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantCommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SeriesBWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PlacementAgentWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_SeriesBWarrantCommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantCommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_SeriesBWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PlacementAgentWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_SeriesBWarrantCommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantCommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_SeriesBWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_PlacementAgentWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_SeriesBWarrantCommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantCommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_SeriesBWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_PlacementAgentWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_SeriesBWarrantCommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantCommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_SeriesBWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_PlacementAgentWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SeriesBWarrantCommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantCommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SeriesBWarrantCommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantCommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_MeasurementInputRiskPremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">RELI:MeasurementInputRiskPremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_MeasurementInputCreditSpreadMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputCreditSpreadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_MeasurementInputPaymentDelayMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">RELI:MeasurementInputPaymentDelayMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_JPKushAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:JPKushAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_custom_JPKushAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:JPKushAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_BarraAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_custom_BarraAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_CCSWriteoffMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:CCSWriteoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_custom_CCSWriteoffMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:CCSWriteoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_AltruisPartialSettlementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:AltruisPartialSettlementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_custom_AltruisPartialSettlementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:AltruisPartialSettlementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_MontanaFinalSettlementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MontanaFinalSettlementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_custom_MontanaFinalSettlementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MontanaFinalSettlementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_EmployeeBenefitsSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_USBenefitsAllianceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_CommercialCoverageSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_SouthwesternMontanaFinancialCenterIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_FortmanInsuranceServicesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_AltruisBenefitsConsultingIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_KushMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_KushMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_KushMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_MedigapMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:MedigapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_MedigapMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:MedigapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_MedigapMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:MedigapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_BarraMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_BarraMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_BarraMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:BarraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_PropertyAndCasualtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_EmployeeBenefitsSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_USBenefitsAllianceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_CommercialCoverageSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_SouthwesternMontanaFinancialCenterIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_FortmanInsuranceServicesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_AltruisBenefitsConsultingIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_KushMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_KushMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_KushMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_MedigapMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:MedigapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_MedigapMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:MedigapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_MedigapMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:MedigapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_BarraMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_BarraMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_BarraMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:BarraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_PropertyAndCasualtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_EmployeeBenefitsSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_USBenefitsAllianceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_CommercialCoverageSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_SouthwesternMontanaFinancialCenterIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_FortmanInsuranceServicesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_AltruisBenefitsConsultingIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_KushMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_KushMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_KushMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_PropertyAndCasualtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_EmployeeBenefitsSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:EmployeeBenefitsSolutionsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_USBenefitsAllianceLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:USBenefitsAllianceLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_CommercialCoverageSolutionsLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:CommercialCoverageSolutionsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_SouthwesternMontanaFinancialCenterIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:SouthwesternMontanaFinancialCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_FortmanInsuranceServicesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:FortmanInsuranceServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_AltruisBenefitsConsultingIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:AltruisBenefitsConsultingIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_KushMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_KushMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_KushMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">RELI:KushMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:RegularMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_PropertyAndCasualtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">RELI:MedicalLifeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">RELI:PropertyAndCasualtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_LTCGlobalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:LTCGlobalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_LTCGlobalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:LTCGlobalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_PriorityHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:PriorityHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_PriorityHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:PriorityHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_BlueCrossBlueShieldMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:BlueCrossBlueShieldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_BlueCrossBlueShieldMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:BlueCrossBlueShieldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_BlueCrossBlueShieldMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:BlueCrossBlueShieldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_BlueCrossBlueShieldMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:BlueCrossBlueShieldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_PriorityHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:PriorityHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_PriorityHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:PriorityHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_LTCGlobalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:LTCGlobalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_LTCGlobalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">RELI:LTCGlobalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_srt_RestatementAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31_srt_RestatementAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="From2022-01-082022-01-10_custom_MedigapHealthcareInsuranceCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-08</startDate>
            <endDate>2022-01-10</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_MeasurementInputRoyaltyRateMember_us-gaap_TradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">RELI:MeasurementInputRoyaltyRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_us-gaap_TradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_MeasurementInputObsolescenceRateMember_us-gaap_TechnologyBasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">RELI:MeasurementInputObsolescenceRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_custom_BackLogMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:BackLogMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-252022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">RELI:BarraAndAssociatesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:APAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-25</startDate>
            <endDate>2022-04-26</endDate>
        </period>
    </context>
    <context id="From2022-04-252022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember_custom_PaidAtClosingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RELI:PaidAtClosingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">RELI:BarraAndAssociatesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:APAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-25</startDate>
            <endDate>2022-04-26</endDate>
        </period>
    </context>
    <context id="From2022-04-252022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember_custom_PayableInSixMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RELI:PayableInSixMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">RELI:BarraAndAssociatesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:APAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-25</startDate>
            <endDate>2022-04-26</endDate>
        </period>
    </context>
    <context id="From2022-04-252022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember_custom_PayableOverTwoYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">RELI:PayableOverTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">RELI:BarraAndAssociatesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:APAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-25</startDate>
            <endDate>2022-04-26</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">RELI:BarraAndAssociatesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:APAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-26</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_us-gaap_TradeNamesMember_custom_BarraMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_us-gaap_CustomerRelationshipsMember_custom_BarraMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_custom_DevelopedTechnologyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:DevelopedTechnologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_BarraMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_BarraMember168706375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_PropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_PropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_custom_RightOfUseAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:RightOfUseAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_TradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_TradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_TechnologyBasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_TechnologyBasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_custom_BackLogMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:BackLogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_custom_BackLogMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:BackLogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_custom_ChargebackReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:ChargebackReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_custom_LeaseLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:LeaseLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_BarraMember_custom_AcquiredAccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:AcquiredAccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_BarraMember_us-gaap_PropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_BarraMember_us-gaap_PropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_BarraMember_custom_RightOfUseAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:RightOfUseAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_BarraMember_us-gaap_TradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_BarraMember_us-gaap_TradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_BarraMember_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_BarraMember_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_BarraMember_custom_AgencyRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:AgencyRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_BarraMember_custom_AgencyRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:AgencyRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_BarraMember_custom_DevelopedTechnologyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_BarraMember_custom_DevelopedTechnologyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_BarraMember_custom_LeaseLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:LeaseLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_BarraMember_us-gaap_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_BarraMember_us-gaap_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_MedigapHealthcareInsuranceCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapHealthcareInsuranceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_BarraMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_TrademarksAndTradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_TrademarksAndTradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_InternallyDevelopedSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:InternallyDevelopedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_InternallyDevelopedSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:InternallyDevelopedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_PurchasedSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:PurchasedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_PurchasedSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:PurchasedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_VideoProductionAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:VideoProductionAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_VideoProductionAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:VideoProductionAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_NoncompetitionAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:NoncompetitionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_NoncompetitionAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:NoncompetitionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_ContractsBacklogMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:ContractsBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ContractsBacklogMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:ContractsBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_TrademarksAndTradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TrademarksAndTradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_InternallyDevelopedSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:InternallyDevelopedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_InternallyDevelopedSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:InternallyDevelopedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_PurchasedSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:PurchasedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PurchasedSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:PurchasedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_VideoProductionAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:VideoProductionAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_VideoProductionAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:VideoProductionAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_NoncompetitionAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:NoncompetitionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_NoncompetitionAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">RELI:NoncompetitionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_EBSandUSBAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:EBSandUSBAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_EBSandUSBAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:EBSandUSBAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_CCSMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">RELI:CCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CCSMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">RELI:CCSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_SWMTMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:SWMTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SWMTMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:SWMTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_FISMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:FISMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_FISMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:FISMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ABCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:ABCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ABCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:ABCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_BarraMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:BarraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_DirectorsAndOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RELI:DirectorsAndOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_DirectorsAndOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RELI:DirectorsAndOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_DirectorsAndOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RELI:DirectorsAndOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_DirectorsAndOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RELI:DirectorsAndOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-22_us-gaap_CommonStockMember_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="AsOf2021-12-22_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="AsOf2021-12-22_us-gaap_CommonStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="From2021-12-222021-12-23_us-gaap_CommonStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-23</endDate>
        </period>
    </context>
    <context id="From2021-12-222021-12-23_custom_SeriesBConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-23</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-22_custom_SeriesBConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-22</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-01-05_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-05</instant>
        </period>
    </context>
    <context id="From2022-01-042022-01-05_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-04</startDate>
            <endDate>2022-01-05</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">RELI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-01-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_SeriesBConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-01-31_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-01-31_custom_MedigapAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:MedigapAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-01-31_custom_SeriesAWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SeriesAWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-01-31_custom_SeriesAWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SeriesAWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-01-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="From2022-03-012022-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-05-31_custom_SeriesCPrepaidWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesCPrepaidWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_SeriesCPrepaidWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesCPrepaidWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-05-31_custom_SeriesCPrepaidWarrantsMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesCPrepaidWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_SeriesCPrepaidWarrantsMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesCPrepaidWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_SeriesAWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SeriesAWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-01-31_custom_SeriesCPrepaidWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesCPrepaidWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="AsOf2022-01-31_custom_SeriesCPrepaidWarrantsMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesCPrepaidWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="AsOf2022-01-31_custom_SeriesDPrepaidWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesDPrepaidWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="AsOf2022-05-01_custom_SeriesCPrepaidWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesCPrepaidWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-01</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_SeriesCPrepaidWarrantsMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesCPrepaidWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_ThreeEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RELI:ThreeEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_ThreeEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">RELI:ThreeEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_CommonStockMember168711000">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">RELI:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_SeriesBWarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">RELI:SeriesBWarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_SeriesCPrepaidWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesCPrepaidWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_SeriesCPrepaidWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesCPrepaidWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_SeriesDPrepaidWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesDPrepaidWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_custom_SeriesDPrepaidWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">RELI:SeriesDPrepaidWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CommercialSolutionsOfInsuranceAgencyLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:CommercialSolutionsOfInsuranceAgencyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_FortmanInsuranceAgencyLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:FortmanInsuranceAgencyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SouthwesternMontanaInsuranceCenterIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:SouthwesternMontanaInsuranceCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_AltruisBenefitsConsultantsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:AltruisBenefitsConsultantsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_JPKushAndAssociatesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:JPKushAndAssociatesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_CommercialSolutionsOfInsuranceAgencyLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:CommercialSolutionsOfInsuranceAgencyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_FortmanInsuranceAgencyLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:FortmanInsuranceAgencyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_SouthwesternMontanaInsuranceCenterIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:SouthwesternMontanaInsuranceCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_AltruisBenefitsConsultantsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:AltruisBenefitsConsultantsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_JPKushAndAssociatesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:JPKushAndAssociatesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_CommercialSolutionsOfInsuranceAgencyLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:CommercialSolutionsOfInsuranceAgencyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_FortmanInsuranceAgencyLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:FortmanInsuranceAgencyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_SouthwesternMontanaInsuranceCenterIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:SouthwesternMontanaInsuranceCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_AltruisBenefitsConsultantsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:AltruisBenefitsConsultantsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_JPKushAndAssociatesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:JPKushAndAssociatesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CommercialSolutionsOfInsuranceAgencyLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:CommercialSolutionsOfInsuranceAgencyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_FortmanInsuranceAgencyLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:FortmanInsuranceAgencyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SouthwesternMontanaInsuranceCenterIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:SouthwesternMontanaInsuranceCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_AltruisBenefitsConsultantsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:AltruisBenefitsConsultantsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_JPKushAndAssociatesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:JPKushAndAssociatesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_CommercialSolutionsOfInsuranceAgencyLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:CommercialSolutionsOfInsuranceAgencyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_FortmanInsuranceAgencyLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:FortmanInsuranceAgencyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SouthwesternMontanaInsuranceCenterIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:SouthwesternMontanaInsuranceCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_AltruisBenefitsConsultantsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:AltruisBenefitsConsultantsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_JPKushAndAssociatesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001812727</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">RELI:JPKushAndAssociatesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Policy">
        <measure>RELI:Policy</measure>
    </unit>
    <unit id="Agent">
        <measure>RELI:Agent</measure>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Integer">
        <measure>RELI:Integer</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-01-01to2022-06-30">0001812727</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-01-01to2022-06-30">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="From2022-01-01to2022-06-30">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate contextRef="From2022-01-01to2022-06-30">--12-31</dei:CurrentFiscalYearEndDate>
    <RELI:ChargebackReserveCurrent
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0100"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:WarrantCommitmentCurrent
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl0117"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:WarrantLiabilityNonCurrent
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0136"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0145"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityNoteSubscriptionsReceivable
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl0185"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:RecognitionAndChangeInFairValueOfWarrantLiability
      contextRef="From2021-04-012021-06-30"
      id="xdx2ixbrl0263"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:RecognitionAndChangeInFairValueOfWarrantLiability
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0265"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0297"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0299"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0305"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0309"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0311"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0312"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-01-012022-03-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0313"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-01-012022-03-31_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0315"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0316"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-03-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0321"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0324"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0331"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-01-012022-03-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0333"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-01-012022-03-31_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0335"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0336"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0341"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2022-01-012022-03-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0343"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2022-01-012022-03-31_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0345"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0346"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0351"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-01-012022-03-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0353"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-01-012022-03-31_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0355"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0356"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-01-012022-03-31"
      id="xdx2ixbrl0357"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross
      contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0361"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross
      contextRef="From2022-01-012022-03-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0363"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross
      contextRef="From2022-01-012022-03-31_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0365"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0366"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross
      contextRef="From2022-01-012022-03-31"
      id="xdx2ixbrl0367"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0371"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0372"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0373"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0374"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0375"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0381"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0383"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-03-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0391"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-04-012022-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0393"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0394"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-04-012022-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0395"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-04-012022-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0397"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0398"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueWarrantsIntoCommonStock
      contextRef="From2022-04-012022-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0401"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueWarrantsIntoCommonStock
      contextRef="From2022-04-012022-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0403"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueWarrantsIntoCommonStock
      contextRef="From2022-04-012022-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0405"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueWarrantsIntoCommonStock
      contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0406"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0411"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0412"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0413"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0414"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0415"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0421"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0423"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0431"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0437"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0447"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0448"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0449"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0452"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0455"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0457"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0460"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0465"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0467"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0470"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueOverAllotmentShares
      contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0477"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueOverAllotmentShares
      contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0479"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueOverAllotmentShares
      contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0482"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0489"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0491"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0494"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0499"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0502"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2021-01-012021-03-31"
      id="xdx2ixbrl0503"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:SharesIssuedDuringPeriodValueToConversionOfDebt
      contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0509"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:SharesIssuedDuringPeriodValueToConversionOfDebt
      contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0511"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:SharesIssuedDuringPeriodValueToConversionOfDebt
      contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0514"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueInitialPublicOffering
      contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0519"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueInitialPublicOffering
      contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0520"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueInitialPublicOffering
      contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0521"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueInitialPublicOffering
      contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0522"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueInitialPublicOffering
      contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0524"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueInitialPublicOffering
      contextRef="From2021-01-012021-03-31"
      id="xdx2ixbrl0525"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets
      contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0531"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets
      contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0536"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets
      contextRef="From2021-01-012021-03-31"
      id="xdx2ixbrl0537"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0543"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0544"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0545"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0546"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-03-31_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0547"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0553"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0555"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-03-31_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0563"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2021-04-012021-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0565"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0566"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2021-04-012021-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0567"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0570"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueInitialPublicOffering
      contextRef="From2021-04-012021-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0573"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueInitialPublicOffering
      contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0574"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueInitialPublicOffering
      contextRef="From2021-04-012021-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0575"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueInitialPublicOffering
      contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0576"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueInitialPublicOffering
      contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0578"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:StockIssuedDuringPeriodValueInitialPublicOffering
      contextRef="From2021-04-012021-06-30"
      id="xdx2ixbrl0579"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-04-012021-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0583"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-04-012021-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0585"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0588"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0593"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0594"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0595"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0596"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0597"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0603"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_custom_SubscriptionReceivableMember"
      id="xdx2ixbrl0605"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_custom_CommonStockIssuableMember"
      id="xdx2ixbrl0613"
      unitRef="Shares"
      xsi:nil="true"/>
    <RELI:EarnoutFairValueAndWriteoffAdjustments
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0637"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:RecognitionAndChangeInFairValueOfWarrantLiability
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0640"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0655"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInRestructuringReserve
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0658"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0673"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ProceedsFromLoanForBusinessAcquisition
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0691"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0694"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:PaymentsOnEarnoutLiabilities
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0697"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2022-01-01to2022-06-30"
      id="xdx2ixbrl0699"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0706"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0712"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2022-01-01to2022-06-30"
      id="xdx2ixbrl0714"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:IssuanceOfSeriesDWarrants
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0733"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:IssuanceOfPlacementAgentWarrants
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0736"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:PrepaidInsuranceAcquiredThroughShorttermFinancing
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0739"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="From2022-01-01to2022-06-30"
      id="xdx2ixbrl0741"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2022-01-01to2022-06-30"
      id="xdx2ixbrl0747"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssued1
      contextRef="From2022-01-01to2022-06-30"
      id="xdx2ixbrl0753"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:IssuanceOfCommonStockPursuantToPurchaseOfSoftware
      contextRef="From2022-01-01to2022-06-30"
      id="xdx2ixbrl0756"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:WarrantCommitment
      contextRef="AsOf2021-12-31_custom_SeriesBWarrantLiabilityMember"
      id="xdx2ixbrl0829"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:WarrantCommitment
      contextRef="AsOf2021-12-31_custom_PlacementAgentWarrantsMember"
      id="xdx2ixbrl0830"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:InitialRecognitionOfWarrantCommitment
      contextRef="From2022-01-012022-03-31_custom_SeriesBWarrantCommitmentMember"
      id="xdx2ixbrl0833"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:WarrantCommitment
      contextRef="AsOf2022-03-31_custom_SeriesBWarrantCommitmentMember"
      id="xdx2ixbrl0848"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:WarrantCommitmentUnrealizedGainLoss
      contextRef="From2022-04-012022-06-30_custom_SeriesBWarrantCommitmentMember"
      id="xdx2ixbrl0853"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:WarrantCommitment
      contextRef="AsOf2022-06-30_custom_SeriesBWarrantCommitmentMember"
      id="xdx2ixbrl0858"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:WarrantCommitment
      contextRef="AsOf2020-12-31_custom_SeriesBWarrantCommitmentMember"
      id="xdx2ixbrl0863"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:WarrantCommitment
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0864"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:AcquisitionsAndSettlements
      contextRef="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_JPKushAcquisitionMember"
      id="xdx2ixbrl0911"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:AcquisitionsAndSettlements
      contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_custom_BarraAcquisitionMember"
      id="xdx2ixbrl0915"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:AcquisitionsAndSettlements
      contextRef="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_CCSWriteoffMember"
      id="xdx2ixbrl0917"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:AcquisitionsAndSettlements
      contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_custom_MontanaFinalSettlementMember"
      id="xdx2ixbrl0924"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember"
      id="xdx2ixbrl0946"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember"
      id="xdx2ixbrl0950"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember"
      id="xdx2ixbrl0953"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember"
      id="xdx2ixbrl0958"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember"
      id="xdx2ixbrl0966"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_KushMember"
      id="xdx2ixbrl0970"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_MedigapMember"
      id="xdx2ixbrl0974"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember"
      id="xdx2ixbrl0988"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember"
      id="xdx2ixbrl0992"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember"
      id="xdx2ixbrl0995"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember"
      id="xdx2ixbrl1000"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember"
      id="xdx2ixbrl1008"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_KushMember"
      id="xdx2ixbrl1012"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_MedigapMember"
      id="xdx2ixbrl1016"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember"
      id="xdx2ixbrl1030"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember"
      id="xdx2ixbrl1034"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember"
      id="xdx2ixbrl1037"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember"
      id="xdx2ixbrl1042"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember"
      id="xdx2ixbrl1050"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_KushMember"
      id="xdx2ixbrl1054"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember"
      id="xdx2ixbrl1064"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember"
      id="xdx2ixbrl1068"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember"
      id="xdx2ixbrl1071"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember"
      id="xdx2ixbrl1076"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember"
      id="xdx2ixbrl1084"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_KushMember"
      id="xdx2ixbrl1088"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_LTCGlobalMember"
      id="xdx2ixbrl1100"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-04-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_BlueCrossBlueShieldMember"
      id="xdx2ixbrl1105"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_LTCGlobalMember"
      id="xdx2ixbrl1115"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="From2022-01-012022-06-30_custom_PurchasedSoftwareMember"
      id="xdx2ixbrl1354"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-06-30_custom_PurchasedSoftwareMember"
      id="xdx2ixbrl1360"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2021-12-31_custom_VideoProductionAssetsMember"
      id="xdx2ixbrl1428"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_custom_BarraMember"
      id="xdx2ixbrl1512"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:DeemedDividend
      contextRef="From2022-04-012022-06-30"
      id="xdx2ixbrl1724"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:DeemedDividend
      contextRef="From2021-04-012021-06-30"
      id="xdx2ixbrl1725"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2021-04-012021-06-30"
      id="xdx2ixbrl1731"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="From2021-04-012021-06-30"
      id="xdx2ixbrl1740"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2021-04-012021-06-30"
      id="xdx2ixbrl1746"
      unitRef="Shares"
      xsi:nil="true"/>
    <RELI:DeemedDividend
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl1761"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl1767"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl1776"
      unitRef="Shares"
      xsi:nil="true"/>
    <RELI:EffectOfSeriesBWarrantLiability
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl1779"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl1782"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2021-12-31_custom_CommercialSolutionsOfInsuranceAgencyLLCMember"
      id="xdx2ixbrl1831"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2021-12-31_custom_BarraMember"
      id="xdx2ixbrl1836"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ChangesDueToAcquisitions
      contextRef="From2022-01-012022-06-30_custom_CommercialSolutionsOfInsuranceAgencyLLCMember"
      id="xdx2ixbrl1839"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ChangesDueToAcquisitions
      contextRef="From2022-01-012022-06-30_custom_FortmanInsuranceAgencyLLCMember"
      id="xdx2ixbrl1840"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ChangesDueToAcquisitions
      contextRef="From2022-01-012022-06-30_custom_SouthwesternMontanaInsuranceCenterIncMember"
      id="xdx2ixbrl1841"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ChangesDueToAcquisitions
      contextRef="From2022-01-012022-06-30_custom_AltruisBenefitsConsultantsIncMember"
      id="xdx2ixbrl1842"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ChangesDueToAcquisitions
      contextRef="From2022-01-012022-06-30_custom_JPKushAndAssociatesIncMember"
      id="xdx2ixbrl1843"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ChangesDueToFairValueAdjustments
      contextRef="From2022-01-012022-06-30_custom_CommercialSolutionsOfInsuranceAgencyLLCMember"
      id="xdx2ixbrl1855"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ChangesDueToFairValueAdjustments
      contextRef="From2022-01-012022-06-30_custom_AltruisBenefitsConsultantsIncMember"
      id="xdx2ixbrl1858"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2022-06-30_custom_CommercialSolutionsOfInsuranceAgencyLLCMember"
      id="xdx2ixbrl1863"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2020-12-31_custom_JPKushAndAssociatesIncMember"
      id="xdx2ixbrl1875"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ChangesDueToBusinessCombinations
      contextRef="From2021-01-012021-12-31_custom_CommercialSolutionsOfInsuranceAgencyLLCMember"
      id="xdx2ixbrl1878"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ChangesDueToBusinessCombinations
      contextRef="From2021-01-012021-12-31_custom_FortmanInsuranceAgencyLLCMember"
      id="xdx2ixbrl1879"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ChangesDueToBusinessCombinations
      contextRef="From2021-01-012021-12-31_custom_SouthwesternMontanaInsuranceCenterIncMember"
      id="xdx2ixbrl1880"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ChangesDueToBusinessCombinations
      contextRef="From2021-01-012021-12-31_custom_AltruisBenefitsConsultantsIncMember"
      id="xdx2ixbrl1881"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ChangesDueToPayments
      contextRef="From2021-01-012021-12-31_custom_CommercialSolutionsOfInsuranceAgencyLLCMember"
      id="xdx2ixbrl1885"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ChangesDueToPayments
      contextRef="From2021-01-012021-12-31_custom_FortmanInsuranceAgencyLLCMember"
      id="xdx2ixbrl1886"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ChangesDueToPayments
      contextRef="From2021-01-012021-12-31_custom_SouthwesternMontanaInsuranceCenterIncMember"
      id="xdx2ixbrl1887"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ChangesDueToPayments
      contextRef="From2021-01-012021-12-31_custom_JPKushAndAssociatesIncMember"
      id="xdx2ixbrl1889"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ChangesDueToFairValueAdjustments
      contextRef="From2021-01-012021-12-31_custom_CommercialSolutionsOfInsuranceAgencyLLCMember"
      id="xdx2ixbrl1892"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ChangesDueToWriteoffs
      contextRef="From2021-01-012021-12-31_custom_FortmanInsuranceAgencyLLCMember"
      id="xdx2ixbrl1900"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ChangesDueToWriteoffs
      contextRef="From2021-01-012021-12-31_custom_SouthwesternMontanaInsuranceCenterIncMember"
      id="xdx2ixbrl1901"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ChangesDueToWriteoffs
      contextRef="From2021-01-012021-12-31_custom_AltruisBenefitsConsultantsIncMember"
      id="xdx2ixbrl1902"
      unitRef="USD"
      xsi:nil="true"/>
    <RELI:ChangesDueToWriteoffs
      contextRef="From2021-01-012021-12-31_custom_JPKushAndAssociatesIncMember"
      id="xdx2ixbrl1903"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2021-12-31_custom_CommercialSolutionsOfInsuranceAgencyLLCMember"
      id="xdx2ixbrl1906"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2022-01-01to2022-06-30">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2022-01-01to2022-06-30">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="From2022-01-01to2022-06-30">2022-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2022-01-01to2022-06-30">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="From2022-01-01to2022-06-30">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2022-01-01to2022-06-30">001-40020</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2022-01-01to2022-06-30">RELIANCE GLOBAL GROUP, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-01-01to2022-06-30">FL</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-01-01to2022-06-30">46-3390293</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-01-01to2022-06-30">300 Blvd. of the Americas</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-01-01to2022-06-30">Suite 105</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-01-01to2022-06-30">Lakewood</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-01-01to2022-06-30">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-01-01to2022-06-30">08701</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-01-01to2022-06-30">732</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-01-01to2022-06-30">380-4600</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember">Common     Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember">RELI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-01-012022-06-30_custom_SeriesAWarrantsMember">Series     A Warrants</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-01-012022-06-30_custom_SeriesAWarrantsMember">RELIW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-01-012022-06-30_custom_SeriesAWarrantsMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="From2022-01-01to2022-06-30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2022-01-01to2022-06-30">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2022-01-01to2022-06-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2022-01-01to2022-06-30">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-01-01to2022-06-30">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2022-01-01to2022-06-30">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2022-08-15" decimals="INF" unitRef="Shares">16457075</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Cash contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">2979769</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4136180</us-gaap:Cash>
    <us-gaap:RestrictedCashCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1417635</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">484542</us-gaap:RestrictedCashCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1072294</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1024831</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">54414</us-gaap:AccountsReceivableRelatedPartiesCurrent>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">7131</us-gaap:AccountsReceivableRelatedPartiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">576691</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2328817</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">6100803</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">7981501</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">164017</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">130359</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1421474</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1067734</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Investments contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1350000</us-gaap:Investments>
    <us-gaap:Investments contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1350000</us-gaap:Investments>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">14751751</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">7078900</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">33486107</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">10050277</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">23284</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">16792</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">57297436</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">27675563</us-gaap:Assets>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1051333</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2759160</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <RELI:ChargebackReserveCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1559541</RELI:ChargebackReserveCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1333484</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">81500</us-gaap:AccountsPayableOtherCurrent>
    <RELI:ShortTermFinancingAgreements contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">376647</RELI:ShortTermFinancingAgreements>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">936263</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">913920</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">528902</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">276009</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3683596</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3297855</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <RELI:WarrantCommitmentCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">37652808</RELI:WarrantCommitmentCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">9469766</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">44981252</us-gaap:LiabilitiesCurrent>
    <us-gaap:DueToRelatedPartiesNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">332225</us-gaap:DueToRelatedPartiesNoncurrent>
    <us-gaap:DueToRelatedPartiesNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">353766</us-gaap:DueToRelatedPartiesNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">12935649</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">7085325</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">930623</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">805326</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">673837</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">516023</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <RELI:WarrantLiabilityNonCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">11026893</RELI:WarrantLiabilityNonCurrent>
    <us-gaap:Liabilities contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">35368993</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">53741692</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30"
      decimals="INF"
      unitRef="USDPShares">0.086</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.086</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">750000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">750000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">9076</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">9076</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">781</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30"
      decimals="INF"
      unitRef="USDPShares">0.086</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.086</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">14614038</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">14614038</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">10956109</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">10956109</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1255408</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">940829</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">34294708</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">26451187</us-gaap:AdditionalPaidInCapital>
    <us-gaap:StockholdersEquityNoteSubscriptionsReceivable contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">20000000</us-gaap:StockholdersEquityNoteSubscriptionsReceivable>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">-13622454</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-33458145</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">21928443</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-26066129</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">57297436</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">27675563</us-gaap:LiabilitiesAndStockholdersEquity>
    <RELI:CommissionIncome
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">4207126</RELI:CommissionIncome>
    <RELI:CommissionIncome
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">2190847</RELI:CommissionIncome>
    <RELI:CommissionIncome
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">8442907</RELI:CommissionIncome>
    <RELI:CommissionIncome
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">4514577</RELI:CommissionIncome>
    <us-gaap:Revenues
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">4207126</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">2190847</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">8442907</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">4514577</us-gaap:Revenues>
    <RELI:CommissionExpense
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">850128</RELI:CommissionExpense>
    <RELI:CommissionExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">558271</RELI:CommissionExpense>
    <RELI:CommissionExpense
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">1754283</RELI:CommissionExpense>
    <RELI:CommissionExpense
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">1087743</RELI:CommissionExpense>
    <us-gaap:SalariesAndWages
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">2176792</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">1110629</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">4258967</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">2029174</us-gaap:SalariesAndWages>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">1759217</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">1202350</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">4212287</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">2206751</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">609383</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">55021</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">1196405</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">78100</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">756403</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">369366</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">1363928</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">702454</us-gaap:DepreciationAndAmortization>
    <us-gaap:OperatingExpenses
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">6151923</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">3295637</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">12785870</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">6104222</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-1944797</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-1104790</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-4342963</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-1589645</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingExpense
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">192763</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">172096</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">300560</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">301167</us-gaap:OtherNonoperatingExpense>
    <RELI:RecognitionAndChangeInFairValueOfWarrantLiability
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">12633251</RELI:RecognitionAndChangeInFairValueOfWarrantLiability>
    <RELI:RecognitionAndChangeInFairValueOfWarrantLiability
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">24479215</RELI:RecognitionAndChangeInFairValueOfWarrantLiability>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">12440488</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-172096</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">24178655</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-301167</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">10495691</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-1276886</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">19835692</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-1890812</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      unitRef="USDPShares">0.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="USDPShares">0.75</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-01-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.59</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-01-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.20</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      unitRef="Shares">18738290</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="Shares">10934489</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="Shares">17238285</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-01-012021-06-30"
      decimals="INF"
      unitRef="Shares">9259738</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      unitRef="Shares">20989290</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="Shares">10934489</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="Shares">20134729</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-01-012021-06-30"
      decimals="INF"
      unitRef="Shares">9259738</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">10956109</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">940829</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">26451187</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_SubscriptionReceivableMember"
      decimals="0"
      unitRef="USD">-20000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-33458145</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-26066129</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">739960</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-01-012022-03-31"
      decimals="0"
      unitRef="USD">739960</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">9076</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">781</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">2670892</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">229694</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-230424</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-03-31_custom_SubscriptionReceivableMember"
      decimals="0"
      unitRef="USD">20000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-03-31"
      decimals="0"
      unitRef="USD">20000051</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">606037</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">52119</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">4711332</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2022-01-012022-03-31"
      decimals="0"
      unitRef="USD">4763451</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <RELI:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">375000</RELI:StockIssuedDuringPeriodSharesWarrantsExercised>
    <RELI:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">32250</RELI:StockIssuedDuringPeriodValueWarrantsExercised>
    <RELI:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">2442750</RELI:StockIssuedDuringPeriodValueWarrantsExercised>
    <RELI:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2022-01-012022-03-31"
      decimals="0"
      unitRef="USD">2475000</RELI:StockIssuedDuringPeriodValueWarrantsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">-3276929</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">-281815</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">281815</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <RELI:StockGrantedDuringPeriodSharesSharebasedCompensationGross
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6000</RELI:StockGrantedDuringPeriodSharesSharebasedCompensationGross>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">516</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-516</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">9340000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31"
      decimals="0"
      unitRef="USD">9340000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-03-31_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">9076</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">781</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">11337109</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">973593</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">34396104</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-24118145</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">11252333</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">179083</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">179083</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <RELI:StockIssuedDuringPeriodSharesWarrantsIntoCommonStock
      contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">3276929</RELI:StockIssuedDuringPeriodSharesWarrantsIntoCommonStock>
    <RELI:StockIssuedDuringPeriodValueWarrantsIntoCommonStock
      contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">281815</RELI:StockIssuedDuringPeriodValueWarrantsIntoCommonStock>
    <RELI:StockIssuedDuringPeriodValueWarrantsIntoCommonStock
      contextRef="From2022-04-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-280479</RELI:StockIssuedDuringPeriodValueWarrantsIntoCommonStock>
    <RELI:StockIssuedDuringPeriodValueWarrantsIntoCommonStock
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">1336</RELI:StockIssuedDuringPeriodValueWarrantsIntoCommonStock>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">10495691</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">10495691</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">9076</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">781</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">14614038</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">1255408</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">34294708</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-13622454</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">21928443</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">395640</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">33912</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">4241028</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">363517</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_custom_CommonStockIssuableMember"
      decimals="INF"
      unitRef="Shares">23341</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_custom_CommonStockIssuableMember"
      decimals="0"
      unitRef="USD">340000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">11559239</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-12359680</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-63012</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">246966</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">246966</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">15000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">1290</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">89760</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">91050</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">1672852</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1800000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">154800</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">8954348</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">9109148</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2021-01-012021-03-31_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      unitRef="USD">250928</us-gaap:PaymentsOfStockIssuanceCosts>
    <RELI:StockIssuedDuringPeriodSharesOverAllotmentShares
      contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">270000</RELI:StockIssuedDuringPeriodSharesOverAllotmentShares>
    <RELI:StockIssuedDuringPeriodValueOverAllotmentShares
      contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">23220</RELI:StockIssuedDuringPeriodValueOverAllotmentShares>
    <RELI:StockIssuedDuringPeriodValueOverAllotmentShares
      contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">1343153</RELI:StockIssuedDuringPeriodValueOverAllotmentShares>
    <RELI:StockIssuedDuringPeriodValueOverAllotmentShares
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">1366373</RELI:StockIssuedDuringPeriodValueOverAllotmentShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">20700</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">20700</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">-394493</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2021-01-012021-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">-33812</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">3944930</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">339264</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-305452</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <RELI:SharesIssuedDuringPeriodSharesToConversionOfDebt
      contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">633333</RELI:SharesIssuedDuringPeriodSharesToConversionOfDebt>
    <RELI:SharesIssuedDuringPeriodValueToConversionOfDebt
      contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">54467</RELI:SharesIssuedDuringPeriodValueToConversionOfDebt>
    <RELI:SharesIssuedDuringPeriodValueToConversionOfDebt
      contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">3745533</RELI:SharesIssuedDuringPeriodValueToConversionOfDebt>
    <RELI:SharesIssuedDuringPeriodValueToConversionOfDebt
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">3800000</RELI:SharesIssuedDuringPeriodValueToConversionOfDebt>
    <RELI:StockIssuedDuringPeriodSharesInitialPublicOffering
      contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1885</RELI:StockIssuedDuringPeriodSharesInitialPublicOffering>
    <RELI:StockIssuedDuringPeriodSharesInitialPublicOffering
      contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember"
      decimals="INF"
      unitRef="Shares">-3</RELI:StockIssuedDuringPeriodSharesInitialPublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets
      contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">23338</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
    <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets
      contextRef="From2021-01-012021-03-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">1984</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
    <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets
      contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember"
      decimals="INF"
      unitRef="Shares">-23338</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
    <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets
      contextRef="From2021-01-012021-03-31_custom_CommonStockIssuableMember"
      decimals="0"
      unitRef="USD">-340000</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
    <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets
      contextRef="From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">338016</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-613926</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-03-31"
      decimals="0"
      unitRef="USD">-613926</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-03-31_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">1147</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">100</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">10929514</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">938542</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">25992263</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-12973606</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-03-31" decimals="0" unitRef="USD">13957299</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">183132</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">183132</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <RELI:StockIssuedDuringPeriodSharesInitialPublicOffering
      contextRef="From2021-04-012021-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">20</RELI:StockIssuedDuringPeriodSharesInitialPublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">14925</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-04-012021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">1284</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-04-012021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">48716</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">50000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-1276886</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-1276886</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">1167</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">100</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">10944439</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">939826</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">26224111</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-14250492</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">12913545</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">19835692</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-1890812</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">1363928</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">702454</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">18291</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">20206</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <RELI:NoncashLeaseExpense
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">24450</RELI:NoncashLeaseExpense>
    <RELI:NoncashLeaseExpense
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">1534</RELI:NoncashLeaseExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">919043</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">521148</us-gaap:ShareBasedCompensation>
    <RELI:EarnoutFairValueAndWriteoffAdjustments
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">354963</RELI:EarnoutFairValueAndWriteoffAdjustments>
    <RELI:RecognitionAndChangeInFairValueOfWarrantLiability
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">24479215</RELI:RecognitionAndChangeInFairValueOfWarrantLiability>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-1711287</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-805092</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-45122</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-75212</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">47283</us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties>
    <us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">7131</us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">126984</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
    <us-gaap:IncreaseDecreaseInRestructuringReserve
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">75068</us-gaap:IncreaseDecreaseInRestructuringReserve>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">6492</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">18035</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-2169325</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">92736</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-1311411</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-1493252</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">20989</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">24138750</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">1608586</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">466190</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">152990</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-24625929</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-1761576</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfOtherDebt
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">447908</us-gaap:RepaymentsOfOtherDebt>
    <us-gaap:RepaymentsOfOtherDebt
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">432833</us-gaap:RepaymentsOfOtherDebt>
    <RELI:ProceedsFromLoanForBusinessAcquisition
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">6520000</RELI:ProceedsFromLoanForBusinessAcquisition>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">214257</us-gaap:PaymentsOfDebtIssuanceCosts>
    <RELI:PaymentsOnEarnoutLiabilities
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">411408</RELI:PaymentsOnEarnoutLiabilities>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">2931</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">21541</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">508307</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">2476336</us-gaap:ProceedsFromWarrantExercises>
    <RELI:RepaymentsOnShorttermFinancing
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">40552</RELI:RepaymentsOnShorttermFinancing>
    <RELI:NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">17853351</RELI:NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">10496221</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">25714021</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">9558012</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-223319</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">6303184</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4620722</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">529581</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4397403</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">6832765</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <RELI:IssuanceOfSeriesDWarrants
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">6930335</RELI:IssuanceOfSeriesDWarrants>
    <RELI:IssuanceOfPlacementAgentWarrants
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">1525923</RELI:IssuanceOfPlacementAgentWarrants>
    <RELI:PrepaidInsuranceAcquiredThroughShorttermFinancing
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">417199</RELI:PrepaidInsuranceAcquiredThroughShorttermFinancing>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">339264</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:InterestPaidNet
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">218528</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">350175</us-gaap:InterestPaidNet>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">3800000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <RELI:CommonStockIssuedPursuantToAcquisition
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">4763451</RELI:CommonStockIssuedPursuantToAcquisition>
    <RELI:CommonStockIssuedPursuantToAcquisition
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">50000</RELI:CommonStockIssuedPursuantToAcquisition>
    <us-gaap:StockIssued1
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">91050</us-gaap:StockIssued1>
    <RELI:IssuanceOfCommonStockPursuantToPurchaseOfSoftware
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">340000</RELI:IssuanceOfCommonStockPursuantToPurchaseOfSoftware>
    <RELI:AcquisitionOfBusinessDeferredPurchasePrice
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">1125000</RELI:AcquisitionOfBusinessDeferredPurchasePrice>
    <RELI:AcquisitionOfBusinessDeferredPurchasePrice
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">0</RELI:AcquisitionOfBusinessDeferredPurchasePrice>
    <RELI:LeaseAssetsAcquiredInExchangeForLeaseLiabilities
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">223922</RELI:LeaseAssetsAcquiredInExchangeForLeaseLiabilities>
    <RELI:LeaseAssetsAcquiredInExchangeForLeaseLiabilities
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">861443</RELI:LeaseAssetsAcquiredInExchangeForLeaseLiabilities>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_80F_eus-gaap--SignificantAccountingPoliciesTextBlock_zeWAZFZ5cqC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1. &lt;span id="xdx_822_zaH8Bt217e27"&gt;SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Reliance
Global Group, Inc., formerly known as Ethos Media Network, Inc. (&#x201c;RELI&#x201d;, &#x201c;Reliance&#x201d;, or the &#x201c;Company&#x201d;)
incorporated in Florida on August 2, 2013.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zHDrYB63LSp4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_zcKS5w2HHGx7"&gt;Basis
of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting
principles in the United States of America (&#x201c;U.S. GAAP&#x201d;) for interim financial information and with the instructions for
Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP
for complete financial statements. In the opinion of management, all adjustments (consisting of recurring accruals) necessary for a fair
presentation have been included. These unaudited condensed consolidated financial statements should be read in conjunction with the audited
consolidated financial statements and the notes thereto, set forth in the Company&#x2019;s annual report on Form 10-K for the year ended
December 31, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited condensed consolidated financial statements include the accounts of Reliance Global Group, Inc. and its wholly
owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_ecustom--LiquidityPolicyTextBlock_zjM206NJluZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zUX1T6recycl"&gt;Liquidity&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2022, the Company&#x2019;s reported cash and restricted cash aggregated balance was approximately $&lt;span id="xdx_901_eus-gaap--RestrictedCashAndCashEquivalents_iI_c20220630_zmlheEmzb7nl" title="Cash and restricted cash"&gt;4,397,000&lt;/span&gt;, current assets
were approximately $&lt;span id="xdx_90E_eus-gaap--AssetsCurrent_iI_pn3d_c20220630_zLkG1HiplZ67" title="Current asset"&gt;6,101,000&lt;/span&gt;, while current liabilities were approximately $&lt;span id="xdx_90C_eus-gaap--LiabilitiesCurrent_iI_pn3d_c20220630_zfNZINzZNXf5" title="Current liabilities"&gt;9,470,000&lt;/span&gt;. As of June 30, 2022, the Company had a working
capital deficit of approximately $&lt;span id="xdx_908_ecustom--WorkingCapitalDeficiency_iNI_di_c20220630_zYkPNQWKNr4a" title="Working capital deficit"&gt;3,369,000&lt;/span&gt; and stockholders&#x2019; equity of approximately $&lt;span id="xdx_90F_eus-gaap--StockholdersEquity_iI_pn3d_c20220630_zR1yBKXFUUWk" title="Stockholders' equity"&gt;21,928,000&lt;/span&gt;. For the six months ended June
30, 2022, the Company reported loss from operations of approximately $&lt;span id="xdx_903_eus-gaap--OperatingIncomeLoss_iN_pn3d_di_c20220101__20220630_zhoRK99RrhS5" title="Operating loss"&gt;4,343,000&lt;/span&gt;, a non-cash, non-operating gain on the recognition and
change in fair value of warrant liabilities of approximately $&lt;span id="xdx_904_ecustom--RecognitionAndChangeInFairValueOfWarrantLiability_pn3d_c20220101__20220630_zU8Ct5P03fpf" title="Recognition and change in fair value of warrant liabilities"&gt;24,479,000&lt;/span&gt;, resulting in an overall net income of approximately $&lt;span id="xdx_904_eus-gaap--NetIncomeLoss_pn3d_c20220101__20220630_z5Tp5cVCrdrj" title="Net income"&gt;19,836,000&lt;/span&gt;.
For the six months ended June 30, 2022, the Company reported negative cash flows from operations of approximately $&lt;span id="xdx_90C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3d_di_c20220101__20220630_zCpU11eivpsa" title="Cash flows from operations activites"&gt;1,311,000&lt;/span&gt;. The Company
completed a capital offering in January 2022 that raised net proceeds of approximately $&lt;span id="xdx_909_ecustom--NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants_iN_di_c20220101__20220131_zzypTyDSMcHg" title="Netproceeds from private placement issuance of shares and warrants"&gt;17,853,000&lt;/span&gt;. Management believes the Company&#x2019;s
financial position and its ability to raise capital to be reasonable and sufficient.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--UseOfEstimates_zEAeP9pyMgGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zq7klqBZY36i"&gt;Use
of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets, liabilities, revenues and expenses, and related disclosures in the financial statements and accompanying notes. Management
bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could
differ materially from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_z4NfRxD2cRgf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_zX5ejGcEIL4c"&gt;Cash
and Restricted Cash&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_ztfGtzNzL7ol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and restricted cash reported on our Condensed Consolidated Balance Sheets are reconciled to the total shown on our Condensed Consolidated
Statements of Cash Flows as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B5_zBvL1V2l6tya" style="display: none"&gt;SCHEDULE
OF RESTRICTED CASH IN STATEMENT OF CASH FLOW&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220630_zQUfFS0I7Bdk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20210630_zXhmNmSsa4xg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--Cash_iI_maRCACEzxqQ_zAyV56KVYhr2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Cash&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,979,769&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;6,348,415&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RestrictedCashCurrent_iI_maRCACEzxqQ_zlkkcI8lwKhb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Restricted cash&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,417,635&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;484,350&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RestrictedCashAndCashEquivalentsAtCarryingValue_iTI_mtRCACEzxqQ_zaHanh1g1kVj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total cash and restricted cash&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,397,404&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,832,765&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zoHrcRMRXE07" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z2iTIIYMxwd7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zVScM1ivfyda"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1 &#x2014; Observable inputs reflecting quoted prices (unadjusted) in active markets for identical assets and liabilities;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2 &#x2014; Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly
or indirectly for substantially the full term of the asset or liability; and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3 &#x2014; Unobservable inputs for the asset or liability, which include management&#x2019;s own assumption about the assumptions market
participants would use in pricing the asset or liability, including assumptions about risk.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Warrant
Liabilities: &lt;/b&gt;The Company re-measures fair value of its Level 3 warrant liabilities at the balance sheet date, using a binomial option
pricing model. The following summarizes the significant unobservable inputs:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zuvTGvxglgH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B1_zXZ6z5Sxqugl" style="display: none"&gt;SCHEDULE
OF FAIR VALUE OF WARRANT COMMITMENT&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220630_zdELOVKAbk4d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20211231_zX1MYhWhCdG7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zj5ouKYrGde" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;Stock price&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2.11&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;6.44&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zbdq5NQdG7Q1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;105&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;90&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Time to expiry&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zr1GMZQNhsNj" title="Warrants and rights outstanding term"&gt;4.51&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zKISL3Mn5ps2" title="Warrants and rights outstanding term"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zkdPrINnuo38" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zUpuuQxKipA" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zIregxJQX2h6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_ecustom--ScheduleOfReconcilesWarrantCommitmentTableTextBlock_zt3kCNHuQ5M9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following reconciles fair value of the liability classified warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_z5bchZTVaKEh" style="display: none"&gt;SCHEDULE
OF RECONCILES WARRANT COMMITMENT&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BE_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantCommitmentMember_zaPZPoar18x8" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Series B Warrant Commitment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B0_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantLiabilityMember_zFVUv6u0gfb8" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Series B warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BA_us-gaap--DerivativeInstrumentRiskAxis_custom--PlacementAgentWarrantsMember_zp5xE03Tw8Yd" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Placement agent warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B3_zULc9txmvSa" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three and Six Months ended June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Series B Warrant Commitment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Series B warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Placement agent warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20220101__20220331_ecustom--WarrantCommitment_iS_zd3vhmbYuyld" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left"&gt;Beginning balance&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;37,652,808&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0829"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0830"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;37,652,808&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--InitialRecognitionOfWarrantCommitment_zyM2U4DD4yj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Initial recognition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0833"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;55,061,119&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,525,923&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;56,587,042&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--WarrantCommitmentUnrealizedGainLoss_zLfiRyNIbvRl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Unrealized (gain) loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,408,311&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(31,980,437&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(946,461&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15,518,587&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--WarrantsExercisedOrTransferred_zVYByWZcDdGd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Warrants exercised or transferred&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(55,061,119&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(55,061,119&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20220401__20220630_ecustom--WarrantCommitment_iS_zrEwvtfbTO" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Ending balance, March 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0848"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;23,080,682&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;579,462&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;23,660,144&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--WarrantCommitmentUnrealizedGainLoss_zmj2QtkAu6Uj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Unrealized gain&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0853"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(12,322,737&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(310,514&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(12,633,251&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20220401__20220630_ecustom--WarrantCommitment_iE_z9HKugYon43e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Ending balance, June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0858"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;10,757,945&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;268,948&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;11,026,893&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BC_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantCommitmentMember_zFjs7ly3vam5" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Series B Warrant Commitment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B0_zTXl22uiCGIi" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Series B Warrant Commitment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20210101__20211231_ecustom--WarrantCommitment_iS_z62K3p0Y2rYb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Beginning balance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0863"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0864"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--InitialRecognitionOfWarrantCommitment_z0J37025AFnf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: left"&gt;Initial recognition&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;20,244,497&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;20,244,497&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--WarrantCommitmentUnrealizedGainLoss_zoUjaLsFSw4i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Unrealized gain&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,408,311&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,408,311&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20210101__20211231_ecustom--WarrantCommitment_iE_z3Ptc0oweq7f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Ending balance&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;37,652,808&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;37,652,808&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zTlHOlOLVKH3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Earn-out
liabilities:&lt;/b&gt; The Company generally values its Level 3 earn-out liabilities using the income valuation approach. Key valuation inputs
include contingent payment arrangement terms, projected revenues and cash flows, rate of return, and probability assessments. The following
table summarizes the significant unobservable inputs used in the fair value measurements:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zJKMYpHycEGh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zYMc3HBmfOK4" style="display: none"&gt;SCHEDULE
OF FAIR VALUE MEASUREMENTS&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June
    30, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 30%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Valuation
    technique&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ValuationTechnique_c20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zJVisLob1nDj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 31%" title="Valuation technique"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Discounted
    cash flow &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ValuationTechnique_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zp63Ik5UVtV" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 30%" title="Valuation technique"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Discounted
    cash flow&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant
    unobservable input&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--SignificantUnobservableInput_c20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zKLexS2RNJ84" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center" title="Significant unobservable input"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Projected
    revenue and probability of achievement&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--SignificantUnobservableInput_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zo8veHrk3uCd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center" title="Significant unobservable input"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Projected
    revenue and probability of achievement&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p id="xdx_8A1_z52fMoZE7ARe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1pON4iBjjBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company values its Level 3 earn-out liability related to the Barra Acquisition using a Monte Carlo simulation in a risk-neutral framework
(a special case of the Income Approach). The following summarizes the significant unobservable inputs:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_zv1lEyyBoaX" style="display: none"&gt;SCHEDULE
OF EARN OUT LIABILITY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: justify"&gt;WACC Risk Premium:&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputRiskPremiumMember_zjVOsHTdDEbj" title="Derivative Liability, Measurement Input"&gt;14.6&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zqMn0spx6Qje" title="Derivative Liability, Measurement Input"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Credit Spread:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputCreditSpreadMember_zpNZCTnxJM2f" title="Derivative Liability, Measurement Input"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Payment Delay (days)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputPaymentDelayMember_zFAkyxntXyB2" title="Derivative Liability, Measurement Input"&gt;90&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--RiskFreeRate_iI_c20220630_zN0olbNccxBj" title="Risk free rate"&gt;USD Yield Curve&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Discounting Convention:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--DiscountingConvention_iI_c20220630_zw9XkpJ31uE8" title="Discounting Convention:"&gt;Mid-period&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Number of Iterations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--NumberOfLterations_iI_uInteger_c20220630_z5RyS1Z4xK0a" title="Number of Iterations"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zItbCfirs94l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Undiscounted
remaining earn out payments are approximately $&lt;span id="xdx_90A_ecustom--PaymentsToUndiscountedRemainingEarnOut_c20220101__20220630_zvpAYsUbwrEf" title="Undiscounted remaining earn out payments"&gt;4,697,644&lt;/span&gt; as of June 30, 2022. The following table reconciles fair value of earn-out liabilities
for the period ending June 30, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zlb5iloLraJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B9_zFHjImYwLSU6" style="display: none"&gt;SCHEDULE
OF GAIN OR LOSSES RECOGNIZED FAIR VALUE&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkOgZJqsn2G4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z5ixBvUV2h84" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--BusinessCombinationContingentConsiderationLiability_iS_zq3ugt4XkIok" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Beginning balance &#x2013; January 1&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;3,813,878&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,931,418&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--AcquisitionsAndSettlements_zz0ozKTtJd6f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Acquisitions and Settlements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--JPKushAcquisitionMember_zpGCww08QqRj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;JP Kush Acquisition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0911"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,694,166&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--BarraAcquisitionMember_ztAsfmTA8Ds3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Barra Acquisition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0915"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--CCSWriteoffMember_z7s1LuppWNR7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;CCS Write-off&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0917"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(81,368&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--AltruisPartialSettlementMember_zTJGFdi49Gl8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Altruis partial settlement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(84,473&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(452,236&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--MontanaFinalSettlementMember_zmXpkl6xJoP4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Montana final settlement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(326,935&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0924"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Period adjustments:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_z7vUDb0QHKck" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair value changes and accretion included in earnings&lt;sup id="xdx_F4F_zCuz3bYtjLKf"&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;354,963&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(278,102&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--BusinessCombinationContingentConsiderationLiability_iE_zgOy9LZAQxhi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Ending balance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,357,433&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,813,878&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: Current portion&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--EarnoutLiabilityCurrent_iI_c20220630_z010j0AI0K63" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Current portion"&gt;(3,683,596&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--EarnoutLiabilityCurrent_iI_c20211231_z8oBx77KZRcf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Current portion"&gt;(3,297,855&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Ending balance, less current portion&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--EarnoutLiabilityNoncurrent_iI_c20220630_zDbKw4KHKjik" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, less current portion"&gt;673,837&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--EarnoutLiabilityNoncurrent_iI_c20211231_zQzivkeBba6b" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, less current portion"&gt;516,023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F04_znbwsMrwCLig" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F16_z4Xsy00weVQ4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Recorded
    as a reduction to general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AA_zB6iCh8OAzef" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z2ebPnKcWApg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_zxNdZQjhrm83"&gt;Revenue
Recognition&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--DisaggregationOfRevenueTableTextBlock_zKQXJmjaBFd8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table disaggregates the Company&#x2019;s revenue by line of business, showing commissions earned:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_z41gn9tNSTfh" style="display: none"&gt;SCHEDULE
OF DISAGGREGATION REVENUE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three Months ended June 30, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z5tiAU5wjKR2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Medical/Life&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20220401__20220630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zdatYq69YXo7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Property and Casualty&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220401__20220630_zHcVQK4rAnib" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-weight: bold"&gt;Regular&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"/&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"/&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"/&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zVdgVoeWie6i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;EBS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;184,851&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0946"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;184,851&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zqGZOvVoHxI6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;USBA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,319&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0950"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,319&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zwjUHp1CEwn2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;CCS/UIS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0953"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;57,195&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;57,195&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zjegoCGCfgt9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Montana&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;451,705&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0958"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;451,705&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_zVsDiEHYJ40d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Fortman&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;357,334&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;205,804&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;563,138&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zs08bofcigH4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Altruis&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;882,171&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0966"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;882,171&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zQUL1vnGobQ8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Kush&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;425,449&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0970"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;425,449&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--MedigapMember_zWg9mMrfBhGa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Medigap&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,359,976&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0974"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,359,976&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--BarraMember_zmAdJPVXBB98" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Barra&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;69,925&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;200,397&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;270,322&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zTbS3j7Pa6Bj" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;3,743,730&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zrRFuj6duqr3" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;463,396&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630_zxCGZQwLBjxi" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;4,207,126&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Six Months ended June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z9Be7lQu9voi" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Medical/Life
&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20220101__20220630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z3tydUEu24g3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Property
and Casualty &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220101__20220630_z8zEBupF4cE7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Regular&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zTy49gmU3rp" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%"&gt;EBS&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;406,035&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0988"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;406,035&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zvWL8aZbZeFa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;USBA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,906&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0992"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,906&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zaP2nNq3HIud" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;CCS/UIS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0995"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;101,077&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;101,077&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zL1mRS9xGWpj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Montana&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;958,426&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1000"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;958,426&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_z3OrVbvYIse8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Fortman&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;689,933&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;403,064&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,092,997&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zybrrU6NCHc7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Altruis&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,187,043&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1008"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,187,043&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zIHzljz06991" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Kush&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;864,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1012"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;864,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--MedigapMember_ztqkCcg9omDf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Medigap&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,537,061&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1016"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,537,061&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--BarraMember_zno0jYB9HFv8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Barra&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;69,925&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;200,397&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;270,322&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zU809EwULDkg" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;7,738,369&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zRszIP2S1nr5" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;704,538&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630_z9IXsbU2PPXf" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;8,442,907&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three Months ended June 30, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zwLsapb9gO1e" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Medical/Life&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20210401__20210630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z1tNbXreF2Mj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Property and Casualty&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20210401__20210630_zJI9fqyJstwj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Regular&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zx4IPaQSDQEi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%"&gt;EBS&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;207,201&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1030"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;207,201&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zV2eUnQeUmu9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;USBA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,395&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1034"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,395&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zEeyxDVrvkKe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;CCS/UIS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1037"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;65,348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;65,348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zMeWaWYAtQU7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Montana&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;404,740&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1042"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;404,740&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_zNnTB9fpj3jc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Fortman&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;276,634&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;226,337&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;502,971&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_z57f2KxlOKCc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Altruis&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;729,874&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1050"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;729,874&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zLDD68scL5Ec" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Kush&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;265,318&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1054"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;265,318&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zzd5vle96J6f" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;1,899,162&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zNPGE7HG8of3" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;291,685&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630_z5plR7MKzIxe" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;2,190,847&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Six Months ended June 30, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zPt3IBocgf3c" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Medical/Life&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20210101__20210630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zIJuwrb9Ylx2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Property and Casualty&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20210101__20210630_zOgSGQXGACTk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Regular&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zhA6r9o7rk3k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%"&gt;EBS&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;416,195&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1064"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;416,195&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zYSuyOjX0ddg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;USBA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27,620&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1068"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27,620&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zastlTuh8MT3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;CCS/UIS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1071"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;154,166&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;154,166&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zsyzyBMUvklk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Montana&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;939,856&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1076"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;939,856&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_z5QRZ4XJduNi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Fortman&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;526,435&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;434,109&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;960,544&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zMTs7cRjWMtc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Altruis&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,750,878&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1084"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,750,878&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zR7DIBwDZLK5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Kush&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;265,318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1088"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;265,318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zr7yWuC1MVu8" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;3,926,302&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zlDmhcXqDkN1" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;588,275&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630_zz5VKg2KWWYa" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;4,514,577&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zulkyUcfW2k4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zurCRq47Ear1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following, are customers representing &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zPtejUWKnux7" title="Concentration Risk, Percentage"&gt;10&lt;/span&gt;% or more of total revenue:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none"&gt;&lt;span id="xdx_8B1_zxT12eyYIe4i"&gt;SCHEDULE OF CONCENTRATIONS OF REVENUES&lt;/span&gt;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Insurance Carrier&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220401__20220630_zJgUo4vQnJpc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20210401__20210630_zrvfG1T5V6bl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the three months ended &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Insurance Carrier&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--LTCGlobalMember_zMC8oySoP9Fj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;LTC Global&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;30&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1100"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--PriorityHealthMember_znq06QgPhkK6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Priority Health&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--BlueCrossBlueShieldMember_zpN2uLLxSJu4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;BlueCross BlueShield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1105"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Insurance Carrier&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20220101__20220630_z7F8k1FxEIp6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20210101__20210630_zOG3RiBI7Prg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the six months ended &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Insurance Carrier&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--BlueCrossBlueShieldMember_z8TBNIihmAI6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;BlueCross BlueShield&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;10&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--PriorityHealthMember_zVZvg9YCUls8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Priority Health&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--LTCGlobalMember_z87VBK7t4WCd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;LTC Global&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1115"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zCaoN9yfGgV8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;No
other single Customer accounted for more than &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zqaquHjgBYCc" title="Concentration Risk, Percentage"&gt;10&lt;/span&gt;% of the Company&#x2019;s commission revenues. The loss of any significant customer, including
Priority Health, BlueCross BlueShield and LTC Global could have a material adverse effect on the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zVHGbjWqayY" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zwCWv1p7BJqj"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company recorded no income tax expense for the three and six months ended June 30, 2022 and 2021 because the estimated annual effective
tax rate was zero. In determining the estimated annual effective income tax rate, the Company analyzes various factors, including projections
of the Company&#x2019;s annual earnings and taxing jurisdictions in which the earnings will be generated, the impact of state and local
income taxes, the ability to use tax credits and net operating loss carry forwards, and available tax planning alternatives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;As
of June 30, 2022 and December 31, 2021, the Company provided a full valuation allowance against its net deferred tax assets since the
Company believes it is more likely than not that its deferred tax assets will not be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_ecustom--PriorPeriodAdjustmentPolicyTextBlock_zRObHgRFIn4f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zh54TYGgWZo2"&gt;Prior
Period Adjustments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company identified certain immaterial adjustments impacting prior reporting periods. Specifically, the Company identified adjustments
to correct certain asset, liability and equity accounts in relation to historical purchase price allocation accounting, historical accrued
revenues and true ups of the common stock issuable account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company assessed the materiality of the adjustments to prior period financial statements in accordance with Securities and Exchange Commission
Staff Accounting Bulletin No. (SAB) 99, &lt;i&gt;Materiality&lt;/i&gt;, and SAB 108, &lt;i&gt;Considering the Effects of Prior Year Misstatements when
Quantifying Misstatements in Current Year Financial Statements&lt;/i&gt;, and ASC 250, &lt;i&gt;Accounting Changes and Error Corrections&lt;/i&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accordingly,
the Company&#x2019;s comparative condensed consolidated financial statements and impacted notes have been revised from amounts previously
reported to reflect these adjustments. The following table illustrates the impact on previously reported amounts and adjusted balances
presented in the condensed consolidated financial statements for the period ended June 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zLtKrbTbf3zc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none"&gt;&lt;span id="xdx_8B1_zy4nmbqtzRT9"&gt;SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION&lt;/span&gt;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Account&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BA_srt--RestatementAxis_srt--ScenarioPreviouslyReportedMember_zIlFdCuKKgL6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;12/31/2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As reported&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BA_srt--RestatementAxis_srt--RestatementAdjustmentMember_ztSl1ChMHY0l" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_zUdl3tyCyjzd" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;12/31/2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Adjusted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20201231_eus-gaap--AccountsReceivableNetCurrent_iI_zeNA3cy2zFy6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Earn-out liability&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;2,631,418&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;300,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;2,931,418&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20201231_eus-gaap--Goodwill_iI_zGbtXLuh31V3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Goodwill&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,265,070&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(503,345&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,761,725&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20201231_eus-gaap--CommonStockSharesSubscriptions_iI_ziWIxMXggjtb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Common stock issuable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;822,116&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(482,116&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;340,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20201231_eus-gaap--AdditionalPaidInCapital_iI_zbUb6d0npFJe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Additional paid-in-capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,377,123&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;182,116&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,559,239&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20201231_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zpywJ39h04S7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accumulated Deficit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,482,281&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;122,601&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,359,680&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Account&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B6_srt--RestatementAxis_srt--ScenarioPreviouslyReportedMember_zDUmDz1cXsN5" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3/31/2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As reported&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BB_srt--RestatementAxis_srt--RestatementAdjustmentMember_zuCTt499jlza" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B7_z0hbKKzwP566" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3/31/2021&lt;/b&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Adjusted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20210331_eus-gaap--CommonStockSharesSubscriptions_iI_zsto9pkjyeNf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Common stock issuable&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;482,116&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;(482,116&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20210331_eus-gaap--AdditionalPaidInCapital_iI_zKSe5SMWXzF3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Additional paid-in-capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,810,147&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;182,116&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,992,263&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43C_c20210331_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zcCV7oP7Zy8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accumulated Deficit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(13,123,609&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;150,003&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,973,606&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zyw2DnQljJT6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zK3FCib1Q3ea" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zSQan6anBzxj"&gt;Recently
Issued Accounting Pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
do not expect any recently issued accounting pronouncements to have a material effect on our financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_859_zU62b4ovln8k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zHDrYB63LSp4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_zcKS5w2HHGx7"&gt;Basis
of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting
principles in the United States of America (&#x201c;U.S. GAAP&#x201d;) for interim financial information and with the instructions for
Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP
for complete financial statements. In the opinion of management, all adjustments (consisting of recurring accruals) necessary for a fair
presentation have been included. These unaudited condensed consolidated financial statements should be read in conjunction with the audited
consolidated financial statements and the notes thereto, set forth in the Company&#x2019;s annual report on Form 10-K for the year ended
December 31, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited condensed consolidated financial statements include the accounts of Reliance Global Group, Inc. and its wholly
owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <RELI:LiquidityPolicyTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_842_ecustom--LiquidityPolicyTextBlock_zjM206NJluZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zUX1T6recycl"&gt;Liquidity&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2022, the Company&#x2019;s reported cash and restricted cash aggregated balance was approximately $&lt;span id="xdx_901_eus-gaap--RestrictedCashAndCashEquivalents_iI_c20220630_zmlheEmzb7nl" title="Cash and restricted cash"&gt;4,397,000&lt;/span&gt;, current assets
were approximately $&lt;span id="xdx_90E_eus-gaap--AssetsCurrent_iI_pn3d_c20220630_zLkG1HiplZ67" title="Current asset"&gt;6,101,000&lt;/span&gt;, while current liabilities were approximately $&lt;span id="xdx_90C_eus-gaap--LiabilitiesCurrent_iI_pn3d_c20220630_zfNZINzZNXf5" title="Current liabilities"&gt;9,470,000&lt;/span&gt;. As of June 30, 2022, the Company had a working
capital deficit of approximately $&lt;span id="xdx_908_ecustom--WorkingCapitalDeficiency_iNI_di_c20220630_zYkPNQWKNr4a" title="Working capital deficit"&gt;3,369,000&lt;/span&gt; and stockholders&#x2019; equity of approximately $&lt;span id="xdx_90F_eus-gaap--StockholdersEquity_iI_pn3d_c20220630_zR1yBKXFUUWk" title="Stockholders' equity"&gt;21,928,000&lt;/span&gt;. For the six months ended June
30, 2022, the Company reported loss from operations of approximately $&lt;span id="xdx_903_eus-gaap--OperatingIncomeLoss_iN_pn3d_di_c20220101__20220630_zhoRK99RrhS5" title="Operating loss"&gt;4,343,000&lt;/span&gt;, a non-cash, non-operating gain on the recognition and
change in fair value of warrant liabilities of approximately $&lt;span id="xdx_904_ecustom--RecognitionAndChangeInFairValueOfWarrantLiability_pn3d_c20220101__20220630_zU8Ct5P03fpf" title="Recognition and change in fair value of warrant liabilities"&gt;24,479,000&lt;/span&gt;, resulting in an overall net income of approximately $&lt;span id="xdx_904_eus-gaap--NetIncomeLoss_pn3d_c20220101__20220630_z5Tp5cVCrdrj" title="Net income"&gt;19,836,000&lt;/span&gt;.
For the six months ended June 30, 2022, the Company reported negative cash flows from operations of approximately $&lt;span id="xdx_90C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3d_di_c20220101__20220630_zCpU11eivpsa" title="Cash flows from operations activites"&gt;1,311,000&lt;/span&gt;. The Company
completed a capital offering in January 2022 that raised net proceeds of approximately $&lt;span id="xdx_909_ecustom--NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants_iN_di_c20220101__20220131_zzypTyDSMcHg" title="Netproceeds from private placement issuance of shares and warrants"&gt;17,853,000&lt;/span&gt;. Management believes the Company&#x2019;s
financial position and its ability to raise capital to be reasonable and sufficient.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</RELI:LiquidityPolicyTextBlock>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4397000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:AssetsCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">6101000</us-gaap:AssetsCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">9470000</us-gaap:LiabilitiesCurrent>
    <RELI:WorkingCapitalDeficiency contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">-3369000</RELI:WorkingCapitalDeficiency>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">21928000</us-gaap:StockholdersEquity>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-01to2022-06-30"
      decimals="-3"
      unitRef="USD">-4343000</us-gaap:OperatingIncomeLoss>
    <RELI:RecognitionAndChangeInFairValueOfWarrantLiability
      contextRef="From2022-01-01to2022-06-30"
      decimals="-3"
      unitRef="USD">24479000</RELI:RecognitionAndChangeInFairValueOfWarrantLiability>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-06-30"
      decimals="-3"
      unitRef="USD">19836000</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-01to2022-06-30"
      decimals="-3"
      unitRef="USD">-1311000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <RELI:NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants
      contextRef="From2022-01-012022-01-31"
      decimals="0"
      unitRef="USD">-17853000</RELI:NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants>
    <us-gaap:UseOfEstimates contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_846_eus-gaap--UseOfEstimates_zEAeP9pyMgGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zq7klqBZY36i"&gt;Use
of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets, liabilities, revenues and expenses, and related disclosures in the financial statements and accompanying notes. Management
bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could
differ materially from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_842_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_z4NfRxD2cRgf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_zX5ejGcEIL4c"&gt;Cash
and Restricted Cash&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_ztfGtzNzL7ol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and restricted cash reported on our Condensed Consolidated Balance Sheets are reconciled to the total shown on our Condensed Consolidated
Statements of Cash Flows as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B5_zBvL1V2l6tya" style="display: none"&gt;SCHEDULE
OF RESTRICTED CASH IN STATEMENT OF CASH FLOW&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220630_zQUfFS0I7Bdk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20210630_zXhmNmSsa4xg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--Cash_iI_maRCACEzxqQ_zAyV56KVYhr2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Cash&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,979,769&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;6,348,415&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RestrictedCashCurrent_iI_maRCACEzxqQ_zlkkcI8lwKhb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Restricted cash&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,417,635&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;484,350&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RestrictedCashAndCashEquivalentsAtCarryingValue_iTI_mtRCACEzxqQ_zaHanh1g1kVj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total cash and restricted cash&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,397,404&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,832,765&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zoHrcRMRXE07" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_89D_eus-gaap--ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_ztfGtzNzL7ol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and restricted cash reported on our Condensed Consolidated Balance Sheets are reconciled to the total shown on our Condensed Consolidated
Statements of Cash Flows as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B5_zBvL1V2l6tya" style="display: none"&gt;SCHEDULE
OF RESTRICTED CASH IN STATEMENT OF CASH FLOW&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220630_zQUfFS0I7Bdk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20210630_zXhmNmSsa4xg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--Cash_iI_maRCACEzxqQ_zAyV56KVYhr2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Cash&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,979,769&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;6,348,415&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RestrictedCashCurrent_iI_maRCACEzxqQ_zlkkcI8lwKhb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Restricted cash&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,417,635&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;484,350&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RestrictedCashAndCashEquivalentsAtCarryingValue_iTI_mtRCACEzxqQ_zaHanh1g1kVj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total cash and restricted cash&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,397,404&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,832,765&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:Cash contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">2979769</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">6348415</us-gaap:Cash>
    <us-gaap:RestrictedCashCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1417635</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">484350</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4397404</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">6832765</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_84C_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z2iTIIYMxwd7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zVScM1ivfyda"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1 &#x2014; Observable inputs reflecting quoted prices (unadjusted) in active markets for identical assets and liabilities;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2 &#x2014; Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly
or indirectly for substantially the full term of the asset or liability; and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3 &#x2014; Unobservable inputs for the asset or liability, which include management&#x2019;s own assumption about the assumptions market
participants would use in pricing the asset or liability, including assumptions about risk.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Warrant
Liabilities: &lt;/b&gt;The Company re-measures fair value of its Level 3 warrant liabilities at the balance sheet date, using a binomial option
pricing model. The following summarizes the significant unobservable inputs:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zuvTGvxglgH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B1_zXZ6z5Sxqugl" style="display: none"&gt;SCHEDULE
OF FAIR VALUE OF WARRANT COMMITMENT&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220630_zdELOVKAbk4d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20211231_zX1MYhWhCdG7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zj5ouKYrGde" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;Stock price&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2.11&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;6.44&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zbdq5NQdG7Q1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;105&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;90&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Time to expiry&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zr1GMZQNhsNj" title="Warrants and rights outstanding term"&gt;4.51&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zKISL3Mn5ps2" title="Warrants and rights outstanding term"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zkdPrINnuo38" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zUpuuQxKipA" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zIregxJQX2h6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_ecustom--ScheduleOfReconcilesWarrantCommitmentTableTextBlock_zt3kCNHuQ5M9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following reconciles fair value of the liability classified warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_z5bchZTVaKEh" style="display: none"&gt;SCHEDULE
OF RECONCILES WARRANT COMMITMENT&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BE_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantCommitmentMember_zaPZPoar18x8" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Series B Warrant Commitment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B0_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantLiabilityMember_zFVUv6u0gfb8" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Series B warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BA_us-gaap--DerivativeInstrumentRiskAxis_custom--PlacementAgentWarrantsMember_zp5xE03Tw8Yd" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Placement agent warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B3_zULc9txmvSa" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three and Six Months ended June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Series B Warrant Commitment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Series B warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Placement agent warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20220101__20220331_ecustom--WarrantCommitment_iS_zd3vhmbYuyld" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left"&gt;Beginning balance&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;37,652,808&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0829"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0830"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;37,652,808&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--InitialRecognitionOfWarrantCommitment_zyM2U4DD4yj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Initial recognition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0833"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;55,061,119&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,525,923&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;56,587,042&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--WarrantCommitmentUnrealizedGainLoss_zLfiRyNIbvRl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Unrealized (gain) loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,408,311&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(31,980,437&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(946,461&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15,518,587&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--WarrantsExercisedOrTransferred_zVYByWZcDdGd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Warrants exercised or transferred&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(55,061,119&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(55,061,119&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20220401__20220630_ecustom--WarrantCommitment_iS_zrEwvtfbTO" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Ending balance, March 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0848"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;23,080,682&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;579,462&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;23,660,144&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--WarrantCommitmentUnrealizedGainLoss_zmj2QtkAu6Uj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Unrealized gain&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0853"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(12,322,737&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(310,514&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(12,633,251&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20220401__20220630_ecustom--WarrantCommitment_iE_z9HKugYon43e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Ending balance, June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0858"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;10,757,945&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;268,948&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;11,026,893&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BC_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantCommitmentMember_zFjs7ly3vam5" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Series B Warrant Commitment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B0_zTXl22uiCGIi" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Series B Warrant Commitment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20210101__20211231_ecustom--WarrantCommitment_iS_z62K3p0Y2rYb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Beginning balance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0863"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0864"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--InitialRecognitionOfWarrantCommitment_z0J37025AFnf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: left"&gt;Initial recognition&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;20,244,497&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;20,244,497&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--WarrantCommitmentUnrealizedGainLoss_zoUjaLsFSw4i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Unrealized gain&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,408,311&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,408,311&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20210101__20211231_ecustom--WarrantCommitment_iE_z3Ptc0oweq7f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Ending balance&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;37,652,808&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;37,652,808&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zTlHOlOLVKH3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Earn-out
liabilities:&lt;/b&gt; The Company generally values its Level 3 earn-out liabilities using the income valuation approach. Key valuation inputs
include contingent payment arrangement terms, projected revenues and cash flows, rate of return, and probability assessments. The following
table summarizes the significant unobservable inputs used in the fair value measurements:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zJKMYpHycEGh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zYMc3HBmfOK4" style="display: none"&gt;SCHEDULE
OF FAIR VALUE MEASUREMENTS&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June
    30, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 30%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Valuation
    technique&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ValuationTechnique_c20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zJVisLob1nDj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 31%" title="Valuation technique"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Discounted
    cash flow &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ValuationTechnique_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zp63Ik5UVtV" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 30%" title="Valuation technique"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Discounted
    cash flow&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant
    unobservable input&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--SignificantUnobservableInput_c20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zKLexS2RNJ84" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center" title="Significant unobservable input"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Projected
    revenue and probability of achievement&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--SignificantUnobservableInput_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zo8veHrk3uCd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center" title="Significant unobservable input"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Projected
    revenue and probability of achievement&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p id="xdx_8A1_z52fMoZE7ARe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1pON4iBjjBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company values its Level 3 earn-out liability related to the Barra Acquisition using a Monte Carlo simulation in a risk-neutral framework
(a special case of the Income Approach). The following summarizes the significant unobservable inputs:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_zv1lEyyBoaX" style="display: none"&gt;SCHEDULE
OF EARN OUT LIABILITY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: justify"&gt;WACC Risk Premium:&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputRiskPremiumMember_zjVOsHTdDEbj" title="Derivative Liability, Measurement Input"&gt;14.6&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zqMn0spx6Qje" title="Derivative Liability, Measurement Input"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Credit Spread:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputCreditSpreadMember_zpNZCTnxJM2f" title="Derivative Liability, Measurement Input"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Payment Delay (days)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputPaymentDelayMember_zFAkyxntXyB2" title="Derivative Liability, Measurement Input"&gt;90&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--RiskFreeRate_iI_c20220630_zN0olbNccxBj" title="Risk free rate"&gt;USD Yield Curve&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Discounting Convention:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--DiscountingConvention_iI_c20220630_zw9XkpJ31uE8" title="Discounting Convention:"&gt;Mid-period&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Number of Iterations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--NumberOfLterations_iI_uInteger_c20220630_z5RyS1Z4xK0a" title="Number of Iterations"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zItbCfirs94l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Undiscounted
remaining earn out payments are approximately $&lt;span id="xdx_90A_ecustom--PaymentsToUndiscountedRemainingEarnOut_c20220101__20220630_zvpAYsUbwrEf" title="Undiscounted remaining earn out payments"&gt;4,697,644&lt;/span&gt; as of June 30, 2022. The following table reconciles fair value of earn-out liabilities
for the period ending June 30, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zlb5iloLraJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B9_zFHjImYwLSU6" style="display: none"&gt;SCHEDULE
OF GAIN OR LOSSES RECOGNIZED FAIR VALUE&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkOgZJqsn2G4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z5ixBvUV2h84" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--BusinessCombinationContingentConsiderationLiability_iS_zq3ugt4XkIok" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Beginning balance &#x2013; January 1&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;3,813,878&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,931,418&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--AcquisitionsAndSettlements_zz0ozKTtJd6f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Acquisitions and Settlements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--JPKushAcquisitionMember_zpGCww08QqRj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;JP Kush Acquisition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0911"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,694,166&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--BarraAcquisitionMember_ztAsfmTA8Ds3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Barra Acquisition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0915"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--CCSWriteoffMember_z7s1LuppWNR7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;CCS Write-off&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0917"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(81,368&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--AltruisPartialSettlementMember_zTJGFdi49Gl8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Altruis partial settlement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(84,473&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(452,236&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--MontanaFinalSettlementMember_zmXpkl6xJoP4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Montana final settlement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(326,935&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0924"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Period adjustments:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_z7vUDb0QHKck" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair value changes and accretion included in earnings&lt;sup id="xdx_F4F_zCuz3bYtjLKf"&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;354,963&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(278,102&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--BusinessCombinationContingentConsiderationLiability_iE_zgOy9LZAQxhi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Ending balance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,357,433&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,813,878&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: Current portion&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--EarnoutLiabilityCurrent_iI_c20220630_z010j0AI0K63" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Current portion"&gt;(3,683,596&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--EarnoutLiabilityCurrent_iI_c20211231_z8oBx77KZRcf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Current portion"&gt;(3,297,855&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Ending balance, less current portion&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--EarnoutLiabilityNoncurrent_iI_c20220630_zDbKw4KHKjik" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, less current portion"&gt;673,837&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--EarnoutLiabilityNoncurrent_iI_c20211231_zQzivkeBba6b" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, less current portion"&gt;516,023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F04_znbwsMrwCLig" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F16_z4Xsy00weVQ4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Recorded
    as a reduction to general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AA_zB6iCh8OAzef" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_890_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zuvTGvxglgH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B1_zXZ6z5Sxqugl" style="display: none"&gt;SCHEDULE
OF FAIR VALUE OF WARRANT COMMITMENT&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220630_zdELOVKAbk4d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20211231_zX1MYhWhCdG7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zj5ouKYrGde" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: justify"&gt;Stock price&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2.11&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;6.44&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zbdq5NQdG7Q1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;105&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;90&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Time to expiry&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zr1GMZQNhsNj" title="Warrants and rights outstanding term"&gt;4.51&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zKISL3Mn5ps2" title="Warrants and rights outstanding term"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zkdPrINnuo38" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zUpuuQxKipA" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-06-30_us-gaap_MeasurementInputSharePriceMember"
      decimals="INF"
      unitRef="Pure">2.11</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2021-12-31_us-gaap_MeasurementInputSharePriceMember"
      decimals="INF"
      unitRef="Pure">6.44</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-06-30_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      unitRef="Pure">105</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2021-12-31_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      unitRef="Pure">90</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2022-06-30_us-gaap_MeasurementInputExpectedTermMember">P4Y6M3D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2021-12-31_us-gaap_MeasurementInputExpectedTermMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-06-30_us-gaap_MeasurementInputExpectedDividendRateMember"
      decimals="INF"
      unitRef="Pure">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2021-12-31_us-gaap_MeasurementInputExpectedDividendRateMember"
      decimals="INF"
      unitRef="Pure">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2022-06-30_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      unitRef="Pure">3.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2021-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      unitRef="Pure">1.10</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <RELI:ScheduleOfReconcilesWarrantCommitmentTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_89D_ecustom--ScheduleOfReconcilesWarrantCommitmentTableTextBlock_zt3kCNHuQ5M9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following reconciles fair value of the liability classified warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_z5bchZTVaKEh" style="display: none"&gt;SCHEDULE
OF RECONCILES WARRANT COMMITMENT&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BE_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantCommitmentMember_zaPZPoar18x8" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Series B Warrant Commitment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B0_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantLiabilityMember_zFVUv6u0gfb8" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Series B warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BA_us-gaap--DerivativeInstrumentRiskAxis_custom--PlacementAgentWarrantsMember_zp5xE03Tw8Yd" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Placement agent warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B3_zULc9txmvSa" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three and Six Months ended June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Series B Warrant Commitment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Series B warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Placement agent warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20220101__20220331_ecustom--WarrantCommitment_iS_zd3vhmbYuyld" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left"&gt;Beginning balance&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;37,652,808&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0829"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0830"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;37,652,808&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--InitialRecognitionOfWarrantCommitment_zyM2U4DD4yj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Initial recognition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0833"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;55,061,119&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,525,923&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;56,587,042&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--WarrantCommitmentUnrealizedGainLoss_zLfiRyNIbvRl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Unrealized (gain) loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,408,311&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(31,980,437&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(946,461&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15,518,587&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--WarrantsExercisedOrTransferred_zVYByWZcDdGd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Warrants exercised or transferred&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(55,061,119&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(55,061,119&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20220401__20220630_ecustom--WarrantCommitment_iS_zrEwvtfbTO" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Ending balance, March 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0848"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;23,080,682&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;579,462&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;23,660,144&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--WarrantCommitmentUnrealizedGainLoss_zmj2QtkAu6Uj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Unrealized gain&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0853"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(12,322,737&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(310,514&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(12,633,251&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20220401__20220630_ecustom--WarrantCommitment_iE_z9HKugYon43e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Ending balance, June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0858"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;10,757,945&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;268,948&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;11,026,893&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4BC_us-gaap--DerivativeInstrumentRiskAxis_custom--SeriesBWarrantCommitmentMember_zFjs7ly3vam5" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Series B Warrant Commitment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_4B0_zTXl22uiCGIi" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Series B Warrant Commitment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20210101__20211231_ecustom--WarrantCommitment_iS_z62K3p0Y2rYb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Beginning balance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0863"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0864"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--InitialRecognitionOfWarrantCommitment_z0J37025AFnf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: left"&gt;Initial recognition&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;20,244,497&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;20,244,497&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--WarrantCommitmentUnrealizedGainLoss_zoUjaLsFSw4i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Unrealized gain&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,408,311&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,408,311&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20210101__20211231_ecustom--WarrantCommitment_iE_z3Ptc0oweq7f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Ending balance&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;37,652,808&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;37,652,808&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</RELI:ScheduleOfReconcilesWarrantCommitmentTableTextBlock>
    <RELI:WarrantCommitment
      contextRef="AsOf2021-12-31_custom_SeriesBWarrantCommitmentMember"
      decimals="0"
      unitRef="USD">37652808</RELI:WarrantCommitment>
    <RELI:WarrantCommitment contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">37652808</RELI:WarrantCommitment>
    <RELI:InitialRecognitionOfWarrantCommitment
      contextRef="From2022-01-012022-03-31_custom_SeriesBWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">55061119</RELI:InitialRecognitionOfWarrantCommitment>
    <RELI:InitialRecognitionOfWarrantCommitment
      contextRef="From2022-01-012022-03-31_custom_PlacementAgentWarrantsMember"
      decimals="0"
      unitRef="USD">1525923</RELI:InitialRecognitionOfWarrantCommitment>
    <RELI:InitialRecognitionOfWarrantCommitment
      contextRef="From2022-01-012022-03-31"
      decimals="0"
      unitRef="USD">56587042</RELI:InitialRecognitionOfWarrantCommitment>
    <RELI:WarrantCommitmentUnrealizedGainLoss
      contextRef="From2022-01-012022-03-31_custom_SeriesBWarrantCommitmentMember"
      decimals="0"
      unitRef="USD">17408311</RELI:WarrantCommitmentUnrealizedGainLoss>
    <RELI:WarrantCommitmentUnrealizedGainLoss
      contextRef="From2022-01-012022-03-31_custom_SeriesBWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">-31980437</RELI:WarrantCommitmentUnrealizedGainLoss>
    <RELI:WarrantCommitmentUnrealizedGainLoss
      contextRef="From2022-01-012022-03-31_custom_PlacementAgentWarrantsMember"
      decimals="0"
      unitRef="USD">-946461</RELI:WarrantCommitmentUnrealizedGainLoss>
    <RELI:WarrantCommitmentUnrealizedGainLoss
      contextRef="From2022-01-012022-03-31"
      decimals="0"
      unitRef="USD">-15518587</RELI:WarrantCommitmentUnrealizedGainLoss>
    <RELI:WarrantsExercisedOrTransferred
      contextRef="From2022-01-012022-03-31_custom_SeriesBWarrantCommitmentMember"
      decimals="0"
      unitRef="USD">-55061119</RELI:WarrantsExercisedOrTransferred>
    <RELI:WarrantsExercisedOrTransferred
      contextRef="From2022-01-012022-03-31"
      decimals="0"
      unitRef="USD">-55061119</RELI:WarrantsExercisedOrTransferred>
    <RELI:WarrantCommitment
      contextRef="AsOf2022-03-31_custom_SeriesBWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">23080682</RELI:WarrantCommitment>
    <RELI:WarrantCommitment
      contextRef="AsOf2022-03-31_custom_PlacementAgentWarrantsMember"
      decimals="0"
      unitRef="USD">579462</RELI:WarrantCommitment>
    <RELI:WarrantCommitment contextRef="AsOf2022-03-31" decimals="0" unitRef="USD">23660144</RELI:WarrantCommitment>
    <RELI:WarrantCommitmentUnrealizedGainLoss
      contextRef="From2022-04-012022-06-30_custom_SeriesBWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">-12322737</RELI:WarrantCommitmentUnrealizedGainLoss>
    <RELI:WarrantCommitmentUnrealizedGainLoss
      contextRef="From2022-04-012022-06-30_custom_PlacementAgentWarrantsMember"
      decimals="0"
      unitRef="USD">-310514</RELI:WarrantCommitmentUnrealizedGainLoss>
    <RELI:WarrantCommitmentUnrealizedGainLoss
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-12633251</RELI:WarrantCommitmentUnrealizedGainLoss>
    <RELI:WarrantCommitment
      contextRef="AsOf2022-06-30_custom_SeriesBWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">10757945</RELI:WarrantCommitment>
    <RELI:WarrantCommitment
      contextRef="AsOf2022-06-30_custom_PlacementAgentWarrantsMember"
      decimals="0"
      unitRef="USD">268948</RELI:WarrantCommitment>
    <RELI:WarrantCommitment contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">11026893</RELI:WarrantCommitment>
    <RELI:InitialRecognitionOfWarrantCommitment
      contextRef="From2021-01-012021-12-31_custom_SeriesBWarrantCommitmentMember"
      decimals="0"
      unitRef="USD">20244497</RELI:InitialRecognitionOfWarrantCommitment>
    <RELI:InitialRecognitionOfWarrantCommitment
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">20244497</RELI:InitialRecognitionOfWarrantCommitment>
    <RELI:WarrantCommitmentUnrealizedGainLoss
      contextRef="From2021-01-012021-12-31_custom_SeriesBWarrantCommitmentMember"
      decimals="0"
      unitRef="USD">17408311</RELI:WarrantCommitmentUnrealizedGainLoss>
    <RELI:WarrantCommitmentUnrealizedGainLoss
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">17408311</RELI:WarrantCommitmentUnrealizedGainLoss>
    <RELI:WarrantCommitment
      contextRef="AsOf2021-12-31_custom_SeriesBWarrantCommitmentMember"
      decimals="0"
      unitRef="USD">37652808</RELI:WarrantCommitment>
    <RELI:WarrantCommitment contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">37652808</RELI:WarrantCommitment>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_897_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zJKMYpHycEGh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zYMc3HBmfOK4" style="display: none"&gt;SCHEDULE
OF FAIR VALUE MEASUREMENTS&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June
    30, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 30%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Valuation
    technique&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ValuationTechnique_c20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zJVisLob1nDj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 31%" title="Valuation technique"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Discounted
    cash flow &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ValuationTechnique_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zp63Ik5UVtV" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 30%" title="Valuation technique"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Discounted
    cash flow&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant
    unobservable input&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--SignificantUnobservableInput_c20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zKLexS2RNJ84" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center" title="Significant unobservable input"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Projected
    revenue and probability of achievement&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--SignificantUnobservableInput_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zo8veHrk3uCd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center" title="Significant unobservable input"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Projected
    revenue and probability of achievement&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <RELI:ValuationTechnique contextRef="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member">Discounted
    cash flow</RELI:ValuationTechnique>
    <RELI:ValuationTechnique contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member">Discounted
    cash flow</RELI:ValuationTechnique>
    <RELI:SignificantUnobservableInput contextRef="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member">Projected
    revenue and probability of achievement</RELI:SignificantUnobservableInput>
    <RELI:SignificantUnobservableInput contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member">Projected
    revenue and probability of achievement</RELI:SignificantUnobservableInput>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member">&lt;p id="xdx_89C_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1pON4iBjjBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company values its Level 3 earn-out liability related to the Barra Acquisition using a Monte Carlo simulation in a risk-neutral framework
(a special case of the Income Approach). The following summarizes the significant unobservable inputs:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_zv1lEyyBoaX" style="display: none"&gt;SCHEDULE
OF EARN OUT LIABILITY&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: justify"&gt;WACC Risk Premium:&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputRiskPremiumMember_zjVOsHTdDEbj" title="Derivative Liability, Measurement Input"&gt;14.6&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zqMn0spx6Qje" title="Derivative Liability, Measurement Input"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Credit Spread:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputCreditSpreadMember_zpNZCTnxJM2f" title="Derivative Liability, Measurement Input"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Payment Delay (days)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_dp_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputPaymentDelayMember_zFAkyxntXyB2" title="Derivative Liability, Measurement Input"&gt;90&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--RiskFreeRate_iI_c20220630_zN0olbNccxBj" title="Risk free rate"&gt;USD Yield Curve&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Discounting Convention:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--DiscountingConvention_iI_c20220630_zw9XkpJ31uE8" title="Discounting Convention:"&gt;Mid-period&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Number of Iterations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--NumberOfLterations_iI_uInteger_c20220630_z5RyS1Z4xK0a" title="Number of Iterations"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2022-06-30_custom_MeasurementInputRiskPremiumMember"
      decimals="INF"
      unitRef="Pure">0.146</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2022-06-30_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      unitRef="Pure">0.50</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2022-06-30_us-gaap_MeasurementInputCreditSpreadMember"
      decimals="INF"
      unitRef="Pure">0.11</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2022-06-30_custom_MeasurementInputPaymentDelayMember"
      decimals="INF"
      unitRef="Pure">0.90</us-gaap:DerivativeLiabilityMeasurementInput>
    <RELI:RiskFreeRate contextRef="AsOf2022-06-30">USD Yield Curve</RELI:RiskFreeRate>
    <RELI:DiscountingConvention contextRef="AsOf2022-06-30">Mid-period</RELI:DiscountingConvention>
    <RELI:NumberOfLterations
      contextRef="AsOf2022-06-30"
      decimals="INF"
      unitRef="Integer">100000</RELI:NumberOfLterations>
    <RELI:PaymentsToUndiscountedRemainingEarnOut
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">4697644</RELI:PaymentsToUndiscountedRemainingEarnOut>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_89F_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zlb5iloLraJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B9_zFHjImYwLSU6" style="display: none"&gt;SCHEDULE
OF GAIN OR LOSSES RECOGNIZED FAIR VALUE&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20220101__20220630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkOgZJqsn2G4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z5ixBvUV2h84" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--BusinessCombinationContingentConsiderationLiability_iS_zq3ugt4XkIok" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Beginning balance &#x2013; January 1&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;3,813,878&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,931,418&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--AcquisitionsAndSettlements_zz0ozKTtJd6f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Acquisitions and Settlements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--JPKushAcquisitionMember_zpGCww08QqRj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;JP Kush Acquisition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0911"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,694,166&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--BarraAcquisitionMember_ztAsfmTA8Ds3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Barra Acquisition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0915"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--CCSWriteoffMember_z7s1LuppWNR7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;CCS Write-off&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0917"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(81,368&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--AltruisPartialSettlementMember_zTJGFdi49Gl8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Altruis partial settlement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(84,473&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(452,236&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--AcquisitionsAndSettlements_hus-gaap--BusinessAcquisitionAxis__custom--MontanaFinalSettlementMember_zmXpkl6xJoP4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Montana final settlement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(326,935&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0924"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Period adjustments:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_z7vUDb0QHKck" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair value changes and accretion included in earnings&lt;sup id="xdx_F4F_zCuz3bYtjLKf"&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;354,963&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(278,102&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--BusinessCombinationContingentConsiderationLiability_iE_zgOy9LZAQxhi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Ending balance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,357,433&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,813,878&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: Current portion&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--EarnoutLiabilityCurrent_iI_c20220630_z010j0AI0K63" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Current portion"&gt;(3,683,596&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--EarnoutLiabilityCurrent_iI_c20211231_z8oBx77KZRcf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Current portion"&gt;(3,297,855&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Ending balance, less current portion&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--EarnoutLiabilityNoncurrent_iI_c20220630_zDbKw4KHKjik" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, less current portion"&gt;673,837&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--EarnoutLiabilityNoncurrent_iI_c20211231_zQzivkeBba6b" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, less current portion"&gt;516,023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F04_znbwsMrwCLig" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F16_z4Xsy00weVQ4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Recorded
    as a reduction to general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2021-12-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">3813878</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">2931418</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <RELI:AcquisitionsAndSettlements
      contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_custom_JPKushAcquisitionMember"
      decimals="0"
      unitRef="USD">1694166</RELI:AcquisitionsAndSettlements>
    <RELI:AcquisitionsAndSettlements
      contextRef="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_BarraAcquisitionMember"
      decimals="0"
      unitRef="USD">600000</RELI:AcquisitionsAndSettlements>
    <RELI:AcquisitionsAndSettlements
      contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_custom_CCSWriteoffMember"
      decimals="0"
      unitRef="USD">-81368</RELI:AcquisitionsAndSettlements>
    <RELI:AcquisitionsAndSettlements
      contextRef="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_AltruisPartialSettlementMember"
      decimals="0"
      unitRef="USD">-84473</RELI:AcquisitionsAndSettlements>
    <RELI:AcquisitionsAndSettlements
      contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_custom_AltruisPartialSettlementMember"
      decimals="0"
      unitRef="USD">-452236</RELI:AcquisitionsAndSettlements>
    <RELI:AcquisitionsAndSettlements
      contextRef="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member_custom_MontanaFinalSettlementMember"
      decimals="0"
      unitRef="USD">-326935</RELI:AcquisitionsAndSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease
      contextRef="From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact000926"
      unitRef="USD">354963</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease
      contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact000927"
      unitRef="USD">-278102</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2022-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">4357433</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2021-12-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">3813878</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <RELI:EarnoutLiabilityCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">-3683596</RELI:EarnoutLiabilityCurrent>
    <RELI:EarnoutLiabilityCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-3297855</RELI:EarnoutLiabilityCurrent>
    <RELI:EarnoutLiabilityNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">673837</RELI:EarnoutLiabilityNoncurrent>
    <RELI:EarnoutLiabilityNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">516023</RELI:EarnoutLiabilityNoncurrent>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_847_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_z2ebPnKcWApg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_zxNdZQjhrm83"&gt;Revenue
Recognition&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--DisaggregationOfRevenueTableTextBlock_zKQXJmjaBFd8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table disaggregates the Company&#x2019;s revenue by line of business, showing commissions earned:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_z41gn9tNSTfh" style="display: none"&gt;SCHEDULE
OF DISAGGREGATION REVENUE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three Months ended June 30, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z5tiAU5wjKR2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Medical/Life&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20220401__20220630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zdatYq69YXo7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Property and Casualty&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220401__20220630_zHcVQK4rAnib" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-weight: bold"&gt;Regular&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"/&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"/&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"/&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zVdgVoeWie6i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;EBS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;184,851&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0946"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;184,851&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zqGZOvVoHxI6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;USBA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,319&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0950"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,319&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zwjUHp1CEwn2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;CCS/UIS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0953"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;57,195&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;57,195&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zjegoCGCfgt9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Montana&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;451,705&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0958"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;451,705&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_zVsDiEHYJ40d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Fortman&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;357,334&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;205,804&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;563,138&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zs08bofcigH4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Altruis&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;882,171&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0966"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;882,171&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zQUL1vnGobQ8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Kush&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;425,449&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0970"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;425,449&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--MedigapMember_zWg9mMrfBhGa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Medigap&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,359,976&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0974"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,359,976&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--BarraMember_zmAdJPVXBB98" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Barra&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;69,925&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;200,397&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;270,322&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zTbS3j7Pa6Bj" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;3,743,730&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zrRFuj6duqr3" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;463,396&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630_zxCGZQwLBjxi" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;4,207,126&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Six Months ended June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z9Be7lQu9voi" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Medical/Life
&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20220101__20220630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z3tydUEu24g3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Property
and Casualty &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220101__20220630_z8zEBupF4cE7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Regular&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zTy49gmU3rp" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%"&gt;EBS&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;406,035&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0988"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;406,035&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zvWL8aZbZeFa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;USBA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,906&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0992"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,906&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zaP2nNq3HIud" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;CCS/UIS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0995"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;101,077&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;101,077&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zL1mRS9xGWpj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Montana&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;958,426&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1000"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;958,426&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_z3OrVbvYIse8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Fortman&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;689,933&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;403,064&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,092,997&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zybrrU6NCHc7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Altruis&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,187,043&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1008"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,187,043&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zIHzljz06991" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Kush&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;864,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1012"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;864,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--MedigapMember_ztqkCcg9omDf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Medigap&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,537,061&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1016"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,537,061&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--BarraMember_zno0jYB9HFv8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Barra&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;69,925&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;200,397&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;270,322&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zU809EwULDkg" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;7,738,369&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zRszIP2S1nr5" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;704,538&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630_z9IXsbU2PPXf" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;8,442,907&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three Months ended June 30, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zwLsapb9gO1e" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Medical/Life&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20210401__20210630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z1tNbXreF2Mj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Property and Casualty&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20210401__20210630_zJI9fqyJstwj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Regular&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zx4IPaQSDQEi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%"&gt;EBS&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;207,201&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1030"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;207,201&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zV2eUnQeUmu9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;USBA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,395&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1034"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,395&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zEeyxDVrvkKe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;CCS/UIS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1037"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;65,348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;65,348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zMeWaWYAtQU7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Montana&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;404,740&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1042"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;404,740&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_zNnTB9fpj3jc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Fortman&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;276,634&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;226,337&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;502,971&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_z57f2KxlOKCc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Altruis&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;729,874&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1050"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;729,874&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zLDD68scL5Ec" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Kush&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;265,318&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1054"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;265,318&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zzd5vle96J6f" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;1,899,162&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zNPGE7HG8of3" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;291,685&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630_z5plR7MKzIxe" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;2,190,847&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Six Months ended June 30, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zPt3IBocgf3c" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Medical/Life&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20210101__20210630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zIJuwrb9Ylx2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Property and Casualty&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20210101__20210630_zOgSGQXGACTk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Regular&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zhA6r9o7rk3k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%"&gt;EBS&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;416,195&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1064"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;416,195&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zYSuyOjX0ddg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;USBA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27,620&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1068"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27,620&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zastlTuh8MT3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;CCS/UIS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1071"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;154,166&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;154,166&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zsyzyBMUvklk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Montana&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;939,856&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1076"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;939,856&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_z5QRZ4XJduNi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Fortman&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;526,435&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;434,109&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;960,544&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zMTs7cRjWMtc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Altruis&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,750,878&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1084"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,750,878&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zR7DIBwDZLK5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Kush&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;265,318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1088"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;265,318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zr7yWuC1MVu8" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;3,926,302&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zlDmhcXqDkN1" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;588,275&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630_zz5VKg2KWWYa" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;4,514,577&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zulkyUcfW2k4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zurCRq47Ear1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following, are customers representing &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zPtejUWKnux7" title="Concentration Risk, Percentage"&gt;10&lt;/span&gt;% or more of total revenue:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none"&gt;&lt;span id="xdx_8B1_zxT12eyYIe4i"&gt;SCHEDULE OF CONCENTRATIONS OF REVENUES&lt;/span&gt;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Insurance Carrier&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220401__20220630_zJgUo4vQnJpc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20210401__20210630_zrvfG1T5V6bl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the three months ended &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Insurance Carrier&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--LTCGlobalMember_zMC8oySoP9Fj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;LTC Global&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;30&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1100"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--PriorityHealthMember_znq06QgPhkK6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Priority Health&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--BlueCrossBlueShieldMember_zpN2uLLxSJu4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;BlueCross BlueShield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1105"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Insurance Carrier&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20220101__20220630_z7F8k1FxEIp6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20210101__20210630_zOG3RiBI7Prg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the six months ended &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Insurance Carrier&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--BlueCrossBlueShieldMember_z8TBNIihmAI6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;BlueCross BlueShield&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;10&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--PriorityHealthMember_zVZvg9YCUls8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Priority Health&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--LTCGlobalMember_z87VBK7t4WCd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;LTC Global&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1115"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zCaoN9yfGgV8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;No
other single Customer accounted for more than &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zqaquHjgBYCc" title="Concentration Risk, Percentage"&gt;10&lt;/span&gt;% of the Company&#x2019;s commission revenues. The loss of any significant customer, including
Priority Health, BlueCross BlueShield and LTC Global could have a material adverse effect on the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_891_eus-gaap--DisaggregationOfRevenueTableTextBlock_zKQXJmjaBFd8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table disaggregates the Company&#x2019;s revenue by line of business, showing commissions earned:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_z41gn9tNSTfh" style="display: none"&gt;SCHEDULE
OF DISAGGREGATION REVENUE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three Months ended June 30, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z5tiAU5wjKR2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Medical/Life&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20220401__20220630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zdatYq69YXo7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Property and Casualty&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220401__20220630_zHcVQK4rAnib" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-weight: bold"&gt;Regular&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"/&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"/&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"/&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zVdgVoeWie6i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;EBS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;184,851&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0946"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;184,851&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zqGZOvVoHxI6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;USBA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,319&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0950"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,319&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zwjUHp1CEwn2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;CCS/UIS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0953"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;57,195&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;57,195&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zjegoCGCfgt9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Montana&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;451,705&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0958"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;451,705&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_zVsDiEHYJ40d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Fortman&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;357,334&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;205,804&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;563,138&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zs08bofcigH4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Altruis&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;882,171&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0966"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;882,171&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zQUL1vnGobQ8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Kush&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;425,449&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0970"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;425,449&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--MedigapMember_zWg9mMrfBhGa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Medigap&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,359,976&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0974"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,359,976&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--BarraMember_zmAdJPVXBB98" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Barra&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;69,925&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;200,397&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;270,322&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zTbS3j7Pa6Bj" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;3,743,730&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zrRFuj6duqr3" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;463,396&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220401__20220630_zxCGZQwLBjxi" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;4,207,126&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Six Months ended June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z9Be7lQu9voi" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Medical/Life
&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20220101__20220630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z3tydUEu24g3" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Property
and Casualty &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220101__20220630_z8zEBupF4cE7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Regular&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zTy49gmU3rp" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%"&gt;EBS&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;406,035&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0988"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;406,035&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zvWL8aZbZeFa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;USBA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,906&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0992"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,906&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zaP2nNq3HIud" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;CCS/UIS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0995"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;101,077&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;101,077&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zL1mRS9xGWpj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Montana&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;958,426&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1000"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;958,426&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_z3OrVbvYIse8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Fortman&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;689,933&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;403,064&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,092,997&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zybrrU6NCHc7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Altruis&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,187,043&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1008"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,187,043&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zIHzljz06991" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Kush&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;864,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1012"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;864,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--MedigapMember_ztqkCcg9omDf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Medigap&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,537,061&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1016"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,537,061&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--BarraMember_zno0jYB9HFv8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Barra&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;69,925&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;200,397&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;270,322&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zU809EwULDkg" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;7,738,369&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zRszIP2S1nr5" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;704,538&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20220630_z9IXsbU2PPXf" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;8,442,907&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Three Months ended June 30, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zwLsapb9gO1e" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Medical/Life&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20210401__20210630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_z1tNbXreF2Mj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Property and Casualty&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20210401__20210630_zJI9fqyJstwj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Regular&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zx4IPaQSDQEi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%"&gt;EBS&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;207,201&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1030"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;207,201&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zV2eUnQeUmu9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;USBA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,395&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1034"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,395&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zEeyxDVrvkKe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;CCS/UIS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1037"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;65,348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;65,348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zMeWaWYAtQU7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Montana&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;404,740&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1042"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;404,740&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_zNnTB9fpj3jc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Fortman&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;276,634&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;226,337&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;502,971&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_z57f2KxlOKCc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Altruis&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;729,874&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1050"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;729,874&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zLDD68scL5Ec" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Kush&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;265,318&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1054"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;265,318&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zzd5vle96J6f" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;1,899,162&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zNPGE7HG8of3" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;291,685&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210401__20210630_z5plR7MKzIxe" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;2,190,847&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Six Months ended June 30, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zPt3IBocgf3c" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Medical/Life&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20210101__20210630__srt--ProductOrServiceAxis__custom--PropertyAndCasualtyMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zIJuwrb9Ylx2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Property and Casualty&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20210101__20210630_zOgSGQXGACTk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Regular&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--EmployeeBenefitsSolutionsLLCMember_zhA6r9o7rk3k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%"&gt;EBS&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;416,195&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1064"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;416,195&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--USBenefitsAllianceLLCMember_zYSuyOjX0ddg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;USBA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27,620&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1068"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27,620&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--CommercialCoverageSolutionsLLCMember_zastlTuh8MT3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;CCS/UIS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1071"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;154,166&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;154,166&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--SouthwesternMontanaFinancialCenterIncMember_zsyzyBMUvklk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Montana&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;939,856&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1076"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;939,856&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--FortmanInsuranceServicesLLCMember_z5QRZ4XJduNi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Fortman&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;526,435&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;434,109&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;960,544&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--AltruisBenefitsConsultingIncMember_zMTs7cRjWMtc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Altruis&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,750,878&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1084"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,750,878&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ConsolidatedEntitiesAxis__custom--KushMember_zR7DIBwDZLK5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Kush&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;265,318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1088"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;265,318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--RegularMember_zr7yWuC1MVu8" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;3,926,302&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630__srt--ProductOrServiceAxis__custom--MedicalLifeMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__custom--PropertyAndCasualtyMember_zlDmhcXqDkN1" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;588,275&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210630_zz5VKg2KWWYa" style="text-align: right" title="Revenue from contract with customer, excluding assessed tax"&gt;4,514,577&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember"
      decimals="0"
      unitRef="USD">184851</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_EmployeeBenefitsSolutionsLLCMember"
      decimals="0"
      unitRef="USD">184851</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember"
      decimals="0"
      unitRef="USD">12319</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_USBenefitsAllianceLLCMember"
      decimals="0"
      unitRef="USD">12319</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember"
      decimals="0"
      unitRef="USD">57195</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_CommercialCoverageSolutionsLLCMember"
      decimals="0"
      unitRef="USD">57195</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember"
      decimals="0"
      unitRef="USD">451705</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_SouthwesternMontanaFinancialCenterIncMember"
      decimals="0"
      unitRef="USD">451705</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember"
      decimals="0"
      unitRef="USD">357334</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember"
      decimals="0"
      unitRef="USD">205804</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_FortmanInsuranceServicesLLCMember"
      decimals="0"
      unitRef="USD">563138</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember"
      decimals="0"
      unitRef="USD">882171</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_AltruisBenefitsConsultingIncMember"
      decimals="0"
      unitRef="USD">882171</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_KushMember"
      decimals="0"
      unitRef="USD">425449</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_KushMember"
      decimals="0"
      unitRef="USD">425449</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_MedigapMember"
      decimals="0"
      unitRef="USD">1359976</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_MedigapMember"
      decimals="0"
      unitRef="USD">1359976</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_BarraMember"
      decimals="0"
      unitRef="USD">69925</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_BarraMember"
      decimals="0"
      unitRef="USD">200397</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_BarraMember"
      decimals="0"
      unitRef="USD">270322</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_RegularMember"
      decimals="0"
      unitRef="USD">3743730</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30_custom_MedicalLifeMember_custom_PropertyAndCasualtyMember"
      decimals="0"
      unitRef="USD">463396</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">4207126</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember"
      decimals="0"
      unitRef="USD">406035</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_EmployeeBenefitsSolutionsLLCMember"
      decimals="0"
      unitRef="USD">406035</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember"
      decimals="0"
      unitRef="USD">25906</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_USBenefitsAllianceLLCMember"
      decimals="0"
      unitRef="USD">25906</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember"
      decimals="0"
      unitRef="USD">101077</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_CommercialCoverageSolutionsLLCMember"
      decimals="0"
      unitRef="USD">101077</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember"
      decimals="0"
      unitRef="USD">958426</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_SouthwesternMontanaFinancialCenterIncMember"
      decimals="0"
      unitRef="USD">958426</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember"
      decimals="0"
      unitRef="USD">689933</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember"
      decimals="0"
      unitRef="USD">403064</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_FortmanInsuranceServicesLLCMember"
      decimals="0"
      unitRef="USD">1092997</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember"
      decimals="0"
      unitRef="USD">2187043</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_AltruisBenefitsConsultingIncMember"
      decimals="0"
      unitRef="USD">2187043</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_KushMember"
      decimals="0"
      unitRef="USD">864040</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_KushMember"
      decimals="0"
      unitRef="USD">864040</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_MedigapMember"
      decimals="0"
      unitRef="USD">2537061</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_MedigapMember"
      decimals="0"
      unitRef="USD">2537061</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_BarraMember"
      decimals="0"
      unitRef="USD">69925</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_BarraMember"
      decimals="0"
      unitRef="USD">200397</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_BarraMember"
      decimals="0"
      unitRef="USD">270322</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_RegularMember"
      decimals="0"
      unitRef="USD">7738369</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-06-30_custom_MedicalLifeMember_custom_PropertyAndCasualtyMember"
      decimals="0"
      unitRef="USD">704538</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">8442907</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember"
      decimals="0"
      unitRef="USD">207201</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_EmployeeBenefitsSolutionsLLCMember"
      decimals="0"
      unitRef="USD">207201</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember"
      decimals="0"
      unitRef="USD">15395</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_USBenefitsAllianceLLCMember"
      decimals="0"
      unitRef="USD">15395</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember"
      decimals="0"
      unitRef="USD">65348</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_CommercialCoverageSolutionsLLCMember"
      decimals="0"
      unitRef="USD">65348</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember"
      decimals="0"
      unitRef="USD">404740</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_SouthwesternMontanaFinancialCenterIncMember"
      decimals="0"
      unitRef="USD">404740</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember"
      decimals="0"
      unitRef="USD">276634</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember"
      decimals="0"
      unitRef="USD">226337</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_FortmanInsuranceServicesLLCMember"
      decimals="0"
      unitRef="USD">502971</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember"
      decimals="0"
      unitRef="USD">729874</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_AltruisBenefitsConsultingIncMember"
      decimals="0"
      unitRef="USD">729874</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_KushMember"
      decimals="0"
      unitRef="USD">265318</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_KushMember"
      decimals="0"
      unitRef="USD">265318</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_RegularMember"
      decimals="0"
      unitRef="USD">1899162</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30_custom_MedicalLifeMember_custom_PropertyAndCasualtyMember"
      decimals="0"
      unitRef="USD">291685</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">2190847</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_EmployeeBenefitsSolutionsLLCMember"
      decimals="0"
      unitRef="USD">416195</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_EmployeeBenefitsSolutionsLLCMember"
      decimals="0"
      unitRef="USD">416195</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_USBenefitsAllianceLLCMember"
      decimals="0"
      unitRef="USD">27620</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_USBenefitsAllianceLLCMember"
      decimals="0"
      unitRef="USD">27620</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_CommercialCoverageSolutionsLLCMember"
      decimals="0"
      unitRef="USD">154166</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_CommercialCoverageSolutionsLLCMember"
      decimals="0"
      unitRef="USD">154166</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_SouthwesternMontanaFinancialCenterIncMember"
      decimals="0"
      unitRef="USD">939856</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_SouthwesternMontanaFinancialCenterIncMember"
      decimals="0"
      unitRef="USD">939856</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember"
      decimals="0"
      unitRef="USD">526435</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_PropertyAndCasualtyMember_custom_RegularMember_custom_FortmanInsuranceServicesLLCMember"
      decimals="0"
      unitRef="USD">434109</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_FortmanInsuranceServicesLLCMember"
      decimals="0"
      unitRef="USD">960544</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_AltruisBenefitsConsultingIncMember"
      decimals="0"
      unitRef="USD">1750878</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_AltruisBenefitsConsultingIncMember"
      decimals="0"
      unitRef="USD">1750878</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember_custom_KushMember"
      decimals="0"
      unitRef="USD">265318</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_KushMember"
      decimals="0"
      unitRef="USD">265318</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_RegularMember"
      decimals="0"
      unitRef="USD">3926302</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30_custom_MedicalLifeMember_custom_PropertyAndCasualtyMember"
      decimals="0"
      unitRef="USD">588275</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">4514577</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_899_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zurCRq47Ear1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following, are customers representing &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zPtejUWKnux7" title="Concentration Risk, Percentage"&gt;10&lt;/span&gt;% or more of total revenue:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none"&gt;&lt;span id="xdx_8B1_zxT12eyYIe4i"&gt;SCHEDULE OF CONCENTRATIONS OF REVENUES&lt;/span&gt;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Insurance Carrier&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220401__20220630_zJgUo4vQnJpc" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20210401__20210630_zrvfG1T5V6bl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the three months ended &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Insurance Carrier&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--LTCGlobalMember_zMC8oySoP9Fj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;LTC Global&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;30&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1100"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--PriorityHealthMember_znq06QgPhkK6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Priority Health&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--BlueCrossBlueShieldMember_zpN2uLLxSJu4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;BlueCross BlueShield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1105"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Insurance Carrier&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20220101__20220630_z7F8k1FxEIp6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20210101__20210630_zOG3RiBI7Prg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the six months ended &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Insurance Carrier&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--BlueCrossBlueShieldMember_z8TBNIihmAI6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;BlueCross BlueShield&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;10&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--PriorityHealthMember_zVZvg9YCUls8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Priority Health&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__dei--LegalEntityAxis__custom--LTCGlobalMember_z87VBK7t4WCd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;LTC Global&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1115"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-04-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_LTCGlobalMember"
      decimals="INF"
      unitRef="Pure">0.30</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-04-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_PriorityHealthMember"
      decimals="INF"
      unitRef="Pure">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_PriorityHealthMember"
      decimals="INF"
      unitRef="Pure">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-04-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_BlueCrossBlueShieldMember"
      decimals="INF"
      unitRef="Pure">0.28</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_BlueCrossBlueShieldMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_BlueCrossBlueShieldMember"
      decimals="INF"
      unitRef="Pure">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_PriorityHealthMember"
      decimals="INF"
      unitRef="Pure">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_PriorityHealthMember"
      decimals="INF"
      unitRef="Pure">0.33</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_LTCGlobalMember"
      decimals="INF"
      unitRef="Pure">0.28</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zVHGbjWqayY" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zwCWv1p7BJqj"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company recorded no income tax expense for the three and six months ended June 30, 2022 and 2021 because the estimated annual effective
tax rate was zero. In determining the estimated annual effective income tax rate, the Company analyzes various factors, including projections
of the Company&#x2019;s annual earnings and taxing jurisdictions in which the earnings will be generated, the impact of state and local
income taxes, the ability to use tax credits and net operating loss carry forwards, and available tax planning alternatives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;As
of June 30, 2022 and December 31, 2021, the Company provided a full valuation allowance against its net deferred tax assets since the
Company believes it is more likely than not that its deferred tax assets will not be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <RELI:PriorPeriodAdjustmentPolicyTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_845_ecustom--PriorPeriodAdjustmentPolicyTextBlock_zRObHgRFIn4f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zh54TYGgWZo2"&gt;Prior
Period Adjustments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company identified certain immaterial adjustments impacting prior reporting periods. Specifically, the Company identified adjustments
to correct certain asset, liability and equity accounts in relation to historical purchase price allocation accounting, historical accrued
revenues and true ups of the common stock issuable account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company assessed the materiality of the adjustments to prior period financial statements in accordance with Securities and Exchange Commission
Staff Accounting Bulletin No. (SAB) 99, &lt;i&gt;Materiality&lt;/i&gt;, and SAB 108, &lt;i&gt;Considering the Effects of Prior Year Misstatements when
Quantifying Misstatements in Current Year Financial Statements&lt;/i&gt;, and ASC 250, &lt;i&gt;Accounting Changes and Error Corrections&lt;/i&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accordingly,
the Company&#x2019;s comparative condensed consolidated financial statements and impacted notes have been revised from amounts previously
reported to reflect these adjustments. The following table illustrates the impact on previously reported amounts and adjusted balances
presented in the condensed consolidated financial statements for the period ended June 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zLtKrbTbf3zc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none"&gt;&lt;span id="xdx_8B1_zy4nmbqtzRT9"&gt;SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION&lt;/span&gt;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Account&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BA_srt--RestatementAxis_srt--ScenarioPreviouslyReportedMember_zIlFdCuKKgL6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;12/31/2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As reported&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BA_srt--RestatementAxis_srt--RestatementAdjustmentMember_ztSl1ChMHY0l" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_zUdl3tyCyjzd" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;12/31/2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Adjusted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20201231_eus-gaap--AccountsReceivableNetCurrent_iI_zeNA3cy2zFy6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Earn-out liability&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;2,631,418&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;300,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;2,931,418&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20201231_eus-gaap--Goodwill_iI_zGbtXLuh31V3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Goodwill&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,265,070&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(503,345&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,761,725&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20201231_eus-gaap--CommonStockSharesSubscriptions_iI_ziWIxMXggjtb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Common stock issuable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;822,116&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(482,116&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;340,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20201231_eus-gaap--AdditionalPaidInCapital_iI_zbUb6d0npFJe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Additional paid-in-capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,377,123&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;182,116&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,559,239&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20201231_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zpywJ39h04S7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accumulated Deficit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,482,281&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;122,601&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,359,680&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Account&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B6_srt--RestatementAxis_srt--ScenarioPreviouslyReportedMember_zDUmDz1cXsN5" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3/31/2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As reported&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BB_srt--RestatementAxis_srt--RestatementAdjustmentMember_zuCTt499jlza" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B7_z0hbKKzwP566" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3/31/2021&lt;/b&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Adjusted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20210331_eus-gaap--CommonStockSharesSubscriptions_iI_zsto9pkjyeNf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Common stock issuable&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;482,116&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;(482,116&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20210331_eus-gaap--AdditionalPaidInCapital_iI_zKSe5SMWXzF3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Additional paid-in-capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,810,147&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;182,116&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,992,263&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43C_c20210331_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zcCV7oP7Zy8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accumulated Deficit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(13,123,609&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;150,003&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,973,606&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zyw2DnQljJT6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</RELI:PriorPeriodAdjustmentPolicyTextBlock>
    <us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_89A_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zLtKrbTbf3zc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none"&gt;&lt;span id="xdx_8B1_zy4nmbqtzRT9"&gt;SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION&lt;/span&gt;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Account&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BA_srt--RestatementAxis_srt--ScenarioPreviouslyReportedMember_zIlFdCuKKgL6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;12/31/2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As reported&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BA_srt--RestatementAxis_srt--RestatementAdjustmentMember_ztSl1ChMHY0l" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_zUdl3tyCyjzd" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;12/31/2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Adjusted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20201231_eus-gaap--AccountsReceivableNetCurrent_iI_zeNA3cy2zFy6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Earn-out liability&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;2,631,418&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;300,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;2,931,418&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20201231_eus-gaap--Goodwill_iI_zGbtXLuh31V3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Goodwill&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,265,070&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(503,345&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,761,725&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20201231_eus-gaap--CommonStockSharesSubscriptions_iI_ziWIxMXggjtb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Common stock issuable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;822,116&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(482,116&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;340,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20201231_eus-gaap--AdditionalPaidInCapital_iI_zbUb6d0npFJe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Additional paid-in-capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,377,123&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;182,116&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,559,239&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20201231_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zpywJ39h04S7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accumulated Deficit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,482,281&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;122,601&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,359,680&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Account&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B6_srt--RestatementAxis_srt--ScenarioPreviouslyReportedMember_zDUmDz1cXsN5" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3/31/2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As reported&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BB_srt--RestatementAxis_srt--RestatementAdjustmentMember_zuCTt499jlza" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B7_z0hbKKzwP566" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3/31/2021&lt;/b&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Adjusted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20210331_eus-gaap--CommonStockSharesSubscriptions_iI_zsto9pkjyeNf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Common stock issuable&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;482,116&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;(482,116&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20210331_eus-gaap--AdditionalPaidInCapital_iI_zKSe5SMWXzF3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Additional paid-in-capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,810,147&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;182,116&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,992,263&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43C_c20210331_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zcCV7oP7Zy8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accumulated Deficit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(13,123,609&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;150,003&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,973,606&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">2631418</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">300000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">2931418</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:Goodwill
      contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">9265070</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-503345</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">8761725</us-gaap:Goodwill>
    <us-gaap:CommonStockSharesSubscriptions
      contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">822116</us-gaap:CommonStockSharesSubscriptions>
    <us-gaap:CommonStockSharesSubscriptions
      contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-482116</us-gaap:CommonStockSharesSubscriptions>
    <us-gaap:CommonStockSharesSubscriptions contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">340000</us-gaap:CommonStockSharesSubscriptions>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">11377123</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">182116</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">11559239</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-12482281</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">122601</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-12359680</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CommonStockSharesSubscriptions
      contextRef="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">482116</us-gaap:CommonStockSharesSubscriptions>
    <us-gaap:CommonStockSharesSubscriptions
      contextRef="AsOf2021-03-31_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-482116</us-gaap:CommonStockSharesSubscriptions>
    <us-gaap:CommonStockSharesSubscriptions contextRef="AsOf2021-03-31" decimals="0" unitRef="USD">0</us-gaap:CommonStockSharesSubscriptions>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">25810147</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2021-03-31_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">182116</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-03-31" decimals="0" unitRef="USD">25992263</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2021-03-31_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-13123609</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2021-03-31_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">150003</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-03-31" decimals="0" unitRef="USD">-12973606</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zK3FCib1Q3ea" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zSQan6anBzxj"&gt;Recently
Issued Accounting Pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
do not expect any recently issued accounting pronouncements to have a material effect on our financial statements.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_803_eus-gaap--BusinessCombinationDisclosureTextBlock_zm807V5hFOp7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2. &lt;span id="xdx_822_zcSPpGDRyCO3"&gt;STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Medigap
Healthcare Insurance Company, LLC Transaction&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 10, 2022, pursuant to an asset purchase agreement, dated December 21, 2021, the Company completed the acquisition of all of the
assets of Medigap Healthcare Insurance Company, LLC (&#x201c;Medigap&#x201d;) for a purchase price of $&lt;span id="xdx_907_eus-gaap--BusinessCombinationBargainPurchaseGainRecognizedAmount_c20220108__20220110__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zdGex3hbZJ0c" title="Business combination bargain purchase gain recognized amount"&gt;20,096,250&lt;/span&gt;, consisting of: (i) payment
to Medigap of $&lt;span id="xdx_909_eus-gaap--PaymentsToAcquireBusinessesGross_c20220108__20220110__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zbFrqd5lUhg8" title="Payments to acquire businesses gross"&gt;18,138,750&lt;/span&gt; in cash and (ii) the issuance to Medigap of &lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220108__20220110__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zdoy4TLYwhDa" title="Issuance of shares acquistions"&gt;606,037&lt;/span&gt; shares of the Company&#x2019;s restricted common stock in
a transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended. The purchase price is subject
to post-closing adjustment to reconcile certain pre-closing credits and liabilities of the parties. &#160;&#160;The shares issued to
Medigap as part of the purchase price are further subject to lock up arrangements pursuant to which 50% of the shares may be sold after
the one-year anniversary of the date of closing of the transaction and the balance of the shares may be sold after the second-year anniversary
of the date of closing of the transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
acquisition of Medigap was accounted for as a business combination in accordance with the acquisition method pursuant to FASB Topic No.
805, Business Combination (ASC 805). Accordingly, the total purchase consideration was allocated to the assets acquired, and liabilities
assumed based on their respective estimated fair values. The acquisition method of accounting requires, among other things, that assets
acquired, and liabilities assumed, if any, in a business purchase combination be recognized at their fair values as of the acquisition
date. The process for estimating the fair values of identifiable intangible assets and certain tangible assets requires the use of significant
estimates and assumptions, including estimating future cash flows, developing appropriate discount rates, estimating the costs, and timing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zPLnyz6qDgO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preliminary allocation of the purchase price in connection with the acquisition of Medigap was calculated as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_zwEO6gUZ0pCi" style="display: none"&gt;SCHEDULE
OF ALLOCATION OF PURCHASE PRICE&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Description&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted Average Useful Life (Years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Property, plant and equipment&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zMKYASwrfsPb" style="width: 16%; text-align: right" title="Property, plant and equipment"&gt;20,666&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zsAYkgl8hwCe" title="Finite lived intangible asset useful life"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Right-of-use asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RightOfUseAssetMember_zKMSL1xLpT3" style="text-align: right" title="Right-of-use asset"&gt;317,787&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Trade names&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_z71FK8rBXQ36" style="text-align: right" title="Trade name and trademarks"&gt;340,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_ze3mfqbe6mHi" title="Finite lived intangible asset useful life"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zIjP7idvbwTg" style="text-align: right" title="Customer relationships"&gt;4,550,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zXfA7XDxZpqe" title="Finite lived intangible asset useful life"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Technology&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_z00qTdaLiKoi" style="text-align: right" title="Technology"&gt;67,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zL9NVu8yuqH2" title="Finite lived intangible asset useful life"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Backlog&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BackLogMember_z8wEoRXfV174" style="text-align: right" title="Backlog"&gt;210,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BackLogMember_z6xedrYk5V07" title="Finite lived intangible asset useful life"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Chargeback reserve&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ChargebackReserveMember_ztJ9cNwbFNll" style="text-align: right" title="Chargeback reserve"&gt;(1,484,473&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LeaseLiabilityMember_z1gCVNCEVtp4" style="text-align: right" title="Lease liability"&gt;(317,787&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Goodwill&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zyKDxIFeMm5l" style="border-bottom: Black 1.5pt solid; text-align: right" title="Goodwill"&gt;19,199,008&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--FinitelivedIntangibleAssetUsefulLives_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zUdpwx64y44k" title="Finite lived intangible asset useful life"&gt;Indefinite&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zsNbik1a7LM7" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase consideration allocated"&gt;22,902,201&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zPijXjFoIbc1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
name was measured at fair value using the relief-from-royalty method under the income approach. Significant inputs used to measure the
fair value include an estimate of projected revenue from the trade name, a pre-tax royalty rate of &lt;span id="xdx_907_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputRoyaltyRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zIuu0nLmg8zb" title="Business combination, measurement input"&gt;0.5&lt;/span&gt;% and a discount rate of &lt;span id="xdx_90F_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zPLeluEmkM15" title="Business combination, measurement input"&gt;11.0&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Customer
relationships were measured at fair value using the multiple-period excess earnings method under the income approach. Significant inputs
used to measure the fair value include an estimate of projected revenue and costs associated with existing customers, and a discount
rate of &lt;span id="xdx_906_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zlCu0KVzIeL" title="Business combination, measurement input"&gt;11.0&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Technology
was measured at fair value using the cost replacement method of the cost approach. Significant inputs used to measure the fair value
include an estimate of cost to replace, an obsolescence rate of&lt;span id="xdx_90E_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputObsolescenceRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zUWYAJOZp89k" title="Business combination, measurement input"&gt; 40.3&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
value assigned to backlog acquired was estimated based upon the contractual nature of the backlog as of the acquisition date, using the
income approach to discount back to present value the cash flows attributable to the backlog, using a discount rate of &lt;span id="xdx_90E_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BackLogMember_zICBdcNsk5dk" title="Business combination, measurement input"&gt;11.0&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Goodwill
of $&lt;span id="xdx_90F_eus-gaap--Goodwill_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zorapMdFfqOf" title="Goodwill"&gt;19,199,008&lt;/span&gt; arising from the acquisition of Medigap consisted of the value of the employee workforce and the residual value after
all identifiable intangible assets were valued. Goodwill recognized pursuant to the acquisition of Medigap is currently expected to be
deductible for income tax purposes. Total acquisition costs for the acquisition of Medigap incurred were $&lt;span id="xdx_90A_eus-gaap--AcquisitionCosts_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_z7oca70usVTf" title="Acquisition costs"&gt;94,065&lt;/span&gt; recorded as a component
of General and administrative expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
approximate revenue and net profit or loss for the acquired business as a standalone entity per ASC 805 from January 10, 2022 to June
30, 2022 was $&lt;span id="xdx_906_eus-gaap--BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_z6RJbXGt5gm1" title="Revenue from acquired entity"&gt;2,537,061&lt;/span&gt; and a loss of $&lt;span id="xdx_901_ecustom--SharesIssuedUponTerminationOfEmployee_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zMJjSNasw3L2" title="Shares issued upon termination of employee"&gt;412,943&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Pro
Forma Information&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
results of operations of Medigap will be included in the Company&#x2019;s consolidated financial statements as of the date of acquisition
through the current period end. The following supplemental pro forma financial information approximate combined financial information
assumes that the acquisition had occurred at the beginning of the six months ended June 30, 2022 and 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zphAC9xbDvx4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none"&gt;&lt;span id="xdx_8BD_zqlCpy4FoW84"&gt;SCHEDULE OF PRO FORMA INFORMATION
RELATED TO ACQUISITION&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zrAY1u9qdTVe" style="font-weight: bold; text-align: center"&gt;June 30,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20210101__20210630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_z5TmFC5JKJNh" style="font-weight: bold; text-align: center"&gt;June 30,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_zPXpL5s2Eiif" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;8,809,482&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;7,071,329&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zvTbC6rbm2w8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Net Income (Loss)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;19,849,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,796,767&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_zrzBLE85Ditc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Earnings (Loss) per common share, basic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.19&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareDiluted_zI9h1oNzNN7k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Earnings (Loss) per common share, diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.59&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.19&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zQhsMwhZcx0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Barra
&lt;span style="background-color: white"&gt;&amp;amp; Associates, LLC&lt;/span&gt; Transaction&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
April 26, 2022, the Company entered into an asset purchase agreement (the &#x201c;APA&#x201d;) with Barra &amp;amp; Associates, LLC (&#x201c;Barra&#x201d;)
pursuant to which the Company purchased all of the assets of Barra &amp;amp; Associates, LLC on April 26, 2022 for a purchase price in the
amount of $&lt;span id="xdx_901_eus-gaap--AssetAcquisitionConsiderationTransferred_c20220425__20220426__us-gaap--TypeOfArrangementAxis__custom--APAMember__us-gaap--AssetAcquisitionAxis__custom--BarraAndAssociatesLLCMember_zQ2D6qSm7tBa" title="Asset Acquisition, Consideration Transferred"&gt;7,725,000&lt;/span&gt; in cash, with $&lt;span id="xdx_906_eus-gaap--AssetAcquisitionConsiderationTransferred_c20220425__20220426__us-gaap--TypeOfArrangementAxis__custom--APAMember__us-gaap--AssetAcquisitionAxis__custom--BarraAndAssociatesLLCMember__srt--StatementScenarioAxis__custom--PaidAtClosingMember_zP5sftOcaWb1" title="Asset Acquisition, Consideration Transferred"&gt;6,000,000&lt;/span&gt; paid to Barra at closing, $&lt;span id="xdx_90C_eus-gaap--AssetAcquisitionConsiderationTransferred_c20220425__20220426__us-gaap--TypeOfArrangementAxis__custom--APAMember__us-gaap--AssetAcquisitionAxis__custom--BarraAndAssociatesLLCMember__srt--StatementScenarioAxis__custom--PayableInSixMonthsMember_zZRfVyOrKJdb" title="Asset Acquisition, Consideration Transferred"&gt;1,125,000&lt;/span&gt; payable in six months from closing, and a final estimated
 earnout of $&lt;span id="xdx_907_eus-gaap--AssetAcquisitionConsiderationTransferred_c20220425__20220426__us-gaap--TypeOfArrangementAxis__custom--APAMember__us-gaap--AssetAcquisitionAxis__custom--BarraAndAssociatesLLCMember__srt--StatementScenarioAxis__custom--PayableOverTwoYearsMember_zR6sAL1clsc" title="Asset Acquisition, Consideration Transferred"&gt;600,000&lt;/span&gt; payable over two years from closing, based upon meeting stated milestones. The source of the cash payment was $&lt;span id="xdx_90E_ecustom--WorkingCapital_iI_c20220426__us-gaap--TypeOfArrangementAxis__custom--APAMember__us-gaap--AssetAcquisitionAxis__custom--BarraAndAssociatesLLCMember_zfED6Fn2nxR8" title="Working capital"&gt;6,520,000&lt;/span&gt;
in funds borrowed from Oak Street Lending (&#x201c;Loan&#x201d;), the Company&#x2019;s existing lender pursuant to a Fifth Amendment to
Credit Agreement and Promissory Note, of even date. The purchase price is subject to post-closing adjustment to reconcile certain pre-closing
credits and liabilities of the parties.&lt;/span&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
acquisition of Barra was accounted for as a business combination in accordance with the acquisition method pursuant to FASB Topic No.
805, Business Combination (ASC 805). Accordingly, the total purchase consideration was allocated to the assets acquired, and liabilities
assumed based on their respective estimated fair values. The acquisition method of accounting requires, among other things, that assets
acquired, and liabilities assumed, if any, in a business purchase combination be recognized at their fair values as of the acquisition
date. The process for estimating the fair values of identifiable intangible assets and certain tangible assets requires the use of significant
estimates and assumptions, including estimating future cash flows, developing appropriate discount rates, estimating the costs, and timing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--BarraMember_zAvj3Cczm2we" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preliminary allocation of the purchase price in connection with the acquisition of Barra was calculated as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none"&gt;&lt;span id="xdx_8B4_z0vHAAqSjuyd" style="display: none"&gt;SCHEDULE OF ALLOCATION OF PURCHASE PRICE&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Description&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted Average Useful Life (Years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Acquired accounts receivable&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AcquiredAccountsReceivableMember_zTEQ44tbOljh" style="width: 16%; text-align: right" title="Acquired accounts receivable"&gt;92,585&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Property, plant and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zEJUiyX6gjEf" style="text-align: right" title="Property, plant and equipment"&gt;8,593&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zq9A0wTgQIB" title="Weighted average useful life"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Right-of-use asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RightOfUseAssetMember_z2RLvyst8of8" style="text-align: right" title="Right-of-use asset"&gt;122,984&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trade names&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_z8wSKvLECqj4" style="text-align: right" title="Trade name and trademarks"&gt;22,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zv073tK0qK19" title="Weighted average useful life"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zF9ypjfpQvz1" style="text-align: right" title="Customer relationships"&gt;550,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zxQh4rOqw2A3" title="Weighted average useful life"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Agency relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AgencyRelationshipsMember_zUNevM86Ndub" style="text-align: right" title="Agency relationships"&gt;2,585,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AgencyRelationshipsMember_zSqsuI7S1rUh" title="Weighted average useful life"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Developed technology&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_z3XK0aUG4hOk" style="text-align: right" title="Developed Technology"&gt;230,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zlmP7oVyy7Ti" title="Weighted average useful life"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LeaseLiabilityMember_zrVPj4rifPd9" style="text-align: right" title="Lease liability"&gt;(122,984&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Goodwill&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zAjUSJnoUlpj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Goodwill"&gt;4,236,822&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--FinitelivedIntangibleAssetUsefulLives_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zYilHFApmoYd" title="Weighted average useful life description"&gt;Indefinite&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zjPXfDbPZwXb" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase consideration allocated"&gt;7,725,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zi2iRZp3dMh2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
name was measured at fair value using the relief-from-royalty method under the income approach. Significant inputs used to measure the
fair value include an estimate of projected revenue from the trade name, a pre-tax royalty rate of &lt;span id="xdx_901_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputRoyaltyRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zlmKsvQaEl2e" title="Business combination, measurement input"&gt;0.5&lt;/span&gt;% and a discount rate of &lt;span id="xdx_90D_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_z0LJVvahPzmj" title="Business combination, measurement input"&gt;19.5&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Customer
and Agency relationships were measured at fair value using the multiple-period excess earnings method under the income approach. Significant
inputs used to measure the fair value include an estimate of projected revenue and costs associated with existing customers, and a discount
rate of &lt;span id="xdx_901_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zN4EsGUFxcki" title="Business combination, measurement input"&gt;19.5&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Developed
technology was measured at fair value using the cost replacement method of the cost approach. Significant inputs used to measure the
fair value include an estimate of cost to replace, an obsolescence rate of &lt;span id="xdx_904_eus-gaap--BusinessCombinationContingentConsiderationLiabilityMeasurementInput_iI_pid_uPure_c20220630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zVQOSjjzPYP7" title="Business combination, measurement input"&gt;28.6&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Goodwill
of $&lt;span id="xdx_90A_eus-gaap--Goodwill_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zKWEGWYZk8Sd" title="Goodwill"&gt;4,236,822 &lt;/span&gt;arising from the acquisition of Barra consisted of the value of the employee workforce and the residual value after
all identifiable intangible assets were valued. Goodwill recognized pursuant to the acquisition of Barra is currently expected to be
deductible for income tax purposes. Total acquisition costs incurred through June 30, 2022 for the acquisition of Barra were $&lt;span id="xdx_902_eus-gaap--AcquisitionCosts_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zDYgeJh9pGoe" title="Acquisition Costs"&gt;72,793&lt;/span&gt; recorded as a component of General and administrative expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
approximate revenue and net profit or loss for the acquired business as a standalone entity per ASC 805 from April 26, 2022 to June 30,
2022 was $&lt;span id="xdx_909_eus-gaap--BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zeKKr04Z9sNc" title="Revenue from acquired entity"&gt;270,321&lt;/span&gt; and a loss of $&lt;span id="xdx_90B_ecustom--SharesIssuedUponTerminationOfEmployee_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zyPGbZ97Jpx4" title="Shares issued upon termination of employee"&gt;38,698&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Pro
Forma Information&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
results of operations of Barra will be included in the Company&#x2019;s consolidated financial statements as of the date of acquisition
through the current period end. The following supplemental pro forma financial information approximate combined financial information
assumes that the acquisition had occurred at the beginning of the six months ended June 30, 2022 and 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--BarraMember_zKn67UKrec71" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none"&gt;&lt;span id="xdx_8B2_zEZwjxQvbmQ9"&gt;SCHEDULE OF PRO FORMA INFORMATION
RELATED TO ACQUISITION&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zqb2SASifGMk" style="font-weight: bold; text-align: center"&gt;June 30,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20210101__20210630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_z2PG1csF5s0j" style="font-weight: bold; text-align: center"&gt;June 30,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_z3UL1f40LbL9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;8,990,529&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;5,364,335&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zT3TvaciS2jc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Net Income (Loss)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;20,070,124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,527,038&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_zi9w5pX9pgY3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Earnings (Loss) per common share, basic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.76&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.16&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareDiluted_zsK40jpQsPcc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Earnings (Loss) per common share, diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.58&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.16&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_z2dE6FBLOyh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount
      contextRef="From2022-01-082022-01-10_custom_MedigapHealthcareInsuranceCompanyMember"
      decimals="0"
      unitRef="USD">20096250</us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="From2022-01-082022-01-10_custom_MedigapHealthcareInsuranceCompanyMember"
      decimals="0"
      unitRef="USD">18138750</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2022-01-082022-01-10_custom_MedigapHealthcareInsuranceCompanyMember"
      decimals="INF"
      unitRef="Shares">606037</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember">&lt;p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zPLnyz6qDgO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preliminary allocation of the purchase price in connection with the acquisition of Medigap was calculated as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_zwEO6gUZ0pCi" style="display: none"&gt;SCHEDULE
OF ALLOCATION OF PURCHASE PRICE&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Description&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted Average Useful Life (Years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Property, plant and equipment&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zMKYASwrfsPb" style="width: 16%; text-align: right" title="Property, plant and equipment"&gt;20,666&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zsAYkgl8hwCe" title="Finite lived intangible asset useful life"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Right-of-use asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RightOfUseAssetMember_zKMSL1xLpT3" style="text-align: right" title="Right-of-use asset"&gt;317,787&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Trade names&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_z71FK8rBXQ36" style="text-align: right" title="Trade name and trademarks"&gt;340,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_ze3mfqbe6mHi" title="Finite lived intangible asset useful life"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zIjP7idvbwTg" style="text-align: right" title="Customer relationships"&gt;4,550,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zXfA7XDxZpqe" title="Finite lived intangible asset useful life"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Technology&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_z00qTdaLiKoi" style="text-align: right" title="Technology"&gt;67,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TechnologyBasedIntangibleAssetsMember_zL9NVu8yuqH2" title="Finite lived intangible asset useful life"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Backlog&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BackLogMember_z8wEoRXfV174" style="text-align: right" title="Backlog"&gt;210,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BackLogMember_z6xedrYk5V07" title="Finite lived intangible asset useful life"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Chargeback reserve&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ChargebackReserveMember_ztJ9cNwbFNll" style="text-align: right" title="Chargeback reserve"&gt;(1,484,473&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LeaseLiabilityMember_z1gCVNCEVtp4" style="text-align: right" title="Lease liability"&gt;(317,787&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Goodwill&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zyKDxIFeMm5l" style="border-bottom: Black 1.5pt solid; text-align: right" title="Goodwill"&gt;19,199,008&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--FinitelivedIntangibleAssetUsefulLives_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zUdpwx64y44k" title="Finite lived intangible asset useful life"&gt;Indefinite&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zsNbik1a7LM7" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase consideration allocated"&gt;22,902,201&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_PropertyPlantAndEquipmentMember"
      decimals="0"
      unitRef="USD">20666</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_PropertyPlantAndEquipmentMember">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_custom_RightOfUseAssetMember"
      decimals="0"
      unitRef="USD">317787</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_TradeNamesMember"
      decimals="0"
      unitRef="USD">340000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_TradeNamesMember">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">4550000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_CustomerRelationshipsMember">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_TechnologyBasedIntangibleAssetsMember"
      decimals="0"
      unitRef="USD">67000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_TechnologyBasedIntangibleAssetsMember">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_custom_BackLogMember"
      decimals="0"
      unitRef="USD">210000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_custom_BackLogMember">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_custom_ChargebackReserveMember"
      decimals="0"
      unitRef="USD">-1484473</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_custom_LeaseLiabilityMember"
      decimals="0"
      unitRef="USD">-317787</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_GoodwillMember"
      decimals="0"
      unitRef="USD">19199008</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <RELI:FinitelivedIntangibleAssetUsefulLives contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember_us-gaap_GoodwillMember">Indefinite</RELI:FinitelivedIntangibleAssetUsefulLives>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember"
      decimals="0"
      unitRef="USD">22902201</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="AsOf2022-06-30_custom_MeasurementInputRoyaltyRateMember_us-gaap_TradeNamesMember"
      decimals="INF"
      unitRef="Pure">0.5</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_us-gaap_TradeNamesMember"
      decimals="INF"
      unitRef="Pure">11.0</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_us-gaap_CustomerRelationshipsMember"
      decimals="INF"
      unitRef="Pure">11.0</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="AsOf2022-06-30_custom_MeasurementInputObsolescenceRateMember_us-gaap_TechnologyBasedIntangibleAssetsMember"
      decimals="INF"
      unitRef="Pure">40.3</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_custom_BackLogMember"
      decimals="INF"
      unitRef="Pure">11.0</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:Goodwill
      contextRef="AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember"
      decimals="0"
      unitRef="USD">19199008</us-gaap:Goodwill>
    <us-gaap:AcquisitionCosts
      contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember"
      decimals="0"
      unitRef="USD">94065</us-gaap:AcquisitionCosts>
    <us-gaap:BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod
      contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember"
      decimals="0"
      unitRef="USD">2537061</us-gaap:BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod>
    <RELI:SharesIssuedUponTerminationOfEmployee
      contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember"
      decimals="0"
      unitRef="USD">412943</RELI:SharesIssuedUponTerminationOfEmployee>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember">&lt;p id="xdx_89C_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zphAC9xbDvx4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none"&gt;&lt;span id="xdx_8BD_zqlCpy4FoW84"&gt;SCHEDULE OF PRO FORMA INFORMATION
RELATED TO ACQUISITION&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zrAY1u9qdTVe" style="font-weight: bold; text-align: center"&gt;June 30,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20210101__20210630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_z5TmFC5JKJNh" style="font-weight: bold; text-align: center"&gt;June 30,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_zPXpL5s2Eiif" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;8,809,482&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;7,071,329&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zvTbC6rbm2w8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Net Income (Loss)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;19,849,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,796,767&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_zrzBLE85Ditc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Earnings (Loss) per common share, basic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.19&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareDiluted_zI9h1oNzNN7k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Earnings (Loss) per common share, diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.59&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.19&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember"
      decimals="0"
      unitRef="USD">8809482</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="From2021-01-012021-06-30_custom_MedigapHealthcareInsuranceCompanyMember"
      decimals="0"
      unitRef="USD">7071329</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember"
      decimals="0"
      unitRef="USD">19849175</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="From2021-01-012021-06-30_custom_MedigapHealthcareInsuranceCompanyMember"
      decimals="0"
      unitRef="USD">-1796767</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember"
      decimals="INF"
      unitRef="USDPShares">0.75</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="From2021-01-012021-06-30_custom_MedigapHealthcareInsuranceCompanyMember"
      decimals="INF"
      unitRef="USDPShares">-0.19</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember"
      decimals="INF"
      unitRef="USDPShares">-0.59</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="From2021-01-012021-06-30_custom_MedigapHealthcareInsuranceCompanyMember"
      decimals="INF"
      unitRef="USDPShares">-0.19</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="From2022-04-252022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember"
      decimals="0"
      unitRef="USD">7725000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="From2022-04-252022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember_custom_PaidAtClosingMember"
      decimals="0"
      unitRef="USD">6000000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="From2022-04-252022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember_custom_PayableInSixMonthsMember"
      decimals="0"
      unitRef="USD">1125000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="From2022-04-252022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember_custom_PayableOverTwoYearsMember"
      decimals="0"
      unitRef="USD">600000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <RELI:WorkingCapital
      contextRef="AsOf2022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember"
      decimals="0"
      unitRef="USD">6520000</RELI:WorkingCapital>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2022-01-012022-06-30_custom_BarraMember168706375">&lt;p id="xdx_89A_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--BarraMember_zAvj3Cczm2we" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preliminary allocation of the purchase price in connection with the acquisition of Barra was calculated as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none"&gt;&lt;span id="xdx_8B4_z0vHAAqSjuyd" style="display: none"&gt;SCHEDULE OF ALLOCATION OF PURCHASE PRICE&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Description&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted Average Useful Life (Years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Acquired accounts receivable&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AcquiredAccountsReceivableMember_zTEQ44tbOljh" style="width: 16%; text-align: right" title="Acquired accounts receivable"&gt;92,585&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Property, plant and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zEJUiyX6gjEf" style="text-align: right" title="Property, plant and equipment"&gt;8,593&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PropertyPlantAndEquipmentMember_zq9A0wTgQIB" title="Weighted average useful life"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Right-of-use asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--RightOfUseAssetMember_z2RLvyst8of8" style="text-align: right" title="Right-of-use asset"&gt;122,984&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trade names&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_z8wSKvLECqj4" style="text-align: right" title="Trade name and trademarks"&gt;22,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zv073tK0qK19" title="Weighted average useful life"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zF9ypjfpQvz1" style="text-align: right" title="Customer relationships"&gt;550,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zxQh4rOqw2A3" title="Weighted average useful life"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Agency relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AgencyRelationshipsMember_zUNevM86Ndub" style="text-align: right" title="Agency relationships"&gt;2,585,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AgencyRelationshipsMember_zSqsuI7S1rUh" title="Weighted average useful life"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Developed technology&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_z3XK0aUG4hOk" style="text-align: right" title="Developed Technology"&gt;230,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--DevelopedTechnologyMember_zlmP7oVyy7Ti" title="Weighted average useful life"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LeaseLiabilityMember_zrVPj4rifPd9" style="text-align: right" title="Lease liability"&gt;(122,984&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Goodwill&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zAjUSJnoUlpj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Goodwill"&gt;4,236,822&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--FinitelivedIntangibleAssetUsefulLives_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zYilHFApmoYd" title="Weighted average useful life description"&gt;Indefinite&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zjPXfDbPZwXb" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase consideration allocated"&gt;7,725,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-06-30_custom_BarraMember_custom_AcquiredAccountsReceivableMember"
      decimals="0"
      unitRef="USD">92585</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-06-30_custom_BarraMember_us-gaap_PropertyPlantAndEquipmentMember"
      decimals="0"
      unitRef="USD">8593</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2022-01-012022-06-30_custom_BarraMember_us-gaap_PropertyPlantAndEquipmentMember">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-06-30_custom_BarraMember_custom_RightOfUseAssetMember"
      decimals="0"
      unitRef="USD">122984</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-06-30_custom_BarraMember_us-gaap_TradeNamesMember"
      decimals="0"
      unitRef="USD">22000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2022-01-012022-06-30_custom_BarraMember_us-gaap_TradeNamesMember">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-06-30_custom_BarraMember_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">550000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2022-01-012022-06-30_custom_BarraMember_us-gaap_CustomerRelationshipsMember">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-06-30_custom_BarraMember_custom_AgencyRelationshipsMember"
      decimals="0"
      unitRef="USD">2585000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2022-01-012022-06-30_custom_BarraMember_custom_AgencyRelationshipsMember">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-06-30_custom_BarraMember_custom_DevelopedTechnologyMember"
      decimals="0"
      unitRef="USD">230000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2022-01-012022-06-30_custom_BarraMember_custom_DevelopedTechnologyMember">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-06-30_custom_BarraMember_custom_LeaseLiabilityMember"
      decimals="0"
      unitRef="USD">-122984</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-06-30_custom_BarraMember_us-gaap_GoodwillMember"
      decimals="0"
      unitRef="USD">4236822</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <RELI:FinitelivedIntangibleAssetUsefulLives contextRef="From2022-01-012022-06-30_custom_BarraMember_us-gaap_GoodwillMember">Indefinite</RELI:FinitelivedIntangibleAssetUsefulLives>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2022-06-30_custom_BarraMember"
      decimals="0"
      unitRef="USD">7725000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="AsOf2022-06-30_custom_MeasurementInputRoyaltyRateMember_us-gaap_TradeNamesMember"
      decimals="INF"
      unitRef="Pure">0.5</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_us-gaap_TradeNamesMember_custom_BarraMember"
      decimals="INF"
      unitRef="Pure">19.5</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_us-gaap_CustomerRelationshipsMember_custom_BarraMember"
      decimals="INF"
      unitRef="Pure">19.5</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="AsOf2022-06-30_us-gaap_MeasurementInputDiscountRateMember_custom_DevelopedTechnologyMember"
      decimals="INF"
      unitRef="Pure">28.6</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:Goodwill
      contextRef="AsOf2022-06-30_custom_BarraMember"
      decimals="0"
      unitRef="USD">4236822</us-gaap:Goodwill>
    <us-gaap:AcquisitionCosts
      contextRef="From2022-01-012022-06-30_custom_BarraMember168706375"
      decimals="0"
      unitRef="USD">72793</us-gaap:AcquisitionCosts>
    <us-gaap:BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod
      contextRef="From2022-01-012022-06-30_custom_BarraMember168706375"
      decimals="0"
      unitRef="USD">270321</us-gaap:BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod>
    <RELI:SharesIssuedUponTerminationOfEmployee
      contextRef="From2022-01-012022-06-30_custom_BarraMember168706375"
      decimals="0"
      unitRef="USD">38698</RELI:SharesIssuedUponTerminationOfEmployee>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="From2022-01-012022-06-30_custom_BarraMember168706375">&lt;p id="xdx_893_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--BarraMember_zKn67UKrec71" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none"&gt;&lt;span id="xdx_8B2_zEZwjxQvbmQ9"&gt;SCHEDULE OF PRO FORMA INFORMATION
RELATED TO ACQUISITION&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zqb2SASifGMk" style="font-weight: bold; text-align: center"&gt;June 30,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20210101__20210630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_z2PG1csF5s0j" style="font-weight: bold; text-align: center"&gt;June 30,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessAcquisitionsProFormaRevenue_z3UL1f40LbL9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;8,990,529&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;5,364,335&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zT3TvaciS2jc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Net Income (Loss)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;20,070,124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,527,038&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareBasic_zi9w5pX9pgY3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Earnings (Loss) per common share, basic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.76&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.16&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--BusinessAcquisitionProFormaEarningsPerShareDiluted_zsK40jpQsPcc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Earnings (Loss) per common share, diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.58&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.16&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="From2022-01-012022-06-30_custom_BarraMember168706375"
      decimals="0"
      unitRef="USD">8990529</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="From2021-01-012021-06-30_custom_BarraMember"
      decimals="0"
      unitRef="USD">5364335</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="From2022-01-012022-06-30_custom_BarraMember168706375"
      decimals="0"
      unitRef="USD">20070124</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="From2021-01-012021-06-30_custom_BarraMember"
      decimals="0"
      unitRef="USD">-1527038</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="From2022-01-012022-06-30_custom_BarraMember168706375"
      decimals="INF"
      unitRef="USDPShares">0.76</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="From2021-01-012021-06-30_custom_BarraMember"
      decimals="INF"
      unitRef="USDPShares">-0.16</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="From2022-01-012022-06-30_custom_BarraMember168706375"
      decimals="INF"
      unitRef="USDPShares">-0.58</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="From2021-01-012021-06-30_custom_BarraMember"
      decimals="INF"
      unitRef="USDPShares">-0.16</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_80C_eus-gaap--GoodwillAndIntangibleAssetsDisclosureTextBlock_zeZ2eAaKlH83" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
3. &lt;span id="xdx_825_zUI8xpZQkF95"&gt;GOODWILL AND OTHER INTANGIBLE ASSETS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table rolls forward the Company&#x2019;s goodwill balance for the periods ending June 30, 2022 and December 31, 2021. &lt;span style="background-color: white"&gt;As
discussed in Note 1 - &lt;i&gt;Prior Period Adjustments&lt;/i&gt;, a&lt;/span&gt; $&lt;span id="xdx_90E_eus-gaap--Goodwill_iI_c20201231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zhTgV7Lhmpz7" title="Goodwill"&gt;(503,345&lt;/span&gt;) adjustment was identified for goodwill which impacted the
closing December 31, 2020 balance in the same amount. Accordingly, the December 31, 2020 balance is adjusted in the following table from
the originally reported balance of $&lt;span id="xdx_904_eus-gaap--Goodwill_iI_c20201231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zBfsKsI5sxTf" title="Goodwill"&gt;9,265,070&lt;/span&gt; to $&lt;span id="xdx_909_eus-gaap--Goodwill_iI_c20201231_zYCdTdGYiaK3" title="Goodwill"&gt;8,761,725&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfGoodwillTextBlock_zBTnTiFIZfjf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span style="display: none"&gt;&lt;span id="xdx_8B5_zmtgNeJ0kQWi"&gt;SCHEDULE OF IMPAIRMENT OF GOODWILL&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Goodwill&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;December 31, 2020&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Goodwill_iS_pp0p0_c20210101__20211231_ze73yHBBxiaa" style="width: 16%; text-align: right" title="Goodwill"&gt;8,761,725&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Goodwill recognized in connection with Kush acquisition on May 1, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_c20210101__20211231_zg8bFG8xE91j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Goodwill acquired during period"&gt;1,288,552&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Goodwill_iS_pp0p0_c20220101__20220630_zPuKIpm4JaNd" style="text-align: right" title="Goodwill"&gt;10,050,277&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Goodwill recognized in connection with Medigap acquisition on January 10, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zMOr3ej7wz8c" style="text-align: right" title="Goodwill acquired during period"&gt;19,199,008&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Goodwill recognized in connection with Barra acquisition on April 26, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_z6HRemAlnwAk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Goodwill acquired during period"&gt;4,236,822&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Goodwill_iE_pp0p0_c20220101__20220630_zXjeJdfRTY69" style="border-bottom: Black 2.5pt double; text-align: right"&gt;33,486,107&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_za1w8KOWyCo3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zNRZKbnTkhjg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table sets forth the major categories of the Company&#x2019;s intangible assets and the weighted-average remaining amortization
period as of June 30, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_zL9Gn6g1VN7h" style="display: none"&gt;SCHEDULE
OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted Average Remaining Amortization period (Years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Gross&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Carrying&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Net&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Carrying Amount&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Trade name and trademarks&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: center"&gt;&lt;span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_z9PuGmUoa0Ge" title="Weighted average remaining amortization period"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zooFf4RYL5kc" style="width: 10%; text-align: right" title="Gross carrying amount"&gt;2,142,858&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zksUHP2yJWg5" style="width: 10%; text-align: right" title="Accumulated amortization"&gt;(804,020&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zcZSWEgTxtW6" style="width: 10%; text-align: right" title="Net carrying amount"&gt;1,338,838&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Internally developed software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_z0N2l6CHeMof" title="Weighted average remaining amortization period"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zD8UljXApcf5" style="text-align: right" title="Gross carrying amount"&gt;1,326,158&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zO2RDVfgZZZ3" style="text-align: right" title="Accumulated amortization"&gt;(131,655&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zKFCvs7GfSck" style="text-align: right" title="Net carrying amount"&gt;1,194,503&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zFJactYejOGc" title="Weighted average remaining amortization period"&gt;9.53&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_znrtJB1YI0oe" style="text-align: right" title="Gross carrying amount"&gt;11,922,290&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zee630SN8k63" style="text-align: right" title="Accumulated amortization"&gt;(1,517,174&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zHvBPq6NYKpf" style="text-align: right" title="Net carrying amount"&gt;10,405,116&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Purchased software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zGVjif2lpjFf" title="Weighted average remaining amortization period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1354"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zXa32kc0rH7g" style="text-align: right" title="Gross carrying amount"&gt;562,327&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zV033eRTcepa" style="text-align: right" title="Accumulated amortization"&gt;(562,327&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zJjcPqadUK0e" style="text-align: right" title="Net carrying amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1360"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Video Production Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zR1jhaIJslti" title="Weighted average remaining amortization period"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zMs6tRIeZ4Y7" style="text-align: right" title="Gross carrying amount"&gt;50,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_znpwbIvVNxUl" style="text-align: right" title="Accumulated amortization"&gt;(23,242&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zq45DqhXBxaa" style="text-align: right" title="Net carrying amount"&gt;26,758&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Non-competition agreements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_z1VIqFQUYD48" title="Weighted average remaining amortization period"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zrmvaS95v7M3" style="text-align: right" title="Gross carrying amount"&gt;3,504,810&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zcsbWn1XYTSd" style="text-align: right" title="Accumulated amortization"&gt;(1,827,590&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_z14muw9eIR3f" style="text-align: right" title="Net carrying amount"&gt;1,677,220&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Contracts Backlog&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractsBacklogMember_zaMEVsEllsNa" title="Weighted average remaining amortization period"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractsBacklogMember_z2wVhmovIwW5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gross carrying amount"&gt;210,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractsBacklogMember_znKFaBLlrNIl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization"&gt;(100,684&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractsBacklogMember_zLhRSkeEdAI4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net carrying amount"&gt;109,316&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630_z2evHmQDOdm6" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross carrying amount"&gt;19,718,443&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630_zih8kYD05oh8" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization"&gt;(4,966,692&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630_zgaEWCTcKEnk" style="border-bottom: Black 2.5pt double; text-align: right" title="Net carrying amount"&gt;14,751,751&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table sets forth the major categories of the Company&#x2019;s intangible assets and the weighted-average remaining amortization
period as of December 31, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted Average Remaining Amortization period (Years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Gross&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Carrying&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Net&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Carrying Amount&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left"&gt;Trade name and trademarks&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zNQwKbQ42Una" title="Weighted average remaining amortization period"&gt;3.5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_z33gOXeZjArf" style="width: 10%; text-align: right" title="Gross carrying amount"&gt;1,777,475&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zPTwnb3oZKlj" style="width: 10%; text-align: right" title="Accumulated amortization"&gt;(609,822&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zLo6nNRVCfVa" style="width: 10%; text-align: right" title="Net carrying amount"&gt;1,167,653&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Internally developed software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_z6VbNr2UP205" title="Weighted average remaining amortization period"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zGvAcnQ3EZ4f" style="text-align: right" title="Gross carrying amount"&gt;595,351&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zbjRQ78J44Ik" style="text-align: right" title="Accumulated amortization"&gt;(28,443&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zjlS78Ne5EL3" style="text-align: right" title="Net carrying amount"&gt;566,908&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zQGXp4Rx8TUk" title="Weighted average remaining amortization period"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zC6XhFSz6Pw5" style="text-align: right" title="Gross carrying amount"&gt;4,237,290&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zc1nwVarlrr8" style="text-align: right" title="Accumulated amortization"&gt;(1,048,726&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyswIb2Sg5J3" style="text-align: right" title="Net carrying amount"&gt;3,188,564&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Purchased software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zCgS3Bzg49Rh" title="Weighted average remaining amortization period"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zue2JVRz2eAd" style="text-align: right" title="Gross carrying amount"&gt;562,327&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zgwqYR54qes4" style="text-align: right" title="Accumulated amortization"&gt;(452,985&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zw3rCEDcHQK" style="text-align: right" title="Net carrying amount"&gt;109,342&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Video Production Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zkXDivMWVru3" title="Weighted average remaining amortization period"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zrstMszoUN1" style="text-align: right" title="Gross carrying amount"&gt;20,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_ziWRbdMXKny8" style="text-align: right" title="Accumulated amortization"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1428"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zKIA7arWwbv8" style="text-align: right" title="Net carrying amount"&gt;20,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Non-competition agreements&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zG1evYRwCCxf" title="Weighted average remaining amortization period"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zXU0Ap5T7MA" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gross carrying amount"&gt;3,504,809&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zKdObrufoOZe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization"&gt;(1,478,376&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_z8gyxk2h3yxd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net carrying amount"&gt;2,026,433&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231_z5WW5B5jNdrc" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross carrying amount"&gt;10,697,252&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231_zTjZNFw0UDcj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization"&gt;(3,618,352&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231_zBCBFnIAnJ7e" style="border-bottom: Black 2.5pt double; text-align: right" title="Net carrying amount"&gt;7,078,900&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zx8ir1RMyk8k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zYbWqPtf52C7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reflects expected amortization expense as of June 30, 2022, for each of the following five years and thereafter:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_z1S0NyhlATId" style="display: none"&gt;SCHEDULE
OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Years ending December 31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220630_zdme31u0Zgi4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amortization Expense&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_maFLIANziEa_zDwHLkgCzdDa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;2022 (remainder of year)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,374,512&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANziEa_zUWP4DkC850f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,461,552&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANziEa_zqbyUPGSbDMi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,083,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANziEa_zpFaEiSGU3gj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,703,824&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_maFLIANziEa_zzeak3V2R4p1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,463,747&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_maFLIANziEa_ziWqp2dai4ee" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,664,666&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANziEa_zNjjHamLhIke" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;14,751,751&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zuSt2WaQE0Yf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:Goodwill
      contextRef="AsOf2020-12-31_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-503345</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2020-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">9265070</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">8761725</us-gaap:Goodwill>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_893_eus-gaap--ScheduleOfGoodwillTextBlock_zBTnTiFIZfjf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span style="display: none"&gt;&lt;span id="xdx_8B5_zmtgNeJ0kQWi"&gt;SCHEDULE OF IMPAIRMENT OF GOODWILL&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Goodwill&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;December 31, 2020&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Goodwill_iS_pp0p0_c20210101__20211231_ze73yHBBxiaa" style="width: 16%; text-align: right" title="Goodwill"&gt;8,761,725&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Goodwill recognized in connection with Kush acquisition on May 1, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_c20210101__20211231_zg8bFG8xE91j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Goodwill acquired during period"&gt;1,288,552&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Goodwill_iS_pp0p0_c20220101__20220630_zPuKIpm4JaNd" style="text-align: right" title="Goodwill"&gt;10,050,277&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Goodwill recognized in connection with Medigap acquisition on January 10, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--MedigapHealthcareInsuranceCompanyMember_zMOr3ej7wz8c" style="text-align: right" title="Goodwill acquired during period"&gt;19,199,008&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Goodwill recognized in connection with Barra acquisition on April 26, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_c20220101__20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_z6HRemAlnwAk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Goodwill acquired during period"&gt;4,236,822&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Goodwill_iE_pp0p0_c20220101__20220630_zXjeJdfRTY69" style="border-bottom: Black 2.5pt double; text-align: right"&gt;33,486,107&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">8761725</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">1288552</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">10050277</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember"
      decimals="0"
      unitRef="USD">19199008</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2022-01-012022-06-30_custom_BarraMember168706375"
      decimals="0"
      unitRef="USD">4236822</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">33486107</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_89F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zNRZKbnTkhjg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table sets forth the major categories of the Company&#x2019;s intangible assets and the weighted-average remaining amortization
period as of June 30, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_zL9Gn6g1VN7h" style="display: none"&gt;SCHEDULE
OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted Average Remaining Amortization period (Years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Gross&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Carrying&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Net&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Carrying Amount&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Trade name and trademarks&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: center"&gt;&lt;span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_z9PuGmUoa0Ge" title="Weighted average remaining amortization period"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zooFf4RYL5kc" style="width: 10%; text-align: right" title="Gross carrying amount"&gt;2,142,858&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zksUHP2yJWg5" style="width: 10%; text-align: right" title="Accumulated amortization"&gt;(804,020&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zcZSWEgTxtW6" style="width: 10%; text-align: right" title="Net carrying amount"&gt;1,338,838&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Internally developed software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_z0N2l6CHeMof" title="Weighted average remaining amortization period"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zD8UljXApcf5" style="text-align: right" title="Gross carrying amount"&gt;1,326,158&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zO2RDVfgZZZ3" style="text-align: right" title="Accumulated amortization"&gt;(131,655&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zKFCvs7GfSck" style="text-align: right" title="Net carrying amount"&gt;1,194,503&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zFJactYejOGc" title="Weighted average remaining amortization period"&gt;9.53&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_znrtJB1YI0oe" style="text-align: right" title="Gross carrying amount"&gt;11,922,290&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zee630SN8k63" style="text-align: right" title="Accumulated amortization"&gt;(1,517,174&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zHvBPq6NYKpf" style="text-align: right" title="Net carrying amount"&gt;10,405,116&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Purchased software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zGVjif2lpjFf" title="Weighted average remaining amortization period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1354"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zXa32kc0rH7g" style="text-align: right" title="Gross carrying amount"&gt;562,327&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zV033eRTcepa" style="text-align: right" title="Accumulated amortization"&gt;(562,327&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zJjcPqadUK0e" style="text-align: right" title="Net carrying amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1360"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Video Production Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zR1jhaIJslti" title="Weighted average remaining amortization period"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zMs6tRIeZ4Y7" style="text-align: right" title="Gross carrying amount"&gt;50,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_znpwbIvVNxUl" style="text-align: right" title="Accumulated amortization"&gt;(23,242&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zq45DqhXBxaa" style="text-align: right" title="Net carrying amount"&gt;26,758&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Non-competition agreements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_z1VIqFQUYD48" title="Weighted average remaining amortization period"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zrmvaS95v7M3" style="text-align: right" title="Gross carrying amount"&gt;3,504,810&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zcsbWn1XYTSd" style="text-align: right" title="Accumulated amortization"&gt;(1,827,590&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_z14muw9eIR3f" style="text-align: right" title="Net carrying amount"&gt;1,677,220&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Contracts Backlog&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractsBacklogMember_zaMEVsEllsNa" title="Weighted average remaining amortization period"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractsBacklogMember_z2wVhmovIwW5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gross carrying amount"&gt;210,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractsBacklogMember_znKFaBLlrNIl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization"&gt;(100,684&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ContractsBacklogMember_zLhRSkeEdAI4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net carrying amount"&gt;109,316&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20220630_z2evHmQDOdm6" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross carrying amount"&gt;19,718,443&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20220630_zih8kYD05oh8" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization"&gt;(4,966,692&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20220630_zgaEWCTcKEnk" style="border-bottom: Black 2.5pt double; text-align: right" title="Net carrying amount"&gt;14,751,751&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table sets forth the major categories of the Company&#x2019;s intangible assets and the weighted-average remaining amortization
period as of December 31, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weighted Average Remaining Amortization period (Years)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Gross&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Carrying&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Net&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Carrying Amount&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left"&gt;Trade name and trademarks&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zNQwKbQ42Una" title="Weighted average remaining amortization period"&gt;3.5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_z33gOXeZjArf" style="width: 10%; text-align: right" title="Gross carrying amount"&gt;1,777,475&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zPTwnb3oZKlj" style="width: 10%; text-align: right" title="Accumulated amortization"&gt;(609,822&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zLo6nNRVCfVa" style="width: 10%; text-align: right" title="Net carrying amount"&gt;1,167,653&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Internally developed software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_z6VbNr2UP205" title="Weighted average remaining amortization period"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zGvAcnQ3EZ4f" style="text-align: right" title="Gross carrying amount"&gt;595,351&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zbjRQ78J44Ik" style="text-align: right" title="Accumulated amortization"&gt;(28,443&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zjlS78Ne5EL3" style="text-align: right" title="Net carrying amount"&gt;566,908&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zQGXp4Rx8TUk" title="Weighted average remaining amortization period"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zC6XhFSz6Pw5" style="text-align: right" title="Gross carrying amount"&gt;4,237,290&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zc1nwVarlrr8" style="text-align: right" title="Accumulated amortization"&gt;(1,048,726&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyswIb2Sg5J3" style="text-align: right" title="Net carrying amount"&gt;3,188,564&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Purchased software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zCgS3Bzg49Rh" title="Weighted average remaining amortization period"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zue2JVRz2eAd" style="text-align: right" title="Gross carrying amount"&gt;562,327&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zgwqYR54qes4" style="text-align: right" title="Accumulated amortization"&gt;(452,985&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PurchasedSoftwareMember_zw3rCEDcHQK" style="text-align: right" title="Net carrying amount"&gt;109,342&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Video Production Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zkXDivMWVru3" title="Weighted average remaining amortization period"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zrstMszoUN1" style="text-align: right" title="Gross carrying amount"&gt;20,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_ziWRbdMXKny8" style="text-align: right" title="Accumulated amortization"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1428"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--VideoProductionAssetsMember_zKIA7arWwbv8" style="text-align: right" title="Net carrying amount"&gt;20,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Non-competition agreements&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zG1evYRwCCxf" title="Weighted average remaining amortization period"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zXU0Ap5T7MA" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gross carrying amount"&gt;3,504,809&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_zKdObrufoOZe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization"&gt;(1,478,376&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--NoncompetitionAgreementsMember_z8gyxk2h3yxd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Net carrying amount"&gt;2,026,433&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20211231_z5WW5B5jNdrc" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross carrying amount"&gt;10,697,252&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20211231_zTjZNFw0UDcj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization"&gt;(3,618,352&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231_zBCBFnIAnJ7e" style="border-bottom: Black 2.5pt double; text-align: right" title="Net carrying amount"&gt;7,078,900&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2022-01-012022-06-30_us-gaap_TrademarksAndTradeNamesMember">P4Y10M24D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_us-gaap_TrademarksAndTradeNamesMember"
      decimals="0"
      unitRef="USD">2142858</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-06-30_us-gaap_TrademarksAndTradeNamesMember"
      decimals="0"
      unitRef="USD">-804020</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-06-30_us-gaap_TrademarksAndTradeNamesMember"
      decimals="0"
      unitRef="USD">1338838</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2022-01-012022-06-30_custom_InternallyDevelopedSoftwareMember">P4Y6M</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_custom_InternallyDevelopedSoftwareMember"
      decimals="0"
      unitRef="USD">1326158</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-06-30_custom_InternallyDevelopedSoftwareMember"
      decimals="0"
      unitRef="USD">-131655</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-06-30_custom_InternallyDevelopedSoftwareMember"
      decimals="0"
      unitRef="USD">1194503</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2022-01-012022-06-30_us-gaap_CustomerRelationshipsMember">P9Y6M10D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">11922290</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">-1517174</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">10405116</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_custom_PurchasedSoftwareMember"
      decimals="0"
      unitRef="USD">562327</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-06-30_custom_PurchasedSoftwareMember"
      decimals="0"
      unitRef="USD">-562327</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2022-01-012022-06-30_custom_VideoProductionAssetsMember">P0Y7M6D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_custom_VideoProductionAssetsMember"
      decimals="0"
      unitRef="USD">50000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-06-30_custom_VideoProductionAssetsMember"
      decimals="0"
      unitRef="USD">-23242</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-06-30_custom_VideoProductionAssetsMember"
      decimals="0"
      unitRef="USD">26758</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2022-01-012022-06-30_custom_NoncompetitionAgreementsMember">P2Y4M24D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_custom_NoncompetitionAgreementsMember"
      decimals="0"
      unitRef="USD">3504810</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-06-30_custom_NoncompetitionAgreementsMember"
      decimals="0"
      unitRef="USD">-1827590</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-06-30_custom_NoncompetitionAgreementsMember"
      decimals="0"
      unitRef="USD">1677220</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2022-01-012022-06-30_custom_ContractsBacklogMember">P0Y6M</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_custom_ContractsBacklogMember"
      decimals="0"
      unitRef="USD">210000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-06-30_custom_ContractsBacklogMember"
      decimals="0"
      unitRef="USD">-100684</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2022-06-30_custom_ContractsBacklogMember"
      decimals="0"
      unitRef="USD">109316</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">19718443</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">-4966692</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">14751751</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2021-01-012021-12-31_us-gaap_TrademarksAndTradeNamesMember">P3Y6M</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-12-31_us-gaap_TrademarksAndTradeNamesMember"
      decimals="0"
      unitRef="USD">1777475</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2021-12-31_us-gaap_TrademarksAndTradeNamesMember"
      decimals="0"
      unitRef="USD">-609822</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2021-12-31_us-gaap_TrademarksAndTradeNamesMember"
      decimals="0"
      unitRef="USD">1167653</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2021-01-012021-12-31_custom_InternallyDevelopedSoftwareMember">P4Y8M12D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-12-31_custom_InternallyDevelopedSoftwareMember"
      decimals="0"
      unitRef="USD">595351</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2021-12-31_custom_InternallyDevelopedSoftwareMember"
      decimals="0"
      unitRef="USD">-28443</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2021-12-31_custom_InternallyDevelopedSoftwareMember"
      decimals="0"
      unitRef="USD">566908</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2021-01-012021-12-31_us-gaap_CustomerRelationshipsMember">P7Y8M12D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-12-31_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">4237290</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2021-12-31_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">-1048726</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2021-12-31_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">3188564</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2021-01-012021-12-31_custom_PurchasedSoftwareMember">P0Y7M6D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-12-31_custom_PurchasedSoftwareMember"
      decimals="0"
      unitRef="USD">562327</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2021-12-31_custom_PurchasedSoftwareMember"
      decimals="0"
      unitRef="USD">-452985</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2021-12-31_custom_PurchasedSoftwareMember"
      decimals="0"
      unitRef="USD">109342</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2021-01-012021-12-31_custom_VideoProductionAssetsMember">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-12-31_custom_VideoProductionAssetsMember"
      decimals="0"
      unitRef="USD">20000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2021-12-31_custom_VideoProductionAssetsMember"
      decimals="0"
      unitRef="USD">20000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2021-01-012021-12-31_custom_NoncompetitionAgreementsMember">P2Y10M24D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2021-12-31_custom_NoncompetitionAgreementsMember"
      decimals="0"
      unitRef="USD">3504809</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2021-12-31_custom_NoncompetitionAgreementsMember"
      decimals="0"
      unitRef="USD">-1478376</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2021-12-31_custom_NoncompetitionAgreementsMember"
      decimals="0"
      unitRef="USD">2026433</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">10697252</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-3618352</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">7078900</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zYbWqPtf52C7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reflects expected amortization expense as of June 30, 2022, for each of the following five years and thereafter:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_z1S0NyhlATId" style="display: none"&gt;SCHEDULE
OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Years ending December 31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220630_zdme31u0Zgi4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amortization Expense&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_maFLIANziEa_zDwHLkgCzdDa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;2022 (remainder of year)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,374,512&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANziEa_zUWP4DkC850f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,461,552&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANziEa_zqbyUPGSbDMi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,083,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANziEa_zpFaEiSGU3gj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,703,824&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_maFLIANziEa_zzeak3V2R4p1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,463,747&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_maFLIANziEa_ziWqp2dai4ee" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,664,666&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANziEa_zNjjHamLhIke" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;14,751,751&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1374512</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">2461552</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">2083450</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1703824</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1463747</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">5664666</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">14751751</us-gaap:FiniteLivedIntangibleAssetsNet>
    <RELI:LongTermDebtAndShortTermFinancingsTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_806_ecustom--LongTermDebtAndShortTermFinancingsTextBlock_zjhyhn874LU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
4. &lt;span id="xdx_827_zqSZ0pkrE164"&gt;LONG-TERM DEBT AND SHORT-TERM FINANCINGS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Long-Term
Debt&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zjbMmOY0rSWg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
composition of the long-term debt follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span style="display: none"&gt;&lt;span id="xdx_8BF_zJrtyNzdmdql" style="display: none"&gt;SCHEDULE OF LONG TERM DEBT&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June 30, &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31, &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Oak Street Funding LLC Term Loan for the acquisition of EBS and USBA, net of deferred financing costs of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--EBSandUSBAMember_z1Q5RkjG52Kd" title="Net of deferred financing cost"&gt;13,497&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--EBSandUSBAMember_zQj1TwfN8J64" title="Net of deferred financing cost"&gt;14,606&lt;/span&gt; as of June 30, 2022 and December 31, 2021, respectively&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--EBSandUSBAMember_zZbvKLnBIPvi" style="width: 16%; text-align: right" title="Long term debt current"&gt;455,391&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--EBSandUSBAMember_zpScUd8AZkW9" style="width: 16%; text-align: right" title="Long term debt current"&gt;485,317&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Oak Street Funding LLC Senior Secured Amortizing Credit Facility for the acquisition of CCS, net of deferred financing costs of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--CreditFacilityAxis__custom--CCSMember_z2WpvhXWozme" title="Net of deferred financing cost"&gt;16,351&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--CreditFacilityAxis__custom--CCSMember_zFvjR0bSeRxh" title="Net of deferred financing cost"&gt;17,626&lt;/span&gt; as of June 30, 2022 and December 31, 2021, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--CreditFacilityAxis__custom--CCSMember_zV4OjkqpPbh1" style="text-align: right" title="Long term debt current"&gt;738,547&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--CreditFacilityAxis__custom--CCSMember_zRPOQNAI0nh4" style="text-align: right" title="Long term debt current"&gt;785,826&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Oak Street Funding LLC Term Loan for the acquisition of SWMT, net of deferred financing costs of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--SWMTMember_zoOBjeJHvlla" title="Net of deferred financing cost"&gt;10,085&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--SWMTMember_zMx3Hy7Usomj" title="Net of deferred financing cost"&gt;11,027&lt;/span&gt; as of June 30, 2022 and December 31, 2021, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--SWMTMember_zHAvmbxOnHjc" style="text-align: right" title="Long term debt current"&gt;835,376&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--SWMTMember_z8DbtxvanTIl" style="text-align: right" title="Long term debt current"&gt;884,720&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Oak Street Funding LLC Term Loan for the acquisition of FIS, net of deferred financing costs of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--FISMember_zR0yya1Weuc1" title="Net of deferred financing cost"&gt;39,752 &lt;/span&gt;and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--FISMember_zIoPPk2htZEg" title="Net of deferred financing cost"&gt;42,660&lt;/span&gt; as of June 30, 2022 and December 31, 2021, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--FISMember_zubETJkAJVgh" style="text-align: right" title="Long term debt current"&gt;2,103,885&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--FISMember_ztGfs2gJt4Qe" style="text-align: right" title="Long term debt current"&gt;2,226,628&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Oak Street Funding LLC Term Loan for the acquisition of ABC, net of deferred financing costs of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--ABCMember_z4d7ImIa1V66" title="Net of deferred financing cost"&gt;45,369&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_908_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--ABCMember_zHI3JyAVNVE7" title="Net of deferred financing cost"&gt;48,609&lt;/span&gt; as of June 30, 2022 and December 31, 2021, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--ABCMember_ziTwG1hXTyp9" style="text-align: right" title="Long term debt current"&gt;3,427,614&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--ABCMember_z0tslES6PHnb" style="text-align: right" title="Long term debt current"&gt;3,616,754&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Oak Street Funding LLC Term Loan for the acquisition of Barra, net of deferred financing costs of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zne1OiYQml26" title="Net of deferred financing cost"&gt;208,901&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90D_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zaY7qgk31TJa" title="Net of deferred financing cost"&gt;0&lt;/span&gt; as of June 30, 2022 and December 31, 2021, respectively&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zhDcrjp2Qv0c" style="border-bottom: Black 1.5pt solid; text-align: right" title="Long term debt current"&gt;6,311,099&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zpFldjFvkDMi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Long term debt current"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1512"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermDebt_iI_c20220630_z9FgkrR3f43k" style="text-align: right" title="Long term debt"&gt;13,871,912&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermDebt_iI_c20211231_zUY96lHUFOIe" style="text-align: right" title="Long term debt"&gt;7,999,245&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: current portion&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LongTermDebtCurrent_iNI_di_c20220630_zPkYc8wDpQy2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Current portion of long-term debt"&gt;(936,263&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--LongTermDebtCurrent_iNI_di_c20211231_zmXBnTIhZcei" style="border-bottom: Black 1.5pt solid; text-align: right" title="Current portion of long-term debt"&gt;(913,920&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Long-term debt&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LongTermDebtNoncurrent_iI_c20220630_z9k2CwFDNtIh" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term debt, excluding current maturities"&gt;12,935,649&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebtNoncurrent_iI_c20211231_zTa1bVOHOcD9" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term debt, excluding current maturities"&gt;7,085,325&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8AE_zn8JrmCv6C02" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Oak
Street Funding LLC &#x2013; Term Loans and Credit Facilities&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zXaJBK35MWd6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;span id="xdx_8B5_z6T44eRoySf4" style="display: none"&gt;SCHEDULE
OF CUMULATIVE MATURITIES OF LONG-TERM LOANS AND CREDIT FACILITIES&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Fiscal year ending December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20220630_znKSwTAoKRVi" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Maturities of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Long-Term Debt&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_iI_maDICAzUlL_zD8tjSnVjkP3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;2022 (remainder of year)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;438,616&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_maDICAzUlL_zJS5wiMGmCQd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,228,897&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_maDICAzUlL_zi7pxzsAMSs3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,542,156&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_maDICAzUlL_zvYm6PemCYx9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,656,383&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_maDICAzUlL_z6Fzq2O3Fc3c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,776,385&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_maDICAzUlL_z1XHiwscUX32" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,563,428&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DebtInstrumentCarryingAmount_iI_mtDICAzUlL_zmUYwoJsExI2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,205,865&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredFinanceCostsNet_iNI_di_zgmv3VFGZPC1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: debt issuance costs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(333,953&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LongTermDebt_iI_ztauDfk8nlR" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;13,871,912&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zsgbDWZmdxe4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Short-Term
Financings&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company financed certain annual insurance premiums through the use of two short-term notes, payable in nine and ten equal monthly
installments of $&lt;span id="xdx_90E_eus-gaap--ShortTermBankLoansAndNotesPayable_iI_c20220630_zqwrpz3jyRdf" title="Notes Payable"&gt;42,894&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--ShortTermBankLoansAndNotesPayable_iI_c20211231_zdYK8rvIgs5c" title="Notes Payable"&gt;4,456&lt;/span&gt; at interest rates of &lt;span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20220630__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_z12nEgwc0eB7" title="Debt Instrument, Interest Rate, Stated Percentage"&gt;7.51&lt;/span&gt;% and &lt;span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_zLvjy2F2EMoj" title="Debt Instrument, Interest Rate, Stated Percentage"&gt;7.95&lt;/span&gt;%, per annum respectively. Policies financed include directors
and officers and errors and omissions insurance coverage with premium financing recognized in 2022 and 2021 of $&lt;span id="xdx_90C_eus-gaap--AmortizationOfDebtDiscountPremium_c20220101__20220630__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_zTTyxOD7qIEh" title="Amortization of Debt Discount (Premium)"&gt;417,199&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--AmortizationOfDebtDiscountPremium_c20210101__20211231__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_zsu1OmMkZ02g" title="Amortization of Debt Discount (Premium)"&gt;0&lt;/span&gt;, respectively.
Outstanding balances as of June 30, 2022 and December 31, 2021, respectively were $&lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20220630__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_z2KaEhXnyrnf" title="Debt Instrument, Face Amount"&gt;376,647&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20211231__srt--TitleOfIndividualAxis__custom--DirectorsAndOfficerMember_zZXcbCXFxPdf" title="Debt Instrument, Face Amount"&gt;0&lt;/span&gt;. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</RELI:LongTermDebtAndShortTermFinancingsTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_890_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_zjbMmOY0rSWg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
composition of the long-term debt follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span style="display: none"&gt;&lt;span id="xdx_8BF_zJrtyNzdmdql" style="display: none"&gt;SCHEDULE OF LONG TERM DEBT&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June 30, &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31, &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Oak Street Funding LLC Term Loan for the acquisition of EBS and USBA, net of deferred financing costs of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--EBSandUSBAMember_z1Q5RkjG52Kd" title="Net of deferred financing cost"&gt;13,497&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--EBSandUSBAMember_zQj1TwfN8J64" title="Net of deferred financing cost"&gt;14,606&lt;/span&gt; as of June 30, 2022 and December 31, 2021, respectively&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--EBSandUSBAMember_zZbvKLnBIPvi" style="width: 16%; text-align: right" title="Long term debt current"&gt;455,391&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--EBSandUSBAMember_zpScUd8AZkW9" style="width: 16%; text-align: right" title="Long term debt current"&gt;485,317&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Oak Street Funding LLC Senior Secured Amortizing Credit Facility for the acquisition of CCS, net of deferred financing costs of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--CreditFacilityAxis__custom--CCSMember_z2WpvhXWozme" title="Net of deferred financing cost"&gt;16,351&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--CreditFacilityAxis__custom--CCSMember_zFvjR0bSeRxh" title="Net of deferred financing cost"&gt;17,626&lt;/span&gt; as of June 30, 2022 and December 31, 2021, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--CreditFacilityAxis__custom--CCSMember_zV4OjkqpPbh1" style="text-align: right" title="Long term debt current"&gt;738,547&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--CreditFacilityAxis__custom--CCSMember_zRPOQNAI0nh4" style="text-align: right" title="Long term debt current"&gt;785,826&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Oak Street Funding LLC Term Loan for the acquisition of SWMT, net of deferred financing costs of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90C_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--SWMTMember_zoOBjeJHvlla" title="Net of deferred financing cost"&gt;10,085&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--SWMTMember_zMx3Hy7Usomj" title="Net of deferred financing cost"&gt;11,027&lt;/span&gt; as of June 30, 2022 and December 31, 2021, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--SWMTMember_zHAvmbxOnHjc" style="text-align: right" title="Long term debt current"&gt;835,376&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--SWMTMember_z8DbtxvanTIl" style="text-align: right" title="Long term debt current"&gt;884,720&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Oak Street Funding LLC Term Loan for the acquisition of FIS, net of deferred financing costs of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90A_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--FISMember_zR0yya1Weuc1" title="Net of deferred financing cost"&gt;39,752 &lt;/span&gt;and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--FISMember_zIoPPk2htZEg" title="Net of deferred financing cost"&gt;42,660&lt;/span&gt; as of June 30, 2022 and December 31, 2021, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--FISMember_zubETJkAJVgh" style="text-align: right" title="Long term debt current"&gt;2,103,885&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--FISMember_ztGfs2gJt4Qe" style="text-align: right" title="Long term debt current"&gt;2,226,628&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Oak Street Funding LLC Term Loan for the acquisition of ABC, net of deferred financing costs of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_903_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--ABCMember_z4d7ImIa1V66" title="Net of deferred financing cost"&gt;45,369&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_908_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--ABCMember_zHI3JyAVNVE7" title="Net of deferred financing cost"&gt;48,609&lt;/span&gt; as of June 30, 2022 and December 31, 2021, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--ABCMember_ziTwG1hXTyp9" style="text-align: right" title="Long term debt current"&gt;3,427,614&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--ABCMember_z0tslES6PHnb" style="text-align: right" title="Long term debt current"&gt;3,616,754&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Oak Street Funding LLC Term Loan for the acquisition of Barra, net of deferred financing costs of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_eus-gaap--OtherDeferredCostsNet_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zne1OiYQml26" title="Net of deferred financing cost"&gt;208,901&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkcgVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90D_eus-gaap--OtherDeferredCostsNet_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zaY7qgk31TJa" title="Net of deferred financing cost"&gt;0&lt;/span&gt; as of June 30, 2022 and December 31, 2021, respectively&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebt_iI_c20220630__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zhDcrjp2Qv0c" style="border-bottom: Black 1.5pt solid; text-align: right" title="Long term debt current"&gt;6,311,099&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--BusinessAcquisitionAxis__custom--BarraMember_zpFldjFvkDMi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Long term debt current"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1512"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermDebt_iI_c20220630_z9FgkrR3f43k" style="text-align: right" title="Long term debt"&gt;13,871,912&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermDebt_iI_c20211231_zUY96lHUFOIe" style="text-align: right" title="Long term debt"&gt;7,999,245&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: current portion&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LongTermDebtCurrent_iNI_di_c20220630_zPkYc8wDpQy2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Current portion of long-term debt"&gt;(936,263&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--LongTermDebtCurrent_iNI_di_c20211231_zmXBnTIhZcei" style="border-bottom: Black 1.5pt solid; text-align: right" title="Current portion of long-term debt"&gt;(913,920&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Long-term debt&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LongTermDebtNoncurrent_iI_c20220630_z9k2CwFDNtIh" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term debt, excluding current maturities"&gt;12,935,649&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebtNoncurrent_iI_c20211231_zTa1bVOHOcD9" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term debt, excluding current maturities"&gt;7,085,325&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:OtherDeferredCostsNet
      contextRef="AsOf2022-06-30_custom_EBSandUSBAMember"
      decimals="0"
      unitRef="USD">13497</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherDeferredCostsNet
      contextRef="AsOf2021-12-31_custom_EBSandUSBAMember"
      decimals="0"
      unitRef="USD">14606</us-gaap:OtherDeferredCostsNet>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-06-30_custom_EBSandUSBAMember"
      decimals="0"
      unitRef="USD">455391</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_custom_EBSandUSBAMember"
      decimals="0"
      unitRef="USD">485317</us-gaap:LongTermDebt>
    <us-gaap:OtherDeferredCostsNet
      contextRef="AsOf2022-06-30_custom_CCSMember"
      decimals="0"
      unitRef="USD">16351</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherDeferredCostsNet
      contextRef="AsOf2021-12-31_custom_CCSMember"
      decimals="0"
      unitRef="USD">17626</us-gaap:OtherDeferredCostsNet>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-06-30_custom_CCSMember"
      decimals="0"
      unitRef="USD">738547</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_custom_CCSMember"
      decimals="0"
      unitRef="USD">785826</us-gaap:LongTermDebt>
    <us-gaap:OtherDeferredCostsNet
      contextRef="AsOf2022-06-30_custom_SWMTMember"
      decimals="0"
      unitRef="USD">10085</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherDeferredCostsNet
      contextRef="AsOf2021-12-31_custom_SWMTMember"
      decimals="0"
      unitRef="USD">11027</us-gaap:OtherDeferredCostsNet>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-06-30_custom_SWMTMember"
      decimals="0"
      unitRef="USD">835376</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_custom_SWMTMember"
      decimals="0"
      unitRef="USD">884720</us-gaap:LongTermDebt>
    <us-gaap:OtherDeferredCostsNet
      contextRef="AsOf2022-06-30_custom_FISMember"
      decimals="0"
      unitRef="USD">39752</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherDeferredCostsNet
      contextRef="AsOf2021-12-31_custom_FISMember"
      decimals="0"
      unitRef="USD">42660</us-gaap:OtherDeferredCostsNet>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-06-30_custom_FISMember"
      decimals="0"
      unitRef="USD">2103885</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_custom_FISMember"
      decimals="0"
      unitRef="USD">2226628</us-gaap:LongTermDebt>
    <us-gaap:OtherDeferredCostsNet
      contextRef="AsOf2022-06-30_custom_ABCMember"
      decimals="0"
      unitRef="USD">45369</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherDeferredCostsNet
      contextRef="AsOf2021-12-31_custom_ABCMember"
      decimals="0"
      unitRef="USD">48609</us-gaap:OtherDeferredCostsNet>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-06-30_custom_ABCMember"
      decimals="0"
      unitRef="USD">3427614</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2021-12-31_custom_ABCMember"
      decimals="0"
      unitRef="USD">3616754</us-gaap:LongTermDebt>
    <us-gaap:OtherDeferredCostsNet
      contextRef="AsOf2022-06-30_custom_BarraMember"
      decimals="0"
      unitRef="USD">208901</us-gaap:OtherDeferredCostsNet>
    <us-gaap:OtherDeferredCostsNet
      contextRef="AsOf2021-12-31_custom_BarraMember"
      decimals="0"
      unitRef="USD">0</us-gaap:OtherDeferredCostsNet>
    <us-gaap:LongTermDebt
      contextRef="AsOf2022-06-30_custom_BarraMember"
      decimals="0"
      unitRef="USD">6311099</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">13871912</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">7999245</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">936263</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">913920</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">12935649</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">7085325</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_893_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zXaJBK35MWd6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;span id="xdx_8B5_z6T44eRoySf4" style="display: none"&gt;SCHEDULE
OF CUMULATIVE MATURITIES OF LONG-TERM LOANS AND CREDIT FACILITIES&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Fiscal year ending December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20220630_znKSwTAoKRVi" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Maturities of &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Long-Term Debt&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_iI_maDICAzUlL_zD8tjSnVjkP3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;2022 (remainder of year)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;438,616&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_maDICAzUlL_zJS5wiMGmCQd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,228,897&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_maDICAzUlL_zi7pxzsAMSs3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,542,156&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_maDICAzUlL_zvYm6PemCYx9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,656,383&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_maDICAzUlL_z6Fzq2O3Fc3c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,776,385&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_iI_maDICAzUlL_z1XHiwscUX32" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,563,428&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DebtInstrumentCarryingAmount_iI_mtDICAzUlL_zmUYwoJsExI2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,205,865&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredFinanceCostsNet_iNI_di_zgmv3VFGZPC1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: debt issuance costs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(333,953&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LongTermDebt_iI_ztauDfk8nlR" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;13,871,912&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">438616</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1228897</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1542156</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1656383</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1776385</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">7563428</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">14205865</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">333953</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebt contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">13871912</us-gaap:LongTermDebt>
    <us-gaap:ShortTermBankLoansAndNotesPayable contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">42894</us-gaap:ShortTermBankLoansAndNotesPayable>
    <us-gaap:ShortTermBankLoansAndNotesPayable contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4456</us-gaap:ShortTermBankLoansAndNotesPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2022-06-30_custom_DirectorsAndOfficerMember"
      decimals="INF"
      unitRef="Pure">0.0751</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-12-31_custom_DirectorsAndOfficerMember"
      decimals="INF"
      unitRef="Pure">0.0795</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2022-01-012022-06-30_custom_DirectorsAndOfficerMember"
      decimals="0"
      unitRef="USD">417199</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2021-01-012021-12-31_custom_DirectorsAndOfficerMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-06-30_custom_DirectorsAndOfficerMember"
      decimals="0"
      unitRef="USD">376647</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-12-31_custom_DirectorsAndOfficerMember"
      decimals="0"
      unitRef="USD">0</us-gaap:DebtInstrumentFaceAmount>
    <RELI:WarrantLiabilitiesTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_800_ecustom--WarrantLiabilitiesTextBlock_zAGXQacax8tk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
5. &lt;span id="xdx_820_zPyD02zfsFi1"&gt;WARRANT LIABILITIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
B Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 22, 2021, the Company entered into a securities purchase agreement with several institutional buyers for the purchase and sale
of (i) warrants to purchase an aggregate of up to &lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20211222__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zu96vSpMatG5" title="Warrant to purchase shares"&gt;9,779,952&lt;/span&gt; shares of the Company&#x2019;s common stock, par value $&lt;span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211222__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zj6MebMfxudh" title="Common stock par value"&gt;0.086&lt;/span&gt; per share at
an exercise price of $&lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211222__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zaEqpQefHyNb" title="Exercise price"&gt;4.09&lt;/span&gt; per share, (ii) an aggregate of &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211222__20211223__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zOYpqkYQ30of" title="Number of shares issued"&gt;2,670,892&lt;/span&gt; shares of Common Stock, and (iii) &lt;span id="xdx_90C_eus-gaap--ConversionOfStockSharesConverted1_c20211222__20211223__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z6YUcT2JAIS6" title="Shares converted"&gt;9,076&lt;/span&gt; shares of the Company&#x2019;s
newly-designated Series B convertible preferred stock, par value $&lt;span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20211222__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zfBbcVD0hzx1" title="Preferred stock par value"&gt;0.086&lt;/span&gt; per share, with a stated value of $&lt;span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_c20211222__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zAqSDRekkM82" title="Share price per share"&gt;1,000&lt;/span&gt; per share, initially
convertible into an aggregate of &lt;span id="xdx_90B_eus-gaap--ConversionOfStockSharesIssued1_c20211222__20211223__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zo1NNnKOcZXh" title="Shares converted"&gt;2,219,084&lt;/span&gt; shares of Common Stock at a conversion price of $&lt;span id="xdx_905_eus-gaap--PreferredStockConvertibleConversionPrice_iI_c20211222__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z5E7Xl5vlUEe" title="Preferred stock conversion price"&gt;4.09&lt;/span&gt; per share, each a freestanding financial
instrument, (the &#x201c;Private Placement&#x201d;). The aggregate purchase price for the Common Shares, the Preferred Shares and the Warrants
was approximately $&lt;span id="xdx_909_ecustom--AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zkYlgW3OEtxj" title="Aggregate purchase price of common shares, preferred shares and warrants"&gt;20,000,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;By
entering into the Private Placement on December 22, 2021, the Company entered into a commitment to issue the Common Shares, Preferred
Shares and Series B Warrants on the Initial Closing Date for a fixed price and exercise price, as applicable. The commitment to issue
Series B Warrants (the &#x201c;Warrant Commitment&#x201d;) represents a derivative financial instrument, other than an outstanding share,
that, at inception, has both of the following characteristics: (i) embodies a conditional obligation indexed to the Company&#x2019;s equity.
The Company classified the commitment to issue the warrants as a derivative liability because it represents a written option that does
not qualify for equity accounting The Company initially measured the derivative liability at its fair value and will subsequently remeasure
the derivative liability, at fair value with changes in fair value recognized in earnings. An option pricing model was utilized to calculate
the fair value of the Warrant Commitment. The Company initially recorded $&lt;span id="xdx_908_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_c20210101__20211231_z5ownjqLX3Sd" title="Unrealized losses"&gt;17,652,808&lt;/span&gt; of non-operating unrealized losses within the recognition
and change in fair value of warrant liabilities account for the year ended December 31, 2021. The Private Placement closed on January
4, 2022, at which time the Company remeasured the derivative liability for the warrants issued in the transaction. The Company recognized
$&lt;span id="xdx_904_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20220101__20220630_zNmfHpoExDjb" title="Unrealized gain"&gt;12,322,737&lt;/span&gt; and $&lt;span id="xdx_905_ecustom--NonOperatingUnrealizedGains_c20220101__20220630_zgi6pGaDvL2i" title="Unrealized gain"&gt;24,748,163&lt;/span&gt; of non-operating unrealized gains within the recognition and change in fair value of warrant liabilities
account on the condensed consolidated statement of operations for the three and six months ended June 30, 2022, respectively, related
to the subsequent changes in its fair value through June 30, 2022. A corresponding derivative liability of $&lt;span id="xdx_90E_ecustom--WarrantCommitment_iI_c20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantLiabilityMember_zn9tLwxEawz" title="Derivative liability"&gt;10,757,945&lt;/span&gt; is included on
Company&#x2019;s condensed consolidated balance sheet as of June 30, 2022. The closing of the Private Placement settled the subscription
receivable reported on the Company&#x2019;s balance sheet as of December 31, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Placement
Agent Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Private Placement, the Company issued &lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20220105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zZrCwpqan901" title="Warrant issued"&gt;244,539&lt;/span&gt; warrants to the placement agent for the Private Placement. The warrants
were issued as compensation for the Placement Agent&#x2019;s services. The Placement Agent Warrants are: (i) exercisable on any day after
the six (6) month anniversary of the issue date, (ii) expire &lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20220105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zHObZVaIH4n3" title="Warrant term"&gt;five years&lt;/span&gt; after the closing of the Private Placement, and (iii) exercisable
at $&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z3Di9BHz1gm" title="Warrant exercise price"&gt;4.09&lt;/span&gt; per share. The Placement Agent Warrants contain terms that may require the Company to transfer assets to settle the warrants.
Therefore, the Placement Agent Warrants are classified as a derivative liability measured at fair value of $&lt;span id="xdx_905_ecustom--IssuanceOfPlacementAgentWarrants_c20220104__20220105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zPIdhyk1V6S7" title="Derivative liability measured at fair value"&gt;1,525,923 &lt;/span&gt;on the date of
issuance and will be remeasured each accounting period with the changes in fair value reported in earnings. The Placement Agent Warrants
are considered financing expense fees paid to the Placement Agent. Since the financing expenses relate to a derivative liability measured
at fair value, this financing expense of $&lt;span id="xdx_903_ecustom--IssuanceOfPlacementAgentWarrants_c20220104__20220105__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zhhirMposu15" title="Derivative liability measured at fair value"&gt;1,525,923&lt;/span&gt;, along with non-operating unrealized gains of $&lt;span id="xdx_902_ecustom--WarrantCommitmentUnrealizedGainLoss_c20220401__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zQK41qxWAPDe" title="Unrealized gain"&gt;310,514&lt;/span&gt; and losses of $&lt;span id="xdx_90E_ecustom--WarrantCommitmentUnrealizedGainLoss_c20220101__20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z13S70B6xUA8" title="Unrealized gain"&gt;268,948&lt;/span&gt;, were
included in the recognition and change in fair value of warrant liabilities account on the condensed consolidated statement of operations
for the three and six months ended June 30, 2022, respectively, A corresponding derivative liability of $&lt;span id="xdx_902_ecustom--WarrantCommitment_iI_c20220630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z1cJZOVgNzF8" title="Derivative liability"&gt;268,948&lt;/span&gt; is included on Company&#x2019;s
condensed consolidated balance sheet as of June 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</RELI:WarrantLiabilitiesTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2021-12-22_us-gaap_CommonStockMember_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Shares">9779952</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-22_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="USDPShares">0.086</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-12-22_us-gaap_CommonStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="USDPShares">4.09</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-12-222021-12-23_us-gaap_CommonStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="Shares">2670892</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2021-12-222021-12-23_custom_SeriesBConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="Shares">9076</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-22_custom_SeriesBConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="USDPShares">0.086</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2021-12-22_custom_SeriesBConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="USDPShares">1000</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2021-12-222021-12-23_us-gaap_CommonStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="Shares">2219084</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="AsOf2021-12-22_custom_SeriesBConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      unitRef="USDPShares">4.09</us-gaap:PreferredStockConvertibleConversionPrice>
    <RELI:AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants
      contextRef="From2021-01-012021-12-31_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">20000000</RELI:AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants>
    <us-gaap:EquitySecuritiesFvNiUnrealizedLoss
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">17652808</us-gaap:EquitySecuritiesFvNiUnrealizedLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">12322737</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <RELI:NonOperatingUnrealizedGains
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">24748163</RELI:NonOperatingUnrealizedGains>
    <RELI:WarrantCommitment
      contextRef="AsOf2022-06-30_custom_SeriesBWarrantLiabilityMember"
      decimals="0"
      unitRef="USD">10757945</RELI:WarrantCommitment>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2022-01-05_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      unitRef="Shares">244539</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2022-01-05_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-01-05_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      unitRef="USDPShares">4.09</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <RELI:IssuanceOfPlacementAgentWarrants
      contextRef="From2022-01-042022-01-05_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember"
      decimals="0"
      unitRef="USD">1525923</RELI:IssuanceOfPlacementAgentWarrants>
    <RELI:IssuanceOfPlacementAgentWarrants
      contextRef="From2022-01-042022-01-05_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember"
      decimals="0"
      unitRef="USD">1525923</RELI:IssuanceOfPlacementAgentWarrants>
    <RELI:WarrantCommitmentUnrealizedGainLoss
      contextRef="From2022-04-012022-06-30_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">310514</RELI:WarrantCommitmentUnrealizedGainLoss>
    <RELI:WarrantCommitmentUnrealizedGainLoss
      contextRef="From2022-01-012022-06-30_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">268948</RELI:WarrantCommitmentUnrealizedGainLoss>
    <RELI:WarrantCommitment
      contextRef="AsOf2022-06-30_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      unitRef="USD">268948</RELI:WarrantCommitment>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zf2I6cV63o01" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
6. &lt;span id="xdx_82C_zI7PKNtaDED2"&gt;EQUITY&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Preferred
Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has been authorized to issue &lt;span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20220630_zIM0TDwVfqY6" title="Preferred stock, shares authorized"&gt;750,000,000&lt;/span&gt; shares of $&lt;span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20220630_zs0UjNisi2Al" title="Preferred stock, par value"&gt;0.086&lt;/span&gt; par value Preferred Stock. The Board of Directors is expressly vested
with the authority to divide any or all of the Preferred Stock into series and to fix and determine the relative rights and preferences
of the shares of each series so established, within certain guidelines established in the Articles of Incorporation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
January 2022, the Company issued &lt;span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_c20220131_zi2d1aPdD5tg" title="Preferred stock shares issued"&gt;9,076&lt;/span&gt; shares of its newly designated Series B convertible preferred stock through the Private Placement
for the purpose of raising capital. These shares remain issued and outstanding as of June 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Series B convertible preferred stock has no voting rights and initially each share of Series B convertible preferred stock may be converted
into &lt;span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_z7W3YWBA81Ke" title="Preferred stock shares authorized"&gt;245&lt;/span&gt; shares of the Company&#x2019;s common stock. The holders of the Series B convertible preferred stock are not entitled to receive
any dividends other than any dividends paid on account of the common stock. In the event of any voluntary or involuntary liquidation,
dissolution or winding up of the Company, the holders shall be entitled to receive out of the assets, whether capital or surplus, of
the Company the same amount that a holder of common stock would receive if the Preferred Stock were fully converted (disregarding for
such purposes any conversion limitations hereunder) to common stock which amounts shall be paid pari passu with all holders of common
stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Common
Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has been authorized to issue &lt;span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20220630_zU8en1ohRcFh" title="Common stock, shares authorized"&gt;2,000,000,000&lt;/span&gt;&#160;&#160; shares of common stock, $&lt;span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220630_z9nXFbN4Is9d" title="Common stock, at par value"&gt;0.086&lt;/span&gt; par value. Each share of issued and outstanding
common stock shall entitle the holder thereof to fully participate in all shareholder meetings, to cast one vote on each matter with
respect to which shareholders have the right to vote, and to share ratably in all dividends and other distributions declared and paid
with respect to common stock, as well as in the net assets of the corporation upon liquidation or dissolution.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
January 2022, the Company issued &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220101__20220131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zBaJaNeZdYhf" title="Number of shares issued"&gt;2,670,892&lt;/span&gt; shares of common stock through the Private Placement for the purpose of raising capital. See
Note 5 - &lt;i&gt;Warrant Liabilities &lt;/i&gt;for proceeds received by the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
January 2022, the Company issued &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20220101__20220131__us-gaap--BusinessAcquisitionAxis__custom--MedigapAcquisitionMember_zo3UYAsVrpOa" title="Stock issued during period, shares, acquisitions"&gt;606,037&lt;/span&gt; shares of common stock pursuant to the Medigap Acquisition.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
January 2022, upon agreement with Series A warrant holders, &lt;span id="xdx_909_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_c20220101__20220131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAWarrantMember_zM2qGfECdDz2" title="Exercise of Series A warrants, shares"&gt;375,000&lt;/span&gt; warrants were exercised at a price of $&lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAWarrantMember_zdJ3HwqjmuD6" title="Warrants exercise price"&gt;6.60 &lt;/span&gt;into &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20220101__20220131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zSGdXGziHjrb" title="Number of shares converted"&gt;375,000&lt;/span&gt; of the Company&#x2019;s
common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2022, the Company issued &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220301__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zI8zsxILvXF6" title="Number of shares issued"&gt;6,000&lt;/span&gt; shares of the Company&#x2019;s common stock due to the vesting of &lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20220301__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQLYbrI32gVg" title="Vesting of stock award"&gt;6,000&lt;/span&gt; stock awards pursuant to
an employee agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
May and June 2022, &lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220531__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zbZVYt08oH8k" title="Class of common stock warrant"&gt;&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zlGw6gPWHPPd" title="Class of common stock warrant"&gt;3,276,929&lt;/span&gt;&lt;/span&gt; Series C prepaid warrants were exchanged for &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220531__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zcNTWEVQoXD6" title="Class of common stock warrant"&gt;&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z3aBcx6kKgpl"&gt;3,276,929&lt;/span&gt;&lt;/span&gt; shares of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2022 and December 31, 2021, there were &lt;span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20220630_zlsq1U6jo7Gj" title="Common stock, shares outstanding"&gt;14,614,038&lt;/span&gt; and &lt;span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20211231_z0PZemuTQLi" title="Common stock, shares outstanding"&gt;10,956,109&lt;/span&gt; shares of Common Stock outstanding, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Series
A warrant holders exercised &lt;span id="xdx_90B_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_c20220101__20220131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAWarrantMember_zvz5rZbio7k2" title="Exercise of Series A warrants, shares"&gt;375,000&lt;/span&gt; Series A warrants in January 2022, resulting in &lt;span id="xdx_904_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_c20220101__20220630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAWarrantMember_zRIPYEAjfFwg" title="Exercise of Series A warrants, shares"&gt;1,695,000&lt;/span&gt; of Series A warrants remaining issued and
outstanding as of June 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
January 2022, as a result of the issuance of common stock in the January 2022 stock offering and the Medigap Acquisition, the Company
received a deficiency notification from Nasdaq indicating violation of Listing Rule 5365(a). As part of its remediation plan, in March
2022, the Company entered into Exchange Agreements with the holders of common stock issued in January 2022. Pursuant to the Exchange
Agreements, the Company issued &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220131__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zqYcwUxBI7qj" title="Class of common stock warrant"&gt;3,276,929&lt;/span&gt; Series C prepaid warrants in exchange for &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220131__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZT8f04HNg4k" title="Class of common stock warrant"&gt;3,276,929&lt;/span&gt; shares of the Company&#x2019;s common stock.
Additionally, as compensation for entering into the Exchange Agreements, the Company issued &lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220131__us-gaap--StatementClassOfStockAxis__custom--SeriesDPrepaidWarrantsMember_zWuFt60SfqTd" title="Class of common stock warrant"&gt;1,222,498&lt;/span&gt; Series D prepaid warrants to the
January 2022 stock offering investors for no additional consideration. The fair value of the Series D prepaid warrants was treated as
a deemed dividend and accordingly was treated as a reduction from income available to common stockholders in the calculation of earnings
per share. Refer to Note 7, &lt;i&gt;Earnings (Loss) Per Share&lt;/i&gt; for additional information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
May and June 2022, the &lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220531__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zb3O69O4dbX6" title="Class of common stock warrant"&gt;&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220501__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zSmn87ckgUdi" title="Class of common stock warrant"&gt;3,276,929&lt;/span&gt;&lt;/span&gt; Series C prepaid warrants were converted for &lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220531__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zY9dYOZBTsH5" title="Class of common stock warrant"&gt;&lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxY3yrZ000L1" title="Class of common stock warrant"&gt;3,276,929&lt;/span&gt;&lt;/span&gt; shares of the Company&#x2019;s common stock for
an exercise price of $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_z8YWEXs0acW8" title="Warrant exercise price"&gt;0.001&lt;/span&gt;.&#160;&#160; Through June 30, 2022, the Company has received payments of $&lt;span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfDebt_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zErpyQVZXEL7" title="Proceeds from issuance of debt"&gt;1,336&lt;/span&gt; from one investor for these
issuances.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Equity-based
Compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Between
February and May 2022, three existing employees were awarded  bonuses consisting&#x202f;of shares of the Company&#x2019;s common stock to
be vested immediately. The shares granted in 2022 were valued at $&lt;span id="xdx_903_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensation_c20220101__20220630__srt--TitleOfIndividualAxis__custom--ThreeEmployeesMember_zLor3DTAoOj8" title="Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture"&gt;766,250&lt;/span&gt;. For the three and six months ended June 30, 2022, compensation
expense on these grants totaled $&lt;span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_c20220401__20220630__srt--TitleOfIndividualAxis__custom--ThreeEmployeesMember_zdMEqhb3VD1h"&gt;100,000&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20220630__srt--TitleOfIndividualAxis__custom--ThreeEmployeesMember_zOoRq5eusDfj"&gt;766,250&lt;/span&gt;, respectively. As of June 30, 2022, these shares have not been issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
April 2022&#160;, pursuant to an agreement between the Company and an Executive, the Executive will be compensated with &lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220430__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxAHuZdmg8de" title="Class of common stock warrant"&gt;60,000&lt;/span&gt; shares
of the Company&#x2019;s Common stock. These shares vest quarterly over a three-year period. The shares granted were valued at $&lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220101__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbCboKSbIbp3" title="Issuance of shares"&gt;178,200&lt;/span&gt;
at the date of the grant. For the three and six months ended June 30, 2022, compensation expense on this grant was $&lt;span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zlXTjO4ApCo5" title="Share based compensation expense"&gt;&lt;span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z4mQzasManxf" title="Share based compensation expense"&gt;70,721&lt;/span&gt;&lt;/span&gt;. As of June
30, 2022, no shares were issued under this contract.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">750000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30"
      decimals="INF"
      unitRef="USDPShares">0.086</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-01-31" decimals="INF" unitRef="Shares">9076</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-06-30_custom_SeriesBConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="Shares">245</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30"
      decimals="INF"
      unitRef="USDPShares">0.086</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-01-012022-01-31_us-gaap_CommonStockMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      unitRef="Shares">2670892</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2022-01-012022-01-31_custom_MedigapAcquisitionMember"
      decimals="INF"
      unitRef="Shares">606037</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <RELI:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="From2022-01-012022-01-31_custom_SeriesAWarrantMember"
      decimals="INF"
      unitRef="Shares">375000</RELI:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-01-31_custom_SeriesAWarrantMember"
      decimals="INF"
      unitRef="USDPShares">6.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="From2022-01-012022-01-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">375000</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-03-012022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2022-03-012022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-05-31_custom_SeriesCPrepaidWarrantsMember"
      decimals="INF"
      unitRef="Shares">3276929</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-06-30_custom_SeriesCPrepaidWarrantsMember"
      decimals="INF"
      unitRef="Shares">3276929</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-05-31_custom_SeriesCPrepaidWarrantsMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">3276929</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-06-30_custom_SeriesCPrepaidWarrantsMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">3276929</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">14614038</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">10956109</us-gaap:CommonStockSharesOutstanding>
    <RELI:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="From2022-01-012022-01-31_custom_SeriesAWarrantMember"
      decimals="INF"
      unitRef="Shares">375000</RELI:StockIssuedDuringPeriodSharesWarrantsExercised>
    <RELI:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="From2022-01-012022-06-30_custom_SeriesAWarrantMember"
      decimals="INF"
      unitRef="Shares">1695000</RELI:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-01-31_custom_SeriesCPrepaidWarrantsMember"
      decimals="INF"
      unitRef="Shares">3276929</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-01-31_custom_SeriesCPrepaidWarrantsMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">3276929</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-01-31_custom_SeriesDPrepaidWarrantsMember"
      decimals="INF"
      unitRef="Shares">1222498</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-05-31_custom_SeriesCPrepaidWarrantsMember"
      decimals="INF"
      unitRef="Shares">3276929</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-05-01_custom_SeriesCPrepaidWarrantsMember"
      decimals="INF"
      unitRef="Shares">3276929</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-05-31_custom_SeriesCPrepaidWarrantsMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">3276929</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-06-30_custom_SeriesCPrepaidWarrantsMember_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">3276929</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-06-30_custom_SeriesCPrepaidWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2022-01-012022-06-30_custom_SeriesCPrepaidWarrantsMember_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">1336</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation
      contextRef="From2022-01-012022-06-30_custom_ThreeEmployeesMember"
      decimals="0"
      unitRef="USD">766250</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2022-04-012022-06-30_custom_ThreeEmployeesMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2022-01-012022-06-30_custom_ThreeEmployeesMember"
      decimals="0"
      unitRef="USD">766250</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-04-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">60000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember168711000"
      decimals="0"
      unitRef="USD">178200</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2022-04-012022-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">70721</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2022-01-012022-06-30_us-gaap_CommonStockMember168711000"
      decimals="0"
      unitRef="USD">70721</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_80C_eus-gaap--EarningsPerShareTextBlock_zktdUqg5ylQc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7. &lt;span id="xdx_825_zZICfQ5klw4i"&gt;EARNINGS (LOSS) PER SHARE&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
earnings per common share (&#x201c;EPS&#x201d;) applicable to common stockholders is computed by dividing earnings applicable to common
stockholders by the weighted-average number of common shares outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
there is a loss from operations, diluted EPS is computed in the same manner as basic EPS is computed. Similarly, if the Company has net
income but its preferred dividend adjustment made in computing income available to common stockholders results in a net loss available
to common stockholders, diluted EPS would be computed in the same manner as basic EPS. Accordingly, for the three and six months ended
June 30, 2021, due to a net loss, the outstanding Series A Convertible Preferred Stock is considered anti-dilutive in which &lt;span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zuWvqITue2X8" title="Anti-dilutive securities"&gt;9,076&lt;/span&gt; and
&lt;span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210101__20210630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zRCA3HELvUNh" title="Anti-dilutive securities"&gt;1,167&lt;/span&gt; were issued and outstanding at June 30, 2022 and 2021, respectively. Series A Convertible Preferred Stock is convertible into common
stock on a &lt;span id="xdx_90D_eus-gaap--PreferredStockConversionBasis_c20220101__20220630_zKJa9trDwEl1" title="Stock conversion basis description"&gt;10 for 1 basis&lt;/span&gt;. The outstanding stock options are considered anti-dilutive in which &lt;span id="xdx_908_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20220630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zMYaxFYgLTgg" title="Anti-dilutive option securities"&gt;163,925&lt;/span&gt; and &lt;span id="xdx_905_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20210101__20210630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_z2Fn11fm1qK7" title="Anti-dilutive option securities"&gt;163,913&lt;/span&gt; were issued and outstanding
at June 30, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following represents the impact of options, stock awards, preferred stock and warrants on basic and diluted EPS for the three and six
months ended June 30, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding
    stock options are considered anti-dilutive, due to the exercise price being greater than the average market price, in which &lt;span id="xdx_906_ecustom--AntidilutiveSharesIssuedAndOutstanding_iI_pid_c20220630_z06pGWt4J6ce" title="Antidilutive shares Issued and Outstanding"&gt;163,925&lt;/span&gt;,
    were issued and outstanding at June 30, 2022. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vested
    Stock awards in the amount of &lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20220630_zSvA29IIh2Ui" title="Vested stock awards"&gt;200,820&lt;/span&gt; have been included in the basic and diluted EPS calculation for the three and six months ended
    June 30, 2022, and nonvested stock awards in the amount of &lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_pid_c20220401__20220630_zVNWqpitU5Qa" title="Non-vested stock awards"&gt;31,916&lt;/span&gt; and &lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_pid_c20220101__20220630_zvyMH0Tp4iU4" title="Non-vested stock awards"&gt;46,084&lt;/span&gt; have been included in the diluted EPS calculation for
    the three and six months ended June 30, 2022, respectively. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding
    Series A warrants are considered anti-dilutive, due to the exercise price being greater than the average market price, in which &lt;span id="xdx_903_ecustom--WarrantSharesIssued_iI_pid_c20220630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAWarrantsMember_z2rCT7ziEZPg" title="Warrant shares issued"&gt;&lt;span id="xdx_901_ecustom--WarrantSharesOutstanding_iI_pid_c20220630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAWarrantsMember_zPXwp3Lgw5yc" title="Warrant shares outstanding"&gt;1,695,000&lt;/span&gt;&lt;/span&gt;,
    were issued and outstanding at June 30, 2022. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Series
    B Convertible Preferred stock are considered dilutive and included in the calculation of diluted EPS. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    &lt;span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantLiabilityMember_zXvb3fErbeIg" title="Antidilutive warrant liabilities"&gt;631,276&lt;/span&gt; potential settlement shares of the warrant liability associated with Series B Warrants are considered dilutive and included
    in the calculation of diluted EPS for the six months ended June 30, 2022. The effects of the warrants that have been recorded in
    net income on the condensed consolidated statement of operations have been eliminated in the calculation of diluted EPS for the three
    and six months ended June 30, 2022. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    potential settlement shares of the warrant liability associated with the Placement Agent Warrants are considered dilutive and anti-dilutive
    for the three and six months ended June 30, 2022, respectively, and is included in Diluted EPS calculation for the three months ended
    June 30, 2022. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_pid_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zpxOmYa9AMG2" title="Issuance of prefunded  Series Warrants in exchange for common shares, shares"&gt;3,276,929&lt;/span&gt; Series C prepaid warrants have been exercised in 2022. &lt;span id="xdx_90E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220401__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_zhZ6tpsEXtQj" title="Antidilutive shares"&gt;1,676,737&lt;/span&gt; and &lt;span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pid_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesCPrepaidWarrantsMember_z8UsLsexVx4a" title="Antidilutive shares"&gt;2,743,896&lt;/span&gt; weighted shares were included as outstanding
    shares in the calculation of basic and diluted EPS for the period prior to exercise for the three and six months ended June 30, 2022,
    respectively, because they represent shares issuable for only nominal consideration. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_pid_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesDPrepaidWarrantsMember_zgmlpR6uLjp2" title="Stock Issued During Period, Shares, Conversion of Units"&gt;1,222,497&lt;/span&gt; Series D prepaid warrants have been included as outstanding shares in the calculation of basic and diluted EPS, as they
    represent shares issuable for only nominal consideration. The Company reduced income available to common stockholders by $&lt;span id="xdx_900_ecustom--IssuanceOfSeriesDWarrants_c20220401__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesDPrepaidWarrantsMember_zPyTO4A1n9W7" title="Issuance of Series D Warrants"&gt;0&lt;/span&gt; and $&lt;span id="xdx_907_ecustom--IssuanceOfSeriesDWarrants_c20220101__20220630__us-gaap--StatementClassOfStockAxis__custom--SeriesDPrepaidWarrantsMember_zdAivslJOLse" title="Issuance of Series D Warrants"&gt;6,930,335&lt;/span&gt;
    for the associated Series D deemed dividend in the calculation of basic and diluted EPS for the three and six months ended June 30,
    2022, respectively. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zGNto2cMfdSb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculations of basic and diluted EPS, are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zMbpD2rSg2W9" style="display: none"&gt;SCHEDULE
OF CALCULATIONS OF BASIC AND DILUTED EPS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220401__20220630_zQy9RwStOng" style="font-weight: bold; text-align: center"&gt;Three Months&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20210401__20210630_zaNbmJd7aBi3" style="font-weight: bold; text-align: center"&gt;Three Months&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NetIncomeLoss_mtNILzGtK_z3QE9XkS9JHh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-bottom: 2.5pt"&gt;Net income (loss)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;10,495,691&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;(1,276,886&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DeemedDividend_iN_di_z3wG0v2CD7O7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Deemed dividend&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1724"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1725"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_z0Dv02ZGUW7e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net income (loss), numerator, basic computation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,495,691&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,276,886&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_z6b43Eqt5ZVa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Recognition and change in fair value of warrant liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(12,633,251&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1731"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_ztJzbLqg3i7a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net income (loss), numerator, diluted computation&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(2,137,560&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1,276,886&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zGmscDeG1a3a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Weighted average shares - denominator basic computation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;18,738,290&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,934,489&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_zjRIAgRGFSnb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Effect of stock awards&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,916&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1740"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--EffectOfSeriesBWarrantLiability_zIR34DvUQKwe" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Effect of Series B warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_z5khnvLLB4ek" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Effect of preferred stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,219,084&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1746"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zUaDKLhgZ1jj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;Weighted average shares, as adjusted - denominator diluted computation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;20,989,290&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,934,489&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--EarningsPerShareBasic_z8Zf0k6QXEPi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Earnings (loss) per common share &#x2013; basic&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;0.56&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(0.12&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--EarningsPerShareDiluted_za5O3Nkr9ovc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Earnings (loss) per common share &#x2013; diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(0.10&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(0.12&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20220101__20220630_zlsBe1hLCvoe" style="font-weight: bold; text-align: center"&gt;Six Months&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20210101__20210630_zROC7RkXvoOa" style="font-weight: bold; text-align: center"&gt;Six Months&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NetIncomeLoss_mtNILzGtK_zWTVW5qp2ZKl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-bottom: 2.5pt"&gt;Net income (loss)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;19,835,692&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;(1,890,812&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DeemedDividend_iN_di_zy3EHCOA6MJh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Deemed dividend&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,930,335&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1761"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zjSYIyZNDBYe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net income (loss), numerator, basic computation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,905,357&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,890,812&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_zlO26JmH0dEb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Recognition and change in fair value of warrant liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(24,748,163&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1767"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_zILyoa8V5bph" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net income (loss), numerator, diluted computation&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(11,842,806&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1,890,812&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_z5DdAS8TLt92" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Weighted average shares - denominator basic computation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,238,285&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,259,738&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ziTY8ZDdAGJ9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Effect of stock awards&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;46,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1776"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--EffectOfSeriesBWarrantLiability_zZk2cRma7Gyb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Effect of Series B warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,219,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1779"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_zNVX6WXu1hHl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Effect of preferred stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;631,276&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1782"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zNd2Utv4N0Lh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;Weighted average shares, as adjusted - denominator diluted computation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;20,134,729&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,259,738&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--EarningsPerShareBasic_zwCrgzWhgowd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Earnings (loss) per common share - basic&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;0.75&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(0.20&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--EarningsPerShareDiluted_zU09KYCDAofg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Earnings (loss) per common share - diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(0.59&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(0.20&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zTeLKq3ljaWd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">9076</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-012021-06-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">1167</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:PreferredStockConversionBasis contextRef="From2022-01-01to2022-06-30">10 for 1 basis</us-gaap:PreferredStockConversionBasis>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-06-30_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      unitRef="Shares">163925</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2021-01-012021-06-30_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      unitRef="Shares">163913</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <RELI:AntidilutiveSharesIssuedAndOutstanding contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">163925</RELI:AntidilutiveSharesIssuedAndOutstanding>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="Shares">200820</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      unitRef="Shares">31916</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="Shares">46084</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <RELI:WarrantSharesIssued
      contextRef="AsOf2022-06-30_custom_SeriesAWarrantsMember"
      decimals="INF"
      unitRef="Shares">1695000</RELI:WarrantSharesIssued>
    <RELI:WarrantSharesOutstanding
      contextRef="AsOf2022-06-30_custom_SeriesAWarrantsMember"
      decimals="INF"
      unitRef="Shares">1695000</RELI:WarrantSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-06-30_custom_SeriesBWarrantLiabilityMember"
      decimals="INF"
      unitRef="Shares">631276</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="From2022-01-012022-06-30_custom_SeriesCPrepaidWarrantsMember"
      decimals="INF"
      unitRef="Shares">3276929</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-04-012022-06-30_custom_SeriesCPrepaidWarrantsMember"
      decimals="INF"
      unitRef="Shares">1676737</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-06-30_custom_SeriesCPrepaidWarrantsMember"
      decimals="INF"
      unitRef="Shares">2743896</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="From2022-01-012022-06-30_custom_SeriesDPrepaidWarrantsMember"
      decimals="INF"
      unitRef="Shares">1222497</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <RELI:IssuanceOfSeriesDWarrants
      contextRef="From2022-04-012022-06-30_custom_SeriesDPrepaidWarrantsMember"
      decimals="0"
      unitRef="USD">0</RELI:IssuanceOfSeriesDWarrants>
    <RELI:IssuanceOfSeriesDWarrants
      contextRef="From2022-01-012022-06-30_custom_SeriesDPrepaidWarrantsMember"
      decimals="0"
      unitRef="USD">6930335</RELI:IssuanceOfSeriesDWarrants>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_891_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zGNto2cMfdSb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculations of basic and diluted EPS, are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zMbpD2rSg2W9" style="display: none"&gt;SCHEDULE
OF CALCULATIONS OF BASIC AND DILUTED EPS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220401__20220630_zQy9RwStOng" style="font-weight: bold; text-align: center"&gt;Three Months&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20210401__20210630_zaNbmJd7aBi3" style="font-weight: bold; text-align: center"&gt;Three Months&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NetIncomeLoss_mtNILzGtK_z3QE9XkS9JHh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-bottom: 2.5pt"&gt;Net income (loss)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;10,495,691&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;(1,276,886&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DeemedDividend_iN_di_z3wG0v2CD7O7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Deemed dividend&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1724"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1725"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_z0Dv02ZGUW7e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net income (loss), numerator, basic computation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,495,691&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,276,886&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_z6b43Eqt5ZVa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Recognition and change in fair value of warrant liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(12,633,251&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1731"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_ztJzbLqg3i7a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net income (loss), numerator, diluted computation&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(2,137,560&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1,276,886&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zGmscDeG1a3a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Weighted average shares - denominator basic computation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;18,738,290&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,934,489&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_zjRIAgRGFSnb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Effect of stock awards&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,916&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1740"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--EffectOfSeriesBWarrantLiability_zIR34DvUQKwe" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Effect of Series B warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_z5khnvLLB4ek" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Effect of preferred stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,219,084&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1746"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zUaDKLhgZ1jj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;Weighted average shares, as adjusted - denominator diluted computation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;20,989,290&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,934,489&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--EarningsPerShareBasic_z8Zf0k6QXEPi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Earnings (loss) per common share &#x2013; basic&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;0.56&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(0.12&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--EarningsPerShareDiluted_za5O3Nkr9ovc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Earnings (loss) per common share &#x2013; diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(0.10&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(0.12&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20220101__20220630_zlsBe1hLCvoe" style="font-weight: bold; text-align: center"&gt;Six Months&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20210101__20210630_zROC7RkXvoOa" style="font-weight: bold; text-align: center"&gt;Six Months&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NetIncomeLoss_mtNILzGtK_zWTVW5qp2ZKl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-bottom: 2.5pt"&gt;Net income (loss)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;19,835,692&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;(1,890,812&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DeemedDividend_iN_di_zy3EHCOA6MJh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Deemed dividend&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,930,335&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1761"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zjSYIyZNDBYe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net income (loss), numerator, basic computation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,905,357&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,890,812&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DerivativeGainLossOnDerivativeNet_iN_di_zlO26JmH0dEb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Recognition and change in fair value of warrant liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(24,748,163&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1767"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_zILyoa8V5bph" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net income (loss), numerator, diluted computation&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(11,842,806&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1,890,812&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_z5DdAS8TLt92" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Weighted average shares - denominator basic computation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,238,285&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,259,738&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ziTY8ZDdAGJ9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Effect of stock awards&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;46,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1776"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--EffectOfSeriesBWarrantLiability_zZk2cRma7Gyb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Effect of Series B warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,219,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1779"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_zNVX6WXu1hHl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Effect of preferred stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;631,276&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1782"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zNd2Utv4N0Lh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;Weighted average shares, as adjusted - denominator diluted computation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;20,134,729&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,259,738&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--EarningsPerShareBasic_zwCrgzWhgowd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Earnings (loss) per common share - basic&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;0.75&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(0.20&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--EarningsPerShareDiluted_zU09KYCDAofg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Earnings (loss) per common share - diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(0.59&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(0.20&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">10495691</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-1276886</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">10495691</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-1276886</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">12633251</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-2137560</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-1276886</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      unitRef="Shares">18738290</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="Shares">10934489</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      unitRef="Shares">31916</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      unitRef="Shares">2219084</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      unitRef="Shares">20989290</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="Shares">10934489</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      unitRef="USDPShares">0.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">19835692</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-1890812</us-gaap:NetIncomeLoss>
    <RELI:DeemedDividend
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">6930335</RELI:DeemedDividend>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">12905357</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-1890812</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">24748163</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-11842806</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-1890812</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="Shares">17238285</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-01-012021-06-30"
      decimals="INF"
      unitRef="Shares">9259738</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="Shares">46084</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <RELI:EffectOfSeriesBWarrantLiability
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">2219084</RELI:EffectOfSeriesBWarrantLiability>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="Shares">631276</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="Shares">20134729</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-01-012021-06-30"
      decimals="INF"
      unitRef="Shares">9259738</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="USDPShares">0.75</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-01-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.59</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-01-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.20</us-gaap:EarningsPerShareDiluted>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_80E_eus-gaap--LesseeOperatingLeasesTextBlock_znNe9KsdI9N1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
8. &lt;span id="xdx_82B_zyTtZJ2h31F3"&gt;LEASES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
lease expense for the three months ended June 30, 2022 and 2021 was $&lt;span id="xdx_906_eus-gaap--OperatingLeaseExpense_c20220401__20220630_zpuqXvMYyyKi" title="Operating Lease, Expense"&gt;156,750&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--OperatingLeaseExpense_c20210401__20210630_zqEAiHLniY9k" title="Operating Lease, Expense"&gt;43,931&lt;/span&gt; respectively. Operating lease expense for the
six months ended June 30, 2022 and 2021 was $&lt;span id="xdx_90B_eus-gaap--OperatingLeaseExpense_c20220101__20220630_zNgmuVL40sh9" title="Operating Lease, Expense"&gt;275,174 &lt;/span&gt;and $&lt;span id="xdx_904_eus-gaap--OperatingLeaseExpense_c20210101__20210630_zj9i9MeHSVsc" title="Operating Lease, Expense"&gt;112,199&lt;/span&gt; respectively. As of June 30, 2022, the weighted average remaining lease
term and weighted average discount rate for the operating leases were &lt;span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20220630_zUVbNOGp7kJ2" title="Weighted average remaining lease term"&gt;4.01&lt;/span&gt; years and &lt;span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20220630_z5pUd0neE8Si" title="Weighted average discount rate"&gt;5.76&lt;/span&gt;% respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zZU6U7jblKgj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Future
minimum lease payment under these operating leases consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_zd78BSLOcZn8" style="display: none"&gt;SCHEDULE
OF FUTURE MINIMUM LEASE PAYMENT&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"&gt;Year ending December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220630_zSzHj4i5aRB6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Operating Lease&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Obligations&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzuGy_zrl6b1uLhx22" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: justify"&gt;2022&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;303,256&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzuGy_zyUHSSjV4Mva" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;546,275&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzuGy_zMRy43sOwxZ6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;253,908&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maLOLLPzuGy_zNa8czfeKkLk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;144,124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_maLOLLPzuGy_zo3z7Tf8TrRd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;113,738&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_maLOLLPzuGy_zuD6r0ScbBtk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;268,202&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzuGy_zqurSQ91mXK7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Total undiscounted operating lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,629,503&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_z69dDRK59Wng" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Less: Imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(169,978&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OperatingLeaseLiability_iI_pp0p0_zlvzQi6wVAH" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Present value of operating lease liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,459,525&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zMTFmP2ar4ze" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">156750</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">43931</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">275174</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">112199</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2022-06-30">P4Y3D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="AsOf2022-06-30" decimals="INF" unitRef="Pure">0.0576</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_893_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zZU6U7jblKgj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Future
minimum lease payment under these operating leases consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_zd78BSLOcZn8" style="display: none"&gt;SCHEDULE
OF FUTURE MINIMUM LEASE PAYMENT&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"&gt;Year ending December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220630_zSzHj4i5aRB6" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Operating Lease&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Obligations&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzuGy_zrl6b1uLhx22" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: justify"&gt;2022&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;303,256&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzuGy_zyUHSSjV4Mva" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;546,275&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzuGy_zMRy43sOwxZ6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;253,908&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maLOLLPzuGy_zNa8czfeKkLk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;144,124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_maLOLLPzuGy_zo3z7Tf8TrRd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;113,738&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_maLOLLPzuGy_zuD6r0ScbBtk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;268,202&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzuGy_zqurSQ91mXK7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Total undiscounted operating lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,629,503&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_z69dDRK59Wng" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Less: Imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(169,978&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OperatingLeaseLiability_iI_pp0p0_zlvzQi6wVAH" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Present value of operating lease liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,459,525&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">303256</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">546275</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">253908</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">144124</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">113738</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">268202</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1629503</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">169978</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1459525</us-gaap:OperatingLeaseLiability>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zzO75Xr7Pdxf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
9. &lt;span id="xdx_820_zCNq6TafMDR1"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Legal
Contingencies&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is subject to various legal proceedings and claims, either asserted or unasserted, arising in the ordinary course of business.
While the outcome of these claims cannot be predicted with certainty, management does not believe the outcome of any of these matters
will have a material adverse effect on our business, financial position, results of operations, or cash flows, and accordingly, no legal
contingencies are accrued as of June 30, 2022 and December 31, 2021. Litigation relating to the insurance brokerage industry is not uncommon.
As such the Company, from time to time have been, subject to such litigation. No assurances can be given with respect to the extent or
outcome of any such litigation in the future.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Earn-out
liabilities&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_ecustom--EarnOutLiabilitiesTableTextBlock_zrOvKquhzsGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following outlines changes to the Company&#x2019;s earn-out liability balances inclusive of accumulated accretion for the respective period
ended June 30, 2022 and December 31, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none"&gt;&lt;span id="xdx_8BA_ztiXawqIV94l"&gt;SCHEDULE
OF EARN-OUT LIABILITY&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B9_us-gaap--BusinessAcquisitionAxis_custom--CommercialSolutionsOfInsuranceAgencyLLCMember_zh0EZXvRKAX" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;CCS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B6_us-gaap--BusinessAcquisitionAxis_custom--FortmanInsuranceAgencyLLCMember_zMEY8WEGwINg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fortman&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BF_us-gaap--BusinessAcquisitionAxis_custom--SouthwesternMontanaInsuranceCenterIncMember_zZmetVieGoTh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Montana&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BD_us-gaap--BusinessAcquisitionAxis_custom--AltruisBenefitsConsultantsIncMember_z49BTelcNEJ8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Altruis&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B0_us-gaap--BusinessAcquisitionAxis_custom--JPKushAndAssociatesIncMember_zlio9T0dcBU8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Kush&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_us-gaap--BusinessAcquisitionAxis_custom--BarraMember_zCq2Ncn36q6c" style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Barra&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_zTCixRRcCqWe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20220101__20220630_eus-gaap--BusinessCombinationContingentConsiderationLiability_iS_z4YGdNEh3432" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 37%"&gt;Ending balance December 31, 2021&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1831"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;515,308&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;615,969&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;992,868&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;1,689,733&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1836"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;3,813,878&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--ChangesDueToAcquisitions_zvYs5RPeYF01" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Changes due to acquisitions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1839"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1840"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1841"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1842"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1843"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ChangesDueToPayments_zrM2j0F5svp7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Changes due to payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(326,935&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(84,473&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(411,408&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--ChangesDueToFairValueAdjustments_z4SvK01G4Msl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Changes due to fair value adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1855"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;32,620&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;37,741&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1858"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;334,602&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(50,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;354,963&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20220101__20220630_eus-gaap--BusinessCombinationContingentConsiderationLiability_iE_zclHYT4qFVQ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Ending balance June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1863"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;547,928&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;326,775&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;908,395&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,024,335&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;550,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,357,433&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B9_us-gaap--BusinessAcquisitionAxis_custom--CommercialSolutionsOfInsuranceAgencyLLCMember_zLOPpVA4E4P2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;CCS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B6_us-gaap--BusinessAcquisitionAxis_custom--FortmanInsuranceAgencyLLCMember_zxubZrMq7Cyl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fortman&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BF_us-gaap--BusinessAcquisitionAxis_custom--SouthwesternMontanaInsuranceCenterIncMember_zrvlD6iWxtM5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Montana&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BD_us-gaap--BusinessAcquisitionAxis_custom--AltruisBenefitsConsultantsIncMember_zGs6z9B0sfqd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Altruis&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B0_us-gaap--BusinessAcquisitionAxis_custom--JPKushAndAssociatesIncMember_z3NRZrpTcyck" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Kush&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_zRR8aMJHhCA8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20210101__20211231_eus-gaap--BusinessCombinationContingentConsiderationLiability_iS_zpm4CbaBI2ua" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%"&gt;Ending balance December 31, 2020&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;81,368&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;432,655&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;522,553&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;1,894,842&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1875"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;2,931,418&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ChangesDueToBusinessCombinations_z1hiuKVdAjzi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Changes due to business combinations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1878"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1879"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1880"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1881"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,694,166&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,694,166&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ChangesDueToPayments_zJHiGXgPK9s6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Changes due to payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1885"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1886"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1887"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(452,236&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1889"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(452,236&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--ChangesDueToFairValueAdjustments_zp20CqLcuidf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Changes due to fair value adjustments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1892"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;82,653&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;93,416&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(449,738&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,433&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(278,102&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ChangesDueToWriteoffs_zs7oQmvTp6Aj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Changes due to write-offs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(81,368&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1900"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1901"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1902"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1903"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(81,368&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20210101__20211231_eus-gaap--BusinessCombinationContingentConsiderationLiability_iE_zvDSOuCOQslb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Ending balance December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1906"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;515,308&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;615,969&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;992,868&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,689,733&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,813,878&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zijsEXqovf5b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <RELI:EarnOutLiabilitiesTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_897_ecustom--EarnOutLiabilitiesTableTextBlock_zrOvKquhzsGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following outlines changes to the Company&#x2019;s earn-out liability balances inclusive of accumulated accretion for the respective period
ended June 30, 2022 and December 31, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none"&gt;&lt;span id="xdx_8BA_ztiXawqIV94l"&gt;SCHEDULE
OF EARN-OUT LIABILITY&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B9_us-gaap--BusinessAcquisitionAxis_custom--CommercialSolutionsOfInsuranceAgencyLLCMember_zh0EZXvRKAX" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;CCS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B6_us-gaap--BusinessAcquisitionAxis_custom--FortmanInsuranceAgencyLLCMember_zMEY8WEGwINg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fortman&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BF_us-gaap--BusinessAcquisitionAxis_custom--SouthwesternMontanaInsuranceCenterIncMember_zZmetVieGoTh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Montana&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BD_us-gaap--BusinessAcquisitionAxis_custom--AltruisBenefitsConsultantsIncMember_z49BTelcNEJ8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Altruis&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B0_us-gaap--BusinessAcquisitionAxis_custom--JPKushAndAssociatesIncMember_zlio9T0dcBU8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Kush&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_us-gaap--BusinessAcquisitionAxis_custom--BarraMember_zCq2Ncn36q6c" style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Barra&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_zTCixRRcCqWe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20220101__20220630_eus-gaap--BusinessCombinationContingentConsiderationLiability_iS_z4YGdNEh3432" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 37%"&gt;Ending balance December 31, 2021&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1831"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;515,308&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;615,969&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;992,868&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;1,689,733&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1836"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 5%; text-align: right"&gt;3,813,878&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--ChangesDueToAcquisitions_zvYs5RPeYF01" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Changes due to acquisitions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1839"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1840"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1841"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1842"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1843"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ChangesDueToPayments_zrM2j0F5svp7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Changes due to payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(326,935&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(84,473&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(411,408&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--ChangesDueToFairValueAdjustments_z4SvK01G4Msl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Changes due to fair value adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1855"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;32,620&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;37,741&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1858"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;334,602&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(50,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;354,963&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20220101__20220630_eus-gaap--BusinessCombinationContingentConsiderationLiability_iE_zclHYT4qFVQ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Ending balance June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1863"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;547,928&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;326,775&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;908,395&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,024,335&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;550,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,357,433&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B9_us-gaap--BusinessAcquisitionAxis_custom--CommercialSolutionsOfInsuranceAgencyLLCMember_zLOPpVA4E4P2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;CCS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B6_us-gaap--BusinessAcquisitionAxis_custom--FortmanInsuranceAgencyLLCMember_zxubZrMq7Cyl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fortman&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BF_us-gaap--BusinessAcquisitionAxis_custom--SouthwesternMontanaInsuranceCenterIncMember_zrvlD6iWxtM5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Montana&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BD_us-gaap--BusinessAcquisitionAxis_custom--AltruisBenefitsConsultantsIncMember_zGs6z9B0sfqd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Altruis&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B0_us-gaap--BusinessAcquisitionAxis_custom--JPKushAndAssociatesIncMember_z3NRZrpTcyck" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Kush&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_zRR8aMJHhCA8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20210101__20211231_eus-gaap--BusinessCombinationContingentConsiderationLiability_iS_zpm4CbaBI2ua" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%"&gt;Ending balance December 31, 2020&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;81,368&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;432,655&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;522,553&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;1,894,842&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1875"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;2,931,418&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ChangesDueToBusinessCombinations_z1hiuKVdAjzi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Changes due to business combinations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1878"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1879"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1880"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1881"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,694,166&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,694,166&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ChangesDueToPayments_zJHiGXgPK9s6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Changes due to payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1885"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1886"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1887"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(452,236&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1889"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(452,236&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--ChangesDueToFairValueAdjustments_zp20CqLcuidf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Changes due to fair value adjustments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1892"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;82,653&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;93,416&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(449,738&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,433&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(278,102&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ChangesDueToWriteoffs_zs7oQmvTp6Aj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Changes due to write-offs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(81,368&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1900"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1901"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1902"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1903"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(81,368&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20210101__20211231_eus-gaap--BusinessCombinationContingentConsiderationLiability_iE_zvDSOuCOQslb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Ending balance December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1906"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;515,308&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;615,969&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;992,868&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,689,733&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,813,878&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</RELI:EarnOutLiabilitiesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2021-12-31_custom_FortmanInsuranceAgencyLLCMember"
      decimals="0"
      unitRef="USD">515308</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2021-12-31_custom_SouthwesternMontanaInsuranceCenterIncMember"
      decimals="0"
      unitRef="USD">615969</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2021-12-31_custom_AltruisBenefitsConsultantsIncMember"
      decimals="0"
      unitRef="USD">992868</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2021-12-31_custom_JPKushAndAssociatesIncMember"
      decimals="0"
      unitRef="USD">1689733</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3813878</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <RELI:ChangesDueToAcquisitions
      contextRef="From2022-01-012022-06-30_custom_BarraMember168706375"
      decimals="0"
      unitRef="USD">600000</RELI:ChangesDueToAcquisitions>
    <RELI:ChangesDueToAcquisitions
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">600000</RELI:ChangesDueToAcquisitions>
    <RELI:ChangesDueToPayments
      contextRef="From2022-01-012022-06-30_custom_SouthwesternMontanaInsuranceCenterIncMember"
      decimals="0"
      unitRef="USD">-326935</RELI:ChangesDueToPayments>
    <RELI:ChangesDueToPayments
      contextRef="From2022-01-012022-06-30_custom_AltruisBenefitsConsultantsIncMember"
      decimals="0"
      unitRef="USD">-84473</RELI:ChangesDueToPayments>
    <RELI:ChangesDueToPayments
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-411408</RELI:ChangesDueToPayments>
    <RELI:ChangesDueToFairValueAdjustments
      contextRef="From2022-01-012022-06-30_custom_FortmanInsuranceAgencyLLCMember"
      decimals="0"
      unitRef="USD">32620</RELI:ChangesDueToFairValueAdjustments>
    <RELI:ChangesDueToFairValueAdjustments
      contextRef="From2022-01-012022-06-30_custom_SouthwesternMontanaInsuranceCenterIncMember"
      decimals="0"
      unitRef="USD">37741</RELI:ChangesDueToFairValueAdjustments>
    <RELI:ChangesDueToFairValueAdjustments
      contextRef="From2022-01-012022-06-30_custom_JPKushAndAssociatesIncMember"
      decimals="0"
      unitRef="USD">334602</RELI:ChangesDueToFairValueAdjustments>
    <RELI:ChangesDueToFairValueAdjustments
      contextRef="From2022-01-012022-06-30_custom_BarraMember168706375"
      decimals="0"
      unitRef="USD">-50000</RELI:ChangesDueToFairValueAdjustments>
    <RELI:ChangesDueToFairValueAdjustments
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">354963</RELI:ChangesDueToFairValueAdjustments>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2022-06-30_custom_FortmanInsuranceAgencyLLCMember"
      decimals="0"
      unitRef="USD">547928</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2022-06-30_custom_SouthwesternMontanaInsuranceCenterIncMember"
      decimals="0"
      unitRef="USD">326775</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2022-06-30_custom_AltruisBenefitsConsultantsIncMember"
      decimals="0"
      unitRef="USD">908395</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2022-06-30_custom_JPKushAndAssociatesIncMember"
      decimals="0"
      unitRef="USD">2024335</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2022-06-30_custom_BarraMember"
      decimals="0"
      unitRef="USD">550000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4357433</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2020-12-31_custom_CommercialSolutionsOfInsuranceAgencyLLCMember"
      decimals="0"
      unitRef="USD">81368</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2020-12-31_custom_FortmanInsuranceAgencyLLCMember"
      decimals="0"
      unitRef="USD">432655</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2020-12-31_custom_SouthwesternMontanaInsuranceCenterIncMember"
      decimals="0"
      unitRef="USD">522553</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2020-12-31_custom_AltruisBenefitsConsultantsIncMember"
      decimals="0"
      unitRef="USD">1894842</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">2931418</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <RELI:ChangesDueToBusinessCombinations
      contextRef="From2021-01-012021-12-31_custom_JPKushAndAssociatesIncMember"
      decimals="0"
      unitRef="USD">1694166</RELI:ChangesDueToBusinessCombinations>
    <RELI:ChangesDueToBusinessCombinations
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">1694166</RELI:ChangesDueToBusinessCombinations>
    <RELI:ChangesDueToPayments
      contextRef="From2021-01-012021-12-31_custom_AltruisBenefitsConsultantsIncMember"
      decimals="0"
      unitRef="USD">-452236</RELI:ChangesDueToPayments>
    <RELI:ChangesDueToPayments
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">-452236</RELI:ChangesDueToPayments>
    <RELI:ChangesDueToFairValueAdjustments
      contextRef="From2021-01-012021-12-31_custom_FortmanInsuranceAgencyLLCMember"
      decimals="0"
      unitRef="USD">82653</RELI:ChangesDueToFairValueAdjustments>
    <RELI:ChangesDueToFairValueAdjustments
      contextRef="From2021-01-012021-12-31_custom_SouthwesternMontanaInsuranceCenterIncMember"
      decimals="0"
      unitRef="USD">93416</RELI:ChangesDueToFairValueAdjustments>
    <RELI:ChangesDueToFairValueAdjustments
      contextRef="From2021-01-012021-12-31_custom_AltruisBenefitsConsultantsIncMember"
      decimals="0"
      unitRef="USD">-449738</RELI:ChangesDueToFairValueAdjustments>
    <RELI:ChangesDueToFairValueAdjustments
      contextRef="From2021-01-012021-12-31_custom_JPKushAndAssociatesIncMember"
      decimals="0"
      unitRef="USD">-4433</RELI:ChangesDueToFairValueAdjustments>
    <RELI:ChangesDueToFairValueAdjustments
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">-278102</RELI:ChangesDueToFairValueAdjustments>
    <RELI:ChangesDueToWriteoffs
      contextRef="From2021-01-012021-12-31_custom_CommercialSolutionsOfInsuranceAgencyLLCMember"
      decimals="0"
      unitRef="USD">-81368</RELI:ChangesDueToWriteoffs>
    <RELI:ChangesDueToWriteoffs
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">-81368</RELI:ChangesDueToWriteoffs>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2021-12-31_custom_FortmanInsuranceAgencyLLCMember"
      decimals="0"
      unitRef="USD">515308</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2021-12-31_custom_SouthwesternMontanaInsuranceCenterIncMember"
      decimals="0"
      unitRef="USD">615969</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2021-12-31_custom_AltruisBenefitsConsultantsIncMember"
      decimals="0"
      unitRef="USD">992868</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="AsOf2021-12-31_custom_JPKushAndAssociatesIncMember"
      decimals="0"
      unitRef="USD">1689733</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3813878</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000926"
          xlink:label="Fact000926"
          xlink:type="locator"/>
        <link:footnote id="Footnote000939" xlink:label="Footnote000939" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Recorded
    as a reduction to general and administrative expenses</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000926"
          xlink:to="Footnote000939"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000927"
          xlink:label="Fact000927"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000927"
          xlink:to="Footnote000939"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>65
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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ME-D!/I]+J7<;Y@N*1VE&_P-02P,$%     @ !5P/57"[\IF'!P  7B   !@
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MGZ$RU+5\H4QT<2>K,K8_=$B8:R/3"HP*4B[*)WNI$K$&\#H[ 'X%\ \%M"M
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MI%C*L@+ ]RNES---%:![SS;Y#U!+ P04    "  %7 ]5J5,<U#(/   TDP
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M<7=*3?Q@YH'UAECDV]/\ FDT08JE2+$,*9:#Q 81%1XC*G1&U#]T3EG7#1E
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MQ=_^@I+X[S[,;]38T0C0?@1HJ/7%;Y""JJ84&QZ]JX52WDFR;R(Q3>B$\[A
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MU2>_ZJ+,UOR9[6U6 @/S<"D#!&EZ <_I,[3F@@BTWUU_^B]02P,$%     @
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MF@]@?Z%47KTP@_H_#!S^&U!+ P04    "  %7 ]5,^.U.%T&  "Z#@  &0
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MO2FUBT:N[>WD0398!O9QB9=+H8P _CZ7>';K%L; _KIZ^7]02P,$%     @
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MVH Z@(.7&FP]B?4TY<(N72_&1A&6FO:&[EL:\UG.BLLZZHZQ^&:F24\)$_!
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MXO\J0A_ ]U..EX]RH0U4GYM._P%02P,$%     @ !5P/5>9,:#4V P  F 8
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M#6ZD;KG"3P"NK ">+Z0TVXTUL/M1<?(/4$L#!!0    (  5<#U5;:(P#-A,
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M!@7"9UH$M=T3 1 E^EU/QI+(<LRKVIAUV.B)'<'2;8.ENS-8GL<P?*CH>5L
MW#EU>P!LZ8DAQT&D(MFF(GWKMJO]IIT)B@7K =1*A)CUN_O[7-ZS$FH5B<<
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M(0@P"&JT*ZC JR#!@TKMZC AU\;',YB2"0_P7;-.[_63=CL['@I"+P!(A_6
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MU=*I2[+.8>ZJRE&)PLQ56Y[L)ZQ-J;W_I'<G\*6<=>^I=E"\$M6J:)HY5,.
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MXLCWL1_1^MA=\,K6/_3STN6[:GST4R+<@41H( >0*C?0X[8/28#ZVR#<]@,
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MPESJ#?!^*D2UF6@#VZMU[U]02P,$%     @ !5P/5;)"N-=W!   \PH  !D
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M MM9+LT"G)\)H;<#L\&N0>[^!U!+ P04    "  %7 ]5BS?U]_L"   [!@
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MQ0\<KNP"?+Z6TAP&=H/FDVGX+U!+ P04    "  %7 ]5FL[Z0+<"  "S!P
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MD$G*,R1@UO..\=$)[A@#N^*:PDINM9$)9<KYK>D,DYX7&$; (%8&@NC'$OK
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M2M\-;'.A#P\09H&>GW&N[COF@E#=[Z+?4$L#!!0    (  5<#U56S)AY@04
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M_^JU241+8!4B4+=\P'8/T<%6J+J5OWI2;D_4]C"T)@W0RU7\D%4Q^'/"9E0
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M0B8@HE/EKOL^VYCBRZVKY8E,%OEFSGTB91+GAW-* LJS">KZ-$GD\TGFH-A
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M-!M^F-VJ36OR_N==J[MEEI;.;N5&]SXAH#=;H32)HIE%VC(!OX(+&&L#QOJ
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M=O^P_/@'F"V7#V$ WLWN)G?3V>0CF-V]NU_<3C[-[N_ JX 6A,7Y:S $#\L
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ML1MHEKY1G_F&]L"H36CC]N(=+6O0C!$HS0.E^06M/!>K)C:J^Z+ISP1NW@B
MIH.@:&7A'Q)"N#TC=)LLHC1DNT2E@CA59X/44Q<E/$%L)]"6_%#J;Y8W:(H(
ME#8!I;F@- ^4YN.&9))ZZ6F:U0$ FDT"I<V@:.51<$@HX=<R2NK0$.5HS.0,
MGXA\8X-NHO0>?;FDFSO*OZ+_T U]H(E\"+R@2;C>$%[Z<L]XNM<X9$!34Z"T
M"2C-!:5YH#0?E#8%I06@M!D4K3RN#BDQG"<U(,_A8- ,&2AM DIS06D>*,T'
MI4U!:0$H;09%*P^10V(.MV?FZBO.6W1-N;I'5LUO9T S=*"T"2C-!:5YH#2_
MH&'\;-^EO:\]=(!F\D!I,RA:+OS^L]/4<A>TRD[OIRA[M,@/;N[O[G\A<)Z=
MBZ_<'^,3#S?<]_')-#__?\#G/T>X)'P5)2F*Z5*&TMX/Y7+$\Q/^^85@V^PL
M]QT3<HN6?5Q3LJ!<&<COEXR)IPL58/\[B]'_4$L#!!0    (  5<#U6)^V76
MA0@  '--   9    >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;+6<77.;.!2&
M_XK&N[/3SK0U$E]V-\F,XZ3;[*1M)FFW%YV]4$"VF?+A DZ:F?WQ*S"U3"#'
M%3WJ16-L](KWH",>A,31?99_+59"E.1[$J?%\6A5ENO7XW$1K$3"BU?96J3R
MET66)[R4F_ER7*QSP<.Z4!*/F65YXX1'Z>CDJ/[N*C\YRC9E'*7B*B?%)DEX
M_G JXNS^>$1'/[ZXCI:KLOIB?'*TYDMQ(\I/ZZM<;HUW*F&4B+2(LI3D8G$\
MFM'7<]^O"M1[_!.)^V+O,ZFLW&;9UVKC(CP>6=41B5@$927!Y9\[,1=Q7"G)
MX_C6B(YV=58%]S__4']3FY=F;GDAYEG\.0K+U?%H,B*A6/!-7%YG]V]%8\BM
M]((L+NK_R7VSKS4BP:8HLZ0I+(\@B=+M7_Z]"<1> >8^48 U!=C/%K"; G9M
M='MDM:TS7O*3HSR[)WFUMU2K/M2QJ4M+-U%:G<:;,I>_1K)<>7(S?WM^]NGR
MG'QX0V:7EQ_FLX\7']Y76U>?KN=O9S?GY.KZ8GY.GIV)DD=Q\9R\))]NSLBS
MWY\?C4MY!)7..&AJ.]W6QIZHS2/OLK1<%>0\#4784WX.EZ<,$!A+ZSO_[(?_
M4P8J_KU)7Q';>D&8Q5C? <'%ST0@B].Z. 4.Q]Z=#KO6LY_0F]=G7.3D6L2\
M:N?%*EH7Y,L[D=R*_-^^B(."52_PNECS0!R/9)H7(K\3HY,_?J.>]6>?6R2Q
MEG=GY]VIU=TGO)]N"OE-49!9\&T3%5&=YE\NY7?DHA1)T>O>P72/)-9R[^[<
MN^"9_UQW."(D_$[DL@,EFT(L-C&)HX7H,PZK3<F#X'E!/))L\X5:).0/19]K
M6,EOE"8[)=:CU++L[2Q[H/0[$49+OB9O!8_+5<!S>:+38I/S-!!DGB5KGCZ
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M+W=O<FMS:&5E=',O<VAE970S-BYX;6RM5VUSXC80_BL:M]/)S5SB-_R6 C-
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M=Z^/8S2[1\_S&;J?S:<#-'G*GR^3V1.:CQ\'+^,[]#)#@]$?KY/%)#=?W8'
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M?.>O&WD_ J8<Y/<5I>)]H":H;ES]?P!02P,$%     @ !5P/506C(CC^"0
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M)>04>),TRLK_P7,5"SM@LLSR-*X&2P9QF*Q^LN]5(38&8'?' %P-P(<.(-4
M4B:Z8E:F=<ERUCL5Z3,01;1$*SZ4M2E'RVS"I/@SCG,A?QO*<7EO?/%Q</GY
MTP#<? ##T7U_=#4\EU?]\7AP/P;]T27X.AA>?;P?7)[TOPSN^E<#<#>X[@]'
MP]$5Z%_?W-T/_^K?#V]&X'9P-[RY!+]>\IR%4?8;. &?Q_+ZY]].N[ED6LS7
MG52LSE>L\ Y6+KA.DWR>@4$RY5/-^ OS>(0- %U9HG6=\&N=SK$1\<]E\@X0
M^#O $&,=(?/P2SZ1PU$Y'!GHD/6?C91XS@Z\#V$2YOSDDUP"4S!,<I;,PH>(
M@WZ6\3P#?W^2\6"8\SC[1U?]%3C1@Q?*\3Y;L D_ZTAIR+AXXIW>+S\A%_ZA
MR]P26*T.=%T':D+O78DTR\"$"?$2)C/ XG29Y+J,5S!N"5-(VU,/!1[R*26G
MW:?-;#2!T T\[.!U8(VILV;J&)GV)Y-EO(Q8+O]@DJ;(P_]8(60ZLBLDNL'A
MA :NZP9XBZPFD+C()[O(NFNRKI'L2.X?!Q35;=:*>@Z2_[9X-@,]Z/D!A'J:
MWIJF9Z1Y+]A4[FIRQP,LF8+R$HQ8S.4*N.;Q Q?:N]\(VO;NMP16R]]?Y^\?
M4P5\FW6P!%:K0["N0V"\#[Z6FW6QL)ZXD.9#^HO"P50W[WJI@0478:K;3L[-
M^!2\<"8R@""(5]L*IF#*7C)=(<Q0I()R*R1#]@BJ/1S:4<$*9W,A8D2Q[_A;
M"U83B#S/DZM;OV+1AM] UG2P@JKIFP\IQ'";KB;0A8&/=^@@PHHNMJ&$%4JM
M7H3X/FD45A.(7,]UR ZFRA$@XT;;D^N?BX1%T0NXY$_2GR]DA<?I8_[,!#?J
MH1FXK1#80JN701D"1(^IB<CH-UK7PA):O1;*<B"SY_AQ7=PS 36J656#PR#\
M5VF5WKTIK?4"*!N#S#[F<&'46!F"7=04QF:@$SADP_'4J2HK@\Q>II4N>DVY
M0P2YCK/-5A.(:Z:WSE89#V3<SP^615^C=@%UX+;KU@0ZTN]"?P=1Y0R0>;^]
M*!^AN0!W/"KKF<W#A=D>FA%;2X EM/I3J[(&&!Y3#K'1>+2MA2VT>BV4]<!F
MZ_'C<KAG@F!+#@O#N,LF[H'RVLLB5J8&FTW-P;*(=6XEP!@'VPY,$TDQ\38#
MZV25K\%F7]-&&"NHNC#*!U+DT6V^NDA(?0^[.P@K!X+-9Q(':B/6G310Z$@[
MN,VU&4F0[SLNW4%5&01LWGQOEV(R9]FA1M&,UEH-+*'5<U?> +M'54:C\VA=
M"TMH]5HH\X'-YL.",K[A' 1H*V%FZKWJH;M7#I69P68S<[@<ZEP*)MC;7K![
MX^I,E9O!9C?32@N#IL+IV6H"J8,#?\>S/E'F@YC/)0Y40C-*BWN':$XM8$#H
MCE, HIP#,>_&7\(I3\&M2*?+5??I520,8FF&;'W(;@FM7@#E& @^:K_!Z$=:
MU\(26KT6&ZT7LR'Y<;'<,X%1XZH2F!%0Z1Y-V2HW0RQU6$C3I3@0PFVCJ G#
MM; Z3V5EB+W^"M'T3:0PTNWVBGG*@X2IGHTR)\1* X8T3R.PZS4.+71AAIHK
MVT#,F_$H34XF:;S@>;A2Q9G@/.;)/F6TVH"QA5:O@3(/Y*@]&&*U"6,+K5X+
M94_(L?LP>R; U5,Q/: /<R#4GIY.O2NMG ^UU)&A3<M"'/D<BK9U<U<@#/2K
MF"IS0^UU9*BFT8)\[#F- P%M)/5\XNUXP*;*C% K/1FJ.;QP/0\WND>:0 RQ
M2\F.8U*JK (U[\,7\LX2;")UX(%-OD7IS*B+9K"V6F +K9[ZQHL91^W#4*M]
M&%MH]5HH;T*/W8?9,X&I_V(>^M;<E9.AEEHP5&-2D,9 FN=[:S[*\U![?1JJ
MZ]- Z/K;IY'F.=^:D_(PU$HWAVJZ.?+QNG%>:9ZM;3;=C9<;8RYFY3N?\HXJ
M6*[><UQ_NWZOM%^^3=E5X:N74J^9F(5)!B+^*(?"=YY<&F+UGN?J(D\7Y:N2
M#VF>IW'Y<<[9E(LB0/[^,4WSUXMB@O7;MKW_ 5!+ P04    "  %7 ]5K.YH
M[04#  "L"0  &0   'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6RMENUNVC 8
MA6_%RJ:ID[;F.X$.(E&@+5-+&8%MVK0?!EX@JA,SVT![][.3-*.0A@E-0L1V
M?(Z?X\2Q&UO*'O@20*#'F"2\J2V%6%WH.I\N(<;\G*X@D7?FE,58R"I;Z'S%
M ,]244QTRS \/<91H@6-M&W @@9="Q(E,&"(K^,8LZ=+('3;U$SMN6$8+99"
M->A!8X47$((8KP9,UO3"91;%D/"()HC!O*FUS(MV7?5/.WR-8,MWRD@EF5#Z
MH"J]65,S%! 0F KE@.5E VT@1!E)C-^YIU8,J82[Y6?WJS2[S#+!'-J4?(MF
M8MG4:AJ:P1ROB1C2[0WD>5SE-Z6$I_]HF_<U-#1=<T'C7"P)XBC)KO@QGX<=
M@>F\(K!R@?6O CL7V&G0C"R-U<$"!PU&MXBIWM)-%=*Y2=4R392HIQ@*)N]&
M4B>"L'W3[8QON^C^"K7N[H>CWH_6J'??1]WO@VX_S-K;7\:]8;>#>OU1JW_=
MN[SMAJ@5AMU1B,XZ('!$^'OT$8W##CI[^[ZA"PFF[/5I#G&905BO0'Q>)^?(
M-CX@R["L$GF[6MZ!J92;J=Q\*=?E=!1S8A5S8J5^[BM^UY3.MA$A""<SU$L$
M3A;1A !J<0Z"HT[$IX3R-0/TLS7A@LE7\5=9Z&P4NWP4M3PO^ I/H:G)]<>!
M;4 +WKTQ/>-3V13\)[,7$V(7$V)7N0?JL: S!NJK, .&Z!P] 6:E3SIS\E(G
M]0G9!*;M.ZXIG^MF-T_EB"?F<8H\SK$\=AE[IG)VV"W',UUWG[W2_41VMV!W
MC[$[9>SN(;M1LQW7V&.O=#^1W2O8O6/L;AF[=\!N^H9=4T%?L%>ZG\CN%^S^
M,7:OC-T_9'<\^<;[>^R5[B>RUPKV6B7[: ERAY\+8&4):@<)7,]S/,_;2U Y
MQHD)ZD6">G4"*C I@Z\??FX<WS7E;X_^L*-O^+6Z\7=]9&#ZSEZJSC%WF"VB
MA","<ZDTSGVY@%AV-L@J@J[2[75"A=RLT^)2'J> J0[R_IQ2\5Q1.W9Q0 O^
M %!+ P04    "  %7 ]5"&.FA;\"  !;"0  &0   'AL+W=O<FMS:&5E=',O
M<VAE970T,2YX;6RMEM%.VS 4AE_%RJ8))"!.TJ:,M9$*8= )2M7"N)AVX3:G
MU)L39[;;PMO/=D+40AL!ZDULQ^?[[?/G)$Y[R<5?.0-0Z#%EF>PX,Z7R$]>5
MDQFD1![Q'#(],^4B)4H/Q8,K<P$DL5#*7!_CT$T)S9RH;>\-1-3F<\5H!@.!
MY#Q-B7@Z!<:7'<=SGF\,Z<-,F1MNU,[) XQ W>4#H4=NI9+0%#))>88$3#M.
MUSN)0Q-O WY26,J5/C*9C#G_:P:]I.-@LR%@,%%&@>AF 6? F!'2V_A7:CK5
MD@9<[3^K?[>YZUS&1,(99_<T4;..<^R@!*9DSM20+R^AS*=I]":<27M%RR(V
M;#EH,I>*IR6L=Y#2K&C)8^G#"N UM@!^"?AO!8(2"-X*-$J@89TI4K$^Q$21
MJ"WX$@D3K=5,QYII:9T^S<QC'RFA9ZGF5'1Q<Q/?]ZZN4+<?HYO;R_,AZO5O
MN_V+WNG5.>J.1N>W([07@R*42=0G0A#SH/;1(;H;Q6CO\W[;57H?1LV=E&N>
M%FOZ6];\,<^.4( /D(]]?P-^5H_',-&X9W%O QZ_'<?KN*O-JQST*P=]JQ=L
M<Y#S9$D9V^1#08:6-"_@(@J"QG'HX5;;7:QF_#K0P[B)_=:+P/AUX'$K]%I^
MLXI;2R*HD@AJDQC"@MHWF4_10% NT !TDQR@;O)'5Z%^T17Z=0WI&,3O39G6
MRIMOUXG,R00ZCOXX21 +<*(OG[P0?]OT_'<I%N](;,W61F5KX\.U44N^U[%=
MBL6%6&.EQ@Z;6!?NEAIK5F8T:\T8"%UD?"[9$QI"SH6"I+:D:M7>:] NQ>(=
MB:VY&%8NAA\NJ5KRO8[M4BP.7WVVOOIA$[?PBY)R5TXR\]MQ3<0#S21B,-4D
M/FIIZT5QE!<#Q7-[N(VYTD>E[<[TWP\($Z#GIYRKYX$Y+ZO_J>@_4$L#!!0
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MKEQ!5N[?E -!U\46R L5@F;%Z0K(')@*D/<7E(JW@=I5J7;1AO\!4$L#!!0
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M.4$\7Q'"7P>RC2K;YN O4$L#!!0    (  5<#U4>@CS><@,  *,*   9
M>&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;-5676_B.!3]*U9VM>I(;?,!!.A"
M)#[:&593BJ"S^S#:!Y/<$&N2F+$=Z.ROWVLGS5*:1AJI+_M"8ON>XW//M<,=
M';GX)A, 19ZR-)=C*U%J?V/;,DP@H_*:[R''E9B+C"H<BITM]P)H9$!9:GN.
MX]L99;D5C,S<2@0C7JB4Y; 21!991L6/*:3\.+9<ZWEBS7:)TA-V,-K3'6Q
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MJ^L>[9''.,OBQ>;;F0B?1%)LD/_^.8ZSW0]%!Z]Q\F-S-V_^#U!+ P04
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M0\\=HK-1_W&?H..:!49/7\B#5_+@&7GX3(14,8ML-N$MYE';4%T90;K.&^^
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M-EVGY: EK$C!U"/?W<,^H=#$6W FRR?:56-#35P44O%T+];]E&;5F[SL)^)
M@/$) =X+<.F[ I4N>T21I"/X#@DS6D<SC3+54JW-T<RLRE0)_9=JG4JF=_?]
MWFS41S\&:#![FCWVT7CX,!S/QFC4OYGVT>3F][C_\(2N>J (9?)SQU6::]3N
M8L^XK1CX!.-[D5VCP/N"L(<QFDU[Z.KCNS"NMEU[Q[5W7,8-3\0=@5X.:?-3
MZ0*[SFSTMLS) KJ.WLD2Q!:<Y-,'/_*^G7$5U*Z"<]$3DZ3-4Z6*2I4Y*]LD
M\ (<1AUW:Z$U:EKC$BVPT2I5XX 6-B+<#.VTL*:%EV@-&RT\HN$PB+V6G1;5
MM.@2+;31HB.:WVCXQIF-UJQIS4NTR$9K'M/\H!F<R*U5TUIG:4\;T$5TI4#8
MF*WC^8Q:VJ"=&=?,^#R3*\)0D2VI7/ B4[!$NKH+HFBV1LP<)I235UURE?50
MQ<<3$>$X] *[*]_[5X*\L[Y&(&4;#=.\,):H-J9/I;+6&>_(PU<_BN/FB=7P
M#\J@?];#Q!2"3*$M804@OCJ:&4;)G#*JJ+WB[,-'_VW*, [Q^Q/G'M1J<^^-
MB5C33&K*2BN]ZZ8^2Z*Z2JJ.XGE9ON=<Z<N@;&[T]0O"#-#_5YRKMXZY$>H+
M/?D+4$L#!!0    (  5<#U7X?5L1Z0(  &T*   9    >&PO=V]R:W-H965T
M<R]S:&5E=#4Q+GAM;*U6;6^;,!#^*Q:;IE;JPCM9,X+4!*9M6K>J4=?/+EP
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M,1J+&J%-<]-,.*G5[7U'N.@%U# 3_2!0:2"^+PGAVXETT'68P5]02P,$%
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M*[:"P3."CPDBI%$H:TJMV!8&R@@(.G5!9*VZ/4(YYK3T4]-2CE'B<;YG)!N
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M$4<P!^ !0\*P/ =WSJ-@?4X%F_]0#G\#4$L#!!0    (  5<#U67BKL<P
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M_#(LLAM(]PJ,2:8MBETR!,>!239O,!8E%5UUID)%27:#,2FUZ(K5$ED;>Y7
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M_KJ\G1R\ERO. ?Z1OWP#4$L#!!0    (  5<#U4RX8'AQP$  !(?   3
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M4')O<',O8V]R92YX;6Q02P$"% ,4    "  %7 ]5F5R<(Q &  "<)P  $P
M            @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M  5<#U5BU:X$. 8  %8C   8              " @0T(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    "  %7 ]5<+ORF8<'  !>(   &
M            @(%[#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#
M%     @ !5P/562W6VX7 P  3PH  !@              ("!.!8  'AL+W=O
M<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    (  5<#U73/JBJ*08  ',;
M   8              " @849  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q0
M2P$"% ,4    "  %7 ]5J5,<U#(/   TDP  &               @('D'P
M>&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ !5P/52K;H!^=
M @  WP8  !@              ("!3"\  'AL+W=O<FMS:&5E=',O<VAE970V
M+GAM;%!+ 0(4 Q0    (  5<#U6]9GPJK@D  &,M   8              "
M@1\R  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    "  %7 ]5
MMK@:[M<2  "#+0  &               @($#/   >&PO=V]R:W-H965T<R]S
M:&5E=#@N>&UL4$L! A0#%     @ !5P/5>_%AD^\"0  /"   !@
M     ("!$$\  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    (
M  5<#U4SX[4X708  +H.   9              " @0)9  !X;"]W;W)K<VAE
M971S+W-H965T,3 N>&UL4$L! A0#%     @ !5P/5:,&C-SX!   ? L  !D
M             ("!EE\  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"
M% ,4    "  %7 ]50IP+(]($  "F"@  &0              @('%9   >&PO
M=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    (  5<#U5NYO]3Z@0
M $$+   9              " @<YI  !X;"]W;W)K<VAE971S+W-H965T,3,N
M>&UL4$L! A0#%     @ !5P/5<E*6X:T!@  >A(  !D              ("!
M[VX  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    "  %7 ]5
MYDQH-38#  "8!@  &0              @(':=0  >&PO=V]R:W-H965T<R]S
M:&5E=#$U+GAM;%!+ 0(4 Q0    (  5<#U6KI&&BA 4  & ,   9
M      " @4=Y  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%
M  @ !5P/55MHC ,V$P  A3$  !D              ("! G\  'AL+W=O<FMS
M:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    "  %7 ]5K+SN_ET,  #K(
M&0              @(%OD@  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+
M 0(4 Q0    (  5<#U693[:,)04  !X/   9              " @0.?  !X
M;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ !5P/547R/!XJ
M!@  9@\  !D              ("!7Z0  'AL+W=O<FMS:&5E=',O<VAE970R
M,"YX;6Q02P$"% ,4    "  %7 ]5LD*XUW<$  #S"@  &0
M@(' J@  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    (  5<
M#U6 S-FB000  "P+   9              " @6ZO  !X;"]W;W)K<VAE971S
M+W-H965T,C(N>&UL4$L! A0#%     @ !5P/58LW]??[ @  .P8  !D
M         ("!YK,  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4
M    "  %7 ]5L!@8@28$   ^"0  &0              @($8MP  >&PO=V]R
M:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    (  5<#U6:SOI MP(  +,'
M   9              " @76[  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL
M4$L! A0#%     @ !5P/5>%ZWP2J P  FA$  !D              ("!8[X
M 'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    "  %7 ]5=5'U
MBL4%  ".)P  &0              @(%$P@  >&PO=V]R:W-H965T<R]S:&5E
M=#(W+GAM;%!+ 0(4 Q0    (  5<#U7,^6%\Q@(  &X'   9
M  " @4#(  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @
M!5P/5:>R2*E< P  ZPT  !D              ("!/<L  'AL+W=O<FMS:&5E
M=',O<VAE970R.2YX;6Q02P$"% ,4    "  %7 ]55LR8>8$%  !,'   &0
M            @('0S@  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4
M Q0    (  5<#U6E>QJ&/@P  +2.   9              " @8C4  !X;"]W
M;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ !5P/5:EX:PR* P
M#A(  !D              ("!_>   'AL+W=O<FMS:&5E=',O<VAE970S,BYX
M;6Q02P$"% ,4    "  %7 ]58QK?)]H$  !'&@  &0              @(&^
MY   >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    (  5<#U66
MEV7QYP8  ',Q   9              " @<_I  !X;"]W;W)K<VAE971S+W-H
M965T,S0N>&UL4$L! A0#%     @ !5P/58G[9=:%"   <TT  !D
M     ("![?   'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  5<#U6L[FCM!0,  *P)   9              "
M@=L2 0!X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ !5P/
M50ACIH6_ @  6PD  !D              ("!%Q8! 'AL+W=O<FMS:&5E=',O
M<VAE970T,2YX;6Q02P$"% ,4    "  %7 ]5'IO(1:<#  !1$P  &0
M        @($-&0$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0
M   (  5<#U4X_,"C)@0  $06   9              " @>L< 0!X;"]W;W)K
M<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ !5P/54P7Y]X] P  0@L
M !D              ("!2"$! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q0
M2P$"% ,4    "  %7 ]5'H(\WG(#  "C"@  &0              @(&\) $
M>&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    (  5<#U427<G7
M)PL  $24   9              " @64H 0!X;"]W;W)K<VAE971S+W-H965T
M-#8N>&UL4$L! A0#%     @ !5P/54Q;BCBG#   #+,  !D
M ("!PS,! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    "  %
M7 ]5X#@=Y)(%  "0'0  &0              @(&A0 $ >&PO=V]R:W-H965T
M<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    (  5<#U5FNX^3MP4   HF   9
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M;',O+G)E;'-02P$"% ,4    "  %7 ]5JVH7-<,$  #W(@  #P
M    @ '/7@$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ !5P/58HQ=E_/
M 0  ,Q\  !H              ( !OV,! 'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ !5P/53+A@>'' 0  $A\  !,
M ( !QF4! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     #P / !;$   OF<!
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>404</ContextCount>
  <ElementCount>304</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>98</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/BalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/StatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficitParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/StatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinations</Role>
      <ShortName>STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssets</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - LONG-TERM DEBT AND SHORT-TERM FINANCINGS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancings</Role>
      <ShortName>LONG-TERM DEBT AND SHORT-TERM FINANCINGS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - WARRANT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/WarrantLiabilities</Role>
      <ShortName>WARRANT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/Equity</Role>
      <ShortName>EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - EARNINGS (LOSS) PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/EarningsLossPerShare</Role>
      <ShortName>EARNINGS (LOSS) PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/Leases</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsTables</Role>
      <ShortName>STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinations</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssets</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - LONG-TERM DEBT AND SHORT-TERM FINANCINGS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsTables</Role>
      <ShortName>LONG-TERM DEBT AND SHORT-TERM FINANCINGS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancings</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/EarningsLossPerShareTables</Role>
      <ShortName>EARNINGS (LOSS) PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://relianceglobalgroup.com/role/EarningsLossPerShare</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/LeasesTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://relianceglobalgroup.com/role/Leases</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://relianceglobalgroup.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/ScheduleOfRestrictedCashInStatementOfCashFlowDetails</Role>
      <ShortName>SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - SCHEDULE OF FAIR VALUE OF WARRANT COMMITMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/ScheduleOfFairValueOfWarrantCommitmentDetails</Role>
      <ShortName>SCHEDULE OF FAIR VALUE OF WARRANT COMMITMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - SCHEDULE OF RECONCILES WARRANT COMMITMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/ScheduleOfReconcilesWarrantCommitmentDetails</Role>
      <ShortName>SCHEDULE OF RECONCILES WARRANT COMMITMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - SCHEDULE OF FAIR VALUE MEASUREMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/ScheduleOfFairValueMeasurementsDetails</Role>
      <ShortName>SCHEDULE OF FAIR VALUE MEASUREMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - SCHEDULE OF EARN OUT LIABILITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails</Role>
      <ShortName>SCHEDULE OF EARN OUT LIABILITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails</Role>
      <ShortName>SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - SCHEDULE OF DISAGGREGATION REVENUE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails</Role>
      <ShortName>SCHEDULE OF DISAGGREGATION REVENUE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - SCHEDULE OF CONCENTRATIONS OF REVENUES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails</Role>
      <ShortName>SCHEDULE OF CONCENTRATIONS OF REVENUES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/SummarizesChangesToPreviouslyIssuedFinancialInformationDetails</Role>
      <ShortName>SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - SCHEDULE OF ALLOCATION OF PURCHASE PRICE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails</Role>
      <ShortName>SCHEDULE OF ALLOCATION OF PURCHASE PRICE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - SCHEDULE OF PRO FORMA INFORMATION RELATED TO ACQUISITION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/ScheduleOfProFormaInformationRelatedToAcquisitionDetails</Role>
      <ShortName>SCHEDULE OF PRO FORMA INFORMATION RELATED TO ACQUISITION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative</Role>
      <ShortName>STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - SCHEDULE OF IMPAIRMENT OF GOODWILL (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/ScheduleOfImpairmentOfGoodwillDetails</Role>
      <ShortName>SCHEDULE OF IMPAIRMENT OF GOODWILL (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails</Role>
      <ShortName>SCHEDULE OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - SCHEDULE OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails</Role>
      <ShortName>SCHEDULE OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsDetailsNarrative</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - SCHEDULE OF LONG TERM DEBT (Details) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical</Role>
      <ShortName>SCHEDULE OF LONG TERM DEBT (Details) (Parenthetical)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - SCHEDULE OF LONG TERM DEBT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails</Role>
      <ShortName>SCHEDULE OF LONG TERM DEBT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - SCHEDULE OF CUMULATIVE MATURITIES OF LONG-TERM LOANS AND CREDIT FACILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails</Role>
      <ShortName>SCHEDULE OF CUMULATIVE MATURITIES OF LONG-TERM LOANS AND CREDIT FACILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - LONG-TERM DEBT AND SHORT-TERM FINANCINGS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsDetailsNarrative</Role>
      <ShortName>LONG-TERM DEBT AND SHORT-TERM FINANCINGS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - WARRANT LIABILITIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative</Role>
      <ShortName>WARRANT LIABILITIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://relianceglobalgroup.com/role/WarrantLiabilities</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - EQUITY (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/EquityDetailsNarrative</Role>
      <ShortName>EQUITY (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://relianceglobalgroup.com/role/Equity</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails</Role>
      <ShortName>SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - EARNINGS (LOSS) PER SHARE (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative</Role>
      <ShortName>EARNINGS (LOSS) PER SHARE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://relianceglobalgroup.com/role/EarningsLossPerShareTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails</Role>
      <ShortName>SCHEDULE OF FUTURE MINIMUM LEASE PAYMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - LEASES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/LeasesDetailsNarrative</Role>
      <ShortName>LEASES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://relianceglobalgroup.com/role/LeasesTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - SCHEDULE OF EARN-OUT LIABILITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails</Role>
      <ShortName>SCHEDULE OF EARN-OUT LIABILITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="form10-q.htm">form10-q.htm</File>
    <File>ex3-13.htm</File>
    <File>ex31-1.htm</File>
    <File>ex31-2.htm</File>
    <File>ex32-1.htm</File>
    <File>reli-20220630.xsd</File>
    <File>reli-20220630_cal.xml</File>
    <File>reli-20220630_def.xml</File>
    <File>reli-20220630_lab.xml</File>
    <File>reli-20220630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="926">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="33">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>70
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form10-q.htm": {
   "axisCustom": 0,
   "axisStandard": 23,
   "contextCount": 404,
   "dts": {
    "calculationLink": {
     "local": [
      "reli-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "reli-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "form10-q.htm"
     ]
    },
    "labelLink": {
     "local": [
      "reli-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "reli-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "reli-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 524,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 145,
    "http://relianceglobalgroup.com/20220630": 76,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 225
   },
   "keyCustom": 66,
   "keyStandard": 238,
   "memberCustom": 67,
   "memberStandard": 27,
   "nsprefix": "RELI",
   "nsuri": "http://relianceglobalgroup.com/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://relianceglobalgroup.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS",
     "role": "http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssets",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "RELI:LongTermDebtAndShortTermFinancingsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - LONG-TERM DEBT AND SHORT-TERM FINANCINGS",
     "role": "http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancings",
     "shortName": "LONG-TERM DEBT AND SHORT-TERM FINANCINGS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "RELI:LongTermDebtAndShortTermFinancingsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "RELI:WarrantLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - WARRANT LIABILITIES",
     "role": "http://relianceglobalgroup.com/role/WarrantLiabilities",
     "shortName": "WARRANT LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "RELI:WarrantLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - EQUITY",
     "role": "http://relianceglobalgroup.com/role/Equity",
     "shortName": "EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - EARNINGS (LOSS) PER SHARE",
     "role": "http://relianceglobalgroup.com/role/EarningsLossPerShare",
     "shortName": "EARNINGS (LOSS) PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - LEASES",
     "role": "http://relianceglobalgroup.com/role/Leases",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://relianceglobalgroup.com/role/CommitmentsAndContingencies",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesPolicies",
     "shortName": "SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables",
     "shortName": "SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS (Tables)",
     "role": "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsTables",
     "shortName": "STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
     "role": "http://relianceglobalgroup.com/role/BalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AccountsReceivableRelatedPartiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "role": "http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsTables",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "RELI:LongTermDebtAndShortTermFinancingsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - LONG-TERM DEBT AND SHORT-TERM FINANCINGS (Tables)",
     "role": "http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsTables",
     "shortName": "LONG-TERM DEBT AND SHORT-TERM FINANCINGS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "RELI:LongTermDebtAndShortTermFinancingsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables)",
     "role": "http://relianceglobalgroup.com/role/EarningsLossPerShareTables",
     "shortName": "EARNINGS (LOSS) PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - LEASES (Tables)",
     "role": "http://relianceglobalgroup.com/role/LeasesTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "RELI:EarnOutLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)",
     "role": "http://relianceglobalgroup.com/role/CommitmentsAndContingenciesTables",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "RELI:EarnOutLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW (Details)",
     "role": "http://relianceglobalgroup.com/role/ScheduleOfRestrictedCashInStatementOfCashFlowDetails",
     "shortName": "SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-06-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30_us-gaap_MeasurementInputSharePriceMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - SCHEDULE OF FAIR VALUE OF WARRANT COMMITMENT (Details)",
     "role": "http://relianceglobalgroup.com/role/ScheduleOfFairValueOfWarrantCommitmentDetails",
     "shortName": "SCHEDULE OF FAIR VALUE OF WARRANT COMMITMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30_us-gaap_MeasurementInputSharePriceMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "RELI:ScheduleOfReconcilesWarrantCommitmentTableTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "RELI:WarrantCommitment",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - SCHEDULE OF RECONCILES WARRANT COMMITMENT (Details)",
     "role": "http://relianceglobalgroup.com/role/ScheduleOfReconcilesWarrantCommitmentDetails",
     "shortName": "SCHEDULE OF RECONCILES WARRANT COMMITMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "RELI:ScheduleOfReconcilesWarrantCommitmentTableTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-012022-03-31",
      "decimals": "0",
      "lang": null,
      "name": "RELI:InitialRecognitionOfWarrantCommitment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "RELI:ValuationTechnique",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - SCHEDULE OF FAIR VALUE MEASUREMENTS (Details)",
     "role": "http://relianceglobalgroup.com/role/ScheduleOfFairValueMeasurementsDetails",
     "shortName": "SCHEDULE OF FAIR VALUE MEASUREMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-012022-06-30_us-gaap_FairValueInputsLevel3Member",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "RELI:ValuationTechnique",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "RELI:RiskFreeRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - SCHEDULE OF EARN OUT LIABILITY (Details)",
     "role": "http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails",
     "shortName": "SCHEDULE OF EARN OUT LIABILITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "RELI:RiskFreeRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "role": "http://relianceglobalgroup.com/role/BalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesIssued",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:PreferredStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "RELI:EarnOutLiabilitiesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE (Details)",
     "role": "http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails",
     "shortName": "SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "lang": null,
      "name": "RELI:EarnoutLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-04-012022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - SCHEDULE OF DISAGGREGATION REVENUE (Details)",
     "role": "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails",
     "shortName": "SCHEDULE OF DISAGGREGATION REVENUE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-04-012022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-04-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_LTCGlobalMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - SCHEDULE OF CONCENTRATIONS OF REVENUES (Details)",
     "role": "http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails",
     "shortName": "SCHEDULE OF CONCENTRATIONS OF REVENUES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-04-012022-06-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_LTCGlobalMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION (Details)",
     "role": "http://relianceglobalgroup.com/role/SummarizesChangesToPreviouslyIssuedFinancialInformationDetails",
     "shortName": "SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
       "RELI:PriorPeriodAdjustmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "RELI:LiquidityPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestrictedCashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "role": "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative",
     "shortName": "SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "0",
      "lang": null,
      "name": "RELI:PaymentsToUndiscountedRemainingEarnOut",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-012022-06-30_us-gaap_CustomerRelationshipsMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - SCHEDULE OF ALLOCATION OF PURCHASE PRICE (Details)",
     "role": "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails",
     "shortName": "SCHEDULE OF ALLOCATION OF PURCHASE PRICE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30_custom_MedigapHealthcareInsuranceCompanyMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - SCHEDULE OF PRO FORMA INFORMATION RELATED TO ACQUISITION (Details)",
     "role": "http://relianceglobalgroup.com/role/ScheduleOfProFormaInformationRelatedToAcquisitionDetails",
     "shortName": "SCHEDULE OF PRO FORMA INFORMATION RELATED TO ACQUISITION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-012022-06-30_custom_MedigapHealthcareInsuranceCompanyMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS (Details Narrative)",
     "role": "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative",
     "shortName": "STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-04-252022-04-26_custom_APAMember_custom_BarraAndAssociatesLLCMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AssetAcquisitionConsiderationTransferred",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - SCHEDULE OF IMPAIRMENT OF GOODWILL (Details)",
     "role": "http://relianceglobalgroup.com/role/ScheduleOfImpairmentOfGoodwillDetails",
     "shortName": "SCHEDULE OF IMPAIRMENT OF GOODWILL (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-012021-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD (Details)",
     "role": "http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails",
     "shortName": "SCHEDULE OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-04-012022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "RELI:CommissionIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)",
     "role": "http://relianceglobalgroup.com/role/StatementsOfOperations",
     "shortName": "Condensed Consolidated Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-04-012022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "RELI:CommissionIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - SCHEDULE OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS (Details)",
     "role": "http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails",
     "shortName": "SCHEDULE OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details Narrative)",
     "role": "http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsDetailsNarrative",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "RELI:LongTermDebtAndShortTermFinancingsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30_custom_CCSMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherDeferredCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - SCHEDULE OF LONG TERM DEBT (Details) (Parenthetical)",
     "role": "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical",
     "shortName": "SCHEDULE OF LONG TERM DEBT (Details) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "RELI:LongTermDebtAndShortTermFinancingsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30_custom_CCSMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherDeferredCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "RELI:LongTermDebtAndShortTermFinancingsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - SCHEDULE OF LONG TERM DEBT (Details)",
     "role": "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails",
     "shortName": "SCHEDULE OF LONG TERM DEBT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "RELI:LongTermDebtAndShortTermFinancingsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30_custom_CCSMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "RELI:LongTermDebtAndShortTermFinancingsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000044 - Disclosure - SCHEDULE OF CUMULATIVE MATURITIES OF LONG-TERM LOANS AND CREDIT FACILITIES (Details)",
     "role": "http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails",
     "shortName": "SCHEDULE OF CUMULATIVE MATURITIES OF LONG-TERM LOANS AND CREDIT FACILITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "RELI:LongTermDebtAndShortTermFinancingsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "RELI:LongTermDebtAndShortTermFinancingsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShortTermBankLoansAndNotesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000045 - Disclosure - LONG-TERM DEBT AND SHORT-TERM FINANCINGS (Details Narrative)",
     "role": "http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsDetailsNarrative",
     "shortName": "LONG-TERM DEBT AND SHORT-TERM FINANCINGS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "RELI:LongTermDebtAndShortTermFinancingsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShortTermBankLoansAndNotesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000046 - Disclosure - WARRANT LIABILITIES (Details Narrative)",
     "role": "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative",
     "shortName": "WARRANT LIABILITIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "RELI:WarrantLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-012021-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:EquitySecuritiesFvNiUnrealizedLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000047 - Disclosure - EQUITY (Details Narrative)",
     "role": "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
     "shortName": "EQUITY (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-01-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:PreferredStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-04-012022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000048 - Disclosure - SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS (Details)",
     "role": "http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails",
     "shortName": "SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "0",
      "lang": null,
      "name": "RELI:DeemedDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockConversionBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000049 - Disclosure - EARNINGS (LOSS) PER SHARE (Details Narrative)",
     "role": "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative",
     "shortName": "EARNINGS (LOSS) PER SHARE (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockConversionBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2020-12-31_us-gaap_PreferredStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)",
     "role": "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-012021-03-31_us-gaap_AdditionalPaidInCapitalMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000050 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE PAYMENT (Details)",
     "role": "http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails",
     "shortName": "SCHEDULE OF FUTURE MINIMUM LEASE PAYMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-04-012022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000051 - Disclosure - LEASES (Details Narrative)",
     "role": "http://relianceglobalgroup.com/role/LeasesDetailsNarrative",
     "shortName": "LEASES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-04-012022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "RELI:EarnOutLiabilitiesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000052 - Disclosure - SCHEDULE OF EARN-OUT LIABILITY (Details)",
     "role": "http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails",
     "shortName": "SCHEDULE OF EARN-OUT LIABILITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "RELI:EarnOutLiabilitiesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "0",
      "lang": null,
      "name": "RELI:ChangesDueToAcquisitions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-012021-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) (Parenthetical)",
     "role": "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficitParenthetical",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2021-01-012021-03-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://relianceglobalgroup.com/role/StatementsOfCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPolicies",
     "shortName": "SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS",
     "role": "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinations",
     "shortName": "STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "form10-q.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 98,
   "tag": {
    "RELI_ABCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ABC [Member]",
        "label": "ABC [Member]"
       }
      }
     },
     "localname": "ABCMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_APAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "APA [Member]",
        "label": "APA [Member]"
       }
      }
     },
     "localname": "APAMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_AcquiredAccountsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired Accounts Receivable [Member]",
        "label": "Acquired Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AcquiredAccountsReceivableMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_AcquisitionOfBusinessDeferredPurchasePrice": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of business deferred purchase price.",
        "label": "Acquisition of business deferred purchase price"
       }
      }
     },
     "localname": "AcquisitionOfBusinessDeferredPurchasePrice",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_AcquisitionsAndSettlements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisitions and settlements.",
        "label": "Montana final settlement"
       }
      }
     },
     "localname": "AcquisitionsAndSettlements",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_AgencyRelationshipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency Relationships [Member]",
        "label": "Agency Relationships [Member]"
       }
      }
     },
     "localname": "AgencyRelationshipsMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate purchase price of common shares, preferred shares and warrants.",
        "label": "Aggregate purchase price of common shares, preferred shares and warrants"
       }
      }
     },
     "localname": "AggregatePurchasePriceOfCommonSharesPreferredSharesAndWarrants",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_AltruisBenefitsConsultantsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Altruis Benefits Consultants Inc [Member]",
        "label": "Altruis Benefits Consultants Inc [Member]"
       }
      }
     },
     "localname": "AltruisBenefitsConsultantsIncMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_AltruisBenefitsConsultingIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Altruis Benefits Consulting, LLC [Member]",
        "label": "Altruis Benefits Consulting, LLC [Member]"
       }
      }
     },
     "localname": "AltruisBenefitsConsultingIncMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_AltruisPartialSettlementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Altruis Partial Settlement [Member]"
       }
      }
     },
     "localname": "AltruisPartialSettlementMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_AntidilutiveSharesIssuedAndOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Antidilutive shares issued and outstanding",
        "label": "Antidilutive shares Issued and Outstanding"
       }
      }
     },
     "localname": "AntidilutiveSharesIssuedAndOutstanding",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "RELI_BackLogMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Back log [Member]",
        "label": "Back log [Member]"
       }
      }
     },
     "localname": "BackLogMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_BarraAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Barra Acquisition [Member]",
        "label": "Barra Acquisition [Member]"
       }
      }
     },
     "localname": "BarraAcquisitionMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_BarraAndAssociatesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Barra and Associates LLC [Member]",
        "label": "Barra and Associates LLC [Member]"
       }
      }
     },
     "localname": "BarraAndAssociatesLLCMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_BarraMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Barra [Member]",
        "label": "Barra [Member]"
       }
      }
     },
     "localname": "BarraMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfImpairmentOfGoodwillDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical",
      "http://relianceglobalgroup.com/role/ScheduleOfProFormaInformationRelatedToAcquisitionDetails",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_BlueCrossBlueShieldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BlueCross BlueShield [Member]",
        "label": "BlueCross BlueShield [Member]"
       }
      }
     },
     "localname": "BlueCrossBlueShieldMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_CCSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CCS [Member]",
        "label": "CCS [Member]"
       }
      }
     },
     "localname": "CCSMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_CCSWriteoffMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "C C S Writeoff [Member]"
       }
      }
     },
     "localname": "CCSWriteoffMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_ChangesDueToAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Changes due to acquisitions.",
        "label": "Changes due to acquisitions"
       }
      }
     },
     "localname": "ChangesDueToAcquisitions",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_ChangesDueToBusinessCombinations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Changes due to business combinations.",
        "label": "Changes due to business combinations"
       }
      }
     },
     "localname": "ChangesDueToBusinessCombinations",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_ChangesDueToFairValueAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Changes due to fair value adjustments.",
        "label": "Changes due to fair value adjustments"
       }
      }
     },
     "localname": "ChangesDueToFairValueAdjustments",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_ChangesDueToPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Changes due to payments.",
        "label": "Changes due to payments"
       }
      }
     },
     "localname": "ChangesDueToPayments",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_ChangesDueToWriteoffs": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Changes due to writeoffs.",
        "label": "Changes due to write-offs"
       }
      }
     },
     "localname": "ChangesDueToWriteoffs",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_ChargebackReserveCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Chargeback reserve current",
        "label": "Chargeback reserve"
       }
      }
     },
     "localname": "ChargebackReserveCurrent",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_ChargebackReserveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Chargeback reserve [Member]",
        "label": "Chargeback reserve [Member]"
       }
      }
     },
     "localname": "ChargebackReserveMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_CommercialCoverageSolutionsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Coverage Solutions LLC [Member]",
        "label": "Commercial Coverage Solutions LLC [Member]"
       }
      }
     },
     "localname": "CommercialCoverageSolutionsLLCMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_CommercialSolutionsOfInsuranceAgencyLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Solutions Of Insurance Agency LLC [Member]",
        "label": "Commercial Solutions Of Insurance Agency LLC [Member]"
       }
      }
     },
     "localname": "CommercialSolutionsOfInsuranceAgencyLLCMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_CommissionExpense": {
     "auth_ref": [],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission expense",
        "label": "Commission expense"
       }
      }
     },
     "localname": "CommissionExpense",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_CommissionIncome": {
     "auth_ref": [],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission income",
        "label": "Commission income"
       }
      }
     },
     "localname": "CommissionIncome",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_CommonStockIssuableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock issuable [Member]",
        "label": "Common stock issuable [Member]"
       }
      }
     },
     "localname": "CommonStockIssuableMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_CommonStockIssuedPursuantToAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock issued pursuant to acquisition",
        "label": "Common stock issued pursuant to acquisition"
       }
      }
     },
     "localname": "CommonStockIssuedPursuantToAcquisition",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_ContractsBacklogMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts backlog [Member]",
        "label": "Contracts backlog [Member]"
       }
      }
     },
     "localname": "ContractsBacklogMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_CustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer [Member]",
        "label": "Customer [Member]"
       }
      }
     },
     "localname": "CustomerMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_DeemedDividend": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deemed Dividend.",
        "label": "DeemedDividend",
        "negatedLabel": "Deemed dividend"
       }
      }
     },
     "localname": "DeemedDividend",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_DevelopedTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Developed Technology [Member]",
        "label": "Developed Technology [Member]"
       }
      }
     },
     "localname": "DevelopedTechnologyMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_DirectorsAndOfficerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Directors and Officer [Member]",
        "label": "Directors and Officer [Member]"
       }
      }
     },
     "localname": "DirectorsAndOfficerMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_DisclosureLeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases",
        "verboseLabel": "Schedule Of Future Minimum Lease Payment"
       }
      }
     },
     "localname": "DisclosureLeasesAbstract",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "xbrltype": "stringItemType"
    },
    "RELI_DisclosureLongtermDebtAndShorttermFinancingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term Debt And Short-term Financings",
        "verboseLabel": "Schedule Of Cumulative Maturities Of Long-term Loans And Credit Facilities"
       }
      }
     },
     "localname": "DisclosureLongtermDebtAndShorttermFinancingsAbstract",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "xbrltype": "stringItemType"
    },
    "RELI_DisclosureWarrantLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Liabilities"
       }
      }
     },
     "localname": "DisclosureWarrantLiabilitiesAbstract",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "xbrltype": "stringItemType"
    },
    "RELI_DiscountingConvention": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discounting convention.",
        "label": "Discounting Convention:"
       }
      }
     },
     "localname": "DiscountingConvention",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "RELI_EBSandUSBAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EBS and USBA [Member]",
        "label": "EBS and USBA [Member]"
       }
      }
     },
     "localname": "EBSandUSBAMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_EarnOutLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earn Out Liabilities [TableTextBlock]",
        "label": "SCHEDULE OF EARN-OUT LIABILITY"
       }
      }
     },
     "localname": "EarnOutLiabilitiesTableTextBlock",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/CommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "RELI_EarnoutFairValueAndWriteoffAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnout fair value and writeoff adjustments",
        "label": "Earn-out fair value and write-off adjustments"
       }
      }
     },
     "localname": "EarnoutFairValueAndWriteoffAdjustments",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_EarnoutLiabilityCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Less: Current portion"
       }
      }
     },
     "localname": "EarnoutLiabilityCurrent",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_EarnoutLiabilityNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Ending balance, less current portion"
       }
      }
     },
     "localname": "EarnoutLiabilityNoncurrent",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_EffectOfSeriesBWarrantLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect of series B warrant liability",
        "label": "Effect of Series B warrant liability"
       }
      }
     },
     "localname": "EffectOfSeriesBWarrantLiability",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_EmployeeBenefitsSolutionsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Benefits, Solutions, LLC [Member]",
        "label": "Employee Benefits, Solutions, LLC [Member]"
       }
      }
     },
     "localname": "EmployeeBenefitsSolutionsLLCMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_FISMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "FIS [Member]",
        "label": "FIS [Member]"
       }
      }
     },
     "localname": "FISMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_FinitelivedIntangibleAssetUsefulLives": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-lived intangible asset, useful lives.",
        "label": "Weighted average useful life description"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetUsefulLives",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "RELI_FortmanInsuranceAgencyLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fortman Insurance Agency LLC [Member]",
        "label": "Fortman Insurance Agency LLC [Member]"
       }
      }
     },
     "localname": "FortmanInsuranceAgencyLLCMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_FortmanInsuranceServicesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fortman Insurance Services, LLC [Member]",
        "label": "Fortman Insurance Services, LLC [Member]"
       }
      }
     },
     "localname": "FortmanInsuranceServicesLLCMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_InitialRecognitionOfWarrantCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial recognition of warrant commitment",
        "label": "Initial recognition"
       }
      }
     },
     "localname": "InitialRecognitionOfWarrantCommitment",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfReconcilesWarrantCommitmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_InternallyDevelopedSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally Developed Software [Member]",
        "label": "Internally Developed Software [Member]"
       }
      }
     },
     "localname": "InternallyDevelopedSoftwareMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_IssuanceOfCommonStockPursuantToPurchaseOfSoftware": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock pursuant to purchase of software",
        "label": "Issuance of common stock pursuant to the purchase of software"
       }
      }
     },
     "localname": "IssuanceOfCommonStockPursuantToPurchaseOfSoftware",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_IssuanceOfPlacementAgentWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of placement agent warrants",
        "label": "Issuance of placement agent warrants",
        "verboseLabel": "Derivative liability measured at fair value"
       }
      }
     },
     "localname": "IssuanceOfPlacementAgentWarrants",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_IssuanceOfSeriesDWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of Series D Warrants.",
        "label": "Issuance of Series D Warrants"
       }
      }
     },
     "localname": "IssuanceOfSeriesDWarrants",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative",
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_JPKushAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "J P Kush Acquisition [Member]"
       }
      }
     },
     "localname": "JPKushAcquisitionMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_JPKushAndAssociatesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "JP Kush and Associates Inc [Member]",
        "label": "JP Kush and Associates Inc [Member]"
       }
      }
     },
     "localname": "JPKushAndAssociatesIncMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_KushMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kush [Member].",
        "label": "Kush [Member]."
       }
      }
     },
     "localname": "KushMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_LTCGlobalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "LTC Global [Member]",
        "label": "LTC Global [Member]"
       }
      }
     },
     "localname": "LTCGlobalMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_LeaseAssetsAcquiredInExchangeForLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease assets acquired in exchange for lease liabilities.",
        "label": "Lease assets acquired in exchange for lease liabilities"
       }
      }
     },
     "localname": "LeaseAssetsAcquiredInExchangeForLeaseLiabilities",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_LeaseLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease liability [Member]",
        "label": "Lease liability [Member]"
       }
      }
     },
     "localname": "LeaseLiabilityMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_LiquidityPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liquidity [PolicyTextBlock]",
        "label": "Liquidity"
       }
      }
     },
     "localname": "LiquidityPolicyTextBlock",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "RELI_LongTermDebtAndShortTermFinancingsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Debt And Short Term Financings [TextBlock]",
        "label": "LONG-TERM DEBT AND SHORT-TERM FINANCINGS"
       }
      }
     },
     "localname": "LongTermDebtAndShortTermFinancingsTextBlock",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "RELI_MeasurementInputObsolescenceRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input Obsolescence Rate [Member]",
        "label": "Measurement Input Obsolescence Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputObsolescenceRateMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_MeasurementInputPaymentDelayMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Payment Delay [Member]"
       }
      }
     },
     "localname": "MeasurementInputPaymentDelayMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_MeasurementInputRiskPremiumMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Risk Premium [Member]"
       }
      }
     },
     "localname": "MeasurementInputRiskPremiumMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_MeasurementInputRoyaltyRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input Royalty Rate [Member]",
        "label": "Measurement Input Royalty Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputRoyaltyRateMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_MedicalLifeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical/Life [Member]",
        "label": "Medical/Life [Member]"
       }
      }
     },
     "localname": "MedicalLifeMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_MedigapAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medigap Acquisition [Member]",
        "label": "Medigap Acquisition [Member]"
       }
      }
     },
     "localname": "MedigapAcquisitionMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_MedigapHealthcareInsuranceCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medigap healthcare insurance company [Member]",
        "label": "Medigap Healthcare Insurance Company [Member]"
       }
      }
     },
     "localname": "MedigapHealthcareInsuranceCompanyMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfImpairmentOfGoodwillDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfProFormaInformationRelatedToAcquisitionDetails",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_MedigapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medigap [Member]",
        "label": "Medigap [Member]"
       }
      }
     },
     "localname": "MedigapMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_MontanaFinalSettlementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Montana Final Settlement [Member]",
        "label": "Montana Final Settlement [Member]"
       }
      }
     },
     "localname": "MontanaFinalSettlementMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants": {
     "auth_ref": [],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net proceeds from private placement issuance of shares and warrants",
        "label": "Net proceeds from private placement issuance of shares and warrants",
        "negatedLabel": "Netproceeds from private placement issuance of shares and warrants"
       }
      }
     },
     "localname": "NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_NonOperatingUnrealizedGains": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non operating unrealized gains.",
        "label": "NonOperatingUnrealizedGains",
        "verboseLabel": "Unrealized gain"
       }
      }
     },
     "localname": "NonOperatingUnrealizedGains",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_NoncashLeaseExpense": {
     "auth_ref": [],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non cash lease expense",
        "label": "Non-cash lease expense"
       }
      }
     },
     "localname": "NoncashLeaseExpense",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_NoncompetitionAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-competition Agreements [Member]",
        "label": "Non-competition Agreements [Member]"
       }
      }
     },
     "localname": "NoncompetitionAgreementsMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_NumberOfLterations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of lterations.",
        "label": "Number of Iterations"
       }
      }
     },
     "localname": "NumberOfLterations",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "RELI_PaidAtClosingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Paid at closing [Member]",
        "label": "Paid at closing [Member]"
       }
      }
     },
     "localname": "PaidAtClosingMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_PayableInSixMonthsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payable in six months [Member]",
        "label": "Payable in six months [Member]"
       }
      }
     },
     "localname": "PayableInSixMonthsMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_PayableOverTwoYearsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payable over two years [Member]",
        "label": "Payable over two years [Member]"
       }
      }
     },
     "localname": "PayableOverTwoYearsMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_PaymentsOnEarnoutLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments on earnout liabilities.",
        "label": "PaymentsOnEarnoutLiabilities",
        "negatedLabel": "Payments on earn-out liabilities"
       }
      }
     },
     "localname": "PaymentsOnEarnoutLiabilities",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_PaymentsToUndiscountedRemainingEarnOut": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to undiscounted remaining earn out.",
        "label": "Undiscounted remaining earn out payments"
       }
      }
     },
     "localname": "PaymentsToUndiscountedRemainingEarnOut",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_PlacementAgentWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Placement Agent Warrants [Member]"
       }
      }
     },
     "localname": "PlacementAgentWarrantsMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfReconcilesWarrantCommitmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_PrepaidInsuranceAcquiredThroughShorttermFinancing": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid insurance acquired through short term financing.",
        "label": "Prepaid insurance acquired through short-term financing"
       }
      }
     },
     "localname": "PrepaidInsuranceAcquiredThroughShorttermFinancing",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_PriorPeriodAdjustmentPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prior period adjustment [Policy Text Block]",
        "label": "Prior Period Adjustments"
       }
      }
     },
     "localname": "PriorPeriodAdjustmentPolicyTextBlock",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "RELI_PriorityHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Priority Health [Member]",
        "label": "Priority Health [Member]"
       }
      }
     },
     "localname": "PriorityHealthMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_ProceedsFromLoanForBusinessAcquisition": {
     "auth_ref": [],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from loan for business acquisition.",
        "label": "Proceeds from loan for business acquisition"
       }
      }
     },
     "localname": "ProceedsFromLoanForBusinessAcquisition",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_PropertyAndCasualtyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property and Casualty [Member]",
        "label": "Property and Casualty [Member]"
       }
      }
     },
     "localname": "PropertyAndCasualtyMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_PurchasedSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased Software [Member]",
        "label": "Purchased Software [Member]"
       }
      }
     },
     "localname": "PurchasedSoftwareMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_RecognitionAndChangeInFairValueOfWarrantLiability": {
     "auth_ref": [],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://relianceglobalgroup.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recognition and change in fair value of warrant liability.",
        "label": "Recognition and change in fair value of warrant liabilities",
        "negatedLabel": "Recognition and change in fair value of warrant liabilities"
       }
      }
     },
     "localname": "RecognitionAndChangeInFairValueOfWarrantLiability",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows",
      "http://relianceglobalgroup.com/role/StatementsOfOperations",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_RegularMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regular [Member]",
        "label": "Regular [Member]"
       }
      }
     },
     "localname": "RegularMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_RepaymentsOnShorttermFinancing": {
     "auth_ref": [],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayments on short term financing.",
        "label": "RepaymentsOnShorttermFinancing",
        "negatedLabel": "Repayments on short-term financing"
       }
      }
     },
     "localname": "RepaymentsOnShorttermFinancing",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_RightOfUseAssetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right of use asset [Member]",
        "label": "Right of use asset [Member]"
       }
      }
     },
     "localname": "RightOfUseAssetMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_RiskFreeRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk free rate.",
        "label": "RiskFreeRate",
        "verboseLabel": "Risk free rate"
       }
      }
     },
     "localname": "RiskFreeRate",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "RELI_SWMTMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SWMT [Member]",
        "label": "SWMT [Member]"
       }
      }
     },
     "localname": "SWMTMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_ScheduleOfReconcilesWarrantCommitmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of reconciles warrant commitment [Table Text Block]",
        "label": "SCHEDULE OF RECONCILES WARRANT COMMITMENT"
       }
      }
     },
     "localname": "ScheduleOfReconcilesWarrantCommitmentTableTextBlock",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "RELI_SecuritiesPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities Purchase Agreement [Member]",
        "label": "Securities Purchase Agreement [Member]"
       }
      }
     },
     "localname": "SecuritiesPurchaseAgreementMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_SeriesAWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A Warrant [Member]",
        "label": "Series A Warrant [Member]"
       }
      }
     },
     "localname": "SeriesAWarrantMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_SeriesAWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A Warrants [Member]",
        "label": "Series A Warrants [Member]"
       }
      }
     },
     "localname": "SeriesAWarrantsMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover",
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_SeriesBConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B Convertible Preferred Stock [Member]",
        "label": "Series B Convertible Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesBConvertiblePreferredStockMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_SeriesBWarrantCommitmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B Warrant Commitment [Member]",
        "label": "Series B Warrant Commitment [Member]"
       }
      }
     },
     "localname": "SeriesBWarrantCommitmentMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfReconcilesWarrantCommitmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_SeriesBWarrantLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B Warrant Liability [Member]",
        "label": "Series B Warrant Liability [Member]"
       }
      }
     },
     "localname": "SeriesBWarrantLiabilityMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative",
      "http://relianceglobalgroup.com/role/ScheduleOfReconcilesWarrantCommitmentDetails",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_SeriesCPrepaidWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C Prepaid Warrants [Member]",
        "label": "Series C Prepaid Warrants [Member]"
       }
      }
     },
     "localname": "SeriesCPrepaidWarrantsMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative",
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_SeriesDPrepaidWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series D Prepaid Warrants [Member]",
        "label": "Series D Prepaid Warrants [Member]"
       }
      }
     },
     "localname": "SeriesDPrepaidWarrantsMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative",
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_SharesIssuedDuringPeriodSharesToConversionOfDebt": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares issued during period shares to conversion of debt.",
        "label": "SharesIssuedDuringPeriodSharesToConversionOfDebt",
        "verboseLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "SharesIssuedDuringPeriodSharesToConversionOfDebt",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "RELI_SharesIssuedDuringPeriodValueToConversionOfDebt": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "shares issued during period value to conversion of debt.",
        "label": "Shares issued due to conversion of debt"
       }
      }
     },
     "localname": "SharesIssuedDuringPeriodValueToConversionOfDebt",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_SharesIssuedUponTerminationOfEmployee": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares issued upon termination of employee.",
        "label": "Shares issued upon termination of employee"
       }
      }
     },
     "localname": "SharesIssuedUponTerminationOfEmployee",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_ShortTermFinancingAgreements": {
     "auth_ref": [],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short term financing agreements.",
        "label": "Short term Financing Agreements"
       }
      }
     },
     "localname": "ShortTermFinancingAgreements",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_SignificantUnobservableInput": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant unobservable input.",
        "label": "Significant unobservable input"
       }
      }
     },
     "localname": "SignificantUnobservableInput",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "RELI_SouthwesternMontanaFinancialCenterIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Southwestern Montana Financial Center, Inc. [Member]",
        "label": "Southwestern Montana Financial Center, Inc. [Member]"
       }
      }
     },
     "localname": "SouthwesternMontanaFinancialCenterIncMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_SouthwesternMontanaInsuranceCenterIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Southwestern Montana Insurance Center Inc [Member]",
        "label": "Southwestern Montana Insurance Center Inc [Member]"
       }
      }
     },
     "localname": "SouthwesternMontanaInsuranceCenterIncMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_StockGrantedDuringPeriodSharesSharebasedCompensationGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock granted during period shares share based compensation gross.",
        "label": "Shares issued for vested stock awards, shares"
       }
      }
     },
     "localname": "StockGrantedDuringPeriodSharesSharebasedCompensationGross",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "RELI_StockIssuedDuringPeriodSharesInitialPublicOffering": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period shares initial public offering",
        "label": "StockIssuedDuringPeriodSharesInitialPublicOffering",
        "verboseLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesInitialPublicOffering",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "RELI_StockIssuedDuringPeriodSharesOverAllotmentShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period shares over allotment shares",
        "label": "StockIssuedDuringPeriodSharesOverAllotmentShares",
        "verboseLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOverAllotmentShares",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "RELI_StockIssuedDuringPeriodSharesWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants (or share units) exercised during the current period.",
        "label": "Exercise of Series A warrants, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesWarrantsExercised",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "RELI_StockIssuedDuringPeriodSharesWarrantsIntoCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period shares warrants into common stock.",
        "label": "Exercise of Series C warrants into common shares, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesWarrantsIntoCommonStock",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "RELI_StockIssuedDuringPeriodValueInitialPublicOffering": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period value initial public offering",
        "label": "Rounding shares related to initial public offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueInitialPublicOffering",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_StockIssuedDuringPeriodValueOverAllotmentShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period value over allotment shares",
        "label": "Over-allotment shares from offering, net of offering costs of $250,928"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOverAllotmentShares",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_StockIssuedDuringPeriodValueWarrantsExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of warrants.",
        "label": "Exercise of Series A warrants"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueWarrantsExercised",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_StockIssuedDuringPeriodValueWarrantsIntoCommonStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period value warrants into common stock.",
        "label": "Exercise of Series C warrants into common shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueWarrantsIntoCommonStock",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_SubscriptionReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subscription receivable [Member]",
        "label": "Subscription receivable [Member]"
       }
      }
     },
     "localname": "SubscriptionReceivableMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_ThreeEmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Employees [Member]",
        "label": "Three Employees [Member]"
       }
      }
     },
     "localname": "ThreeEmployeesMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_USBenefitsAllianceLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Benefits Alliance, LLC [Member]",
        "label": "US Benefits Alliance, LLC [Member]"
       }
      }
     },
     "localname": "USBenefitsAllianceLLCMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_ValuationTechnique": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation technique.",
        "label": "Valuation technique"
       }
      }
     },
     "localname": "ValuationTechnique",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "RELI_VideoProductionAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Video Production Assets [Member]",
        "label": "Video Production Assets [Member]"
       }
      }
     },
     "localname": "VideoProductionAssetsMember",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "RELI_WarrantCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant commitment.",
        "label": "Derivative liability",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "WarrantCommitment",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfReconcilesWarrantCommitmentDetails",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_WarrantCommitmentCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant commitment current",
        "label": "Warrant commitment"
       }
      }
     },
     "localname": "WarrantCommitmentCurrent",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_WarrantCommitmentUnrealizedGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrealized (gain) loss.",
        "label": "Unrealized gain"
       }
      }
     },
     "localname": "WarrantCommitmentUnrealizedGainLoss",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfReconcilesWarrantCommitmentDetails",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_WarrantLiabilitiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant Liabilities [TextBlock]",
        "label": "WARRANT LIABILITIES"
       }
      }
     },
     "localname": "WarrantLiabilitiesTextBlock",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/WarrantLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "RELI_WarrantLiabilityNonCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant liability non current",
        "label": "Warrant liabilities"
       }
      }
     },
     "localname": "WarrantLiabilityNonCurrent",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_WarrantSharesIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant shares issued",
        "label": "Warrant shares issued"
       }
      }
     },
     "localname": "WarrantSharesIssued",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "RELI_WarrantSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant shares outstanding",
        "label": "Warrant shares outstanding"
       }
      }
     },
     "localname": "WarrantSharesOutstanding",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "RELI_WarrantsExercisedOrTransferred": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants exercised or transferred.",
        "label": "Warrants exercised or transferred"
       }
      }
     },
     "localname": "WarrantsExercisedOrTransferred",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfReconcilesWarrantCommitmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_WorkingCapital": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Working capital.",
        "label": "Working capital"
       }
      }
     },
     "localname": "WorkingCapital",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "RELI_WorkingCapitalDeficiency": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Working capital deficiency.",
        "label": "Working capital deficiency",
        "negatedLabel": "Working capital deficit"
       }
      }
     },
     "localname": "WorkingCapitalDeficiency",
     "nsuri": "http://relianceglobalgroup.com/20220630",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r470",
      "r472",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r75",
      "r203",
      "r208",
      "r214",
      "r343",
      "r344",
      "r345",
      "r346",
      "r395",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r75",
      "r203",
      "r208",
      "r214",
      "r343",
      "r344",
      "r345",
      "r346",
      "r395",
      "r456"
     ],
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r151",
      "r270",
      "r272",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r197",
      "r198",
      "r199",
      "r200",
      "r219",
      "r238",
      "r291",
      "r294",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r437",
      "r440",
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r151",
      "r270",
      "r272",
      "r439"
     ],
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r149",
      "r198",
      "r199",
      "r270",
      "r271",
      "r410",
      "r436",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r149",
      "r198",
      "r199",
      "r270",
      "r271",
      "r410",
      "r436",
      "r438"
     ],
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r185",
      "r197",
      "r198",
      "r199",
      "r200",
      "r219",
      "r238",
      "r277",
      "r291",
      "r294",
      "r297",
      "r298",
      "r299",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r437",
      "r440",
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r185",
      "r197",
      "r198",
      "r199",
      "r200",
      "r219",
      "r238",
      "r277",
      "r291",
      "r294",
      "r297",
      "r298",
      "r299",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r437",
      "r440",
      "r457",
      "r458"
     ],
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAdjustmentMember": {
     "auth_ref": [
      "r77",
      "r78",
      "r79",
      "r80",
      "r81",
      "r82",
      "r83",
      "r85",
      "r87",
      "r88",
      "r90",
      "r91",
      "r116",
      "r354",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Adjustment [Member]"
       }
      }
     },
     "localname": "RestatementAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsDetailsNarrative",
      "http://relianceglobalgroup.com/role/SummarizesChangesToPreviouslyIssuedFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r1",
      "r77",
      "r78",
      "r79",
      "r80",
      "r81",
      "r82",
      "r83",
      "r84",
      "r85",
      "r87",
      "r88",
      "r89",
      "r90",
      "r91",
      "r92",
      "r116",
      "r159",
      "r160",
      "r312",
      "r353",
      "r354",
      "r355",
      "r356",
      "r381",
      "r390",
      "r391",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsDetailsNarrative",
      "http://relianceglobalgroup.com/role/SummarizesChangesToPreviouslyIssuedFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r1",
      "r77",
      "r78",
      "r79",
      "r80",
      "r81",
      "r82",
      "r83",
      "r84",
      "r85",
      "r87",
      "r88",
      "r89",
      "r90",
      "r91",
      "r92",
      "r116",
      "r159",
      "r160",
      "r312",
      "r353",
      "r354",
      "r355",
      "r356",
      "r381",
      "r390",
      "r391",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450"
     ],
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsDetailsNarrative",
      "http://relianceglobalgroup.com/role/SummarizesChangesToPreviouslyIssuedFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r1",
      "r77",
      "r79",
      "r80",
      "r81",
      "r82",
      "r83",
      "r84",
      "r85",
      "r87",
      "r88",
      "r90",
      "r91",
      "r116",
      "r159",
      "r160",
      "r312",
      "r353",
      "r354",
      "r355",
      "r356",
      "r381",
      "r390",
      "r391",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsDetailsNarrative",
      "http://relianceglobalgroup.com/role/SummarizesChangesToPreviouslyIssuedFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r86",
      "r92",
      "r196",
      "r292"
     ],
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r86",
      "r92",
      "r196",
      "r292",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r152",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts payable and other accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableOtherCurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Other payables"
       }
      }
     },
     "localname": "AccountsPayableOtherCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r153",
      "r154"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts receivable",
        "verboseLabel": "Earn-out liability"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets",
      "http://relianceglobalgroup.com/role/SummarizesChangesToPreviouslyIssuedFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableRelatedPartiesCurrent": {
     "auth_ref": [
      "r14",
      "r74",
      "r392",
      "r394"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer.",
        "label": "Accounts receivable, related parties"
       }
      }
     },
     "localname": "AccountsReceivableRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AcquisitionCosts": {
     "auth_ref": [
      "r413",
      "r414"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.",
        "label": "Acquisition Costs"
       }
      }
     },
     "localname": "AcquisitionCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r15",
      "r398"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid-in capital",
        "verboseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets",
      "http://relianceglobalgroup.com/role/SummarizesChangesToPreviouslyIssuedFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r77",
      "r78",
      "r79",
      "r301",
      "r302",
      "r303",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.",
        "label": "Share based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r216",
      "r252",
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Warrants sold during public offering at quoted price"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to reconcile net income (loss) to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r300"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r46",
      "r60",
      "r225",
      "r376"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r60",
      "r225",
      "r230",
      "r231",
      "r378"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of debt issuance costs and accretion of debt discount"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive shares"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionConsiderationTransferred": {
     "auth_ref": [
      "r337",
      "r338",
      "r339",
      "r340"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.",
        "label": "Asset Acquisition, Consideration Transferred"
       }
      }
     },
     "localname": "AssetAcquisitionConsiderationTransferred",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition."
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r9",
      "r73",
      "r138",
      "r141",
      "r147",
      "r157",
      "r203",
      "r204",
      "r205",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r343",
      "r345",
      "r368",
      "r396",
      "r398",
      "r417",
      "r426"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets [Default Label]",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r3",
      "r20",
      "r73",
      "r157",
      "r203",
      "r204",
      "r205",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r343",
      "r345",
      "r368",
      "r396",
      "r398"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Current asset",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Presentation and Principles of Consolidation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r290",
      "r293",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfImpairmentOfGoodwillDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical",
      "http://relianceglobalgroup.com/role/ScheduleOfProFormaInformationRelatedToAcquisitionDetails",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r290",
      "r293",
      "r315",
      "r316",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfImpairmentOfGoodwillDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical",
      "http://relianceglobalgroup.com/role/ScheduleOfProFormaInformationRelatedToAcquisitionDetails",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfProFormaInformationRelatedToAcquisitionDetails",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": {
     "auth_ref": [
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Earnings (Loss) per common share, basic"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfProFormaInformationRelatedToAcquisitionDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": {
     "auth_ref": [
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Earnings (Loss) per common share, diluted"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfProFormaInformationRelatedToAcquisitionDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "SCHEDULE OF PRO FORMA INFORMATION RELATED TO ACQUISITION"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total revenue reported by the acquired entity for its previous full fiscal year before the business acquisition.",
        "label": "Revenue from acquired entity"
       }
      }
     },
     "localname": "BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r313",
      "r314"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Net Income (Loss)"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfProFormaInformationRelatedToAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r313",
      "r314"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "verboseLabel": "Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfProFormaInformationRelatedToAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount": {
     "auth_ref": [
      "r325",
      "r326",
      "r327",
      "r329",
      "r330",
      "r335"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity.",
        "label": "Business combination bargain purchase gain recognized amount"
       }
      }
     },
     "localname": "BusinessCombinationBargainPurchaseGainRecognizedAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r328",
      "r331",
      "r334"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance \u2013 January 1"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r328",
      "r332"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Earn-out liability, current portion"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business combination, measurement input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r328",
      "r332"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Earn-out liability, less current portion"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r321",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "STRATEGIC INVESTMENTS AND BUSINESS COMBINATIONS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r317",
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Purchase consideration allocated"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r5",
      "r398",
      "r452",
      "r453"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://relianceglobalgroup.com/role/ScheduleOfRestrictedCashInStatementOfCashFlowDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets",
      "http://relianceglobalgroup.com/role/ScheduleOfRestrictedCashInStatementOfCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r63",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r56",
      "r62",
      "r68"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash and restricted cash at end of period",
        "periodStartLabel": "Cash and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r56",
      "r369"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r11",
      "r12",
      "r13",
      "r71",
      "r73",
      "r96",
      "r100",
      "r107",
      "r110",
      "r112",
      "r120",
      "r121",
      "r122",
      "r157",
      "r203",
      "r208",
      "r209",
      "r210",
      "r214",
      "r215",
      "r235",
      "r236",
      "r241",
      "r245",
      "r252",
      "r368",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover",
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative",
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Warrant exercise price"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
        "label": "Warrant issued"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of common stock warrant"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r193",
      "r194",
      "r195",
      "r201",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r77",
      "r78",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover",
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, at par value",
        "verboseLabel": "Common stock par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheetsParenthetical",
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheetsParenthetical",
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r13",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "verboseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheetsParenthetical",
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesSubscriptions": {
     "auth_ref": [
      "r13",
      "r233"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.",
        "label": "Common stock issuable"
       }
      }
     },
     "localname": "CommonStockSharesSubscriptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummarizesChangesToPreviouslyIssuedFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r13",
      "r398"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock, $0.086 par value; 2,000,000,000 shares authorized and 14,614,038 and 10,956,109 issued and outstanding as of June 30, 2022 and December 31, 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r129",
      "r130",
      "r151",
      "r365",
      "r366",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r129",
      "r130",
      "r151",
      "r365",
      "r366",
      "r451",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r129",
      "r130",
      "r151",
      "r365",
      "r366",
      "r451",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r129",
      "r130",
      "r151",
      "r365",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "LTC Global",
        "verboseLabel": "Concentration Risk, Percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r129",
      "r130",
      "r151",
      "r365",
      "r366",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "auth_ref": [
      "r65",
      "r66",
      "r67"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of preferred stock into common stock"
       }
      }
     },
     "localname": "ConversionOfStockAmountConverted1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "auth_ref": [
      "r65",
      "r66",
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Shares converted"
       }
      }
     },
     "localname": "ConversionOfStockSharesConverted1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "auth_ref": [
      "r65",
      "r66",
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Issued",
        "verboseLabel": "Shares converted"
       }
      }
     },
     "localname": "ConversionOfStockSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r128",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "auth_ref": [
      "r65",
      "r67"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of debt into equity"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r10",
      "r226",
      "r418",
      "r425"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Total"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r217",
      "r228",
      "r229",
      "r377",
      "r379",
      "r380"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r26",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r220",
      "r378"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedLabel": "Less: debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFairValueMeasurementsDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r60",
      "r183"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r60",
      "r137"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative",
      "http://relianceglobalgroup.com/role/ScheduleOfReconcilesWarrantCommitmentDetails",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r348"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "negatedLabel": "Recognition and change in fair value of warrant liability"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r33",
      "r347",
      "r349",
      "r350",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative",
      "http://relianceglobalgroup.com/role/ScheduleOfReconcilesWarrantCommitmentDetails",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilityMeasurementInput": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure derivative liability.",
        "label": "Derivative Liability, Measurement Input"
       }
      }
     },
     "localname": "DerivativeLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "SCHEDULE OF DISAGGREGATION REVENUE"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DueToRelatedPartiesNoncurrent": {
     "auth_ref": [
      "r28",
      "r74",
      "r206",
      "r208",
      "r209",
      "r213",
      "r214",
      "r215",
      "r392"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.",
        "label": "Loans payable, related parties, less current portion"
       }
      }
     },
     "localname": "DueToRelatedPartiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r42",
      "r82",
      "r83",
      "r85",
      "r86",
      "r87",
      "r93",
      "r96",
      "r110",
      "r111",
      "r112",
      "r116",
      "r117",
      "r355",
      "r356",
      "r421",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic earnings (loss) per share",
        "verboseLabel": "Earnings (loss) per common share - basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails",
      "http://relianceglobalgroup.com/role/StatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareBasicLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r42",
      "r82",
      "r83",
      "r85",
      "r86",
      "r87",
      "r96",
      "r110",
      "r111",
      "r112",
      "r116",
      "r117",
      "r355",
      "r356",
      "r421",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Diluted earnings (loss) per share",
        "verboseLabel": "Earnings (loss) per common share - diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails",
      "http://relianceglobalgroup.com/role/StatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "EARNINGS (LOSS) PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r37",
      "r38",
      "r39",
      "r77",
      "r78",
      "r79",
      "r81",
      "r88",
      "r91",
      "r119",
      "r158",
      "r252",
      "r259",
      "r301",
      "r302",
      "r303",
      "r311",
      "r312",
      "r354",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r391",
      "r441",
      "r442",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative",
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGain": {
     "auth_ref": [
      "r156"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain",
        "verboseLabel": "Unrealized gain"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedLoss": {
     "auth_ref": [
      "r156"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Unrealized losses"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfFairValueOfWarrantCommitmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfFairValueOfWarrantCommitmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "SCHEDULE OF EARN OUT LIABILITY"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r222",
      "r228",
      "r229",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r289",
      "r357",
      "r400",
      "r401",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFairValueMeasurementsDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r222",
      "r228",
      "r229",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r289",
      "r357",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFairValueMeasurementsDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r360",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "SCHEDULE OF FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r222",
      "r228",
      "r229",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r289",
      "r400",
      "r401",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFairValueMeasurementsDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": {
     "auth_ref": [
      "r360",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease": {
     "auth_ref": [
      "r360",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair value changes and accretion included in earnings"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r363",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Weighted average useful life",
        "verboseLabel": "Weighted average remaining amortization period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r7",
      "r179"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r180"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "2022 (remainder of year)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "SCHEDULE OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r180"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r180"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r180"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r175",
      "r176",
      "r179",
      "r181",
      "r411",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r179",
      "r412"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Gross carrying amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r175",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r179",
      "r411"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Net carrying amount",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAmortizationExpenseOfAcquiredIntangiblesAssetsDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r6",
      "r161",
      "r162",
      "r169",
      "r173",
      "r398",
      "r416"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, Ending Balance",
        "periodStartLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets",
      "http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsDetailsNarrative",
      "http://relianceglobalgroup.com/role/ScheduleOfImpairmentOfGoodwillDetails",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative",
      "http://relianceglobalgroup.com/role/SummarizesChangesToPreviouslyIssuedFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r163",
      "r173"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill acquired during period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfImpairmentOfGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "GOODWILL AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill [Member]"
       }
      }
     },
     "localname": "GoodwillMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r36",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount due to the reporting entity for good and services provided to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, member of their immediate families, affiliates, or other parties with the ability to exert significant influence.",
        "label": "Increase (Decrease) in Accounts Receivable, Related Parties",
        "negatedLabel": "Accounts receivable, related parties"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivableRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayable": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Increase (Decrease) in Other Accounts Payable",
        "verboseLabel": "Other payables"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.",
        "label": "Accounts payables and other accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other non-current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expense and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInRestructuringReserve": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the carrying amount (including both current and noncurrent portions of the accrual) of the liability pertaining to the exit from or disposal of business activities or restructuring pursuant to a duly authorized plan, excluding costs or losses pertaining to an entity newly acquired in a business combination and to asset retirement obligations.",
        "label": "Charge back reserve"
       }
      }
     },
     "localname": "IncreaseDecreaseInRestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": {
     "auth_ref": [
      "r105",
      "r106",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.",
        "label": "Effect of preferred stock"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r97",
      "r98",
      "r99",
      "r112",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Effect of stock awards"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r174",
      "r177"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangibles, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r55",
      "r57",
      "r64"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r432"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investment in NSURE, Inc."
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "SCHEDULE OF FUTURE MINIMUM LEASE PAYMENT"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r387"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total undiscounted operating lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r387"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r387"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r387"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r387"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r387"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r387"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r387"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: Imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r24",
      "r73",
      "r142",
      "r157",
      "r203",
      "r204",
      "r205",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r344",
      "r345",
      "r346",
      "r368",
      "r396",
      "r397"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r19",
      "r73",
      "r157",
      "r368",
      "r398",
      "r419",
      "r430"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and stockholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r4",
      "r25",
      "r73",
      "r157",
      "r203",
      "r204",
      "r205",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r344",
      "r345",
      "r346",
      "r368",
      "r396",
      "r397",
      "r398"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r10",
      "r221",
      "r227",
      "r228",
      "r229",
      "r418",
      "r427"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long term debt",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Current portion of long-term debt",
        "negatedLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets",
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r75",
      "r202",
      "r224"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r75",
      "r202",
      "r224"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r75",
      "r202",
      "r224"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r75",
      "r202",
      "r224"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r75",
      "r202",
      "r224"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "verboseLabel": "2022 (remainder of year)"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCumulativeMaturitiesOfLong-termLoansAndCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r10"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long term debt, less current portion",
        "verboseLabel": "Long term debt, excluding current maturities"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets",
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketingAndAdvertisingExpense": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising.",
        "label": "Marketing and advertising"
       }
      }
     },
     "localname": "MarketingAndAdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputCreditSpreadMember": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using amount above (below) yield between two debt instruments similar in maturity, but different in credit quality.",
        "label": "Measurement Input, Credit Spread [Member]"
       }
      }
     },
     "localname": "MeasurementInputCreditSpreadMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.",
        "label": "Measurement Input, Expected Dividend Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFairValueOfWarrantCommitmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input, Expected Term [Member]"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFairValueOfWarrantCommitmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfFairValueOfWarrantCommitmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFairValueOfWarrantCommitmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using share price of saleable stock.",
        "label": "Measurement Input, Share Price [Member]"
       }
      }
     },
     "localname": "MeasurementInputSharePriceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFairValueOfWarrantCommitmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfFairValueOfWarrantCommitmentDetails",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarnOutLiabilityDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfFairValueOfWarrantCommitmentDetails",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r56",
      "r58",
      "r61"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "negatedLabel": "Cash flows from operations activites",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r34",
      "r35",
      "r39",
      "r41",
      "r61",
      "r73",
      "r80",
      "r82",
      "r83",
      "r85",
      "r86",
      "r90",
      "r91",
      "r108",
      "r138",
      "r140",
      "r143",
      "r146",
      "r148",
      "r157",
      "r203",
      "r204",
      "r205",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r356",
      "r368",
      "r420",
      "r434"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://relianceglobalgroup.com/role/StatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net loss",
        "terseLabel": "Net income",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails",
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows",
      "http://relianceglobalgroup.com/role/StatementsOfOperations",
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r82",
      "r83",
      "r85",
      "r86",
      "r93",
      "r94",
      "r109",
      "r112",
      "r138",
      "r140",
      "r143",
      "r146",
      "r148"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net income (loss), numerator, basic computation"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r95",
      "r101",
      "r102",
      "r103",
      "r104",
      "r109",
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net income (loss), numerator, diluted computation"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recently Issued Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OffsettingAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Offsetting Assets [Line Items]"
       }
      }
     },
     "localname": "OffsettingAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfReconcilesWarrantCommitmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OffsettingAssetsTable": {
     "auth_ref": [
      "r31",
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.",
        "label": "Offsetting Assets [Table]"
       }
      }
     },
     "localname": "OffsettingAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfReconcilesWarrantCommitmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r138",
      "r140",
      "r143",
      "r146",
      "r148"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "negatedLabel": "Operating loss",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfOperations",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r383"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Present value of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFutureMinimumLeasePaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r383"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Current portion of leases payable"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r383"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Leases payable, less current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r382"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r386",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r385",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r8"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDeferredCostsNet": {
     "auth_ref": [
      "r8"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net amount of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs or deferred acquisition costs of insurance companies.",
        "label": "Net of deferred financing cost"
       }
      }
     },
     "localname": "OtherDeferredCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingExpense": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Expense",
        "negatedLabel": "Other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income (expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Payment of debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of stock issuance costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r48",
      "r333"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to acquire businesses gross"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Business acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Purchase of intangibles"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockConversionBasis": {
     "auth_ref": [
      "r12",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describe the conversion features of preferred stock if preferred stock is convertible. That is, shares of preferred stock into which another convertible security was converted, or shares of preferred stock into which another class of preferred stock was converted.",
        "label": "Stock conversion basis description"
       }
      }
     },
     "localname": "PreferredStockConversionBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockConvertibleConversionPrice": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share conversion price of preferred stock.",
        "label": "Preferred stock conversion price"
       }
      }
     },
     "localname": "PreferredStockConvertibleConversionPrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r12",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred stock, par value",
        "verboseLabel": "Preferred stock par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheetsParenthetical",
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred stock, shares authorized",
        "verboseLabel": "Preferred stock shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheetsParenthetical",
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r12",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred stock, shares issued",
        "verboseLabel": "Preferred stock shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheetsParenthetical",
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r12",
      "r398"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred stock, $0.086 par value; 750,000,000 shares authorized and 9,076 and 0 issued and outstanding as of June 30, 2022 and December 31, 2021, respectively"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid expense and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from issuance of debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.",
        "label": "Proceeds from loans payable, related parties"
       }
      }
     },
     "localname": "ProceedsFromRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds from exercise of warrants into common stock"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment [Member]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r184",
      "r398",
      "r423",
      "r431"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfOtherDebt": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for the payment of debt classified as other.",
        "label": "Repayments of Other Debt",
        "negatedLabel": "Principal repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfOtherDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.",
        "label": "Repayments of Related Party Debt",
        "negatedLabel": "Payments of loans payable, related parties"
       }
      }
     },
     "localname": "RepaymentsOfRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r5",
      "r62",
      "r68",
      "r415",
      "r428"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r5",
      "r62",
      "r68"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/ScheduleOfRestrictedCashInStatementOfCashFlowDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "totalLabel": "Total cash and restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfRestrictedCashInStatementOfCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r5",
      "r68"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://relianceglobalgroup.com/role/ScheduleOfRestrictedCashInStatementOfCashFlowDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets",
      "http://relianceglobalgroup.com/role/ScheduleOfRestrictedCashInStatementOfCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfImpairmentOfGoodwillDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r16",
      "r259",
      "r398",
      "r429",
      "r445",
      "r450"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit",
        "verboseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets",
      "http://relianceglobalgroup.com/role/SummarizesChangesToPreviouslyIssuedFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r77",
      "r78",
      "r79",
      "r81",
      "r88",
      "r91",
      "r158",
      "r301",
      "r302",
      "r303",
      "r311",
      "r312",
      "r354",
      "r441",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r135",
      "r136",
      "r139",
      "r144",
      "r145",
      "r149",
      "r150",
      "r151",
      "r269",
      "r270",
      "r410"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from contract with customer, excluding assessed tax"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r70",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r40",
      "r73",
      "r135",
      "r136",
      "r139",
      "r144",
      "r145",
      "r149",
      "r150",
      "r151",
      "r157",
      "r203",
      "r204",
      "r205",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r368",
      "r422"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "totalLabel": "Total revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalariesAndWages": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.",
        "label": "Salaries and wages"
       }
      }
     },
     "localname": "SalariesAndWages",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficitParenthetical",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r129",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r315",
      "r316",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfProFormaInformationRelatedToAcquisitionDetails",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r27",
      "r75",
      "r228",
      "r230",
      "r253",
      "r256",
      "r257",
      "r258",
      "r376",
      "r377",
      "r380",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "SCHEDULE OF LONG TERM DEBT"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": {
     "auth_ref": [
      "r275",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.",
        "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]"
       }
      }
     },
     "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r285",
      "r286",
      "r287",
      "r288",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFairValueMeasurementsDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfGainOrLossesRecognizedFairValueDetails",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "auth_ref": [
      "r96",
      "r100",
      "r110",
      "r112",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share.",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": {
     "auth_ref": [
      "r89",
      "r90",
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.",
        "label": "SUMMARIZES THE CHANGES TO THE PREVIOUSLY ISSUED FINANCIAL INFORMATION"
       }
      }
     },
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r175",
      "r178",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "SCHEDULE OF IMPAIRMENT OF GOODWILL"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "SCHEDULE OF CUMULATIVE MATURITIES OF LONG-TERM LOANS AND CREDIT FACILITIES"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfConcentrationsOfRevenuesDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "SCHEDULE OF ALLOCATION OF PURCHASE PRICE"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "auth_ref": [
      "r68",
      "r415",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfEarn-outLiabilityDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfImpairmentOfGoodwillDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetails",
      "http://relianceglobalgroup.com/role/ScheduleOfLongTermDebtDetailsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r11",
      "r12",
      "r13",
      "r71",
      "r120",
      "r121",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r238",
      "r239",
      "r241",
      "r245",
      "r250",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "SCHEDULE OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r127",
      "r129",
      "r130",
      "r131",
      "r365",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "SCHEDULE OF CONCENTRATIONS OF REVENUES"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [
      "r11",
      "r12",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A preferred stock.",
        "label": "Series A Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Stock compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement.",
        "label": "Vested stock awards"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options forfeited.",
        "label": "Non-vested stock awards"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options vested.",
        "label": "Vesting of stock award"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Share price per share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Beginning balance, shares",
        "periodStartLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBankLoansAndNotesPayable": {
     "auth_ref": [
      "r21",
      "r433"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.",
        "label": "Notes Payable"
       }
      }
     },
     "localname": "ShortTermBankLoansAndNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Long-termDebtAndShort-termFinancingsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r69",
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r11",
      "r12",
      "r13",
      "r71",
      "r73",
      "r96",
      "r100",
      "r107",
      "r110",
      "r112",
      "r120",
      "r121",
      "r122",
      "r157",
      "r203",
      "r208",
      "r209",
      "r210",
      "r214",
      "r215",
      "r235",
      "r236",
      "r241",
      "r245",
      "r252",
      "r368",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover",
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative",
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r30",
      "r37",
      "r38",
      "r39",
      "r77",
      "r78",
      "r79",
      "r81",
      "r88",
      "r91",
      "r119",
      "r158",
      "r252",
      "r259",
      "r301",
      "r302",
      "r303",
      "r311",
      "r312",
      "r354",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r391",
      "r441",
      "r442",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative",
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover",
      "http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsDetailsNarrative",
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit",
      "http://relianceglobalgroup.com/role/SummarizesChangesToPreviouslyIssuedFinancialInformationDetails",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r77",
      "r78",
      "r79",
      "r119",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Cover",
      "http://relianceglobalgroup.com/role/GoodwillAndOtherIntangibleAssetsDetailsNarrative",
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit",
      "http://relianceglobalgroup.com/role/SummarizesChangesToPreviouslyIssuedFinancialInformationDetails",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation": {
     "auth_ref": [
      "r295",
      "r304"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture"
       }
      }
     },
     "localname": "StockGrantedDuringPeriodValueSharebasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares issued for vested stock awards"
       }
      }
     },
     "localname": "StockGrantedDuringPeriodValueSharebasedCompensationGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r65",
      "r66",
      "r67"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Common stock issued in lieu of services"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r12",
      "r13",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Issuance of shares acquistions",
        "terseLabel": "Stock issued during period, shares, acquisitions",
        "verboseLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r29",
      "r223",
      "r252",
      "r253",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "verboseLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "auth_ref": [
      "r12",
      "r13",
      "r252",
      "r253",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).",
        "label": "Issuance of prefunded Series C Warrants in exchange for common shares, shares",
        "terseLabel": "Stock Issued During Period, Shares, Conversion of Units",
        "verboseLabel": "Number of shares converted"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EarningsLossPerShareDetailsNarrative",
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Shares, Issued for Services",
        "verboseLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r12",
      "r13",
      "r252",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Beginning balance, shares",
        "verboseLabel": "Number of shares issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.",
        "label": "Stock Issued During Period, Shares, Purchase of Assets",
        "verboseLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r30",
      "r252",
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Shares issued pursuant to acquisition of Kush"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r30",
      "r252",
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Shares issued due to conversion of preferred stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": {
     "auth_ref": [
      "r30",
      "r252",
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).",
        "label": "Issuance of prefunded Series C Warrants in exchange for common shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfUnits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
        "label": "Shares issued for services"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r12",
      "r13",
      "r252",
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Shares issued due to public offering, net of offering costs of $1,672,852",
        "verboseLabel": "Issuance of shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.",
        "label": "Shares issued pursuant to software purchase"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValuePurchaseOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r13",
      "r17",
      "r18",
      "r73",
      "r155",
      "r157",
      "r368",
      "r398"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' equity",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value",
        "totalLabel": "Total stockholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets",
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficit",
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 equity (deficit):"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r72",
      "r236",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r251",
      "r259",
      "r260",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/Equity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNoteSubscriptionsReceivable": {
     "auth_ref": [
      "r12",
      "r13",
      "r17",
      "r233"
     ],
     "calculation": {
      "http://relianceglobalgroup.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note received instead of cash as contribution to equity. The transaction may be a sale of capital stock or a contribution to paid-in capital.",
        "label": "Stockholders' Equity Note, Subscriptions Receivable",
        "negatedLabel": "Stock subscription receivable"
       }
      }
     },
     "localname": "StockholdersEquityNoteSubscriptionsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/EquityDetailsNarrative",
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficitParenthetical",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosure of cash and non-cash investing and financing transactions:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r270",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r270",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time."
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfDisaggregationRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfAllocationOfPurchasePriceDetails",
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfIntangibleAssetsAndWeighted-averageRemainingAmortizationPeriodDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/StrategicInvestmentsAndBusinessCombinationsDetailsNarrative",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r123",
      "r124",
      "r125",
      "r126",
      "r132",
      "r133",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/SummaryOfBusinessAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.",
        "label": "Risk free rate"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFairValueOfWarrantCommitmentDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Warrants and rights outstanding term",
        "verboseLabel": "Warrant term"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfFairValueOfWarrantCommitmentDetails",
      "http://relianceglobalgroup.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r95",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted average number of shares outstanding - Diluted",
        "verboseLabel": "Weighted average shares, as adjusted - denominator diluted computation"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails",
      "http://relianceglobalgroup.com/role/StatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r93",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted average number of shares outstanding - Basic",
        "verboseLabel": "Weighted average shares - denominator basic computation"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://relianceglobalgroup.com/role/ScheduleOfCalculationsOfBasicAndDilutedEpsDetails",
      "http://relianceglobalgroup.com/role/StatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2029-109256"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.23)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128088960&loc=d3e3913-113898"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126965701&loc=d3e15009-113911"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6387-128476"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6393-128476"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6396-128476"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6527-128477"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6571-128477"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(f)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6829253&loc=SL6831962-166255"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii))",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r459": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r460": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r461": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r462": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r463": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r464": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r465": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r466": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r467": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r468": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r469": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r470": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r471": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r472": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r473": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r474": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r475": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r476": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r477": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r478": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r479": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>71
<FILENAME>0001493152-22-022662-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-22-022662-xbrl.zip
M4$L#!!0    (  5<#U6K-7K+I@$  "H$   *    97@S+3$S+FAT;<U404^#
M,!2^F_@?GDWT) .R. UT)#!0EZ C&S'Q9!CK6)71"E6)O]YVK'/QL'CP( ?*
M>\WWO;ZOWP/?IG>Q=WR$;R,_E"NH!Z?C-(X\;':KW#6WVSB8A(\P2Q_C:(B6
MK!(.V!87D-(U:>">?,"4K;/JO$N<PXS4=(DD4$(3C1.D%496TJ)R(">5(+4+
MZZPN:&4(QAVP=N&<"<'6,H.\LVK><!>;R0&RFA8KH<$;% Z\J%W1.170[]E]
M; ;>88H_/<^OR?#X[@9FT]$0D;9OV/TGR[)[S[Q X,?I$"%-OB*J0P<N["O>
MNO!!%V+EP.#2XBWZGXUIFA/#@&M*RH4#25805SKC]8U4.9$&<F'"!655XT"<
M-0(,8VM$'(X?=/D?W ,N+WK.Z@6I=[F@S/(7L'L7TI -*^E"UD_]((Y@%,5Q
MXH?A^/YFB"RTB6>)/]+QML:6+V=EF?%&'DU_[:2V+>O4!65\HZ&?I'._*C/5
M'.^D%C3/2BV5U,:%?>U*LMP@0HW8H_Y6/PW5^$W52W4@5ZF%EF5/3%.IV2GV
MUS=OJEGOAE_]([X 4$L#!!0    (  5<#U6D:M<3+ @  %4^   *    97@S
M,2TQ+FAT;>U;;6_BN!;^CL1_\%;:52M!H>UVKU18)*!T!XD+%<VL=CZ:Q '?
MAC@3)U#VU]_GV E0^L;,=F9@1:66)O'+<^SCYSP^#O4/SG][C6*A_J'3O,8G
MHY^ZTW5ZG4:]8C_QM)(]KK<&UY_8G?.IU_G]R%=A<L7.JE'"'#D5FO7%G W5
ME(<E>Z/$[D0L_2-41-7;O-Z4QV,97K'J4>.7<*2C6KURNU%DVZ9K;-D8BBY_
M:RP1#TF9!W*,1[$<3Y*C1OUFT'?6.RC[?"J#Q=5;79BR6OXM+"*TU&IT'B9R
M))-BX>+L]*Q>:6&PJ/G&-S;%%6$BXO>T)9^!_42/F6AWAD[WIMMN.MU!OU@8
MW+#;8;??[MXV>ZSS5Z?]T>G^V6&#&Q3I#%FS?[W/LP5[E]85"S?=?A/_PU"8
MQ9KM]N!CW^GV_\BMW7=+/P[O/C;[3K'@#-A=ITT3S"ZJYS"/.1\Z>V[=77/8
M:O8[=^7!7[W.IV*AV7;(L/-J]?S[6?:_5"?27^PKH7P#^-U2L=#Y.^:L)1:F
MO"MBZH,E$YY<[:U9>SXK9Z?%0I=-^$RP6,RDF L/$R+84$0J3MA(R'#,?!D(
M;W]MW/,I.L<4M;C&Q*B031?L/E1SS,=8E#!34K//*8_!HL$",V@FS5-H/U0)
M<]$4ER'CX8*E81*G@NF$)V(*VF7*9QP6H:;D ?.YBULQ4U.9L$39<IL%BH50
MN$)K'B^HS)3?"^,LRT8U[GG A3X#TH;4"15P9>RF4Q0+41U0/!&S^42Z$Z93
M^K.J/Q>QR!HA"Z92!X)[Y(1SF4Q@H8X$ 4'WU' $<,J#H3/4\]AH88?$#L3^
M3OF>>^S%:QXK0"<A'(&<:C7Q)3@IBN-QO/9<AKZ*X8(2[<C0#5(/;<*YUB:Y
M!,^4Y/P1?(/\FOP]"):.6RQD/J,W^L;B\"2U7"*O2@,4@+<J>)3I3QM +M<3
MY@=JKG-7CL58ZB3FZ(G330L<,$MK#JES-"NXA./@E#\0_J]P2N?1!/X2Z\^I
MJNG,[3(]0ERC?%_BTDQME_%8&.*!4\A1(&BRF8#KC@*I)U2<BDU!M$2V=.U)
M[09*IZA'%!RKP'I3%"M7>+@-;SB&]W@"[FA=I//@3G@X%JP)'AZF 4P[N^#E
ML\MC<6+JGEUZ]LI>2A+.H75CVP%1X)I[6V\C-*_T5"P\ZLI_U)6/KLC43:]'
M"=(+_S;)YC1;O0YK=WJ]N]MF&YN]WX^J1^;ZMGE]G5]_L8ESZ243*EK]N<9&
M*D;H*[LJ"'BD 2C_[\ADB.K.\,L[F)';NCS(!RQ1T5&6;ZH[UU\-N'IZ?BG#
M;SCLSO5.HN0GKR)\QC5M(]OEZ]X/IR<T0 C/(C0RZFW:*9'$<WE*H7G+*B3T
M1H+EW67B3:4Q&D"PFTE-(=2B0%$1FL9H3[?2CNMA/!8!-[24*;@5LY2R$$\/
M):(Q &D52(\G!NU(2T_R6)(5T@I-(RQ":BG5I/T,CVN+A>2B";U*"Z!*$.JI
M9L1IM:0!)\F0LUNF(E'<BM(U>4%=V4T0(CHJK^^#X!_X,]R5I;NC:_4[P]J9
M!?H4Z\%9OBNLT?XR^::Z>U'</2'TK6N^R.LYC!6Y4U$$A)GTB*ZY5B$G&<PU
MJ)YV],3A/#:\;1D]D'PD YDL:-/T7-\48@SQ&DZU@>%1T=7&T,(QDOLA,RU*
MXPBLKLU6SW6AJ0P*DR 8BQ ;N #DCB<BHM!!1=(PL1R.$",C2-[#PMQI6#NS
M. \L_H-AN7O"XF+&@Y2D:B:%P6["]X6;R!DH23^3/UJF'[80X?9R(Z642U02
MXZ@([:QMXFJDTN0-&-OL%?BRM*#<G/]VQI6-\JR?"4;9F !4S<)!#X>EM,NP
M=F8Y'7CW!\/R]H1W,R++>7>#&NGD*TMWFB?/\N\7:&9*:RC736/B/M#D2O-N
MMFKA3)5.\)#><T"#&@Z8']>QXQ?0^*!S"-F-TAEZ%_QJ3^XV3_U.++@)U\N\
M"XE@P_W"RQ(T4-%F;#(-OV"!O!=!=IBW4:GTCX>K]C+?5TRVM;'_6>.]@7_Y
MU<<?YN6 Y3(KK6(\Z8YU!U^%>W+1-]PD/P\SF]@GN< E-IYZ,E&Q7FX9S0VT
M.9W*)!'B%5DU4MB4TG-/ J!IY!@+  )&DTK")V4ET7^Q8#3.YU3" +-2T] E
M,TX.9QR',X[#&<</B^V(1EDV"E@D.(G.'^DHTY4"))+MBY;'#'/![VF/8S-#
M9I=CLEOFO9;\7'\+:EH+^/8\@,?"XG@V<G(/M;58!LX7J2S+B:$*^ BKI&1W
M6QHCH-,I> *F&XLR\?+L>Q"'G=1^P-J9173821W.(;9CVW"1)=MCB*P2N$\8
M80CV-*_B931;LAL-&<Y4,!.TVPCY.'NE,,ZTI)A&@5H(/)U/E!60_!&)@W1?
MV9'E6[DM6?KT>^TQ#@+MGY%"Q#TZ)2J/5)*H*5H^O8R2[9U]:<=E]>?WG(IK
M2MM>6;3-=(PUR,XN2^R\>G[^ZLI]+W,NWM6:UN+J5=39].>@6P%W[RUT9EZW
M^ H#?OW/NUI0[S8JNF*!KWUCH%[I-@YA[ #K,2QR$ LD]Y*#A^PNK)T1.^V)
M%'Y&,0_"3>E\C W6\EZKN^T)E]A\A>SXUKX^ .WQI,[)OSO/"0-^*I?9C12!
M=\5N(?AJ:.!SBFTX5:RQ061>FK]B/8[P62[G4W_=_3-'9<TI8QD9DW+[EI'H
M-[KW5G2"I2N-M*Z)-C73XVCW5.QLB**G06A%&<\0P>-9"(1O:BS=?*WIU8#F
MCI$[1;V"P<G':6UT*S2\=@CK%?I:N/V>.'V=_/]02P,$%     @ !5P/50O!
M+TPU"   03\   H   !E>#,Q+3(N:'1M[5OO;^*X%OV.Q/_@5VE7K02%MMNW
M$K!(%.@.$@\JFMG=^6@2![P-,1,G,.Q?_\ZU$Z"4MLQL9P9V&6G:)O&/<^WK
M<X^OD]H[YW_=>CY7>]=NM/";T;^:TW&Z[7JM9'_C:2E]7+OIMSZP>^=#M_W+
MB:_"N,(NRM.8.7(B-.N).1NH"0\+]D:!W8M(^B>HB*IW6;T)CT8RK+#R2?W'
M<*BGU5KI;J/(KDU7V;(Q%%W^K[)8?(J+/) C/(KD:!R?U&NW_9ZSWD'1YQ,9
M+"JO=6'*:OF7L(C0TDV]_6DLAS+.YZXNSB]KI1L,%C5?_\JFN"*,1?26MF0S
M<)CH,1/-]L#IW'::#:?3[^5S_5MV-^CTFIV[1I>U_V@WWSN=W]JL?XLB[0%K
M]%J'/%NP=VE=/G?;Z37P-PR%6:S1;/;?]YQ.[]?,VD.W]/W@_GVCY^1S3I_=
MMYLTP>RJ? GSF/.N?>#6W3<&-XU>^[[8_Z/;_I#/-9H.&799+G]#/ODST;'T
M%X=**%\!?J>0S_TN@T#R">N*H9I)%Z5=$5%'+![SN'*PMAWXU%R<YW,=-N8S
MP2(QDV(N/$R(8 ,Q55',AD*&(^;+0'B':^.!3]$EINB&:TR,"MEDP1Y"-<=\
MC$0!,R4U^YCP"%0:+#"#9M(\A?9#%3,737$9,AXN6!+&42*8CGDL)N!>IGS&
M81%J2AXPG[NX%3$UD3&+E2VW62"?"X4KM.;1@LI,^(,PSK)L5..>!USH,R"!
M2)U0 5=&;C)!L1#5 <43$9N/I3MF.J$?J_IS$8FT$;)@(G4@N$=..)?Q&!;J
MJ2 @Z)X:G@*<\F#H#/4\-ES8(;$#<;A3?N >>_62QPK020A'(*=:37P!3HKB
M>!RM/9>AKR*XH$0[,G2#Q$.;<*ZU22[ ,R4Y_Q2^07Y-_AX$2\?-YU*?T1M]
M8W%XDEHND%<E 0K 6Q4\RO2G#2"7ZS'S S77F2M'8B1U'''TQ.FF!0Z8A36'
MU!F:%5S"<73*[PC_)SBE\V@"?XSTQT15=>IVJ1XAKE&^+W%IIK;#>"0,\< I
MY# 0--E,P'6'@=1C*D[%)B!:(ENZ]J1V Z43U",*CE1@O6D:*5=XN UO.(7W
M> +N:%VD_<D=\W D6 ,\/$@"F'9QQ8L7UZ?BS-2]N/;LE;V4I)Y#Z\:V Z+
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MFV2G868+^R03N,3&$T_&*M++#:.Y@38G$QG'0KP@JH8*6U)Z[DD -(V<8@%
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M/4ES@J/QG#8NR7^O.BALT[5)V$L_,M!!T,%<ZB!/:^>TA/W@'2;-Q$S[C'!
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M+N V0B KB EG0,M@GT+:Q+P\K1OZ$S)MLB?RSD1=9)I(.6@%<#:#WG8='BS
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MHZQ?8K^I+Y??7 $NX8Z^ %RH@ MEQT9FH51A?@]]?MTBY<YH,7@JI%\O#$0
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M6F1+(FP734J?8O/7 ENN%-E*>7.Z!J+:3J7B<=/DKBOLOX3-2]6PQ3<S&_:
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MYS91!69%;6M]<*491G/,?)3XJT_N1;O84NW-+V(@2BB'Y<0:]B=!_YT9P&7
MB1$*G-/L@A<\OHSH+4V7@.Y^HZ# B5O?0W"JLO2+B$X+K/>N16XJWT4&F.9.
M:;0)!8):-]R2TN-4$NT@6 D1K"41YE02[2!8"1&L)>'_ ]$6$6WV K[*1 Q,
MR:D92+(Q4,313T+55/"+Z&BJ>=(1^[("/VK(?6 05?!)U+2^J)+6!R11![K<
ML9\UY#& [Z(&ZRQMZGX>7"P2S=<5GL0I(W--[U4-F**L JDDZDB-&1$Y"GF:
M)05F@?\JC&#-8<\<N+A.Z=:6V73P=27SPGJ@WH%Z::7>P=>5/%\7R]D1<,Z-
M@/,L-1M-[VD*/"T-*PC>E.O-L2%EZ'QI:.;KW7C\8-A^_ 1HN6@D19IWA#&6
MP5!P]N"UJ+=[!$N3!%K'+'&"#[BV!8*_1TC:L*4X5O+TB];(9/#Z'NWVM$/3
M,$5<QX9([\>NJ%":&^/*]?E8R(X^UDE6V)PFP2+ L]28-K'RQDTG!HQFGP(F
MFEN-$>(K6N%D(Y'R^]] !G4,0C"GCN*6@OG,IP#I$_O._H7J*[<=]>63 EF]
MJU_V3N6KJ_(ZM9:)UET15UY2\*8HD!EZ==K>OHMORK179$F; K2W,MQJ</M]
MY_]"]<7$JKX"I(O*_)5R607/A2K8B18+Z*3EUP@S[IOPQ*@\ E(_<Z!^6E1W
M/.T7,Z0@,"3#AP1UVT1&=AX?RF16QH>^B\0&R4]?7V1C"BC1#"ED69*GU@]6
MK".?<V&F[R(,4<I"Z*LQ2PJ9+,D(PM9,S$.@*IG>Y@/U#M1+*_4.@:KD!:JH
MLN=J'J3C-;Z^%T0#2.@:#E1#1 _A<_!F@'XT:@ >A 8\ :!)^B&W@5515@-M
MK:OB$9OC<JYT0;]<7[[6.]&&N2R8 /@=.#]X$$\FN/O]GSI, #XT@-"!S.N0
M>6=%?]^+S*'K$V.<^]*[Q9:T\:*,.L[-J.-/6"I>SPN=8TF:7=EG+UEG<%#)
MR^X,U'(O)"\6F0IE-!WNP<DQ9@_4.U OK=0[W(,3> _>#(0?&.U.K?^>N1WO
M.P;_%#C4QD#9\>1;GHF]2O_&?"I20@KPX1<8VI%G6#*;-B1*@"D=N@/TX:Z\
M#IFY YFW0>:=.=@BF/NZE;*)7U NQ<P(W2KF<+U-IHUZH-Z!>FFEWN%ZF\#K
M+1L0ZCW?MIRVR(';'+>[NEA\O#SM?0B[QWD7)U.#=UKB<FCT=K_=4V=TYG9V
MA9IX#K)!8:6GI#&V$J>;T]IKKU@OO72S.T-Y]ZYT34=!Q.5,'"DP">XD%QK-
M> <4]D%W9W:.[OZ]M%T2K]B[$.%8PO9<CLSN*Q9W+HG^@"U*3EB9R(0%PC^X
M)9)_MSA0[T"]M%+OX)9(H%N"7PP)7OY\-VF1$6I,3%!(\_.=Q?X^&-J!S27A
M$)G="ID/D=FMD#F)U\:@<]\\,KOS8G1A,5AQ7.2- H1VP=T[KLIODLGR9"ZW
MNO![GBR[[O$6@IQ)H%>D]U)GA-6 S6L]G#Y0_S56NL\@]7M$AH.\'.3E("\'
M>4DX&=8%=/I.M#F0(1(R^*.#"R'0P4O-\>B#+U:'?/6Y'8]';!42^,50!01+
M^0.!QX/^M$96";<<9+(4:\E)IMJ01^/AQ>79.CDD:Q(@6DS<>*M-:)+F0^-Y
MAU4M<<E<&'BQ</';0%AB47$N2@SNI+%LH9H0MJ,F?/+,\E>E<D'1SJ5.Q&T
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M*\54FY+<[!L>^3_OR@-Y7'R[Y;AMG2B>F>,MT,9S1VXHS]Z 5YY/:P&$8J]
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M6L4!G[=&G%6$V+% P.$!QK'+-;/H8A*2^"?-75U7A#<.S;HD0_-0ZZJRX[:
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M:*6%$>^'>ON:EC\Z(TG\\;N,:QL?G+2_25VKAPK['?1(S?2OP =0CH]H#(E
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M,Z,_A^G"&Z*9YI*"IQW&.?GMY=M'.FTN[+3]PS_%M<LWJ LV2S&9?%GMQ!P
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MDKQO"Q<L181H( TQY;*=#4A8SG3=+G2%+/=4!L/O^E51'Q]U4"]#.(QU,A#
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MB$UHG%*2%SB2YOW2>!*X:7!.J\^>,?-&I]_(YTX-=EM*=BZ]-CT"&"I!W1%
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M%H#[ HX]P"RSB0Q7Y5#8%5&/X$WD83 ]NG=2:++6A#Q"DEH(KN^)#E&7O];
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MCRX,\S,&8J49ZV !#-4! "&5LTD^ ,(75[D5[^JG=R4Y70@(2TO3=UM%3KO
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M^3[@E^##4+B[JMR!QZEJ>HJ!9=6NSCT^FK'R2<+/?8*[K$T.3OCJ(?RP)WX
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MB_@38:#"/__U-^$%U[3D2#.]H,-M&Z_5^B)>A 5 ;.%>XFE9UK9M#4CDK [
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M,JOVQO2B$$$(A =G 9\E\'>)O^"7MT>K\.&F6#G(09RC.N94D2QDBR25]XJ
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MI*N7,M_EKUY$[I9)A"K1HRUYEH(P,GX+7LL$C-^.Z?1' C^3A.; 6&F8S)6
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MR&PF1U*1\+L.X$YKS=3^B-,.ZT.CC\2'9A+#?>6X>GP7![0T>;_<P7-F3QB
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MV:_X.<;3P1T[VUP96$5&;[:Y8H-WVPCQ5GU;R84;=5R>L^4,G1KLG[3C9?4
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M]\>-&&(,9=JQ_6,>V!PR9-L(.O/3-B+>MA&%G[81R7)X?)4Y/Z'^GU#_=[%
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M29B,-).FFLU,4F3P*"!1G]-&Q$!2%A#C %"3Z_<1:8826("L8)J?GO3M1X6
M]7[@0:!8> B,X$X+1 /9$P%0FNHY40>SP0%?,"$)VVI@>R$I1!DH"@Z6C_14
MY0.GAXDR#]A,1=P 23>3<<$AV)\2Y(_^"+VJ\PQ8.%"&Q!1P&1H4_A>1KB<(
M@ (V=D)O2N9<SHF& KD&?Q_M+-S6H3@79+RE>BJ7,5=P#N"6*NKIB6L'72,;
MO#9 63K?+0DL-=/',A^6 )Z!_3H]<5P,OJ70C\]@Q-A<@'3-F0G&!>@6F(F7
MMX&C;7CS;:4VY[>?L]%*NTI/)2)256:Z'!3C$I2].D2^9L@)73"AGK'Y?S5"
MT#G0PEL#MV0)"QU1[DM @L^Q*.GW9^,9$) "DL>J@(2)D1QM)9;"(FQ1X4]/
M_*H#UF1PVE/[8A_)E0KH3B LO:VFXC.W^*P]%K.2*U6P6FHWSIH/7:)>*UW4
MZK7NBSM!\#ND"R;?G\_T1ET4W\R+Y85NSY3ZGS,1FS&E+U%[,R0+O'@**C1S
M.HHT0_9,<U SK(@2M%26]7KY#O'_VVJ4J;X^S]NWI>?X^P&6RYV0SKE#=#^T
MJ,N&I^ZEHDX!C_G3\Z[Z4GBJ7BUJC6'\!-6_G@JB7H8G:@?(_M%"T, :99CC
M!FX')H'+:.DUN6\0^'4L3!]%X4KICN(GL/[U5!"X$I[ )0F8+J)V(<C"0)QJ
MX'K__[/WI4V-(\O:WXG@/^C..^=&]T482]ZGYTR$,?MFL-F_3,A2V1;(DM%B
M8W[]FUE56KR!3=M@@>Z)<VX#DBJK*BO7)[/0ZU%,UXDL;+:T?4D,]6SWJ+CX
MA>44Q&)AT[,O[-'YL>>TRZ96=AP+9*Y+HBMJZ%;I,JVIVU=+6%$<.!;+*<^^
MG-O8W-9?O<J3?*::F?Q37OV=U?OC'_K5F"S5RV5%?Z[5U,K3#5D\S]!<^6)6
M8F+6+).?6#M+QA@ C)0&=HD$!@ABC2Z*)5WC09A(EJT.LNEN7SO;;6>RF>5B
MRC,%, 1W6<$&=T'&?86/A);GIB#+9^MR6LR\<L?BS CNSYWIJRF^=_#3Q/2?
MM"G)FQF)"Z)_W[#RWEM6G)-R8F8&Q&NR,U-W9@Y3\=VWNL(NE?)OMQ!+=FGJ
M+LU@;[YW=THE62SFDS/T&[OSFM'Z[HX)8KZ(C6G?AI7%9&-F5;"OW)\1DYE^
M) N^E[TR8E&"_\Z _OK-NK2=,$1?84'K'8]<6A&'Q?GWI7?GY&KGY&XO+2T0
ME3C;;26<*D'S:#9/B1"V='CKK&?BW1=M?#[MV72,:7_%V%]YVE^YCF'E:<^L
M(.W3+Q2:)M=>ZS\59D-](R(2JI'RQ0+X^87<NRWN=%I,I]]N /M%%G,1S;P6
MLV23=: T60?Z)0K_OMBG\D-Z+^?TNDLJ]'B7*ORH*H_WW'+Z7:B94E4P=E1\
M7II/YBS%^9]RSW!&SHNES'N*VG_&>Y$7ZKM/6=QB5LP6WE.!M/2U7:WCM%K4
M+)+O%GJ]>U:2Q.R[.@F\6@*4GJP']Q3=IOW2R_3:*ZX3L_7><5K:SYXZ*W.!
MWXA^; +=O"A("2F/?R7;K&9Z+K?@&]]BO6BS'>5)O#Z?.EE2*B4CB_EW7!F1
M[.NB]O4#$C&9@EC(3NH9_=WW>%:!5TP$WL<?C&5D5S*9K)A?5F.(.._JK";I
M[V_K[\6[IABNN=F"./-6M,=Y1Y>TH8N(N65R6;&4?]MM75Q[EDQQ&7BJW7]?
M5./@[C+[M'=]45QN!&_TLKQA:-508<9;R[CJO0AFU,KY5[(%W^LNS(_)/'^,
M/Y++%L22/']SDF2'%[[#'^&9R'FQD-QMNPJ[O4RH6;HH9DK)+J_ +B_#J9+%
MM)P5,S/D>)(-7OH&1]RK=ZO@=WI3R6XN;#???3N<F,D5Q.P,Z-'%-<V*38'W
MY$X&2;&T^_'%TB?5\^YU.;N;/9>3:NE%5$L_>XU[^_2I4!D82;7T,JJE[9ZQ
MD]=OGMW37%(MO<AJZ7TG_U+:3CO-)RVIEEY(M73FK'9O=R_5@?KXK:NE7VJU
MHG)Z=-"NE)=0-K[T$N#,Z(VPDIR1%E "W.UD*PUE^U#VWG._S^PEP-GTVR7
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M-&.U<3JBBP)3J:JNA50CS4AY*K;;'W/NO8$MLJA4)\B<"ABB(%<<O:D3[#)
M-UT@9DMI,:X(:Z X8^A^S <G\$A<$3_3!_L,_[\%3]@!RSD$=MUV4D+5LX$2
MT$,":![7$EJVU5]?B["9T!@@9SH>#@HS55HM8$8'2(M>6@@+@'2W@(UU\%I
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MLW*>AV=C9?J>H%D>V(@SV7AS?H7S<9!SF&D>[^?C&99AAA'GX^-E?. 5E@L
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M,U,TY!$_A_AG)I=[!ST*@JL-@V9!Z?(Y%!>!>S>&+7))Q_%3L$"VQP?.Y^;
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M-ZH;;A3S7PU%[V 30]UO74MHRUV0SI[I_P1*Q]9IBIW[Z1:ZE=B"2 6QS J
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M34Y@:TDN=(K54ABU6LHIFKD6]GAQ7MSG^WF[]FFKU2>(\OL+%)[=48P_HI?
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M+76IJE55S(K$BRB3[3/>H=E78W6"PT:'<[I+D5)R)6*<@?KU$DNMC.>47J7
MM@$"60V1XS%D^0T>J6D/=$2>,C.EIQSPRXB>/\DX'.]JD5!^@^!+:(:1T.I7
M1I^VR]X=2O+=G6- =TTL&TS+T2B[&#"3UB*(:=RYJC*/L[242OWM.HMG(;>
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M:'GF)VS)%V1)TC D_K=7?P%02P,$%     @ !5P/57( \'&5%   RM0  !$
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M[8#V/9=S_&%L\2WE4K<0$,@@0#RZHJ8UB4=3U8SO61.GLG9O2RZ'<"7?B7M
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M;6'E]H%;4Y]IY#]5<%B,0)[%T@J\E"43OS7M+LC_QIQ'9U[X ,-C\RN1W-G
MIGQIQT2>Y\3\JY,GE_==R)(%#5;C"EO0?1<R)OOT8!3<QB9>K8P-=-^%C$G
M9ZU@^4QII6FZ,_*;7Q7Y_C)ZU0]^_@=02P,$%     @ !5P/52P^+CZ>%0
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M3-6UE>$XT\KECTY"I233O[2&_>@&B#5>Q G!'OAW5N4,_?T/"B/'B.#(+^\
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MFJ>FA,+!JD('LI7B(T*OGHU!";\AEQQ%LCAPU24T,7D?5&/.R%:="FYR9(W
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MRD$X&O6<?L%>Y(<6B4-N"; V"INV0/Q%%(-B;]1)FH:5[TZNY!UMGO2+>[0
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M^N_)WZ-@E:&%ZTD!6FOT5I'XZ3(>#Y#4W]=L\8N?3Y,5>G%C59:_ZL_%%;,
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M!*U/K7BKR Y76>0"5D  *COW*]ULF*,->ZYCA<@9^&&<!P;?].'6[=$AN&R
M&XYJ3'C735[[YN_\0N'R<=#KXE\?%%H>Y77!U>AA/5@_>7B#4.H:"6;8BV)'
M]7#8YQXNXHX*+ 02:P"79:'N70P XGZV)</P$K>." %.C\9+>926O8AX4.HU
MBYV]HL)>[["\/GY&Q%HBZ14@T[7Q -720$AS 2'RL69$9C@*5]]1$"+B9P+8
M_)A$Q)XS-WV;_]";_ @/O^J.3UEF()A^K1FF&TS"M>6;?A 1MGRWMD+1JA'V
M:S[$LC0FDCR YL^W-6.11MQN=U3&#-5@Z$U+M%+$'1\NFWZ)J30:LDR <'RH
M&0Z66L$5^[Y!\Q$QI<5[3"PHQD\UBY%Y<):L/)C +;5K\_!6@;NDG# +Z 7O
M9I<URS/./Q$GV6QI:SJ=J;0L<]2"DGQ?K\6AA%T[C;:ZH5QNGQ?]ZH:K?A2$
MF*I=@Q?;BYSTM3GZ?V=NO<!6[@J#T;MDTQI.Y0B?ZNQ!P&<X5QZ%1UFR$>,J
M5JW'BY1;[CM[[][R O'ZXU%_,)I/XSB\&?LDC<53_M1>%XS7!>.!:H)>I8H.
MEB6K5'BU.:Z-G0>7VZD]QGL9;D 8M0%,IF@[MY,:)[^,U 4X%13*U<BE7S=0
M6MK\SP&FIK5_MGI8CG)1_1]!1T7>?YG5A,ORH?]N>;6Y0KZ]6EOD6^DS[JCG
MCW#0%0I#HS"W/,E;@DOOI+F>VIQ[Q2"(L"L6A-8G8&W@M>PLK -@34_%F>6Q
M:L;Q77Z$X,(2VZVKJ+DN)R"TI+ <"V?=/ -D_[S$SZ\=Y":PT!_V:-!?'H9H
M:7FQU7 #G&RT5:Y1>PZQ(NK!]=",R!-2P,V,-CELT?")PY$8!B@\[R%2MT2U
M/ 9*2[W1>*?AO'\;&VJYCI"C5DUOT-"TQ%P*Z]X,P"AD%Q-*VV=D>2'?SUG4
MM/&'GR2$"=();@=UN^:\"/4)#@+VPVSE(@]^8BMV?4'M&R]"*"%=/K&0B-7Y
M[')ZT80>ZO0#:XDN2ZCLF5X/EXJ>UBIOV1>SH;&S+5I3[=7] P7]E>4O43#'
M$X*>71P%WL8,@@@YN]"IC$BX'KAW.0_<_=V=,37_.9CUYI\'O?YG8W3+?A['
MOTZF@R_F^'XV_+UGSF;W[ D2<V2,^J8Q[)FCF_'T+JF:H=A!-PNM,#['<].A
MX,I2T%;176M+B<CW=M1.&T<;+/;C.U8AIUI6MIBB8$LLG.J2:Z3NVE4L60R3
MVHQ-5U[*O(R)@F;-YZQ $BR4L5X9*E7%K.5%K!H43=K9!&C,J.)!S_/,(3Y%
M3YB$"%:.:3=1+P5I*?!\QZ7(UFTK,IQ_14'(+:A[- F/.JBH;R$#AHAD$ AE
MCC[#CI]O9)4;D1M7<ARA$*Z2F';C]7KX1<V=15I)$A(O<5-I%B26[/S=C15(
M )!M"^V%?T!H,_M2J2O\>HW]68CM;[.515 PBQX#F[A/<? E[Q+/ZZ<]*!+D
MG]5)4VGC<IQ8>I8WL5S']/O6DQM:G"4"=- >'![=9_7C5(M;#RU6,975/W7]
M94#WVF@=>2PPG]52M5W.H2+NJSU6DBR MDM-3&&;\6+W;H#OS-RE[U+B+:K4
MV-O'GB?8H^SLPM!'+*>"58XNMH:]+[:&_<Z"SZ_N9^9H,)OUC-%U;V;>CLP;
MLV^,YCVCWQ_?C^;FZ+8W&0_-OID)4._MOK +5>]"U;M0]2Y4O0M5[T+5VPZ4
MEN; +E3]]%!U16[<^F/5N256]-DPNVCU+EI=MZ.OBU;OHM7_U-'JNAR"IX2K
M<\^_1FN&WEG_PF1[7'.JA1:U:\^9!C#0C-U3@,#(6E-&#LCC.?\YS9N/M> (
M%<M0W- QU! "6AXT)Z/4:'S\]JOYE0\/&JDH-BF>TIA++BA.A1Z7("2N'2)6
MX'J5U+E>#?X=N<_T "M^)W7GK.#W?&BZ@EME6ZT4)Q!TRI2J^)'-0!QKD6W6
M'DSR9&MG9]V^SN@B,0KYMNV! J"];C, <#)\Q>2;ZR]3MW7B!J4:>-'CVZP]
MU+P%XA:2WXS:6BHR'MO?5MBC5 1LO^0]B9YOVP)(^+1#>%1]"?=D/,9/\6OK
M<0E2JGD,<< YOPL:MP<1B'@(D@_U;DKLH>IE*A2J+L1I/Z:_>PQ[O/C*X@O\
M_0.^P&Y5>IP6(%2=+PB\CZK6TPB%,BOIH%D+$ +)A@#X12$ 3!>GO#V[#G*N
M-O<!<DQ_M_H-.W2?8\V$BX[D&*V"K@Q/$*Z?ZMT5*564(ALA)V#55">$7J!"
M-/$L.S96L%1(%CDV7B11HG1G2+>!(O38B-4'; &4-3 (X?IKS:GWUH91$\SQ
MO>^X01S#AYPI8@*ADXU%*XZCHLM/G.0NU;DE>)5@!KRNZN-I.SW!7'_49+D
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M-IN;HRUX]V@'P1:/1QL[;"X?,DOT8>H-L<4OG]#D#%\ )M52>G-%+]7(NW2
M1MA=#Z@4AC6M,\%4+ E@#JNWN#0N" 8R3ODC@]?C3%< &$\DT(;<(#(-)Q(B
MYI\0]7WY.N[[(BCB4%%"A:Q+@FCA=HDB%?0^OMF@&W*&?89PI5'Q!A&/Q.^!
M@&/099SL2V48M%+:)XL&D'4\JD3!,JF/3]C?Y)\"9M,O.-X^$8BS%S+D;O'M
MGB;)6FZ$*%R=GQIIPR7S)A6OR\=1!L"P= IJ(?=M90,%W A*F14Z@Q<OQ*%S
MQ&Q!Y7/5$6W#_4=; <!I4Q$M6*TR 9W7!MR',KLRK^/V*6-GIN;\^>"TV<B0
M%F?1N@SR4C=KU^ 4)F)X&Z=TV$2/ ?D@Q&= $EC8>A'/?L+*$_CMZ[:DL>S8
M$L;P#NV=,K/H/_<%>^NLN,\4V2;KE0F.YMDSW;]@!U6LPRSK['ZDQQ1QB=<X
M?XE#>GF85%]GWTU1?\Z^W6WZ4:=5VD]GZN2KP0R[;LLK/OI,+),>34S3-P,;
MV]X[-2L<O]-ZN<^)V^$E8KOFM_@+^T09CVNGZSRYH&UQA+F'21$,F<>@E5*Q
M3CZ#HCU&989V^\<D#LGL<8.I.78(1^>2]1\(:8N2I:7^'^_/_O!/'\[^^/L/
M4+G+"SB1O((R /8J"F1!WX$F=/[*X;Z=&9*N6\Y"/G+0461"K^ZK R"ELE"V
M7K6K"YV8*L!ZW[K;Y\6>GA(3!QNTRM2+_F5?/$&E:Y5J93)?9?H "*LNEK4C
M]4;9%YP_9@4V;DJ, .[,JRIB<70]K0K6**Z^XCR,"^%@:(H!9S$XDPK6Q-^,
MTO;N-B=#%IXTK#ZGOI$LK>@5M%D=9..8@;S''$)!I07?'#04S41"A3IH%NHQ
MCZ+AFYAFSK.4#!;T=N]R\Y#&Y92YIL0&@/%;7SS;6:=@P#M[#T$MI  JZ(0S
M9/S=$;+MTXC,0RLFSU'=#6@\(_Y:Q39NLIQN2;%GKD#SFW?E PFN- * X88"
M6D]3WQS'];!/0G)8SOPC12SI]ZQB'H<;TA]S=2#F='/..\ !A1:ZP@1;L#K%
M] +H]R H\5]P4=:9H%% IC/12:?4DJ)P3/9L/M28VXGV(07NS[FG6/+.XZ/
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M"!*G*(GQG@5PX?PE#@\/0C!N9718WO*[3MA YH?9IB3+8>E#:A.,>-CL&%E
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MVB-^=W&/KF=S*,]1= [+!EFB:1A/.$NCRSC9EZ-W+$=:\W1H.J7(BO/2,:8
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M&+IED'5W,<P M[V"I!!TPX8?.1M2^B0VUMQ"TH,4;H-Q<53-AE!D'F9/>0I
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M1Q5O^B(NZ2(#UWO8J/,Y&')(0 DOJA(1=C.*T.+1V]M1'9RZQZ-$,3C/!=B
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MW<TGID-O'3$M,+>+JB-VAN[&<!%((>LA,$(.5Q+XT!<$0R4=.B$BA_&E81"
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M/UM^]=OON9/**[YOG9Z_'+]/*V9HU=EN=[B730VD8L[F7AJ0PXRG71GOA#(
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MTH%E6FVDZ%RS3AA8FYF1"BU5J2!ZE:#:5/+M6N_PKBF(A1_5B\-J(2NLXO6
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MALD^8H'B(4L"0._L\E?B9!QQBP 0SSP57$C40 R?<;;^O^JN*+=1&(A>90Y
M/_8(52-6D;)IM<KVGQ:W0@H0T82VMU^/;<!@&S!0V?ZI4H=Y&?/&V(P],Q(^
M;K U/PW\$G0$#1K[$EPGT'B&(V@U@T8U0-V *Q>B\;<]VF4?E_(C.?^NRMN%
M2K!X: R'OI%4N$@'J0U<_+X'DZ/3;O^<V7>FW:@$3"<F*6L%G5K.EL.#VSRX
MN?=TYJNJ;]H75J9$OT*V@O#H>;M4<W6=UC<&I%FUB@>^_>EWB@_WSP2S3KKT
M'LU%CH:/IMS2 QO<[Y1IK!!'EWI\@&LK J^ \8"I+;17<G8U5:@D,'9N7L!!
M#R]JB]8Z*2C<SXR\(V_9:X8I794A9KK0 Q+GZ3>1[AG25L3Q0)3SD-%7K;BL
M\D0$O(\-O!$QC^8K&VV- TL2CO!M%)@X"'E7B3#*XOU$JAR]3G^2JPB%D9U:
M3U5&7Y OR?DOR9.L2#''5DR74LD9\\'KN%V+Z1'QFW5%2;1!@>\0F?G[(A#@
MW[CJ%3CH&N1(@%#^&\B^.)*OZ^F3G&O"ZS>LM X5,$S3&.G'?+M &X#'(H '
MQ;Y 74^?Y6KZ!4ZHK _5MR2;B@9#-E:GVX9N1 J:\%X';"E'X5!(C^F-WH1S
M! J9\I[^EHRCK/^$W[]=2<6ZFM5KQWD/*TS:]5V8SWR"\H)_BN L<I&?-N=[
M8/RHQY%H=X8,EWK$WI2&:DBB<ER%'<!TM?\AA:FS\%<YKOV7=L=B5,(C9F8J
MJBGI*:5L8()-]*\(#79$%<^)V.6-B.MCUB\8JZ-K6LHCRBR4'=(FLGYVLA'$
MSW?'?00= "!"R(6+/?$>SE%1DW[,)..F%!+)2;K+\&A&H=9.[W_MRWTW:*5.
M,?)ESB;Y*JLIVS5!CC$9XV/1M1FG^PDACYY5\W55^6FNBM@32>2J!#KCR%^Y
M6Q0<,"Z$M,/U@ <XVGV7YHCG[D;&W"UV$![QNE1S917.<"(I1(Y!23M8$49R
MO!# TK[N72\VW39Z76Q!0N5]W->RB'F7'AB+KAN=+Y88@3(_[G)90KQ+1XQ-
MQTT.&$N,4'D?=;@LXMV= V9NQZ>];TN  K2 F7XW2S/PPQLW]QZLX3] RC=B
MV4=2_Q6IJ->$&3]>\7Q)CO]9,VP""H7N2?V7<"^# D<%#JNQ!;GI0#_1YJ:)
M_GFAV+3E/U!+ P04    "  %7 ]5^8IB3+Q0   12 4 %0   ')E;&DM,C R
M,C V,S!?<')E+GAM;.U]77/C.++E^T;L?]#V1FST/%1W5_7TS/3<F=V09=FE
M.[*DD>2NV_>E@R8AB5,4J>&'R^Y?OP!)211)  F24$(NW=CM<=D B#PG 202
MB<3?_M_+UNL]DS!R __OW[S_[H=O>L2W \?UUW__YG'QKK\8C$;?]*+8\AW+
M"WSR]V_\X)O_]W__Y__HT?_[V_]Z]ZYWYQ+/^6OO-K#?C?Q5\!^]B;4E?^W=
M$Y^$5AR$_]'[Q?(2]IO@SO5(V!L$VYU'8D+_D'WXK[V?OGO_TU/OW3M N[\0
MWPG"Q_GHT.XFCG?17[___LN7+]_YP;/U)0@_1]_9P1;6X"*VXB0ZM/;#RP_Y
M_V75_^:Y_N>_LO\\61'I4;S\Z*\OD?OW;]AW\\]^^?&[(%Q__^&'']Y__U\/
MXX6](5OKG>LSW&SRS;X6:Z6NWON??_[Y^_2O^Z*5DB]/H;?_QH_?[[MS:)G^
MU164+_0D<O\:I=T;![85I[1+/]/CEF#_>K<O]H[]ZMW[#^]^?/_=2^1\LP<_
M13 ,/#(GJQ[[7\K>X:LA\5S6M;47/%G>.@R2'>/N>U;N^T% =9-V.FUA$Y+5
MW[]AY>F'/GSXX4\__L ^\[]/"L6O.ZJCD<M4[)O>]^V[<&-Y[&^+#2%Q).M*
M;6&]79I9(?'C#8E=V_*4^E=;L_/.LN%%MO1#T70UW;$I@>J<%$AQ+:V=7,2!
M_7D3> Z=G(;_3MSX]9:L7-N-5?HL;01'!"5E:=ZB5N$&5K2Y\X(O2CI4J=1]
M%Y/MU@I?IZN;)')]$D5]WUFX:]^E,%E^W+?M(/%CNJ[. H\"1^3=;]J@!O3I
M^"-KUQ[YSR2*4TAI9_;]HNOYD^M#Q[5R4YV+<Q\$SA?7\^AWIU1SPY%/U\:U
M^^21?A0!)GEH_<X[/@[\];N8A-M;\A0S;=@$89S^XHZ"YMM4%Z2=5VFC<P$^
M66%(57?L6D^NY\: 0<"OT7GGLFE-UJ'34MUWP@I]1L$XB*(9"1<;.KU*NR2H
MT[T.$FKHR;7LI%3GG:#3Q-8]3!Z#()T&Z;X%H%" JOA+@[8E0O]2H=JCI47G
MS>X%/6T6<T4$"MBTP;.OCC!YU%I!62EA@JBW=)8U =9Y>4U-ZP,0VYJRYUPK
M8+T$-]#]+&-OB)-X9+J:TSDA=.V8.&PC,_(/6YOCSN:6Q);KR2>:%FUJ%/#.
M<L/4 3==Y2;?$79ER10:T\J9'5 MH0K27B)X6^?@Z(&.VR3,MM;-R1&THE$(
M-B5.D\.&XE6Y_Y(&-';]WG+]:<CF<A(QA:#FS^_$.>"I+(E:>QH%NW4C:[T.
MR3HU<.;DF?@-Q(&THE$(NC#85)5S3R4;LFD'U <(L"%-ICM5@6BPH;8:7=V"
M64B>W2")O-=1%"54-S*3Q_+8^4FX37L(E:^3UO'W*WF')FP:CMUGZ>:\LP]H
M5-V^Y^5G0=/5+ GM#37+9M0T4!^#T)8T"C,+@SNF/04EFA./FC;.,NC;_T[<
MR%51VY;M8NX\E56U?=,:>1UM=W1ERNS3_>Y2F41 (SI%*&V"*;B?B+O>4!UZ
M9SV3T%K3UK=T5:;307]+]YGN[RG<=.OF!HZZL%U^3N?T4_CV\&5'_(C]D@VI
MD#A'(:),"O4YJ4WS9W>OJ [:INUIY).Y3):YQR3_O-JYHW)+YQ6F5?_/88DF
MV\1+R7ZPXB1,3TVROJ1^JW%@^:DG@ZJ_&]]9=GZPHFZH=O(=%-^?ZBAKT^89
M3M%4Q8&WH.F43;7#XEHZQY+EV:F2IUNQ&RMR;4K_K>LE=!4=[AH,&K4&S^),
M5F9#H0V=_JB$SCKD@=HOVV2;^I)GUFLSAR&P)4W><N792%A+L_/L7=#6>R9J
M0=3Y74@BRDDZ=L;T%R=5R$M,?(<X^X98SQO$&,9NS.KE$:#O>^]8N&C"5('^
MF)7,^[3O%=WPGG0DW0 'I:#%?8AJ&CP9$?N[=?#\O4/<[QE,[(<4KQ0K^H_?
MT@_UGR*Z(;,/$6.>]42\M/W?:)E2D>];]VIE14]I7&<2O5M;UB[K&O'B:/^;
M8Q_S7_QV.#)(#T)J.IH7+)<K][;(;#\\[;D5VON&Z8\GM%;#4?,2W^]2*_&=
MO7&]@T:LPF#+@R__8"#L=1 Z)/S[-^]_^ $=;ZK^9$1_C "8%\HBX\[!50Q^
MH?LY 1\,(&#@6=$^+++_XD)XJ%:Y1#JJ4AR&!18IQ2[=!LRAP6>CKJQA-/!4
MJ\1(G20Y%7A,!-MMX*==>B#;I^.R6D-$M:B,A\/PU\0 7X_*T//$+.A((P*J
MEM-\.![]MB AW:+U\UU;Q(66%>:4!6+[(QZV@LYW ZZB#;:W^Y:TQ7H3[+0$
M$&%= /--@SW E1ZCP-JGWW=8'^X\:UV/:ZD($-CWJ,C6BH4%[2V)[-#=,8 D
M")^4Q)Y_U8"N$1)IAIB3M1OEY_4'&<13!J<*]BRM-(D(Q4:BHN_[B>7-R2X(
M)0R<E@0"_T<C@*\3$@GO?R96&)/0>X5 7BD,1/TG(U#GB(IEE5 #*0LX@"!?
M+0V$_D]&0,\3%@G[Q89X'KO$;OD@O:\K#\3_ST;@SQ?8  :&S\P8H-+ 22A4
M ?+P%^-XJ(B-1$46+$+%" $D5 H#X?_9"/@YHJ("/_0=*.R'HN -E4&HE^1$
MPOS.C6S+RWIT1W]7Y_8M=+VF.!1[W-VL5%Y4_'\E5@A&OU 8BCWN!E<BZYF1
M'R1A>-(9X83#+PW%'G=K*Y/VS. /_=B-7UG2I$G"<?G28M524+!QM[,\Z5!
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M>M^=*EIM:>:\ 3O86.&:/%GVYSE%+GPF?))8>7YQ] S2<";$@I@YJE(E41U
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M"[36E[/& 7 P-RWPP(HV=U[PA?,B]I^;[(18F[VT4:.R_1Y$5=K7U-1"NRO
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M\[@838:+1:\_N>TM1O>3T=UHT)\L>_W!8/HX68XF][W9E-H"H^$"YXF2JI2
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MBT>6C7PTZ4\&H_ZX-YK<3></V>7:JV^_"XN?:E":D47FR"^5,\/45/?:E\3
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ML?YZ\EB?)33ZPO-8]_W8==@>D.Y=CA'WPQ?;2^BVBT7\LCC") .W9EU\K6]
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MRZ8!   J!   "@              @ $     97@S+3$S+FAT;5!+ 0(4 Q0
M   (  5<#U6D:M<3+ @  %4^   *              "  <X!  !E>#,Q+3$N
M:'1M4$L! A0#%     @ !5P/50O!+TPU"   03\   H              ( !
M(@H  &5X,S$M,BYH=&U02P$"% ,4    "  %7 ]56OCFXHL$  !O(@  "@
M            @ %_$@  97@S,BTQ+FAT;5!+ 0(4 Q0    (  5<#U66T;Z3
MC)<! 'QU%0 ,              "  3(7  !F;W)M,3 M<2YH=&U02P$"% ,4
M    "  %7 ]5<@#P<944  #*U   $0              @ 'HK@$ <F5L:2TR
M,#(R,#8S,"YX<V102P$"% ,4    "  %7 ]5+#XN/IX5   ?"0$ %0
M        @ &LPP$ <F5L:2TR,#(R,#8S,%]C86PN>&UL4$L! A0#%     @
M!5P/511#2/>@/@  H0,$ !4              ( !?=D! ')E;&DM,C R,C V
M,S!?9&5F+GAM;%!+ 0(4 Q0    (  5<#U6DD_W<$G4  "%>!@ 5
M      "  5 8 @!R96QI+3(P,C(P-C,P7VQA8BYX;6Q02P$"% ,4    "  %
M7 ]5^8IB3+Q0   12 4 %0              @ &5C0( <F5L:2TR,#(R,#8S
?,%]P<F4N>&UL4$L%!@     *  H 90(  (3> @    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
